(this["webpackJsonpgraph-notes"]=this["webpackJsonpgraph-notes"]||[]).push([[0],{11:function(e,i,r){e.exports={wrapper:"Landing_wrapper__2kTiL",header:"Landing_header__3yUAp",subheader:"Landing_subheader__3PLEM",notes__wrapper:"Landing_notes__wrapper__3HX6d",notes__item:"Landing_notes__item__2rtMi"}},16:function(e,i,r){e.exports={button:"AddButton_button__2O-ji"}},17:function(e,i,r){e.exports={button:"NavigationButton_button__3Sx8C"}},18:function(e,i,r){e.exports={wrapper:"Document_wrapper__-t_2E"}},28:function(e,i,r){},29:function(e,i,r){"use strict";r.r(i);var t=r(1),n=r.n(t),h=r(14),a=r.n(h),l=r(12),c=r(3),d=r(5),o=r(15),s=r.n(o),x=r(2),y=r(4),v=r.n(y),u=r(10),m=r(16),L=r.n(m),p=r(0),f=function(e){return Object(p.jsxs)("button",{className:L.a.button,onClick:function(){return e.onClickHandler((function(e){return!e}))},children:[console.log(e.showContent),e.showContent?Object(p.jsx)(u.b,{}):Object(p.jsx)(u.a,{})]})};function g(e){return 0===e?v.a.text__hierarchy_0:1===e?v.a.text__hierarchy_1:2===e?v.a.text__hierarchy_2:3===e?v.a.text__hierarchy_3:void 0}function b(e){if(e<4)return!0}function w(e,i,r){var t=parseInt(i.slice(0,2));if(console.log("current:",t,"total: ",i),2===i.length)return function(e,i,r){return e.children[i].text=r,e}(e,t,r);var n=i.slice(2);return w(e.children[t],n,r),e}var C=function(e){var i,r=Object(t.useState)(!!e.expandable&&2!==e.hierarchyLevel),n=Object(c.a)(r,2),h=n[0],a=n[1],l=Object(t.useState)(e.text),d=Object(c.a)(l,2),o=d[0],y=d[1],u=Object(t.useRef)(),m=Object(x.h)(),L=Object(t.useRef)(!0);return Object(t.useEffect)((function(){if(!L.current){var i=setTimeout((function(){var i;if(console.log("Setting index"),null===(i=e.object)||void 0===i?void 0:i.index){var r=JSON.parse(localStorage.getItem(m.documentId));localStorage.setItem(m.documentId,JSON.stringify(w(r,e.object.index,o)))}}),2e3);return function(){return clearTimeout(i)}}L.current=!1}),[o]),0===e.text.trim().length?Object(p.jsx)(p.Fragment,{}):Object(p.jsxs)("div",{className:b(e.hierarchyLevel)?"":v.a.container,children:[!b(e.hierarchyLevel)&&Object(p.jsx)("div",{className:v.a.document__toggle,children:Object(p.jsx)("div",{className:v.a.icon__wrapper,onClick:function(){return a((function(e){return!e}))},children:Object(p.jsx)("svg",{viewBox:"0 0 100 100",className:"".concat(v.a.document__toggle_icon," ").concat(h?v.a.toggle__open:v.a.toggle__closed),children:Object(p.jsx)("polygon",{points:"5.9,88.2 50,11.8 94.1,88.2 "})})})}),Object(p.jsxs)("div",{className:e.mindMapMode?v.a.text__wrapper_mindmap:v.a.text__wrapper_document,children:[Object(p.jsx)("div",{className:"".concat(e.mindMapMode?v.a.text__card_mindmap:v.a.text__card_document," ").concat((i=e.hierarchyLevel,1===i?v.a.text__card__hierarchy_1:2===i?v.a.text__card__hierarchy_2:3===i?v.a.text__card__hierarchy_3:void 0)),children:Object(p.jsxs)("div",{className:"".concat(e.mindMapMode?v.a.text_mindmap:v.a.text_document," ").concat(e.expandable&&v.a.text_expandable," ").concat(!e.mindMapMode&&g(e.hierarchyLevel),"\n            "),children:[b(e.hierarchyLevel)&&Object(p.jsx)(f,{showContent:h,onClickHandler:a}),Object(p.jsx)(s.a,{html:o,className:v.a.text__input,innerRef:u,onChange:function(e){y(e.target.value)}})]})}),h&&Object(p.jsx)("div",{style:{display:"flex",flexFlow:"column"},children:e.children})]})]})},T=n.a.memo(C),D=(r(28),function(e){return Object(p.jsx)("div",{children:Object(p.jsx)("input",{type:"file",name:"filename",onChange:function(i){return e.submitHandler(i.target.files[0])}})})}),P=function e(i,r){var t,n;return i.hierarchyLevel<1?(console.log("root text",i.text,i.hierarchyLevel),Object(p.jsx)(T,{mindMapMode:r,expandable:!0,text:i.text,object:i,hierarchyLevel:i.hierarchyLevel,children:i.children.map((function(i){return e(i,r)}))})):0!==(null===i||void 0===i||null===(t=i.children)||void 0===t?void 0:t.length)&&(null===i||void 0===i||null===(n=i.children)||void 0===n?void 0:n.length)?Object(p.jsx)(T,{mindMapMode:r,expandable:!0,text:i.text,object:i,hierarchyLevel:i.hierarchyLevel,children:i.children.map((function(i){return e(i,r)}))}):Object(p.jsx)(T,{mindMapMode:r,expandable:!1,text:i.text,object:i,hierarchyLevel:i.hierarchyLevel})};function A(e){return Array.from(e.childNodes).reduce((function(e,i){return i.nodeType===Node.TEXT_NODE?e+" "+i.nodeValue:"a"===i.localName?e+" "+i.text:e}),"")}function I(e,i){var r=arguments.length>2&&void 0!==arguments[2]?arguments[2]:"";if(0===e.children[e.children.length-1].children.length){var t=e.children.length-1+1,n=r+t.toString().padStart(2,"0");return H(e,Object(d.a)(Object(d.a)({},i),{},{index:n}))}var h=e.children.length-1,a=r+h.toString().padStart(2,"0");return I(e.children[e.children.length-1],i,a)}function k(e,i){var r=arguments.length>2&&void 0!==arguments[2]?arguments[2]:"";if(0===e.children.length)return H(e,Object(d.a)(Object(d.a)({},i),{},{index:r+"00"}));var t=e.children.length-1,n=r+t.toString().padStart(2,"0");return k(e.children[e.children.length-1],i,n)}function S(e,i,r){var t=arguments.length>3&&void 0!==arguments[3]?arguments[3]:"";if(1===r){var n=e.children.length-1+1,h=t+n.toString().padStart(2,"0");return H(e,Object(d.a)(Object(d.a)({},i),{},{index:h}))}var a=e.children.length-1,l=t+a.toString().padStart(2,"0");return S(e.children[e.children.length-1],i,r-1,l)}function H(e,i){return e.children.push(i),e}var M=r(7),R=r(17),E=r.n(R),O=function(e){return Object(p.jsx)("div",{className:E.a.button,children:e.children})},N=function(){return Object(p.jsxs)("div",{style:{marginTop:"2rem",backgroundColor:"white",padding:"2rem",maxWidth:"1000px",minWidth:"1000px",borderRadius:"1rem"},children:[Object(p.jsx)("div",{style:{display:"flex",flexFlow:"row",justifyContent:"flex-start",marginBottom:"2rem"},children:Object(p.jsx)(M.b,{to:"/graph-notes/",children:Object(p.jsx)(O,{children:"< Back"})})}),Object(p.jsx)(x.a,{})]})},V={cnb:{text:"Circulation and Breathing",hierarchyLevel:0,children:[{text:"Introduction",hierarchyLevel:1,children:[{text:" [002] Process at Membranes",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Define a carrier and a channel, and give examples.",hierarchyLevel:4,children:[],index:"00000000"},{text:" Explain why most cells have a negative plasma membrane restingvoltage",hierarchyLevel:4,children:[],index:"00000001"},{text:" Predict what will happen to the resting voltage of a typical cellwhen the potassium concentration in the extracellular fluid rises (as happens,for instance during haemolysis and during kidney",hierarchyLevel:4,children:[],index:"00000002"},{text:" failure)",hierarchyLevel:4,children:[],index:"00000003"},{text:" Define ionotropic cell surface receptor and give an example",hierarchyLevel:4,children:[],index:"00000004"},{text:" Define metabotropic cell surface receptor and give an example",hierarchyLevel:4,children:[],index:"00000005"}],index:"000000"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Membrane Transport",hierarchyLevel:4,children:[{text:" Driving forces  electrochemical equilibrium",hierarchyLevel:5,children:[{text:" Chemical driving forces  concentration gradient of ions acrossmembranes",hierarchyLevel:6,children:[],index:"000001000000"},{text:" Electrical driving forces  charge gradient across membranes",hierarchyLevel:6,children:[],index:"000001000001"}],index:"0000010000"},{text:" Types",hierarchyLevel:5,children:[{text:" Passive Transport",hierarchyLevel:6,children:[{text:" Simple Diffusion",hierarchyLevel:7,children:[],index:"00000100010000"},{text:" Facilitated Diffusion  channel proteins, carrier proteins",hierarchyLevel:7,children:[],index:"00000100010001"}],index:"000001000100"},{text:" Active Transport",hierarchyLevel:6,children:[{text:" Primary Active Transport",hierarchyLevel:7,children:[],index:"00000100010100"},{text:" Secondary Active Transport",hierarchyLevel:7,children:[],index:"00000100010101"}],index:"000001000101"}],index:"0000010001"}],index:"00000100"},{text:" Simple Diffusion",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Diffusion is the result of the movement of molecules due tothermal motion",hierarchyLevel:6,children:[],index:"000001010000"}],index:"0000010100"},{text:" Factors affecting Rate of Simple Diffusion",hierarchyLevel:5,children:[{text:" Magnitude of Driving Force (electrochemical equilibrium)",hierarchyLevel:6,children:[],index:"000001010100"},{text:" Membrane Surface Area",hierarchyLevel:6,children:[],index:"000001010101"},{text:" Membrane Permeability",hierarchyLevel:6,children:[],index:"000001010102"}],index:"0000010101"},{text:" Factors affecting Membrane Permeability",hierarchyLevel:5,children:[{text:" Lipid solubility of diffusion substance (phospholipid bilayer)",hierarchyLevel:6,children:[],index:"000001010200"},{text:" Size and shape of diffusing substance",hierarchyLevel:6,children:[],index:"000001010201"},{text:" Temperature",hierarchyLevel:6,children:[],index:"000001010202"},{text:" Membrane thickness",hierarchyLevel:6,children:[],index:"000001010203"}],index:"0000010102"}],index:"00000101"},{text:" Facilitated Diffusion",hierarchyLevel:4,children:[{text:" Purpose ",hierarchyLevel:5,children:[{text:" Required when the membrane permeability is very low, and hencerate of simple diffusion is very low",hierarchyLevel:6,children:[],index:"000001020000"}],index:"0000010200"},{text:" Driving Force",hierarchyLevel:5,children:[{text:" Chemical force (concentration)",hierarchyLevel:6,children:[],index:"000001020100"},{text:" Electrochemical force (charge)",hierarchyLevel:6,children:[],index:"000001020101"}],index:"0000010201"},{text:" Components",hierarchyLevel:5,children:[{text:" Carrier proteins",hierarchyLevel:6,children:[],index:"000001020200"},{text:" Channel proteins / Ion channels",hierarchyLevel:6,children:[],index:"000001020201"}],index:"0000010202"}],index:"00000102"},{text:" Active Transport",hierarchyLevel:4,children:[{text:" Driving Force",hierarchyLevel:5,children:[{text:" Use energy to transport molecules across the membrane againstconcentration gradient",hierarchyLevel:6,children:[],index:"000001030000"}],index:"0000010300"}],index:"00000103"}],index:"000001"},{text:" Carriers",hierarchyLevel:3,children:[{text:" Properties",hierarchyLevel:4,children:[{text:" Slower than channel proteins  1000 molecules / seconds",hierarchyLevel:5,children:[],index:"0000020000"},{text:" Very selective on the molecules that is able to transport",hierarchyLevel:5,children:[],index:"0000020001"},{text:" Reversable and saturable",hierarchyLevel:5,children:[],index:"0000020002"}],index:"00000200"},{text:" Location",hierarchyLevel:4,children:[{text:" Integrated into the plasma membrane (integral membrane proteins)",hierarchyLevel:5,children:[],index:"0000020100"}],index:"00000201"},{text:" Structure",hierarchyLevel:4,children:[{text:" Formed from a single polypeptide with 12 transmembrane \u03b1helices",hierarchyLevel:5,children:[],index:"0000020200"}],index:"00000202"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" Molecules will move down the concentration gradient",hierarchyLevel:5,children:[],index:"0000020300"}],index:"00000203"},{text:" Types",hierarchyLevel:4,children:[{text:" Uniporter  transport only one molecular species",hierarchyLevel:5,children:[],index:"0000020400"},{text:" Cotransporter  coupled transport of 2 different molecularspecies",hierarchyLevel:5,children:[],index:"0000020401"},{text:" Symporter  coupled transport of 2 different molecular species inthe same direction ",hierarchyLevel:5,children:[],index:"0000020402"},{text:" Antiporter - coupled transport of 2 different molecular speciesin the opposite direction",hierarchyLevel:5,children:[],index:"0000020403"}],index:"00000204"},{text:" Examples",hierarchyLevel:4,children:[{text:" Glucose uniporter (GLUT1, GLUT2)",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Glucose binds to the carrier proteins, causing it to change itsshape",hierarchyLevel:7,children:[],index:"00000205000000"},{text:" The energy from the binding is used to flip the transporter",hierarchyLevel:7,children:[],index:"00000205000001"},{text:" The transporter releases glucose (ligand/subtrate), this causes achange in shape again, causing it to switch back",hierarchyLevel:7,children:[],index:"00000205000002"}],index:"000002050000"},{text:" Properties",hierarchyLevel:6,children:[{text:" Can only open on one side at once",hierarchyLevel:7,children:[],index:"00000205000100"}],index:"000002050001"},{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"00000205000200"}],index:"000002050002"}],index:"0000020500"},{text:" Na - glucose symporter (SGLT1)",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Movement of Na provides energy to move glucose intothe cell",hierarchyLevel:7,children:[],index:"00000205010000"}],index:"000002050100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"000002050101"}],index:"0000020501"},{text:" Band 3 Protein (HCO  / Cl )",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" CO  is taken into the red blood cell, converted intoHCO  . Band 3 Protein enables the movement of HCO back into the blood plasma for transport",hierarchyLevel:7,children:[],index:"00000205020000"},{text:" HCO  moves back into the red blood cell,converted into CO  and moves out of the red blood cell at the lungsto be exhaled",hierarchyLevel:7,children:[],index:"00000205020001"}],index:"000002050200"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" HCO  binds to the protein, causes theshape to change, opening out on the other side, releasing the HCO out of the cell",hierarchyLevel:7,children:[],index:"00000205020100"},{text:" Cl  binds from the outside, causes the shape tochange, opening out on the inside, releasing Cl  into the cell",hierarchyLevel:7,children:[],index:"00000205020101"}],index:"000002050201"},{text:" Random Info",hierarchyLevel:6,children:[{text:" Band 3 protein binds to spectrin keeps the red blood cell itconcave shape",hierarchyLevel:7,children:[],index:"00000205020200"}],index:"000002050202"},{text:" Location",hierarchyLevel:6,children:[{text:" Red blood cells",hierarchyLevel:7,children:[],index:"00000205020300"}],index:"000002050203"}],index:"0000020502"}],index:"00000205"}],index:"000002"},{text:" Ion Channels",hierarchyLevel:3,children:[{text:" Properties",hierarchyLevel:4,children:[{text:" Narrow and hence highly selective ",hierarchyLevel:5,children:[],index:"0000030000"},{text:" Voltage-gated / Ligand-gated - able to open and close dependingon the triggers",hierarchyLevel:5,children:[],index:"0000030001"},{text:" Much faster than carrier proteins (100 million ions / second)",hierarchyLevel:5,children:[],index:"0000030002"},{text:" Always passive - cannot couple to energy source to perform activetransport",hierarchyLevel:5,children:[],index:"0000030003"}],index:"00000300"},{text:" Prevalence",hierarchyLevel:4,children:[{text:" In all animal cells",hierarchyLevel:5,children:[],index:"0000030100"}],index:"00000301"},{text:" Specificity Size Problem",hierarchyLevel:4,children:[{text:" Ion channels that have larger pores to allow large molecules toenter will also allow smaller molecules to enter",hierarchyLevel:5,children:[],index:"0000030200"},{text:" Hence, there is a built-in filters within the ion channels toprevent unwanted smaller molecules to enter",hierarchyLevel:5,children:[],index:"0000030201"}],index:"00000302"},{text:" Mechanisms",hierarchyLevel:4,children:[{text:" Voltage-gated Channel Mechanism",hierarchyLevel:5,children:[{text:" When the voltage reaches the threshold potential, the voltage-gatedion channel will open",hierarchyLevel:6,children:[],index:"000003030000"},{text:" An inactivating mechanism would cause the voltage gated ionchannel to close again",hierarchyLevel:6,children:[],index:"000003030001"},{text:" A decrease in the membrane potential would cause the voltagegated ion channel to close again",hierarchyLevel:6,children:[],index:"000003030002"}],index:"0000030300"},{text:" Ligand-gated Channel Mechanism",hierarchyLevel:5,children:[{text:" ATP can bind on the intracellular side of the ligand-gatedchannel, causing the channel to open",hierarchyLevel:6,children:[],index:"000003030100"}],index:"0000030301"}],index:"00000303"}],index:"000003"},{text:" Active Transport Pumps",hierarchyLevel:3,children:[{text:" Mechanism Types",hierarchyLevel:4,children:[{text:" Primary active transport  uses energy source (ATP) to directlytransport molecules",hierarchyLevel:5,children:[],index:"0000040000"},{text:" Secondary active transport  uses energy of a concentration orelectrochemical gradient created by primary active transport",hierarchyLevel:5,children:[],index:"0000040001"}],index:"00000400"},{text:" Pump Types",hierarchyLevel:4,children:[{text:" Uniporter",hierarchyLevel:5,children:[],index:"0000040100"},{text:" Antiporter",hierarchyLevel:5,children:[],index:"0000040101"}],index:"00000401"},{text:" Examples",hierarchyLevel:4,children:[{text:" Brief Examples",hierarchyLevel:5,children:[],index:"0000040200"},{text:" Sodium Potassium Pump (primary active transport)",hierarchyLevel:5,children:[{text:" Properties",hierarchyLevel:6,children:[{text:" Slow  100 cycles / seconds",hierarchyLevel:7,children:[],index:"00000402010000"},{text:" Utilizes 25% of energy of most cells",hierarchyLevel:7,children:[],index:"00000402010001"}],index:"000004020100"},{text:" Purpose",hierarchyLevel:6,children:[{text:" Pumps 3 Na  ions out of the cell and 2 K ions into the cell",hierarchyLevel:7,children:[],index:"00000402010100"},{text:" Maintains Na  and K  cell membranegradients\ufffd\ufffd\ufffd\ufffd ",hierarchyLevel:7,children:[],index:"00000402010101"}],index:"000004020101"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Phosphorylation causes the sodium potassium pump to change itsshape",hierarchyLevel:7,children:[],index:"00000402010200"},{text:" The shape change expels Na  to the outside, andextracellular K  binds",hierarchyLevel:7,children:[],index:"00000402010201"},{text:" K  binding triggers release of phosphate group",hierarchyLevel:7,children:[],index:"00000402010202"},{text:" Loss of phosphate restores the original conformation of the pumpprotein",hierarchyLevel:7,children:[],index:"00000402010203"},{text:" K  is released and Na  sites are ready tobind to Na  again and the cycle repeats",hierarchyLevel:7,children:[],index:"00000402010204"}],index:"000004020102"},{text:" Diagram",hierarchyLevel:6,children:[],index:"000004020103"},{text:" Drugs - Ouabain",hierarchyLevel:6,children:[{text:" Mechanism",hierarchyLevel:7,children:[{text:" Ouabain blocks the Na  and K  pump",hierarchyLevel:8,children:[],index:"0000040201040000"},{text:" This leads to the accumulation of ions within the cell,increasing the osmolarity of the cell",hierarchyLevel:8,children:[],index:"0000040201040001"},{text:" This causes water to move in via osmosis",hierarchyLevel:8,children:[],index:"0000040201040002"},{text:" Influx of water causes cell lysis",hierarchyLevel:8,children:[],index:"0000040201040003"}],index:"00000402010400"},{text:" Diagram",hierarchyLevel:7,children:[],index:"00000402010401"}],index:"000004020104"}],index:"0000040201"},{text:" Na  - Glucose Transporter (SGLT) [symporter]",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Sodium potassium pumps out Na  ions from the apicalside of the epithelial cell",hierarchyLevel:7,children:[],index:"00000402020000"},{text:" This causes the concentration of Na  ions in the cellto decrease and the concentration of K  ions in the cell to increase",hierarchyLevel:7,children:[],index:"00000402020001"},{text:" Decrease of Na  concentration in the cell causes Na ions from the gut lumen to move into the cell via facilitated diffusion throughthe SGLT symporter. The energy released from the movement of Na ions is used to cotransport glucose into the cell",hierarchyLevel:7,children:[],index:"00000402020002"},{text:" The influx of glucose results in the concentration of glucosewithin the cell to be higher than the concentration of glucose at theextracellular fluid. ",hierarchyLevel:7,children:[],index:"00000402020003"},{text:" Glucose moves out of the cells at the apical end via GLUT2, aglucose uniporter",hierarchyLevel:7,children:[],index:"00000402020004"}],index:"000004020200"},{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"00000402020100"}],index:"000004020201"}],index:"0000040202"}],index:"00000402"}],index:"000004"},{text:" Membrane Resting Potential",hierarchyLevel:3,children:[{text:" Channel States at Resting Potential",hierarchyLevel:4,children:[{text:" Permeable (leaky channels)  K",hierarchyLevel:5,children:[],index:"0000050000"},{text:" Not Permeable  ",hierarchyLevel:5,children:[],index:"0000050001"}],index:"00000500"},{text:" Leak Channels",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" K  will continuously move out of the cell down theconcentration gradient",hierarchyLevel:6,children:[],index:"000005010000"},{text:" This causes the K  concentration to continuouslydecrease",hierarchyLevel:6,children:[],index:"000005010001"},{text:" This causes the increase in negativity of the cell",hierarchyLevel:6,children:[],index:"000005010002"},{text:" Na  - K  pump increases the concentrationof K  within the cell again and further increases the negativity ofthe cell (3:2)",hierarchyLevel:6,children:[],index:"000005010003"}],index:"0000050100"},{text:" Driving Forces",hierarchyLevel:5,children:[],index:"0000050101"},{text:" Properties",hierarchyLevel:5,children:[{text:" A small (relative) number of ions are required to cross themembrane to set up a membrane potential ",hierarchyLevel:6,children:[],index:"000005010200"}],index:"0000050102"}],index:"00000501"},{text:" Resting Membrane Potential",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" -40 mV  -90mV ",hierarchyLevel:6,children:[],index:"000005020000"}],index:"0000050200"},{text:" Importance",hierarchyLevel:5,children:[{text:" Changes in membrane potential changes cellular activity",hierarchyLevel:6,children:[],index:"000005020100"}],index:"0000050201"},{text:" Factors affecting resting membrane potential",hierarchyLevel:5,children:[{text:" Determined by ion gradients across the plasma membrane",hierarchyLevel:6,children:[],index:"000005020200"},{text:" Determined by the number and kind of ion channels that are opened",hierarchyLevel:6,children:[{text:" Resting Membrane Potential  K  channel opened, Na channels closed",hierarchyLevel:7,children:[],index:"00000502020100"},{text:" Depolarization  Na  channels opened",hierarchyLevel:7,children:[],index:"00000502020101"}],index:"000005020201"}],index:"0000050202"},{text:" Properties",hierarchyLevel:5,children:[{text:" Resting potential is altered by changes in K  ionconcentration and not Na  ion concentration in the environment",hierarchyLevel:6,children:[],index:"000005020300"},{text:" At resting potential, K  ion channels are opened andNa  ion channels are closed. Hence, permeability of K  ismuch higher than permeability of Na , hence changing the K concentration in the surrounding will have a significant impact on the membranepotential as K  ions quickly move in / out",hierarchyLevel:6,children:[],index:"000005020301"}],index:"0000050203"},{text:" Reading Membrane Potentials",hierarchyLevel:5,children:[{text:" Negative  inside of the cell is more negative than the outside",hierarchyLevel:6,children:[],index:"000005020400"},{text:" Positive  inside of the cell is more positive than the outside",hierarchyLevel:6,children:[],index:"000005020401"}],index:"0000050204"}],index:"00000502"},{text:" Equilibrium Potentials",hierarchyLevel:4,children:[{text:" Formula",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"000005030000"},{text:" Explanation",hierarchyLevel:6,children:[{text:" 1 / valence charge of the ion * the number of factor e in theratio of inside and outside concentration of the ion",hierarchyLevel:7,children:[],index:"00000503000100"}],index:"000005030001"},{text:" Assumptions",hierarchyLevel:6,children:[{text:" Equation analyses the membrane potential as a result of only oneion",hierarchyLevel:7,children:[],index:"00000503000200"},{text:" Cell membrane must be completely permeable to that ion",hierarchyLevel:7,children:[],index:"00000503000201"},{text:" Ion must be in equilibrium on both sides of the cell membrane",hierarchyLevel:7,children:[],index:"00000503000202"}],index:"000005030002"}],index:"0000050300"}],index:"00000503"}],index:"000005"},{text:" Signal Induction Receptors",hierarchyLevel:3,children:[{text:" Types",hierarchyLevel:4,children:[{text:" Ionotropic Receptors  ligand-gated ion channels ",hierarchyLevel:5,children:[],index:"0000060000"},{text:" Metabotropic Receptors  ligand binding with G protein (coupledto intracellular signalling)",hierarchyLevel:5,children:[],index:"0000060001"}],index:"00000600"},{text:" Ionotropic Receptors",hierarchyLevel:4,children:[{text:" Examples",hierarchyLevel:5,children:[{text:" General Examples",hierarchyLevel:6,children:[],index:"000006010000"},{text:" Ligand-gated Ion Channels",hierarchyLevel:6,children:[{text:" Mechanism",hierarchyLevel:7,children:[{text:" Binding of ligand changes conformation of the channel",hierarchyLevel:8,children:[],index:"0000060100010000"},{text:" Gate opens to allow and ion to enter or exit the cell",hierarchyLevel:8,children:[],index:"0000060100010001"}],index:"00000601000100"},{text:" Diagram",hierarchyLevel:7,children:[],index:"00000601000101"}],index:"000006010001"}],index:"0000060100"}],index:"00000601"},{text:" Metabotropic Cell Surface Receptors",hierarchyLevel:4,children:[{text:" Examples",hierarchyLevel:5,children:[{text:" Metabotropic glutamate receptors",hierarchyLevel:6,children:[],index:"000006020000"},{text:" Muscarinic acetylcholine receptors (mAChR)",hierarchyLevel:6,children:[],index:"000006020001"},{text:" GABA  receptor",hierarchyLevel:6,children:[],index:"000006020002"},{text:" Adrenergic receptors",hierarchyLevel:6,children:[],index:"000006020003"},{text:" Histaminergic receptors",hierarchyLevel:6,children:[],index:"000006020004"},{text:" Dopaminergic receptors",hierarchyLevel:6,children:[],index:"000006020005"}],index:"0000060200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0000060201"}],index:"00000602"},{text:" Ionotropic vs Metabotropic Receptors",hierarchyLevel:4,children:[],index:"00000603"}],index:"000006"}],index:"0000"},{text:" [009] Tutorial: Excitable Cells (Membrane Potential)",hierarchyLevel:2,children:[{text:" Understanding 1: Potential",hierarchyLevel:3,children:[{text:" Question to be answered",hierarchyLevel:4,children:[{text:" What does potential refer to?",hierarchyLevel:5,children:[],index:"0001000000"},{text:" How can we generate a potential? (even outside the biologycontext)",hierarchyLevel:5,children:[],index:"0001000001"}],index:"00010000"},{text:" Definitions",hierarchyLevel:4,children:[{text:" Potential  Potential is the difference between the energybetween two points. In simple terms, it is the difference in electrical chargesbetween two points.",hierarchyLevel:5,children:[],index:"0001000100"}],index:"00010001"},{text:" Illustration 1: Dissolving KCl",hierarchyLevel:4,children:[{text:" Fundamental Principles",hierarchyLevel:5,children:[{text:" A potential difference is generated through the differentialdiffusion speeds of ions, hence generating a difference in charges between twolocations",hierarchyLevel:6,children:[],index:"000100020000"},{text:" Diffusion of ions is driven by the concentration differencebetween two points",hierarchyLevel:6,children:[],index:"000100020001"},{text:" Speed of diffusion of ions is driven by the size of the ion",hierarchyLevel:6,children:[],index:"000100020002"}],index:"0001000200"},{text:" Assumptions ",hierarchyLevel:5,children:[{text:" K  diffuses much faster than Cl",hierarchyLevel:6,children:[],index:"000100020100"},{text:" This assumption is not true but is used for the sake ofillustration. Cl  in this example can be replaced with a largenegatively charge protein, which will then make sense as it diffuses slower",hierarchyLevel:6,children:[],index:"000100020101"}],index:"0001000201"},{text:" Narrative",hierarchyLevel:5,children:[{text:" When KCl is put into water, it will ionize",hierarchyLevel:6,children:[],index:"000100020200"},{text:" In the initial phases, K  and Cl  arehighly concentrated in the area in which they are placed in. However, even atthis phase, because the number of K  and Cl  ions are thesame at the left electrode, the charges cancel each other out and the voltmeterwill record a 0V reading. On the right electrode, there are no charges andthere for that will record a 0V reading too.",hierarchyLevel:6,children:[],index:"000100020201"},{text:" Due to the difference in concentration, K  and Cl ions start diffusing from the left to the right, down the concentrationgradient. Due to the differing speed of diffusion, there are more K ions on the right electrode than the number of Cl  ions. Cl takes a longer time to travel to the right electrode. ",hierarchyLevel:6,children:[],index:"000100020202"},{text:" As a result, due to the presence of more K  ion andless Cl  ions, there is a net positive charge at the rightelectrode. This causes the voltmeter to read a more positive reading as more K ions quickly travel to the right electrode.",hierarchyLevel:6,children:[],index:"000100020203"},{text:" However, given time, as the Cl  ions start arriving atthe right electrode, the net positive charge on the right electrode iscancelled out by the negative charged carried by the Cl  ions. Thiscauses the reading of the voltmeter to return back to 0V.",hierarchyLevel:6,children:[],index:"000100020204"}],index:"0001000202"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0001000203"},{text:" Important Note",hierarchyLevel:5,children:[{text:" It is important to note that simple a diffusion concentrationgradient is not sufficient to generate a potential.",hierarchyLevel:6,children:[],index:"000100020400"},{text:" There need to be differential diffusion of electrical charges.",hierarchyLevel:6,children:[],index:"000100020401"},{text:" This is because if K  and Cl  ions bothhave a concentration gradient and both diffuse at the same speed, they willboth move to the right electrode together and their charges will immediatelycancel each other out, resulting in the lack of a net positive charge and hencethe lack of a potential.",hierarchyLevel:6,children:[],index:"000100020402"},{text:" The differential diffusion mechanism is necessary to generate apotential.",hierarchyLevel:6,children:[],index:"000100020403"}],index:"0001000204"}],index:"00010002"}],index:"000100"},{text:" Understanding 2: Potential in Membranes",hierarchyLevel:3,children:[{text:" Question to be answered",hierarchyLevel:4,children:[{text:" How can any type of potential be generated across membranes?",hierarchyLevel:5,children:[],index:"0001010000"}],index:"00010100"},{text:" Illustration 2: KCl across membranes",hierarchyLevel:4,children:[{text:" Fundamental Principles",hierarchyLevel:5,children:[{text:" Differential diffusion of ions can be generated across membranesthrough the differential opening of ion channels",hierarchyLevel:6,children:[],index:"000101010000"},{text:" Differential diffusion of ions results in a membrane potential",hierarchyLevel:6,children:[],index:"000101010001"}],index:"0001010100"},{text:" Assumptions",hierarchyLevel:5,children:[{text:" It is accepted by the scientific community that the potentialoutside of the cell will ALWAYS be taken as 0.",hierarchyLevel:6,children:[],index:"000101010100"},{text:" Therefore, the voltage reading measures the charges inside of thecell and compares it with the outside benchmark of 0.",hierarchyLevel:6,children:[],index:"000101010101"},{text:" If the inside of the cell is more negative than the outside ofthe cell, then the voltage reading will read to be less than 0.",hierarchyLevel:6,children:[],index:"000101010102"},{text:" If the inside of the cell is more positive than the outside ofthe cell, then the voltage reading will read to be more than 0 (outsidebenchmark).",hierarchyLevel:6,children:[],index:"000101010103"},{text:" The 0 value at the outside of the cell serves as a humangenerated arbitrary reference point for comparison. This is kind of like how weuse Standard Hydrogen Electrode as a benchmark of comparison forvoltaic/electrolytic cells. This is kind of similar to how we use 0 Celsius forfreezing point of water as a reference point for temperature of other objects.",hierarchyLevel:6,children:[],index:"000101010104"}],index:"0001010101"},{text:" Illustration Setup",hierarchyLevel:5,children:[{text:" K  channels are open",hierarchyLevel:6,children:[],index:"000101010200"},{text:" There are no Cl  channels",hierarchyLevel:6,children:[],index:"000101010201"},{text:" There are more K  ions inside the cell than outside ofthe cell",hierarchyLevel:6,children:[],index:"000101010202"},{text:" There are more Cl  ions inside the cell than outsideof the cell",hierarchyLevel:6,children:[],index:"000101010203"},{text:" The ratio of K  to Cl  ions is the sameinside the cell and also outside the cell",hierarchyLevel:6,children:[],index:"000101010204"}],index:"0001010102"},{text:" Narrative",hierarchyLevel:5,children:[{text:" Initially, because the ratio of K  and Cl ions inside the cell is the same, the charges will cancel each other outtherefore there is a net neutral charge. Hence, the voltmeter reads a 0Vreading.",hierarchyLevel:6,children:[],index:"000101010300"},{text:" However, due to the presence of the K  ion channels,and the lack of the Cl  ion channels, only K  will beable to diffuse.",hierarchyLevel:6,children:[],index:"000101010301"},{text:" As there is a higher concentration of K  inside thecell and a lower concentration of K  outside of the cell, K will move from the left to the right, down the concentration gradient throughthe K  ion channels.",hierarchyLevel:6,children:[],index:"000101010302"},{text:" The movement of K  ions and the lack of movement of Cl ions generates a differential diffusion which is essential for generating apotential.",hierarchyLevel:6,children:[],index:"000101010303"},{text:" As K  moves outside the cell, and Cl remains in the cell, the inside of the cell becomes more and more negative.This causes a decrease in the voltmeter reading until it reaches E .",hierarchyLevel:6,children:[],index:"000101010304"},{text:" This process is driven by the concentration / chemical gradientof K .",hierarchyLevel:6,children:[],index:"000101010305"},{text:" However, due to diffusion the inside of the cell becomes more anmore negative, and the outside of the cell becomes more an more positive. As aresult, the negative charges inside the cell will start to attract the K ions to move back into the cell.",hierarchyLevel:6,children:[],index:"000101010306"},{text:" This results in a electrical driving force which opposes the chemicaldriving force. As more K  ions diffuse to the outside, theelectrical driving force becomes stronger and stronger until the electrical andchemical driving force is equal and equilibrium is reached.",hierarchyLevel:6,children:[],index:"000101010307"},{text:" At E  (equilibrium of potassium), there is no netmovement of potassium ions between the membrane. Therefore, the voltage remainsa constant negative value.",hierarchyLevel:6,children:[],index:"000101010308"}],index:"0001010103"},{text:" Narrative: Adding more potassium channels",hierarchyLevel:5,children:[{text:" Once the equilibrium point is reached, where the chemical andelectrical driving forces are the same, adding more potassium channels(increasing the permeability of the membrane) does not result in any netmovement of ions. Therefore, adding more potassium channels will results in thevoltage reading on the voltmeter to remain the same.",hierarchyLevel:6,children:[],index:"000101010400"},{text:" Driving forces are the only thing that can cause a movement ofions. Ion channels can enable the driving force to take effect (by allowingthem to move across the membrane). They are enablers. They can allow a force tocarry out its effect. However, they are unable to create the force themselves.This means that if there isnt any inherent net driving force available,increasing the enablers (channels) will not have any effect.",hierarchyLevel:6,children:[],index:"000101010401"},{text:" As a channel ion, you can open as many doors as you want. But ifpeople dont want to walk through the door, there is nothing much you can do.If people want to walk through the door, you can also stop them from doing soby closing the door. You cannot change the will of the people, you can onlychange whether their wills will result in successful action.",hierarchyLevel:6,children:[],index:"000101010402"},{text:" This phenomenon can be seen in Cl  channels in cells.",hierarchyLevel:6,children:[],index:"000101010403"}],index:"0001010104"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0001010105"},{text:" Interesting note",hierarchyLevel:5,children:[{text:" At the equilibrium point, the concentration of K  ionson the inside and on the outside may not be the same. This means that at theequilibrium point, there is still a chemical driving force, and there is stillpotential for more K  ions to diffuse outside down the concentrationgradient. However, K  ions does not diffuse outside the cell despitethe concentration gradient due to the forces exerted by the negative charges onthe inside of the cell, pulling and holding K  ions back from movingto the outside of the cell.",hierarchyLevel:6,children:[],index:"000101010600"}],index:"0001010106"}],index:"00010101"},{text:" Illustration 3: K Cl  and addition of Na across membranes",hierarchyLevel:4,children:[{text:" Fundamental Principles",hierarchyLevel:5,children:[{text:" Opposing direction of differential diffusion enables cancellingof potential",hierarchyLevel:6,children:[],index:"000101020000"}],index:"0001010200"},{text:" Assumptions",hierarchyLevel:5,children:[{text:" Permeability of K  ion channels and Na  ionchannels are the same",hierarchyLevel:6,children:[],index:"000101020100"},{text:" Hence, for every K  ion that moves from the left tothe right, one Na  ion will move from the right to the left.",hierarchyLevel:6,children:[],index:"000101020101"}],index:"0001010201"},{text:" Narrative",hierarchyLevel:5,children:[{text:" Initially, only the K  channels are open, and thisresults in the establishment of the equilibrium potential of potassium (E )as shown in the previous illustration.",hierarchyLevel:6,children:[],index:"000101020200"},{text:" After the establishing E , the Na  channelsare opened. ",hierarchyLevel:6,children:[],index:"000101020201"},{text:" As the inside of the cell is now negative (due to the outwarddiffusion of K  initially), Na  ions will be attracted bythe negative charges and move inside the cell (electrical driving force)",hierarchyLevel:6,children:[],index:"000101020202"},{text:" As the concentration of Na  ions outside of the cellis much higher than the concentration of Na  ion inside the cell, Na ions will move into the cell.",hierarchyLevel:6,children:[],index:"000101020203"},{text:" The two driving forces, causes massive influx of Na ions into the cell. This differential diffusion results in the inside of thecell becoming more positive again, causing the voltmeter reading to increase.",hierarchyLevel:6,children:[],index:"000101020204"},{text:" As Na  ions move inside the cell, the concentrationgradient of Na  ions becomes less steep. As the inside of the cellbecomes less negative (more positive), the electrical gradient becomes lesssteep. As long as there is the slightest negative charge on the inside of thecell, the Na  ions will move into the cell to neutralize thenegative charge, causing the net charges across the membrane to be 0. Moreover,the inside of the cell will only be more negative because there are more Na ion outside of the cell. ",hierarchyLevel:6,children:[],index:"000101020205"},{text:" Therefore, at the equilibrium point, the concentration of Na ions on both sides of the cell are equal. The charges on both sides of the cellshould be equal. And the voltmeter will show a reading of 0V (equal electricalcharges).",hierarchyLevel:6,children:[],index:"000101020206"}],index:"0001010202"},{text:" Narrative: Closing Potassium Channels and leaving Sodium ChannelsOpen",hierarchyLevel:5,children:[{text:" Going back to the start of the illustration when there is a bigconcentration gradient between K  and Na .",hierarchyLevel:6,children:[],index:"000101020300"},{text:" At the start because there is a equal concentration of K on the inside and equal concentration of Na  on the outside, andequal concentration of Cl  on both sides, there is no net charge onthe inside and hence the voltmeter records 0V.",hierarchyLevel:6,children:[],index:"000101020301"},{text:" Opening the Na  channels and not opening the K channels will only allow the Na  channels to diffuse from theoutside of the cell to inside of the cell (right to left). This results indifferential diffusion. ",hierarchyLevel:6,children:[],index:"000101020302"},{text:" Movement of Na  ions into the cell results in theinside to become more positive, resulting in the rise in the membrane potentialfrom 0V to E .",hierarchyLevel:6,children:[],index:"000101020303"},{text:" As Na  diffuses in, the concentration gradient of Na becomes less steep and hence the chemical driving force becomes weaker. Asinside of the cell becomes more positive, the positive charge inside of thecell will repel more Na  ions from entering the cell (even if thereis still a concentration gradient).",hierarchyLevel:6,children:[],index:"000101020304"},{text:" Eventually, the chemical force driving Na  inwards andthe electrical force pushing Na  outwards will be the same and a newequilibrium potential (E ) is established.",hierarchyLevel:6,children:[],index:"000101020305"}],index:"0001010203"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0001010204"},{text:" Interesting point",hierarchyLevel:5,children:[{text:" Channels and driving forces",hierarchyLevel:6,children:[{text:" If we open both potassium channels and sodium channels first andallow for the concentration equilibrium to be established, then closing thepotassium channels again will not do anything to the membrane potential.",hierarchyLevel:7,children:[],index:"00010102050000"},{text:" There much be a driving force to cause a change in the potential.Opening and closing the channels cannot re-create a driving force. It can onlyallow an existing driving force to take effect. At the concentrationequilibrium, there is no longer a chemical or electrical driving force,therefore, closing the potassium channels again will do nothing.",hierarchyLevel:7,children:[],index:"00010102050001"}],index:"000101020500"},{text:" Partial permeabilities",hierarchyLevel:6,children:[{text:" Definitions",hierarchyLevel:7,children:[{text:" E   when only K  channels are fully openand other channels are fully closed",hierarchyLevel:8,children:[],index:"0001010205010000"},{text:" E   when only Na  channels are fully openand all other channels are fully closed",hierarchyLevel:8,children:[],index:"0001010205010001"},{text:" 0  when both K  and Na  channels are fullyopen",hierarchyLevel:8,children:[],index:"0001010205010002"}],index:"00010102050100"},{text:" Explanation",hierarchyLevel:7,children:[{text:" In real life, channels are not binary, they are not either fullyopen or fully closed. They can be partially open and partially closed.",hierarchyLevel:8,children:[],index:"0001010205010100"},{text:" Therefore, depending on the ratio of the permeability between theK  and Na  ion channels the membrane potential will bebetween E  and E . ",hierarchyLevel:8,children:[],index:"0001010205010101"},{text:" If the permeability of Na  channels are much higherthan K  channels, then the membrane potential will be very close toE",hierarchyLevel:8,children:[],index:"0001010205010102"},{text:" If the permeability of K  channels are much higherthan Na  channels, then the membrane potential will be very close toE",hierarchyLevel:8,children:[],index:"0001010205010103"},{text:" It is important to note that in the above examples E and E  can be maintained for prolonged periods because one of thechannels are closed and there is completely no movement of the opposing ion.",hierarchyLevel:8,children:[],index:"0001010205010104"},{text:" However, when we are partial opening, E  and E can never be maintained. Initially, ions may pass through one of thechannels more slowly compared to the other opposing channel, this generates E / E  . However, as the other ion has been given time to move passthe slower channel, The voltage will go back to 0 again.",hierarchyLevel:8,children:[],index:"0001010205010105"}],index:"00010102050101"},{text:" Example",hierarchyLevel:7,children:[{text:" If we go back to the starting point of this illustration with theK  and Na  concentration gradients in place.",hierarchyLevel:8,children:[],index:"0001010205010200"},{text:" K  channels are highly permeable (mostly open) and Na channels are barely permeable (mostly closed).",hierarchyLevel:8,children:[],index:"0001010205010201"},{text:" Initially, due to the concentration gradient of K inside of the cell, K  will quickly diffuse to the outside of thecell. ",hierarchyLevel:8,children:[],index:"0001010205010202"},{text:" Initially, due to the concentration gradient of Cl outside of the cell, Cl  will diffuse to the inside of the cell.However, due to the low permeability of Cl  ion channels, only verylittle Cl  ions are able to move into the cell (even though it has alarge concentration gradient, the channels serves as a bottleneck in themovement, and hence it takes time).",hierarchyLevel:8,children:[],index:"0001010205010203"},{text:" Therefore, in the early stages, large number of K ions will move out of the cell, while only small number of Na  ionswill move into the cell. This causes the inside of the cell to be temporarilymore negative, resulting in the membrane potential to be negative, and thevoltmeter will read a voltage which is close to E",hierarchyLevel:8,children:[],index:"0001010205010204"},{text:" However, as time passes, K  ions will have been donediffusing and the concentration of K  ions will be the same on bothsides. Na  ions will eventually have enough time to diffuses acrossthe membrane, resulting in the concentration of Na  ions to also bethe same concentration on both sides.",hierarchyLevel:8,children:[],index:"0001010205010205"},{text:" Therefore, given time, and in the long run, both K ions and Na  ions will reach their concentration equilibrium,resulting in there to be no net charge on the inside of the cell and thevoltmeter reading will be 0V.",hierarchyLevel:8,children:[],index:"0001010205010206"},{text:" This phenomenon is very similar to Illustration 1 of KCl inwater.",hierarchyLevel:8,children:[],index:"0001010205010207"}],index:"00010102050102"},{text:" Diagram",hierarchyLevel:7,children:[],index:"00010102050103"}],index:"000101020501"}],index:"0001010205"}],index:"00010102"},{text:" Illustration 4: Adding Na - K  Pump",hierarchyLevel:4,children:[{text:" Purpose of Sodium Potassium Pump",hierarchyLevel:5,children:[{text:" At resting potential, Na  channels are partiallyclosed and K  channels are partially opened. Given time, themembrane potential will return to 0V.",hierarchyLevel:6,children:[],index:"000101030000"},{text:" Sodium potassium pump maintains the concentration gradient toprevent the inevitable return to 0V",hierarchyLevel:6,children:[],index:"000101030001"},{text:" Sodium potassium pump results in net negative charge on inside toprevent the inevitable return to 0V.",hierarchyLevel:6,children:[],index:"000101030002"}],index:"0001010300"},{text:" Fundamental Principles",hierarchyLevel:5,children:[{text:" Sodium potassium pump pumps the Na  ions out of thecell quite quickly. However, Na  ions diffuse into the cell quiteslowly. Therefore, Na  ions will never have enough time to diffuseinto the cell to reach concentration equilibrium. Hence, inevitable return to0V is avoided",hierarchyLevel:6,children:[],index:"000101030100"}],index:"0001010301"},{text:" Narrative",hierarchyLevel:5,children:[{text:" K  channels are almost fully open and Cl channels are almost fully closed. Therefore, K  ion will diffuse outmuch faster than Na  will diffuse in",hierarchyLevel:6,children:[],index:"000101030200"},{text:" Hence, K  ions starts diffusing out quickly, and as Na ions are slow to diffuse in, this results in a net negative charge on theinside of the cell (negative reading on the voltmeter).",hierarchyLevel:6,children:[],index:"000101030201"},{text:" Normally, when given time, Na  ions will have time todiffuse in and cause the membrane potential to rise again back to 0V. However,due to the presence of the sodium potassium pump, Na  ions arepumped out quickly, such that the concentration of Na  ions outsideof the cell will almost be the original concentration. Therefore as Na ions is never given time to diffuse in, it will never have a chance of causingthe membrane potential to return to 0V.",hierarchyLevel:6,children:[],index:"000101030202"},{text:" However, if the sodium potassium pump pumps K  ionsback in too quickly, it will cause the concentration of K  inside ofthe cell to be almost the same as the original concentration, resulting in themembrane potential to be 0V. However, this does not happen.",hierarchyLevel:6,children:[],index:"000101030203"},{text:" At 0V, there is a strong concentration gradient and no electricalopposing force. Therefore, K  ions moves out of the cell via the K channels much faster than the sodium-potassium pump can pump the K ions back in (also because it only pumps 2K  ions at a time, not 3).As the membrane potential decreases to a level closer to the resting potential,diffusion of K  ions results in a less steep concentration gradient.Accumulation of negative charges on the inside of the cell results in astronger electrical opposing force. As a result, at the membrane potential, therate of outflow of K  ions via K  channels is the same asthe rate of inflow of K  ions via the sodium-potassium pump.",hierarchyLevel:6,children:[],index:"000101030204"},{text:" Driving forces at Equilibrium",hierarchyLevel:6,children:[{text:" Concentration gradient force = electrical gradient force +sodium-potassium pump",hierarchyLevel:7,children:[],index:"00010103020500"}],index:"000101030205"},{text:" Therefore, to maintain the equilibrium of resting potential, thesodium-potassium pump is crucial. Without the sodium potassium pump, aconcentration equilibrium will be reached, resulting in a lower membranepotential.",hierarchyLevel:6,children:[],index:"000101030206"}],index:"0001010302"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0001010303"},{text:" Interesting point",hierarchyLevel:5,children:[{text:" If K  diffuses so much faster than Na ,wouldnt the sodium-potassium pump run out of Na  to pump out whilestill having many K  remaining to pump in?",hierarchyLevel:6,children:[],index:"000101030400"},{text:" If the sodium-potassium pump pumps out more sodium and lesspotassium per pump, and assuming that the concentration of both K and Na  is the same at the start, the sodium-potassium pump will definitelyrun out of Na  to pump while still having K  left over.",hierarchyLevel:6,children:[{text:" This imbalance ensures that even when there is no Na inside the cell, there is still quite a good amount of K  outside ofthe cell, ensuring that the negative membrane potential is maintained.",hierarchyLevel:7,children:[],index:"00010103040100"}],index:"000101030401"}],index:"0001010304"}],index:"00010103"},{text:" Illustration 5: Inhibiting Na - K  pump",hierarchyLevel:4,children:[{text:" Fundamental Principles",hierarchyLevel:5,children:[],index:"0001010400"},{text:" Narrative",hierarchyLevel:5,children:[{text:" When the sodium-potassium pump is disabled, Na  willfinally have time to diffuse across the Na  channels, enabling themembrane potential to reach back to 0V.",hierarchyLevel:6,children:[],index:"000101040100"}],index:"0001010401"},{text:" Explanation of 3 observations",hierarchyLevel:5,children:[{text:" Initial Spike",hierarchyLevel:6,children:[{text:" Membrane lost ability of net negative charge generation persodium-potassium pump action",hierarchyLevel:7,children:[],index:"00010104020000"}],index:"000101040200"},{text:" Gradual Increase",hierarchyLevel:6,children:[{text:" Concentration gradient difference in Na  results ingradual diffusion across the membrane and gradual increase of membrane potentialback to 0V",hierarchyLevel:7,children:[],index:"00010104020100"}],index:"000101040201"},{text:" Not completely 0V",hierarchyLevel:6,children:[{text:" Presence of negatively charged proteins on the inside of the cell",hierarchyLevel:7,children:[],index:"00010104020200"}],index:"000101040202"}],index:"0001010402"},{text:" Diagram",hierarchyLevel:5,children:[{text:" \\",hierarchyLevel:6,children:[],index:"000101040300"}],index:"0001010403"}],index:"00010104"}],index:"000101"}],index:"0001"}]},{text:"Nervous System",hierarchyLevel:1,children:[{text:" [005] Autonomic Nervous System  Organisation",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Viscera  the internal organs in the main cavities of the body,especially those in the abdomen, e.g. the intestines.",hierarchyLevel:5,children:[],index:"0100000000"}],index:"01000000"},{text:" Components of the Nervous System",hierarchyLevel:4,children:[{text:" Central Nervous System",hierarchyLevel:5,children:[{text:" Brain",hierarchyLevel:6,children:[],index:"010000010000"},{text:" Spinal Cord",hierarchyLevel:6,children:[],index:"010000010001"}],index:"0100000100"},{text:" Peripheral Nervous System",hierarchyLevel:5,children:[{text:" Autonomous Nervous System  interaction between CNS and visceralorgans",hierarchyLevel:6,children:[{text:" Sympathetic Division",hierarchyLevel:7,children:[],index:"01000001010000"},{text:" Parasympathetic Division",hierarchyLevel:7,children:[],index:"01000001010001"}],index:"010000010100"},{text:" Somatic Nervous System  enables voluntary control",hierarchyLevel:6,children:[{text:" Spinal motor neurones",hierarchyLevel:7,children:[],index:"01000001010100"}],index:"010000010101"}],index:"0100000101"}],index:"01000001"}],index:"010000"},{text:" Autonomic Nervous System",hierarchyLevel:3,children:[{text:" Autonomic Nervous System",hierarchyLevel:4,children:[{text:" Divisions",hierarchyLevel:5,children:[{text:" Sympathetic division",hierarchyLevel:6,children:[],index:"010001000000"},{text:" Parasympathetic division",hierarchyLevel:6,children:[],index:"010001000001"}],index:"0100010000"},{text:" Function",hierarchyLevel:5,children:[{text:" Regulate the operation of internal organs",hierarchyLevel:6,children:[],index:"010001000100"}],index:"0100010001"},{text:" Structure",hierarchyLevel:5,children:[{text:" Each organ is connected to both parasympathetic nerves andsympathetic nerves. Both nerves exert an effect to enable the regulation of theorgan.",hierarchyLevel:6,children:[],index:"010001000200"}],index:"0100010002"},{text:" Diagram",hierarchyLevel:5,children:[{text:" Left: Sympathetic nervous system to visceral organs",hierarchyLevel:6,children:[],index:"010001000300"},{text:" Right: Parasympathetic nervous system to visceral organs",hierarchyLevel:6,children:[],index:"010001000301"}],index:"0100010003"}],index:"01000100"},{text:" Neuron Chain",hierarchyLevel:4,children:[{text:" General Principle",hierarchyLevel:5,children:[{text:" 2 neuron chain structure",hierarchyLevel:6,children:[],index:"010001010000"}],index:"0100010100"},{text:" Organization",hierarchyLevel:5,children:[{text:" Somatic Motor Pathway: Relay Neuron => Motor Neuron =>Skeletal Muscle",hierarchyLevel:6,children:[],index:"010001010100"},{text:" Sympathetic Pathway: Relay Neuron => Sympathetic preganglionicneuron => Sympathetic postganglionic neuron",hierarchyLevel:6,children:[],index:"010001010101"},{text:" Parasympathetic Pathway: Relay Neuron => Parasympatheticpreganglionic neuron => Parasympathetic postganglionic neuron",hierarchyLevel:6,children:[],index:"010001010102"}],index:"0100010101"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0100010102"}],index:"01000101"},{text:" Ganglia",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Ganglia - Swellings on peripheral nerves that contain neuronalcell bodies",hierarchyLevel:6,children:[],index:"010001020000"},{text:" White rami  nerves containing the preganglionic neuronalprojections to the ganglia (myelinated)",hierarchyLevel:6,children:[],index:"010001020001"},{text:" Grey rami  nerves containing the postganglionic neuronalprojections to the ganglia (unmyelinated)",hierarchyLevel:6,children:[],index:"010001020002"}],index:"0100010200"},{text:" Structure",hierarchyLevel:5,children:[{text:" Contains the neuronal cell body of the autonomic post-ganglionicneuron",hierarchyLevel:6,children:[],index:"010001020100"},{text:" Contains the synapse between the pre-ganglionic neuron andpost-ganglionic neuron",hierarchyLevel:6,children:[],index:"010001020101"}],index:"0100010201"},{text:" Function",hierarchyLevel:5,children:[{text:" Enables neuron to neuron communication",hierarchyLevel:6,children:[],index:"010001020200"}],index:"0100010202"},{text:" Ganglionic Synapse",hierarchyLevel:5,children:[{text:" Property",hierarchyLevel:6,children:[{text:" Utilizes fast neurotransmission via acetylcholineneurotransmitter, which acts on nicotinic acetylcholine receptors which arefast acting, causing rapid depolarization in the post-ganglionic neuron,resulting the in generation of an action potential",hierarchyLevel:7,children:[],index:"01000102030000"}],index:"010001020300"}],index:"0100010203"}],index:"01000102"}],index:"010001"},{text:" Sympathetic Nervous System",hierarchyLevel:3,children:[{text:" Sympathetic nervous system",hierarchyLevel:4,children:[{text:" Origin",hierarchyLevel:5,children:[{text:" Neuron project from different vertebrae of the spinal cord",hierarchyLevel:6,children:[],index:"010002000000"}],index:"0100020000"},{text:" Trend",hierarchyLevel:5,children:[{text:" Neurons that are found higher up on the spinal cord will projectto organs higher up in the body",hierarchyLevel:6,children:[],index:"010002000100"}],index:"0100020001"}],index:"01000200"},{text:" Sympathetic Ganglia",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Paravertebral chain  sympathetic chain of ganglion",hierarchyLevel:6,children:[],index:"010002010000"},{text:" Prevertebral ganglia  abdominal ganglia found in front of theaorta",hierarchyLevel:6,children:[],index:"010002010001"}],index:"0100020100"},{text:" Properties",hierarchyLevel:5,children:[{text:" Sympathetic preganglionic neurons (SPN) have short axons as theydo not need to project too far to synapse with the postganglionic neurons inthe abdomen",hierarchyLevel:6,children:[],index:"010002010100"}],index:"0100020101"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0100020102"},{text:" Sympathetic preganglionic neurons",hierarchyLevel:5,children:[{text:" Location",hierarchyLevel:6,children:[{text:" Project from the central nervous system (CNS) to the sympatheticpostganglionic neuron",hierarchyLevel:7,children:[],index:"01000201030000"}],index:"010002010300"},{text:" Description",hierarchyLevel:6,children:[{text:" Cell body starts at the lateral horn, axon moves via the ventralhorns and into the white ramus",hierarchyLevel:7,children:[],index:"01000201030100"}],index:"010002010301"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010002010302"}],index:"0100020103"},{text:" Adrenal gland sympathetic neurons (special case)",hierarchyLevel:5,children:[{text:" Properties",hierarchyLevel:6,children:[{text:" Does not have a sympathetic post-ganglionic neuron",hierarchyLevel:7,children:[],index:"01000201040000"},{text:" Sympathetic preganglionic neuron has a much longer axon to reachthe adrenal medulla",hierarchyLevel:7,children:[],index:"01000201040001"},{text:" Cells of  adrenal medulla are similar to neurons , and release adrenaline andnoradrenaline into the bloodstream, resulting in a systemic effect. Incomparison, the postganglionic neurons release adrenaline directly onto thetissue, resulting in only a local effect. ",hierarchyLevel:7,children:[],index:"01000201040002"}],index:"010002010400"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010002010401"}],index:"0100020104"},{text:" Sympathetic post ganglionic neurons",hierarchyLevel:5,children:[{text:" Location",hierarchyLevel:6,children:[{text:" Project from the sympathetic preganglionic neuron to the targetorgan",hierarchyLevel:7,children:[],index:"01000201050000"}],index:"010002010500"},{text:" Target Organs",hierarchyLevel:6,children:[{text:" Smooth muscle",hierarchyLevel:7,children:[],index:"01000201050100"},{text:" Cardiac muscle",hierarchyLevel:7,children:[],index:"01000201050101"},{text:" Glands",hierarchyLevel:7,children:[],index:"01000201050102"}],index:"010002010501"},{text:" Properties",hierarchyLevel:6,children:[{text:" Projections have extensive branching to allow for multiple pointsof contact with their targets (one-to-many relation)",hierarchyLevel:7,children:[],index:"01000201050200"},{text:" Axons are long to reach the targets",hierarchyLevel:7,children:[],index:"01000201050201"}],index:"010002010502"}],index:"0100020105"},{text:" Varicosities",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Allow for crude neurotransmission, bathe target cells with asmuch neurotransmitters as possible to cause a concerted action by the targetorgan (volume transmission)",hierarchyLevel:7,children:[],index:"01000201060000"}],index:"010002010600"},{text:" Structure",hierarchyLevel:6,children:[{text:" Swellings along the length of the axon of sympatheticpostganglionic neuron",hierarchyLevel:7,children:[],index:"01000201060100"}],index:"010002010601"},{text:" Function",hierarchyLevel:6,children:[{text:" Swelling contain the components required to releaseneurotransmitters",hierarchyLevel:7,children:[],index:"01000201060200"},{text:" Large numbers of varicosities along the axon enables multiplepoints of contact and release points of neurotransmitters and hence activationof action potential in target organ at multiple sites",hierarchyLevel:7,children:[],index:"01000201060201"}],index:"010002010602"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010002010603"}],index:"0100020106"}],index:"01000201"}],index:"010002"},{text:" Parasympathetic Nervous System",hierarchyLevel:3,children:[{text:" Parasympathetic nervous system",hierarchyLevel:4,children:[{text:" Origins",hierarchyLevel:5,children:[{text:" Cranial origin / Cranial output",hierarchyLevel:6,children:[],index:"010003000000"},{text:" Sacral origin / Sacral output",hierarchyLevel:6,children:[],index:"010003000001"}],index:"0100030000"},{text:" Trend",hierarchyLevel:5,children:[{text:" The higher the location of the output on the spinal cord, thehigher the target organ",hierarchyLevel:6,children:[],index:"010003000100"}],index:"0100030001"},{text:" Properties",hierarchyLevel:5,children:[{text:" Have much lesser number of output points compared to thesympathetic nervous system",hierarchyLevel:6,children:[],index:"010003000200"}],index:"0100030002"},{text:" Nervous Structure",hierarchyLevel:5,children:[{text:" 4 cranial nerves project out to link with respective targetorgans",hierarchyLevel:6,children:[],index:"010003000300"}],index:"0100030003"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0100030004"}],index:"01000300"},{text:" Parasympathetic Ganglia",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Nerve nuclei  cranial nerve nuclei are a series of bilateralgrey matter motor and sensory nuclei located in the midbrain, pons and medullathat are the collections of afferent and efferent cell bodies for many of thecranial nerves.",hierarchyLevel:6,children:[],index:"010003010000"}],index:"0100030100"},{text:" Location",hierarchyLevel:5,children:[{text:" Located close to the target organ",hierarchyLevel:6,children:[],index:"010003010100"},{text:" Embedded within the target organ (heart, lungs)",hierarchyLevel:6,children:[],index:"010003010101"}],index:"0100030101"}],index:"01000301"},{text:" Parasympathetic preganglionic neurons (PPN)",hierarchyLevel:4,children:[{text:" Location",hierarchyLevel:5,children:[{text:" Within cranial nerve nuclei (nerve fibres)",hierarchyLevel:6,children:[],index:"010003020000"},{text:" Within lateral horn of sacral spinal segments",hierarchyLevel:6,children:[],index:"010003020001"}],index:"0100030200"},{text:" Properties",hierarchyLevel:5,children:[{text:" Long axon",hierarchyLevel:6,children:[],index:"010003020100"},{text:" Extensive branching",hierarchyLevel:6,children:[],index:"010003020101"}],index:"0100030201"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0100030202"}],index:"01000302"},{text:" Parasympathetic postganglionic neurons",hierarchyLevel:4,children:[{text:" Location",hierarchyLevel:5,children:[{text:" Project from parasympathetic preganglionic neurons to targetorgans",hierarchyLevel:6,children:[],index:"010003030000"}],index:"0100030300"},{text:" Targets",hierarchyLevel:5,children:[{text:" Smooth muscle",hierarchyLevel:6,children:[],index:"010003030100"},{text:" Cardiac muscle",hierarchyLevel:6,children:[],index:"010003030101"},{text:" Glands",hierarchyLevel:6,children:[],index:"010003030102"}],index:"0100030301"},{text:" Properties",hierarchyLevel:5,children:[{text:" Short axon",hierarchyLevel:6,children:[],index:"010003030200"},{text:" Minimal branching (close to target organ)",hierarchyLevel:6,children:[],index:"010003030201"}],index:"0100030302"}],index:"01000303"}],index:"010003"},{text:" Other Properties",hierarchyLevel:3,children:[{text:" Divergent and Convergent Properties of Autonomic Nervous System",hierarchyLevel:4,children:[{text:" Divergence",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Amplify a single signal into multiple effector points",hierarchyLevel:7,children:[],index:"01000400000000"}],index:"010004000000"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Sympathetic Nervous System",hierarchyLevel:7,children:[{text:" oA single point from the  Central Nervous System (CNS)branches out into several sympathetic ganglion",hierarchyLevel:8,children:[],index:"0100040000010000"},{text:" Each sympathetic ganglion exerts its effects on different targetcells / tissues",hierarchyLevel:8,children:[],index:"0100040000010001"}],index:"01000400000100"},{text:" Parasympathetic Nervous System",hierarchyLevel:7,children:[{text:" A single point from the Central Nervous System (CNS) branches outinto several parasympathetic ganglion",hierarchyLevel:8,children:[],index:"0100040000010100"},{text:" Each parasympathetic ganglion exerts its effects on differentparts of the target organ",hierarchyLevel:8,children:[],index:"0100040000010101"}],index:"01000400000101"}],index:"010004000001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010004000002"}],index:"0100040000"},{text:" Convergence",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Integrate various CNS outflow into one effect",hierarchyLevel:7,children:[],index:"01000400010000"}],index:"010004000100"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Directs multiple outputs to a single target",hierarchyLevel:7,children:[],index:"01000400010100"},{text:" Multiple preganglionic neurons synapses with a singlepostganglionic neuron, which integrates the signal",hierarchyLevel:7,children:[],index:"01000400010101"},{text:" The postganglionic neuron transmits the signal to one point inthe target organ",hierarchyLevel:7,children:[],index:"01000400010102"}],index:"010004000101"}],index:"0100040001"}],index:"01000400"}],index:"010004"}],index:"0100"},{text:" [006] Autonomic Nervous System  Physiology andPharmacology",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Neurotransmission",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" A wave of depolarisation reaches axon terminal of thepre-synaptic neuron",hierarchyLevel:6,children:[],index:"010100000000"},{text:" Depolarisation of membrane potential causes voltage-gated Ca ion channels to open, leading to influx of Ca  ions",hierarchyLevel:6,children:[],index:"010100000001"},{text:" Influx of Ca  ions causes synaptic vesiclescontaining neurotransmitters to migrate and fuse with the pre-synapticmembrane. Neurotransmitters are released into the synaptic cleft via exocytosis",hierarchyLevel:6,children:[],index:"010100000002"},{text:" Neurotransmitters diffuse across the synaptic cleft and binds tothe receptors on the post-synaptic membrane",hierarchyLevel:6,children:[],index:"010100000003"},{text:" The ligand-gated Na+ ion channels on the post-synaptic membraneopens, leading to the influx of Na+ ions",hierarchyLevel:6,children:[],index:"010100000004"},{text:" Influx of Na+ ions leads to depolarisation of post-synapticmembrane which travels downwards to the axon hillock as a graded potential. Ifthe membrane potential at the axon hillock is above the threshold (-55mV), anaction potential is generated.",hierarchyLevel:6,children:[],index:"010100000005"}],index:"0101000000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0101000001"}],index:"01010000"},{text:" Neurotransmitters at Autonomic Ganglia",hierarchyLevel:4,children:[{text:" Components",hierarchyLevel:5,children:[{text:" Neurotransmitters",hierarchyLevel:6,children:[{text:" Acetylcholine (ACh)",hierarchyLevel:7,children:[],index:"01010001000000"},{text:" ATP",hierarchyLevel:7,children:[],index:"01010001000001"},{text:" Adrenaline",hierarchyLevel:7,children:[],index:"01010001000002"},{text:" Noradrenaline",hierarchyLevel:7,children:[],index:"01010001000003"}],index:"010100010000"},{text:" Receptors (by mechanism)",hierarchyLevel:6,children:[{text:" Ligand-gated ion channels (Ionotropic receptors) ",hierarchyLevel:7,children:[{text:" Nicotinic acetylcholine receptor (Ach)",hierarchyLevel:8,children:[],index:"0101000100010000"},{text:" Nucleotide receptors (ATP)",hierarchyLevel:8,children:[],index:"0101000100010001"}],index:"01010001000100"},{text:" G protein coupled receptors (Metabotropic receptors)",hierarchyLevel:7,children:[{text:" Muscarinic acetylcholine receptors",hierarchyLevel:8,children:[],index:"0101000100010100"},{text:" \u03b1/\u03b2 adrenoceptors",hierarchyLevel:8,children:[],index:"0101000100010101"}],index:"01010001000101"}],index:"010100010001"},{text:" Receptors (by class)",hierarchyLevel:6,children:[],index:"010100010002"}],index:"0101000100"},{text:" Mechanism Outline",hierarchyLevel:5,children:[{text:" Preganglionic neurons  Release neurotransmitters (Acetylcholineand ATP)",hierarchyLevel:6,children:[],index:"010100010100"},{text:" Postganglionic neurons  Express neurotransmitter receptors",hierarchyLevel:6,children:[],index:"010100010101"}],index:"0101000101"},{text:" Mechanism at Ganglion",hierarchyLevel:5,children:[{text:" Preganglionic neurons form numerous  synapses with the postganglionicneurons",hierarchyLevel:6,children:[],index:"010100010200"},{text:" Action potential arrives at the preganglionic neuron, resultingin the release of Acetylcholine neurotransmitter and ATP neurotransmitter intothe synaptic cleft via exocytosis",hierarchyLevel:6,children:[],index:"010100010201"},{text:" Acetylcholine binds to the nicotinic acetylcholine receptors(nAChR), and ATP binds to nucleotide receptors",hierarchyLevel:6,children:[],index:"010100010202"},{text:" Nicotinic acetylcholine receptors and nucleotide receptors(ligand-gated ion channels) open which results in the influx of ions. Thiscauses the formation of an action potential in the postganglionic neuron",hierarchyLevel:6,children:[],index:"010100010203"}],index:"0101000102"},{text:" Mechanism at Neuroeffector Junction",hierarchyLevel:5,children:[{text:" Axon end of postganglionic neuron releases neurotransmitters.",hierarchyLevel:6,children:[],index:"010100010300"},{text:" Neurotransmitters binds to G protein coupled receptors(metabotropic receptors) (muscarinic acetylcholine receptors), which activatessecond messenger system within the target cell.",hierarchyLevel:6,children:[],index:"010100010301"},{text:" Second messenger systems activate intracellular mechanisms whichopens ion channels on the plasma membrane. This is causing an influx of ionsinto the cell which results in the target cell exerting its effect",hierarchyLevel:6,children:[],index:"010100010302"},{text:" ",hierarchyLevel:6,children:[],index:"010100010303"}],index:"0101000103"}],index:"01010001"},{text:" Central Link",hierarchyLevel:4,children:[],index:"01010002"}],index:"010100"},{text:" Autonomic Nervous System in Homeostasis",hierarchyLevel:3,children:[{text:" Overall Function of Autonomic Nervous System",hierarchyLevel:4,children:[{text:" Maintain homeostasis in the body",hierarchyLevel:5,children:[],index:"0101010000"}],index:"01010100"},{text:" Mechanisms of Homeostatic Maintenance",hierarchyLevel:4,children:[{text:" General Control",hierarchyLevel:5,children:[{text:" Opposing actions of sympathetic and parasympathetic divisions on organs",hierarchyLevel:6,children:[],index:"010101010000"}],index:"0101010100"},{text:" Fine Control",hierarchyLevel:5,children:[{text:" Altering balance of activity between sympathetic andparasympathetic division to enable fine control of organ function",hierarchyLevel:6,children:[],index:"010101010100"}],index:"0101010101"}],index:"01010101"},{text:" Mechanism of Heart Rate Control",hierarchyLevel:4,children:[{text:" General",hierarchyLevel:5,children:[{text:" Heart will beat at the pacemaker frequency without control fromsympathetic or parasympathetic divisions of autonomic nervous system",hierarchyLevel:6,children:[],index:"010101020000"},{text:" Parasympathetic division drives the heart rate down to theresting heart rate",hierarchyLevel:6,children:[],index:"010101020001"}],index:"0101010200"},{text:" Sympathetic Mechanism",hierarchyLevel:5,children:[{text:" Sympathetic postganglionic neurons release Adrenaline which bindsto G-protein coupled \u03b2  adrenoreceptors on the cells in the SAnode.",hierarchyLevel:6,children:[],index:"010101020100"},{text:" This results in the activation of the G-protein, causing therelease of cyclic AMP (cAMP) within the cell",hierarchyLevel:6,children:[],index:"010101020101"},{text:" Release of cAMP within the cell increases the permeability of ionchannels. This increases the speed of depolarization from the funny current,resulting in the threshold potential to be reached earlier. Hence, the heartmuscle cells contract earlier.",hierarchyLevel:6,children:[],index:"010101020102"},{text:" Constant shortened time for reaching threshold potential resultsin increase in number of contractions and hence increased heart rate",hierarchyLevel:6,children:[],index:"010101020103"}],index:"0101010201"},{text:" Vagal / Parasympathetic Mechanism",hierarchyLevel:5,children:[{text:" Parasympathetic postganglionic neurons release Acetylcholinewhich binds to G-coupled M  muscarinic acetylcholine receptors onthe cells in the SA node.",hierarchyLevel:6,children:[],index:"010101020200"},{text:" This  results in the activation of the G protein, causing theactivation of protein kinase A.",hierarchyLevel:6,children:[],index:"010101020201"},{text:" Protein kinase A results in the decrease in the concentration ofcAMP within the cell",hierarchyLevel:6,children:[],index:"010101020202"},{text:" Lower levels of cAMP results in the decrease in the permeabilityof ion channels. This causes the decrease the speed of depolarization  from the funny current,resulting in the threshold potential to be reached later. Hence, the heartmuscle cells contract later.",hierarchyLevel:6,children:[],index:"010101020203"},{text:" Constant lengthened time for reaching threshold potential resultsin decrease in number of contractions and hence decreased heart rate.",hierarchyLevel:6,children:[],index:"010101020204"}],index:"0101010202"},{text:" Drugs",hierarchyLevel:5,children:[{text:" Sympathetic Mechanism  prevented using \u03b2-blockers(beta-selective adrenergic antagonist) (propranolol)",hierarchyLevel:6,children:[],index:"010101020300"},{text:" Parasympathetic Mechanism  prevented using atropine",hierarchyLevel:6,children:[],index:"010101020301"}],index:"0101010203"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0101010204"},{text:" Balancing Property of Sympathetic and Parasympathetic Division",hierarchyLevel:5,children:[{text:" Truism",hierarchyLevel:6,children:[{text:" Both sympathetic and parasympathetic pathways are almost alwaysactivated",hierarchyLevel:7,children:[],index:"01010102050000"}],index:"010101020500"},{text:" Experimentation",hierarchyLevel:6,children:[{text:" At the resting heart rate, propranolol which disables thesympathetic mechanism, has an effect. This shows that even at resting heartrate, the sympathetic division plays a role.",hierarchyLevel:7,children:[],index:"01010102050100"}],index:"010101020501"}],index:"0101010205"},{text:" Daily Fluctuation of Heart Rate",hierarchyLevel:5,children:[{text:" Properties",hierarchyLevel:6,children:[{text:" Heart rate is lowest overnight",hierarchyLevel:7,children:[],index:"01010102060000"},{text:" Rises first thing in the morning",hierarchyLevel:7,children:[],index:"01010102060001"},{text:" Fine adjustments are made during the day depending on activity",hierarchyLevel:7,children:[],index:"01010102060002"}],index:"010101020600"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010101020601"}],index:"0101010206"}],index:"01010102"},{text:" Mechanism of Control of Vasculature (Sympathetic Division)",hierarchyLevel:4,children:[{text:" Mechanism (Sympathetic Division)",hierarchyLevel:5,children:[{text:" Low",hierarchyLevel:6,children:[{text:" Less amount of noradrenaline is released from the sympatheticpostganglionic neuron. Noradrenaline binds to \u03b1 adrenoreceptors, whichcauses very little contraction of the artery",hierarchyLevel:7,children:[],index:"01010103000000"}],index:"010101030000"},{text:" Normal",hierarchyLevel:6,children:[{text:" Moderate amount of noradrenaline is released from the sympatheticpostganglionic neuron. Noradrenaline binds to \u03b1 adrenoreceptors, whichcauses a slight contraction of the artery",hierarchyLevel:7,children:[],index:"01010103000100"}],index:"010101030001"},{text:" High",hierarchyLevel:6,children:[{text:" High amount of noradrenaline is released from the sympatheticpostganglionic neuron. Noradrenaline binds to \u03b1 adrenoreceptors, whichcauses significant contraction of the artery",hierarchyLevel:7,children:[],index:"01010103000200"}],index:"010101030002"}],index:"0101010300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0101010301"},{text:" Mechanism (Parasympathetic Division)  Genitalia, coronaryarteries",hierarchyLevel:5,children:[{text:" Understanding",hierarchyLevel:6,children:[{text:" Muscarinic acetylcholine receptors are found on all vasculature,including vasculature without parasympathetic innervation. ",hierarchyLevel:7,children:[],index:"01010103020000"},{text:" Muscarinic acetylcholine receptors are found on both smoothmuscles on vasculature and on endothelium",hierarchyLevel:7,children:[],index:"01010103020001"},{text:" Muscarinic acetylcholine receptors are fully functional in allvasculature, but will not be activated without the parasympathetic division toacetylcholine",hierarchyLevel:7,children:[],index:"01010103020002"}],index:"010101030200"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Parasympathetic postganglionic neuron releases acetylcholin e",hierarchyLevel:7,children:[],index:"01010103020100"},{text:" Acetylcholine binds to muscarinic acetylcholine receptors whichresults in the vasodilation of the vasculature",hierarchyLevel:7,children:[],index:"01010103020101"}],index:"010101030201"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010101030202"}],index:"0101010302"}],index:"01010103"}],index:"010101"}],index:"0101"},{text:" [059] CNS control of circulation",hierarchyLevel:2,children:[{text:" Learning Outcome",hierarchyLevel:3,children:[{text:" To describe and explain the function of central nervous controlof the circulation in health and disease (in relation to different behaviouralstates, changes in posture and haemorrhage)",hierarchyLevel:4,children:[],index:"01020000"}],index:"010200"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Cerebrum Diencephalon  generates complex patterns ofcardiovascular response associated with various behaviours",hierarchyLevel:5,children:[],index:"0102010000"},{text:" Brainstem  critical for basic reflex control of cardiovascularfunction for essential life support; parasympathetic outflow for the heart(impt)",hierarchyLevel:5,children:[],index:"0102010001"},{text:" Spinal cord  critical for basic reflex control of cardiovascularfunction for essential life support; T1-L3 are sympathetic outflow controllingcardiovascular function (impt)",hierarchyLevel:5,children:[],index:"0102010002"}],index:"01020100"},{text:" Diagram",hierarchyLevel:4,children:[],index:"01020101"},{text:" Blood Pressure Distribution",hierarchyLevel:4,children:[{text:" Overall Characteristics",hierarchyLevel:5,children:[{text:" Bell shaped distribution throughout the population",hierarchyLevel:6,children:[],index:"010201020000"}],index:"0102010200"},{text:" Age Classifications",hierarchyLevel:5,children:[{text:" Young Adult  120 / 80",hierarchyLevel:6,children:[],index:"010201020100"},{text:" 70 year old  170 / 90",hierarchyLevel:6,children:[],index:"010201020101"},{text:" High Blood Pressure (resting)  140 / 90",hierarchyLevel:6,children:[],index:"010201020102"}],index:"0102010201"},{text:" Time of Day Distribution",hierarchyLevel:5,children:[],index:"0102010202"},{text:" Activity Distribution",hierarchyLevel:5,children:[],index:"0102010203"}],index:"01020102"},{text:" White Coat Syndrome",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Patients may feel stressed and fearful when visiting the doctor",hierarchyLevel:6,children:[],index:"010201030000"},{text:" This results in higher than normal blood pressure readings whenthe patient visits the doctor.",hierarchyLevel:6,children:[],index:"010201030001"}],index:"0102010300"},{text:" Diagnosis",hierarchyLevel:5,children:[{text:" Utilise ambulatory blood pressure monitory (ABPM) /self-monitoring",hierarchyLevel:6,children:[],index:"010201030100"},{text:" Send the patient home with a blood pressure monitor and tell thepatient to record the blood pressure at home.",hierarchyLevel:6,children:[],index:"010201030101"},{text:" Compare the blood pressure at home and in the clinic.",hierarchyLevel:6,children:[],index:"010201030102"}],index:"0102010301"},{text:" Solution",hierarchyLevel:5,children:[{text:" Ensure that patients are as relaxed as possible",hierarchyLevel:6,children:[],index:"010201030200"}],index:"0102010302"}],index:"01020103"},{text:" Interpreting Ambulatory Blood Pressure (ABP) Profile",hierarchyLevel:4,children:[{text:" Ranges",hierarchyLevel:5,children:[{text:" During the day  < 135 / 85 mm Hg",hierarchyLevel:6,children:[],index:"010201040000"},{text:" During the night  < 120 / 75 mm Hg",hierarchyLevel:6,children:[],index:"010201040001"},{text:" Over 24 hours  < 130 / 80 mm Hg",hierarchyLevel:6,children:[],index:"010201040002"}],index:"0102010400"},{text:" Variance",hierarchyLevel:5,children:[{text:" Mean day-time and night-time (sleep) ABP should differ by >10%",hierarchyLevel:6,children:[],index:"010201040100"},{text:" Day-time and night-time (sleep) ABP should be < 20% abovenormal values",hierarchyLevel:6,children:[],index:"010201040101"}],index:"0102010401"}],index:"01020104"}],index:"010201"},{text:" Autonomic Nervous System",hierarchyLevel:3,children:[{text:" Innervations by Autonomic Nervous System",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0102020000"},{text:" Parasympathetic Innervations",hierarchyLevel:5,children:[{text:" Vagus nerve  heart (effector), baroreceptors aorta (sensory)",hierarchyLevel:6,children:[],index:"010202000100"}],index:"0102020001"},{text:" Sympathetic Innervations",hierarchyLevel:5,children:[{text:" T1, T2, T3, T4  heart",hierarchyLevel:6,children:[],index:"010202000200"},{text:" T10, T11, T12  adrenal gland (adrenaline/noradrenaline)",hierarchyLevel:6,children:[],index:"010202000201"},{text:" T1 - L2  vasculature",hierarchyLevel:6,children:[],index:"010202000202"}],index:"0102020002"}],index:"01020200"},{text:" Innervations on the Heart",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0102020100"},{text:" Sympathetic Innervation",hierarchyLevel:5,children:[{text:" SA node",hierarchyLevel:6,children:[],index:"010202010100"},{text:" AV node",hierarchyLevel:6,children:[],index:"010202010101"},{text:" Ventricular myocardium",hierarchyLevel:6,children:[],index:"010202010102"}],index:"0102020101"},{text:" Parasympathetic Innervation",hierarchyLevel:5,children:[{text:" Atria",hierarchyLevel:6,children:[],index:"010202010200"},{text:" SA node",hierarchyLevel:6,children:[],index:"010202010201"},{text:" AV node",hierarchyLevel:6,children:[],index:"010202010202"},{text:" Ventricular myocardium (less)",hierarchyLevel:6,children:[],index:"010202010203"}],index:"0102020102"}],index:"01020201"},{text:" Interplay between Sympathetic and Parasympathetic systems in theHeart",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Myogenic heart rate is 100 bpm (SA node)",hierarchyLevel:6,children:[],index:"010202020000"},{text:" Parasympathetic action reduces it",hierarchyLevel:6,children:[],index:"010202020001"},{text:" Sympathetic action increases it",hierarchyLevel:6,children:[],index:"010202020002"}],index:"0102020200"}],index:"01020202"},{text:" Autonomic Control of Blood Vessels",hierarchyLevel:4,children:[{text:" Sympathetic Control via Indirect Sympathetic Chain",hierarchyLevel:5,children:[{text:" Mechanism ",hierarchyLevel:6,children:[{text:" Sympathetic postganglionic neuron projects out into the bloodvessels.",hierarchyLevel:7,children:[],index:"01020203000000"},{text:" Noradrenaline accumulates at the varicosities of thepostganglionic neuron.",hierarchyLevel:7,children:[],index:"01020203000001"},{text:" Upon the arrival of the action potential on the postganglionicneurons, noradrenaline is released, binding to the \u03b11-adrenoreceptors,causing vasoconstriction.",hierarchyLevel:7,children:[],index:"01020203000002"}],index:"010202030000"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010202030001"}],index:"0102020300"},{text:" Sympathetic Control via Direct Sympathetic Chain (adrenal gland)",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Adrenaline is released from the adrenal gland",hierarchyLevel:7,children:[],index:"01020203010000"},{text:" Adrenaline binds to the \u03b22-adrenoreceptors, leading tovasodilatation.",hierarchyLevel:7,children:[],index:"01020203010001"}],index:"010202030100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010202030101"}],index:"0102020301"}],index:"01020203"},{text:" Negative Feedback Control of Blood Pressure Monitoring",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0102020400"}],index:"01020204"}],index:"010202"},{text:" Arterial Baroreflex",hierarchyLevel:3,children:[{text:" Mechanism of Arterial Baroreflex",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"010203000000"},{text:" ",hierarchyLevel:6,children:[],index:"010203000001"}],index:"0102030000"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Baroreceptors in the aorta arch sense the amount of stretchcaused by the ejection of blood from the left ventricle",hierarchyLevel:6,children:[],index:"010203000100"},{text:" Baroreceptors in the carotid sinuses sense the amount of stretchcaused by the ejection of blood from the left ventricle.",hierarchyLevel:6,children:[],index:"010203000101"},{text:" A nerve impulse is sent from the aortic baroreceptor via thevagus nerve to the brain stem.",hierarchyLevel:6,children:[],index:"010203000102"},{text:" A nerve impulse is sent from the carotid sinus baroreceptor viathe nasopharyngeal nerve to the brain stem.",hierarchyLevel:6,children:[],index:"010203000103"},{text:" Upon receiving the nerve impulses, the brain stem inhibitssympathetic activation and increases parasympathetic activation.",hierarchyLevel:6,children:[],index:"010203000104"},{text:" This leads to bradycardia and vasodiltation.",hierarchyLevel:6,children:[],index:"010203000105"}],index:"0102030001"}],index:"01020300"},{text:" Effect of Blood Pressure Changes on Nerve Activity",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0102030100"},{text:" Observations",hierarchyLevel:5,children:[{text:" There is an increased rate of carotid sinus nerve impulse firingwhen the arterial pressure is higher.",hierarchyLevel:6,children:[],index:"010203010100"},{text:" Increased nerve impulse firing frate from the carotid sinusresults in reduced firing rate of the sympathetic cardiac nerve and thesympathetic vasoconstrictor nerves.",hierarchyLevel:6,children:[],index:"010203010101"}],index:"0102030101"}],index:"01020301"},{text:" Pressure Range Limitation of Baroreceptors",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0102030200"},{text:" Observations",hierarchyLevel:5,children:[{text:" Increased action potential firing only starts from 50mm Hg",hierarchyLevel:6,children:[],index:"010203020100"},{text:" Followed by slow increase in firing until 80mm Hg, as 50mm Hg to80mm Hg there is still space in the aorta and barely any distention.",hierarchyLevel:6,children:[],index:"010203020101"},{text:" After 80mm Hg, there is increased distention of the aorta and theafferent impulses increases significantly.",hierarchyLevel:6,children:[],index:"010203020102"},{text:" After 120mm Hg, the aorta is reaching the limit of distension.Therefore, further increases in pressure does not cause significant stretchingof the aorta, leading to a lesser increase in the afferent impulses.",hierarchyLevel:6,children:[],index:"010203020103"}],index:"0102030201"}],index:"01020302"},{text:" Valsalva Manuouevre",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Observe the baroreceptor reflex clinically",hierarchyLevel:6,children:[],index:"010203030000"}],index:"0102030300"},{text:" Procedure",hierarchyLevel:5,children:[{text:" Patients take a deep breath",hierarchyLevel:6,children:[],index:"010203030100"},{text:" Try to blow air out while holding the mouth and nose closed",hierarchyLevel:6,children:[],index:"010203030101"},{text:" This generates significant pressure within the chest and anincrease in the intrathoracic pressure.",hierarchyLevel:6,children:[],index:"010203030102"},{text:" Increase in the intrathoracic pressure will increase the pressurein the great veins, preventing venous return.",hierarchyLevel:6,children:[],index:"010203030103"},{text:" Reduced venous return causes fall in preload, resulting in fallin stroke volume, resulting in the fall in cardiac output.",hierarchyLevel:6,children:[],index:"010203030104"},{text:" Due to the fall in stroke volume, the body compensates byincreasing heart rate to maintain blood pressure.",hierarchyLevel:6,children:[],index:"010203030105"},{text:" After 30 seconds, the patient will release the pressure,resulting in the intrathoracic pressure to return to normal, this results in ahuge increase in venous return.",hierarchyLevel:6,children:[],index:"010203030106"},{text:" As a result, this results a massive increase in the strokevolume. The body responds by initiating bradycardia",hierarchyLevel:6,children:[],index:"010203030107"}],index:"0102030301"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0102030302"},{text:" Observations",hierarchyLevel:5,children:[{text:" Gaps between the arterial pressure peaks decreased during holdingof pressure, indicating increased heart rate.",hierarchyLevel:6,children:[],index:"010203030300"},{text:" Gaps between arterial pressure peaks increased after holding ofpressure, indicating decreased heart rate.",hierarchyLevel:6,children:[],index:"010203030301"},{text:" Slight increase in the arterial pressure towards the end of theholding period, indicating compensation by vasoconstriction.",hierarchyLevel:6,children:[],index:"010203030302"}],index:"0102030303"}],index:"01020303"},{text:" Effect of Gravity on Venous return",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0102030400"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Changing to a standing posture results in the pooling of blood atthe lower limbs. This significantly reduces the venous return.",hierarchyLevel:6,children:[],index:"010203040100"},{text:" If the baroreceptor reflex does not work, the lack of venousreturn will cause blood pressure to plummet, hence resulting in syncope(fainting).",hierarchyLevel:6,children:[],index:"010203040101"},{text:" The baroreceptor reflex increases the cardiac output, resultingin greater venous return to compensate for the standing posture.",hierarchyLevel:6,children:[],index:"010203040102"}],index:"0102030401"}],index:"01020304"},{text:" Effect of Acute Haemorrhage on Venous return",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0102030500"}],index:"01020305"},{text:" Effect of Acute Cardiac Failure with Baroreceptor reflex",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0102030600"},{text:" Consequences",hierarchyLevel:5,children:[{text:" Increasing cardiac work results in cardiac hypertrophy.",hierarchyLevel:6,children:[],index:"010203060100"},{text:" Cardiac hypertrophy invades into the lumen space, resulting inreduction in stroke volume, resulting in reduction in blood pressure.",hierarchyLevel:6,children:[],index:"010203060101"},{text:" This results in the activation of the baroreceptor reflex again,leading to more compensation by sympathetic nervous system.",hierarchyLevel:6,children:[],index:"010203060102"},{text:" Increase sympathetic nervous system activation leads to the heartbeating harder and faster again, leading to a vicious cycle.",hierarchyLevel:6,children:[],index:"010203060103"},{text:" Loss in blood pressure will result in activation of therenin-angiotensin-system, resulting in increase fluid retention, causingincreased preload and increase contractility and heart, leading to a viciouscycle.",hierarchyLevel:6,children:[],index:"010203060104"}],index:"0102030601"}],index:"01020306"},{text:" Adjustment of Baroreceptor reflex during exercise",hierarchyLevel:4,children:[{text:" Problem",hierarchyLevel:5,children:[{text:" During exercise, the blood pressure increases significantly toincrease blood flow to the muscles.",hierarchyLevel:6,children:[],index:"010203070000"},{text:" However, this might activate the baroreceptor reflex which maycounteract and compensate to oppose the increased blood pressure",hierarchyLevel:6,children:[],index:"010203070001"}],index:"0102030700"},{text:" Solution",hierarchyLevel:5,children:[{text:" During exercise, the sensitivity of the baroreceptor reflex isreduced, hence requiring is much higher increase in blood pressure to triggerthe baroreceptor reflex.",hierarchyLevel:6,children:[],index:"010203070100"}],index:"0102030701"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" The central command of the brain knows about the impendingexercise, resulting in feeding forward to the parasympathetic system andsympathetic nervous system.",hierarchyLevel:6,children:[],index:"010203070200"},{text:" In the parasympathetic nervous system, this causes increase infiring down the cardiac vagal nerve, causing it to be harder to activate theparasympathetic system in the heart.",hierarchyLevel:6,children:[],index:"010203070201"},{text:" In the sympathetic nervous system, this causes increased firingto the heart.",hierarchyLevel:6,children:[],index:"010203070202"},{text:" The chemoreceptor responds to the increased pCO ,which sends a signal to inhibit the parasympathetic nervous system whileincreasing activation of the sympathetic nervous system.",hierarchyLevel:6,children:[],index:"010203070203"},{text:" Feedback from the muscles and joints causes the sending of asignal to inhibit the parasympathetic nervous system while increasingactivation of the sympathetic nervous system.",hierarchyLevel:6,children:[],index:"010203070204"},{text:" Due to the numerous inputs received by the parasympathetic andsympathetic nervous system, the sympathetic and nervous system now becomes lesssensitive to the opposing inputs provided by the baroreceptors. As a result,the baroreceptors require a much large input to overcome all the other opposinginputs.",hierarchyLevel:6,children:[],index:"010203070205"}],index:"0102030702"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0102030703"}],index:"01020307"}],index:"010203"},{text:" Other receptors",hierarchyLevel:3,children:[{text:" Atrial receptors",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Stretch receptors located in the atria",hierarchyLevel:6,children:[],index:"010204000000"}],index:"0102040000"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Increased filling pressure stimulates atrial receptors,stimulating it to increase cardiac output",hierarchyLevel:6,children:[],index:"010204000100"},{text:" Increased cardiac output results in more blood being ejected fromthe heart, resulting in the ability of the ventricles to take in more bloodfrom the atria, hence reducing atrial filling pressure.",hierarchyLevel:6,children:[],index:"010204000101"}],index:"0102040001"}],index:"01020400"},{text:" Ventricular Mechanoreceptors",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" During the overfilling of the ventricles, the ventricularmechanoreceptors are activated.",hierarchyLevel:6,children:[],index:"010204010000"},{text:" The ventricular mechanoreceptors stimulates bradycardia andvasodilation.",hierarchyLevel:6,children:[],index:"010204010001"},{text:" This prepares the heart to eject more blood than normal.Bradycardia enables for more time for the pressure in the heart to decreaseagain during isovolumetric relaxation before the next very forcefulcontraction. Vasodilation enables ease of ejection of blood into the aorta.",hierarchyLevel:6,children:[],index:"010204010002"}],index:"0102040100"}],index:"01020401"},{text:" Chemoreceptors",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0102040200"},{text:" Normal Mechanism",hierarchyLevel:5,children:[{text:" Decrease in PO  is detected by the peripheralchemoreceptors and the increase in PCO  is detected by the centralchemoreceptors.",hierarchyLevel:6,children:[],index:"010204020100"},{text:" The chemoreceptors stimulates increase in ventilation rate torestore PCO  and PO  concentrations.",hierarchyLevel:6,children:[],index:"010204020101"},{text:" The chemoreceptors stimulates increase in firing of thesympathetic nervous system, leading to increase heart rate, cardiac output andblood pressure. Sympathetic nervous system stimulates vasoconstriction, furtherincreasing blood pressure.",hierarchyLevel:6,children:[],index:"010204020102"}],index:"0102040201"},{text:" Abnormal Mechanism",hierarchyLevel:5,children:[{text:" Decrease in PO  is detected by the peripheralchemoreceptors and the increase in PCO  is detected by the centralchemoreceptors.",hierarchyLevel:6,children:[],index:"010204020200"},{text:" The chemoreceptors stimulates increase in ventilation rate torestore PCO  and PO  concentrations.",hierarchyLevel:6,children:[],index:"010204020201"},{text:" However, due to respiratory disease, an increased ventilationrate cannot be achieved. The stretch receptors in the lungs detect the lack ofincrease in ventilation rate.",hierarchyLevel:6,children:[],index:"010204020202"},{text:" The stretch receptors stimulates the increase in firing of theparasympathetic nervous system, resulting in bradycardia. A lowered heart rateenables a lower delivery of oxygenate blood to tissues that do not reallyrequire it. A lowered heart rate conserves energy used by the heart, and hencerequires less oxygen to maintain itself.",hierarchyLevel:6,children:[],index:"010204020203"}],index:"0102040202"}],index:"01020402"}],index:"010204"}],index:"0102"}]},{text:"Heart",hierarchyLevel:1,children:[{text:" [004] Cardiac Action Potentials",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Understand generation of action potentials and spontaneousheartbeat",hierarchyLevel:4,children:[],index:"02000000"},{text:" Understand propagation of action potentials",hierarchyLevel:4,children:[],index:"02000001"},{text:" Understand excitation-contraction coupling",hierarchyLevel:4,children:[],index:"02000002"},{text:" Understand pathophysiology of EC coupling",hierarchyLevel:4,children:[],index:"02000003"}],index:"020000"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" General Properties",hierarchyLevel:4,children:[{text:" A heart can spontaneously beat even when removed from body",hierarchyLevel:5,children:[],index:"0200010000"}],index:"02000100"},{text:" Electrical System",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Action potentials start from the sinoatrial node, whichpropagates throughout the right and left atrium and to the atrioventricularnode",hierarchyLevel:6,children:[],index:"020001010000"},{text:" From the atrioventricular node, the action potential travels tothe Bundle of His, into the two bundle branches and into the Purkinje fibreswhich innervates the left and right ventricles",hierarchyLevel:6,children:[],index:"020001010001"}],index:"0200010100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0200010101"},{text:" Property",hierarchyLevel:5,children:[{text:" Full spontaneous generation  spontaneous activity of generationof action potential can be initiated form any part of the electrical system. Ifone part of the system fails, another part can conduct the spontaneousgeneration of action potentials instead. Cardiomyocytes can generate its ownaction potential",hierarchyLevel:6,children:[],index:"020001010200"},{text:" Dominance of pacemaker  the part of the electrical system withthe highest frequency will become the dominant pacemaker, and will beresponsible for the generation of action potential",hierarchyLevel:6,children:[],index:"020001010201"}],index:"0200010102"},{text:" Frequency Ranking",hierarchyLevel:5,children:[{text:" SA node  highest frequency (100 fires / min)  primary pacemaker",hierarchyLevel:6,children:[],index:"020001010300"},{text:" AV node  medium frequency (60  40 fires / min)  secondarypacemaker",hierarchyLevel:6,children:[],index:"020001010301"},{text:" Others  lower frequency (< 40 fires / min)  tertiary pacemaker",hierarchyLevel:6,children:[],index:"020001010302"},{text:" Cardiomyocytes  very low frequency",hierarchyLevel:6,children:[],index:"020001010303"}],index:"0200010103"}],index:"02000101"},{text:" Cardiomyocytes",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Able to generate its own action potential",hierarchyLevel:6,children:[],index:"020001020000"}],index:"0200010200"},{text:" Structure",hierarchyLevel:5,children:[{text:" Nucelli (one per cell) are centrally located within each cell",hierarchyLevel:6,children:[],index:"020001020100"},{text:" Contains an intercalated disc which enables for attachment withother cells",hierarchyLevel:6,children:[],index:"020001020101"}],index:"0200010201"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"020001020200"}],index:"0200010202"}],index:"02000102"},{text:" Cardiac Fibers",hierarchyLevel:4,children:[{text:" Structure",hierarchyLevel:5,children:[{text:" Fibres branch and interconnect",hierarchyLevel:6,children:[],index:"020001030000"},{text:" Consists of individual cells attached end-to-end",hierarchyLevel:6,children:[],index:"020001030001"}],index:"0200010300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0200010301"}],index:"02000103"}],index:"020001"},{text:" Cardiac Action Potentials",hierarchyLevel:3,children:[{text:" Cardiac Action Potential",hierarchyLevel:4,children:[{text:" Methodology of Experimentation",hierarchyLevel:5,children:[{text:" Measure and detect the membrane potential of a cell in each partof the conducting system",hierarchyLevel:6,children:[],index:"020002000000"}],index:"0200020000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0200020001"},{text:" Analysis",hierarchyLevel:5,children:[{text:" Order of Depolarization: SA Node > Atrium > AV Node >Purkinje Fibre > Endocardium > Midmyocardium > Epicardium",hierarchyLevel:6,children:[],index:"020002000200"},{text:" Shape: Each location has a slightly different shape ofdepolarization (rate of depolarization)",hierarchyLevel:6,children:[],index:"020002000201"}],index:"0200020002"}],index:"02000200"},{text:" Types of Action Potentials",hierarchyLevel:4,children:[{text:" Steps",hierarchyLevel:5,children:[{text:" [0] Fast depolarization",hierarchyLevel:6,children:[],index:"020002010000"},{text:" [1] Small repolarization",hierarchyLevel:6,children:[],index:"020002010001"},{text:" [2] Plateau",hierarchyLevel:6,children:[],index:"020002010002"},{text:" [3] Repolarization",hierarchyLevel:6,children:[],index:"020002010003"},{text:" [4] Resting membrane potential",hierarchyLevel:6,children:[],index:"020002010004"}],index:"0200020100"},{text:" Spontaneous Action Potential (Slow)",hierarchyLevel:5,children:[{text:" Starts with a slow upstroke of membrane potential followed by arapid rise",hierarchyLevel:6,children:[],index:"020002010100"},{text:" This is because the generation of action potential occurs withinthe cell, and it needs to hit the threshold potential before the fast upstroke",hierarchyLevel:6,children:[],index:"020002010101"}],index:"0200020101"},{text:" Induced Action Potential (Fast)",hierarchyLevel:5,children:[{text:" Starts with a very fast upstroke of the membrane potential, thisis due to the activation of the action potential being from a neighboring celland not from within",hierarchyLevel:6,children:[],index:"020002010200"}],index:"0200020102"}],index:"02000201"},{text:" Ion Currents in Action Potentials",hierarchyLevel:4,children:[{text:" Analysis",hierarchyLevel:5,children:[{text:" Maintenance of peak depolarization is due to Ca influx",hierarchyLevel:6,children:[],index:"020002020000"},{text:" Repolarization is mainly driven by outflow of K  ions",hierarchyLevel:6,children:[],index:"020002020001"}],index:"0200020200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0200020201"}],index:"02000202"},{text:" Importance of Spontaneous Action Potentials",hierarchyLevel:4,children:[{text:" Determine the pacemaker which triggers the excitatory wave of theheart",hierarchyLevel:5,children:[],index:"0200020300"},{text:" Regulate the frequency of heartbeat by changing the shape ofaction potentials in the SA node",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" By increasing the threshold for rapid depolarization, it takes alonger time for the cell to achieve the threshold membrane potential. Hence,the rate of heartbeat will slow down.",hierarchyLevel:7,children:[],index:"02000203010000"},{text:" By decreasing the threshold for rapid depolarization, it takes ashorter time or the cell to achieve the threshold membrane potential. Hence,the rate of the heartbeat will speed up.",hierarchyLevel:7,children:[],index:"02000203010001"},{text:" By decreasing the slope of depolarization, it takes a longer timefor the cell to achieve the threshold membrane potential. Hence, the rate ofheartbeat will slow down.",hierarchyLevel:7,children:[],index:"02000203010002"},{text:" By increasing the slope of depolarization, it takes a shortertime or the cell to achieve the threshold membrane potential. Hence, the rateof the heartbeat will speed up.",hierarchyLevel:7,children:[],index:"02000203010003"}],index:"020002030100"},{text:" Components",hierarchyLevel:6,children:[{text:" Parasympathetic System",hierarchyLevel:7,children:[],index:"02000203010100"},{text:" Sympathetic System",hierarchyLevel:7,children:[],index:"02000203010101"}],index:"020002030101"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020002030102"}],index:"0200020301"}],index:"02000203"},{text:" Importance of Ventricular Action Potentials",hierarchyLevel:4,children:[{text:" Contraction",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" To trigger contraction of the ventricles",hierarchyLevel:7,children:[],index:"02000204000000"}],index:"020002040000"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Rapid depolarization causes the influx of Ca  ions,this results in the triggering of the contraction of the ventricular cells",hierarchyLevel:7,children:[],index:"02000204000100"}],index:"020002040001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020002040002"}],index:"0200020400"},{text:" Relaxation",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" To trigger the relaxation of ventricles",hierarchyLevel:7,children:[],index:"02000204010000"}],index:"020002040100"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Ca2+ signal  becomes weaker and weaker andeventually turns off",hierarchyLevel:7,children:[],index:"02000204010100"},{text:" Turning off of the Ca  signal causes the relaxationof the ventricular cells",hierarchyLevel:7,children:[],index:"02000204010101"},{text:" Turning off of the Ca  signal causes therepolarization of the ventricular cells",hierarchyLevel:7,children:[],index:"02000204010102"}],index:"020002040101"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020002040102"}],index:"0200020401"}],index:"02000204"},{text:" Action Potential Refractory Period",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" To prevent two contractions of the heart at the same time",hierarchyLevel:6,children:[],index:"020002050000"},{text:" Serves as a safety mechanism to prevent the cardiomyocyte fromcontracting again during an ongoing contraction",hierarchyLevel:6,children:[],index:"020002050001"}],index:"0200020500"},{text:" General Mechanism",hierarchyLevel:5,children:[{text:" Cardiomyocytes needs to be repolarized before it can receiveanother action potential and contract again",hierarchyLevel:6,children:[],index:"020002050100"},{text:" Repolarization of cardiomyocytes occurs during the relaxation ofthe cardiomyocytes",hierarchyLevel:6,children:[],index:"020002050101"},{text:" Therefore, cardiomyocytes cannot receive a second actionpotential during an ongoing contraction",hierarchyLevel:6,children:[],index:"020002050102"}],index:"0200020501"},{text:" Types",hierarchyLevel:5,children:[{text:" Effective Refractory Period",hierarchyLevel:6,children:[{text:" Timeframe",hierarchyLevel:7,children:[{text:" Rapid Depolarization => Before Repolarization",hierarchyLevel:8,children:[],index:"0200020502000000"}],index:"02000205020000"},{text:" Property",hierarchyLevel:7,children:[{text:" No new action potential can be generated during the ERP",hierarchyLevel:8,children:[],index:"0200020502000100"}],index:"02000205020001"}],index:"020002050200"},{text:" Relative Refractory Period",hierarchyLevel:6,children:[{text:" Timeframe",hierarchyLevel:7,children:[{text:" Repolarization => Before Resting Membrane Potential",hierarchyLevel:8,children:[],index:"0200020502010000"}],index:"02000205020100"},{text:" Property",hierarchyLevel:7,children:[{text:" New action potential with lower amplitude can be triggered",hierarchyLevel:8,children:[],index:"0200020502010100"}],index:"02000205020101"}],index:"020002050201"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020002050202"}],index:"0200020502"}],index:"02000205"}],index:"020002"},{text:" Mechanism of Excitation Contraction Coupling",hierarchyLevel:3,children:[{text:" Structure of Cardiac Muscle Cells",hierarchyLevel:4,children:[],index:"02000300"},{text:" Structure of Muscular Contraction",hierarchyLevel:4,children:[],index:"02000301"},{text:" Muscular Contraction",hierarchyLevel:4,children:[{text:" Mechanism of Entry of Ca   activating of muscularcontraction",hierarchyLevel:5,children:[{text:" Extracellular Pathway (transmembrane)",hierarchyLevel:6,children:[{text:" Action potential is propagated outside of the muscle cell via themovement of Ca  ions",hierarchyLevel:7,children:[],index:"02000302000000"},{text:" The Ca  action potential travels down the T tubule ofthe muscle cell",hierarchyLevel:7,children:[],index:"02000302000001"},{text:" Arriving of an action potential at the T tubule activates aL-type Ca  channel on the cardiomyocyte sacrolemmal membrane, whichenables the calcium to enter the cell ",hierarchyLevel:7,children:[],index:"02000302000002"}],index:"020003020000"},{text:" Intracellular Pathway (subsacrolemmal)",hierarchyLevel:6,children:[{text:" Entry of Ca  ions form the extracellular pathwaytriggers Ryanodine receptors (RyR2) on the sarcoplasmic reticulum (sarcoplasmicreticulum luminal calcium storage)",hierarchyLevel:7,children:[],index:"02000302000100"},{text:" Opening of the Ryanodine receptors causes the outflow of Ca ions from the sarcoplasmic reticulum",hierarchyLevel:7,children:[],index:"02000302000101"},{text:" Increase in Ca  concentration in the sarcoplasmresults in the contraction of the muscle cell",hierarchyLevel:7,children:[],index:"02000302000102"}],index:"020003020001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020003020002"}],index:"0200030200"},{text:" Mechanism of Reuptake of Ca   activating muscularrelaxation",hierarchyLevel:5,children:[{text:" Ca  ATPase pumps Ca  from the sarcoplasmto outside of the cell",hierarchyLevel:6,children:[],index:"020003020100"},{text:" Sacrolemmal Na  / Ca  exchanger exchangesCa  from the sarcoplasm to outside of the cell for entry of Na into the cell",hierarchyLevel:6,children:[],index:"020003020101"},{text:" Sacroplasmic Reticulum Ca  ATPase pumps Ca from the sarcoplasm back into the sarcoplasmic reticulum (reuptake)",hierarchyLevel:6,children:[],index:"020003020102"},{text:" Decrease in Ca  concentration results in therelaxation of muscles (blocking by ToI)",hierarchyLevel:6,children:[],index:"020003020103"}],index:"0200030201"},{text:" Mechanism of Muscular Contraction",hierarchyLevel:5,children:[{text:" Definitions",hierarchyLevel:6,children:[{text:" TnT  Troponin T (structural)",hierarchyLevel:7,children:[],index:"02000302020000"},{text:" TnC  Troponin C (Ca  binding)",hierarchyLevel:7,children:[],index:"02000302020001"},{text:" TnI  Troponin I (inhibits actin-myosin binding)",hierarchyLevel:7,children:[],index:"02000302020002"}],index:"020003020200"},{text:" Process",hierarchyLevel:6,children:[{text:" Troponin I block the binding between actin and myosin",hierarchyLevel:7,children:[],index:"02000302020100"},{text:" When the Ca  signal arrives, it binds to Troponin C,and rearranges the troponin complex such that Troponin I is no longer blockingthe binding between the actin and myosin",hierarchyLevel:7,children:[],index:"02000302020101"},{text:" Myosin head then binds to actin molecules",hierarchyLevel:7,children:[],index:"02000302020102"}],index:"020003020201"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020003020202"}],index:"0200030202"}],index:"02000302"},{text:" Mechanism of Regulation of Contractile Force (via sympatheticpathway)",hierarchyLevel:4,children:[{text:" Overview Explanation",hierarchyLevel:5,children:[{text:" Sympathetic pathway innervates the sacrolemmal membrane andtherefore can directly cause a generation of stronger muscular contractileforce",hierarchyLevel:6,children:[],index:"020003030000"},{text:" Parasympathetic pathway does not innervate the sacrolemmalmembrane and therefore cannot directly control the contractile force",hierarchyLevel:6,children:[],index:"020003030001"},{text:" Both sympathetic and parasympathetic pathway innervatesspontaneous muscle cells (SA node) enabling control of heart rate",hierarchyLevel:6,children:[],index:"020003030002"}],index:"0200030300"},{text:" Overview Diagram",hierarchyLevel:5,children:[],index:"0200030301"},{text:" Process",hierarchyLevel:5,children:[{text:" Catecholamines (adrenaline, noradrenaline) bind to metabotropiccell surface receptors, resulting in the activation of G proteins.",hierarchyLevel:6,children:[],index:"020003030200"},{text:" G proteins activate Adenylyl cyclase (AC) which results in therelease of cyclic Adenosine monophosphate (cAMP) in the sarcoplasm",hierarchyLevel:6,children:[],index:"020003030201"},{text:" Increase in cAMP activates protein kinase A.",hierarchyLevel:6,children:[],index:"020003030202"},{text:" Protein kinase A phosphorylates  RyR and L-type Ca channel, which causes larger calcium fluxes and greater release of Ca ,leading to a stronger muscular contraction",hierarchyLevel:6,children:[],index:"020003030203"},{text:" Protein kinase A phosphorylates sacrolemmal Na  / Ca exchanger and phospholamban (linked to sacroplasmic Reticulum Ca ATPase), which causes a greater rate of reuptake and removal of Ca ions, leading to successful relaxation of muscles",hierarchyLevel:6,children:[],index:"020003030204"}],index:"0200030302"},{text:" Process Diagram",hierarchyLevel:5,children:[],index:"0200030303"}],index:"02000303"},{text:" Mechanism of Phospholamban and Sacroplasmic Reticulum Ca ATPase",hierarchyLevel:4,children:[{text:" Function of Phospholamban",hierarchyLevel:5,children:[{text:" Limits the Sacroplasmic Reticulum Ca2+ ATPase activity",hierarchyLevel:6,children:[],index:"020003040000"}],index:"0200030400"},{text:" Mechanism\ufffd ",hierarchyLevel:5,children:[{text:" Protein kinase A phosphorylates phospholamban, causing it to moveaway from Sacroplasmic Reticulum Ca2+ ATPase",hierarchyLevel:6,children:[],index:"020003040100"},{text:" Decoupling of phospholamban with Sacroplasmic Reticulum Ca2+ATPase, enables Sacroplasmic Reticulum Ca2+ ATPase activity to no longer belimited",hierarchyLevel:6,children:[],index:"020003040101"},{text:" Therefore, activity of Sacroplasmic Reticulum Ca2+ ATPaseincreases, increasing the rate of re-uptake of Ca ions",hierarchyLevel:6,children:[],index:"020003040102"}],index:"0200030401"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0200030402"}],index:"02000304"}],index:"020003"},{text:" Diagnostics, pathology and therapy of Excitation Contraction Coupling",hierarchyLevel:3,children:[{text:" Importance of Understanding the Channels causing Ionic Currentsof Action Potential",hierarchyLevel:4,children:[{text:" Identifying a channel enables us to understand its role in pathology.This enables us to understand diseases related to certain genes and proteins",hierarchyLevel:5,children:[],index:"0200040000"},{text:" Identifying channels enables us to find drugs which acts asinhibitors for these channels",hierarchyLevel:5,children:[],index:"0200040001"}],index:"02000400"},{text:" Overview of Channels",hierarchyLevel:4,children:[],index:"02000401"},{text:" Types",hierarchyLevel:4,children:[{text:" I  (current funny)  Na",hierarchyLevel:5,children:[{text:" Properties",hierarchyLevel:6,children:[{text:" Normal Voltage-gated Ion channel behavior",hierarchyLevel:7,children:[{text:" Voltage-gated Ion Channel opens when depolarization of themembrane potential reaches a threshold potential (upwards)",hierarchyLevel:8,children:[],index:"0200040200000000"}],index:"02000402000000"},{text:" I  channel behavior",hierarchyLevel:7,children:[{text:" I  opens when there is hyperpolarization of themembrane potential (downwards)",hierarchyLevel:8,children:[],index:"0200040200000100"}],index:"02000402000001"}],index:"020004020000"},{text:" Implications",hierarchyLevel:6,children:[{text:" Hyperpolarization occurs naturally without any external stimulus",hierarchyLevel:7,children:[],index:"02000402000100"},{text:" Therefore, using hyperpolarization as a trigger for activation ofI  enables the spontaneous (self-activation) action potentialsto be generated.",hierarchyLevel:7,children:[],index:"02000402000101"}],index:"020004020001"}],index:"0200040200"},{text:" Fast voltage dependent Na  channels  similar tochannels found in neurons",hierarchyLevel:5,children:[],index:"0200040201"},{text:" T-type  highly sensitive to voltage (low threshold channels)",hierarchyLevel:5,children:[],index:"0200040202"},{text:" L-type  less sensitive to voltage (high threshold channels) requires high calcium levels, generates and maintains the peak membranepotential",hierarchyLevel:5,children:[],index:"0200040203"},{text:" K inward rectifying / delayed rectifier  similar tochannels found in neurones",hierarchyLevel:5,children:[],index:"0200040204"},{text:" K ATP sensitive  functions as a metabolic sensor",hierarchyLevel:5,children:[],index:"0200040205"},{text:" K  acetyl-choline sensitive  regulated by theparasympathetic system",hierarchyLevel:5,children:[],index:"0200040206"},{text:" Cl  - voltage dependent ion channels",hierarchyLevel:5,children:[],index:"0200040207"}],index:"02000402"},{text:" Diseases related to ion channels",hierarchyLevel:4,children:[{text:" Channelopathies",hierarchyLevel:5,children:[{text:" Definitions",hierarchyLevel:6,children:[{text:" Channelopathies  mutations in ion channels (K  and Na )responsible for action potential generation",hierarchyLevel:7,children:[],index:"02000403000000"}],index:"020004030000"},{text:" Prevalence",hierarchyLevel:6,children:[{text:" Rare",hierarchyLevel:7,children:[],index:"02000403000100"}],index:"020004030001"},{text:" Effects",hierarchyLevel:6,children:[{text:" Does not cause any problems with resting heart function mutations that cause problems in resting heart function would have caused theindividual to die in the early embryonic stage",hierarchyLevel:7,children:[],index:"02000403000200"},{text:" Responsible for 85% of Sudden Death Syndrome",hierarchyLevel:7,children:[],index:"02000403000201"}],index:"020004030002"},{text:" Disease manifestations",hierarchyLevel:6,children:[{text:" Long QT Syndrome",hierarchyLevel:7,children:[],index:"02000403000300"},{text:" Idiopathic Ventricular Fibrillation",hierarchyLevel:7,children:[],index:"02000403000301"}],index:"020004030003"}],index:"0200040300"},{text:" Refractory period errors",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" During the relative refractory period, a new action potential canbe triggered, leading to arrhythmias",hierarchyLevel:7,children:[],index:"02000403010000"}],index:"020004030100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020004030101"}],index:"0200040301"},{text:" Excitation Contraction Coupling Errors leading to Heart Failure",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" When the heart starts to fail, it leads to a reduced arterialblood pressure.",hierarchyLevel:7,children:[],index:"02000403020000"},{text:" This triggers a reflex which activates the sympathetic system,which tries to maintain the activity of the heart to maintain the bloodpressure",hierarchyLevel:7,children:[],index:"02000403020001"},{text:" This leads to a constant activation of the heart by thesympathetic system. ",hierarchyLevel:7,children:[],index:"02000403020002"},{text:" Long-lasting activation of the heart leads to pathologicalchanges",hierarchyLevel:7,children:[{text:" Hyperphosphorylation of RyR2 receptors, resulting in Ca leak, which causes contraction of the heart out of the rhythm",hierarchyLevel:8,children:[],index:"0200040302000300"},{text:" Reduces the trigger signal from L-type Ca  channels,resulting in the heart being unable to contract as strongly",hierarchyLevel:8,children:[],index:"0200040302000301"},{text:" Downregulation of sarcoplasmic reticulum Ca  ATPase,which leads to the loss of capacity in the uptake of calcium, resulting in thereduce of calcium storage",hierarchyLevel:8,children:[],index:"0200040302000302"},{text:" Upregulation of sacrolemmal Na  Ca exchange, removing more Ca  hence less Ca  can be usedto trigger a contraction",hierarchyLevel:8,children:[],index:"0200040302000303"}],index:"02000403020003"},{text:" This leads to the derangement of the calcium signaling networkand hence the loss of contractile force",hierarchyLevel:7,children:[],index:"02000403020004"}],index:"020004030200"}],index:"0200040302"}],index:"02000403"},{text:" Drugs and Mechanisms",hierarchyLevel:4,children:[{text:" Ca  inhibition",hierarchyLevel:5,children:[{text:" Effects",hierarchyLevel:6,children:[{text:" Reduced frequency of action potential (SA)",hierarchyLevel:7,children:[],index:"02000404000000"},{text:" Reduced peak of action potential (SA)",hierarchyLevel:7,children:[],index:"02000404000001"},{text:" Faster repolarization of membrane potential (ventricle), hencelower force of muscular contraction, hence lower cardiac output and hence lesscardiac work done",hierarchyLevel:7,children:[],index:"02000404000002"}],index:"020004040000"},{text:" Extended Effects",hierarchyLevel:6,children:[{text:" Reduce frequency and cardiac output",hierarchyLevel:7,children:[],index:"02000404000100"},{text:" Stimulates vasodilation, which lowers peripheral resistance",hierarchyLevel:7,children:[],index:"02000404000101"},{text:" Lowered cardiac output and lowered peripheral resistance causesthe arterial blood pressure to fall",hierarchyLevel:7,children:[],index:"02000404000102"}],index:"020004040001"},{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"02000404000200"}],index:"020004040002"}],index:"0200040400"}],index:"02000404"},{text:" Electrocardiogram (ECG)",hierarchyLevel:4,children:[{text:" Concept",hierarchyLevel:5,children:[{text:" Records changes in the electrical potential on the surface of thechest, which reflects the actual cardiac action potentials on the surface ofthe heart",hierarchyLevel:6,children:[],index:"020004050000"}],index:"0200040500"},{text:" Principle",hierarchyLevel:5,children:[{text:" The potential both sides of the membrane is different",hierarchyLevel:6,children:[],index:"020004050100"},{text:" The potential on different parts of the heart is different",hierarchyLevel:6,children:[],index:"020004050101"}],index:"0200040501"},{text:" Mechanism of Function",hierarchyLevel:5,children:[{text:" Analyzing the differences of membrane potentials of differentparts of the heart (resting and activated) using different leads and electrodeson different parts of the body",hierarchyLevel:6,children:[],index:"020004050200"},{text:" An activation of the heart leads to depolarization and theformation of the action potential, which propagates from the top right of theheart (SA) to the bottom left of the heart (apex of ventricles)",hierarchyLevel:6,children:[],index:"020004050201"},{text:" The direction of movement of action potential is the cardiac vector",hierarchyLevel:6,children:[],index:"020004050202"},{text:" Electrodes are placed on different sides of the cardiac vector,forming the triangle (Eindhoven triangle)",hierarchyLevel:6,children:[],index:"020004050203"},{text:" When a depolarization travels to a positive pole of the lead, itresults in a positive deflection of the ECG at that lead",hierarchyLevel:6,children:[],index:"020004050204"},{text:" When a repolarization travels to a negative pole of the lead, itresults in a negative deflection of the ECG at that lead",hierarchyLevel:6,children:[],index:"020004050205"},{text:" Different waves of the ECG corresponds to the differentactivation of different parts of the heart",hierarchyLevel:6,children:[],index:"020004050206"},{text:" Repolarization moves backwards from the vector, from the parts ofthe heart that is depolarized last to the parts that are repolarized first",hierarchyLevel:6,children:[],index:"020004050207"}],index:"0200040502"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"020004050300"}],index:"0200040503"}],index:"02000405"},{text:" Skeletal Muscle",hierarchyLevel:4,children:[],index:"02000406"},{text:" Sliding Filament Model of MuscleContraction",hierarchyLevel:4,children:[],index:"02000407"}],index:"020004"}],index:"0200"},{text:" [007] Muscles and Blood Vessels",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Muscle Types",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" Skeletal muscle",hierarchyLevel:6,children:[],index:"020100000000"},{text:" Cardiac muscle",hierarchyLevel:6,children:[],index:"020100000001"},{text:" Smooth muscle",hierarchyLevel:6,children:[],index:"020100000002"}],index:"0201000000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0201000001"}],index:"02010000"}],index:"020100"},{text:" Skeletal Muscle",hierarchyLevel:3,children:[{text:" Organization",hierarchyLevel:4,children:[{text:" Myofibres  muscle cell",hierarchyLevel:5,children:[],index:"0201010000"}],index:"02010100"},{text:" Properties",hierarchyLevel:4,children:[{text:" Very large  100\u03bcm in diameter",hierarchyLevel:5,children:[],index:"0201010100"},{text:" Very long  3cm",hierarchyLevel:5,children:[],index:"0201010101"},{text:" Many nuclei on periphery",hierarchyLevel:5,children:[],index:"0201010102"},{text:" No special junction between cells",hierarchyLevel:5,children:[],index:"0201010103"},{text:" Contains many mitochondria",hierarchyLevel:5,children:[],index:"0201010104"}],index:"02010101"}],index:"020101"},{text:" Cardiac Muscle",hierarchyLevel:3,children:[{text:" General Organisation",hierarchyLevel:4,children:[],index:"02010200"},{text:" Organisation of Purkinje Fibres",hierarchyLevel:4,children:[],index:"02010201"}],index:"020102"},{text:" Smooth Muscle",hierarchyLevel:3,children:[{text:" Properties",hierarchyLevel:4,children:[{text:" Small cells",hierarchyLevel:5,children:[],index:"0201030000"},{text:" 2-5 \u03bcm in diameter",hierarchyLevel:5,children:[],index:"0201030001"},{text:" 300 \u03bcm long",hierarchyLevel:5,children:[],index:"0201030002"},{text:" Spindle shaped",hierarchyLevel:5,children:[],index:"0201030003"},{text:" Singe central nucleus",hierarchyLevel:5,children:[],index:"0201030004"},{text:" Not striated",hierarchyLevel:5,children:[],index:"0201030005"},{text:" Joined by gap junctions",hierarchyLevel:5,children:[],index:"0201030006"},{text:" Innervated by autonomic nerves",hierarchyLevel:5,children:[],index:"0201030007"},{text:" No sarcomeres",hierarchyLevel:5,children:[],index:"0201030008"},{text:" No t-tubules ",hierarchyLevel:5,children:[],index:"0201030009"}],index:"02010300"},{text:" Organisation of Smooth Muscle",hierarchyLevel:4,children:[{text:" Structural Diagram",hierarchyLevel:5,children:[],index:"0201030100"},{text:" Histological Diagram",hierarchyLevel:5,children:[],index:"0201030101"},{text:" Histological Analysis",hierarchyLevel:5,children:[{text:" Nuclei is cigar shaped",hierarchyLevel:6,children:[],index:"020103010200"},{text:" Nuclei is within the cells not in the periphery of each cell(like in skeletal)",hierarchyLevel:6,children:[],index:"020103010201"},{text:" Connective tissue stains much less than smooth muscle",hierarchyLevel:6,children:[],index:"020103010202"},{text:" Connective tissue has a smaller number of nuclei compared tosmooth muscle",hierarchyLevel:6,children:[],index:"020103010203"}],index:"0201030102"},{text:" Histological Diagram",hierarchyLevel:5,children:[],index:"0201030103"},{text:" Histological Analysis",hierarchyLevel:5,children:[{text:" Skeletal muscle has much less nuclei than in smooth muscle",hierarchyLevel:6,children:[],index:"020103010400"},{text:" Nuclei: Smooth muscle > Connective Tissue > Skeletal muscle",hierarchyLevel:6,children:[],index:"020103010401"},{text:" Smooth muscle has nuclei located centrally in the cell whileSkeletal muscle has nuclei located in the periphery",hierarchyLevel:6,children:[],index:"020103010402"},{text:" Different shade of staining between skeletal and connectivetissue",hierarchyLevel:6,children:[],index:"020103010403"},{text:" Artifact present between skeletal muscle, connective tissue andsmooth muscle",hierarchyLevel:6,children:[],index:"020103010404"}],index:"0201030104"}],index:"02010301"},{text:" Contraction of Smooth Muscle",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0201030200"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Contraction acts like a string bag",hierarchyLevel:6,children:[],index:"020103020100"},{text:" Contraction activated by the movements of actin and myosin",hierarchyLevel:6,children:[],index:"020103020101"}],index:"0201030201"}],index:"02010302"},{text:" Stomach",hierarchyLevel:4,children:[{text:" Explanation",hierarchyLevel:5,children:[{text:" Multiple layers of smooth muscle is present in the stomach indifferent orientations, enabling complex churning movements of the stomach",hierarchyLevel:6,children:[],index:"020103030000"}],index:"0201030300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0201030301"}],index:"02010303"}],index:"020103"},{text:" Vascular Muscle",hierarchyLevel:3,children:[{text:" Pressure",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0201040000"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Much higher pressure in arteries than veins and capillaries",hierarchyLevel:6,children:[],index:"020104000100"},{text:" Physiology of arteries is different to accommodate for higherblood pressure",hierarchyLevel:6,children:[],index:"020104000101"}],index:"0201040001"}],index:"02010400"},{text:" Organization",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0201040100"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Much larger amount of smooth muscle ",hierarchyLevel:6,children:[],index:"020104010100"},{text:" Component proteins of smooth muscle in arteries is different",hierarchyLevel:6,children:[],index:"020104010101"}],index:"0201040101"}],index:"02010401"},{text:" Structure",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0201040200"},{text:" Components",hierarchyLevel:5,children:[{text:" Tunica Intima",hierarchyLevel:6,children:[{text:" Endothelium",hierarchyLevel:7,children:[],index:"02010402010000"},{text:" Basement membrane",hierarchyLevel:7,children:[],index:"02010402010001"},{text:" Internal elastic lamina",hierarchyLevel:7,children:[],index:"02010402010002"}],index:"020104020100"},{text:" Tunica Media",hierarchyLevel:6,children:[{text:" Smooth muscle",hierarchyLevel:7,children:[],index:"02010402010100"},{text:" External elastic lamina",hierarchyLevel:7,children:[],index:"02010402010101"}],index:"020104020101"},{text:" Tunica Adventitia",hierarchyLevel:6,children:[{text:" Connective tissue",hierarchyLevel:7,children:[],index:"02010402010200"}],index:"020104020102"}],index:"0201040201"},{text:" Explanation",hierarchyLevel:5,children:[{text:" The elastic lamina only exists in the arterial system and not inthe vein system",hierarchyLevel:6,children:[],index:"020104020200"}],index:"0201040202"}],index:"02010402"},{text:" Elastic arteries (aorta)",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0201040300"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Tunica media is full of elastic fibres within the smooth musclelayer",hierarchyLevel:6,children:[],index:"020104030100"}],index:"0201040301"}],index:"02010403"},{text:" Muscular Arteries",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0201040400"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Tunica media is dominated by smooth muscle layer, with elasticlayer on the inside and the outside",hierarchyLevel:6,children:[],index:"020104040100"}],index:"0201040401"}],index:"02010404"},{text:" Vascular Structures",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0201040500"},{text:" Types of Capillaries",hierarchyLevel:5,children:[],index:"0201040501"},{text:" Atherosclerosis",hierarchyLevel:5,children:[],index:"0201040502"}],index:"02010405"}],index:"020104"}],index:"0201"},{text:" [044] Spread of Excitation through the Heart",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Explain the origin of the heartbeat",hierarchyLevel:4,children:[],index:"02020000"},{text:" Draw and label a diagram of the heat and locate the primary andsecondary pacemakers of the heart",hierarchyLevel:4,children:[],index:"02020001"},{text:" Explain how excitation spread through the myocardium",hierarchyLevel:4,children:[],index:"02020002"},{text:" Draw and label a diagram of the heart and locate the specializedconducting fibres of the heart",hierarchyLevel:4,children:[],index:"02020003"},{text:" Describe the influence of the autonomic nervous system",hierarchyLevel:4,children:[],index:"02020004"},{text:" Describe and explain the time-relationship between electricalexcitation and muscle contraction",hierarchyLevel:4,children:[],index:"02020005"},{text:" Draw and label an ECG obtained with standard limb leads",hierarchyLevel:4,children:[],index:"02020006"},{text:" Describe in basic terms how, and which, electrical events of theheart give rise to electrical potentials on the skin which can be recorded asthe electrocardiogram",hierarchyLevel:4,children:[],index:"02020007"},{text:" Define the terms: inotropic and chronotropic in relation to heartfunction",hierarchyLevel:4,children:[],index:"02020008"}],index:"020200"},{text:" Cardiac Action Potential",hierarchyLevel:3,children:[{text:" Structure and Function of the Cardiac Action Potential",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0202010000"}],index:"02020100"},{text:" Types of Cardiac Action Potential",hierarchyLevel:4,children:[{text:" Slow Depolarization (spontaneous generation)",hierarchyLevel:5,children:[{text:" Origin cell",hierarchyLevel:6,children:[{text:" Unstable myocyte",hierarchyLevel:7,children:[],index:"02020101000000"}],index:"020201010000"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Hyperpolarization due to the constant action of the sodiumpotassium pump results in the activation of Na  I channels",hierarchyLevel:7,children:[],index:"02020101000100"},{text:" Influx of Na ions via the I  channelsresults in the threshold potential being reached.",hierarchyLevel:7,children:[],index:"02020101000101"},{text:" Reaching of the threshold potential results in the opening ofvoltage-gated calcium channels, resulting in the rapid influx of calcium ions. ",hierarchyLevel:7,children:[],index:"02020101000102"},{text:" Influx of calcium ions causes faster depolarization of themembrane potential to +30 mV.",hierarchyLevel:7,children:[],index:"02020101000103"},{text:" Influx of calcium ion causes the contraction of the myocyte.",hierarchyLevel:7,children:[],index:"02020101000104"},{text:" Depolarization also causes slow responding K  channelsto open, resulting in the influx of K  ions into the cell.",hierarchyLevel:7,children:[],index:"02020101000105"},{text:" This causes the repolarization and hyperpolarization of the cellmembrane potential to less than -70mV, and the cycle repeats.",hierarchyLevel:7,children:[],index:"02020101000106"}],index:"020201010001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020201010002"}],index:"0202010100"},{text:" Fast Depolarization (peer dependent generation)",hierarchyLevel:5,children:[{text:" Origin cell",hierarchyLevel:6,children:[{text:" Regular myocyte",hierarchyLevel:7,children:[],index:"02020101010000"}],index:"020201010100"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Entry of Na  ions via desmosomes results in thedepolarization of the membrane potential and hence activation of the voltagegated Na  channels.",hierarchyLevel:7,children:[],index:"02020101010100"},{text:" This results in the extremely rapid depolarization of themembrane potential.",hierarchyLevel:7,children:[],index:"02020101010101"},{text:" Continuous exit of K+ ions results in a slight r epolarization of themembrane potential.",hierarchyLevel:7,children:[],index:"02020101010102"},{text:" However,  the opening of the Ca2+ channels r esults in the steady andcontinuous influx of Ca  ions, results in the maintenance of themembrane potential at +10mV, causing the formation of the plateau phase.",hierarchyLevel:7,children:[],index:"02020101010103"},{text:" Entry of Ca  ions also results in the contraction ofthe myocyte.",hierarchyLevel:7,children:[],index:"02020101010104"},{text:" Closure of the Ca  channels results in the relaxationof the myocyte. Continuous movement of K ions out of the cellsresults in the repolarization of the membrane potential.",hierarchyLevel:7,children:[],index:"02020101010105"}],index:"020201010101"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020201010102"}],index:"0202010101"}],index:"02020101"},{text:" Phases of the Cardiac Cycle",hierarchyLevel:4,children:[{text:" Phases",hierarchyLevel:5,children:[{text:" Phase 0: Upstroke, rapid depolarization from (Na / Ca )",hierarchyLevel:6,children:[],index:"020201020000"},{text:" Phase 1: Rapid initial repolarization (K )",hierarchyLevel:6,children:[],index:"020201020001"},{text:" Phase 2: The Plateau (Ca  / K )",hierarchyLevel:6,children:[],index:"020201020002"},{text:" Phase 3: Rapid repolarization (K )",hierarchyLevel:6,children:[],index:"020201020003"},{text:" Phase 4: Resting potential (K ) or Pacemaking Potential(Na )",hierarchyLevel:6,children:[],index:"020201020004"}],index:"0202010200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0202010201"}],index:"02020102"},{text:" Unstable Myocyte Dominance",hierarchyLevel:4,children:[{text:" Principle",hierarchyLevel:5,children:[{text:" The highest frequency unstable myocyte will take over as thepacemaker. This is because the high frequency unstable myocyte will trigger thedepolarization in neighbouring myocytes before it could self-activates its ownaction potential",hierarchyLevel:6,children:[],index:"020201030000"},{text:" If the highest frequency unstable myocyte fails, then the nexthighest frequency unstable  myocyte will take over as the pacem aker.",hierarchyLevel:6,children:[],index:"020201030001"}],index:"0202010300"},{text:" Hierarchy of Pacemaker Frequency",hierarchyLevel:5,children:[{text:" SA Node  100 bpm",hierarchyLevel:6,children:[],index:"020201030100"},{text:" AV Node  40 bpm",hierarchyLevel:6,children:[],index:"020201030101"},{text:" Purkinje fibres  <30bpm",hierarchyLevel:6,children:[],index:"020201030102"}],index:"0202010301"}],index:"02020103"},{text:" Varying shapes of Action Potential in the Heart",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0202010400"}],index:"02020104"},{text:" Conduction Times in the Heart",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0202010500"},{text:" Observations",hierarchyLevel:5,children:[{text:" Rapid depolarization from SA node to right atrium",hierarchyLevel:6,children:[],index:"020201050100"},{text:" Some delay for left atrium depolarization, resulting in secondpart of P wave or biphasic P wave",hierarchyLevel:6,children:[],index:"020201050101"},{text:" 100-150ms delay for AV node to depolarize and activate a newaction potential",hierarchyLevel:6,children:[],index:"020201050102"},{text:" Relatively quick conduction time throughout the ventricles",hierarchyLevel:6,children:[],index:"020201050103"},{text:" Significant delay before repolarization",hierarchyLevel:6,children:[],index:"020201050104"}],index:"0202010501"}],index:"02020105"}],index:"020201"},{text:" ECG",hierarchyLevel:3,children:[{text:" Segments of an ECG",hierarchyLevel:4,children:[],index:"02020200"}],index:"020202"},{text:" ECG Limb Leads",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Lead  a combination of electrodes that enables to see theelectrical activity of a particular plane in the heart (does not refer toelectrodes).",hierarchyLevel:5,children:[],index:"0202030000"}],index:"02020300"},{text:" Types Limb Leads",hierarchyLevel:4,children:[{text:" Standard Limb Leads",hierarchyLevel:5,children:[{text:" Lead I: Right arm to left arm (across the chest)  left movement(+ve)",hierarchyLevel:6,children:[],index:"020203010000"},{text:" Lead II: Right arm to left leg",hierarchyLevel:6,children:[],index:"020203010001"},{text:" Lead III: Left arm to left leg",hierarchyLevel:6,children:[],index:"020203010002"},{text:" Reference electrode on right leg ",hierarchyLevel:6,children:[],index:"020203010003"}],index:"0202030100"},{text:" Augmented Limb Leads",hierarchyLevel:5,children:[],index:"0202030101"}],index:"02020301"},{text:" Principle behind using limb leads",hierarchyLevel:4,children:[{text:" Limb leads contains mainly skeletal muscle which has the lowestresistivity.",hierarchyLevel:5,children:[],index:"0202030200"},{text:" Due to the low resistivity, the placement location of the lead onthe limb does not matter as the electrical signals conducts very quicklythrough the limb.",hierarchyLevel:5,children:[],index:"0202030201"},{text:" Therefore, doctors typically put the limb leads at the very startof the limb, right at the chest.",hierarchyLevel:5,children:[],index:"0202030202"}],index:"02020302"},{text:" Limb Lead Placement Location",hierarchyLevel:4,children:[{text:" Principles",hierarchyLevel:5,children:[{text:" Equidistant from the heart",hierarchyLevel:6,children:[],index:"020203030000"},{text:" Equidistant on the limbs",hierarchyLevel:6,children:[],index:"020203030001"},{text:" Aligned on the torso",hierarchyLevel:6,children:[],index:"020203030002"}],index:"0202030300"},{text:" Placement Procedure (chest)",hierarchyLevel:5,children:[{text:" Start from the mid clavicular line, feel for the sternal anglegap in the chest (rib 2), and place the RA lead and LA lead right below rib 2of the chest",hierarchyLevel:6,children:[],index:"020203030100"},{text:" Place the RL and LL aligned to the RA and LA, towards the bottomof the ribcage.",hierarchyLevel:6,children:[],index:"020203030101"},{text:" This forms a box around the heart.",hierarchyLevel:6,children:[],index:"020203030102"}],index:"0202030301"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0202030302"}],index:"02020303"},{text:" Leads",hierarchyLevel:4,children:[{text:" Lead I",hierarchyLevel:5,children:[{text:" Recorded Movements",hierarchyLevel:6,children:[{text:" A left movement of positive charges will result in a +ve reading",hierarchyLevel:7,children:[],index:"02020304000000"}],index:"020203040000"},{text:" Formula",hierarchyLevel:6,children:[{text:" Lead I = V   V",hierarchyLevel:7,children:[],index:"02020304000100"}],index:"020203040001"},{text:" Explanation of Formula",hierarchyLevel:6,children:[{text:" In depolarization, a wave of positive ions moves.",hierarchyLevel:7,children:[],index:"02020304000200"},{text:" The formula takes the voltage on the left and subtracts it withthe voltage on the right.",hierarchyLevel:7,children:[],index:"02020304000201"},{text:" During depolarization, the depolarization reaches the right andhence the voltage is initially more positive, and therefore the reading will benegative or close to 0.",hierarchyLevel:7,children:[],index:"02020304000202"},{text:" As the depolarization travels to the left, the voltage on theleft becomes more and more positive than the right, and therefore the readingwill be more positive.",hierarchyLevel:7,children:[],index:"02020304000203"}],index:"020203040002"},{text:" Explanation of Diagram",hierarchyLevel:6,children:[{text:" Initial depolarization of atria  +ve right to left (+ve)",hierarchyLevel:7,children:[],index:"02020304000300"},{text:" Return of depolarization to SA node  +ve left to right (-ve)",hierarchyLevel:7,children:[],index:"02020304000301"},{text:" Depolarization of bundle of His  +ve right to left (+ve)",hierarchyLevel:7,children:[],index:"02020304000302"},{text:" Depolarization of ventricles  +ve left to right (-ve)",hierarchyLevel:7,children:[],index:"02020304000303"},{text:" Repolarization of bundle of His - -ve left to right (+ve)",hierarchyLevel:7,children:[],index:"02020304000304"}],index:"020203040003"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020203040004"}],index:"0202030400"},{text:" Lead II",hierarchyLevel:5,children:[{text:" Recorded Movements",hierarchyLevel:6,children:[{text:" A left and downwards movement of positive charges will results ina +ve reading",hierarchyLevel:7,children:[],index:"02020304010000"}],index:"020203040100"},{text:" Formula",hierarchyLevel:6,children:[{text:" Lead II = V   V",hierarchyLevel:7,children:[],index:"02020304010100"}],index:"020203040101"},{text:" Key observations",hierarchyLevel:6,children:[{text:" Greater ventricular positive signal because the bundle of His isalmost directly parallel to the leads.",hierarchyLevel:7,children:[],index:"02020304010200"},{text:" The same applies for ventricular repolarization via the T wave.",hierarchyLevel:7,children:[],index:"02020304010201"}],index:"020203040102"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020203040103"}],index:"0202030401"},{text:" Lead III",hierarchyLevel:5,children:[{text:" Recorded Movement",hierarchyLevel:6,children:[{text:" A right and downwards of positive charges will result in a +vereading",hierarchyLevel:7,children:[],index:"02020304020000"}],index:"020203040200"},{text:" Formula",hierarchyLevel:6,children:[{text:" Lead III = V  V",hierarchyLevel:7,children:[],index:"02020304020100"}],index:"020203040201"},{text:" Key observations",hierarchyLevel:6,children:[{text:" Smaller positive potential. While depolarization generally movedownwards, there is very little left to right movement.",hierarchyLevel:7,children:[],index:"02020304020200"}],index:"020203040202"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020203040203"}],index:"0202030402"},{text:" Lead aVL (augmented vector left)",hierarchyLevel:5,children:[{text:" Recorded Movement",hierarchyLevel:6,children:[{text:" An upwards and leftwards movement of positive charges willresults in a +ve reading",hierarchyLevel:7,children:[],index:"02020304030000"}],index:"020203040300"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020203040301"}],index:"0202030403"},{text:" Lead aVR (augmented vector right)",hierarchyLevel:5,children:[{text:" Recorded Movement",hierarchyLevel:6,children:[{text:" A downwards and much more leftward movement of positive chargeswill result in a +ve reading",hierarchyLevel:7,children:[],index:"02020304040000"}],index:"020203040400"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020203040401"}],index:"0202030404"},{text:" Lead aVF (augmented vector foot)",hierarchyLevel:5,children:[{text:" Recorded Movement",hierarchyLevel:6,children:[{text:" A downward excitation of positive charges will results in a +vereading",hierarchyLevel:7,children:[],index:"02020304050000"}],index:"020203040500"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020203040501"}],index:"0202030405"}],index:"02020304"},{text:" Einthovens Triangle",hierarchyLevel:4,children:[{text:" Application of Einthovens Triangle  identify position of theheart",hierarchyLevel:5,children:[{text:" Measure the QRS amplitude on the 3 Leads",hierarchyLevel:6,children:[],index:"020203050000"},{text:" Observe which leads has the highest QRS amplitude.",hierarchyLevel:6,children:[],index:"020203050001"},{text:" The lead with the highest QRS amplitude is the lead where thelead which the heart is the most aligned to.",hierarchyLevel:6,children:[],index:"020203050002"},{text:" To find the exact angle, plot each QRS amplitude on hex-axialdiagram, draw perpendicular lines onto the end of the magnitude of each lead,and find the intersection point.",hierarchyLevel:6,children:[],index:"020203050003"},{text:" This enables doctors to  detect left axis deviation  or right axis deviation ofthe heart due to ventricular hypertrophy.",hierarchyLevel:6,children:[],index:"020203050004"}],index:"0202030500"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"020203050100"}],index:"0202030501"}],index:"02020305"}],index:"020203"},{text:" Chest Lead ECG",hierarchyLevel:3,children:[{text:" Principles",hierarchyLevel:4,children:[{text:" The 6 electrodes converge at a central cortex of the heart.",hierarchyLevel:5,children:[],index:"0202040000"},{text:" The cortex of the heart is set to a voltage of 0, and theelectrical signals moving away from the cortex of the heart is recorded.",hierarchyLevel:5,children:[],index:"0202040001"}],index:"02020400"},{text:" Observations",hierarchyLevel:4,children:[{text:" Lead that is aligned with the Bundle of His will give a verylarge QRS complex.",hierarchyLevel:5,children:[],index:"0202040100"},{text:" Due to the transverse plane, the shapes of the ECG will bedifferent.",hierarchyLevel:5,children:[],index:"0202040101"}],index:"02020401"},{text:" Big Picture",hierarchyLevel:4,children:[{text:" Chest Leads (6) and Limb Leads (3 standard, 3 augmented) are usedtogether to form a 12 lead ECG",hierarchyLevel:5,children:[],index:"0202040200"}],index:"02020402"},{text:" Fetal ECG",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Electrodes are placed on the abdomen to record the fetal ECG.",hierarchyLevel:6,children:[],index:"020204030000"},{text:" An additional electrode is inserted through the vagina to filterout the materal ECG and only retain the fetal ECG.",hierarchyLevel:6,children:[],index:"020204030001"}],index:"0202040300"}],index:"02020403"},{text:" Diagram",hierarchyLevel:4,children:[],index:"02020404"}],index:"020204"}],index:"0202"},{text:" [046] ECG and heart disease",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" To list key information that can be gained from an ECG",hierarchyLevel:4,children:[],index:"02030000"},{text:" To list common indications for recording an ECG",hierarchyLevel:4,children:[],index:"02030001"},{text:" To gain familiarity with a 12 lead ECG",hierarchyLevel:4,children:[],index:"02030002"},{text:" To describe the basic PQRST nomenclature and how the leads relateto anatomy",hierarchyLevel:4,children:[],index:"02030003"},{text:" To appreciate the basic principles of ECG interpretation withexamples",hierarchyLevel:4,children:[],index:"02030004"}],index:"020300"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Purpose of ECG",hierarchyLevel:4,children:[{text:" Detect rhythm disturbances",hierarchyLevel:5,children:[{text:" Sinus node dysfunction",hierarchyLevel:6,children:[],index:"020301000000"},{text:" Supra-ventricular and ventricular arrhythmias",hierarchyLevel:6,children:[],index:"020301000001"},{text:" AV node dysfunction",hierarchyLevel:6,children:[],index:"020301000002"},{text:" Intra-ventricular conduction",hierarchyLevel:6,children:[],index:"020301000003"},{text:" Myocardial ischaemia / infarction",hierarchyLevel:6,children:[],index:"020301000004"}],index:"0203010000"},{text:" Detect secondary effects of diseases",hierarchyLevel:5,children:[{text:" Lung disorders",hierarchyLevel:6,children:[],index:"020301000100"},{text:" Systemic medical conditions",hierarchyLevel:6,children:[],index:"020301000101"},{text:" Electrolyte disturbance",hierarchyLevel:6,children:[],index:"020301000102"},{text:" Environmental disturbance",hierarchyLevel:6,children:[],index:"020301000103"}],index:"0203010001"},{text:" Detect Chamber hypertrophy / damage",hierarchyLevel:5,children:[],index:"0203010002"},{text:" Detect congenital heart disease / inherited electrical disorders",hierarchyLevel:5,children:[],index:"0203010003"}],index:"02030100"},{text:" Limitations of an ECG",hierarchyLevel:4,children:[{text:" Unable to show cardiac function  electrical activity does notalways correlate with proper contraction (Pulseless Electrical Activity normal ECG but non beating heart)",hierarchyLevel:5,children:[],index:"0203010100"},{text:" Only shows a static snapshot in time of electrical activity",hierarchyLevel:5,children:[],index:"0203010101"},{text:" Unable to detect underlying coronary heart disease",hierarchyLevel:5,children:[],index:"0203010102"},{text:" Unable to detect intermittent conduction problems",hierarchyLevel:5,children:[],index:"0203010103"}],index:"02030101"},{text:" Application of ECG as a clinical indication",hierarchyLevel:4,children:[{text:" Investigation of symptoms or signs  palpitations, chest pain,shortness of breath, syncope",hierarchyLevel:5,children:[],index:"0203010200"},{text:" Investigation of a sick patient",hierarchyLevel:5,children:[],index:"0203010201"},{text:" Monitoring therapy",hierarchyLevel:5,children:[],index:"0203010202"},{text:" Choice of therapy",hierarchyLevel:5,children:[],index:"0203010203"},{text:" Routine medical checkup",hierarchyLevel:5,children:[],index:"0203010204"},{text:" Risk stratification",hierarchyLevel:5,children:[],index:"0203010205"},{text:" Family screening",hierarchyLevel:5,children:[],index:"0203010206"}],index:"02030102"}],index:"020301"},{text:" ECG Nomenclature and Characteristics",hierarchyLevel:3,children:[{text:" Parts of the ECG graph",hierarchyLevel:4,children:[],index:"02030200"},{text:" Classification of Leads to Anatomy",hierarchyLevel:4,children:[],index:"02030201"}],index:"020302"},{text:" Interpretation of ECG",hierarchyLevel:3,children:[{text:" Interpreting Axis Deviation",hierarchyLevel:4,children:[{text:" Interpretation",hierarchyLevel:5,children:[{text:" Lead I is negative when potential moves right",hierarchyLevel:6,children:[],index:"020303000000"},{text:" Lead I is positive when potential moves left",hierarchyLevel:6,children:[],index:"020303000001"},{text:" aVF is positive when potential moves down",hierarchyLevel:6,children:[],index:"020303000002"},{text:" aVF is negative when potential moves up",hierarchyLevel:6,children:[],index:"020303000003"},{text:" Turning the heart changes the up, down, left, right, direction ofthe movement of potential down the bundle of His",hierarchyLevel:6,children:[],index:"020303000004"}],index:"0203030000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0203030001"},{text:" Causes of Axis Deviation",hierarchyLevel:5,children:[],index:"0203030002"}],index:"02030300"},{text:" Interpreting His-Purkinje network",hierarchyLevel:4,children:[{text:" Narrow QRS complex (<120ms)",hierarchyLevel:5,children:[{text:" Diagnosis",hierarchyLevel:6,children:[{text:" Normal ventricular activation",hierarchyLevel:7,children:[],index:"02030301000000"}],index:"020303010000"}],index:"0203030100"},{text:" Broad QRS complex (>= 120ms)",hierarchyLevel:5,children:[{text:" Diagnosis",hierarchyLevel:6,children:[{text:" Abnormal ventricular activation ",hierarchyLevel:7,children:[],index:"02030301010000"},{text:" Bundle branch block",hierarchyLevel:7,children:[],index:"02030301010001"},{text:" Ventricular pre-excitation",hierarchyLevel:7,children:[],index:"02030301010002"}],index:"020303010100"}],index:"0203030101"},{text:" Independent ventricular activation",hierarchyLevel:5,children:[{text:" Diagnosis",hierarchyLevel:6,children:[{text:" Ventricular tachycardia",hierarchyLevel:7,children:[],index:"02030301020000"}],index:"020303010200"}],index:"0203030102"}],index:"02030301"},{text:" Bundle Branch Block",hierarchyLevel:4,children:[{text:" Left Bundle Branch Block",hierarchyLevel:5,children:[{text:" Characteristics",hierarchyLevel:6,children:[{text:" V1  QRS complex is inverted",hierarchyLevel:7,children:[],index:"02030302000000"},{text:" V6  peak has a notch",hierarchyLevel:7,children:[],index:"02030302000001"}],index:"020303020000"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020303020001"}],index:"0203030200"},{text:" Right Bundle Branch Block",hierarchyLevel:5,children:[{text:" Characteristics",hierarchyLevel:6,children:[{text:" V1  SRS pattern",hierarchyLevel:7,children:[],index:"02030302010000"},{text:" Trend towards left axis deviation",hierarchyLevel:7,children:[],index:"02030302010001"}],index:"020303020100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020303020101"}],index:"0203030201"}],index:"02030302"},{text:" Interpreting Myocardial Infarction (MI)",hierarchyLevel:4,children:[{text:" Characteristics",hierarchyLevel:5,children:[{text:" ST elevation",hierarchyLevel:6,children:[],index:"020303030000"}],index:"0203030300"},{text:" Diagram",hierarchyLevel:5,children:[{text:" Inferior MI",hierarchyLevel:6,children:[],index:"020303030100"},{text:" Antero-Lateral MI",hierarchyLevel:6,children:[],index:"020303030101"}],index:"0203030301"}],index:"02030303"},{text:" Interpreting Ischemia",hierarchyLevel:4,children:[{text:" Characteristics",hierarchyLevel:5,children:[{text:" ST depression",hierarchyLevel:6,children:[],index:"020303040000"}],index:"0203030400"},{text:" Leads",hierarchyLevel:5,children:[{text:" II, III",hierarchyLevel:6,children:[],index:"020303040100"}],index:"0203030401"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0203030402"}],index:"02030304"},{text:" Interpreting Atrial Fibrillation",hierarchyLevel:4,children:[{text:" Characteristics",hierarchyLevel:5,children:[{text:" Lack of P wave",hierarchyLevel:6,children:[],index:"020303050000"}],index:"0203030500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0203030501"}],index:"02030305"},{text:" Preparation procedures when analyzing ECG",hierarchyLevel:4,children:[{text:" Check the person having their ECG recorded. Ensure the right personis being recorded.",hierarchyLevel:5,children:[],index:"0203030600"},{text:" Check time of recording and the date of birth.",hierarchyLevel:5,children:[],index:"0203030601"},{text:" Look at computer generated statistics",hierarchyLevel:5,children:[{text:" QRSD  QRS duration",hierarchyLevel:6,children:[],index:"020303060200"},{text:" QT  QT interval",hierarchyLevel:6,children:[],index:"020303060201"},{text:" Interpretation of ECG by the programmes",hierarchyLevel:6,children:[],index:"020303060202"},{text:" Speed of the ECG recording",hierarchyLevel:6,children:[],index:"020303060203"},{text:" Voltage of ECG recording",hierarchyLevel:6,children:[],index:"020303060204"}],index:"0203030602"}],index:"02030306"},{text:" ECG Interpretation",hierarchyLevel:4,children:[{text:" Steps",hierarchyLevel:5,children:[{text:" General",hierarchyLevel:6,children:[{text:" Rate",hierarchyLevel:7,children:[],index:"02030307000000"},{text:" Rhythm",hierarchyLevel:7,children:[],index:"02030307000001"},{text:" Axis",hierarchyLevel:7,children:[],index:"02030307000002"}],index:"020303070000"},{text:" Wave specific",hierarchyLevel:6,children:[{text:" P wave",hierarchyLevel:7,children:[],index:"02030307000100"},{text:" PR interval",hierarchyLevel:7,children:[],index:"02030307000101"},{text:" QRS complex",hierarchyLevel:7,children:[],index:"02030307000102"},{text:" ST segment",hierarchyLevel:7,children:[],index:"02030307000103"},{text:" T wave",hierarchyLevel:7,children:[],index:"02030307000104"},{text:" QT interval",hierarchyLevel:7,children:[],index:"02030307000105"}],index:"020303070001"}],index:"0203030700"},{text:" Rate",hierarchyLevel:5,children:[{text:" Formula",hierarchyLevel:6,children:[{text:" Paper speed is 25mm/s = 1500mm/min = 300big squares/min",hierarchyLevel:7,children:[],index:"02030307010000"},{text:" Heart rate/min = 300 / number of large squares between beats",hierarchyLevel:7,children:[],index:"02030307010001"}],index:"020303070100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020303070101"}],index:"0203030701"},{text:" Rhythm",hierarchyLevel:5,children:[{text:" Sinus Rhythm",hierarchyLevel:6,children:[{text:" Characteristics",hierarchyLevel:7,children:[{text:" Each QRS is preceded by a normal P wave, indicating SA nodeorigin of conduction (pacemaker)",hierarchyLevel:8,children:[],index:"0203030702000000"},{text:" PR interval is 120  200ms, indicating intact AV node conduction",hierarchyLevel:8,children:[],index:"0203030702000001"},{text:" 1:1 P:QRS ratio indicating no AV block",hierarchyLevel:8,children:[],index:"0203030702000002"},{text:" QRS shape is normal and duration is < 120ms, indicating rapidand synchronized ventricular depolarization",hierarchyLevel:8,children:[],index:"0203030702000003"}],index:"02030307020000"},{text:" Diagram",hierarchyLevel:7,children:[],index:"02030307020001"}],index:"020303070200"},{text:" Bradycardia < 60 beats / min",hierarchyLevel:6,children:[{text:" Characteristics",hierarchyLevel:7,children:[{text:" Failure of impulse generation due to SA node disease",hierarchyLevel:8,children:[],index:"0203030702010000"},{text:" Failure of impulse propagation due to AV node or His Purkinjedisease (AV block)",hierarchyLevel:8,children:[],index:"0203030702010001"}],index:"02030307020100"},{text:" Diagram",hierarchyLevel:7,children:[],index:"02030307020101"}],index:"020303070201"},{text:" Tachycardia > 100 beats / min",hierarchyLevel:6,children:[{text:" Narrow Complex (< 120ms)",hierarchyLevel:7,children:[{text:" Characteristics",hierarchyLevel:8,children:[{text:" Conduction via intact conduction system",hierarchyLevel:9,children:[],index:"020303070202000000"},{text:" Supra-ventricular tachycardia",children:[],index:"020303070202000001"}],index:"0203030702020000"}],index:"02030307020200"},{text:" Broad Complex (> 120ms)",hierarchyLevel:7,children:[{text:" Characteristics",hierarchyLevel:8,children:[{text:" Conduction system impaired",hierarchyLevel:9,children:[],index:"020303070202010000"},{text:" Supra-ventricular tachycardia with Bundle Branch Block",children:[],index:"020303070202010001"}],index:"0203030702020100"}],index:"02030307020201"},{text:" Atrial Flutter",hierarchyLevel:7,children:[{text:" Diagram",hierarchyLevel:8,children:[],index:"0203030702020200"}],index:"02030307020202"},{text:" Atrial Fibrillation",hierarchyLevel:7,children:[{text:" Diagram",hierarchyLevel:8,children:[],index:"0203030702020300"}],index:"02030307020203"}],index:"020303070202"}],index:"0203030702"}],index:"02030307"},{text:" Interpreting AV block (Bradycardia)",hierarchyLevel:4,children:[{text:" 1  degree AV block",hierarchyLevel:5,children:[{text:" Characteristics",hierarchyLevel:6,children:[{text:" All P waves are conducted but with prolonged PR interval",hierarchyLevel:7,children:[],index:"02030308000000"}],index:"020303080000"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020303080001"}],index:"0203030800"},{text:" 2  degree AV block",hierarchyLevel:5,children:[{text:" Characteristics",hierarchyLevel:6,children:[{text:" 2: 1 AV block  2 P waves for 1 QRS complex",hierarchyLevel:7,children:[],index:"02030308010000"}],index:"020303080100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020303080101"}],index:"0203030801"},{text:" 3  degree AV block",hierarchyLevel:5,children:[{text:" Characteristics",hierarchyLevel:6,children:[{text:" QRS complexes are regular but slow",hierarchyLevel:7,children:[],index:"02030308020000"},{text:" Very slow heart rate",hierarchyLevel:7,children:[],index:"02030308020001"},{text:" No relationship between P waves and QRS complex  PR interval isvariable, QRS is regular, showing that P waves are not triggering the QRScomplex (complete heart block)",hierarchyLevel:7,children:[],index:"02030308020002"}],index:"020303080200"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020303080201"}],index:"0203030802"}],index:"02030308"}],index:"020303"}],index:"0203"},{text:" [050] The cardiac cycle",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Describe with the aid of a diagram, the pressure changesoccurring in the heart and aorta during a cardiac cycle",hierarchyLevel:4,children:[],index:"02040000"},{text:" Describe with the aid of a diagram the way the heart valves arecontrolled by pressure differences between the chambers of the heart, atria andventricles, and the arteries, the aorta and pulmonary artery",hierarchyLevel:4,children:[],index:"02040001"},{text:" Describe and explain the phases of the cardiac cycle and thevents which delineate them",hierarchyLevel:4,children:[],index:"02040002"},{text:" Explain what is meant by isovolumetric contraction andisovolumetric relaxation in relation to the cardiac cycle",hierarchyLevel:4,children:[],index:"02040003"},{text:" Describe how the heart is filled with blood during the passivefilling phase and contribution of atrial contraction to cardiac filling",hierarchyLevel:4,children:[],index:"02040004"},{text:" Describe how blood is pumped by the heart into circulation",hierarchyLevel:4,children:[],index:"02040005"},{text:" Show with the aid of a diagram the principle heart sounds andtheir associated events in the cardiac cycle",hierarchyLevel:4,children:[],index:"02040006"},{text:" Describe common valvular abnormalities and their consequences.",hierarchyLevel:4,children:[],index:"02040007"}],index:"020400"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Wiggers diagram  shows the pressure, volume and heart soundsfor the left side of the heart",hierarchyLevel:5,children:[],index:"0204010000"},{text:" Starlings Law  energy of contraction of the ventricle is afunction of the initial length of the muscle fibres. A normal heart will ejectall blood entered during diastole. A normal heart will automatically adjustoutput to match venous return.",hierarchyLevel:5,children:[],index:"0204010001"},{text:" Isovolumetric contraction  contraction of the ventricles,increase in pressure, no change in volume",hierarchyLevel:5,children:[],index:"0204010002"},{text:" Isovolumetric relaxation  relaxation of the ventricles, decreasein pressure, no change in volume",hierarchyLevel:5,children:[],index:"0204010003"},{text:" Inotrope  an agent that alters the force or energy of muscularcontractions",hierarchyLevel:5,children:[],index:"0204010004"},{text:" **NOTE: remaining information in this lecture is repeated in[053] and will be covered there",hierarchyLevel:5,children:[],index:"0204010005"}],index:"02040100"},{text:" Comparisons between left and right ventricle stroke volume",hierarchyLevel:4,children:[{text:" Observations",hierarchyLevel:5,children:[{text:" Stroke volume between the left and right ventricles is the same",hierarchyLevel:6,children:[],index:"020401010000"},{text:" Blood exits the left ventricle at a much higher pressure than theright ventricles",hierarchyLevel:6,children:[],index:"020401010001"},{text:" Less work is required by the ventricle to output the same volumeof blood",hierarchyLevel:6,children:[],index:"020401010002"}],index:"0204010100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0204010101"}],index:"02040101"},{text:" Factors affecting the Pressure volume  loops",hierarchyLevel:4,children:[{text:" Preload",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" There is greater filling of the ventricles, resulting in higherend diastole volume of the ventricles.",hierarchyLevel:7,children:[],index:"02040102000000"},{text:" The ventricles have to contract harder to empty out the increasevolume of blood.",hierarchyLevel:7,children:[],index:"02040102000001"},{text:" This results in more work done by the ventricles and a greatercardiac output.",hierarchyLevel:7,children:[],index:"02040102000002"}],index:"020401020000"},{text:" Diagram (red line)",hierarchyLevel:6,children:[],index:"020401020001"}],index:"0204010200"},{text:" Afterload",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Due to hypertension, there is higher pressure in the aorta.",hierarchyLevel:7,children:[],index:"02040102010000"},{text:" As a result, the heart has to contract harder duringisovolumetric contraction to reach a pressure higher than the aorta.",hierarchyLevel:7,children:[],index:"02040102010001"},{text:" This results in more work done by the ventricles but without anincrease in cardiac output. ",hierarchyLevel:7,children:[],index:"02040102010002"},{text:" Due to the more work done, this increases the risk to cardiacfailure.",hierarchyLevel:7,children:[],index:"02040102010003"}],index:"020401020100"},{text:" Diagram (blue line)",hierarchyLevel:6,children:[],index:"020401020101"}],index:"0204010201"}],index:"02040102"},{text:" Frank-Starling Mechanism",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Frank-Starling Mechanism  the relationship between theend-diastolic volume and intraventricular pressure for an isolated dogventricle",hierarchyLevel:6,children:[],index:"020401030000"}],index:"0204010300"},{text:" Relationship",hierarchyLevel:5,children:[{text:" The higher the end diastolic volume, the greater theintraventricular pressure until a certain point.",hierarchyLevel:6,children:[],index:"020401030100"},{text:" Beyond the normal range, increasing the end diastolic volumenegative affects the ability of the ventricles to contract, resulting inlowered intraventricular pressure.",hierarchyLevel:6,children:[],index:"020401030101"}],index:"0204010301"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0204010302"}],index:"02040103"},{text:" Effect of Sympathetic Stimulation on Pressure-Volume loops",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Sympathetic stimulation causes positive inotropy which result ina more forceful contraction of the heart.",hierarchyLevel:6,children:[],index:"020401040000"},{text:" This results in the generation of more pressure and eject agreater volume of blood. This results in the end systolic volume to be lower.",hierarchyLevel:6,children:[],index:"020401040001"},{text:" As a result, more cardiac work is done and a greater strokevolume is achieved.",hierarchyLevel:6,children:[],index:"020401040002"}],index:"0204010400"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0204010401"}],index:"02040104"},{text:" Heart sounds",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Stenosis  narrowing",hierarchyLevel:6,children:[],index:"020401050000"},{text:" Regurgitation  the backflow of blood resulting from the failureof valves to close properly",hierarchyLevel:6,children:[],index:"020401050001"}],index:"0204010500"},{text:" Interpretation",hierarchyLevel:5,children:[{text:" The first heart sound is from the contraction of the atrium.",hierarchyLevel:6,children:[],index:"020401050100"},{text:" The second heart sound is from the closure of the mitral valve.",hierarchyLevel:6,children:[],index:"020401050101"},{text:" The third heart sound is from the close of the aortic valve.",hierarchyLevel:6,children:[],index:"020401050102"},{text:" The fourth heart sound is from ventricular relaxation resultingin turbulent entry of blood to ventricles",hierarchyLevel:6,children:[],index:"020401050103"}],index:"0204010501"},{text:" Explanation of Heart murmurs",hierarchyLevel:5,children:[{text:" Any sounds outside of the 4 heart sound points is an indicationof a valve problem.",hierarchyLevel:6,children:[],index:"020401050200"}],index:"0204010502"},{text:" Types of Valve failures and murmurs",hierarchyLevel:5,children:[{text:" Aortic stenosis  systolic murmur",hierarchyLevel:6,children:[],index:"020401050300"},{text:" Mitral stenosis  presystolic murmur",hierarchyLevel:6,children:[],index:"020401050301"},{text:" Aortic regurgitation  systolic murmur and early diastolic murmur",hierarchyLevel:6,children:[],index:"020401050302"},{text:" Mitral regurgitation  pansystolic murmur and flow murmur",hierarchyLevel:6,children:[],index:"020401050303"}],index:"0204010503"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0204010504"}],index:"02040105"},{text:" Time Course of gas exchange",hierarchyLevel:4,children:[{text:" Understanding",hierarchyLevel:5,children:[{text:" The blood takes a short amount of time to reach maximum oxygensaturation.",hierarchyLevel:6,children:[],index:"020401060000"},{text:" The remaining amount of time is used for the oxygen to enter thered blood cells and bind to haemoglobin.",hierarchyLevel:6,children:[],index:"020401060001"},{text:" During exercise, the duration of systole is significantlyshortened. However, due to rapid diffusion, the blood is still able to reachmaximum oxygen saturation even with the shorter systolic period.",hierarchyLevel:6,children:[],index:"020401060002"}],index:"0204010600"},{text:" Abnormal Function",hierarchyLevel:5,children:[{text:" In disease, the blood takes a longer time to reach maximum oxygensaturation.",hierarchyLevel:6,children:[],index:"020401060100"},{text:" As a result, due to the shorter systolic period during exercise,the blood is unable to reach maximum oxygen saturation.",hierarchyLevel:6,children:[],index:"020401060101"}],index:"0204010601"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0204010602"}],index:"02040106"}],index:"020401"}],index:"0204"},{text:" [053] Cardiodynamics and cardiac output",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" To understand the key factors that determine cardiac output",hierarchyLevel:4,children:[],index:"02050000"},{text:" To explain how cardiac output can be changed",hierarchyLevel:4,children:[],index:"02050001"}],index:"020500"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Cardiodynamics  dynamics of the heart which explains themovements and forces developed during the cardiac cycle",hierarchyLevel:5,children:[],index:"0205010000"},{text:" Ventricular systole  contraction, isovolumetric contractionfollowed by ejection",hierarchyLevel:5,children:[],index:"0205010001"},{text:" Ventricular diastole  relaxation + dilatation, isovolumetricrelaxation followed by filling",hierarchyLevel:5,children:[],index:"0205010002"},{text:" End diastolic volume (EDV)  maximum volume before contraction",hierarchyLevel:5,children:[],index:"0205010003"},{text:" End systolic volume (ESV)  the residual volume followingcontraction",hierarchyLevel:5,children:[],index:"0205010004"},{text:" Stroke Volume  the amount of blood pumped by heart per beat",hierarchyLevel:5,children:[],index:"0205010005"},{text:" Isovolumetric contraction / relaxation  large changes inpressure at constant volume, large changes in volume with small changes inpressure",hierarchyLevel:5,children:[],index:"0205010006"},{text:" Cardiac output (CO) = Heart rate x Stroke Volume",hierarchyLevel:5,children:[],index:"0205010007"},{text:" Stroke Volume = ventricular end diastolic volume  ventricularend systolic volume",hierarchyLevel:5,children:[],index:"0205010008"},{text:" Ejection fraction = stroke volume / end diastolic volume",hierarchyLevel:5,children:[],index:"0205010009"}],index:"02050100"}],index:"020501"},{text:" Pressures and Volumes in the Cardiac Cycle",hierarchyLevel:3,children:[{text:" Phases of the Cardiac Cycle",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0205020000"}],index:"02050200"},{text:" Relationship between Pressure and Volume in the Cardiac Cycle (PVLoop)",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0205020100"},{text:" Important Variables from the PV Loop",hierarchyLevel:5,children:[{text:" End diastolic volume",hierarchyLevel:6,children:[],index:"020502010100"},{text:" End systolic volume",hierarchyLevel:6,children:[],index:"020502010101"},{text:" Stroke Volume",hierarchyLevel:6,children:[],index:"020502010102"},{text:" Ejection Fraction = Stroke Volume / End Diastolic Volume",hierarchyLevel:6,children:[],index:"020502010103"},{text:" Arterial elastance (Ea) = End systolic pressure / Stroke volume(measures contractility)",hierarchyLevel:6,children:[],index:"020502010104"},{text:" Diastolic Arteriole Pressure (DAP)",hierarchyLevel:6,children:[],index:"020502010105"},{text:" Systolic Arteriole Pressure (SAP)",hierarchyLevel:6,children:[],index:"020502010106"},{text:" Pulse Pressure (PP)",hierarchyLevel:6,children:[],index:"020502010107"},{text:" Stroke Work",hierarchyLevel:6,children:[],index:"020502010108"}],index:"0205020101"}],index:"02050201"},{text:" End Diastolic Pressure Volume Relationship",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" End Diastolic Pressure Volume Relationship (EDPVR)  describesthe changes in pressure when the ventricles are relaxed as its filled withblood",hierarchyLevel:6,children:[],index:"020502020000"}],index:"0205020200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0205020201"},{text:" Explanation",hierarchyLevel:5,children:[{text:" At low volume, increasing the volume does not affect the pressureas there is still much empty space in the ventricles.",hierarchyLevel:6,children:[],index:"020502020200"},{text:" However, above 125ml, the ventricle is full and has to start tostretch and expand to accommodate the additional volume.",hierarchyLevel:6,children:[],index:"020502020201"},{text:" The stretching of the ventricle results in the application ofinward pressure on the fluid, resulting in the rapid rise in left ventricularpressure.",hierarchyLevel:6,children:[],index:"020502020202"}],index:"0205020202"}],index:"02050202"},{text:" End Systolic Pressure Volume Relationship",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" End Systolic Pressure Volume Relationship (ESPVR)  shows thepeak pressure the ventricles containing a certain amount of blood can generate",hierarchyLevel:6,children:[],index:"020502030000"}],index:"0205020300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0205020301"},{text:" Explanation",hierarchyLevel:5,children:[{text:" The more blood the ventricles are filled with, the greater thepressure the ventricles are able to generate during ventricular contraction.",hierarchyLevel:6,children:[],index:"020502030200"}],index:"0205020302"}],index:"02050203"},{text:" PV Loop and EDPVR and ESPVR",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0205020400"},{text:" Explanation",hierarchyLevel:5,children:[{text:" The PV loops will always be contained by ESPVR and EDPVR.",hierarchyLevel:6,children:[],index:"020502040100"},{text:" ESPVR measures the maximum amount of pressure generated by thecontraction of the ventricle at any given volume. Therefore, the heart cannotpossibly exceed that maximum amount of pressure. Hence, it is contained byESPVR.",hierarchyLevel:6,children:[],index:"020502040101"},{text:" EDPVR measures the amount of pressure in the ventricles as the ventriclesare filled by blood in the relaxed state. Therefore, because the ventricles arealready relaxed the heart cannot possibly have a lower pressure at any givenvolume. Hence, it is contained by EDPVR.",hierarchyLevel:6,children:[],index:"020502040102"},{text:" Hence, ESPVR and EDPVR determines the operation range of theheart in terms of both volume and pressure.",hierarchyLevel:6,children:[],index:"020502040103"}],index:"0205020401"}],index:"02050204"}],index:"020502"},{text:" Determinants of Cardiac Output (Intrinsic Regulation)",hierarchyLevel:3,children:[{text:" Preload",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Preload  the end diastolic (passive) tension (stretch) inmyocardial fibres (ventricular wall stress experienced at the end of diastole) ",hierarchyLevel:6,children:[],index:"020503000000"}],index:"0205030000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0205030001"},{text:" Formula",hierarchyLevel:5,children:[{text:" Wall stress = P x R / 2 x w",hierarchyLevel:6,children:[],index:"020503000200"},{text:" P = Pressure",hierarchyLevel:6,children:[],index:"020503000201"},{text:" R = Radius",hierarchyLevel:6,children:[],index:"020503000202"},{text:" w = Wall thickness",hierarchyLevel:6,children:[],index:"020503000203"},{text:" Preload  enddiastolic pressure or volume",hierarchyLevel:6,children:[],index:"020503000204"}],index:"0205030002"},{text:" Factors Affecting Preload",hierarchyLevel:5,children:[{text:" Central Venous Pressure  central venous pressure influencesfilling of the ventricles and hence end diastolic volume",hierarchyLevel:6,children:[],index:"020503000300"}],index:"0205030003"}],index:"02050300"},{text:" Length-tension relationship of cardiomyocytes",hierarchyLevel:4,children:[{text:" Early Relationships",hierarchyLevel:5,children:[{text:" The degree of stretch of the muscle fibres before the contractiondetermines the strength of the foregoing contraction",hierarchyLevel:6,children:[],index:"020503010000"},{text:" Increasing the amount of blood (end diastolic volume) in theventricles leads to a more forceful contraction",hierarchyLevel:6,children:[],index:"020503010001"}],index:"0205030100"},{text:" Frank-Starling Law of the Heart",hierarchyLevel:5,children:[{text:" The total energy liberated at each heartbeat is determined by thediastolic volume of the heart and therefore by the muscle fibre length at thebeginning of contraction",hierarchyLevel:6,children:[],index:"020503010100"}],index:"0205030101"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0205030102"},{text:" Importance of Frank-Starling mechanism",hierarchyLevel:5,children:[{text:" Frank-Startling mechanism enables the heart to balance the outputsof the right and left ventricles.",hierarchyLevel:6,children:[],index:"020503010300"},{text:" This is important because the pulmonary pump and systemic pump ofthe heart are connected in series and hence the volume should be aligned toprevent causing problems.",hierarchyLevel:6,children:[],index:"020503010301"}],index:"0205030103"}],index:"02050301"},{text:" PV Loop with Increased Preload with Frank-Starling Mechanism",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0205030200"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Increased output from the right ventricle leads to increasedpreload. ",hierarchyLevel:6,children:[],index:"020503020100"},{text:" Increased preload leads to increased volume at whichisovolumetric contraction starts. ",hierarchyLevel:6,children:[],index:"020503020101"},{text:" Due to the increase volume, the ventricles are able to contractwith a greater force, hence forcing all the additional volume out, eventuallyreaching the same end systolic volume as before. ",hierarchyLevel:6,children:[],index:"020503020102"},{text:" Due to the stronger contraction force, the stroke volume hasincreased.",hierarchyLevel:6,children:[],index:"020503020103"},{text:" The output from the right and left ventricles are balanced.",hierarchyLevel:6,children:[],index:"020503020104"}],index:"0205030201"}],index:"02050302"},{text:" Afterload",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Active tension in myocardial fibres required to generateventricular pressure above that in the aorta (aortic valve opens and blood isexpelled from the heart)",hierarchyLevel:6,children:[],index:"020503030000"}],index:"0205030300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0205030301"},{text:" Formula",hierarchyLevel:5,children:[{text:" Wall stress = P x R / 2 x w",hierarchyLevel:6,children:[],index:"020503030200"},{text:" P = Pressure",hierarchyLevel:6,children:[],index:"020503030201"},{text:" R = Radius",hierarchyLevel:6,children:[],index:"020503030202"},{text:" w = Wall thickness",hierarchyLevel:6,children:[],index:"020503030203"},{text:" Afterload  arterialblood pressure (pressure that the heart has to pump against)",hierarchyLevel:6,children:[],index:"020503030204"}],index:"0205030302"},{text:" Factors affecting Afterload",hierarchyLevel:5,children:[{text:" Central Aortic Pressure",hierarchyLevel:6,children:[],index:"020503030300"}],index:"0205030303"}],index:"02050303"},{text:" PV Loop with increased Afterload",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0205030400"},{text:" Explanation (first cycle)",hierarchyLevel:5,children:[{text:" Due to the increase in the central aortic pressure, the diastolicarterial pressure increases and the systolic arterial pressure increases.",hierarchyLevel:6,children:[],index:"020503040100"},{text:" The heart has to pump harder in isovolumetric contraction toreach a pressure higher than the diastolic arterial pressure (aortic pressure),to start ejecting blood out. ",hierarchyLevel:6,children:[],index:"020503040101"},{text:" (Explanation in terms of aortic pressure) After ventricular contraction,the ventricles start to relax, resulting in the pressure in the ventricles tostart to fall. However, due to the higher aortic pressure, the ventricularpressure falls below the aortic pressure earlier at a higher ventricularvolume. This results in the early closure of the aortic valve, resulting inless blood being pumped into the aorta.",hierarchyLevel:6,children:[],index:"020503040102"},{text:" (Explanation in terms of maximum contractility) Due to the higherpressure, the heart reaches the end systolic pressure at a higher volume. Theheart started at the same volume but at a higher pressure. For a given volume,the heart has a maximum pressure it can generate. Therefore, due to the higherstarting pressure, the heart reaches the maximum pressure it can generateearlier, resulting in more blood to be left in the heart at the end of systole.",hierarchyLevel:6,children:[],index:"020503040103"},{text:" As a result of the higher end systole volume, the stroke volumedecreases.",hierarchyLevel:6,children:[],index:"020503040104"}],index:"0205030401"},{text:" Explanation (second cycle)",hierarchyLevel:5,children:[{text:" There is a higher end systolic volume after the firstcontraction. The venous pressure and venous filling of the ventricles have notchanged. As a result, increased starting volume at the same venous pressurewill result in an increase in preload (end diastolic volume).",hierarchyLevel:6,children:[],index:"020503040200"},{text:" Increased preload leads to increase in stroke volume, allowingthe stroke volume to return to its original level. However, due to theincreased arterial pressure, more stroke work has to be done to achieve thesame stroke volume.",hierarchyLevel:6,children:[],index:"020503040201"}],index:"0205030402"}],index:"02050304"}],index:"020503"},{text:" Inotropic State (Extrinsic Regulation)",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Inotropic state  describe the potential contractile force thatthe heart can develop",hierarchyLevel:5,children:[],index:"0205040000"}],index:"02050400"},{text:" Types of Inotropic Effect",hierarchyLevel:4,children:[{text:" Positive Inotropic effect (sympathetic)",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" Increase the energy of contraction for any given resting fibrelength or end diastolic volume",hierarchyLevel:7,children:[],index:"02050401000000"}],index:"020504010000"},{text:" Explanation",hierarchyLevel:6,children:[{text:" This is because the properties of the cardiomyocytes have changedin response to sympathetic or hormonal stimulation.",hierarchyLevel:7,children:[],index:"02050401000100"}],index:"020504010001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020504010002"}],index:"0205040100"}],index:"02050401"},{text:" Positive Inotropic Effect on PV Loop",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0205040200"},{text:" Explanation  at rest",hierarchyLevel:5,children:[{text:" As the cardiomyocytes are now able to contract with a greaterforce, at each ventricular volume, the maximum amount of left ventricularpressure generated is now greater.",hierarchyLevel:6,children:[],index:"020504020100"},{text:" As a result, the heart is able to contract more volume out of theheart before reaching its maximum amount of left ventricular pressure. Thisresults in the increase in stroke volume, while the preload and afterloadremains the same.",hierarchyLevel:6,children:[],index:"020504020101"}],index:"0205040201"},{text:" Explanation  during exercise",hierarchyLevel:5,children:[{text:" Positive Inotropic effect is stimulated when the body isexercising. The exercising body results in a higher systolic blood pressure anda higher diastolic blood pressure.",hierarchyLevel:6,children:[],index:"020504020200"},{text:" Due to the increase contractility of the heart, the heart is ableto pump out the same stroke volume at higher systolic arterial pressures.",hierarchyLevel:6,children:[],index:"020504020201"}],index:"0205040202"}],index:"02050402"},{text:" Effect of Sympathetic Innervation on Cardiac Output",hierarchyLevel:4,children:[],index:"02050403"},{text:" Effect of Parasympathetic Innervation on Cardiac Output",hierarchyLevel:4,children:[],index:"02050404"}],index:"020504"}],index:"0205"},{text:" [054] Heart Disease  the modern epidemic",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Understand the origins of cardiovascular disease (CVD), includingthe main environmental and genetic risk factors that predispose to it",hierarchyLevel:4,children:[],index:"02060000"},{text:" Know the prevalence and severity (deaths) of CVD within the UK,Europe and the World.",hierarchyLevel:4,children:[],index:"02060001"},{text:" List the six main steps in the evolution of atherosclerosis",hierarchyLevel:4,children:[],index:"02060002"},{text:" Describe the Response-to-Injury pathway considered to driveatherogenesis",hierarchyLevel:4,children:[],index:"02060003"},{text:" Recognize the roles that LDL and HDL have in plasma cholesteroltransport and in atherosclerosis risk",hierarchyLevel:4,children:[],index:"02060004"},{text:" Explain and describe the principal means of CVD prevention,including both lifestyle and pharmalogical",hierarchyLevel:4,children:[],index:"02060005"},{text:" Have awareness of current advances in potential gene-targetingtherapeutics",hierarchyLevel:4,children:[],index:"02060006"}],index:"020600"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Hyperlipidaemia  a high level of cholesterol or triglycerides inyour blood",hierarchyLevel:5,children:[],index:"0206010000"}],index:"02060100"},{text:" Epidemiology of Cardiovascular disease",hierarchyLevel:4,children:[{text:" Cardiovascular disease kills many people in proportion to totaldeaths",hierarchyLevel:5,children:[],index:"0206010100"},{text:" Global mortality of cardiovascular disease is falling",hierarchyLevel:5,children:[],index:"0206010101"},{text:" Global obesity is rising, increasing as a risk factor to cardiovasculardisease",hierarchyLevel:5,children:[],index:"0206010102"},{text:" Most cardiovascular deaths are from poor countries",hierarchyLevel:5,children:[],index:"0206010103"}],index:"02060101"},{text:" General Info on Cardiovascular disease",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Initial fatty streak lesion is reversible",hierarchyLevel:6,children:[],index:"020601020000"}],index:"0206010200"},{text:" Affected Locations",hierarchyLevel:5,children:[{text:" Coronary arteries",hierarchyLevel:6,children:[],index:"020601020100"},{text:" Around heart valves",hierarchyLevel:6,children:[],index:"020601020101"},{text:" Aorta",hierarchyLevel:6,children:[],index:"020601020102"},{text:" Cerebral blood vessels",hierarchyLevel:6,children:[],index:"020601020103"},{text:" Peripheral blood vessels in the legs",hierarchyLevel:6,children:[],index:"020601020104"}],index:"0206010201"},{text:" Risk factors",hierarchyLevel:5,children:[{text:" Hyperlipidaemia",hierarchyLevel:6,children:[],index:"020601020200"},{text:" Hypertension",hierarchyLevel:6,children:[],index:"020601020201"},{text:" Smoking",hierarchyLevel:6,children:[],index:"020601020202"},{text:" Low exercise",hierarchyLevel:6,children:[],index:"020601020203"},{text:" Poor diet",hierarchyLevel:6,children:[],index:"020601020204"},{text:" Obesity",hierarchyLevel:6,children:[],index:"020601020205"},{text:" Type 2 Diabetes ",hierarchyLevel:6,children:[],index:"020601020206"}],index:"0206010202"},{text:" Development",hierarchyLevel:5,children:[{text:" Pre-teen / Early-teen: start as fatty streaks",hierarchyLevel:6,children:[],index:"020601020300"},{text:" Adult: Formation of established lesions",hierarchyLevel:6,children:[],index:"020601020301"},{text:" Older: Lesion ruptures and cause thrombus formation",hierarchyLevel:6,children:[],index:"020601020302"}],index:"0206010203"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0206010204"}],index:"02060102"}],index:"020601"},{text:" Pathophysiology",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Adaptive thickening  the thickening of initma smooth muscle ofthe artery",hierarchyLevel:5,children:[],index:"0206020000"},{text:" Lesion - a region in an organ or tissue which has suffered damagethrough injury or disease, such as a wound, ulcer, abscess, or tumour",hierarchyLevel:5,children:[],index:"0206020001"}],index:"02060200"},{text:" Types of Lesions",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" Type I  adaptive thickening of the smooth muscle",hierarchyLevel:6,children:[],index:"020602010000"},{text:" Type II  macrophage foam cells can be seen",hierarchyLevel:6,children:[],index:"020602010001"},{text:" Type III  small pools of extracellular lipids can be seen",hierarchyLevel:6,children:[],index:"020602010002"},{text:" Type IV  core of extracellular lipids can be seen",hierarchyLevel:6,children:[],index:"020602010003"},{text:" Type V  fibrous thickening can be seen",hierarchyLevel:6,children:[],index:"020602010004"},{text:" Type VI  blood vessel ruptures, leading to thrombus formation.",hierarchyLevel:6,children:[],index:"020602010005"}],index:"0206020100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0206020101"}],index:"02060201"},{text:" Causes of endothelial damage",hierarchyLevel:4,children:[{text:" Presence of free radicals",hierarchyLevel:5,children:[],index:"0206020200"},{text:" Turbulent bloodflow",hierarchyLevel:5,children:[],index:"0206020201"},{text:" Oxidised LDL",hierarchyLevel:5,children:[],index:"0206020202"},{text:" Glycated proteins",hierarchyLevel:5,children:[],index:"0206020203"},{text:" Bacteria/viral infection",hierarchyLevel:5,children:[],index:"0206020204"}],index:"02060202"},{text:" Process of Atherosclerosis",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Presence of free radicals results in damage to endothelium.",hierarchyLevel:6,children:[],index:"020602030000"},{text:" Damage to endothelium stimulates an inflammatory response,resulting in the recruitment of blood monocytes.",hierarchyLevel:6,children:[],index:"020602030001"},{text:" LDL in the bloodstream is oxidized by free radical present on thetunica intima. Oxidized LDL moves through the endothelial layer viatranscytosis, damaging the endothelial layer in the process.",hierarchyLevel:6,children:[],index:"020602030002"},{text:" Monocytes differentiate to form macrophages. Macrophages take upoxidized LDL, resulting in the formation of macrophage foam cells. This resultsin the formation of a Type II lesion with fatty streaks.",hierarchyLevel:6,children:[],index:"020602030003"},{text:" Oxidized LDL signals to the endothelial cells, stimulating theupregulation of adhesion molecules. This causes more monocytes to be recruitedand differentiate into macrophage foam cells.",hierarchyLevel:6,children:[],index:"020602030004"},{text:" Presence of macrophage foam cells enables small pools ofextracellular lipid to begin to accumulate. This results in the formation of aType III lesion.",hierarchyLevel:6,children:[],index:"020602030005"},{text:" Continuous damage to the artery results in macrophages releasingcytokines and growth factors.",hierarchyLevel:6,children:[],index:"020602030006"},{text:" Cytokines and growth factors stimulates the migration of smoothmuscle cells into the lipid deposits, and proliferates. This results in theformation of a Type IV lesion.",hierarchyLevel:6,children:[],index:"020602030007"},{text:" Upon proliferation, smooth muscle cells start synthesizing anextracellular matrix, forming a fibrous cap. The fibrous cap stabilizes theunstable lipid core deposit. This results in the formation of a Type V lesion.",hierarchyLevel:6,children:[],index:"020602030008"},{text:" As the fibrous cap develops, calcium starts building up withinthe lesion, resulting in its hardening and calcification. This results in theformation of a Type VI complicated lesion. If the lesion is too thin, thecalcified lesion can rupture and form a thrombus. ",hierarchyLevel:6,children:[],index:"020602030009"}],index:"0206020300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0206020301"}],index:"02060203"},{text:" Risk factors for atherosclerosis",hierarchyLevel:4,children:[{text:" Non-modifiable risks",hierarchyLevel:5,children:[{text:" Male gender",hierarchyLevel:6,children:[],index:"020602040000"},{text:" Post-menopausal women",hierarchyLevel:6,children:[],index:"020602040001"},{text:" Age > 50 years",hierarchyLevel:6,children:[],index:"020602040002"},{text:" Previous history of disease",hierarchyLevel:6,children:[],index:"020602040003"},{text:" Family history",hierarchyLevel:6,children:[],index:"020602040004"}],index:"0206020400"},{text:" Modifiable risks",hierarchyLevel:5,children:[{text:" High cholesterol level",hierarchyLevel:6,children:[],index:"020602040100"},{text:" High LDL",hierarchyLevel:6,children:[],index:"020602040101"},{text:" Low HDL",hierarchyLevel:6,children:[],index:"020602040102"},{text:" Smoking",hierarchyLevel:6,children:[],index:"020602040103"},{text:" High blood pressure",hierarchyLevel:6,children:[],index:"020602040104"},{text:" Diabetes",hierarchyLevel:6,children:[],index:"020602040105"},{text:" High level of homocysteine",hierarchyLevel:6,children:[],index:"020602040106"},{text:" Obesity",hierarchyLevel:6,children:[],index:"020602040107"},{text:" High alcohol intake",hierarchyLevel:6,children:[],index:"020602040108"},{text:" Psychological stress",hierarchyLevel:6,children:[],index:"020602040109"},{text:" Sedentary lifestyle",hierarchyLevel:6,children:[],index:"020602040110"},{text:" Dietary sodium",hierarchyLevel:6,children:[],index:"020602040111"}],index:"0206020401"}],index:"02060204"},{text:" Gene-Environmental Interactions in Atherosclerosis",hierarchyLevel:4,children:[{text:" Understanding",hierarchyLevel:5,children:[{text:" Both genetic factors and environmental factors are required foratherosclerosis",hierarchyLevel:6,children:[],index:"020602050000"},{text:" The overall risk for atherosclerosis is a combination of geneticfactors and environmental factors",hierarchyLevel:6,children:[],index:"020602050001"}],index:"0206020500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0206020501"}],index:"02060205"},{text:" Collateral Damage of Atherosclerosis",hierarchyLevel:4,children:[],index:"02060206"},{text:" Clinical Signs of Cholesterol Deposition",hierarchyLevel:4,children:[{text:" Benign fatty fibrous yellowish plaques / nodules",hierarchyLevel:5,children:[],index:"0206020700"},{text:" Xanthelasma",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" Cutaneous deposition of lipid in the skin of the eyelids asyellowish, slightly elevated areas",hierarchyLevel:7,children:[],index:"02060207010000"}],index:"020602070100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020602070101"}],index:"0206020701"},{text:" Corneal arcus",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" Greyish-white ring opacity in the periphery of the cornea due tocholesterol lipid infiltration of the corneal stroma",hierarchyLevel:7,children:[],index:"02060207020000"}],index:"020602070200"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020602070201"}],index:"0206020702"},{text:" Palmar crease xanthomas",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" Creases on the palms with accumulation of lipid-laden macrophages;a feature of type III hyperlipidaemia",hierarchyLevel:7,children:[],index:"02060207030000"}],index:"020602070300"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020602070301"}],index:"0206020703"}],index:"02060207"}],index:"020602"},{text:" Plasma Lipoproteins",hierarchyLevel:3,children:[{text:" Structure of Lipoproteins",hierarchyLevel:4,children:[{text:" Structure",hierarchyLevel:5,children:[{text:" Inner hydrophobic core  contains payload",hierarchyLevel:6,children:[],index:"020603000000"},{text:" Outer single layer of phospholipid, cholesterol, protein",hierarchyLevel:6,children:[],index:"020603000001"}],index:"0206030000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0206030001"}],index:"02060300"},{text:" Types of Lipoproteins",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0206030100"},{text:" Triglyceride-rich lipoproteins",hierarchyLevel:5,children:[{text:" Chylomicrons  triglycerides are extracted and degraded forenergy",hierarchyLevel:6,children:[],index:"020603010100"},{text:" VLDL  deposits in arteries if not cleared quickly, degraded forenergy in tissues",hierarchyLevel:6,children:[],index:"020603010101"}],index:"0206030101"},{text:" Cholesterol transporters",hierarchyLevel:5,children:[{text:" LDL  cholesterol rich",hierarchyLevel:6,children:[],index:"020603010200"},{text:" HDL  protein rich, picks up excess cholesterol and brings itback to the liver, only high quality HDLs are able to effectively clear excesscholesterol (quality + quantity)",hierarchyLevel:6,children:[],index:"020603010201"}],index:"0206030102"}],index:"02060301"},{text:" Mechanism of LDL utilization",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" LDL in the bloodstream binds to LDL receptors, resulting in theendocytosis of LDL",hierarchyLevel:6,children:[],index:"020603020000"},{text:" The cholesterol within LDL is used for the synthesis of steroidhormones in the smooth endoplasmic reticulum.",hierarchyLevel:6,children:[],index:"020603020001"}],index:"0206030200"},{text:" Abnormal Function: Lack of LDL Receptors",hierarchyLevel:5,children:[{text:" The lack of LDL receptors results in the inability of LDL toenter the cells.",hierarchyLevel:6,children:[],index:"020603020100"},{text:" This causes LDL cholesterol levels increases in the blood.",hierarchyLevel:6,children:[],index:"020603020101"}],index:"0206030201"}],index:"02060302"},{text:" Mechanism of HDL Reverse Cholesterol Transport",hierarchyLevel:4,children:[{text:" Excess cholesterol from extrahepatic cells are converted into aninsoluble form.",hierarchyLevel:5,children:[],index:"0206030300"},{text:" Insoluble cholesterol is then loaded onto LDL, which thendelivers the cholesterol back to the liver.",hierarchyLevel:5,children:[],index:"0206030301"}],index:"02060303"},{text:" Atheroprotection from Nitric oxide",hierarchyLevel:4,children:[{text:" High plasma HDL and low plasma content stimulates the release ofnitric oxide",hierarchyLevel:5,children:[],index:"0206030400"},{text:" Nitric oxide inhibits platelet activation and relaxes vascularsmooth muscle, hence providing protection from atherosclerosis.",hierarchyLevel:5,children:[],index:"0206030401"}],index:"02060304"}],index:"020603"},{text:" Treatments",hierarchyLevel:3,children:[{text:" Prevention Measures",hierarchyLevel:4,children:[{text:" Low in saturated fat diet",hierarchyLevel:5,children:[],index:"0206040000"},{text:" Stop smoking",hierarchyLevel:5,children:[],index:"0206040001"},{text:" Control obesity",hierarchyLevel:5,children:[],index:"0206040002"},{text:" Increase exercise",hierarchyLevel:5,children:[],index:"0206040003"},{text:" Control blood pressure",hierarchyLevel:5,children:[],index:"0206040004"}],index:"02060400"},{text:" Treatment Measures",hierarchyLevel:4,children:[{text:" Cholesterol lowering durg",hierarchyLevel:5,children:[],index:"0206040100"},{text:" Anti-smoking measures",hierarchyLevel:5,children:[],index:"0206040101"},{text:" Anti-hypertensives",hierarchyLevel:5,children:[],index:"0206040102"},{text:" Anti-coagulatns",hierarchyLevel:5,children:[],index:"0206040103"},{text:" Fibrinolytics",hierarchyLevel:5,children:[],index:"0206040104"},{text:" Nitrates",hierarchyLevel:5,children:[],index:"0206040105"}],index:"02060401"}],index:"020604"}],index:"0206"},{text:" [056] Cardiodynamics and cardiac output 2",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Understand the two key equations",hierarchyLevel:4,children:[],index:"02070000"},{text:" Understand the 5 key things that make the heart work normally",hierarchyLevel:4,children:[],index:"02070001"},{text:" Understand heart pathology  CO and SVR in Ht failure / sepsis /blood loss / cardiac arrest",hierarchyLevel:4,children:[],index:"02070002"},{text:" Understand the Frank Starling Relationship (curves)",hierarchyLevel:4,children:[],index:"02070003"},{text:" Understand what happens during the fluid challenge",hierarchyLevel:4,children:[],index:"02070004"},{text:" Understand the 5 ways to measure cardiac output and why we do so",hierarchyLevel:4,children:[],index:"02070005"}],index:"020700"},{text:" Mean Arterial Pressure, Cardiac output, Systemic Vascular Resistance",hierarchyLevel:3,children:[{text:" Formulas",hierarchyLevel:4,children:[{text:" Mean Arterial Pressure  Central venous pressure = Cardiac outputx Systemic vascular resistance",hierarchyLevel:5,children:[],index:"0207010000"},{text:" Central venous pressure = 3-5mm Hg (very small)",hierarchyLevel:5,children:[],index:"0207010001"},{text:" Mean Arterial Pressure (MAP) = Cardiac output (CO) x SystemicVascular Resistance (SVR)",hierarchyLevel:5,children:[],index:"0207010002"},{text:" Cardiac output = Heart rate (HR) x Stroke Volume (SV)",hierarchyLevel:5,children:[],index:"0207010003"}],index:"02070100"},{text:" Definitions",hierarchyLevel:4,children:[{text:" Cardiac output (CO)  the amount of blood leaving the heart perminute (4-6L / min)",hierarchyLevel:5,children:[],index:"0207010100"},{text:" Systemic Vascular Resistance (SVR)  measure of how dilated orconstricted the arterial side of the circulation is",hierarchyLevel:5,children:[],index:"0207010101"}],index:"02070101"},{text:" Relationships",hierarchyLevel:4,children:[{text:" The greater the vasodilatation, the lower the systemic vascularresistance",hierarchyLevel:5,children:[],index:"0207010200"}],index:"02070102"},{text:" 5 components determining stroke volume",hierarchyLevel:4,children:[{text:" Myocardium  a damaged myocardium pumps less hard, leading todecreased stroke volume",hierarchyLevel:5,children:[],index:"0207010300"},{text:" Rhythm  atrial fibrillation results in less blood entering theventricles, lowering preload, hence lowering stroke volume",hierarchyLevel:5,children:[],index:"0207010301"},{text:" Valves  damaged valves results in regurgitation of blood,resulting in less blood leaving the heart hence slower stroke volume",hierarchyLevel:5,children:[],index:"0207010302"},{text:" Blood Volume  decreased blood volume due to bleeding results inless blood entering and leaving the heart, hence slower stroke volume.",hierarchyLevel:5,children:[],index:"0207010303"},{text:" Proper ventricular relaxation  improper relaxation results ininability for the heart to fill, resulting in lower stroke volume",hierarchyLevel:5,children:[],index:"0207010304"}],index:"02070103"},{text:" Effect of Systemic Vascular Resistance on Mean Arterial Pressure",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" During sepsis and anaphylaxis, there is reduced vascular tone,resulting in vasodilation.",hierarchyLevel:6,children:[],index:"020701040000"},{text:" Vasodilation reduces the systemic vascular resistance. ",hierarchyLevel:6,children:[],index:"020701040001"},{text:" If cardiac output remains the same, the decrease in systemicvascular resistance will cause the mean arterial pressure to fall.",hierarchyLevel:6,children:[],index:"020701040002"}],index:"0207010400"}],index:"02070104"},{text:" Diagnosing Low Blood Pressure",hierarchyLevel:4,children:[{text:" Possible Diagnosis",hierarchyLevel:5,children:[{text:" Low cardiac output",hierarchyLevel:6,children:[],index:"020701050000"},{text:" Low systemic vascular resistance",hierarchyLevel:6,children:[],index:"020701050001"}],index:"0207010500"},{text:" Evidence for low Systemic Vascular Resistance",hierarchyLevel:5,children:[{text:" Due to vasodilation, more blood should flow to the extremitiesresulting in patients having warm hands, and a flushed and red face.",hierarchyLevel:6,children:[],index:"020701050100"},{text:" The body compensates by increasing cardiac output to raise theblood pressure",hierarchyLevel:6,children:[],index:"020701050101"}],index:"0207010501"},{text:" Evidence for low Cardiac output",hierarchyLevel:5,children:[{text:" Due to low cardiac output , the body compensates byvasoconstriction, resulting in patients having cold and clammy hands.",hierarchyLevel:6,children:[],index:"020701050200"}],index:"0207010502"},{text:" Mechanism for Compensation",hierarchyLevel:5,children:[{text:" Low blood pressure is detected by the baroreceptors in the aortaand the carotid sinuses.",hierarchyLevel:6,children:[],index:"020701050300"},{text:" This stimulates a nerve impulse which results in the increase insympathetic outflow. ",hierarchyLevel:6,children:[],index:"020701050301"},{text:" As a result, there is increased binding to \u03b11-adrenoreceptorsin the blood vessels and \u03b21-adrenoreceptors in the heat.",hierarchyLevel:6,children:[],index:"020701050302"},{text:" This causes vasoconstriction, leading to increase in bloodpressure in the heart.",hierarchyLevel:6,children:[],index:"020701050303"}],index:"0207010503"}],index:"02070105"}],index:"020701"},{text:" Oxygen Delivery",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Huffners Constant  the amount of oxygen each gram ofhaemoglobin is able to carry (1.34ml O )",hierarchyLevel:5,children:[],index:"0207020000"}],index:"02070200"},{text:" Formulas",hierarchyLevel:4,children:[{text:" Oxygen Delivery (DO ) = Cardiac Output x OxygenContent",hierarchyLevel:5,children:[],index:"0207020100"},{text:" Cardiac Output = Heart Rate x Stroke Volume",hierarchyLevel:5,children:[],index:"0207020101"},{text:" Oxygen Content = Haemoglobin concentration x Haemoglobinsaturation (%HbO ) x Huffners Constant + dissolved oxygen",hierarchyLevel:5,children:[],index:"0207020102"},{text:" as the difference in oxygen saturation is used, theHuffners constant will often cancel out",hierarchyLevel:5,children:[],index:"0207020103"}],index:"02070201"},{text:" Deriving Values",hierarchyLevel:4,children:[{text:" Haemoglobin concentration  ctHB (from arterial blood gas result)",hierarchyLevel:5,children:[],index:"0207020200"},{text:" Haemoglobin saturation  patient via monitors (SpO %)",hierarchyLevel:5,children:[],index:"0207020201"}],index:"02070202"},{text:" Example Calculation of Oxygen Delivery",hierarchyLevel:4,children:[{text:" Given values",hierarchyLevel:5,children:[{text:" Hb = 138 g/L",hierarchyLevel:6,children:[],index:"020702030000"},{text:" Sa02 is 96% or 0.96",hierarchyLevel:6,children:[],index:"020702030001"},{text:" CO = 5L / min",hierarchyLevel:6,children:[],index:"020702030002"}],index:"0207020300"},{text:" Calculation",hierarchyLevel:5,children:[{text:" DO2 = 5L/min x (1.34 x 138 x 0.96) + (small dissolved insolution) = 887.7ml/min",hierarchyLevel:6,children:[],index:"020702030100"}],index:"0207020301"}],index:"02070203"},{text:" Determinants of Reduced Oxygen Delivery",hierarchyLevel:4,children:[{text:" Reduced Cardiac output  treat via increasing stroke volume orheart rate",hierarchyLevel:5,children:[],index:"0207020400"},{text:" Reduced HbO  % saturation  treat via providing oxygenvia face mask",hierarchyLevel:5,children:[],index:"0207020401"},{text:" Reduced Haemoglobin concentration  treat by providing bloodtransfusion",hierarchyLevel:5,children:[],index:"0207020402"}],index:"02070204"}],index:"020702"},{text:" Pathological States",hierarchyLevel:3,children:[{text:" Strategy in Understanding Pathological States",hierarchyLevel:4,children:[{text:" Understand the primary injury or problem",hierarchyLevel:5,children:[],index:"0207030000"},{text:" Understand how the effect of the injury is sensed / detected bythe cardiovascular system",hierarchyLevel:5,children:[],index:"0207030001"},{text:" Understand how the cardiovascular system compensates for theproblem (via heart, blood vessels and kidneys)",hierarchyLevel:5,children:[],index:"0207030002"}],index:"02070300"}],index:"020703"},{text:" Heart Failure",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Reduced heart function",hierarchyLevel:5,children:[],index:"0207040000"},{text:" Heart is unable to pump enough blood to maintain blood flow tomeet the oxygen demand of the body",hierarchyLevel:5,children:[],index:"0207040001"}],index:"02070400"},{text:" Types of Heart Failure",hierarchyLevel:4,children:[{text:" Acute heart failure",hierarchyLevel:5,children:[],index:"0207040100"},{text:" Chronic heart failure",hierarchyLevel:5,children:[],index:"0207040101"},{text:" Left sided heart failure",hierarchyLevel:5,children:[],index:"0207040102"},{text:" Right sided heart failure",hierarchyLevel:5,children:[],index:"0207040103"},{text:" Both sided heart failure",hierarchyLevel:5,children:[],index:"0207040104"}],index:"02070401"},{text:" Causes",hierarchyLevel:4,children:[{text:" Myocardium  myocardial infarction",hierarchyLevel:5,children:[],index:"0207040200"},{text:" Rhythm  abnormal rhythm",hierarchyLevel:5,children:[],index:"0207040201"},{text:" Valves  valves stenosis or regurgitation",hierarchyLevel:5,children:[],index:"0207040202"},{text:" Venous Return (return of oxygenated blood)  bleeding",hierarchyLevel:5,children:[],index:"0207040203"},{text:" Relaxation for ventricular filling  obstruction (tamponade) ofthe heart by pericardial effusion",hierarchyLevel:5,children:[],index:"0207040204"}],index:"02070402"},{text:" Effects of Cardiac Damage",hierarchyLevel:4,children:[{text:" Decreased contraction on the heart, leading to decreased strokevolume, leading to decreased cardiac output, leading to decreased oxygendelivery to tissues.",hierarchyLevel:5,children:[],index:"0207040300"}],index:"02070403"},{text:" Compensatory Mechanisms for Heart Failure",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0207040400"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Decrease in cardiac output cause the body to compensate byincreasing the blood pressure.",hierarchyLevel:6,children:[],index:"020704040100"},{text:" Hence, the body increases the sympathetic firing, resulting inincrease heart rate and increased contractility of the cardiomyocytes. Thisresults in greater stroke volume and hence higher pressure.",hierarchyLevel:6,children:[],index:"020704040101"},{text:" Moreover, increased sympathetic firing leads to thevasoconstriction, leading to increased systemic vascular resistance, leading toincreased blood pressure.",hierarchyLevel:6,children:[],index:"020704040102"},{text:" High blood pressure combined with greater stroke volume resultsin greater venous return, causing an increased in the preload.",hierarchyLevel:6,children:[],index:"020704040103"},{text:" Increase in preload, increases ventricular contraction, leadingto increased cardiac output, hence restoring the cardiac output to the originallevel.",hierarchyLevel:6,children:[],index:"020704040104"}],index:"0207040401"},{text:" Consequences of Compensatory Mechanisms",hierarchyLevel:5,children:[{text:" Increased contractility of the heart, raised systemic vascularpressure, leads to greater stroke work done, resulting in created damage to theheart",hierarchyLevel:6,children:[],index:"020704040200"},{text:" Increase in oxygen demand of the heart",hierarchyLevel:6,children:[],index:"020704040201"},{text:" Release of atrial natriuretic peptide leads to vasoconstrictionbut also increased fluid retention in the kidneys, increasing blood pressure.",hierarchyLevel:6,children:[],index:"020704040202"}],index:"0207040402"},{text:" Frank-Starling Law in Heart Failure",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"02070404030000"}],index:"020704040300"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Decreasing heart function leads to the movement from the red lineto line 3,4,5.",hierarchyLevel:7,children:[],index:"02070404030100"},{text:" As a result, for a given end-diastolic pressure, there is a lowerstroke volume.",hierarchyLevel:7,children:[],index:"02070404030101"}],index:"020704040301"}],index:"0207040403"},{text:" Effects of Atrial Natriuretic Peptide in Heart Failure",hierarchyLevel:5,children:[{text:" ANP results in increase in glomerular filtration rate and reducereabsorption of sodium.",hierarchyLevel:6,children:[],index:"020704040400"},{text:" Release of atrial natriuretic peptide results in natriuresiswhere sodium is released into the urine,  resulting in the increased loss  of water. This reduces theblood volume, reducing the stretch of the heart in diastole.",hierarchyLevel:6,children:[],index:"020704040401"}],index:"0207040404"},{text:" Mechanism for Severe Heart Failure  Decompensation",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"02070404050000"}],index:"020704040500"}],index:"0207040405"}],index:"02070404"}],index:"020704"},{text:" Hypovolaemia",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Hypo  low",hierarchyLevel:5,children:[],index:"0207050000"},{text:" vol  volume",hierarchyLevel:5,children:[],index:"0207050001"},{text:" aemia  blood",hierarchyLevel:5,children:[],index:"0207050002"},{text:" Hypovolaemia  low blood volume",hierarchyLevel:5,children:[],index:"0207050003"},{text:" Juxtaglomerular Apparatus  a specialized structure formed by thedistal convoluted tubule and the glomerular afferent arteriole",hierarchyLevel:5,children:[],index:"0207050004"},{text:" Positive chronotropy  increases in the heart rate (quicken time)",hierarchyLevel:5,children:[],index:"0207050005"}],index:"02070500"},{text:" Mechanism of Hypovolaemia",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0207050100"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Blood is lost from the body by bleeding, resulting in low bloodvolume.",hierarchyLevel:6,children:[],index:"020705010100"},{text:" As a result, the ventricles will fill less during diastole,resulting in the heart to pump less strongly.",hierarchyLevel:6,children:[],index:"020705010101"},{text:" This results in lower stroke volume and lower cardiac output.",hierarchyLevel:6,children:[],index:"020705010102"},{text:" Lower cardiac output results in lower Mean Arterial Pressure,which is detected by the baroreceptors in the aorta and the carotid sinuses.",hierarchyLevel:6,children:[],index:"020705010103"},{text:" Lower cardiac output results in decreased renal blood flow, whichis detected by the Juxtaglomerular Apparatus. ",hierarchyLevel:6,children:[],index:"020705010104"},{text:" A compensation mechanism is activated, where there is increasedsympathetic activation, resulting in the heart beating faster and stronger,hence increasing the heart rate and the stroke volume. Moreover, sympatheticactivation of \u03b11-adrenoreceptors results in the constriction of the bloodvessels. This causes positive inotropy, leading to the increase in systemicvascular resistance.",hierarchyLevel:6,children:[],index:"020705010105"},{text:" Increase in cardiac output and systemic vascular resistance leadsto the increase in mean arterial pressure.",hierarchyLevel:6,children:[],index:"020705010106"},{text:" Compensatory mechanisms results in the increase in theFrank-Starling relationship from the red line to 2. Due to blood loss, the leftventricles cannot be filled to a very high volume (lack of blood volume), andhence the line ends earlier.",hierarchyLevel:6,children:[],index:"020705010107"}],index:"0207050101"}],index:"02070501"},{text:" Treatment",hierarchyLevel:4,children:[{text:" Stop the bleeding",hierarchyLevel:5,children:[],index:"0207050200"},{text:" Provide intravenous fluid (fresh frozen plasma, crystalloid,packed red cells, platelets)",hierarchyLevel:5,children:[],index:"0207050201"}],index:"02070502"},{text:" Renin-angiotensin-aldosterone system (RAS)",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0207050300"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Low blood volume in hypovolaemia is detected by thejuxtaglomerular complex in the kidneys.",hierarchyLevel:6,children:[],index:"020705030100"},{text:" The juxtaglomerular complex stimulates the kidneys to releaseRenin. ",hierarchyLevel:6,children:[],index:"020705030101"},{text:" Renin increases water retention by increasing the permeability ofthe collecting ducts. This results in increased blood volume in an attempt tocorrect hypovolaemia.",hierarchyLevel:6,children:[],index:"020705030102"}],index:"0207050301"}],index:"02070503"}],index:"020705"},{text:" Sepsis",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Organ dysfunction caused by infection",hierarchyLevel:5,children:[],index:"0207060000"},{text:" Systemic, generalized inflammation in response to an infection",hierarchyLevel:5,children:[],index:"0207060001"}],index:"02070600"},{text:" Systems affected by sepsis",hierarchyLevel:4,children:[{text:" Cardiovascular system (CVS)",hierarchyLevel:5,children:[],index:"0207060100"},{text:" Respiratory system (RS)",hierarchyLevel:5,children:[],index:"0207060101"},{text:" Gastrointestinal system (GI)",hierarchyLevel:5,children:[],index:"0207060102"},{text:" Genitourinal system (GU)",hierarchyLevel:5,children:[],index:"0207060103"},{text:" Nervous system (NS)",hierarchyLevel:5,children:[],index:"0207060104"}],index:"02070601"},{text:" Symptoms",hierarchyLevel:4,children:[{text:" Due to vasodilatation, more blood flows to the surface of theskin, resulting in the patient presenting as red and flushed.",hierarchyLevel:5,children:[],index:"0207060200"}],index:"02070602"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" Inflammation leads to abnormal vasodilation.",hierarchyLevel:5,children:[],index:"0207060300"},{text:" In response, the body initiates a compensatory mechanism toattempt to vasoconstrict the blood vessels. ",hierarchyLevel:5,children:[],index:"0207060301"},{text:" However, due to blood vessel damage during sepsis, the bloodvessels are unable to vasoconstrict.",hierarchyLevel:5,children:[],index:"0207060302"},{text:" Due to extensive vasodilation, the systemic vascular resistancefalls, resulting in the fall of the cardiac output, which causes the fall inthe mean arterial pressure.",hierarchyLevel:5,children:[],index:"0207060303"},{text:" Due to the fall in the mean arterial pressure, the heart willattempt to compensate by increasing the heart rate and the contractility. ",hierarchyLevel:5,children:[],index:"0207060304"},{text:" However, the blood pressure may continue to remain low.",hierarchyLevel:5,children:[],index:"0207060305"},{text:" Due to sepsis, the Frank-Sterling graph moves from the red lineto 1, because there is less resistance for the heart to pump against, andincreased sympathetic activation results in strong contractions, this leads toa higher stroke volume at a given pressure.",hierarchyLevel:5,children:[],index:"0207060306"}],index:"02070603"},{text:" Diagram",hierarchyLevel:4,children:[],index:"02070604"}],index:"020706"},{text:" Cardiac Arrest",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Cardiac output = 0",hierarchyLevel:5,children:[],index:"0207070000"},{text:" No pulse felt",hierarchyLevel:5,children:[],index:"0207070001"},{text:" No / very low blood pressure",hierarchyLevel:5,children:[],index:"0207070002"}],index:"02070700"},{text:" Types of Cardiac Arrest",hierarchyLevel:4,children:[{text:" Ventricular Fibrillation (shockable)",hierarchyLevel:5,children:[],index:"0207070100"},{text:" Ventricular Tachycardia (shockable)",hierarchyLevel:5,children:[],index:"0207070101"},{text:" Asystole (non-shockable)",hierarchyLevel:5,children:[],index:"0207070102"},{text:" Pulseless Electrical Activity (non-shockable)",hierarchyLevel:5,children:[],index:"0207070103"}],index:"02070701"},{text:" Treatment ",hierarchyLevel:4,children:[{text:" DR ABC",hierarchyLevel:5,children:[],index:"0207070200"},{text:" Restart Cardiac Contractions with an AED",hierarchyLevel:5,children:[],index:"0207070201"}],index:"02070702"}],index:"020707"},{text:" Clinical Applications",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Fluid challenge  a method of identifying those patients likely tobenefit from an increase in intravenous volume in order to guide further volumeresuscitation",hierarchyLevel:5,children:[],index:"0207080000"}],index:"02070800"},{text:" Purpose of Measuring Cardiac Output",hierarchyLevel:4,children:[{text:" Diagnose problems",hierarchyLevel:5,children:[],index:"0207080100"},{text:" Choose treatments",hierarchyLevel:5,children:[],index:"0207080101"},{text:" Give fluid",hierarchyLevel:5,children:[],index:"0207080102"},{text:" Measure oxygen delivery",hierarchyLevel:5,children:[],index:"0207080103"}],index:"02070801"},{text:" Method of Measuring Cardiac Output",hierarchyLevel:4,children:[{text:" Oesophageal Doppler Monitor",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" measures blood flow using ultrasound",hierarchyLevel:7,children:[],index:"02070802000000"}],index:"020708020000"},{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"02070802000100"}],index:"020708020001"},{text:" Procedure",hierarchyLevel:6,children:[{text:" Insert a probe down the oesphagus",hierarchyLevel:7,children:[],index:"02070802000200"},{text:" Probe uses ultrasound and the Doppler effect to measure thedistance travelled by blood",hierarchyLevel:7,children:[],index:"02070802000201"},{text:" Distance by blood is multiplied with the cross sectional area toproduce stroke volume (in aorta)",hierarchyLevel:7,children:[],index:"02070802000202"},{text:" The greater the distance travelled by blood, the greater thestroke volume",hierarchyLevel:7,children:[],index:"02070802000203"}],index:"020708020002"}],index:"0207080200"},{text:" Pulmonary artery catheter",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Measures temperature changes and calculates flow",hierarchyLevel:7,children:[],index:"02070802010000"}],index:"020708020100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020708020101"},{text:" Procedure",hierarchyLevel:6,children:[{text:" A large canula inserted into the right side of the patient next,into the right internal jugular vein, via right atrium, via right ventricle andinto the pulmonary artery",hierarchyLevel:7,children:[],index:"02070802010200"},{text:" The tip of the catheter contains a temperature probe. Cold fluidis injected via the catheter.",hierarchyLevel:7,children:[],index:"02070802010201"},{text:" The faster the blood is flowing, the lesser the impact of thecold fluid on the localized temperature as the cold fluid is quickly washedaway. Hence, the temperature probe will record a lesser difference intemperature.",hierarchyLevel:7,children:[],index:"02070802010202"}],index:"020708020102"}],index:"0207080201"},{text:" ECHO cardiography",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" An ultrasound picture that looks at structure and function",hierarchyLevel:7,children:[],index:"02070802020000"}],index:"020708020200"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020708020201"},{text:" Procedure",hierarchyLevel:6,children:[{text:" An ultrasound probe is placed on the chest to get different viewof the heart",hierarchyLevel:7,children:[],index:"02070802020200"},{text:" The images can be used to interpret structure and function, valvefunction, ejection fraction",hierarchyLevel:7,children:[],index:"02070802020201"}],index:"020708020202"}],index:"0207080202"},{text:" Dye dilution LiDCO",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Use dyes for pulse contour analysis to derive stroke volume",hierarchyLevel:7,children:[],index:"02070802030000"}],index:"020708020300"},{text:" Procedure",hierarchyLevel:6,children:[{text:" Inject dye and measure dye concentration changes",hierarchyLevel:7,children:[],index:"02070802030100"}],index:"020708020301"}],index:"0207080203"}],index:"02070802"},{text:" Method of Determining Systemic Vascular Resistance",hierarchyLevel:4,children:[{text:" Measure cardiac output",hierarchyLevel:5,children:[],index:"0207080300"},{text:" Measure mean arterial pressure",hierarchyLevel:5,children:[],index:"0207080301"},{text:" Calculate systemic vascular resistance with formula",hierarchyLevel:5,children:[],index:"0207080302"}],index:"02070803"},{text:" Using Systemic Vascular Resistance",hierarchyLevel:4,children:[{text:" Measure systemic vascular resistance before treatment",hierarchyLevel:5,children:[],index:"0207080400"},{text:" Apply treatment with fluid, inotropes and vasoconstrictors",hierarchyLevel:5,children:[],index:"0207080401"},{text:" Measure systemic vascular resistance after treatment",hierarchyLevel:5,children:[],index:"0207080402"}],index:"02070804"},{text:" Procedures of Fluid Challenge",hierarchyLevel:4,children:[{text:" Metrics before fluid challenge",hierarchyLevel:5,children:[{text:" Cardiac output = 5L / min",hierarchyLevel:6,children:[],index:"020708050000"},{text:" Stroke volume = 70 ml",hierarchyLevel:6,children:[],index:"020708050001"},{text:" HR = 71 beats / min",hierarchyLevel:6,children:[],index:"020708050002"}],index:"0207080500"},{text:" Procedure (1)",hierarchyLevel:5,children:[{text:" 500ml of fluid injected intravenously into the patient",hierarchyLevel:6,children:[],index:"020708050100"},{text:" This increases the blood volume, resulting in greater preload,and hence greater force of contraction during systole.",hierarchyLevel:6,children:[],index:"020708050101"},{text:" This increases cardiac output.",hierarchyLevel:6,children:[],index:"020708050102"}],index:"0207080501"},{text:" Metrics after fluid challenge 1",hierarchyLevel:5,children:[{text:" Cardiac output = 7L / min",hierarchyLevel:6,children:[],index:"020708050200"},{text:" Stroke volume = 100 ml",hierarchyLevel:6,children:[],index:"020708050201"},{text:" HR = 70 beats / min",hierarchyLevel:6,children:[],index:"020708050202"}],index:"0207080502"},{text:" Procedure (2)",hierarchyLevel:5,children:[{text:" Another 500ml of fluid injected intravenously into the patient",hierarchyLevel:6,children:[],index:"020708050300"},{text:" This increases the blood volume, resulting in greater preload,and hence greater force of contraction during systole.",hierarchyLevel:6,children:[],index:"020708050301"},{text:" This increases cardiac output.",hierarchyLevel:6,children:[],index:"020708050302"}],index:"0207080503"},{text:" Metrics after fluid challenge 2",hierarchyLevel:5,children:[{text:" Cardiac output = 7.4L / min",hierarchyLevel:6,children:[],index:"020708050400"},{text:" Stroke volume = 110 ml",hierarchyLevel:6,children:[],index:"020708050401"},{text:" HR = 68 beats / min",hierarchyLevel:6,children:[],index:"020708050402"}],index:"0207080504"},{text:" Metrics after fluid challenge 3",hierarchyLevel:5,children:[{text:" Cardiac output = 7.5L / min",hierarchyLevel:6,children:[],index:"020708050500"},{text:" Stroke volume = 112 ml",hierarchyLevel:6,children:[],index:"020708050501"},{text:" HR = 67 beats / min",hierarchyLevel:6,children:[],index:"020708050502"}],index:"0207080505"},{text:" Interpretations",hierarchyLevel:5,children:[{text:" There is a limitation to the amount of increase contractility ofthe heart in response to increase in volumes. The heart has a maximum amount ofstretch is can experience, and a maximum amount of contractility it couldproduce.",hierarchyLevel:6,children:[],index:"020708050600"},{text:" At higher volumes, a further increase in the preload does notsignificantly increase the stroke volume.",hierarchyLevel:6,children:[],index:"020708050601"},{text:" Therefore, each subsequent fluid challenges given sees adiminishing marginal increase in the stroke volume.",hierarchyLevel:6,children:[],index:"020708050602"}],index:"0207080506"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0207080507"}],index:"02070805"}],index:"020708"}],index:"0207"}]},{text:"Blood and Circulation",hierarchyLevel:1,children:[{text:" [011] Microcirculation and Tissue Fluid Exchange",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Parts of Circulatory System",hierarchyLevel:4,children:[{text:" Cardiovascular System",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Delivers blood to peripheral tissues and the lung",hierarchyLevel:7,children:[],index:"03000000000000"},{text:" Collects blood from peripheral tissues and the lung",hierarchyLevel:7,children:[],index:"03000000000001"}],index:"030000000000"},{text:" Components",hierarchyLevel:6,children:[{text:" Heart",hierarchyLevel:7,children:[],index:"03000000000100"},{text:" Blood vessels",hierarchyLevel:7,children:[],index:"03000000000101"}],index:"030000000001"}],index:"0300000000"},{text:" Lymphatic System",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Collects lymph from peripheral tissues and recycles it into thecardiovascular system",hierarchyLevel:7,children:[],index:"03000000010000"}],index:"030000000100"},{text:" Components",hierarchyLevel:6,children:[{text:" Lymph vessels",hierarchyLevel:7,children:[],index:"03000000010100"},{text:" Lymph nodes",hierarchyLevel:7,children:[],index:"03000000010101"}],index:"030000000101"}],index:"0300000001"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0300000002"}],index:"03000000"}],index:"030000"},{text:" Microcirculatory and Capillary System",hierarchyLevel:3,children:[{text:" General Flow of Blood",hierarchyLevel:4,children:[{text:" Arteriole",hierarchyLevel:5,children:[],index:"0300010000"},{text:" Metarteriole  contains some smooth muscle",hierarchyLevel:5,children:[],index:"0300010001"},{text:" Precapillary sphincter  final part containing smooth muscle,able to contract to regulate circulation",hierarchyLevel:5,children:[],index:"0300010002"},{text:" Preferential channel  channels which are always open, bypassesthe precapillary sphincter",hierarchyLevel:5,children:[],index:"0300010003"},{text:" True Capillaries",hierarchyLevel:5,children:[],index:"0300010004"}],index:"03000100"},{text:" Regulation of blood flow",hierarchyLevel:4,children:[{text:" Short-term regulation",hierarchyLevel:5,children:[{text:" Contraction and relaxation of precapillary sphincter",hierarchyLevel:6,children:[],index:"030001010000"}],index:"0300010100"},{text:" Long-term regulation",hierarchyLevel:5,children:[{text:" High metabolic rate tissues  high capillary density",hierarchyLevel:6,children:[],index:"030001010100"},{text:" Low metabolic rate tissues  low capillary density",hierarchyLevel:6,children:[],index:"030001010101"}],index:"0300010101"}],index:"03000101"},{text:" Determinant of Capillary Tension",hierarchyLevel:4,children:[{text:" oLaplaces  Law",hierarchyLevel:5,children:[{text:" Tension  dynes / cm",hierarchyLevel:7,children:[],index:"030001020000"},{text:" Pressure  dynes / cm",hierarchyLevel:7,children:[],index:"030001020001"},{text:" Radius  cm",hierarchyLevel:7,children:[],index:"030001020002"}],index:"0300010200"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Internal pressure of capillaries can be very high. However, dueto the small radius of the capillaries the overall tension will still be small.This ensures that the capillary will not rupture in high pressure situations(lower limb capillaries when patient is standing)",hierarchyLevel:6,children:[],index:"030001020100"}],index:"0300010201"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0300010202"}],index:"03000102"},{text:" Transcapillary Exchange Mechanism",hierarchyLevel:4,children:[{text:" Modes",hierarchyLevel:5,children:[{text:" Diffusion",hierarchyLevel:6,children:[],index:"030001030000"},{text:" Convection (Filtration / Reabsorption)",hierarchyLevel:6,children:[],index:"030001030001"},{text:" Pinocytosis",hierarchyLevel:6,children:[],index:"030001030002"}],index:"0300010300"}],index:"03000103"},{text:" Structural Classification of Capillaries",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" Closed",hierarchyLevel:6,children:[],index:"030001040000"},{text:" Fenestrated",hierarchyLevel:6,children:[],index:"030001040001"},{text:" Discontinuous",hierarchyLevel:6,children:[],index:"030001040002"}],index:"0300010400"}],index:"03000104"},{text:" Closed Capillaries",hierarchyLevel:4,children:[{text:" Structure and Function",hierarchyLevel:5,children:[],index:"0300010500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0300010501"}],index:"03000105"},{text:" Fenestrated Capillary",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Facilitate transport of molecules in and out of the capillary",hierarchyLevel:6,children:[],index:"030001060000"}],index:"0300010600"},{text:" Locations",hierarchyLevel:5,children:[{text:" Pancreas",hierarchyLevel:6,children:[],index:"030001060100"},{text:" Kidney",hierarchyLevel:6,children:[],index:"030001060101"}],index:"0300010601"},{text:" Structure and Function",hierarchyLevel:5,children:[],index:"0300010602"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0300010603"}],index:"03000106"},{text:" Discontinuous Capillary",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Enable the migration of macrophages into the capillary",hierarchyLevel:6,children:[],index:"030001070000"}],index:"0300010700"},{text:" Location",hierarchyLevel:5,children:[{text:" Liver sinusoid",hierarchyLevel:6,children:[],index:"030001070100"},{text:" Bone marrow",hierarchyLevel:6,children:[],index:"030001070101"},{text:" Spleen",hierarchyLevel:6,children:[],index:"030001070102"}],index:"0300010701"},{text:" Structure and Function",hierarchyLevel:5,children:[],index:"0300010702"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0300010703"}],index:"03000107"}],index:"030001"},{text:" Transcapillary Exchange",hierarchyLevel:3,children:[{text:" Purpose",hierarchyLevel:4,children:[{text:" Homeostatic maintenance of capillary molecules and fluids",hierarchyLevel:5,children:[],index:"0300020000"}],index:"03000200"},{text:" Exchange Mechanisms",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" Diffusion",hierarchyLevel:6,children:[],index:"030002010000"},{text:" Convection  filtration + reabsorption",hierarchyLevel:6,children:[],index:"030002010001"},{text:" Pinocytosis",hierarchyLevel:6,children:[],index:"030002010002"}],index:"0300020100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0300020101"}],index:"03000201"},{text:" Diffusion",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Result of random Brownian movement of water and solutes",hierarchyLevel:6,children:[],index:"030002020000"}],index:"0300020200"},{text:" Rate of Exchange",hierarchyLevel:5,children:[{text:" 3L / min / kg",hierarchyLevel:6,children:[],index:"030002020100"}],index:"0300020201"},{text:" Modes",hierarchyLevel:5,children:[{text:" Paracellular mechanism",hierarchyLevel:6,children:[],index:"030002020200"},{text:" Transcellular mechanism  channel proteins (aquaporins)",hierarchyLevel:6,children:[],index:"030002020201"}],index:"0300020202"}],index:"03000202"},{text:" Pinocytosis",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Organelle / membrane assisted",hierarchyLevel:6,children:[],index:"030002030000"}],index:"0300020300"},{text:" Modes",hierarchyLevel:5,children:[{text:" Receptor-mediated transport",hierarchyLevel:6,children:[],index:"030002030100"},{text:" Fluid-phase transport with vesicles",hierarchyLevel:6,children:[],index:"030002030101"},{text:" Transendothelial channel with fused vesicles",hierarchyLevel:6,children:[],index:"030002030102"}],index:"0300020301"}],index:"03000203"},{text:" Convection  filtration + reabsorption",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Colloid osmotic pressure  osmotic force created bymacromolecules that cannot be filtered",hierarchyLevel:6,children:[],index:"030002040000"},{text:" Oncotic pressure  osmotic force created by macromolecules thatcannot be filtered",hierarchyLevel:6,children:[],index:"030002040001"}],index:"0300020400"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Result of osmotic pressure differences",hierarchyLevel:6,children:[],index:"030002040100"},{text:" Result of hydrostatic pressure differences",hierarchyLevel:6,children:[],index:"030002040101"}],index:"0300020401"},{text:" Rate of Exchange",hierarchyLevel:5,children:[{text:" 0.6 mL / min / kg",hierarchyLevel:6,children:[],index:"030002040200"}],index:"0300020402"},{text:" Components",hierarchyLevel:5,children:[{text:" NOTE: higher the osmotic pressure, more the water wants to movein (direction is different from capillary pressure)",hierarchyLevel:6,children:[],index:"030002040300"}],index:"0300020403"},{text:" Diagram  Starling Forces",hierarchyLevel:5,children:[],index:"0300020404"},{text:" Pressures across a capillary",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030002040500"},{text:" Observations",hierarchyLevel:6,children:[{text:" Capillary Pressure (Pc) is higher are the start of the capillaryand decreases as it reaches to the end of the capillary",hierarchyLevel:7,children:[],index:"03000204050100"},{text:" Osmotic pressure within capillary is constant at 26",hierarchyLevel:7,children:[],index:"03000204050101"},{text:" Osmotic pressure within interstitial fluid is constant at 3",hierarchyLevel:7,children:[],index:"03000204050102"},{text:" Interstitial pressure is constant at 0",hierarchyLevel:7,children:[],index:"03000204050103"}],index:"030002040501"},{text:" Explanation",hierarchyLevel:6,children:[{text:" High capillary osmotic pressure causes water to want to move fromthe interstitial fluid into the capillaries",hierarchyLevel:7,children:[],index:"03000204050200"},{text:" Very high capillary pressure at the start of the capillary overcomes the capillary osmotic pressure, resulting in the net outflow of water andsolutes. Hence, filtration occurs.",hierarchyLevel:7,children:[],index:"03000204050201"},{text:" Lower capillary pressure at the end of the capillary is unable toovercome the capillary osmotic pressure, resulting in the net inflow of waterand solutes. Hence, reabsorption occurs.",hierarchyLevel:7,children:[],index:"03000204050202"},{text:" Net outflow of the solutes at the start of the capillary ishigher than the net inflow of solutes at the end of the capillary, resulting ina net leakage of fluids out of the capillary",hierarchyLevel:7,children:[],index:"03000204050203"},{text:" Excess fluid is drained by the lymphatic vessels through thelymphatic system",hierarchyLevel:7,children:[],index:"03000204050204"}],index:"030002040502"},{text:" Diagram",hierarchyLevel:6,children:[],index:"030002040503"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Net filtration at the start of the capillary leads to the outflowof water",hierarchyLevel:7,children:[],index:"03000204050400"},{text:" Outflow of water increases the concentration of plasma proteinswithin the capillary and hence increasing the osmolality.",hierarchyLevel:7,children:[],index:"03000204050401"},{text:" Increase in osmolality results in an gradual increase in oncoticpressure from the starts of the capillary to the end of the capillary.",hierarchyLevel:7,children:[],index:"03000204050402"}],index:"030002040504"}],index:"0300020405"},{text:" Pressures in a pulmonary capillaries",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030002040600"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Net movement of water and solutes in the pulmonary capillaries isalways inwards",hierarchyLevel:7,children:[],index:"03000204060100"},{text:" This protects against pulmonary oedema in the alveoli",hierarchyLevel:7,children:[],index:"03000204060101"}],index:"030002040601"}],index:"0300020406"},{text:" Pressures in glomerulus",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030002040700"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Net movement of water and solutes in glomerulus is alwaysoutwards",hierarchyLevel:7,children:[],index:"03000204070100"},{text:" This allows for filtration mechanism of the glomerulus",hierarchyLevel:7,children:[],index:"03000204070101"}],index:"030002040701"}],index:"0300020407"}],index:"03000204"}],index:"030002"},{text:" Imbalance of tissue fluid homeostasis",hierarchyLevel:3,children:[{text:" Volume of movement in circulatory system",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0300030000"},{text:" Explanation",hierarchyLevel:5,children:[{text:" 3L of lymph fluid generated in 24 hours",hierarchyLevel:6,children:[],index:"030003000100"},{text:" Hence, if lymphatic system is not working 3L of fluid will bestuck in the peripheral tissues in 24 hours",hierarchyLevel:6,children:[],index:"030003000101"}],index:"0300030001"}],index:"03000300"},{text:" Abnormal Function: Oedema  imbalance of tissue fluid homeostasis",hierarchyLevel:4,children:[{text:" Cause",hierarchyLevel:5,children:[{text:" Filtration > Reabsorption + Lymph drainage",hierarchyLevel:6,children:[],index:"030003010000"}],index:"0300030100"}],index:"03000301"},{text:" Cause 1: Congestive Heart Failure  increased venous pressure",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0300030200"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Increased venous pressure means that there is a shorter sectionof the capillary at which the net movement of water and solutes is inwards",hierarchyLevel:6,children:[],index:"030003020100"},{text:" As, length of net outward movement > length of net inwardmovement, the net change of fluid is outwards in a greater magnitude",hierarchyLevel:6,children:[],index:"030003020101"},{text:" The lymphatic drainage speed remains the same.",hierarchyLevel:6,children:[],index:"030003020102"},{text:" Therefore, increased leakage of capillary fluid starts toaccumulate in the peripheral tissue, resulting in oedema.",hierarchyLevel:6,children:[],index:"030003020103"}],index:"0300030201"}],index:"03000302"},{text:" Cause 2: Inflammation",hierarchyLevel:4,children:[{text:" Arteriolar vasodilation (hyperemia)",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030003030000"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Release of inflammatory mediators such as thrombin, bradikynin,histamine results in arteriolar vasodilation",hierarchyLevel:7,children:[],index:"03000303000100"},{text:" Arteriolar vasodilation results in increased arteriole pressure /tension (Laplaces equation)",hierarchyLevel:7,children:[],index:"03000303000101"},{text:" Increased arteriole pressure means that there is a longer sectionof the start of the capillary at which the net movement of water and solutes isoutwards",hierarchyLevel:7,children:[],index:"03000303000102"},{text:" As, length of net outward movement > length of net inwardmovement, the net change of fluid is outwards in a greater magnitude",hierarchyLevel:7,children:[],index:"03000303000103"},{text:" The lymphatic drainage speed remains the same.",hierarchyLevel:7,children:[],index:"03000303000104"},{text:" Therefore, increased leakage of capillary fluid starts toaccumulate in the peripheral tissue, resulting in oedema.",hierarchyLevel:7,children:[],index:"03000303000105"}],index:"030003030001"}],index:"0300030300"},{text:" Increased capillary permeability",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030003030100"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Release of inflammatory mediators such as thrombin, bradikynin,histamine results in increased capillary permeability",hierarchyLevel:7,children:[],index:"03000303010100"},{text:" Increase in capillary permeability increases the K constant inStarlings hypothesis",hierarchyLevel:7,children:[],index:"03000303010101"},{text:" K constant is multiplied by the net filtrate amount",hierarchyLevel:7,children:[],index:"03000303010102"},{text:" Therefore, increasing K constant will also increase the overallfiltrate amount.",hierarchyLevel:7,children:[],index:"03000303010103"},{text:" The lymphatic drainage speed remains the same.",hierarchyLevel:7,children:[],index:"03000303010104"},{text:" Therefore, increased filtrate amount results in the accumulationof fluid in the peripheral tissue, resulting in oedema.",hierarchyLevel:7,children:[],index:"03000303010105"}],index:"030003030101"}],index:"0300030301"}],index:"03000303"},{text:" Haemorrhage",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0300030400"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Haemorrhage results in loss of significant blood volume. Smallerblood volume results in the decrease in the arteriole pressure.",hierarchyLevel:6,children:[],index:"030003040100"},{text:" Decreased arteriole pressure means that there is a longer sectionof the end of the capillary at which the net movement of water and solutes isinwards.",hierarchyLevel:6,children:[],index:"030003040101"},{text:" As, length of net inward movement > length of net outwardmovement, the net change of fluid is inwards in a greater magnitude",hierarchyLevel:6,children:[],index:"030003040102"},{text:" This results in an increase in blood volume and a lowering of theinterstitial fluid volume",hierarchyLevel:6,children:[],index:"030003040103"}],index:"0300030401"}],index:"03000304"},{text:" Cause 3: Liver Failure  reduced plasma protein levels",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0300030500"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Nephrotic syndrome leads to the loss of plasma proteins. Thisresults in the lower plasma protein levels remaining the in capillaries.",hierarchyLevel:6,children:[],index:"030003050100"},{text:" Lower protein levels within the capillary decreases the osmoticpressure of the capillaries.",hierarchyLevel:6,children:[],index:"030003050101"},{text:" As a result, here is a longer section of the start of thecapillary at which the capillary pressure is higher than the capillary osmoticpressure and hence net movement of water and solutes is outwards",hierarchyLevel:6,children:[],index:"030003050102"},{text:" As, length of net outward movement > length of net inwardmovement, the net change of fluid is outwards in a greater magnitude",hierarchyLevel:6,children:[],index:"030003050103"},{text:" The lymphatic drainage speed remains the same.",hierarchyLevel:6,children:[],index:"030003050104"},{text:" Therefore, increased leakage of capillary fluid starts toaccumulate in the peripheral tissue, resulting in oedema.",hierarchyLevel:6,children:[],index:"030003050105"}],index:"0300030501"}],index:"03000305"},{text:" Cause 4: Reduced lymph drainage",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0300030600"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Problems with the lymphatic vessels results in reduced lymphdrainage",hierarchyLevel:6,children:[],index:"030003060100"},{text:" Reduced lymph drainage results in the accumulation of excesstissue fluid in the peripheral tissues, resulting in oedema",hierarchyLevel:6,children:[],index:"030003060101"}],index:"0300030601"}],index:"03000306"}],index:"030003"}],index:"0300"},{text:" [013] Body Fluid Compartments",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Total Body Water Composition",hierarchyLevel:4,children:[{text:" Body Fluids (60% of body weight  42L for 70kg individual)",hierarchyLevel:5,children:[{text:" Extracellular fluid (20% - 14L)",hierarchyLevel:6,children:[{text:" Interstitial fluid (16% - 11L)",hierarchyLevel:7,children:[],index:"03010000000000"},{text:" Plasma (4% - 3L)",hierarchyLevel:7,children:[],index:"03010000000001"}],index:"030100000000"},{text:" Intracellular fluid (40% - 28L)",hierarchyLevel:6,children:[],index:"030100000001"},{text:" Transcellular fluids",hierarchyLevel:6,children:[{text:" Aqueous humour",hierarchyLevel:7,children:[],index:"03010000000200"},{text:" Vitreous humour",hierarchyLevel:7,children:[],index:"03010000000201"},{text:" Synovial fluid",hierarchyLevel:7,children:[],index:"03010000000202"}],index:"030100000002"}],index:"0301000000"}],index:"03010000"}],index:"030100"},{text:" Measuring Body Fluid",hierarchyLevel:3,children:[{text:" Dilution Principle",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" An unknown volume of body fluid is present in an individual",hierarchyLevel:6,children:[],index:"030101000000"},{text:" Dissolve a known amount of solute in the individual",hierarchyLevel:6,children:[],index:"030101000001"},{text:" Measure the concentration of the solute in the individual",hierarchyLevel:6,children:[],index:"030101000002"},{text:" Use the concentration of the solute and the total amount ofsolute the determine the amount of solvent / body fluid present in theindividual",hierarchyLevel:6,children:[],index:"030101000003"}],index:"0301010000"},{text:" Equation",hierarchyLevel:5,children:[{text:" Volume = amount / concentration",hierarchyLevel:6,children:[],index:"030101000100"}],index:"0301010001"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0301010002"}],index:"03010100"},{text:" Choice of Solute",hierarchyLevel:4,children:[{text:" Principle",hierarchyLevel:5,children:[{text:" To measure a particular body fluid compartment, the solute mustonly be able to only dissolve in that compartment and NOT any other compartment",hierarchyLevel:6,children:[],index:"030101010000"}],index:"0301010100"},{text:" Table",hierarchyLevel:5,children:[],index:"0301010101"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0301010102"}],index:"03010101"},{text:" In vivo considerations",hierarchyLevel:4,children:[{text:" In vitro",hierarchyLevel:5,children:[],index:"0301010200"},{text:" In vivo",hierarchyLevel:5,children:[],index:"0301010201"},{text:" Considerations",hierarchyLevel:5,children:[],index:"0301010202"}],index:"03010102"}],index:"030101"},{text:" Composition of body fluids",hierarchyLevel:3,children:[{text:" Diagram",hierarchyLevel:4,children:[],index:"03010200"},{text:" Principle",hierarchyLevel:4,children:[{text:" Composition of body fluids in intracellular and extracellularareas are determined by the presence of transport proteins on the plasmamembrane",hierarchyLevel:5,children:[],index:"0301020100"}],index:"03010201"},{text:" Example",hierarchyLevel:4,children:[{text:" Na  / K  ATPase ensures high concentrationof Na  on the outside and high concentration of K  on theinside",hierarchyLevel:5,children:[],index:"0301020200"}],index:"03010202"},{text:" Observations",hierarchyLevel:4,children:[{text:" Cations are balanced by presence of anions",hierarchyLevel:5,children:[],index:"0301020300"},{text:" Total concentration of intracellular solutes = Totalconcentration of extracellular solutes",hierarchyLevel:5,children:[],index:"0301020301"}],index:"03010203"}],index:"030102"},{text:" Osmotic Pressure",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Osmotic pressure  The osmotic pressure is the pressure that isjust sufficient to prevent the movement of water into a solution across asemi-permeable membrane",hierarchyLevel:5,children:[],index:"0301030000"},{text:" Hydrostatic pressure  The hydrostatic pressure is the pressureexerted by the water molecules trying to move into the membrane",hierarchyLevel:5,children:[],index:"0301030001"}],index:"03010300"},{text:" Explanation",hierarchyLevel:4,children:[{text:" The higher the solute concentration, the higher the osmoticpressure",hierarchyLevel:5,children:[],index:"0301030100"},{text:" This is because the higher the solute concentration, the morewater wants to move in.",hierarchyLevel:5,children:[],index:"0301030101"},{text:" However, if water just moves in, then there is no longer anypressure. Therefore, osmotic pressure, is the force preventing the water frommoving in, hence maintaining the state at which there is a pressure differencebetween the two sides.",hierarchyLevel:5,children:[],index:"0301030102"}],index:"03010301"},{text:" Units",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" Osmolarity (moles / L)  moles of solute particles per litre ofwater",hierarchyLevel:6,children:[],index:"030103020000"},{text:" Osmolality (Osmol / kg)  osmoles of solute particles per kg ofwater",hierarchyLevel:6,children:[],index:"030103020001"},{text:" Osmole (Osmol)  1 mole of any non-dissociable substance",hierarchyLevel:6,children:[],index:"030103020002"}],index:"0301030200"},{text:" Relationship",hierarchyLevel:5,children:[{text:" 1 mole NaCl in 1 kg of water",hierarchyLevel:6,children:[{text:" NaCl is dissociable. Na  and Cl  is notdissociable. Use Na  and Cl  to calculate",hierarchyLevel:7,children:[],index:"03010302010000"},{text:" Osmolality  = 2 Osmol / kg",hierarchyLevel:7,children:[],index:"03010302010001"},{text:" Osmolarity = 1 mol / L",hierarchyLevel:7,children:[],index:"03010302010002"}],index:"030103020100"}],index:"0301030201"},{text:" Total Osmolality",hierarchyLevel:5,children:[{text:" The total osmolality of a solution is the sum of the osmolalitydue to each of the constituents of the solution",hierarchyLevel:6,children:[],index:"030103020200"}],index:"0301030202"},{text:" Osmolality in Blood Plasma",hierarchyLevel:5,children:[{text:" Na , Cl , HCO contribute most of osmolality",hierarchyLevel:6,children:[],index:"030103020300"},{text:" Glucose and small molecules < 10 mOsmol / kg",hierarchyLevel:6,children:[],index:"030103020301"},{text:" Plasma proteins 1 mOsmol / kg ( < 0.5% of total plasmaosmolality)",hierarchyLevel:6,children:[],index:"030103020302"}],index:"0301030203"}],index:"03010302"},{text:" Tonicity",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Tonicity  the measure of an osmotic pressure gradient betweentwo solutions separated by a semi-permeable membrane",hierarchyLevel:6,children:[],index:"030103030000"},{text:" Tonicity of Solution  the influence of the osmolality ofsolution on the volume of cells",hierarchyLevel:6,children:[],index:"030103030001"},{text:" Iso-osmotic  Two solutions with same osmolality, with or withouteffective osmoles",hierarchyLevel:6,children:[],index:"030103030002"},{text:" Iso-tonic  Two solutions with the same osmolality, witheffective osmoles",hierarchyLevel:6,children:[],index:"030103030003"},{text:" Effective osmole  non-dissociable solute that is unable to passthrough the plasma membrane",hierarchyLevel:6,children:[],index:"030103030004"},{text:" Ineffective osmole  non-dissociable solute that is able to passthrough the plasma membrane",hierarchyLevel:6,children:[],index:"030103030005"}],index:"0301030300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0301030301"},{text:" Mechanism of Iso-osmotic solution and non-isotonic solution",hierarchyLevel:5,children:[{text:" The solution is iso-osmotic",hierarchyLevel:6,children:[],index:"030103030200"},{text:" After the cell is placed in the solution, due to the presence ofineffective osmoles in the solution, the ineffective osmoles enter the cell viadiffusion down the concentration gradient",hierarchyLevel:6,children:[],index:"030103030201"},{text:" Entry of ineffective osmoles into the cell increases theosmolality of the cell to a level higher than that of the solution.",hierarchyLevel:6,children:[],index:"030103030202"},{text:" Hence, water moves into the cell by osmosis, resulting in celllysis.",hierarchyLevel:6,children:[],index:"030103030203"}],index:"0301030302"}],index:"03010303"},{text:" Effect of Solution Injection in Body Fluid Compartments",hierarchyLevel:4,children:[{text:" Acronyms",hierarchyLevel:5,children:[{text:" TBW  total body water",hierarchyLevel:6,children:[],index:"030103040000"},{text:" ECF  extracellular fluid",hierarchyLevel:6,children:[],index:"030103040001"},{text:" ICF  intracellular fluid",hierarchyLevel:6,children:[],index:"030103040002"}],index:"0301030400"},{text:" Addition of 1L of water",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030103040100"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Water enters into the extracellular fluid first.",hierarchyLevel:7,children:[],index:"03010304010100"},{text:" Water distributes evenly throughout the entire body. This isbecause water is permeable both inside and outside the cell, and in bloodvessels",hierarchyLevel:7,children:[],index:"03010304010101"}],index:"030103040101"}],index:"0301030401"},{text:" Addition of 1L of 0.9% Saline",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030103040200"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Na  is an effective osmole and is unable to enter thecell (partly due to Na - K  ATP synthase)",hierarchyLevel:7,children:[],index:"03010304020100"},{text:" 0.9% saline is iso-osmotic",hierarchyLevel:7,children:[],index:"03010304020101"},{text:" Due to Na  being an effective osmole, 0.9% saline isisotonic.",hierarchyLevel:7,children:[],index:"03010304020102"},{text:" Therefore, there is no net movement of water and the 1L of salineremains in the extracellular fluid.",hierarchyLevel:7,children:[],index:"03010304020103"}],index:"030103040201"}],index:"0301030402"},{text:" Addition of 1L Plasma Protein (intravenous)",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030103040300"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Plasma proteins is an effective osmole and remains in the bloodvessels, hence injected solution is iso-tonic and iso-osmotic.",hierarchyLevel:7,children:[],index:"03010304030100"},{text:" There is no net movement of water between the blood vessels andthe interstitial fluid or cells",hierarchyLevel:7,children:[],index:"03010304030101"},{text:" 1L of plasma protein solution remains in the blood vessels",hierarchyLevel:7,children:[],index:"03010304030102"}],index:"030103040301"}],index:"0301030403"}],index:"03010304"}],index:"030103"}],index:"0301"},{text:" [015] Haemoglobin Structure and Function",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Types of Haemoglobin",hierarchyLevel:4,children:[{text:" Haemaglobin A  2 \u03b1 chains, 2 \u03b2 chains",hierarchyLevel:5,children:[],index:"0302000000"},{text:" Haemaglobin B  2 \u03b1 chains, 2 \u03b3 chains",hierarchyLevel:5,children:[],index:"0302000001"},{text:" Haemaglobin C  2 \u03b1 chains, 2 \u03b4 chains",hierarchyLevel:5,children:[],index:"0302000002"}],index:"03020000"},{text:" Overall Structure",hierarchyLevel:4,children:[{text:" Tetrameter",hierarchyLevel:5,children:[],index:"0302000100"},{text:" 2 pairs of globin chains",hierarchyLevel:5,children:[],index:"0302000101"},{text:" Each globin contains haem group  allow for oxygen binding",hierarchyLevel:5,children:[],index:"0302000102"}],index:"03020001"},{text:" Globin Structure",hierarchyLevel:4,children:[{text:" Primary",hierarchyLevel:5,children:[{text:" \u03b2, \u03b3, \u03b4  146 amino acids",hierarchyLevel:6,children:[],index:"030200020000"},{text:" \u03b1  141 amino acids",hierarchyLevel:6,children:[],index:"030200020001"},{text:" 9 conserved amino acids for O  binding",hierarchyLevel:6,children:[],index:"030200020002"}],index:"0302000200"},{text:" Secondary",hierarchyLevel:5,children:[{text:" 70% alpha helix",hierarchyLevel:6,children:[],index:"030200020100"}],index:"0302000201"},{text:" Tertiary",hierarchyLevel:5,children:[{text:" Folding determined by siting of inward facing non-polar residues",hierarchyLevel:6,children:[],index:"030200020200"}],index:"0302000202"},{text:" Quartenary",hierarchyLevel:5,children:[{text:" Tetrameric with 2 dimers",hierarchyLevel:6,children:[{text:" 1  Dimer  \u03b11, \u03b21",hierarchyLevel:7,children:[],index:"03020002030000"},{text:" 2  Dimer  \u03b12, \u03b22",hierarchyLevel:7,children:[],index:"03020002030001"},{text:" 1  Dimer sits on top of 2  Dimer",hierarchyLevel:7,children:[],index:"03020002030002"}],index:"030200020300"},{text:" Structure of globin changes upon oxygenation",hierarchyLevel:6,children:[],index:"030200020301"},{text:" Subunits able to interact with other molecules to causeallosteric effects",hierarchyLevel:6,children:[],index:"030200020302"}],index:"0302000203"}],index:"03020002"},{text:" Haem Structure",hierarchyLevel:4,children:[{text:" Components",hierarchyLevel:5,children:[{text:" Protoporphyrin ring  contains iron at the centre",hierarchyLevel:6,children:[],index:"030200030000"},{text:" Haem iron  6 coordinating valencies (4  nitrogen pyrrole rings,2  histidine residues in globin)",hierarchyLevel:6,children:[],index:"030200030001"},{text:" Distal histidine bond  unstable and easily replaced by oxygen tofor Oxyhaemoglobin",hierarchyLevel:6,children:[],index:"030200030002"}],index:"0302000300"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"030200030100"}],index:"0302000301"}],index:"03020003"},{text:" Haem Synthesis",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" ALA synthase combines Succinate and Glycine via a condensationreaction to form delta amino-laevulinic acid (d-ALA)",hierarchyLevel:6,children:[],index:"030200040000"},{text:" ALA dehydrase converts d-ALA into Porphobilinogen (PBG)",hierarchyLevel:6,children:[],index:"030200040001"},{text:" Urophorphyrinogen I synthase converts Porphobilinogen intoUrophorphobilinogen",hierarchyLevel:6,children:[],index:"030200040002"},{text:" Uroporphyrinogen decarboxylase converts Urophorphobilinogen intoCoproporphyrin III",hierarchyLevel:6,children:[],index:"030200040003"},{text:" Coproporphyrinogen oxidase converts Coproporphyrinogen into Protoporphyrin",hierarchyLevel:6,children:[],index:"030200040004"},{text:" Ferrochelatase inserts iron into Protoporphyrin to form haem",hierarchyLevel:6,children:[],index:"030200040005"}],index:"0302000400"},{text:" Rate Determining Stem",hierarchyLevel:5,children:[{text:" ALA synthase",hierarchyLevel:6,children:[],index:"030200040100"}],index:"0302000401"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0302000402"}],index:"03020004"},{text:" Genetic Control of Globin Synthesis",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Each globin gene contains 3 exons and 2 introns",hierarchyLevel:6,children:[],index:"030200050000"},{text:" Globin genes contains introns beginning with G-T and ending withA-G di-nucleotides",hierarchyLevel:6,children:[],index:"030200050001"},{text:" Beginning and ending sequence are recognized and are splicedaway, leaving behind the exons to be translated",hierarchyLevel:6,children:[],index:"030200050002"},{text:" Upon translation, globin protein from different globin genescombine to form the tetramer",hierarchyLevel:6,children:[],index:"030200050003"}],index:"0302000500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0302000501"},{text:" Change in Globin Concentration",hierarchyLevel:5,children:[{text:" \u03b1 globin is produced very early into the pregnancy.Therefore, failure to produce \u03b1 globin will result in problems for thefetus",hierarchyLevel:6,children:[],index:"030200050200"},{text:" \u03b2 globin is produced right before birth. Therefore, failureto produce \u03b2 globin will only cause problems after birth.",hierarchyLevel:6,children:[],index:"030200050201"}],index:"0302000502"},{text:" Locations of globin Production",hierarchyLevel:5,children:[{text:" \u03b3  liver and spleen",hierarchyLevel:6,children:[],index:"030200050300"},{text:" \u03b2  bone marrow",hierarchyLevel:6,children:[],index:"030200050301"}],index:"0302000503"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0302000504"}],index:"03020005"},{text:" O  binding on Haemoglobin",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Binding of O  on one globin chain increases theaffinity of the other globin chains to oxygen (cooperative)",hierarchyLevel:6,children:[],index:"030200060000"},{text:" H  and CO  binding on globin promotes therelease of O  (Bohr effect)",hierarchyLevel:6,children:[],index:"030200060001"},{text:" DPG lowers O  affinity",hierarchyLevel:6,children:[],index:"030200060002"}],index:"0302000600"},{text:" Process",hierarchyLevel:5,children:[{text:" O  binds to the globin chains, resulting in changes tothe quaternary structure of haemoglobin",hierarchyLevel:6,children:[],index:"030200060100"},{text:" Binding of O  results in the breaking of salt bridges,and hence proximal His is transmitted to subunits.",hierarchyLevel:6,children:[],index:"030200060101"},{text:" As a result, there is rotation of \u03b1\u03b2 globin pairs overeach other at 15.",hierarchyLevel:6,children:[],index:"030200060102"},{text:" As a result, haemoglobin changes from an open and taut (T)structure into a compact and relaxed (R) structure.",hierarchyLevel:6,children:[],index:"030200060103"}],index:"0302000601"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0302000602"}],index:"03020006"},{text:" DPG binding on Haemoglobin",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" DPG  2,3 Diphosphoglyceric Acid",hierarchyLevel:6,children:[],index:"030200070000"},{text:" P50  Oxygen partial pressure at which haemoglobin is 50%saturated",hierarchyLevel:6,children:[],index:"030200070001"}],index:"0302000700"},{text:" Process",hierarchyLevel:5,children:[{text:" DPG binds to the central cavity of deoxy-Hb, which forms crosslinks with positively changed \u03b2 residues. This stablises DPG.",hierarchyLevel:6,children:[],index:"030200070100"},{text:" DPG does not bind to the Oxy-Hb central cavity as the cavity istoo small to fit DPG",hierarchyLevel:6,children:[],index:"030200070101"},{text:" Stabilization of deoxy-Hb shifts the equilibrium towards deox-Hb,resulting in the decease in O  affinity.",hierarchyLevel:6,children:[],index:"030200070102"},{text:" This results in a rightward shift in the oxygen dissociation curve.",hierarchyLevel:6,children:[],index:"030200070103"}],index:"0302000701"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0302000702"},{text:" Clinical Effects of DPG",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030200070300"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Loss of DPG in stored (refrigerated) red cells results in theoxygen dissociations curve to shift rig htwards again",hierarchyLevel:7,children:[],index:"03020007030100"},{text:" Rightwards shift of the oxygen dissociation curve results in the decreaseof P",hierarchyLevel:7,children:[],index:"03020007030101"},{text:" In people with lung disease or are at high altitudes, the bodyadapts by producing more DPG. This results in the leftward shift of the oxygendissociation curve, causing an increase in P",hierarchyLevel:7,children:[],index:"03020007030102"}],index:"030200070301"},{text:" Interpretation",hierarchyLevel:6,children:[{text:" A decrease in P  means that a lower oxygenconcentration is required in order to unload oxygen (must be very far away fromthe lungs), oxygen is less readily unloaded",hierarchyLevel:7,children:[],index:"03020007030200"},{text:" An increase of P  means that even with a higheroxygen concentration, oxygen can be unloaded (does not have to be very far awayfrom the lungs), oxygen is more readily unloaded",hierarchyLevel:7,children:[],index:"03020007030201"}],index:"030200070302"}],index:"0302000703"}],index:"03020007"}],index:"030200"},{text:" Haemoglobin Disorders",hierarchyLevel:3,children:[{text:" Types of Disorders",hierarchyLevel:4,children:[{text:" Structural globin defects  HbSS (sickle cell)",hierarchyLevel:5,children:[],index:"0302010000"},{text:" Decreased globin synthesis  thalassaemia",hierarchyLevel:5,children:[],index:"0302010001"}],index:"03020100"},{text:" Prevalence of Disorders",hierarchyLevel:4,children:[],index:"03020101"},{text:" Pathophysiology of Thalassemia",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" There is a reduced production of \u03b1 or \u03b2 globin",hierarchyLevel:6,children:[],index:"030201020000"},{text:" Excess of unaffected globin leads to globin imbalance andprecipitation of large insoluble precipitates.",hierarchyLevel:6,children:[],index:"030201020001"},{text:" Large insoluble precipitates causes cell damage, leading tohaemolysis in red blood cells and ineffective erythropoiesis in the bonemarrow.",hierarchyLevel:6,children:[],index:"030201020002"},{text:" Increased haemolysis leads to the enlargement of the spleen,leading to splenomegaly.",hierarchyLevel:6,children:[],index:"030201020003"},{text:" Haemolysis and ineffective erythropoiesis leads to anaemia. Thisleads to further release of erythropoietin, which causes erythroid marrowexpansion.",hierarchyLevel:6,children:[],index:"030201020004"},{text:" Erythroid marrow expansion leads to skeletal deformities andosteopenia.",hierarchyLevel:6,children:[],index:"030201020005"},{text:" Erythroid marrow expansion results in increased iron absorption.",hierarchyLevel:6,children:[],index:"030201020006"},{text:" Increased iron absorption and blood transfusion (to treatanaemia) results in iron overload.",hierarchyLevel:6,children:[],index:"030201020007"}],index:"0302010200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0302010201"}],index:"03020102"},{text:" Classification of Thalassemias",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" 0 mutation  deletion of all genes",hierarchyLevel:6,children:[],index:"030201030000"},{text:" + mutation  deletion of 1 gene",hierarchyLevel:6,children:[],index:"030201030001"}],index:"0302010300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0302010301"},{text:" \u03b1 globin  deletion mutations",hierarchyLevel:5,children:[{text:" 0 mutation  deletion of both \u03b1 genes on the allele",hierarchyLevel:6,children:[],index:"030201030200"},{text:" + mutation  deletion of 1 \u03b1 gene on the allele",hierarchyLevel:6,children:[],index:"030201030201"}],index:"0302010302"},{text:" \u0392 globin  point mutations of the gene (severity of themutation) (200 types of mutations)",hierarchyLevel:5,children:[{text:" 0 mutation  severe point mutation",hierarchyLevel:6,children:[],index:"030201030300"},{text:" + mutation  mild point mutation",hierarchyLevel:6,children:[],index:"030201030301"}],index:"0302010303"},{text:" Classification",hierarchyLevel:5,children:[{text:" \u03b1 thalassaemias",hierarchyLevel:6,children:[],index:"030201030400"},{text:" \u03b2 thalassaemias",hierarchyLevel:6,children:[{text:" \u0392 Thallassaemia intermedia  mild homozygous / amelioratingfactor (does not require regular blood transfusions)",hierarchyLevel:7,children:[],index:"03020103040100"}],index:"030201030401"}],index:"0302010304"}],index:"03020103"},{text:" Clinical Presentation  of  \u03b2-Thalassaemia",hierarchyLevel:4,children:[{text:" Signs and Symptoms",hierarchyLevel:5,children:[{text:" Severe transfusion dependent anaemia",hierarchyLevel:6,children:[],index:"030201040000"},{text:" Presents 1-2 months after birth",hierarchyLevel:6,children:[],index:"030201040001"},{text:" Anaemia requiring transfusion",hierarchyLevel:6,children:[],index:"030201040002"},{text:" Expansion of bone marrow",hierarchyLevel:6,children:[],index:"030201040003"},{text:" Cardiac death from iron overload",hierarchyLevel:6,children:[],index:"030201040004"}],index:"0302010400"},{text:" Iron Overload",hierarchyLevel:5,children:[{text:" Organs Affected",hierarchyLevel:6,children:[{text:" Pituitary gland",hierarchyLevel:7,children:[],index:"03020104010000"},{text:" Heart",hierarchyLevel:7,children:[],index:"03020104010001"},{text:" Liver",hierarchyLevel:7,children:[],index:"03020104010002"},{text:" Pancreas",hierarchyLevel:7,children:[],index:"03020104010003"},{text:" Gonadal",hierarchyLevel:7,children:[],index:"03020104010004"}],index:"030201040100"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Iron overload results in presence of non-transferrin-bound ironin the blood plasma",hierarchyLevel:7,children:[],index:"03020104010100"},{text:" Iron in the blood plasma is taken up into specific organs",hierarchyLevel:7,children:[],index:"03020104010101"},{text:" Iron within specific organs serves as a catalyst to generate freehydroxyl radicals",hierarchyLevel:7,children:[],index:"03020104010102"},{text:" Free hydroxyl radicals cause tissue damage",hierarchyLevel:7,children:[],index:"03020104010103"}],index:"030201040101"}],index:"0302010401"}],index:"03020104"},{text:" Treatment of \u03b2-Thalassaemia",hierarchyLevel:4,children:[{text:" Standard Treatment",hierarchyLevel:5,children:[{text:" Blood Transfusion",hierarchyLevel:6,children:[{text:" 3-4 weeks",hierarchyLevel:7,children:[],index:"03020105000000"},{text:" Attain mean haemoglobin 12g / dl",hierarchyLevel:7,children:[],index:"03020105000001"}],index:"030201050000"},{text:" Chelation",hierarchyLevel:6,children:[{text:" Desferrioxamine",hierarchyLevel:7,children:[{text:" 40mg/kg 8-10h > 6 times / week",hierarchyLevel:8,children:[],index:"0302010500010000"},{text:" Start at 3  year or ferritin >= 1000ug / L",hierarchyLevel:8,children:[],index:"0302010500010001"}],index:"03020105000100"},{text:" Deferasirox (Exjade)  Oral 20-40mg / kg once daily",hierarchyLevel:7,children:[],index:"03020105000101"},{text:" Deferiprone (Oral) 25mg / kg tds",hierarchyLevel:7,children:[],index:"03020105000102"}],index:"030201050001"},{text:" Monitoring",hierarchyLevel:6,children:[{text:" Serum ferritin",hierarchyLevel:7,children:[],index:"03020105000200"},{text:" Liver Iron Concentration",hierarchyLevel:7,children:[],index:"03020105000201"},{text:" Heart iron and function (MRI)",hierarchyLevel:7,children:[],index:"03020105000202"},{text:" Organ damage",hierarchyLevel:7,children:[],index:"03020105000203"}],index:"030201050002"}],index:"0302010500"},{text:" Iron overload vs Iron chelator overload",hierarchyLevel:5,children:[],index:"0302010501"},{text:" Other Treatments",hierarchyLevel:5,children:[{text:" Bone marrow transplantation",hierarchyLevel:6,children:[],index:"030201050200"},{text:" Antenatal Diagnosis / Screening",hierarchyLevel:6,children:[],index:"030201050201"},{text:" Gene Therapy  gene replacement, gene beta to gamma switching",hierarchyLevel:6,children:[],index:"030201050202"}],index:"0302010502"}],index:"03020105"},{text:" Sickle Cell Anaemia (SS)",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Autosomal reccesive",hierarchyLevel:6,children:[],index:"030201060000"},{text:" Heterozygous condition  50% HbA, 50% HbS, results in healthypatient",hierarchyLevel:6,children:[],index:"030201060001"},{text:" Homozygous condition  100% HbS, results in sickle cell disease",hierarchyLevel:6,children:[],index:"030201060002"},{text:" Compound Heterozygous  condition  HbSC, like HbSSbut milder",hierarchyLevel:6,children:[],index:"030201060003"}],index:"0302010600"},{text:" Process",hierarchyLevel:5,children:[{text:" \u03b2 globin gene of 6  position experiences amissense mutation where glutamic acid is switched to valine",hierarchyLevel:6,children:[],index:"030201060100"},{text:" This results in the polymerization of deoxygenated HbS, whichleads to red cell distortion.",hierarchyLevel:6,children:[],index:"030201060101"},{text:" Red cell distortion leads to the blockage of blood vessels(vaso-occlusion ). Micro-vascular obstruction leads to acute crises andchronic progressive organ damage.",hierarchyLevel:6,children:[],index:"030201060102"},{text:" Red cell distortion leads to the sequestration of red blood cellsin the spleen and in the chest (leads to chest syndrome)",hierarchyLevel:6,children:[],index:"030201060103"},{text:" Red cell distortion leads to increased haemolysis of distortedred blood cells. This leads to haemolytic anaemia.",hierarchyLevel:6,children:[],index:"030201060104"}],index:"0302010601"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0302010602"}],index:"03020106"},{text:" Clinical Presentation of Sickle Cell Anaemia (SS)",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Infarction  death of tissue resulting from failure of bloodsupply",hierarchyLevel:6,children:[],index:"030201070000"}],index:"0302010700"},{text:" Signs and Symptoms",hierarchyLevel:5,children:[{text:" Chronic haemolytic anaemia",hierarchyLevel:6,children:[],index:"030201070100"},{text:" Sequestration crises",hierarchyLevel:6,children:[],index:"030201070101"},{text:" Infarction of the spleen leading to increased risk of infection(Pneumococcus)",hierarchyLevel:6,children:[],index:"030201070102"},{text:" Sudden onset of painful (infarctive) crises ",hierarchyLevel:6,children:[],index:"030201070103"},{text:" Stroke in 10% of children",hierarchyLevel:6,children:[],index:"030201070104"}],index:"0302010701"},{text:" Signs and Symptoms (chronic)",hierarchyLevel:5,children:[],index:"0302010702"},{text:" Prevalence of Symptoms",hierarchyLevel:5,children:[],index:"0302010703"},{text:" Vaso-occlusive pain syndromes ",hierarchyLevel:5,children:[{text:" Hand  foot (6 months  4 years)",hierarchyLevel:6,children:[],index:"030201070400"},{text:" Limb pain",hierarchyLevel:6,children:[],index:"030201070401"},{text:" Back pain",hierarchyLevel:6,children:[],index:"030201070402"},{text:" Chest pain  ribs / sternum",hierarchyLevel:6,children:[],index:"030201070403"},{text:" Abdominal pain  bowl infarction, cholecystitis",hierarchyLevel:6,children:[],index:"030201070404"},{text:" Priapism",hierarchyLevel:6,children:[],index:"030201070405"}],index:"0302010704"}],index:"03020107"},{text:" Sickle Chest Syndrome",hierarchyLevel:4,children:[{text:" Signs",hierarchyLevel:5,children:[{text:" Hypoxia",hierarchyLevel:6,children:[],index:"030201080000"}],index:"0302010800"},{text:" Diagnosis",hierarchyLevel:5,children:[{text:" Pulse Oximetry  4% of more drop in the oxygen tension showspossibility of chest syndrome",hierarchyLevel:6,children:[],index:"030201080100"}],index:"0302010801"}],index:"03020108"},{text:" Prognosis of Sickle Cell Anaemia",hierarchyLevel:4,children:[],index:"03020109"},{text:" Management of Sickle Cell Anaemia",hierarchyLevel:4,children:[{text:" Prevent and treat acute complications",hierarchyLevel:5,children:[{text:" Prevent and treat infections (esp. pneumococcal)",hierarchyLevel:6,children:[],index:"030201100000"},{text:" Prevent painful crises  Education of patients and parents aboutrisks",hierarchyLevel:6,children:[],index:"030201100001"},{text:" Educate about splenic sequestration",hierarchyLevel:6,children:[],index:"030201100002"},{text:" Recognize complications early (especially chest syndrome) ",hierarchyLevel:6,children:[],index:"030201100003"},{text:" Treat pain rapidly and effectively",hierarchyLevel:6,children:[],index:"030201100004"},{text:" Stroke primary and secondary prevention",hierarchyLevel:6,children:[],index:"030201100005"}],index:"0302011000"},{text:" Prevent Organ damage",hierarchyLevel:5,children:[{text:" Stroke & Cognitive loss",hierarchyLevel:6,children:[],index:"030201100100"},{text:" Renal disease",hierarchyLevel:6,children:[],index:"030201100101"},{text:" Pulmonary hypertension",hierarchyLevel:6,children:[],index:"030201100102"}],index:"0302011001"},{text:" Specific anti-sickling options",hierarchyLevel:5,children:[{text:" Transfusion",hierarchyLevel:6,children:[],index:"030201100200"},{text:" Hydroxyurea",hierarchyLevel:6,children:[],index:"030201100201"}],index:"0302011002"},{text:" Curative ",hierarchyLevel:5,children:[{text:" Stem cell transplantation",hierarchyLevel:6,children:[],index:"030201100300"},{text:" Gene Therapy",hierarchyLevel:6,children:[],index:"030201100301"}],index:"0302011003"}],index:"03020110"},{text:" Patient Lifecycle",hierarchyLevel:4,children:[{text:" Well at birth (High Hb F) ",hierarchyLevel:5,children:[],index:"0302011100"},{text:" Infancy",hierarchyLevel:5,children:[{text:" sequestration crises (spleen) ",hierarchyLevel:6,children:[],index:"030201110100"},{text:"  pneumococcal sepsis in infancy ",hierarchyLevel:6,children:[],index:"030201110101"}],index:"0302011101"},{text:" Childhood ",hierarchyLevel:5,children:[{text:" hand-foot infarction ",hierarchyLevel:6,children:[],index:"030201110200"},{text:" painful crises",hierarchyLevel:6,children:[],index:"030201110201"},{text:" chest syndrome",hierarchyLevel:6,children:[],index:"030201110202"},{text:" stroke",hierarchyLevel:6,children:[],index:"030201110203"}],index:"0302011102"},{text:" Adult",hierarchyLevel:5,children:[{text:" Painful crises as adult (long bones, chest, abdomen, CNS)",hierarchyLevel:6,children:[],index:"030201110300"},{text:" Chest syndrome",hierarchyLevel:6,children:[],index:"030201110301"}],index:"0302011103"},{text:" Pregnancy",hierarchyLevel:5,children:[{text:" maternal & foetal morbidity & mortality ",hierarchyLevel:6,children:[],index:"030201110400"}],index:"0302011104"},{text:" Old age",hierarchyLevel:5,children:[{text:" renal failure",hierarchyLevel:6,children:[],index:"030201110500"}],index:"0302011105"}],index:"03020111"}],index:"030201"}],index:"0302"},{text:" [032] Blood gases in critical illness andanaesthesia",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Distinguish the key 'acid base' information on a blood gas",hierarchyLevel:4,children:[],index:"03030000"},{text:" Understand the 3 basic steps to reading blood gases: pH, pCO2,HCO3- /Base Excess (BEx)",hierarchyLevel:4,children:[],index:"03030001"},{text:" Recognise the 4 uncompensated pathologies of blood gases:respiratory acidosis/alkalosis & metabolic acidosis/alkalosis",hierarchyLevel:4,children:[],index:"03030002"},{text:" Understand the causes of the pathologies illustrated by bloodgases",hierarchyLevel:4,children:[],index:"03030003"},{text:" Understand how the body compensates for these pathologies",hierarchyLevel:4,children:[],index:"03030004"},{text:" Give examples of acid base disorders",hierarchyLevel:4,children:[],index:"03030005"},{text:" Be able to work out a basic SBA / OCAPE station",hierarchyLevel:4,children:[],index:"03030006"}],index:"030300"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Process of taking Blood Gas",hierarchyLevel:4,children:[{text:" Taking a sample of blood from the blood vessel",hierarchyLevel:5,children:[],index:"0303010000"},{text:" Inserting the sample of blood into the machine",hierarchyLevel:5,children:[],index:"0303010001"},{text:" Measuring the pH, pO2 and pCO2",hierarchyLevel:5,children:[],index:"0303010002"}],index:"03030100"},{text:" Elements of Blood Gas",hierarchyLevel:4,children:[{text:" Acid/Base parts",hierarchyLevel:5,children:[{text:" pH, pCO , HCO",hierarchyLevel:6,children:[],index:"030301010000"}],index:"0303010100"},{text:" pO  and other oxygen information",hierarchyLevel:5,children:[],index:"0303010101"},{text:" Na , Haemoglobin, etc.",hierarchyLevel:5,children:[],index:"0303010102"}],index:"03030101"},{text:" Source of Blood Sample",hierarchyLevel:4,children:[{text:" Artery",hierarchyLevel:5,children:[],index:"0303010200"},{text:" Vein",hierarchyLevel:5,children:[],index:"0303010201"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0303010202"}],index:"03030102"}],index:"030301"},{text:" Units",hierarchyLevel:3,children:[{text:" pH",hierarchyLevel:4,children:[{text:" Formula",hierarchyLevel:5,children:[{text:" pH = -log  [H ]",hierarchyLevel:6,children:[],index:"030302000000"}],index:"0303020000"},{text:" Definitions",hierarchyLevel:5,children:[{text:" Acidaemia  abnormally high blood acidity",hierarchyLevel:6,children:[],index:"030302000100"},{text:" Alkalaemia  abnormally high blood alkalinity",hierarchyLevel:6,children:[],index:"030302000101"},{text:" nano Mole (nm)  1 x 10",hierarchyLevel:6,children:[],index:"030302000102"},{text:" micro Mole (nm)  1 x 10",hierarchyLevel:6,children:[],index:"030302000103"},{text:" milli Mole (nm)  1 x 10",hierarchyLevel:6,children:[],index:"030302000104"}],index:"0303020001"},{text:" Common H  Concentrations",hierarchyLevel:5,children:[],index:"0303020002"}],index:"03030200"},{text:" pCO",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Partial pressure of CO",hierarchyLevel:6,children:[],index:"030302010000"}],index:"0303020100"},{text:" Factors affecting pCO",hierarchyLevel:5,children:[{text:" Higher ventilation rate lowers blood pCO",hierarchyLevel:6,children:[],index:"030302010100"},{text:" Lower ventilation rate increases blood pCO",hierarchyLevel:6,children:[],index:"030302010101"}],index:"0303020101"},{text:" Relationship between pCO  and pH",hierarchyLevel:5,children:[{text:" Increase in pCO  results in more CO combining with H O to form H CO",hierarchyLevel:6,children:[],index:"030302010200"},{text:" H CO  dissociates to form H  andHCO , resulting in the increase in pH",hierarchyLevel:6,children:[],index:"030302010201"}],index:"0303020102"}],index:"03030201"},{text:" HCO",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Bicarbonate (HCO )  a metabolic ion, a base",hierarchyLevel:6,children:[],index:"030302020000"},{text:" Standard Bicarbonate (sHCO )  thecalculated bicarbonate concentration after the sample has been equilibrated(standardised) with CO  of 5.3kPa at 37C, saturated with O servesas a  pure measure of the metabolic component",hierarchyLevel:6,children:[],index:"030302020001"},{text:" Actual Bicarbonate (aHCO )  thebicarbonate calculated from the measured CO2 and pH",hierarchyLevel:6,children:[],index:"030302020002"}],index:"0303020200"},{text:" Factors affecting HCO  / BEx",hierarchyLevel:5,children:[{text:" Metabolic problems (not due to the lungs)",hierarchyLevel:6,children:[],index:"030302020100"}],index:"0303020201"},{text:" Normal Ranges",hierarchyLevel:5,children:[{text:" 22 - 26 mEq / L HCO",hierarchyLevel:6,children:[],index:"030302020200"}],index:"0303020202"}],index:"03030202"},{text:" Base Excess",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Base Excess (BEx)",hierarchyLevel:6,children:[{text:" The amount of strong acid required to neutralize oxygenated blood",hierarchyLevel:7,children:[],index:"03030203000000"},{text:" The amount of strong acid required to return the pH of oxygenatedblood to 7.40 at a temperature of 37C and a pCO2 of 40 mmHg (5.3 kPa)",hierarchyLevel:7,children:[],index:"03030203000001"}],index:"030302030000"},{text:" Standard Base Excess (sBEx)",hierarchyLevel:6,children:[{text:" The calculated base excess after the sample has been equilibrated(standardised) with CO  of 5.3kPa at 37C, saturated with O and a Haemoglobin 5g/dL",hierarchyLevel:7,children:[],index:"03030203000100"}],index:"030302030001"}],index:"0303020300"},{text:" Understanding of Calculation of Base Excess",hierarchyLevel:5,children:[{text:" When the body produces an excess of base (bicarbonate) bymetabolic processes, the bicarbonate will combine with H  to formcarbonic acid.",hierarchyLevel:6,children:[],index:"030302030100"},{text:" This reduces the acidity of the blood, causing metabolicalkalosis.",hierarchyLevel:6,children:[],index:"030302030101"},{text:" By measuring the amount of acid, we need to make the blood at pH7.4, we are measuring the amount of excess bicarbonate ions introduced bymetabolic processes. Hence, this gives the base excess.",hierarchyLevel:6,children:[],index:"030302030102"}],index:"0303020301"},{text:" Purpose",hierarchyLevel:5,children:[{text:" Used as a measure of the metabolic component of acid basedisorders",hierarchyLevel:6,children:[],index:"030302030200"}],index:"0303020302"},{text:" Characteristics",hierarchyLevel:5,children:[{text:" Changes by the same amount as a change in HCO",hierarchyLevel:6,children:[],index:"030302030300"}],index:"0303020303"},{text:" Normal Ranges",hierarchyLevel:5,children:[{text:" -2 to +2 mEq / L",hierarchyLevel:6,children:[],index:"030302030400"}],index:"0303020304"},{text:" Interpretation",hierarchyLevel:5,children:[{text:" Metabolic acidosis: BEx < - 2 mEq / L",hierarchyLevel:6,children:[],index:"030302030500"},{text:" Metabolic alkalosis: BEx > +2 mEq / L",hierarchyLevel:6,children:[],index:"030302030501"}],index:"0303020305"}],index:"03030203"},{text:" pO",hierarchyLevel:4,children:[{text:" Definition of pO",hierarchyLevel:5,children:[{text:" The partial pressure of O",hierarchyLevel:6,children:[],index:"030302040000"}],index:"0303020400"},{text:" Purpose",hierarchyLevel:5,children:[{text:" Important to track oxygen levels as it is required forrespiration in the production of ATP",hierarchyLevel:6,children:[],index:"030302040100"}],index:"0303020401"},{text:" Factors affecting pO",hierarchyLevel:5,children:[{text:" Increasing the FiO  (% of oxygen in air breathed in)increases the amount of oxygen in the alveoli and hence increases in PO in blood",hierarchyLevel:6,children:[],index:"030302040200"}],index:"0303020402"},{text:" Normal Ranges",hierarchyLevel:5,children:[{text:" 10  13.2 kPa",hierarchyLevel:6,children:[],index:"030302040300"}],index:"0303020403"}],index:"03030204"}],index:"030302"},{text:" Pathologies",hierarchyLevel:3,children:[{text:" Types of Pathologies",hierarchyLevel:4,children:[{text:" Respiratory Acidosis",hierarchyLevel:5,children:[],index:"0303030000"},{text:" Respiratory Alkalosis",hierarchyLevel:5,children:[],index:"0303030001"},{text:" Metabolic Acidosis",hierarchyLevel:5,children:[],index:"0303030002"},{text:" Metabolic Alkalosis",hierarchyLevel:5,children:[],index:"0303030003"}],index:"03030300"},{text:" Temporal Classification of Pathologies",hierarchyLevel:4,children:[{text:" Acute  hours (sudden)",hierarchyLevel:5,children:[],index:"0303030100"},{text:" Chronic  days (longer term and persistent)",hierarchyLevel:5,children:[],index:"0303030101"},{text:" Simple / Uncompensated  body does not adapt to pH changes",hierarchyLevel:5,children:[],index:"0303030102"},{text:" Compensated  body adapts to limit pH changes",hierarchyLevel:5,children:[],index:"0303030103"}],index:"03030301"},{text:" Respiratory Acidosis",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" High pCO , and hence low pH",hierarchyLevel:6,children:[],index:"030303020000"}],index:"0303030200"},{text:" Example",hierarchyLevel:5,children:[],index:"0303030201"},{text:" Cause",hierarchyLevel:5,children:[{text:" Hypoventilation",hierarchyLevel:6,children:[{text:" Central control  centrally depressant drugs, fatigue, CO narcosis, encephalitis, brainstem disease, trauma to the brain",hierarchyLevel:7,children:[],index:"03030302020000"},{text:" Airway obstruction  bronchitis, emphysema",hierarchyLevel:7,children:[],index:"03030302020001"},{text:" Respiratory muscle weakness or paralysis  residual neuromuscularblockade",hierarchyLevel:7,children:[],index:"03030302020002"},{text:" Reduced lung volume  pneumonia, reduced artificial ventilation,structural chest abnormalities",hierarchyLevel:7,children:[],index:"03030302020003"}],index:"030303020200"},{text:" Excess CO  production / administration",hierarchyLevel:6,children:[{text:" Hypermetabolism  due to malignant hyperthermia",hierarchyLevel:7,children:[],index:"03030302020100"},{text:" Breathing circuit error",hierarchyLevel:7,children:[],index:"03030302020101"},{text:" Failure of CO  absorber  rebreathing",hierarchyLevel:7,children:[],index:"03030302020102"},{text:" Inadvertent CO  administration",hierarchyLevel:7,children:[],index:"03030302020103"}],index:"030303020201"}],index:"0303030202"}],index:"03030302"},{text:" Respiratory Alkalosis",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Low pCO , and hence high pH",hierarchyLevel:6,children:[],index:"030303030000"}],index:"0303030300"},{text:" Example",hierarchyLevel:5,children:[],index:"0303030301"},{text:" Cause",hierarchyLevel:5,children:[{text:" Hyperventilation",hierarchyLevel:6,children:[{text:" Central control  pain anxiety, fever, inflammation, infections,cerebrovascular incident",hierarchyLevel:7,children:[],index:"03030303020000"},{text:" Hypoxaemia  high altitude, severe anaemia, right to left shunts",hierarchyLevel:7,children:[],index:"03030303020001"},{text:" Drugs  aspirin, stimulants, doxapram, methylxanthines(aminophylline)",hierarchyLevel:7,children:[],index:"03030303020002"},{text:" Salicylate",hierarchyLevel:7,children:[],index:"03030303020003"},{text:" Catecholamines",hierarchyLevel:7,children:[],index:"03030303020004"}],index:"030303030200"},{text:" Endocrine  pregnancy and hyperthyroidism (increased metabolicrate by normalize CO )",hierarchyLevel:6,children:[],index:"030303030201"},{text:" Early respiratory disease",hierarchyLevel:6,children:[],index:"030303030202"},{text:" Lung Pathology  pneumothorax / haemothorax, pulmonary infection,pulmonary oedema, aspiration, pulmonary emobilsm, interstitial lung disease",hierarchyLevel:6,children:[],index:"030303030203"},{text:" Excess external mechanical ventilation",hierarchyLevel:6,children:[],index:"030303030204"}],index:"0303030302"}],index:"03030303"},{text:" Metabolic Acidosis",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Too much H  or lowered HCO ,and hence low pH",hierarchyLevel:6,children:[],index:"030303040000"}],index:"0303030400"},{text:" Example",hierarchyLevel:5,children:[],index:"0303030401"},{text:" Cause",hierarchyLevel:5,children:[{text:" Acid ingestion",hierarchyLevel:6,children:[{text:" aspirin overdose",hierarchyLevel:7,children:[],index:"03030304020000"}],index:"030303040200"},{text:" Increased Acid Production",hierarchyLevel:6,children:[{text:" Tissue hypoperfusion  lactic acidosis due to hypovolaemia,sepsis, heart failure, fits",hierarchyLevel:7,children:[],index:"03030304020100"},{text:" Diabetic Ketoacidosis  due to beta hydroxybutyrate andacetoacetate",hierarchyLevel:7,children:[],index:"03030304020101"},{text:" Hepatic Failure  excess saline containing fluids (eg. mostcolloids)",hierarchyLevel:7,children:[],index:"03030304020102"},{text:" Hyperchloraemia  due to chloride / saline/ salt containing IVfluids",hierarchyLevel:7,children:[],index:"03030304020103"},{text:" Liver failure  due to drugs such as metformin, alcohols and HIV",hierarchyLevel:7,children:[],index:"03030304020104"},{text:" Glucose-6-Phosphate Dehyrogenase Deficiency (G6PD)",hierarchyLevel:7,children:[],index:"03030304020105"},{text:" Drugs  metformin, alcohols, nucleoside reverse transcriptaseinhibitors",hierarchyLevel:7,children:[],index:"03030304020106"},{text:" Thiamine deficiency",hierarchyLevel:7,children:[],index:"03030304020107"}],index:"030303040201"},{text:" Decrease acid elimination",hierarchyLevel:6,children:[{text:" Kidney failure  due to organic acids such as sulphuric acid",hierarchyLevel:7,children:[],index:"03030304020200"},{text:" Distal renal tubular acidosis",hierarchyLevel:7,children:[],index:"03030304020201"},{text:" Bicarbonate loss",hierarchyLevel:7,children:[],index:"03030304020202"},{text:" Diarrhoea  due to large ileostomy leading to small bowel fluidloses",hierarchyLevel:7,children:[],index:"03030304020203"}],index:"030303040202"},{text:" Increased bicarbonate loss",hierarchyLevel:6,children:[{text:" Diarrhoea  due to large ileostomy leading to small bowel fluidloses",hierarchyLevel:7,children:[],index:"03030304020300"},{text:" Small bowel fistula",hierarchyLevel:7,children:[],index:"03030304020301"},{text:" Urethroenterostomy  leading to proximal renal tubular acidosis",hierarchyLevel:7,children:[],index:"03030304020302"}],index:"030303040203"}],index:"0303030402"}],index:"03030304"},{text:" Metabolic Alkalosis",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Too much HCO , too much H removed, and hence high pH",hierarchyLevel:6,children:[],index:"030303050000"}],index:"0303030500"},{text:" Example",hierarchyLevel:5,children:[],index:"0303030501"},{text:" Cause",hierarchyLevel:5,children:[{text:" Increased acid loss",hierarchyLevel:6,children:[{text:" Prolonged vomiting / loss of gastric fluid",hierarchyLevel:7,children:[],index:"03030305020000"},{text:" Conns syndrome, Cushings syndrome, Bartter syndrome",hierarchyLevel:7,children:[],index:"03030305020001"},{text:" Base administration, retention or concentration",hierarchyLevel:7,children:[],index:"03030305020002"}],index:"030303050200"},{text:" Increased Base Administration, Retention or Concentration",hierarchyLevel:6,children:[{text:" Given excess bicarbonate",hierarchyLevel:7,children:[],index:"03030305020100"},{text:" Loss of Na+, K+, Cl- (diuretics)",hierarchyLevel:7,children:[],index:"03030305020101"},{text:" Renal compensation / retention of bicarbonate",hierarchyLevel:7,children:[],index:"03030305020102"},{text:" Excess buffer in renal haemofilteration fluid (eg. lactate)",hierarchyLevel:7,children:[],index:"03030305020103"},{text:" Potassium deficienc y",hierarchyLevel:7,children:[],index:"03030305020104"}],index:"030303050201"}],index:"0303030502"}],index:"03030305"},{text:" Treatment for Pathologies",hierarchyLevel:4,children:[{text:" Treat the underlying cause of the pathology",hierarchyLevel:5,children:[],index:"0303030600"}],index:"03030306"}],index:"030303"},{text:" Compensation",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Compensation is the process of the body altering metabolism andrespiration to bring the pH back to the set point",hierarchyLevel:5,children:[],index:"0303040000"}],index:"03030400"},{text:" Types of Compensation",hierarchyLevel:4,children:[{text:" Metabolic compensation  used when encountering respiratory pCO pathologies",hierarchyLevel:5,children:[],index:"0303040100"},{text:" Respiratory compensation  used when encountering metabolic HCO / BEx pathologies",hierarchyLevel:5,children:[],index:"0303040101"}],index:"03030401"},{text:" Metabolic Compensation",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Low  occurs in 12 hours",hierarchyLevel:6,children:[],index:"030304020000"}],index:"0303040200"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Changes HCO  by changing the renal HCO reabsorption or loss",hierarchyLevel:6,children:[],index:"030304020100"}],index:"0303040201"},{text:" Purpose",hierarchyLevel:5,children:[{text:" Used when encountering respiratory pathologies",hierarchyLevel:6,children:[],index:"030304020200"}],index:"0303040202"},{text:" Respiratory Acidosis",hierarchyLevel:5,children:[{text:" Example",hierarchyLevel:6,children:[],index:"030304020300"},{text:" Process",hierarchyLevel:6,children:[{text:" During respiratory acidosis, there is high pCO , whichresults in the generation of more H ions from the dissociations ofcarbonic acid.",hierarchyLevel:7,children:[],index:"03030402030100"},{text:" In 12 hours, the body compensates by retaining more HCO ions in the kidneys, hence increasing the concentration of HCO in the blood. ",hierarchyLevel:7,children:[],index:"03030402030101"},{text:" Higher HCO  concentration shifts theequilibrium back to the right, causing more H  ions to combine withHCO  to form carbonic acid.",hierarchyLevel:7,children:[],index:"03030402030102"},{text:" This increases the pH back to normal levels",hierarchyLevel:7,children:[],index:"03030402030103"}],index:"030304020301"},{text:" Differentiating between Metabolic Alkalosis with Respiratorycompensation vs Respiratory Acidosis with Metabolic Compensation",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"03030402030200"}],index:"030304020302"}],index:"0303040203"},{text:" Respiratory Alkalosis",hierarchyLevel:5,children:[{text:" Example",hierarchyLevel:6,children:[],index:"030304020400"},{text:" Process",hierarchyLevel:6,children:[{text:" During respiratory alkalosis, there is low pCO . Lowerconcentration of CO  shifts the position of the equilibrium towardsthe right, resulting in more H  ions combining with HCO ,resulting in high pH.",hierarchyLevel:7,children:[],index:"03030402040100"},{text:" In 12 hours, the body compensates by losing more HCO ions via the kidneys, hence reducing the concentration of HCO in the blood.",hierarchyLevel:7,children:[],index:"03030402040101"},{text:" Lower HCO  concentration shifts theposition of equilibrium back towards the left, resulting in more carbonic aciddissociating to release H  ions.",hierarchyLevel:7,children:[],index:"03030402040102"},{text:" This lowers the pH back to normal levels",hierarchyLevel:7,children:[],index:"03030402040103"}],index:"030304020401"}],index:"0303040204"}],index:"03030402"},{text:" Respiratory Compensation",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Immediate, fast response",hierarchyLevel:6,children:[],index:"030304030000"}],index:"0303040300"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Changing respiratory rate to change pCO",hierarchyLevel:6,children:[],index:"030304030100"}],index:"0303040301"},{text:" Purpose",hierarchyLevel:5,children:[{text:" Used when encountering metabolic pathologies",hierarchyLevel:6,children:[],index:"030304030200"}],index:"0303040302"},{text:" Metabolic Acidosis",hierarchyLevel:5,children:[{text:" Example",hierarchyLevel:6,children:[],index:"030304030300"},{text:" Process",hierarchyLevel:6,children:[{text:" During metabolic acidosis, concentration of HCO decreases shifting the position of equilibrium to the left, causing morecarbonic acid to dissociate into H  ions and HCO .This results in a higher pH.",hierarchyLevel:7,children:[],index:"03030403030100"},{text:" Instantaneously, the body responds with respiratory compensationby increasing the ventilation rate, resulting in more CO beingremoved from the body. This causes the concentration of CO  todecrease.",hierarchyLevel:7,children:[],index:"03030403030101"},{text:" Lowered concentration of CO  results in the rightwardshift of the equilibrium, resulting in more H  ions combining withHCO  ions to form carbonic acid. ",hierarchyLevel:7,children:[],index:"03030403030102"},{text:" This increases the pH back to normal levels",hierarchyLevel:7,children:[],index:"03030403030103"}],index:"030304030301"}],index:"0303040303"},{text:" Metabolic Alkalosis",hierarchyLevel:5,children:[{text:" Example",hierarchyLevel:6,children:[],index:"030304030400"},{text:" Process",hierarchyLevel:6,children:[{text:" During metabolic alkalosis, concentration of HCO increases shifting the position of equilibrium to the right, causing more H ions to combine with HCO  ions to form carbonic acid.This causes a high pH.",hierarchyLevel:7,children:[],index:"03030403040100"},{text:" Instantaneously, the body compensates by decreasing the rate ofventilation, resulting in less CO  being removed from the body. Thiscauses the concentration of CO  to increase.",hierarchyLevel:7,children:[],index:"03030403040101"},{text:" Higher concentration of CO  results in the leftwardshift of the equilibrium, resulting in more carbonic acid dissociating torelease H  ions. ",hierarchyLevel:7,children:[],index:"03030403040102"},{text:" This lowers the pH back to normal levels.",hierarchyLevel:7,children:[],index:"03030403040103"}],index:"030304030401"}],index:"0303040304"}],index:"03030403"},{text:" Exceptions",hierarchyLevel:4,children:[{text:" Metabolic Compensation for Metabolic Acidosis",hierarchyLevel:5,children:[{text:" Initially, the body uses instantaneous respiratory compensation.",hierarchyLevel:6,children:[],index:"030304040000"},{text:" In 12 hours, the body alters the processing of bicarbonate in thekidneys and activates metabolic compensation",hierarchyLevel:6,children:[],index:"030304040001"}],index:"0303040400"},{text:" Respiratory Compensation for Respiratory Acidosis (not possible)",hierarchyLevel:5,children:[{text:" Respiratory acidosis is due to a defect in ventilation.",hierarchyLevel:6,children:[],index:"030304040100"},{text:" The body will try to breathe harder but it will not work.",hierarchyLevel:6,children:[],index:"030304040101"}],index:"0303040401"}],index:"03030404"},{text:" Chart",hierarchyLevel:4,children:[],index:"03030405"}],index:"030304"}],index:"0303"},{text:" [049] Dependence of flow on driving pressure",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Demonstrate and understanding of the relationship betweenpressure and flow in the circulation",hierarchyLevel:4,children:[],index:"03040000"},{text:" Describe the organization of the cardiovascular system withrespect to the distribution of flows ,pressures, velocities and volumes.",hierarchyLevel:4,children:[],index:"03040001"},{text:" Describe and explain the role of change in blood vessel radius indetermining flow",hierarchyLevel:4,children:[],index:"03040002"},{text:" Explain the concepts of resistance and compliance in relation tothe circulation",hierarchyLevel:4,children:[],index:"03040003"},{text:" Explain the conditions under which Poiseuilles law applies, andits application in considering the circulation of blood.",hierarchyLevel:4,children:[],index:"03040004"}],index:"030400"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Formulas",hierarchyLevel:4,children:[{text:" Cardiac output = Heart Rate x Stroke volume",hierarchyLevel:5,children:[],index:"0304010000"},{text:" Arterial Blood Pressure = Cardiac output x Total PeripheralResistance",hierarchyLevel:5,children:[],index:"0304010001"},{text:" Perfusion Pressure = Arterial Blood Pressure  Right atrialpressure",hierarchyLevel:5,children:[],index:"0304010002"},{text:" Perfusion Pressure = A rterial Blood Pressure  0",hierarchyLevel:5,children:[],index:"0304010003"},{text:" Perfusion Pressure = Arterial Blood Pressure  Venous  Pressure",hierarchyLevel:5,children:[],index:"0304010004"},{text:" Blood Flow (Q) = Pressure difference (P1  P2) / Resistance toFlow (R)",hierarchyLevel:5,children:[],index:"0304010005"}],index:"03040100"},{text:" Interpreting Blood Pressure Trace",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0304010100"},{text:" Interpretation",hierarchyLevel:5,children:[{text:" Systolic Blood Pressure  the maximum blood pressure in the graph",hierarchyLevel:6,children:[],index:"030401010100"},{text:" Diastole Blood Pressure  the minimum blood pressure on the graph",hierarchyLevel:6,children:[],index:"030401010101"},{text:" Pulse Pressure  the difference between systolic blood pressureand diastolic blood pressure",hierarchyLevel:6,children:[],index:"030401010102"},{text:" Mean arterial pressure = diastolic pressure + 1/3 pulse pressure",hierarchyLevel:6,children:[],index:"030401010103"},{text:" Mean arterial pressure = 1/3 systolic pressure + 2/3 diastolicpressure",hierarchyLevel:6,children:[],index:"030401010104"}],index:"0304010101"}],index:"03040101"}],index:"030401"},{text:" Pressure and Flow",hierarchyLevel:3,children:[{text:" Relationship between Pressure and Flow",hierarchyLevel:4,children:[{text:" Principle",hierarchyLevel:5,children:[{text:" If there is no pressure difference, there is no flow.",hierarchyLevel:6,children:[],index:"030402000000"}],index:"0304020000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0304020001"},{text:" Explanation",hierarchyLevel:5,children:[{text:" During left ventricular systole, the ventricle generates 120mm Hgof pressure. This pressure is transferred to the arteries, resulting in thepressure in the arteries to rise to 120mm Hg.",hierarchyLevel:6,children:[],index:"030402000200"},{text:" During left ventricular diastole, the pressure in the ventriclesdrop to 0mm Hg. The pressure in the arteries drops to 80mm Hg, but is variabledepending on vasoconstriction and vasodilation.",hierarchyLevel:6,children:[],index:"030402000201"},{text:" As a result the mean arterial pressure is 90mm Hg.",hierarchyLevel:6,children:[],index:"030402000202"},{text:" As the blood moves towards the capillary bed, the pressure dropssignificantly. When the blood arrives at the capillary beds, the pressure is30mm Hg. When the blood is in the middle of the capillaries, the pressure dropsto 20mm Hg. When the blood enters the venules, the pressure drops to 10mm Hg.",hierarchyLevel:6,children:[],index:"030402000203"},{text:" Due to the lack of muscular walls to push the blood forward, thepressure in the veins maintains at 10mm Hg.",hierarchyLevel:6,children:[],index:"030402000204"},{text:" The right atrium has a pressure of 2mm Hg, hence allowing for thehigher pressured venous blood (at 10mm Hg) to enter the arteries.",hierarchyLevel:6,children:[],index:"030402000205"},{text:" During ventricular diastole, the right ventricle has a pressureof 0mm Hg, hence allowing for the passive filling of blood from the rightatrium (2mm Hg). ",hierarchyLevel:6,children:[],index:"030402000206"},{text:" The right ventricle contracts, increasing the pressure to 25mmHg, which is significantly lower than the pressure in the left ventricles. Thiscauses the blood pressure in the pulmonary artery to rise to 25mm Hg.",hierarchyLevel:6,children:[],index:"030402000207"},{text:" As the blood arrives at the pulmonary capillaries, the pressuredrops to 12mm Hg, and it further drops to 8mm Hg as it enters the pulmonaryveins.",hierarchyLevel:6,children:[],index:"030402000208"},{text:" As the pressure in the left ventricle is lower at 5mm Hg, thisallows the blood from the pulmonary veins to return to the left atrium.",hierarchyLevel:6,children:[],index:"030402000209"}],index:"0304020002"}],index:"03040200"},{text:" Pressure drops across vessels",hierarchyLevel:4,children:[{text:" Formula",hierarchyLevel:5,children:[{text:" Flow = \u0394 Pressure / Resistance",hierarchyLevel:6,children:[],index:"030402010000"},{text:" Flow = Difference in Pressure between two points / Resistance",hierarchyLevel:6,children:[],index:"030402010001"},{text:" Blood Flow (Q) = Pressure difference (P1  P2) / Resistance toFlow (R)",hierarchyLevel:6,children:[],index:"030402010002"},{text:" Current = Voltage / Resistance (V = IR) ",hierarchyLevel:6,children:[],index:"030402010003"}],index:"0304020100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0304020101"},{text:" Explanation",hierarchyLevel:5,children:[{text:" The greatest fall in pressure is the transition between arteriesto arterioles. This is because of the change in resistance is the greatest fromarteries to arterioles.",hierarchyLevel:6,children:[],index:"030402010200"}],index:"0304020102"}],index:"03040201"},{text:" Calculating Laminar Flow of Fluid through a rigid cylindricaltube",hierarchyLevel:4,children:[{text:" Formula",hierarchyLevel:5,children:[{text:" Q = \u0394P\u03c0 r  / 8 \u03b7 L (Poiseuilles Law)",hierarchyLevel:6,children:[],index:"030402020000"},{text:" L = length of tube",hierarchyLevel:6,children:[],index:"030402020001"},{text:" \u03b7 = viscosity of fluid",hierarchyLevel:6,children:[],index:"030402020002"},{text:" r = radius of tube",hierarchyLevel:6,children:[],index:"030402020003"},{text:" Q = flow",hierarchyLevel:6,children:[],index:"030402020004"},{text:" R = 8\u03b7L/\u03c0 x 1 / r  ",hierarchyLevel:6,children:[],index:"030402020005"},{text:" R   1/ r",hierarchyLevel:6,children:[],index:"030402020006"},{text:" Q   r",hierarchyLevel:6,children:[],index:"030402020007"}],index:"0304020200"},{text:" Interpretation",hierarchyLevel:5,children:[{text:" Doubling of the radius will result in a decrease of theresistance by 16 times.",hierarchyLevel:6,children:[],index:"030402020100"},{text:" Doubling of the radius will result in a increase of the flow by16 times.",hierarchyLevel:6,children:[],index:"030402020101"}],index:"0304020201"}],index:"03040202"}],index:"030402"},{text:" Adaptations of Circulatory Design",hierarchyLevel:3,children:[{text:" Parallel Arrangement of Circulatory System",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Enables the body to differentially regulate resistance to bloodflow, enabling the appropriate distribution of cardiac output",hierarchyLevel:6,children:[],index:"030403000000"}],index:"0304030000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0304030001"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Vasoconstriction of a blood vessel increases the resistance inthat area. As a result, the flow is reduced. This increases the blood flow toother areas of the body.",hierarchyLevel:6,children:[],index:"030403000200"}],index:"0304030002"}],index:"03040300"},{text:" Distribution of Blood Flow in the Circulatory System",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0304030100"},{text:" Explanation",hierarchyLevel:5,children:[{text:" More blood flow to the kidneys for filtration of nitrogenouswastes and maintenance of water potential.",hierarchyLevel:6,children:[],index:"030403010100"},{text:" More blood flow to the liver for detoxification.",hierarchyLevel:6,children:[],index:"030403010101"},{text:" More blood flow to the skeletal muscle due to oxygen consumption.",hierarchyLevel:6,children:[],index:"030403010102"},{text:" More blood flow to the brain.",hierarchyLevel:6,children:[],index:"030403010103"}],index:"0304030101"}],index:"03040301"},{text:" Adaptations in Pressures, Velocities and Cross-sectional areas",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0304030200"},{text:" Truisms",hierarchyLevel:5,children:[{text:" Velocity / Flow  Cross Sectional Area",hierarchyLevel:6,children:[],index:"030403020100"},{text:" Pressure  TotalCross Sectional Area",hierarchyLevel:6,children:[],index:"030403020101"},{text:" Mean velocity is dependent on the cross sectional area of asingle vessel",hierarchyLevel:6,children:[],index:"030403020102"},{text:" Pressure is dependent on the combined cross sectional area of allcombined vessels",hierarchyLevel:6,children:[],index:"030403020103"},{text:" Branching results in ",hierarchyLevel:6,children:[{text:" Decrease in single vessel cross sectional area, hence decrease invelocity",hierarchyLevel:7,children:[],index:"03040302010400"},{text:" Increase in the total combined cross sectional area, hencedecrease in pressure",hierarchyLevel:7,children:[],index:"03040302010401"}],index:"030403020104"},{text:" Merging results in",hierarchyLevel:6,children:[{text:" Increase in single vessel cross sectional area, hence increase invelocity",hierarchyLevel:7,children:[],index:"03040302010500"},{text:" Decrease in the total combined cross sectional area, henceincrease in pressure",hierarchyLevel:7,children:[],index:"03040302010501"}],index:"030403020105"}],index:"0304030201"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Moving from the large arteries to the smaller arteries, the crosssectional area of each artery decreases. Due to the smaller cross sectionalarea (radius), there is reduced flow and hence reduced mean velocity for eachof the arteries.",hierarchyLevel:6,children:[],index:"030403020200"},{text:" However, as there are many more small arteries than largearteries, the combined cross sectional area of the smaller arteries is muchlarger than the cross sectional area of one large artery. ",hierarchyLevel:6,children:[],index:"030403020201"},{text:" Moving from small arteries to arterioles, there is the mostsignificant branching and therefore there is the greatest increase in the totalcombined cross sectional area. Rapid increase in total cross sectional arearesults in the rapid fall in the pressure. This also results in the greatestdecrease in flow per vessel and hence greatest decrease in mean velocity of theblood.",hierarchyLevel:6,children:[],index:"030403020202"},{text:" The significant increase in cross sectional area enablesignificant drop in blood pressure to a low enough level at which thecapillaries are able to tolerate.",hierarchyLevel:6,children:[],index:"030403020203"},{text:" As veins join together to form larger veins, this results in theincrease in total cross sectional area, and hence increases the flow pervessel, increasing the mean velocity of blood in the veins. This allows forblood to be brought back to the heart quickly.",hierarchyLevel:6,children:[],index:"030403020204"}],index:"0304030202"}],index:"03040302"},{text:" Adaptations of the veins",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Capacitance  the ability for a blood vessel to stay distendedand hold the blood in place",hierarchyLevel:6,children:[],index:"030403030000"}],index:"0304030300"},{text:" Formula",hierarchyLevel:5,children:[{text:" Tension = Pressure  Radius (Laplace law) ",hierarchyLevel:6,children:[],index:"030403030100"}],index:"0304030301"},{text:" Structure and Function of Veins vs Arteries",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"030403030200"}],index:"0304030302"}],index:"03040303"},{text:" Distribution of Blood Volume to Blood Vessels",hierarchyLevel:4,children:[{text:" Body at Rest",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030403040000"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Most of the blood is in the small veins and venules. This is dueto the capacitance of the veins in being distended and holding the blood inplace. Veins do not have thick smooth and elastic layers to stretch and recoilto generate a pressure to force blood back towards the heart.",hierarchyLevel:7,children:[],index:"03040304000100"}],index:"030403040001"}],index:"0304030400"},{text:" Body when Standing",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030403040100"},{text:" Explanation",hierarchyLevel:6,children:[{text:" The hydrostatic pressure depends on the height of the column ofblood above it. Therefore the hydrostatic pressure is the highest at the feet.",hierarchyLevel:7,children:[],index:"03040304010100"},{text:" The low 10mm Hg venous blood pressure is unable to overcome thehigh 100mm Hg hydrostatic pressure in the legs. This causes blood to pool inthe lower extremities.",hierarchyLevel:7,children:[],index:"03040304010101"},{text:" The same problem does not occur in the arteries as the arteriesoperate at a higher pressure that is able to overcome the high hydrostaticpressure.",hierarchyLevel:7,children:[],index:"03040304010102"},{text:" Human body movement, results in the contraction of themusculature, which squeezes the blood along the veins. Due to the thin walls ofthe veins, the veins can be easily compressed by the musculature and easilypush blood towards the heart. Due to the thick walls of the arteries, thearteries cannot be easily compressed by the musculature.",hierarchyLevel:7,children:[],index:"03040304010103"}],index:"030403040101"}],index:"0304030401"}],index:"03040304"},{text:" Abnormal Function: Lack of Blood Flow",hierarchyLevel:4,children:[{text:" Formulas",hierarchyLevel:5,children:[{text:" Resistance  1 / r  (derived from Poiseuilles Law) ",hierarchyLevel:6,children:[],index:"030403050000"},{text:" Flow = \u0394 Pressure / Resistance",hierarchyLevel:6,children:[],index:"030403050001"}],index:"0304030500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0304030501"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Due to atherosclerosis, the lumen of the blood vessel is narrowedand the radius of the blood vessel decreases. ",hierarchyLevel:6,children:[],index:"030403050200"},{text:" Decreased radius increases resistance to blood flow. Increaseresistance decreases the blood flow, resulting in the lack of blood flow to thearea.",hierarchyLevel:6,children:[],index:"030403050201"},{text:" This leads to the ulceration of the skin and the formation ofgangrenous necrotic lesions.",hierarchyLevel:6,children:[],index:"030403050202"}],index:"0304030502"}],index:"03040305"}],index:"030403"}],index:"0304"},{text:" [050] Nervous, local and humoral control",hierarchyLevel:2,children:[{text:" Learning Objectives",hierarchyLevel:3,children:[{text:" To understand how different control mechanisms act on vascularsmooth muscle vascular resistance, and so regulate blood pressure and thedistribution of blood flow",hierarchyLevel:4,children:[],index:"03050000"},{text:" To understand the physiological significance and mechanism bywhich the nervous system controls blood pressure and flow",hierarchyLevel:4,children:[],index:"03050001"},{text:" To appreciate the vital role the endothelium plays in controllingvascular tone.",hierarchyLevel:4,children:[],index:"03050002"},{text:" Describe with the aid of a diagram the basic anatomy of avascular bed",hierarchyLevel:4,children:[],index:"03050003"},{text:" Describe with the aid of a diagram the components of a smallvessel",hierarchyLevel:4,children:[],index:"03050004"},{text:" Explain why arterioles are the main source of vascular resistance",hierarchyLevel:4,children:[],index:"03050005"},{text:" Explain how blood flow through a vascular bed can be controlledby the regulation of vascular tone",hierarchyLevel:4,children:[],index:"03050006"},{text:" Describe the innervation of blood vessels by autonomic nerves andhow this regulates vascular tone and the distribution of blood flow",hierarchyLevel:4,children:[],index:"03050007"},{text:" Name and describe the blood-borne (humoral) factors thatinfluence vascular smooth muscle",hierarchyLevel:4,children:[],index:"03050008"},{text:" Explain the concepts of laminar and turbulent flow, and shearstress",hierarchyLevel:4,children:[],index:"03050009"},{text:" Describe how the endothelium can regulate vascular tone and itsrelationship with shear stress",hierarchyLevel:4,children:[],index:"03050010"},{text:" Explain how an organ/tissue can influence its own blood flow anddescribe the local control mechanisms involved",hierarchyLevel:4,children:[],index:"03050011"},{text:" Consider how individual control mechanisms can be manipulated tocounteract vascular dysfunction",hierarchyLevel:4,children:[],index:"03050012"},{text:" Consider the role of shear stress and the endothelium in vasculardisease",hierarchyLevel:4,children:[],index:"03050013"}],index:"030500"},{text:" Basic Mechanisms",hierarchyLevel:3,children:[{text:" Formulas",hierarchyLevel:4,children:[{text:" Blood Flow (Q) = \u0394 Pressure / Resistance to Flow (R)",hierarchyLevel:5,children:[],index:"0305010000"},{text:" R \u221d1 / r",hierarchyLevel:5,children:[],index:"0305010001"}],index:"03050100"},{text:" Effect of Diameter on Vascular Resistance",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0305010100"},{text:" Explanation",hierarchyLevel:5,children:[{text:" The closer to the wall of the blood vessel, the greater the resistanceto blood flow. Therefore, the further the distance away from the walls of theblood vessel, the faster the blood flow.",hierarchyLevel:6,children:[],index:"030501010100"},{text:" In a large blood vessel, the average distance away from the wallsof the blood vessel is higher and therefore there is higher overall velocity ofblood flow.",hierarchyLevel:6,children:[],index:"030501010101"},{text:" In the small blood vessel, the average distance away from thewalls of the blood vessel is shorter and therefore there is a lower overallvelocity of blood flow.",hierarchyLevel:6,children:[],index:"030501010102"},{text:" By vasoconstriction and vasodilation, the velocity of blood flowcan be altered.",hierarchyLevel:6,children:[],index:"030501010103"}],index:"0305010101"}],index:"03050101"},{text:" Ca  Dependent smooth muscle contraction",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" P  purinoceptor  ligand-gated, non-selected cationchannels",hierarchyLevel:6,children:[],index:"030501020000"}],index:"0305010200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0305010201"},{text:" Mechanism of Ca  Entry",hierarchyLevel:5,children:[{text:" Binding of noradrenaline on the \u03b11 adrenal receptors(metabotropic), results in the activation of G . ",hierarchyLevel:6,children:[],index:"030501020200"},{text:" G  stimulates membrane depolarization of the vascularsmooth muscle. This results in the opening of L-type voltage-gated Ca channels on the plasma membrane. This leads to the influx in Ca ions.",hierarchyLevel:6,children:[],index:"030501020201"},{text:" ATP binds to the P  purinoceptor and causes it toopen. Ca  ions and Na  ions enters the cells via thepurinoceptor, resulting in the depolarization of the blood muscle. Thisdepolarization also opens L-type voltage-gated Ca  channels.",hierarchyLevel:6,children:[],index:"030501020202"},{text:" Stretching of the smooth muscle cells stimulates non-selectivecation channels to open. This enables the influx of Ca  and Na ion channels. ",hierarchyLevel:6,children:[],index:"030501020203"}],index:"0305010202"},{text:" Mechanism of Ca  action",hierarchyLevel:5,children:[{text:" Ca  ions binds to Calmodulin (CaM) to formCalcium-Calmodulin complex (Ca-CaM).",hierarchyLevel:6,children:[],index:"030501020300"},{text:" Calcium-calmodulin complex binds to an activates Myosin Light ChainKinase.",hierarchyLevel:6,children:[],index:"030501020301"},{text:" The activated Myosin Light Chain kinase phosphorylates MyosinLight Chain (MLC) to form MLC-P.",hierarchyLevel:6,children:[],index:"030501020302"},{text:" MLC-P acts like ATP in binding to actin, stimulating the movementof the actin molecule, resulting in the contraction of the muscle.",hierarchyLevel:6,children:[],index:"030501020303"},{text:" MLC-phosphatase dephosphylates MLC-P to regain MLC, resulting inthe relaxation of the muscle.",hierarchyLevel:6,children:[],index:"030501020304"}],index:"0305010203"},{text:" Drugs targeting mechanism of Ca  entry",hierarchyLevel:5,children:[{text:" Formulas",hierarchyLevel:6,children:[{text:" Blood Flow (Q) = \u0394 Pressure / Resistance to Flow (R)",hierarchyLevel:7,children:[],index:"03050102040000"},{text:" R \u221d1 / r",hierarchyLevel:7,children:[],index:"03050102040001"}],index:"030501020400"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" L-type voltage-gated Ca  channel blockers blocks the openingof L-type voltage-gated Ca  channels, hence reducing Ca influx into vascular smooth muscle and hence inhibiting vasoconstriction. Thelack of vasoconstriction increases the lumen / radius of the blood vessels, andthis reduces blood pressure.",hierarchyLevel:7,children:[],index:"03050102040100"}],index:"030501020401"}],index:"0305010204"}],index:"03050102"}],index:"030501"},{text:" Control of Vascular Resistance",hierarchyLevel:3,children:[{text:" Types of Control",hierarchyLevel:4,children:[{text:" Extrinsic control",hierarchyLevel:5,children:[{text:" Function",hierarchyLevel:6,children:[{text:" Provides the means to coordinate vascular resistance in thecirculation as a whole and to regulate the distribution of blood flow todifferent tissues/organs.",hierarchyLevel:7,children:[],index:"03050200000000"}],index:"030502000000"},{text:" Components",hierarchyLevel:6,children:[{text:" Nervous  sympathetic, parasympathetic divisions",hierarchyLevel:7,children:[],index:"03050200000100"},{text:" Humoral  adrenaline, angiotensin II, vasopressin, natriureticpeptides",hierarchyLevel:7,children:[],index:"03050200000101"}],index:"030502000001"}],index:"0305020000"},{text:" Local control",hierarchyLevel:5,children:[{text:" Function",hierarchyLevel:6,children:[{text:" Provides the means for an individual vascular bed to regulatesits own blood flow.",hierarchyLevel:7,children:[],index:"03050200010000"}],index:"030502000100"},{text:" Components",hierarchyLevel:6,children:[{text:" Endothelium derived factors",hierarchyLevel:7,children:[],index:"03050200010100"},{text:" Direct stimulation by stretch",hierarchyLevel:7,children:[],index:"03050200010101"},{text:" Metabolic factors",hierarchyLevel:7,children:[],index:"03050200010102"}],index:"030502000101"}],index:"0305020001"}],index:"03050200"}],index:"030502"},{text:" Nervous Control",hierarchyLevel:3,children:[{text:" Nervous Control",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Produce rapid changes in blood pressure and blood flow",hierarchyLevel:6,children:[],index:"030503000000"}],index:"0305030000"},{text:" Factors",hierarchyLevel:5,children:[{text:" Baroreceptors (stretch)",hierarchyLevel:6,children:[],index:"030503000100"},{text:" Chemoreceptors (O , CO )",hierarchyLevel:6,children:[],index:"030503000101"},{text:" Stimulation of skeletal muscle receptors during exercise",hierarchyLevel:6,children:[],index:"030503000102"},{text:" Stimulation of visceral and cutaneous nociceptors (painreceptors)",hierarchyLevel:6,children:[],index:"030503000103"},{text:" Mental stress",hierarchyLevel:6,children:[],index:"030503000104"}],index:"0305030001"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Sympathetic nerves release noradrenaline which binds to \u03b11-adrenoreceptors,stimulating smooth muscle contraction.",hierarchyLevel:6,children:[],index:"030503000200"},{text:" The endothelium of the blood vessel releases relaxing factors.",hierarchyLevel:6,children:[],index:"030503000201"},{text:" The opposing contraction factors and relaxing factors results invascular tone.",hierarchyLevel:6,children:[],index:"030503000202"},{text:" Increasing the contraction factors (greater tonic control) andreduction on relaxing factors results in vasocontraction.",hierarchyLevel:6,children:[],index:"030503000203"},{text:" Decreasing in contraction factors (lower tonic control) andincrease in relaxing factors results in vasodilation.",hierarchyLevel:6,children:[],index:"030503000204"}],index:"0305030002"},{text:" Drugs",hierarchyLevel:5,children:[{text:" \u03b11-adrenoreceptor antagonists block the contractile responseto noradrenaline",hierarchyLevel:6,children:[],index:"030503000300"}],index:"0305030003"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0305030004"}],index:"03050300"},{text:" Baroreceptor Reflex",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0305030100"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" When a person stands up, there is a sudden decrease inhydrostatic blood pressure.",hierarchyLevel:6,children:[],index:"030503010100"},{text:" Decrease in blood pressure results in decreased stimulation ofbaroreceptors in the aortic arch and carotid sinuses.",hierarchyLevel:6,children:[],index:"030503010101"},{text:" As a result, less impulses are sent to the medulla in the brain. ",hierarchyLevel:6,children:[],index:"030503010102"},{text:" The medulla responds by increasing the activity of vascularsympathetic efferents.",hierarchyLevel:6,children:[],index:"030503010103"},{text:" Increased activity of vascular sympathetic efferent results invasoconstriction and hence causing an increase in blood pressure.",hierarchyLevel:6,children:[],index:"030503010104"}],index:"0305030101"}],index:"03050301"},{text:" Cutaneous Blood Flow",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Cutaneous vascular sympathetic nerves are not baroreceptorsensitive (as there would be external stimuli of skin stretching which isunrelated to blood pressure)",hierarchyLevel:6,children:[],index:"030503020000"},{text:" Cutaneous arterioles are innervated by thermosensitivesympathetic nerves (for shunting and increase heat loss). Hypothermia wouldstimulate cutaneous vasoconstriction.",hierarchyLevel:6,children:[],index:"030503020001"},{text:" Emotional stimuli can stimulate cutaneous vasoconstriction.",hierarchyLevel:6,children:[],index:"030503020002"}],index:"0305030200"}],index:"03050302"},{text:" Parasympathetic Vasodilator Nerves",hierarchyLevel:4,children:[{text:" Principles",hierarchyLevel:5,children:[{text:" Most vascular beds are not innervated by parasympathetic nerves,except for cerebral circulation and corpus cavernosum penile erectile tissue.",hierarchyLevel:6,children:[],index:"030503030000"},{text:" This is because the response to reduce sympathetic stimulation isslow, while parasympathetic nerves can stimulate rapid vasodilation. Therefore,the difference in speed of adjustment will results in problems.",hierarchyLevel:6,children:[],index:"030503030001"}],index:"0305030300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0305030301"},{text:" Mechanism (from parasympathetic NANC nerve)",hierarchyLevel:5,children:[{text:" The wave of depolarization reaches the end of the parasympatheticnonadrenergic noncholinergic (NANC) nerves in the cerebral circulation andcorpus cavernosum penile erectile tissue.",hierarchyLevel:6,children:[],index:"030503030200"},{text:" Depolarization of the membrane potential stimulates the openingof voltage-gated Ca  channels, resulting in the influx of Ca ions. ",hierarchyLevel:6,children:[],index:"030503030201"},{text:" The rise in Ca  ions stimulates nitric oxide synthase(nNOS) to produce nitric oxide (NO).",hierarchyLevel:6,children:[],index:"030503030202"},{text:" Nitric oxide diffuses into the smooth muscle cell and stimulatessoluble Guanylate cyclase enzyme (sGC).",hierarchyLevel:6,children:[],index:"030503030203"},{text:" Activated guanylate cyclase enzyme converts guanosinetriphosphate (GTP) into cyclic guanosine monophosphate (cGMP / cyclic GMP).",hierarchyLevel:6,children:[],index:"030503030204"},{text:" Cyclic GMP results in the relaxation of the smooth musclemyocyte.",hierarchyLevel:6,children:[],index:"030503030205"}],index:"0305030302"},{text:" Mechanism (from endothelial cell)",hierarchyLevel:5,children:[{text:" Acetylcholine binds to muscarinic acetylcholine receptors,activating Gq. ",hierarchyLevel:6,children:[],index:"030503030300"},{text:" This activates nitric oxide synthase (eNOS) to produce nitricoxide.",hierarchyLevel:6,children:[],index:"030503030301"},{text:" Nitric oxide diffuses into the smooth muscle myocyte andstimulates soluble Guanylate cyclase enzyme (sGC).",hierarchyLevel:6,children:[],index:"030503030302"},{text:" Activated guanylate cyclase enzyme converts guanosinetriphosphate (GTP) into cyclic guanosine monophosphate (cGMP / cyclic GMP).",hierarchyLevel:6,children:[],index:"030503030303"},{text:" Cyclic GMP results in the relaxation of the smooth musclemyocyte.",hierarchyLevel:6,children:[],index:"030503030304"},{text:"  As there is no parasympathetic innervation to thevasculature, there is no source of acetylcholine to bind to the muscarinicacetylcholine receptors. Therefore, smooth muscle relaxation cannot bestimulates via the endothelial cell mechanism.",hierarchyLevel:6,children:[],index:"030503030305"}],index:"0305030303"}],index:"03050303"}],index:"030503"},{text:" Humoral Control",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Resistance arterioles  small diameter blood vessel in themicrocirculation that contributes significantly to the creation of theresistance to flow and regulation of blood flow",hierarchyLevel:5,children:[],index:"0305040000"}],index:"03050400"},{text:" Properties of Humoral Control",hierarchyLevel:4,children:[{text:" Humoral control of vascular resistance via the endocrine systemis slower than autonomic nervous system",hierarchyLevel:5,children:[],index:"0305040100"},{text:" Humoral control acts together with autonomic nervous system tocontrol blood pressure and flow.",hierarchyLevel:5,children:[],index:"0305040101"}],index:"03050401"},{text:" Basic Mechanism of Humoral Control",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Depolarization of the sympathetic nerve (direct) results in therelease of adrenaline from the adrenal medulla in the adrenal gland. ",hierarchyLevel:6,children:[],index:"030504020000"},{text:" Adrenaline binds to \u03b11-adrenoreceptors, stimulatingvasoconstriction in vascular beds (resistance arterioles).",hierarchyLevel:6,children:[],index:"030504020001"},{text:" Adrenaline binds to \u03b22-adrenoreceptors, stimulatingvasodilation in the arterioles in the skeletal muscle and heart.",hierarchyLevel:6,children:[],index:"030504020002"},{text:" As a result, less blood is supplied to other parts of the bodyand more blood is supplied to the skeletal muscle and heart. This facilitatesthe fight or flight response of the body.",hierarchyLevel:6,children:[],index:"030504020003"}],index:"0305040200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0305040201"}],index:"03050402"},{text:" Mechanism of Action of Angiotensin II",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Juxtaglomerular apparatus  specialized structure formed by thedistal convoluted tubule and the glomerular afferent arteriole. It is locatednear the vascular pole of the glomerulus and its main function is to regulateblood pressure and the filtration rate of the glomerulus",hierarchyLevel:6,children:[],index:"030504030000"},{text:" Angiotensinogen  an \u03b12-globulin precursor of angiotensin,and is a yin hormone produced in the liver, kidney, adrenal glands, brain,heart and blood vessels, and adipose tissues",hierarchyLevel:6,children:[],index:"030504030001"},{text:" Angiotensin I  a 10 amino acid peptide",hierarchyLevel:6,children:[],index:"030504030002"},{text:" Angiotensin II  a 8 amino acid peptide",hierarchyLevel:6,children:[],index:"030504030003"}],index:"0305040300"},{text:" General Characteristics",hierarchyLevel:5,children:[{text:" A potent vasoconstrictor",hierarchyLevel:6,children:[],index:"030504030100"},{text:" Promotes long term increases in blood pressure",hierarchyLevel:6,children:[],index:"030504030101"}],index:"0305040301"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0305040302"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Renal hypotension, decreased distal tubular Na , andincreased sympathetic stimulation by \u03b21-adrenoreceptors stimulate thejuxtaglomerular apparatus cells of the kidney. ",hierarchyLevel:6,children:[],index:"030504030300"},{text:" The juxtaglomerular apparatus cells of the kidney release theenzyme renin into the bloodstream.",hierarchyLevel:6,children:[],index:"030504030301"},{text:" Renin acts on angiotensinogen to form angiotensin I.",hierarchyLevel:6,children:[],index:"030504030302"},{text:" Angiotensin converting enzyme converts angiotensin I to formangiotensin II.",hierarchyLevel:6,children:[],index:"030504030303"},{text:" Angiotensin II binds to AT1 receptors (Gq linked G-proteincoupled receptors) on the vascular smooth muscle. This results in smooth musclecontraction and hence vasoconstriction.",hierarchyLevel:6,children:[],index:"030504030304"},{text:" Angiotensin II increases the sympathetic stimulation ofvasculature by central and peripheral mechanisms. ",hierarchyLevel:6,children:[],index:"030504030305"},{text:" Angiotensin II promotes reabsorption of water and salt in thekidney.",hierarchyLevel:6,children:[],index:"030504030306"},{text:" Angiotensin II causes release of aldosterone which promotes thereabsorption of water and salt in the kidney. Increase in reabsorption of waterand salt results in the increase in blood volume and hence increase in bloodpressure.",hierarchyLevel:6,children:[],index:"030504030307"}],index:"0305040303"},{text:" Drug Mechanism",hierarchyLevel:5,children:[{text:" Angiotensin-converting enzyme (ACE) inhibitors are used toprevent the production of angiotensin II from angiotensin I.",hierarchyLevel:6,children:[],index:"030504030400"},{text:" This prevents vasoconstriction from occurring and serves aretreatment for hypertension.",hierarchyLevel:6,children:[],index:"030504030401"}],index:"0305040304"}],index:"03050403"},{text:" Mechanism of Action of Vasopressin",hierarchyLevel:4,children:[{text:" General Characteristics",hierarchyLevel:5,children:[{text:" An anti-diuretic hormone",hierarchyLevel:6,children:[],index:"030504040000"},{text:" 9 amino acid peptide",hierarchyLevel:6,children:[],index:"030504040001"},{text:" Synthesized in the cell bodies of neurones in the hypothalamus",hierarchyLevel:6,children:[],index:"030504040002"}],index:"0305040400"},{text:" Definitions",hierarchyLevel:5,children:[{text:" Dilation  passive enlargement",hierarchyLevel:6,children:[],index:"030504040100"},{text:" Dilatation  active enlargement",hierarchyLevel:6,children:[],index:"030504040101"}],index:"0305040401"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0305040402"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Vasopressin is synthesized in the cell bodies of neurones in thehypothalamus. ",hierarchyLevel:6,children:[],index:"030504040300"},{text:" Vasopressin is then transported along neuronal axons to theposterior pituitary gland where is it secreted into the bloodstream.",hierarchyLevel:6,children:[],index:"030504040301"},{text:" Increased osmolality and decreased stimulation of baroreceptorsresults in increase release of vasopressin from the posterior pituitary gland.",hierarchyLevel:6,children:[],index:"030504040302"},{text:" Vasopressin binds to V1 receptors (Gq-linked G-protein coupledreceptors) which results in smooth muscle contraction. This then results invasoconstriction.",hierarchyLevel:6,children:[],index:"030504040303"},{text:" Vasopressin binds to V1 receptors on the arterioles of the brainand heart. This stimulates endothelium dependent vasodilatation. Hence, thisallows for preferential blood flow to the vital organs.",hierarchyLevel:6,children:[],index:"030504040304"},{text:" Vasopressin binds to V2 receptors, stimulating increased waterreabsorption by the kidneys.",hierarchyLevel:6,children:[],index:"030504040305"}],index:"0305040403"},{text:" Interplay between Mechanism",hierarchyLevel:5,children:[{text:" At normal concentrations, the water reabsorption effect ofvasopressin predominates over the vasoconstriction effect .",hierarchyLevel:6,children:[],index:"030504040400"}],index:"0305040404"}],index:"03050404"},{text:" Mechanism of Action of Natriuretic Peptides",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Atrial natriuretic peptide (ANP)  28 amino acid peptide,released from atria in response to atrial stretch and sympathetic stimulation",hierarchyLevel:6,children:[],index:"030504050000"},{text:" Brain natriuretic peptide (BNP)  32 amino acid peptide, releasedfrom ventricles in response to atrial stretch and sympathetic stimulation",hierarchyLevel:6,children:[],index:"030504050001"},{text:" Natriuretic peptide receptor-A (NPR-A)  a guanylate cyclase receptor/ the principle receptor of ANP",hierarchyLevel:6,children:[],index:"030504050002"},{text:" Natriuretic peptide receptor-B (NPR-B)  a guanylate cyclasereceptor / the principle receptor of BNP",hierarchyLevel:6,children:[],index:"030504050003"},{text:" Natriuresis  the process of sodium excretion in the urinethrough the action of the kidneys",hierarchyLevel:6,children:[],index:"030504050004"}],index:"0305040500"},{text:" Shared Mechanisms",hierarchyLevel:5,children:[{text:" ANP and BNP stimulate NPR-A and NPR-B, which stimulates theincrease in cGMP, which promotes smooth muscle relaxation. This results invasodilation.",hierarchyLevel:6,children:[],index:"030504050100"},{text:" ANP and BNP stimulate natriuresis in the kidneys. This results inincreased excretion of sodium and hence resulting in increased water loss.",hierarchyLevel:6,children:[],index:"030504050101"}],index:"0305040501"}],index:"03050405"}],index:"030504"},{text:" Local Control",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Autacoids  are biological factors (molecules) which act likelocal hormones, have a brief duration, and act near their site of synthesis",hierarchyLevel:5,children:[],index:"0305050000"},{text:" Prostacyclin  member of the prostaglandin family, and serves asa potent vasodilator and inhibitor of platelet aggregation",hierarchyLevel:5,children:[],index:"0305050001"},{text:" Endothelium-derived hyperpolarizing factor (EDHF)  a substanceand/or electrical signal that is generated or synthesized in and released fromthe endothelium; its action is to hyperpolarize vascular smooth muscle cells,causing these cells to relax, thus allowing the blood vessel to expand indiameter.",hierarchyLevel:5,children:[],index:"0305050002"},{text:" 5-hydroxytryptamine (5-HT)  serotonin, is a monoamineneurotransmitter.",hierarchyLevel:5,children:[],index:"0305050003"},{text:" Vascular bed  the vascular system, or a part thereof.",hierarchyLevel:5,children:[],index:"0305050004"}],index:"03050500"},{text:" Characteristics of Local Control",hierarchyLevel:4,children:[{text:" A range of local mechanisms control vascular resistance and bloodflow within a vascular bed",hierarchyLevel:5,children:[],index:"0305050100"},{text:" Local control occurs via endothelium or by direct effects onvascular smooth muscle",hierarchyLevel:5,children:[],index:"0305050101"}],index:"03050501"},{text:" Endothelial Control",hierarchyLevel:4,children:[{text:" Structure and Function of Endothelium",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"030505020000"}],index:"0305050200"},{text:" General Mechanism",hierarchyLevel:5,children:[{text:" Blood flow, hypoxia and autacoids stimulates the endothelium torelease nitric oxide, prostacyclin (PGI ) and EDHF. This causesvasodilatation.",hierarchyLevel:6,children:[],index:"030505020100"}],index:"0305050201"},{text:" Mechanism  Prostacyclin (PGI ) Pathway",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030505020200"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Autacoids, shear stress and hypoxia stimulates cyclooxygenase(COX) to produce prostacyclin (PGI ).",hierarchyLevel:7,children:[],index:"03050502020100"},{text:" Prostacyclin is released from the endothelial cell and binds tothe prostacyclin receptors on the plasma membrane of the smooth muscle cell. ",hierarchyLevel:7,children:[],index:"03050502020101"},{text:" Binding of prostacyclin to prostacyclin receptors (Gs-linkedG-protein coupled receptors) which activates the linked Gs protein. ",hierarchyLevel:7,children:[],index:"03050502020102"},{text:" Gs then activates adenylyl cyclase.",hierarchyLevel:7,children:[],index:"03050502020103"},{text:" Activated adenylyl cyclase produces the second messenger cyclicadenosine monophosphate (cyclic AMP), which stimulates smooth musclerelaxation.",hierarchyLevel:7,children:[],index:"03050502020104"},{text:" This leads to vasodilatation.",hierarchyLevel:7,children:[],index:"03050502020105"}],index:"030505020201"}],index:"0305050202"},{text:" Mechanism  Nitric Oxide (NO) Pathway",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030505020300"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Autocoids, shear stress and hypoxia stimulates nitric oxidesynthase (NOS) to produce nitric oxide.",hierarchyLevel:7,children:[],index:"03050502030100"},{text:" Nitric oxide is released from the endothelial cell and enters thesmooth muscle cell. ",hierarchyLevel:7,children:[],index:"03050502030101"},{text:" Nitric oxide activates soluble Guanylate cyclase to producesecond messenger, cyclic guanosine monophosphate (cyclic GMP). ",hierarchyLevel:7,children:[],index:"03050502030102"},{text:" Cyclic GMP stimulates smooth muscle relaxation which leads tovasodilatation.",hierarchyLevel:7,children:[],index:"03050502030103"}],index:"030505020301"}],index:"0305050203"},{text:" Mechanism  Endothelium derived hyperpolarizing factor (EDHF)",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030505020400"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Autocoids, shear stress and hypoxia stimulates the release ofEDHF (identity unknown) in the endothelial cell.",hierarchyLevel:7,children:[],index:"03050502040100"},{text:" EDHF stimulates the hyperpolarization of the smooth muscle cell.",hierarchyLevel:7,children:[],index:"03050502040101"},{text:" The hyperpolarization of the smooth muscle cell closesvoltage-gated Ca  channels, which results in smooth musclerelaxation and hence vasodilatation.",hierarchyLevel:7,children:[],index:"03050502040102"},{text:" EDHF is more important in vasodilatation inresistance arterioles ",hierarchyLevel:7,children:[],index:"03050502040103"}],index:"030505020401"}],index:"0305050204"},{text:" Mechanism of Autocoids in vasodilation",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030505020500"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Mast cells or basophils releasees histamine and bradykinin(inflammatory mediators)",hierarchyLevel:7,children:[],index:"03050502050100"},{text:" Activated platelets release adenosine diphosphate (ADP),5-hydroxytryptamine (serotonin), and thrombin.",hierarchyLevel:7,children:[],index:"03050502050101"},{text:" Histamine, bradykinin, ADP, serotonin, and thrombin bind to theirrespective receptors on the endothelial cells, resulting in the activation ofnitric oxide synthase (eNOS). ",hierarchyLevel:7,children:[],index:"03050502050102"},{text:" Activated nitric oxide synthase produces nitric oxide, which isreleased from the endothelial cell and diffuses into the smooth muscle myocyte.",hierarchyLevel:7,children:[],index:"03050502050103"},{text:" Nitric oxide activates soluble guanylate cyclase which convertsguanosine triphosphate into cyclic guanosine monophosphate.",hierarchyLevel:7,children:[],index:"03050502050104"},{text:" Cyclic guanosine monophosphate stimulates smooth musclerelaxation, resulting in vasodilatation.",hierarchyLevel:7,children:[],index:"03050502050105"},{text:" Vasodilatation increases blood flow to promote the local healingprocess as part of the inflammatory response.",hierarchyLevel:7,children:[],index:"03050502050106"},{text:" Vasodilatation increases blood flow in vascular beds to protectagainst thrombus formation.",hierarchyLevel:7,children:[],index:"03050502050107"}],index:"030505020501"}],index:"0305050205"},{text:" Mechanism of Blood Flow on vasodilatation",hierarchyLevel:5,children:[{text:" Definitions",hierarchyLevel:6,children:[{text:" Concentric  denoting circles, arcs, or other shapes which sharethe same centre, the larger often completely surrounding the smaller",hierarchyLevel:7,children:[],index:"03050502060000"},{text:" Pulsatile  pulsating; relating to pulsation.",hierarchyLevel:7,children:[],index:"03050502060001"}],index:"030505020600"},{text:" Diagram",hierarchyLevel:6,children:[],index:"030505020601"},{text:" Understanding",hierarchyLevel:6,children:[{text:" In relatively straight portion of vessels, blood flow is laminarand in concentric layers.",hierarchyLevel:7,children:[],index:"03050502060200"},{text:" The outer layers (closest to the walls) produces a frictional andtangential force, resulting in sheer stress.",hierarchyLevel:7,children:[],index:"03050502060201"}],index:"030505020602"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Increasing in blood flow results in the increase in sheer stress.",hierarchyLevel:7,children:[],index:"03050502060300"},{text:" Shear stress stimulates the release of ATP which stimulatesnitric oxide production.",hierarchyLevel:7,children:[],index:"03050502060301"},{text:" Larger shear stress results in greater pulling of the endothelialcells. This stimulates the release of nitric oxide.",hierarchyLevel:7,children:[],index:"03050502060302"},{text:" Stretch from the pulsatile blood pressure stimulates nitric oxideproduction in the endothelum",hierarchyLevel:7,children:[],index:"03050502060303"},{text:" Nitric oxide is protective against atherosclerosis, explainingthe benefits of exercise.",hierarchyLevel:7,children:[],index:"03050502060304"}],index:"030505020603"}],index:"0305050206"},{text:" Mechanism of Endothelin in vasodilatation",hierarchyLevel:5,children:[{text:" Properties",hierarchyLevel:6,children:[{text:" The most potent and long lasting endogenous vasoconstrictor.",hierarchyLevel:7,children:[],index:"03050502070000"}],index:"030505020700"},{text:" Diagram",hierarchyLevel:6,children:[],index:"030505020701"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Endothelin converting enzyme (ECE) converts Big endothelin-1 (aprecursor) into endothelin (ET ).",hierarchyLevel:7,children:[],index:"03050502070200"},{text:" At low concentrations, endothelin binds to endothelin receptortype B (ET ) on the plasma membrane of the endothelial cell. Thisstimulates the production and release of nitric oxide. The nitric oxidediffuses into the smooth muscle myocyte and stimulate smooth muscle relaxation.",hierarchyLevel:7,children:[],index:"03050502070201"},{text:" Angiotensin II, vasopressin, thrombin, cytokines and shear stressand cause high concentration of endothelin to be produced.",hierarchyLevel:7,children:[],index:"03050502070202"},{text:" At high concentrations, endothelin binds to the endothelinreceptor type B and type A (ET ) (Gq-linked G-protein coupledreceptors) located on the vascular smooth muscle. This results in smooth musclecontraction.",hierarchyLevel:7,children:[],index:"03050502070203"}],index:"030505020702"}],index:"0305050207"}],index:"03050502"},{text:" Autoregulatory control",hierarchyLevel:4,children:[{text:" Definition of Autoregulation",hierarchyLevel:5,children:[{text:" A process which allows the vascular bed to maintain constantblood flow when perfusion pressure is changing but the metabolic demand remainsthe same. ",hierarchyLevel:6,children:[],index:"030505030000"},{text:" This is achieved by changing vascular resistance.",hierarchyLevel:6,children:[],index:"030505030001"}],index:"0305050300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0305050301"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" At very low arterial pressures, increase in arterial pressureresults in significant increases in the blood flow.",hierarchyLevel:6,children:[],index:"030505030200"},{text:" However, from 70mm Hg, increases in arterial pressure does notresult in any increase in blood flow.",hierarchyLevel:6,children:[],index:"030505030201"},{text:" The increase in blood flow stretches the vascular walls,stimulating the opening of stretch activated non-selective cation channels onthe vascular smooth muscle. This results in myogenic contraction, hencereducing the blood flow back to the plateau level.",hierarchyLevel:6,children:[],index:"030505030202"}],index:"0305050302"}],index:"03050503"},{text:" Functional (Active) Hyperaemia Control",hierarchyLevel:4,children:[{text:" Definition of Functional Hyperaemia",hierarchyLevel:5,children:[{text:" A process where an increase in the metabolic demand in the tissue(exercise) can increase flow to the tissue to meet the increased metabolicdemand.",hierarchyLevel:6,children:[],index:"030505040000"}],index:"0305050400"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0305050401"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Mediated by hypoxia and metabolites/ mediators released from thetissue surrounding the blood vessels (adenosine, H , CO ,K ). Metabolites and mediators act directly on smooth muscle toproduce vasorelaxation.",hierarchyLevel:6,children:[],index:"030505040200"}],index:"0305050402"}],index:"03050504"},{text:" Reactive Hyperaemia Control",hierarchyLevel:4,children:[{text:" Definition of Reactive Hyperaemia",hierarchyLevel:5,children:[{text:" A process where there is an increase in blood flow following aninterruption of arterial blood supply, above the level that occurred beforeocclusion.",hierarchyLevel:6,children:[],index:"030505050000"}],index:"0305050500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0305050501"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Mediated by hypoxia and metabolites / mediators released from thetissue surrounding the blood vessels.",hierarchyLevel:6,children:[],index:"030505050200"}],index:"0305050502"}],index:"03050505"}],index:"030505"}],index:"0305"},{text:" [051] Factors influencing coronary cerebral,skeletal muscle and skin",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Understand the various determinants of blood flow in coronary,cerebral, skeletal muscle and skin circulations",hierarchyLevel:4,children:[],index:"03060000"},{text:" Know the difference between neurohumoral control, local metaboliccontrol and autoregulation",hierarchyLevel:4,children:[],index:"03060001"},{text:" Know how clinical pathology can influence these control mechanismsand lead to overt signs and symptoms of disease",hierarchyLevel:4,children:[],index:"03060002"}],index:"030600"},{text:" Coronary Circulation",hierarchyLevel:3,children:[{text:" Characteristics of Coronary Blood Flow",hierarchyLevel:4,children:[{text:" Oxygen extraction of the coronary blood is high at rest (70-80%).",hierarchyLevel:5,children:[],index:"0306010000"},{text:" Therefore, it is difficult for the heart to further extract moreoxygen during exercise.",hierarchyLevel:5,children:[],index:"0306010001"},{text:" Instead, the heart increases coronary blood flow by 5 timesduring exercise.",hierarchyLevel:5,children:[],index:"0306010002"}],index:"03060100"},{text:" Coronary Blood Supply",hierarchyLevel:4,children:[{text:" Right coronary artery",hierarchyLevel:5,children:[{text:" Right ventricle",hierarchyLevel:6,children:[],index:"030601010000"},{text:" Posterior wall of left ventricle",hierarchyLevel:6,children:[],index:"030601010001"},{text:" Posterior 1/3 septum",hierarchyLevel:6,children:[],index:"030601010002"}],index:"0306010100"},{text:" Left coronary artery",hierarchyLevel:5,children:[{text:" Lateral and anterior walls of left ventricle",hierarchyLevel:6,children:[],index:"030601010100"},{text:" Anterior 2/3 septum",hierarchyLevel:6,children:[],index:"030601010101"}],index:"0306010101"}],index:"03060101"},{text:" Determinants of Coronary Blood Flow",hierarchyLevel:4,children:[{text:" Coronary perfusion pressure",hierarchyLevel:5,children:[],index:"0306010200"},{text:" Perfusion time",hierarchyLevel:5,children:[],index:"0306010201"},{text:" Vasomotor tone",hierarchyLevel:5,children:[],index:"0306010202"},{text:" Vessel wall diameter",hierarchyLevel:5,children:[],index:"0306010203"}],index:"03060102"},{text:" Coronary Perfusion Pressure",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Coronary Perfusion Pressure  the pressure gradient that drivescoronary blood pressure",hierarchyLevel:6,children:[],index:"030601030000"},{text:" Aortic diastolic pressure  the pressure in the aortic root afterclosure of the aortic valve and relaxation of the left ventricle (end pressure)",hierarchyLevel:6,children:[],index:"030601030001"},{text:" Left ventricular end diastolic pressure (LVEDP) - the pressurein left ventricle just before the ventricle contracts (start pressure)",hierarchyLevel:6,children:[],index:"030601030002"}],index:"0306010300"},{text:" Formula",hierarchyLevel:5,children:[{text:" Coronary Perfusion Pressure = Aortic diastolic pressure  Leftventricular end diastolic pressure",hierarchyLevel:6,children:[],index:"030601030100"}],index:"0306010301"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0306010302"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" When the ventricles contract, the intramuscular vessels arecompressed and twisted. As a result, there is no coronary blood flow.",hierarchyLevel:6,children:[],index:"030601030300"},{text:" When the pressure in the ventricles are high enough, the aorticvalve opens and the pressure in the ventricles drop while the pressure in theaorta increases. However, as the ventricles are still contracted and pressingon the intraventricular vessels, the pressure gradient between the aorta andthe ventricles are no high enough for high coronary blood flow.",hierarchyLevel:6,children:[],index:"030601030301"},{text:" When the ventricles relax and the aortic valve closes, thepressure in the intraventricular vessels decreases significantly, resulting inthe maximal pressure gradient. This enables coronary blood flow of 100ml / minto be reached.",hierarchyLevel:6,children:[],index:"030601030302"}],index:"0306010303"}],index:"03060103"},{text:" Perfusion Time / Heart Rate",hierarchyLevel:4,children:[{text:" Understanding",hierarchyLevel:5,children:[{text:" There is no coronary blood flow during ventricular contraction",hierarchyLevel:6,children:[],index:"030601040000"},{text:" The more time the heart spends in systole, the less time there isfor coronary blood flow.",hierarchyLevel:6,children:[],index:"030601040001"},{text:" The more time the heart spends in diastole, the more time thereis for coronary blood flow.",hierarchyLevel:6,children:[],index:"030601040002"},{text:" The faster the heart beats, the less time is spent duringdiastole, hence the lower the coronary blood flow.",hierarchyLevel:6,children:[],index:"030601040003"},{text:" The slower the heart beats, the more time is spent duringdiastole, hence the higher the coronary blood flow.",hierarchyLevel:6,children:[],index:"030601040004"}],index:"0306010400"},{text:" Application in Clinical Settings",hierarchyLevel:5,children:[{text:" During ischemic heart disease, due to the narrowing of thecoronary arteries, there is less blood flow to the cardiac muscles.",hierarchyLevel:6,children:[],index:"030601040100"},{text:" By  using beta blockers to slow  down the heart rate, thereis more time spend in diastole, hence increasing the coronary blood flow to thecardiac muscles.",hierarchyLevel:6,children:[],index:"030601040101"}],index:"0306010401"}],index:"03060104"},{text:" Vessel Wall Diameter",hierarchyLevel:4,children:[{text:" Understanding",hierarchyLevel:5,children:[{text:" Vessel diameter  blood flow",hierarchyLevel:6,children:[],index:"030601050000"}],index:"0306010500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0306010501"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Atherosclerosis results in the formation of cholesterol plaquesand artery stenosis. This can be seen in the thickening in the vessel wall.",hierarchyLevel:6,children:[],index:"030601050200"},{text:" Initially, the blood vessel compensates by vasodilation, howeverthis mechanism can be quickly exhausted as artery stenosis continues. Thisleads to a drop in blood flow rate.",hierarchyLevel:6,children:[],index:"030601050201"}],index:"0306010502"}],index:"03060105"},{text:" Vasomotor tone",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0306010600"},{text:" Components",hierarchyLevel:5,children:[{text:" Humoral control",hierarchyLevel:6,children:[],index:"030601060100"},{text:" Autonomic nervous control",hierarchyLevel:6,children:[],index:"030601060101"},{text:" Vascular endothelium",hierarchyLevel:6,children:[],index:"030601060102"},{text:" Autoregulation",hierarchyLevel:6,children:[],index:"030601060103"},{text:" Local metabolic O  demand",hierarchyLevel:6,children:[],index:"030601060104"}],index:"0306010601"}],index:"03060106"},{text:" Abnormal Function: Ischemic Heart Disease",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0306010700"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Lipid deposits appear on the coronary arteries. This leads tosmooth muscle proliferation, causing stenosis.",hierarchyLevel:6,children:[],index:"030601070100"},{text:" Arterial stenosis leads to increase amount of resistance, leadingto increase in the amount of pressure required to pump blood out into thearteries. This increases afterload. ",hierarchyLevel:6,children:[],index:"030601070101"},{text:" To compensate for the increased amount of work required, the leftventricles start to grow in size, leading to left ventricular hypertrophy. ",hierarchyLevel:6,children:[],index:"030601070102"},{text:" Increase in the number of cells in the left ventricles leads to agreater O  demand.",hierarchyLevel:6,children:[],index:"030601070103"},{text:" To meet the increased O  demand, the heart increasesits heart rate. This leads to reduced time spent in diastole, leading to lesscoronary blood flow.",hierarchyLevel:6,children:[],index:"030601070104"},{text:" Lowered coronary blood flow leads to cardiomyocytes to becomehypoxic. This leads to the release of mediators such as adenosine. Adenosinestimulates vasorelaxation as an attempt increase the coronary blood flow.",hierarchyLevel:6,children:[],index:"030601070105"},{text:" However, if adequate coronary blood flow is still not achieved,this leads to ischemia.",hierarchyLevel:6,children:[],index:"030601070106"}],index:"0306010701"}],index:"03060107"},{text:" Abnormal Function: Angina",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Pain experienced from lack of myocyte oxygen",hierarchyLevel:6,children:[],index:"030601080000"}],index:"0306010800"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Angina occurs when coronary artery stenosis becomes critical andall mechanisms to increase flow are exhausted, leading to supply being unableto meet demand.",hierarchyLevel:6,children:[],index:"030601080100"}],index:"0306010801"},{text:" Variations",hierarchyLevel:5,children:[{text:" > 80% stenosis  unstable angina (at rest)",hierarchyLevel:6,children:[],index:"030601080200"},{text:" >50% stenosis  exercise induced angina",hierarchyLevel:6,children:[],index:"030601080201"}],index:"0306010802"}],index:"03060108"}],index:"030601"},{text:" Cerebral circulation",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Intracranial Pressure (ICP)  pressure in the brain",hierarchyLevel:5,children:[],index:"0306020000"},{text:" Cerebral perfusion pressure (CPP) = Mean Arterial Pressure Intracranial pressure",hierarchyLevel:5,children:[],index:"0306020001"}],index:"03060200"},{text:" Importance of Cerebral Circulation",hierarchyLevel:4,children:[{text:" Ischemia leading to a reduction in cerebral blood flow leads toloss of consciousness within seconds",hierarchyLevel:5,children:[],index:"0306020100"},{text:" Adequate cerebral blood flow must be maintained to ensureconstant delivery of O  and substrates and removal of waste productsof metabolism",hierarchyLevel:5,children:[],index:"0306020101"},{text:" Insufficient blood supply for 3-8 minutes leads to permanentbrain damage",hierarchyLevel:5,children:[],index:"0306020102"}],index:"03060201"},{text:" Characteristics of Cerebral Circulation",hierarchyLevel:4,children:[{text:" Cerebral blood flow  50ml / 100g / min",hierarchyLevel:5,children:[],index:"0306020200"},{text:" Limited anaerobic ability  the brain is only able to withstandvery short period of ischaemia due to limited capacity to metaboliseanaerobically",hierarchyLevel:5,children:[],index:"0306020201"},{text:" Function Hyperaemia  the brain is able to divert blood flow toareas with maximum activity",hierarchyLevel:5,children:[],index:"0306020202"},{text:" High consumption of oxygen  the cerebral metabolic rate for O (CMRO ) is higher than other parts of the body",hierarchyLevel:5,children:[],index:"0306020203"}],index:"03060202"},{text:" Anatomy of the Head",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0306020300"},{text:" Parts of the Head",hierarchyLevel:5,children:[{text:" Skull",hierarchyLevel:6,children:[],index:"030602030100"},{text:" Brain",hierarchyLevel:6,children:[],index:"030602030101"},{text:" Cerebrospinal fluid",hierarchyLevel:6,children:[],index:"030602030102"},{text:" Blood",hierarchyLevel:6,children:[],index:"030602030103"}],index:"0306020301"},{text:" Characteristics",hierarchyLevel:5,children:[{text:" Contains a fixed volume  an increase in the volume will resultin increase in intracranial pressure",hierarchyLevel:6,children:[],index:"030602030200"}],index:"0306020302"}],index:"03060203"},{text:" Determinants of Cerebral Blood Flow",hierarchyLevel:4,children:[{text:" Autoregulation",hierarchyLevel:5,children:[],index:"0306020400"},{text:" Carbon dioxide and oxygen",hierarchyLevel:5,children:[],index:"0306020401"},{text:" Cerebral metabolism",hierarchyLevel:5,children:[],index:"0306020402"},{text:" Humoral factors",hierarchyLevel:5,children:[],index:"0306020403"}],index:"03060204"},{text:" Autoregulation in determining Cerebral Blood Flow",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0306020500"},{text:" Properties",hierarchyLevel:5,children:[{text:" Remains relatively constant between 60-160mm Hg.",hierarchyLevel:6,children:[],index:"030602050100"},{text:" Blood pressure limits of cerebral autoregulation are not anall-or-none physiological response",hierarchyLevel:6,children:[],index:"030602050101"}],index:"0306020501"},{text:" Mediators",hierarchyLevel:5,children:[{text:" Endothelium-derived relaxing factor (EDRF)",hierarchyLevel:6,children:[],index:"030602050200"},{text:" Nitric oxide (NO)",hierarchyLevel:6,children:[],index:"030602050201"}],index:"0306020502"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" The increase in mean arterial pressure stretches the vascularwalls, stimulating the opening of stretch activated non-selective cationchannels on the vascular smooth muscle. This results in myogenic contraction,hence reducing the blood flow back to the plateau level.",hierarchyLevel:6,children:[],index:"030602050300"},{text:" The decrease in mean arterial pressure relaxes the vascularwalls, no longer stimulating the stretch activated non-selective cationchannels, and hence causing them to close. This results in myogenic relaxation,hence increasing the blood flow back to the plateau level.",hierarchyLevel:6,children:[],index:"030602050301"}],index:"0306020503"},{text:" Abnormal Function: Chronic Hypertension",hierarchyLevel:5,children:[{text:" Patients with chronic hypertension has a higher autoregulationrange.",hierarchyLevel:6,children:[],index:"030602050400"}],index:"0306020504"}],index:"03060205"},{text:" Carbon dioxide in determining cerebral blood flow",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0306020600"},{text:" Properties",hierarchyLevel:5,children:[{text:" Remains relatively constant between 30-80 mm Hg (3-10 kPa)",hierarchyLevel:6,children:[],index:"030602060100"}],index:"0306020601"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Increasing pCO  shifts the equilibrium to the left andmore carbonic acid dissociates to release H  ions. This results inthe lowering of the pH.",hierarchyLevel:6,children:[],index:"030602060200"},{text:" H  ions serves as a mediator which causes directvasodilatation, hence increasing cerebral blood flow.",hierarchyLevel:6,children:[],index:"030602060201"},{text:" H  ions enhances the release of NO and opens K channels.",hierarchyLevel:6,children:[],index:"030602060202"},{text:" This eventually  results in the decrease in intracellular  Ca .",hierarchyLevel:6,children:[],index:"030602060203"}],index:"0306020602"}],index:"03060206"},{text:" Oxygen in determining cerebral blood flow",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0306020700"},{text:" Properties",hierarchyLevel:5,children:[{text:" Oxygen has no effect on cerebral blood flow within normal limits(> 55mm Hg) (7.2kPa)",hierarchyLevel:6,children:[],index:"030602070100"}],index:"0306020701"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" A drop in pO  to below 55mm Hg or 7.2 kPa results inhypoxia. Hypoxia stimulates the cerebrovascular smooth muscle to promoteadenosine release.",hierarchyLevel:6,children:[],index:"030602070200"},{text:" Adenosine serves as a mediator to stimulate vasodilatation, henceincreasing cerebral blood flow.",hierarchyLevel:6,children:[],index:"030602070201"}],index:"0306020702"}],index:"03060207"},{text:" Cerebral metabolism in determining cerebral blood flow",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Cerebral metabolic rate (CMR)  the rate at which the brainutilizes metabolic substrates",hierarchyLevel:6,children:[],index:"030602080000"}],index:"0306020800"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0306020801"},{text:" Properties",hierarchyLevel:5,children:[{text:" The brain has the highest metabolic requirements in the body",hierarchyLevel:6,children:[],index:"030602080200"}],index:"0306020802"},{text:" Mediators  vasoactive metabolic mediators",hierarchyLevel:5,children:[{text:" H",hierarchyLevel:6,children:[],index:"030602080300"},{text:" CO",hierarchyLevel:6,children:[],index:"030602080301"},{text:" K",hierarchyLevel:6,children:[],index:"030602080302"},{text:" NO",hierarchyLevel:6,children:[],index:"030602080303"}],index:"0306020803"},{text:" Mechanism of Flow-Metabolic Coupling",hierarchyLevel:5,children:[{text:" Local or global increases in metabolic demand activatesvasoactive metabolic mediators.",hierarchyLevel:6,children:[],index:"030602080400"},{text:" Vasoactive metabolic mediators stimulates vasodilatation,resulting in increased blood flow and hence substrate delivery.",hierarchyLevel:6,children:[],index:"030602080401"}],index:"0306020804"}],index:"03060208"},{text:" Humoral Factors in determining cerebral blood flow",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Plays a minor role in the cerebral circulation",hierarchyLevel:6,children:[],index:"030602090000"},{text:" Can be stimulated via pathological states such as hypertensionand seizures, leading to vasodilatation and increase in cerebral blood flow.",hierarchyLevel:6,children:[],index:"030602090001"}],index:"0306020900"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Sympathetic activation leads to vasoconstriction, henceincreasing cerebral blood flow",hierarchyLevel:6,children:[],index:"030602090100"},{text:" Sympathetic activation in patients with hypertension leads to theshifting of the autoregulation curve to the right, increasing theautoregulation ranges.",hierarchyLevel:6,children:[],index:"030602090101"},{text:" Parasympathetic activation during pathological states leads tovasodilatation",hierarchyLevel:6,children:[],index:"030602090102"}],index:"0306020901"}],index:"03060209"},{text:" Cerebral Adaptations to Increased Intracranial Pressure",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Hernia  when an internal part of the body pushes through aweakness in the muscle or surrounding tissue wall",hierarchyLevel:6,children:[],index:"030602100000"}],index:"0306021000"},{text:" Understandings",hierarchyLevel:5,children:[{text:" Monro-Kellie Principle  the sum of volumes in the brain isconstant",hierarchyLevel:6,children:[],index:"030602100100"},{text:" Increase in brain volume due to intracranial haemorrhage, tumouror cerebral oedema, is compensated by decrease in brain volume in other partsof the brain or increase in intracranial pressure.",hierarchyLevel:6,children:[],index:"030602100101"},{text:" Increase in intracranial pressure stops cerebral blood perfusion,leading to Cushings Reflex to maintain perfusion",hierarchyLevel:6,children:[],index:"030602100102"}],index:"0306021001"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0306021002"},{text:" Mechanism of Initial Compensation",hierarchyLevel:5,children:[{text:" Increase in the Glial tissue and Neuronal Tissue due to thegrowth of the tumour is initially compensated by the drainage of blood andcerebrospinal fluid from the brain",hierarchyLevel:6,children:[],index:"030602100300"},{text:" However, as the tumour continues to grow, further drainage ofblood and cerebrospinal fluid is no longer possible.",hierarchyLevel:6,children:[],index:"030602100301"},{text:" As a result, the intracranial pressure starts to increase. ",hierarchyLevel:6,children:[],index:"030602100302"},{text:" Increase in intracranial pressure results in reduction ofconsciousness and brain hernia.",hierarchyLevel:6,children:[],index:"030602100303"}],index:"0306021003"},{text:" Mechanism of Cushings Reflex",hierarchyLevel:5,children:[{text:" Due to the increased intracranial pressure, cerebral perfusion isreduced to zero.",hierarchyLevel:6,children:[],index:"030602100400"},{text:" As a result the Mean Arterial Pressure in the brain is now equalsto the Intracerebral pressure. (CPP = MAP  ICP) (MAP > ICP) (ICP  ) (MAP = ICP) (0 =MAP  ICP)",hierarchyLevel:6,children:[],index:"030602100401"},{text:" The lack of cerebral perfusion leads to ischaemia. Ischaemiastimulates the vasomotor region of the medulla to increase sympatheticactivity. ",hierarchyLevel:6,children:[],index:"030602100402"},{text:" Increase in sympathetic activity leads to a systemic rise inblood pressure, which helps to increase Mean Arterial Pressure to a level thatis higher than Intracranial pressure. Hence, this restores cerebral perfusionpressure, allowing for cerebral circulation to resume.",hierarchyLevel:6,children:[],index:"030602100403"},{text:" Moreover, cerebral blood vessels are stimulate to undergovasodilatation, helping to improve blood flow.",hierarchyLevel:6,children:[],index:"030602100404"},{text:" The combined effects of the Cushings reflex (sympatheticactivity), leads to hypertension, bradycardia and irregular respirations,forming the Cushings Triad.",hierarchyLevel:6,children:[],index:"030602100405"}],index:"0306021004"},{text:" Cushings Triad",hierarchyLevel:5,children:[],index:"0306021005"}],index:"03060210"},{text:" Summary of Determinants of Cerebral Blood Flow",hierarchyLevel:4,children:[],index:"03060211"},{text:" Management of Raised Intracranial Pressure",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Quiescent  in a state of inactivity or dormancy",hierarchyLevel:6,children:[],index:"030602120000"}],index:"0306021200"},{text:" Problem",hierarchyLevel:5,children:[{text:" Increasing intracranial pressure leads to reduced level ofconsciousness",hierarchyLevel:6,children:[],index:"030602120100"},{text:" An unconscious patient is unable to protect their airway andmaintain ventilation.",hierarchyLevel:6,children:[],index:"030602120101"},{text:" When the brain experiences direct trauma, autoregulation cannotoccur.",hierarchyLevel:6,children:[],index:"030602120102"}],index:"0306021201"},{text:" Solution",hierarchyLevel:5,children:[{text:" Apply anaesthesia  causes quiescent brain activity, reducingmetabolic demand",hierarchyLevel:6,children:[],index:"030602120200"},{text:" Apply intubation and mechanical ventilation  control patient pO and pCO",hierarchyLevel:6,children:[],index:"030602120201"},{text:" Position patient with 30 degrees head up tilt  aid venousdrainage away from the head",hierarchyLevel:6,children:[],index:"030602120202"}],index:"0306021202"}],index:"03060212"}],index:"030602"},{text:" Skeletal Circulation",hierarchyLevel:3,children:[{text:" Random Info",hierarchyLevel:4,children:[{text:" Stitch is due to ischaemic pain from the gut due to blood beingdiverted away",hierarchyLevel:5,children:[],index:"0306030000"}],index:"03060300"},{text:" Characteristics of Skeletal Circulation",hierarchyLevel:4,children:[{text:" Skeletal muscle blood flow (at rest)  1-2ml / 100g / min",hierarchyLevel:5,children:[],index:"0306030100"},{text:" Skeletal muscle vasculature contributes most of peripheralvascular resistance",hierarchyLevel:5,children:[],index:"0306030101"},{text:" During exercise skeletal blood flow can increase 50 fold to50-100ml / 100g / min rapidly to respond to fight or flight situations",hierarchyLevel:5,children:[],index:"0306030102"},{text:" During exercise blood is diverted from other organs to skeletalmuscles",hierarchyLevel:5,children:[],index:"0306030103"}],index:"03060301"},{text:" Determinants of Skeletal Blood Flow",hierarchyLevel:4,children:[{text:" Humoral Control",hierarchyLevel:5,children:[],index:"0306030200"},{text:" Extrinsic Muscular Contraction",hierarchyLevel:5,children:[],index:"0306030201"},{text:" Metabolic Control",hierarchyLevel:5,children:[],index:"0306030202"}],index:"03060302"},{text:" Humoral control in determining skeletal blood flow",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Sympathetic innervation allows for vasoconstriction via  \u03b11and  \u03b12 receptors , vasodilatation via \u03b22receptors",hierarchyLevel:6,children:[],index:"030603030000"}],index:"0306030300"}],index:"03060303"},{text:" Metabolic control in determining skeletal blood flow",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Local metabolic control is dominant during exercise",hierarchyLevel:6,children:[],index:"030603040000"}],index:"0306030400"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Exercise results in the oxygen demand exceeding oxygen supply.This results in skeletal muscle entering a hypoxic state. Hypoxia stimulatesthe release and accumulation of mediators such as adenosine, H , CO ,lactate, and K  channels open.",hierarchyLevel:6,children:[],index:"030603040100"},{text:" These mediators act directly on smooth muscle to producevasodilatation. Vasodilatation results in increased blood flow, restoringoxygen delivery and removal of metabolites.",hierarchyLevel:6,children:[],index:"030603040101"}],index:"0306030401"}],index:"03060304"},{text:" Extrinsic Muscular Contraction in determining skeletal blood flow",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0306030500"},{text:" Mechanism  rhythmic contractions",hierarchyLevel:5,children:[{text:" Coordinated, rhythmical skeletal muscle contraction serves as theskeletal pump mechanism, pumping venous blood back towards the heart. ",hierarchyLevel:6,children:[],index:"030603050100"},{text:" This enhances blood flow and ensures that the pressure differenceis maintained between arterioles and venules.",hierarchyLevel:6,children:[],index:"030603050101"}],index:"0306030501"},{text:" Mechanism  sustained contractions",hierarchyLevel:5,children:[{text:" Sustained skeletal muscle contractions lasting longer than 10seconds leads to the interruption of blood flow. ",hierarchyLevel:6,children:[],index:"030603050200"},{text:" This leads to the demand of oxygen to exceed supply, causingischaemia and the build up of lactate from anaerobic metabolism. ",hierarchyLevel:6,children:[],index:"030603050201"},{text:" Accumulation of lactate results in pain and weakness.",hierarchyLevel:6,children:[],index:"030603050202"}],index:"0306030502"}],index:"03060305"},{text:" Abnormal Function: Peripheral Vascular Disease",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Peripheral Vascular Disease (PVD)  caused by lipid deposits andcholesterol build up in vessels downstream from the aorta",hierarchyLevel:6,children:[],index:"030603060000"},{text:" Claudication  pain experienced from peripheral vascular diseaseischaemia",hierarchyLevel:6,children:[],index:"030603060001"}],index:"0306030600"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0306030601"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Patients who smoke or have a history of poorly controlleddiabetes causes lipid deposites and cholesterol build up in the vesselsdownstream from the aorta. ",hierarchyLevel:6,children:[],index:"030603060200"},{text:" This results in stenosis down the legs of the patient. ",hierarchyLevel:6,children:[],index:"030603060201"},{text:" During exercise, the stenosis results in the oxygen demandexceeding supply, leading to iscahemia and pain.",hierarchyLevel:6,children:[],index:"030603060202"}],index:"0306030602"},{text:" Treatment",hierarchyLevel:5,children:[{text:" Inserting stents to open up the vessels to restore blood flow",hierarchyLevel:6,children:[],index:"030603060300"}],index:"0306030603"}],index:"03060306"}],index:"030603"},{text:" Skin Circulation",hierarchyLevel:3,children:[{text:" Characteristics of Skin Circulation",hierarchyLevel:4,children:[{text:" Skin circulatory blood flow averages at 5ml / 100g / min (3ml cold climate) (8ml  hot climate)",hierarchyLevel:5,children:[],index:"0306040000"},{text:" Main role for skin circulation is for thermoregulation of bodytemperature",hierarchyLevel:5,children:[],index:"0306040001"},{text:" Skin contains arteriovenous anastomoses",hierarchyLevel:5,children:[],index:"0306040002"}],index:"03060400"},{text:" Definitions",hierarchyLevel:4,children:[{text:" Arteriovenous anastomoses  direct connections between smallarteries and small veins",hierarchyLevel:5,children:[],index:"0306040100"}],index:"03060401"},{text:" Determinants of Skin Blood Flow",hierarchyLevel:4,children:[{text:" Humoral Control",hierarchyLevel:5,children:[],index:"0306040200"},{text:" Local Metabolic Control",hierarchyLevel:5,children:[],index:"0306040201"}],index:"03060402"},{text:" Humoral control in determining skin blood flow",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Hyperaemia - an excess of blood in the vessels supplying an organor other part of the body",hierarchyLevel:6,children:[],index:"030604030000"}],index:"0306040300"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Cold environment lowers the temperature of the blood",hierarchyLevel:6,children:[],index:"030604030100"},{text:" The thermoreceptors in the thermoregulatory centre in theposterior hypothalamus detects the lowered temperature of the blood",hierarchyLevel:6,children:[],index:"030604030101"},{text:" The hypothalamus increases the sympathetic activity, resulting inthe activation  of  \u03b12  receptors.",hierarchyLevel:6,children:[],index:"030604030102"},{text:" This results in the constriction of skin arterioles, divertingblood through the arteriovenous anastomoses, hence reducing superficialcapillary blood flow. This reduces heat loss.",hierarchyLevel:6,children:[],index:"030604030103"},{text:" After prolonged exposure, intermittent dilatation occurs, helpingto prevent skin ischaemia and nerosis (hyperaemia)",hierarchyLevel:6,children:[],index:"030604030104"}],index:"0306040301"}],index:"03060403"},{text:" Local metabolic control in determining skin blood flow",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0306040400"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" In hot climates, sweat glands are activated.",hierarchyLevel:6,children:[],index:"030604040100"},{text:" Activated sweat glands stimulates the production of Bradykinin.",hierarchyLevel:6,children:[],index:"030604040101"},{text:" Bradykinin serves as a potent vasodilator, resulting in thevasodilatation of the arterioles. ",hierarchyLevel:6,children:[],index:"030604040102"},{text:" As a result, more blood flows through the capillary bed, closerto the surface of the skin, resulting in increased heat loss",hierarchyLevel:6,children:[],index:"030604040103"}],index:"0306040401"}],index:"03060404"},{text:" Abnormal Function: Raynauds Phenomenon",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Raynauds phenomenon  have excessive sympathetic response tocold",hierarchyLevel:6,children:[],index:"030604050000"},{text:" Vasospasm  narrowing of the arteries caused by a persistentcontraction of the blood vessels",hierarchyLevel:6,children:[],index:"030604050001"},{text:" Cyanosis - change of body tissue color to a bluish-purple hue asa result of having decreased amounts of oxygen bound to the hemoglobin in thered blood cell",hierarchyLevel:6,children:[],index:"030604050002"}],index:"0306040500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0306040501"},{text:" Targets  most susceptible to cold injury",hierarchyLevel:5,children:[{text:" Hands",hierarchyLevel:6,children:[],index:"030604050200"},{text:" Feet",hierarchyLevel:6,children:[],index:"030604050201"}],index:"0306040502"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" When exposed to cold, \u03b12 receptors become more sensitive andvasoconstrictor effect becomes enhanced.",hierarchyLevel:6,children:[],index:"030604050300"},{text:" This results in intense vasospasms, resulting in white/palelooking skin.",hierarchyLevel:6,children:[],index:"030604050301"},{text:" The lack of blood flow leads to cyanosis, leading to blue skin.",hierarchyLevel:6,children:[],index:"030604050302"},{text:" There is then rapid blood reflow, resulting in red skin.",hierarchyLevel:6,children:[],index:"030604050303"}],index:"0306040503"}],index:"03060405"}],index:"030604"}],index:"0306"},{text:" [057] Hypertension  the action of therapeutics",hierarchyLevel:2,children:[{text:" Learning Objectives",hierarchyLevel:3,children:[{text:" Understand blood pressure and hypertension",hierarchyLevel:4,children:[],index:"03070000"},{text:" Understand the consequences of hypertension",hierarchyLevel:4,children:[],index:"03070001"},{text:" Understand how the sympathetic nervous system and reninangiotensin aldosterone system contributes to hypertension",hierarchyLevel:4,children:[],index:"03070002"},{text:" Understand the commonly used therapies for treating hypertension",hierarchyLevel:4,children:[],index:"03070003"}],index:"030700"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Normal Blood Pressure  120 / 80 mm Hg",hierarchyLevel:5,children:[],index:"0307010000"},{text:" Hypertension  > 140mm Hg / > 90mm Hg",hierarchyLevel:5,children:[],index:"0307010001"},{text:" Haemorrhage  blood loss",hierarchyLevel:5,children:[],index:"0307010002"},{text:" Calibre  internal diameter of the blood vessel",hierarchyLevel:5,children:[],index:"0307010003"}],index:"03070100"},{text:" Trends",hierarchyLevel:4,children:[{text:" 2 mm Hg increase in blood pressure results in 7% increase risk ofmortality from ischaemic heart disease",hierarchyLevel:5,children:[],index:"0307010100"},{text:" Systolic blood pressure increases with age",hierarchyLevel:5,children:[],index:"0307010101"},{text:" Systolic blood pressure is higher in men",hierarchyLevel:5,children:[],index:"0307010102"}],index:"03070101"},{text:" Hypertension Pressure Profiles",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0307010200"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Hypertension results in increased pressure in arteries andarterioles before declining in the capillaries",hierarchyLevel:6,children:[],index:"030701020100"},{text:" This put additional stress on arteries and arterioles, increasingthe risk of haemorrhage due to the rupture of blood vessels.",hierarchyLevel:6,children:[],index:"030701020101"}],index:"0307010201"}],index:"03070102"},{text:" Consequences of Hypertension",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0307010300"},{text:" Effect of Increased Afterload",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"030701030100"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Due to the increase in the central aortic pressure, the diastolicarterial pressure increases and the systolic arterial pressure increases.",hierarchyLevel:7,children:[],index:"03070103010100"},{text:" The heart has to pump harder in isovolumetric contraction toreach a pressure higher than the diastolic arterial pressure (aortic pressure),to start ejecting blood out. ",hierarchyLevel:7,children:[],index:"03070103010101"},{text:" After ventricular contraction, the ventricles start to relax,resulting in the pressure in the ventricles to start to fall. However, due tothe higher aortic pressure, the ventricular pressure falls below the aorticpressure earlier at a higher ventricular volume. This results in the earlyclosure of the aortic valve, resulting in less blood being pumped into theaorta.",hierarchyLevel:7,children:[],index:"03070103010102"},{text:" As a result of the higher end systole volume, the stroke volumedecreases.",hierarchyLevel:7,children:[],index:"03070103010103"}],index:"030701030101"}],index:"0307010301"}],index:"03070103"},{text:" Treatment for Hypertension",hierarchyLevel:4,children:[{text:" Formulas",hierarchyLevel:5,children:[{text:" V = I R",hierarchyLevel:6,children:[],index:"030701040000"},{text:" Mean arterial blood pressure = Cardiac output x Total peripheralresistance",hierarchyLevel:6,children:[],index:"030701040001"},{text:" Cardiac output = Heart rate x Stroke Volume",hierarchyLevel:6,children:[],index:"030701040002"}],index:"0307010400"},{text:" Targets",hierarchyLevel:5,children:[{text:" Modify total peripheral resistance",hierarchyLevel:6,children:[],index:"030701040100"},{text:" Modify heart rate",hierarchyLevel:6,children:[],index:"030701040101"}],index:"0307010401"}],index:"03070104"},{text:" Types of Hypertension",hierarchyLevel:4,children:[{text:" Primary hypertension",hierarchyLevel:5,children:[{text:" Characteristics",hierarchyLevel:6,children:[{text:" No identifiable cause",hierarchyLevel:7,children:[],index:"03070105000000"},{text:" Starts with cardiac output, and overtime, due to ineffectiveincrease in flow, results in increase in vascular resistance to furtherredirect flow",hierarchyLevel:7,children:[],index:"03070105000001"}],index:"030701050000"},{text:" Treatment",hierarchyLevel:6,children:[{text:" Interventional lifestyle changes (exercise, decrease sodiumintake, lose weight)",hierarchyLevel:7,children:[],index:"03070105000100"}],index:"030701050001"}],index:"0307010500"},{text:" Secondary hypertension",hierarchyLevel:5,children:[{text:" Characteristics",hierarchyLevel:6,children:[{text:" Identifiable cause",hierarchyLevel:7,children:[],index:"03070105010000"}],index:"030701050100"},{text:" Examples",hierarchyLevel:6,children:[{text:" Phaechrocytoma",hierarchyLevel:7,children:[{text:" Mechanism",hierarchyLevel:8,children:[{text:" Tumour of chromaffin tissue results in the secretion ofadrenaline and noradrenaline, which results in hypertension",hierarchyLevel:9,children:[],index:"030701050101000000"}],index:"0307010501010000"},{text:" Treatment",hierarchyLevel:8,children:[{text:" Surgery to remove the tumour",hierarchyLevel:9,children:[],index:"030701050101000100"},{text:" Adrenoreceptor antagonists",hierarchyLevel:9,children:[],index:"030701050101000101"}],index:"0307010501010001"}],index:"03070105010100"},{text:" Coarctation (narrowing) of aorta",hierarchyLevel:7,children:[{text:" Mechanism",hierarchyLevel:8,children:[{text:" Aorta narrows due to atherosclerosis",hierarchyLevel:9,children:[],index:"030701050101010000"}],index:"0307010501010100"},{text:" Treatment",hierarchyLevel:8,children:[{text:" Surgery",hierarchyLevel:9,children:[],index:"030701050101010100"},{text:" Ballon angioplasty",hierarchyLevel:9,children:[],index:"030701050101010101"}],index:"0307010501010101"}],index:"03070105010101"}],index:"030701050101"}],index:"0307010501"}],index:"03070105"},{text:" Selfish Brain Hypothesis",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0307010600"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Vertebral artery hypoplasia results in increase cerebral vascularresistance.",hierarchyLevel:6,children:[],index:"030701060100"},{text:" Higher cerebral vascular resistance reduces cerebral perfusion. ",hierarchyLevel:6,children:[],index:"030701060101"},{text:" Decrease in cerebral perfusion results in an increase insympathetic nervous activity.",hierarchyLevel:6,children:[],index:"030701060102"},{text:" Increased sympathetic nervous activity results invasoconstriction in organs other than the brain, resulting in essentialhypertension. ",hierarchyLevel:6,children:[],index:"030701060103"},{text:" This helps to redirect the blood towards the brain, and thehigher blood pressure helps to overcome the higher cerebral vascularresistance.",hierarchyLevel:6,children:[],index:"030701060104"}],index:"0307010601"}],index:"03070106"}],index:"030701"},{text:" Treatment Targets for Hypertension",hierarchyLevel:3,children:[{text:" Targets",hierarchyLevel:4,children:[{text:" Sympathetic nervous system  continuous firing of sympatheticnervous system leads to hypertension",hierarchyLevel:5,children:[],index:"0307020000"},{text:" Renin  Angiotensin  Aldosterone System",hierarchyLevel:5,children:[],index:"0307020001"}],index:"03070200"},{text:" Summary Table  Receptors",hierarchyLevel:4,children:[],index:"03070201"},{text:" Summary Table  Hormones",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0307020200"},{text:" o",hierarchyLevel:5,children:[],index:"0307020201"}],index:"03070202"},{text:" Summary Table  Conflict Battles",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0307020300"}],index:"03070203"},{text:" Conclusions",hierarchyLevel:4,children:[{text:" Sympathetic release of adrenaline and noradrenaline increasesblood pressure",hierarchyLevel:5,children:[],index:"0307020400"},{text:" Inhibiting sympathetic lowers blood pressure",hierarchyLevel:5,children:[],index:"0307020401"}],index:"03070204"}],index:"030702"},{text:" Drugs for Hypertension",hierarchyLevel:3,children:[{text:" \u03b11 adrenoceptor antagonist",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Preventing binding to \u03b11 receptor prevents vasoconstriction,allow for vasodilation",hierarchyLevel:6,children:[],index:"030703000000"},{text:" Allow for decrease in total peripheral resistance, allow fordecrease in mean arterial pressure",hierarchyLevel:6,children:[],index:"030703000001"}],index:"0307030000"},{text:" Net Effect",hierarchyLevel:5,children:[{text:" Reduction in mean arterial pressure",hierarchyLevel:6,children:[],index:"030703000100"}],index:"0307030001"},{text:" Example",hierarchyLevel:5,children:[{text:" Prazosin",hierarchyLevel:6,children:[],index:"030703000200"}],index:"0307030002"}],index:"03070300"},{text:" \u03b2 adrenoceptor antagonist",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Preventing binding to \u03b21 receptor prevents positivechronotropy and inotropy, preventing increase in heart rate and increase incontractility.",hierarchyLevel:6,children:[],index:"030703010000"},{text:" This lowers heart rate and lowers stroke volume, hence loweringcardiac output.",hierarchyLevel:6,children:[],index:"030703010001"},{text:" Lowered cardiac output lowers mean arterial pressure",hierarchyLevel:6,children:[],index:"030703010002"}],index:"0307030100"},{text:" Net Effect",hierarchyLevel:5,children:[{text:" Lowered mean arterial pressure",hierarchyLevel:6,children:[],index:"030703010100"}],index:"0307030101"},{text:" Example",hierarchyLevel:5,children:[{text:" Propranolol",hierarchyLevel:6,children:[],index:"030703010200"}],index:"0307030102"}],index:"03070301"},{text:" Renin-angiotensin-aldosterone system (RAAS) inhibitors",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0307030200"},{text:" Mechanism  ACE Inhibitors (Captopril)",hierarchyLevel:5,children:[{text:" Angiotensin converting enzyme inhibitor prevents the formation ofangiotensin II from angiotensin I",hierarchyLevel:6,children:[],index:"030703020100"},{text:" Lack of angiotensin II prevents the binding to AT1 receptors,hence preventing vasoconstriction.",hierarchyLevel:6,children:[],index:"030703020101"},{text:" This allows for vasodilatation, allowing for the reduction in thetotal peripheral resistance, hence lowering the mean arterial pressure.",hierarchyLevel:6,children:[],index:"030703020102"}],index:"0307030201"},{text:" Mechanism  Angiotensin II receptor antagonists",hierarchyLevel:5,children:[{text:" Preventing binding of angiotensin II to AT receptors, hencepreventing vasoconstriction and salt retention.",hierarchyLevel:6,children:[],index:"030703020200"}],index:"0307030202"},{text:" Mechanism  Aldosterone antagonists / analogs (spironolactone)",hierarchyLevel:5,children:[{text:" Prevent aldosterone secretion, preventing increased waterreabsorption, preventing increase in the blood volume, prevent increase inblood pressure.",hierarchyLevel:6,children:[],index:"030703020300"}],index:"0307030203"}],index:"03070302"},{text:" Ca  channel blockers (Minoxidil)",hierarchyLevel:4,children:[{text:" Understanding",hierarchyLevel:5,children:[{text:" K  - ATP channels  binding of ATP to the potassiumchannel prevents it from opening",hierarchyLevel:6,children:[],index:"030703030000"}],index:"0307030300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0307030301"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Minoxidil prevents the binding of ATP to the K channel, resulting in the K  remaining open.",hierarchyLevel:6,children:[],index:"030703030200"},{text:" This leads to the outflow of K  ions outside the cell,resulting in the hyperpolarization of the cell.",hierarchyLevel:6,children:[],index:"030703030201"},{text:" Hyperpolarization of the cell results in the inability of thecell to reach threshold potential.",hierarchyLevel:6,children:[],index:"030703030202"},{text:" Therefore, voltage-gated Ca  channels is unable toopen and Ca  ions are unable to enter the cell.",hierarchyLevel:6,children:[],index:"030703030203"},{text:" As a result, there is no Ca  ions to stimulatecontraction, resulting in vasodilation, and hence decrease in the totalperipheral resistance and hence decrease in the mean arterial blood pressure.",hierarchyLevel:6,children:[],index:"030703030204"}],index:"0307030302"}],index:"03070303"},{text:" Nitric oxide donors",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Addition of nitric oxide donors results in it breaking down andreleasing nitric oxide in the vasculature.",hierarchyLevel:6,children:[],index:"030703040000"},{text:" Nitric oxide activates soluble guanylate cyclase which convertsguanosine triphosphate into cyclic guanosine monophosphate.",hierarchyLevel:6,children:[],index:"030703040001"},{text:" Cyclic guanosine monophosphate stimulates smooth musclerelaxation, resulting in vasodilatation.",hierarchyLevel:6,children:[],index:"030703040002"},{text:" This results in a decrease in the total peripheral resistance andhence decrease in the mean arterial blood pressure.",hierarchyLevel:6,children:[],index:"030703040003"}],index:"0307030400"}],index:"03070304"},{text:" Summary",hierarchyLevel:4,children:[],index:"03070305"}],index:"030703"}],index:"0307"},{text:" [058] Simulated physiology  hypovolaemia",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Describe and understand the relationship between cardiac output,stroke volume and heart rate",hierarchyLevel:4,children:[],index:"03080000"},{text:" Describe and understand the relationship between mean arterialpressure, cardiac output and total peripheral resistance",hierarchyLevel:4,children:[],index:"03080001"},{text:" Describe and understand the normal mechanisms of blood pressureregulation, and how these act in response to haemorrhage",hierarchyLevel:4,children:[],index:"03080002"}],index:"030800"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Hypovolaemia  reduction in the volume of blood of intravascularcirculating volume",hierarchyLevel:5,children:[],index:"0308010000"}],index:"03080100"},{text:" Causes of Hypovolaemia",hierarchyLevel:4,children:[{text:" Loss of blood via trauma and bleeding",hierarchyLevel:5,children:[],index:"0308010100"},{text:" Dehydration by diarrhoea and vomiting",hierarchyLevel:5,children:[],index:"0308010101"}],index:"03080101"},{text:" Deriving calculations",hierarchyLevel:4,children:[{text:" Stroke Volume = ECG (End diastolic volume)  ECG (End systolicvolume)",hierarchyLevel:5,children:[],index:"0308010200"},{text:" Cardiac Output = Stroke Volume x Heart Rate",hierarchyLevel:5,children:[],index:"0308010201"},{text:" MAP = CO x TPR",hierarchyLevel:5,children:[],index:"0308010202"}],index:"03080102"}],index:"030801"},{text:" Hypovolaemia",hierarchyLevel:3,children:[{text:" Mechanisms of Hypovolaemia",hierarchyLevel:4,children:[{text:" Due to low blood volume, there is decreased venous return of theheart, resulting in lower preload. ",hierarchyLevel:5,children:[],index:"0308020000"},{text:" This results in lowered force of contraction of the heart,resulting in lowered cardiac output.",hierarchyLevel:5,children:[],index:"0308020001"},{text:" Lower cardiac output results in lower mean arterial pressure.",hierarchyLevel:5,children:[],index:"0308020002"},{text:" Lower mean arterial pressure results in hypoperfusion (lack ofblood flow), this results in less supply or oxygen and nutrients and lessability to remove waste supply. ",hierarchyLevel:5,children:[],index:"0308020003"},{text:" This leads to damage to the organs, resulting in organ failure.Severe organ failure leads to death",hierarchyLevel:5,children:[],index:"0308020004"}],index:"03080200"},{text:" Diagram",hierarchyLevel:4,children:[],index:"03080201"},{text:" Mechanism of Response to Hypovolaemia",hierarchyLevel:4,children:[{text:" Formula",hierarchyLevel:5,children:[{text:" CO = SV x HR",hierarchyLevel:6,children:[],index:"030802020000"},{text:" MAP = CO x TPR",hierarchyLevel:6,children:[],index:"030802020001"}],index:"0308020200"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Increase heart rate to make up for the reduced stroke volume",hierarchyLevel:6,children:[],index:"030802020100"},{text:" Increase total peripheral resistance to make up for reducedcardiac output",hierarchyLevel:6,children:[],index:"030802020101"}],index:"0308020201"}],index:"03080202"},{text:" Mechanism of Blood Pressure Monitoring",hierarchyLevel:4,children:[{text:" Baroreceptors",hierarchyLevel:5,children:[{text:" General Mechanism",hierarchyLevel:6,children:[{text:" Arterial baroreceptors detect the degree of stretch in the aortaand carotid sinus",hierarchyLevel:7,children:[],index:"03080203000000"},{text:" Changes in blood pressure engage the autonomic nervous system tooppose the change",hierarchyLevel:7,children:[],index:"03080203000001"}],index:"030802030000"},{text:" Parasympathetic Mechanism",hierarchyLevel:6,children:[{text:" Stimulation of the baroreceptors results in decreased activationof the parasympathetic system, and hence there is decreased vagal output to theheart.",hierarchyLevel:7,children:[],index:"03080203000100"},{text:" Decreased vagal output to the heart results in less acetylcholinebeing released from the parasympathetic postganglionic neuron.",hierarchyLevel:7,children:[],index:"03080203000101"},{text:" This results in lowered rate of firing of the SA node and hencedecreased heart rate.",hierarchyLevel:7,children:[],index:"03080203000102"}],index:"030802030001"},{text:" Sympathetic Mechanism",hierarchyLevel:6,children:[{text:" Stimulation of the baroreceptors results in increased activationof the sympathetic nervous system, and hence there is increased sympatheticoutput to the heart.",hierarchyLevel:7,children:[],index:"03080203000200"},{text:" Increase sympathetic output to the heart results in moreadrenaline being released by the postganglionic neuron.",hierarchyLevel:7,children:[],index:"03080203000201"},{text:" This results in the steepness of the slope of depolarization,which causes increased rate of firing of the SA node, causing positivechronotropy and hence increased heart rate.",hierarchyLevel:7,children:[],index:"03080203000202"},{text:" Additionally, binding of adrenaline to \u03b21-adrenoreceptors incardiac myocytes results positive inotropy, resulting in an increase in thecontractility of the heart, resulting in increased stroke volume.",hierarchyLevel:7,children:[],index:"03080203000203"},{text:" Moreover, binding of adrenaline to \u03b21-adrenoreceptors in theblood vessels via peripheral stimulation results in venous contraction andarterial contraction. Venous contraction results in increased venous return,which increases preload and hence increases stroke volume. Arterial contractionresults in increased total peripheral resistance and hence increases meanarterial pressure.",hierarchyLevel:7,children:[],index:"03080203000204"}],index:"030802030002"},{text:" Overall Net Effect",hierarchyLevel:6,children:[{text:" Increases in heart rate and stroke volume increases cardiac output",hierarchyLevel:7,children:[],index:"03080203000300"},{text:" Increases in cardiac output and total peripheral resistanceincreases mean arterial pressure.",hierarchyLevel:7,children:[],index:"03080203000301"}],index:"030802030003"},{text:" Diagram",hierarchyLevel:6,children:[],index:"030802030004"}],index:"0308020300"},{text:" Kidneys",hierarchyLevel:5,children:[{text:" General Mechanism",hierarchyLevel:6,children:[{text:" Hypovolaemia activates RAAS, resulting in the release ofangiotensin II.",hierarchyLevel:7,children:[],index:"03080203010000"},{text:" Angiotensin II stimulates production of aldosterone, whichincreases salt and water retention.",hierarchyLevel:7,children:[],index:"03080203010001"},{text:" Angiotensin II results in vasocontrictoin.",hierarchyLevel:7,children:[],index:"03080203010002"},{text:" Mechanisms via the ADH axis results in increased water retentionand arteriole contraction.",hierarchyLevel:7,children:[],index:"03080203010003"},{text:" Mechanisms via the stress response pathway increases cardiaccontractility, and stimulates arterial vasoconstriction, and salt and waterretention.",hierarchyLevel:7,children:[],index:"03080203010004"}],index:"030802030100"},{text:" Overall Net Effect",hierarchyLevel:6,children:[{text:" Increase in salt and water retention results in increase bloodvolume and hence increased preload and increased stroke volume and increasedcardiac output.",hierarchyLevel:7,children:[],index:"03080203010100"},{text:" Vasoconstriction results in increase in total peripheralresistance.",hierarchyLevel:7,children:[],index:"03080203010101"},{text:" Increase in cardiac output and increase in total peripheralresistance results in an increase in mean arterial pressure.",hierarchyLevel:7,children:[],index:"03080203010102"}],index:"030802030101"},{text:" Diagram",hierarchyLevel:6,children:[],index:"030802030102"}],index:"0308020301"}],index:"03080203"},{text:" Fluid Shifts in Hypovolaemia",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" In a healthy human being, the hydrostatic pressure of water inwanting to move out of the blood vessel is equal to the oncotic pressure ofwater wanting to move into the cell due to the osmolality.",hierarchyLevel:6,children:[],index:"030802040000"},{text:" However, due to hypovolaemia, there is lowered flow of blood andlowered blood pressure. As a result the hydrostatic pressure of blood is lowerthan the oncotic pressure.",hierarchyLevel:6,children:[],index:"030802040001"},{text:" As the hydrostatic pressure is unable to resist the oncoticpressure, resulting in fluid moving into the capillary, diluting the blood.",hierarchyLevel:6,children:[],index:"030802040002"},{text:" After the movement of fluid into the capillaries, the hydrostaticpressure will increase and the oncotic pressure will decrease (due to lowerosmolality). When the hydrostatic and oncotic pressures are balanced fluidmovement will stop.",hierarchyLevel:6,children:[],index:"030802040003"}],index:"0308020400"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0308020401"}],index:"03080204"},{text:" Summary",hierarchyLevel:4,children:[],index:"03080205"}],index:"030802"}],index:"0308"}]},{text:"Respiratory System",hierarchyLevel:1,children:[{text:" [017] Factors influencing Gas Exchange",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Conducting zone  nose \u2192 trachea \u2192 main bronchi\u2192 terminal bronchi (dead space)",hierarchyLevel:5,children:[],index:"0400000000"},{text:" Respiratory zone  alveoli",hierarchyLevel:5,children:[],index:"0400000001"},{text:" Pa   partial pressure of oxygen",hierarchyLevel:5,children:[],index:"0400000002"}],index:"04000000"},{text:" Ficks Law on Rate of Diffusion",hierarchyLevel:4,children:[{text:" Components",hierarchyLevel:5,children:[{text:" Tissue Area (A) \u221d Rate",hierarchyLevel:6,children:[],index:"040000010000"},{text:" Diffusion constant (D)  the rate of diffusion of the gas andsolubility of gas \u221d Rate",hierarchyLevel:6,children:[],index:"040000010001"},{text:" Difference in partial pressures (P1  P2) \u221d Rate",hierarchyLevel:6,children:[],index:"040000010002"},{text:" Tissue thickness (T) \u221d 1 / Rate",hierarchyLevel:6,children:[],index:"040000010003"}],index:"0400000100"},{text:" Formula",hierarchyLevel:5,children:[],index:"0400000101"}],index:"04000001"}],index:"040000"},{text:" Determining Factors",hierarchyLevel:3,children:[{text:" Respiratory Factors affecting gaseous exchange",hierarchyLevel:4,children:[{text:" Diffusion limitation",hierarchyLevel:5,children:[],index:"0400010000"},{text:" Decreased P  high altitude",hierarchyLevel:5,children:[],index:"0400010001"},{text:" Hypoventilation  reduction of ventilation by  half doubles theamount of carbon dioxide  in the blood, andaccumulation of carbon dioxide in the alveoli",hierarchyLevel:5,children:[],index:"0400010002"},{text:" Right-to-left shunt / shunt-like effect  blood bypassing of thelungs / alveoli, resulting in no gas exchange, blood passing the lungs normallybut no gaseous exchange taking place",hierarchyLevel:5,children:[],index:"0400010003"},{text:" Ventilation/perfusion inequality  ventilated but no bloodsupply, with blood supply but no ventilation",hierarchyLevel:5,children:[],index:"0400010004"}],index:"04000100"},{text:" Transfer Factor (TF ) Determinants ",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Transfer factor is a test of the diffusing capacity of the lungsfor gases like oxygen, carbon dioxide, and carbon monoxide",hierarchyLevel:6,children:[],index:"040001010000"}],index:"0400010100"},{text:" Factors",hierarchyLevel:5,children:[{text:" Reduced ventilation  pulmonary oedema",hierarchyLevel:6,children:[],index:"040001010100"},{text:" Reduced perfusion (blood flow)  pulmonary embolism",hierarchyLevel:6,children:[],index:"040001010101"},{text:" Reduced lung area  pneumonectomy (surgical remove of lung)",hierarchyLevel:6,children:[],index:"040001010102"},{text:" Reduced haemoglobin  anaemia",hierarchyLevel:6,children:[],index:"040001010103"},{text:" Increased cardiac output  exercise",hierarchyLevel:6,children:[],index:"040001010104"},{text:" Increased haemoglobin  alveolar haemorrhage, polycythaemia ",hierarchyLevel:6,children:[],index:"040001010105"}],index:"0400010101"}],index:"04000101"},{text:" Factors affecting Oxygen Delivery to Tissues",hierarchyLevel:4,children:[{text:" Oxygen content of blood  P , haemoglobinconcentration",hierarchyLevel:5,children:[],index:"0400010200"},{text:" Cardiac output  stroke volume, heart rate",hierarchyLevel:5,children:[],index:"0400010201"},{text:" Blood vessels  plumbing",hierarchyLevel:5,children:[],index:"0400010202"}],index:"04000102"},{text:" Measuring  Gas Exchan ge",hierarchyLevel:4,children:[{text:" Principle",hierarchyLevel:5,children:[{text:" To measure the rate of gas exchange in the lungs, measure therate of diffusion of Carbon Monoxide into the blood",hierarchyLevel:6,children:[],index:"040001030000"}],index:"0400010300"},{text:" Reason for Choice of Carbon Monoxide",hierarchyLevel:5,children:[{text:" Highly soluble gas and diffuse rapidly across the membrane",hierarchyLevel:6,children:[],index:"040001030100"},{text:" High partial pressure generated through testing systemadministration, high pressure gradient (no carbon monoxide in blood)",hierarchyLevel:6,children:[],index:"040001030101"},{text:" Highly bound to haemoglobin and carried away, ensuring no buildup of carbon monoxide partial pressure, preventing the reaching of partialpressure equilibrium",hierarchyLevel:6,children:[],index:"040001030102"}],index:"0400010301"}],index:"04000103"}],index:"040001"},{text:" Ventilation and Perfusion",hierarchyLevel:3,children:[{text:" Ventilation and Perfusion",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" V  gas flow",hierarchyLevel:6,children:[],index:"040002000000"},{text:" Q  blood flow",hierarchyLevel:6,children:[],index:"040002000001"},{text:" Deadspace  V normal / low Q",hierarchyLevel:6,children:[],index:"040002000002"},{text:" Shunt  V low / normal Q",hierarchyLevel:6,children:[],index:"040002000003"}],index:"0400020000"},{text:" Explanations",hierarchyLevel:5,children:[{text:" Deadspace  Tidal volume (air) does not come into contact withperfused areas",hierarchyLevel:6,children:[],index:"040002000100"},{text:" Shunt  Cardiac output bypasses ventilated alveoli",hierarchyLevel:6,children:[],index:"040002000101"}],index:"0400020001"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0400020002"}],index:"04000200"},{text:" Unequal of Alveolar Ventilation",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Alveoli at the base of the lung is compressed by the mass on top(gravity), resulting in high transpulmonary pressure. Therefore, the volume ofthe alveoli at the base of the lungs is much smaller in the exhaled state.",hierarchyLevel:6,children:[],index:"040002010000"},{text:" Alveoli at the apex of the lung is not very compressed as thereis little mass above it. This results in lower transpulmonary pressure.Therefore, the volume of the alveoli at the apex of the lung is larger than thealveoli at the base of the lung.",hierarchyLevel:6,children:[],index:"040002010001"},{text:" During inspiration, the alveoli at the base of the lung willexpand must more in % volume compared to the alveoli at the apex of the lungs(due to its smaller starting volume). Therefore, alveoli at the base of thelungs takes in more new air compared to alveoli at the top of the lungs.",hierarchyLevel:6,children:[],index:"040002010002"},{text:" Due to the differential increase in volumes, the base of thelungs moves outwards and upwards much more than the apex of the lungs.",hierarchyLevel:6,children:[],index:"040002010003"}],index:"0400020100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0400020101"}],index:"04000201"},{text:" Unequal Alveolar Perfusion (blood flow)",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Alveoli at the base of the lung is compressed by the mass on top,resulting in high transpulmonary pressure. Therefore, the volume of the alveoliat the base of the lungs is much smaller in the exhaled state. Due to thesmaller volume of alveoli, the capillaries surrounding the alveoli is notcompressed. Therefore, there is lower resistance to blood flow in thecapillaries surrounding the alveoli at the base of the lungs",hierarchyLevel:6,children:[],index:"040002020000"},{text:" Alveoli at the apex of the lung is not very compressed as thereis little mass above it. This results in lower transpulmonary pressure.Therefore, the volume of the alveoli at the apex of the lung is larger than thealveoli at the base of the lung. Due to the larger volume of alveoli, thecapillaries surrounding the alveoli is compressed. Therefore, there is higherresistance to blood flow in the capillaries surrounding the alveoli at the apexof the lungs.",hierarchyLevel:6,children:[],index:"040002020001"},{text:" For blood flow to occur, the pressure of the arteries must begreater than the pressure exerted by the alveoli on the capillaries.",hierarchyLevel:6,children:[],index:"040002020002"}],index:"0400020200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0400020201"}],index:"04000202"},{text:" Unequal change in Alveolar Ventilation and Alveolar Perfusion",hierarchyLevel:4,children:[{text:" Truisms",hierarchyLevel:5,children:[{text:" Both  ventilation (V) and perfusion  (Q) increases down thelung (towards gravity)",hierarchyLevel:6,children:[],index:"040002030000"},{text:" Perfusion (Q) increases more than ventilation (V) down the lung",hierarchyLevel:6,children:[],index:"040002030001"},{text:" V/Q decreases down the lung",hierarchyLevel:6,children:[],index:"040002030002"}],index:"0400020300"},{text:" Effect of Positioning",hierarchyLevel:5,children:[{text:" Changes to V and Q and V/Q depends on the direction of force ofgravity.",hierarchyLevel:6,children:[],index:"040002030100"},{text:" Both V and Q increases towards the direction of gravity.",hierarchyLevel:6,children:[],index:"040002030101"}],index:"0400020301"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"040002030200"}],index:"0400020302"}],index:"04000203"},{text:" Recruitment and Distension",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" To ensure that there is low resistance within the pulmonarycapillaries to maintain a high cardiac output",hierarchyLevel:6,children:[],index:"040002040000"}],index:"0400020400"},{text:" Components",hierarchyLevel:5,children:[{text:" Recruitment  more blood capillaries are opened up for perfusion",hierarchyLevel:6,children:[],index:"040002040100"},{text:" Distension  more blood capillaries are closed off to preventperfusion",hierarchyLevel:6,children:[],index:"040002040101"}],index:"0400020401"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0400020402"},{text:" Regulatory Mechanism (Recruitment)",hierarchyLevel:5,children:[{text:" Parasympathetic nerves releases acetylcholine neurotransmitters.Acetylcholine neurotransmitters binds to the Muscarinic (M3) receptors on theendothelium.",hierarchyLevel:6,children:[],index:"040002040300"},{text:" This causes vasodilation, leading to recruitment and perfusion ofnew blood capillaries",hierarchyLevel:6,children:[],index:"040002040301"}],index:"0400020403"},{text:" Regulatory Mechanism (Distention)",hierarchyLevel:5,children:[{text:" Sympathetic nerves releases noradrenaline neurotransmitters.Noradrenaline binds to \u03b11 adrenal receptors on smooth muscle of arteriesand arterioles.",hierarchyLevel:6,children:[],index:"040002040400"},{text:" This causes vasoconstriction, leading to the closing off of bloodcapillaries to perfusion.",hierarchyLevel:6,children:[],index:"040002040401"},{text:" This prevents blood from flowing to areas without ventilation.",hierarchyLevel:6,children:[],index:"040002040402"}],index:"0400020404"},{text:" Regulatory Mechanism (Passive  recruitment and distention)",hierarchyLevel:5,children:[{text:" Pressure difference between extra and intra alveolar vesselsresults in recruitment or distention.",hierarchyLevel:6,children:[],index:"040002040500"}],index:"0400020405"}],index:"04000204"},{text:" Responses to Ventilation-Perfusion Inequalities",hierarchyLevel:4,children:[{text:" Hypoxic (low PO )  ensure blood flows to ventilatedarea",hierarchyLevel:5,children:[{text:" Vasocontraction of pulmonary arterioles to constrict blood awayfrom a shunt or poorly ventilated (hypoventilated) alveoli towards betterventilated alveoli",hierarchyLevel:6,children:[],index:"040002050000"}],index:"0400020500"},{text:" oHypocapnic (low PCO2)   ensure air flows toperfused area",hierarchyLevel:5,children:[{text:" Bronchoconstriction of bronchioles diverts ventilation away froma deadspace or poorly perfused (hyperventilated) alveoli towards alveoli thatare better perfused.",hierarchyLevel:6,children:[],index:"040002050100"}],index:"0400020501"}],index:"04000205"},{text:" Abnormal Function",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Hypoxia  deficiency in the amount of oxygen reaching the tissues(low PO in tissues)",hierarchyLevel:6,children:[],index:"040002060000"},{text:" Hypoxemia  the oxygen concentration within the arterial blood isabnormally low (low PO  in blood)",hierarchyLevel:6,children:[],index:"040002060001"},{text:" NOTE: possible to experience hypoxia without hypoxemia (cyanidepoisoning)",hierarchyLevel:6,children:[],index:"040002060002"}],index:"0400020600"},{text:" Pulmonary Hypertension",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Occurs over time due to chronic hypoxia, leading to chronicvasocontriction of pulmonary arterioles to contract blood away from poorlyventilated alveoli.",hierarchyLevel:7,children:[],index:"04000206010000"}],index:"040002060100"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Due to vasocontraction of pulmonary arterioles, the right side ofthe heart needs to pump harder into the lungs.",hierarchyLevel:7,children:[],index:"04000206010100"},{text:" Over time, this leads to right ventricle dilatation which leadsto right ventricular failure.",hierarchyLevel:7,children:[],index:"04000206010101"}],index:"040002060101"}],index:"0400020601"},{text:" Hypoxemic Hypoxia (Hypoxia + Hypoxemia)",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" Insufficient oxygen reaching the blood and tissues",hierarchyLevel:7,children:[],index:"04000206020000"}],index:"040002060200"},{text:" Cause",hierarchyLevel:6,children:[{text:" Low inspired PO  (due to altitude)",hierarchyLevel:7,children:[],index:"04000206020100"},{text:" Hypoventilation  slow breathing rate (opiates)",hierarchyLevel:7,children:[],index:"04000206020101"},{text:" Impairment of diffusion of O  into blood (fibrosis)",hierarchyLevel:7,children:[],index:"04000206020102"},{text:" Ventilation-perfusion inequalities ",hierarchyLevel:7,children:[{text:" Low V / normal Q  Right to left shunts",hierarchyLevel:8,children:[{text:" collapsed alveoli",hierarchyLevel:9,children:[],index:"040002060201030000"},{text:" pulmonary edema",hierarchyLevel:9,children:[],index:"040002060201030001"}],index:"0400020602010300"},{text:" Normal V / low Q",hierarchyLevel:8,children:[{text:" Apex under perfused  due to gravity",hierarchyLevel:9,children:[],index:"040002060201030100"}],index:"0400020602010301"}],index:"04000206020103"}],index:"040002060201"}],index:"0400020602"},{text:" Anaemic Hypoxia",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" Reduction of oxygen-carrying capacity of blood due to decreasedtotal haemoglobin or altered haemoglobin constituents, hence insufficientoxygen to tissues.",hierarchyLevel:7,children:[],index:"04000206030000"}],index:"040002060300"},{text:" Cause",hierarchyLevel:6,children:[{text:" Decreased concentration of functional haemoglobin ( PO2normal but low O2 content )",hierarchyLevel:7,children:[],index:"04000206030100"},{text:" Reduced number of erythrocytes (due to blood loss  haemorrhage)",hierarchyLevel:7,children:[],index:"04000206030101"}],index:"040002060301"}],index:"0400020603"},{text:" Stagnant Hypoxia",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" Inadequate blood flow leads to insufficient oxygen to tissues",hierarchyLevel:7,children:[],index:"04000206040000"}],index:"040002060400"},{text:" Cause",hierarchyLevel:6,children:[{text:" Inadequate blood flow",hierarchyLevel:7,children:[],index:"04000206040100"}],index:"040002060401"}],index:"0400020604"},{text:" Histotoxic Hypoxia",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" Impaired use of oxygen by tissues",hierarchyLevel:7,children:[],index:"04000206050000"}],index:"040002060500"},{text:" Cause",hierarchyLevel:6,children:[{text:" There is normal oxygen delivery to cells, but due to poisoning bycyanide, the tissues are unable to utilize the oxygen to carryout oxidativephosphorylation.",hierarchyLevel:7,children:[],index:"04000206050100"}],index:"040002060501"}],index:"0400020605"}],index:"04000206"}],index:"040002"},{text:" Pulmonary Vascular Resistance",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Intra-alveolar vasculature  capillaries surrounding the alveoli",hierarchyLevel:5,children:[],index:"0400030000"},{text:" Extra-alveolar vasculature  capillaries before and after thealveoli",hierarchyLevel:5,children:[],index:"0400030001"}],index:"04000300"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" During inhalation, entry of air causes the alveoli to expand,stretching the intra-alveolar capillaries and increasing the intra-alveolarpressure.",hierarchyLevel:5,children:[],index:"0400030100"},{text:" During inhalation, expansion of the thoracic cavity opens up morespace, causing the extra-alveolar pressure to decrease.",hierarchyLevel:5,children:[],index:"0400030101"},{text:" During exhalation, exit of air causes the alveoli to contract,decreasing the intra-alveolar pressure.",hierarchyLevel:5,children:[],index:"0400030102"},{text:" During exhalation, increase in thoracic cavity pressure causesextra-alveolar pressure to increase.",hierarchyLevel:5,children:[],index:"0400030103"}],index:"04000301"},{text:" Diagram",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0400030200"}],index:"04000302"}],index:"040003"},{text:" Oxygen Transport in blood",hierarchyLevel:3,children:[{text:" Table",hierarchyLevel:4,children:[],index:"04000400"},{text:" Mechanism of Oxygen Dissociation",hierarchyLevel:4,children:[{text:" As the blood moves away from the lungs, the partial pressure ofoxygen decreases. However, due to the flattening of the right side of theoxygen dissociation curve, haemoglobin affinity for oxygen remains very highand barely any oxygen is unloaded.",hierarchyLevel:5,children:[],index:"0400040100"},{text:" As the blood arrives at the tissues, the partial pressure ofoxygen decreases significantly. Due to the steep downward sloping portion ofthe oxygen dissociation curve, the oxygen affinity of haemoglobin decreasesdrastically. This causes the oxygen to dissociate with haemoglobin. Oxygen thendiffuses into the tissues and enters the cells.",hierarchyLevel:5,children:[],index:"0400040101"}],index:"04000401"},{text:" Effects of Shifts on Oxygen Dissociation Curve",hierarchyLevel:4,children:[{text:" A leftward shift in the oxygen dissociation curve causes thesteep portion of the oxygen dissociation curve to be only attained a loweroxygen partial pressure. This means that oxygen will only be unloaded far awayfrom the lungs or that the tissues must be severely lacking in oxygen foroxygen to be unloaded by haemoglobin.",hierarchyLevel:5,children:[],index:"0400040200"},{text:" A rightward shift in the oxygen dissocation curve causes thesteep portion of the oxygen dissociation curve to be attained at a higheroxygen partial pressure. This means that oxygen will start dissociating fromhaemoglobin even before the red blood cells reaches the tissues.",hierarchyLevel:5,children:[],index:"0400040201"}],index:"04000402"},{text:" Factors causing Shifts on Oxygen Dissociation Curve",hierarchyLevel:4,children:[{text:" Rightward Shift  decreased Hb affinity for O  (dissociatefaster)",hierarchyLevel:5,children:[{text:" Increase partial pressure of carbon dioxide",hierarchyLevel:6,children:[],index:"040004030000"},{text:" Decreased pH",hierarchyLevel:6,children:[],index:"040004030001"},{text:" Increased temperature",hierarchyLevel:6,children:[],index:"040004030002"},{text:" Increased DPG (2,3-disphosphoglycerate)",hierarchyLevel:6,children:[],index:"040004030003"}],index:"0400040300"},{text:" Leftward Shift  increased Hb affinity for O (dissociate slower)",hierarchyLevel:5,children:[{text:" Decrease partial pressure of carbon dioxide",hierarchyLevel:6,children:[],index:"040004030100"},{text:" Increased pH",hierarchyLevel:6,children:[],index:"040004030101"},{text:" Decreased temperature",hierarchyLevel:6,children:[],index:"040004030102"},{text:" Decreased DPG (2,3-disphosphoglycerate)",hierarchyLevel:6,children:[],index:"040004030103"}],index:"0400040301"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Lowered pH (H  ions) reduces in lower Hb affinity forO",hierarchyLevel:6,children:[],index:"040004030200"},{text:" Increasing partial pressure of carbon dioxide results in thelowering of the pH due to the acidic nature of carbon dioxide. Lowered pHresults in lowered Hb affinity.",hierarchyLevel:6,children:[],index:"040004030201"},{text:" Increased temperature increases the vibrations and kinetic energyand hence higher chance of dissociations.",hierarchyLevel:6,children:[],index:"040004030202"},{text:" DPG lowers Hb affinity for O  (mechanism stated in[015])",hierarchyLevel:6,children:[],index:"040004030203"}],index:"0400040302"}],index:"04000403"}],index:"040004"},{text:" Circulatory System",hierarchyLevel:3,children:[{text:" Types",hierarchyLevel:4,children:[{text:" Pulmonary Circulation",hierarchyLevel:5,children:[],index:"0400050000"},{text:" Systemic Circulation",hierarchyLevel:5,children:[],index:"0400050001"}],index:"04000500"},{text:" Comparison",hierarchyLevel:4,children:[{text:" Table",hierarchyLevel:5,children:[],index:"0400050100"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Formulas",hierarchyLevel:6,children:[{text:" Blood pressure = Cardiac Output x Total Peripheral resistance",hierarchyLevel:7,children:[],index:"04000501010000"},{text:" Cardiac Output = Blood Pressure / Total Peripheral resistance",hierarchyLevel:7,children:[],index:"04000501010001"}],index:"040005010100"},{text:" Understanding",hierarchyLevel:6,children:[{text:" There is low blood pressure to not absolutely destroy thepulmonary capillaries.",hierarchyLevel:7,children:[],index:"04000501010100"},{text:" To achieve a high cardiac output with a low blood pressure, theremust be very low peripheral resistance",hierarchyLevel:7,children:[],index:"04000501010101"}],index:"040005010101"}],index:"0400050101"}],index:"04000501"}],index:"040005"}],index:"0400"},{text:" [018] Control of Ventilation",hierarchyLevel:2,children:[{text:" Learning Objectives",hierarchyLevel:3,children:[{text:" Describe where and how ventilation is initiated",hierarchyLevel:4,children:[],index:"04010000"},{text:" Describe the factors that influence ventilatory control",hierarchyLevel:4,children:[],index:"04010001"},{text:" Discuss the roles of CO  and O  in thecontrol of breathing",hierarchyLevel:4,children:[],index:"04010002"}],index:"040100"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Components of Ventilation Control System",hierarchyLevel:4,children:[{text:" Central Controller",hierarchyLevel:5,children:[],index:"0401010000"},{text:" Effectors",hierarchyLevel:5,children:[],index:"0401010001"},{text:" Sensors",hierarchyLevel:5,children:[],index:"0401010002"}],index:"04010100"},{text:" Overall Mechanism",hierarchyLevel:4,children:[{text:" Cortex fires action potentials to control breathing",hierarchyLevel:5,children:[{text:" Disruptors / Overtakes",hierarchyLevel:6,children:[{text:" Voluntary control of breathing via pyramidal tracts",hierarchyLevel:7,children:[],index:"04010101000000"},{text:" Hypothalamus control due to emotion and temperature",hierarchyLevel:7,children:[],index:"04010101000001"}],index:"040101010000"}],index:"0401010100"},{text:" Action potentials are carried by descending respiratory motorneurons to diaphragm, intercostals and ancillary respiratory muscles",hierarchyLevel:5,children:[],index:"0401010101"},{text:" Chemoreceptors detect the changes in CO  and O in the blood and sends a signal to the medulla.",hierarchyLevel:5,children:[],index:"0401010102"}],index:"04010101"},{text:" Diagram",hierarchyLevel:4,children:[],index:"04010102"}],index:"040101"},{text:" Central Chemoreceptors (CC)",hierarchyLevel:3,children:[{text:" Location",hierarchyLevel:4,children:[{text:" Ventral medulla",hierarchyLevel:5,children:[],index:"0401020000"}],index:"04010200"},{text:" Purpose",hierarchyLevel:4,children:[{text:" Monitor the chemical composition of arterial blood to ensure themaintenance of homeostasis of O  and CO  concentration",hierarchyLevel:5,children:[],index:"0401020100"}],index:"04010201"},{text:" Stimulus",hierarchyLevel:4,children:[{text:" [H ]",hierarchyLevel:5,children:[],index:"0401020200"}],index:"04010202"},{text:" Understanding",hierarchyLevel:4,children:[{text:" H  and HCO  ions are unable topass through the blood brain barrier",hierarchyLevel:5,children:[],index:"0401020300"},{text:" CO  can pass through the blood brain barrier",hierarchyLevel:5,children:[],index:"0401020301"}],index:"04010203"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" When the concentration of CO  is high, CO diffuses across the blood brain barrier into the extracellular fluid and thecerebrospinal fluid (CSF).",hierarchyLevel:5,children:[],index:"0401020400"},{text:" CO  in the CSF combines with H O toform carbonic acid which dissociates with H  ions and hydrogencarbonate ions.",hierarchyLevel:5,children:[],index:"0401020401"},{text:" Due to the lack of pH buffers in the CSF, a small change in thepartial pressure of CO  results in a large change in theconcentration of H  ions and hence a significant decrease in pH.",hierarchyLevel:5,children:[],index:"0401020402"},{text:" Higher concentration of H  ions is detected by thechemoreceptor, which stimulates the response of increasing ventilation rate.",hierarchyLevel:5,children:[],index:"0401020403"},{text:" Increased ventilation rate results in CO  beingremoved from the body, reestablishing normal PaCO  and eventuallyresulting in the rise in the pH levels again. ",hierarchyLevel:5,children:[],index:"0401020404"}],index:"04010204"},{text:" Diagram",hierarchyLevel:4,children:[],index:"04010205"},{text:" Experiment",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Normal PaCO  = 35mmHg (4.6kPa)",hierarchyLevel:6,children:[],index:"040102060000"},{text:" Normal PaO  = 100mmHg (13.3kPa)",hierarchyLevel:6,children:[],index:"040102060001"}],index:"0401020600"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0401020601"},{text:" Results",hierarchyLevel:5,children:[{text:" 1mmHg rise in PCO  increases ventilation rate by2-3L/min",hierarchyLevel:6,children:[],index:"040102060200"},{text:" Hypoxia (low PaO ) increases sensitivity to PaCO due to synergistic effect of hypoxia (vasoconstriction) and hypercapnia(bronchoconstriction)",hierarchyLevel:6,children:[],index:"040102060201"},{text:" Sleep, respiratory depressants and high PaCO  reducessensitivity to PaCO",hierarchyLevel:6,children:[],index:"040102060202"}],index:"0401020602"}],index:"04010206"},{text:" Chronic Lung Disease",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" High PCO  results in the increase in ventilation rate.",hierarchyLevel:6,children:[],index:"040102070000"},{text:" However, due to chronic lung disease, increasing ventilation isnot effective in reducing PaCO .",hierarchyLevel:6,children:[],index:"040102070001"},{text:" After a few hours, the body transports HCO is transported into the cerebrospinal fluid in response.",hierarchyLevel:6,children:[],index:"040102070002"},{text:" Addition of HCO  shifts the position ofequilibrium towards the left, resulting in HCO  ionscombining with H  ions to form H CO , hencedecreasing the CSF pH to a normal level.",hierarchyLevel:6,children:[],index:"040102070003"},{text:" This enables a higher tolerate of higher CO  levels,without an extreme response in ventilation rate.",hierarchyLevel:6,children:[],index:"040102070004"}],index:"0401020700"}],index:"04010207"}],index:"040102"},{text:" Peripheral chemoreceptors (PC)",hierarchyLevel:3,children:[{text:" Location",hierarchyLevel:4,children:[{text:" Aortic bodies",hierarchyLevel:5,children:[],index:"0401030000"},{text:" Aorta",hierarchyLevel:5,children:[],index:"0401030001"},{text:" Internal/External carotid artery",hierarchyLevel:5,children:[],index:"0401030002"},{text:" Carotid bodies",hierarchyLevel:5,children:[],index:"0401030003"},{text:" Carotid artery",hierarchyLevel:5,children:[],index:"0401030004"}],index:"04010300"},{text:" Stimulus",hierarchyLevel:4,children:[{text:" PaO",hierarchyLevel:5,children:[],index:"0401030100"},{text:" PaCO  / H  (lesser extent)",hierarchyLevel:5,children:[],index:"0401030101"}],index:"04010301"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" Lowered PaO  results in increases ventilation rate inseconds",hierarchyLevel:5,children:[],index:"0401030200"}],index:"04010302"},{text:" Experimentation",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0401030300"},{text:" Analysis",hierarchyLevel:5,children:[{text:" Non-linear relationship between ventilation rate an PO",hierarchyLevel:6,children:[],index:"040103030100"},{text:" Requires a very low PO  to have an effect onventilation rate, as only at very low PO   oxygen dissociates withhaemoglobin",hierarchyLevel:6,children:[],index:"040103030101"},{text:" Elevated PaCO  increases the sensitivity ofventilation of PO , due to synergistic effect of hypoxia(vasoconstriction) and hypercapnia (bronchoconstriction)",hierarchyLevel:6,children:[],index:"040103030102"}],index:"0401030301"}],index:"04010303"},{text:" Response to pH",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0401030400"},{text:" Mechanism (low pH)",hierarchyLevel:5,children:[{text:" Low pH levels due to metabolic acidosis  causes a rightward shiftin the CO -ventilation curve.",hierarchyLevel:6,children:[],index:"040103040100"},{text:" As a result, even at a lower PCO , a higherventilation rate can be attained.",hierarchyLevel:6,children:[],index:"040103040101"},{text:" Increased ventilation rate results in a reduction of PaCO in the blood, which causes the pH to rise slightly, hence compensating formetabolic acidosis.",hierarchyLevel:6,children:[],index:"040103040102"}],index:"0401030401"},{text:" Mechanism (high pH)",hierarchyLevel:5,children:[{text:" High pH levels due to metabolic alkalosis causes a leftward shiftin the CO -ventilation curve.",hierarchyLevel:6,children:[],index:"040103040200"},{text:" As a result, even at a higher PCO , only a lowerventilation rate is achieved.",hierarchyLevel:6,children:[],index:"040103040201"},{text:" Lowered ventilation rate results in a increase of PaCO in the blood, which causes the pH to fall slightly, hence compensating formetabolic alkalosis.",hierarchyLevel:6,children:[],index:"040103040202"}],index:"0401030402"}],index:"04010304"}],index:"040103"},{text:" Other receptors",hierarchyLevel:3,children:[{text:" Pulmonary Stretch receptors",hierarchyLevel:4,children:[{text:" Location",hierarchyLevel:5,children:[{text:" Airway smooth muscle",hierarchyLevel:6,children:[],index:"040104000000"}],index:"0401040000"},{text:" Mechanism (Hering-Breuer reflex)  COPD ",hierarchyLevel:5,children:[{text:" Hyperinflation of the lungs is detected by pulmonary stretchreceptors",hierarchyLevel:6,children:[],index:"040104000100"},{text:" Pulmonary stretch receptors cause  shallower and shorterinspiratio n.",hierarchyLevel:6,children:[],index:"040104000101"}],index:"0401040001"}],index:"04010400"},{text:" Airway / irritant receptors",hierarchyLevel:4,children:[{text:" Location",hierarchyLevel:5,children:[{text:" Epithelial cells of upper and lower airways",hierarchyLevel:6,children:[],index:"040104010000"}],index:"0401040100"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Inhalation of noxious agents is detected by airway / irritantreceptors.",hierarchyLevel:6,children:[],index:"040104010100"},{text:" Irritant receptors cause bronchoconstriction and laryngealconstriction, hypoventilation, coughing and sneezing",hierarchyLevel:6,children:[],index:"040104010101"}],index:"0401040101"}],index:"04010401"},{text:" Juxtapulmonary (J) receptors",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Pulmonary vascular congestion  results in increasedrespiratory rate.",hierarchyLevel:6,children:[],index:"040104020000"},{text:" This causes breathlessness in heart failure.",hierarchyLevel:6,children:[],index:"040104020001"}],index:"0401040200"}],index:"04010402"},{text:" Other Sensors",hierarchyLevel:4,children:[{text:" Joint and muscle proprioceptors  moving limbs stimulatesventilation",hierarchyLevel:5,children:[],index:"0401040300"},{text:" Temperature effects  skin heating stimulates ventilation",hierarchyLevel:5,children:[],index:"0401040301"},{text:" Pain  results in brief apnoea (cessation of ventilation)followed by hyperventilation",hierarchyLevel:5,children:[],index:"0401040302"},{text:" Diving reflex  face immersion in cold water results in cessationof ventilation and decreased heart rate",hierarchyLevel:5,children:[],index:"0401040303"}],index:"04010403"},{text:" Responses to Exercise",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Exercise increases venous PaCO .",hierarchyLevel:6,children:[],index:"040104040000"},{text:" A mixture of neural and temperature/muscle stretch receptorsdetects the effects of exercise.",hierarchyLevel:6,children:[],index:"040104040001"},{text:" Neural and temperature/muscle stretch receptors increaseventilation rate immediately and matches the increase O  uptake andCO  output",hierarchyLevel:6,children:[],index:"040104040002"},{text:" Increased ventilation rate results in arterial PaCO to remain at a constant level.",hierarchyLevel:6,children:[],index:"040104040003"}],index:"0401040400"},{text:" Property",hierarchyLevel:5,children:[{text:" Ventilation is not a limiting factor",hierarchyLevel:6,children:[],index:"040104040100"},{text:" Cardiac output is the limiting factor",hierarchyLevel:6,children:[],index:"040104040101"}],index:"0401040401"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"040104040200"}],index:"0401040402"}],index:"04010404"}],index:"040104"}],index:"0401"},{text:" [019] Acid-base Balance",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Importance of Acid-base balance in the body",hierarchyLevel:4,children:[{text:" Deviation from normal pH causes reduced oxygen delivery totissues",hierarchyLevel:5,children:[],index:"0402000000"},{text:" Deviation from normal pH causes electrolyte disturbances andchanges in heart muscle contractility",hierarchyLevel:5,children:[],index:"0402000001"}],index:"04020000"},{text:" Definitions",hierarchyLevel:4,children:[{text:" Acid  molecule capable of donating a proton ",hierarchyLevel:5,children:[],index:"0402000100"},{text:" Base  capable of accepting a proton",hierarchyLevel:5,children:[],index:"0402000101"},{text:" pH  -log [H ]",hierarchyLevel:5,children:[],index:"0402000102"},{text:" Buffers  weak acid and conjugate base",hierarchyLevel:5,children:[],index:"0402000103"}],index:"04020001"},{text:" Numbers",hierarchyLevel:4,children:[{text:" pKa H CO  = 6.1",hierarchyLevel:5,children:[],index:"0402000200"}],index:"04020002"},{text:" Formulas",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0402000300"}],index:"04020003"}],index:"040200"},{text:" Maintenance of Buffer Solution",hierarchyLevel:3,children:[{text:" Lungs",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Removes CO  from the body depending on pH levels",hierarchyLevel:6,children:[],index:"040201000000"}],index:"0402010000"},{text:" Efficiency",hierarchyLevel:5,children:[{text:" Excrete 10 000 mEq of H CO  in 24 hours",hierarchyLevel:6,children:[],index:"040201000100"},{text:" Able to change acid base balance faster and in greater magnitude",hierarchyLevel:6,children:[],index:"040201000101"}],index:"0402010001"}],index:"04020100"},{text:" Kidney",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Production of HCO  and removal of H ions",hierarchyLevel:6,children:[],index:"040201010000"}],index:"0402010100"},{text:" Efficiency",hierarchyLevel:5,children:[{text:" Excrete 100 mEq of fixed acids in 24 hours",hierarchyLevel:6,children:[],index:"040201010100"},{text:" Less able to change acid base balance",hierarchyLevel:6,children:[],index:"040201010101"}],index:"0402010101"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Carbonic anhydrase in renal tubules cells converts carbon dioxideand water into carbonic acid",hierarchyLevel:6,children:[],index:"040201010200"},{text:" Carbonic acid dissociates to form HCO ions and H  ions",hierarchyLevel:6,children:[],index:"040201010201"},{text:" HCO  ions are reabsorbed into the blood.",hierarchyLevel:6,children:[],index:"040201010202"},{text:" H  ions pass into the lumen of the tubule and iseliminated from the body in urine.",hierarchyLevel:6,children:[],index:"040201010203"}],index:"0402010102"}],index:"04020101"},{text:" Diagram",hierarchyLevel:4,children:[],index:"04020102"}],index:"040201"},{text:" Types of Acid-base Disturbance",hierarchyLevel:3,children:[{text:" Davenport Diagram",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0402020000"},{text:" Trends",hierarchyLevel:5,children:[{text:" Increasing plasma HCO  increases the pH",hierarchyLevel:6,children:[],index:"040202000100"},{text:" Increasing PCO  causes a leftward shift in the graph",hierarchyLevel:6,children:[{text:" For the same HCO  concentration, the pH islower",hierarchyLevel:7,children:[],index:"04020200010100"}],index:"040202000101"}],index:"0402020001"},{text:" Interpretation",hierarchyLevel:5,children:[{text:" Red line ( CAB )  buffer line",hierarchyLevel:6,children:[],index:"040202000200"}],index:"0402020002"}],index:"04020200"},{text:" Types of Acid-base Disturbance Diagram",hierarchyLevel:4,children:[],index:"04020201"},{text:" Respiratory Acidosis",hierarchyLevel:4,children:[{text:" Causes",hierarchyLevel:5,children:[{text:" COPD, obesity, neuromuscular disorders, chest wall deformities,exhaustion, CNS depression following stroke / opioids, leads to the inabilityto meet respiratory needs and hence leading to respiratory acidosis.",hierarchyLevel:6,children:[],index:"040202020000"}],index:"0402020200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0402020201"},{text:" Mechanism (Disturbance)",hierarchyLevel:5,children:[{text:" Hypoventilation causes PCO  to rise significantly.Increase in PCO  results in the leftward shift of the curve,resulting in a significant decrease in pH.",hierarchyLevel:6,children:[],index:"040202020200"},{text:" However, increase in PCO  shifts the equilibrium tothe right and causes HCO  to rise slightly. This resultsin the right and upwards movement along the curve. This causes the pH toincrease slightly.",hierarchyLevel:6,children:[],index:"040202020201"},{text:" Overall, the is a slight decrease in pH with an increase in PCO and HCO . HCO  / PCO ratio falls and pH falls.",hierarchyLevel:6,children:[],index:"040202020202"}],index:"0402020202"},{text:" Mechanism (Reaction)",hierarchyLevel:5,children:[{text:" Kidney starts to produce more HCO  byabsorbance and via carbonic anhydrase.",hierarchyLevel:6,children:[],index:"040202020300"},{text:" Increase in HCO  results in the rightwardmovement along the curve.",hierarchyLevel:6,children:[],index:"040202020301"},{text:" This causes the pH to increase back to the original levels, andhence respiratory acidosis is compensated",hierarchyLevel:6,children:[],index:"040202020302"}],index:"0402020203"}],index:"04020202"},{text:" Respiratory alkalosis",hierarchyLevel:4,children:[{text:" Causes",hierarchyLevel:5,children:[{text:" Pulmonary embolism, salicylates, anxiety, stroke / CNS lesions,results in hyperventilation, resulting in respiratory alkalosis",hierarchyLevel:6,children:[],index:"040202030000"}],index:"0402020300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0402020301"},{text:" Mechanism (Disturbance)",hierarchyLevel:5,children:[{text:" Hyperventilation causes PCO  to fall significantly.Fall in PCO  results in the rightward shift of the curve, resultingin a significant increase in pH.",hierarchyLevel:6,children:[],index:"040202030200"},{text:" However, decrease in PCO  shifts the equilibrium tothe left and causes HCO  to fall slightly. This resultsin the left and downwards movement along the curve. This causes the pH to fallslightly.",hierarchyLevel:6,children:[],index:"040202030201"},{text:" Overall, the is a slight increase in pH with a decrease in PCO and HCO . HCO  / PCO ratio rises and pH rises.",hierarchyLevel:6,children:[],index:"040202030202"}],index:"0402020302"},{text:" Mechanism (Reaction)",hierarchyLevel:5,children:[{text:" Kidney starts to excrete more HCO .",hierarchyLevel:6,children:[],index:"040202030300"},{text:" Decrease in HCO  results in the left anddownward movement along the curve.",hierarchyLevel:6,children:[],index:"040202030301"},{text:" This causes the pH to decrease back to the original levels, andhence respiratory alkalosis is compensated",hierarchyLevel:6,children:[],index:"040202030302"}],index:"0402020303"}],index:"04020203"},{text:" Metabolic Acidosis",hierarchyLevel:4,children:[{text:" Causes",hierarchyLevel:5,children:[{text:" Increased acid production (diabetic ketoacidosis / hypoxia)",hierarchyLevel:6,children:[],index:"040202040000"},{text:" Loss of HCO",hierarchyLevel:6,children:[],index:"040202040001"},{text:" Inability of the kidney to excrete acid (chronic kidney disease)",hierarchyLevel:6,children:[],index:"040202040002"}],index:"0402020400"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0402020401"},{text:" Mechanism (Disturbance)",hierarchyLevel:5,children:[{text:" Tissue hypoxia/ketoacidosis causes HCO  tofall. This causes a left and downward movement along the curve, resulting in asignificant fall in pH.",hierarchyLevel:6,children:[],index:"040202040200"}],index:"0402020402"},{text:" Mechanism (Reaction)",hierarchyLevel:5,children:[{text:" Lungs increase in ventilation, hence lowering PCO .Decrease in PCO  causes a rightward shift in the curve, resulting inthe significant increase in pH above the set point.",hierarchyLevel:6,children:[],index:"040202040300"},{text:" Decrease in PCO  shifts the equilibrium to the left,hence causing HCO  to decrease.",hierarchyLevel:6,children:[],index:"040202040301"},{text:" Decrease in HCO  results in the rightwardand downward movement long the curve. This causes a slight decrease in pH backto the set point.",hierarchyLevel:6,children:[],index:"040202040302"},{text:" Hence, metabolic acidosis is compensated.",hierarchyLevel:6,children:[],index:"040202040303"}],index:"0402020403"}],index:"04020204"},{text:" Metabolic Alkalosis",hierarchyLevel:4,children:[{text:" Causes",hierarchyLevel:5,children:[{text:" Vomiting  loss of gastric acid",hierarchyLevel:6,children:[],index:"040202050000"},{text:" Diuretic  excretion of ions resulting in alkalotic state",hierarchyLevel:6,children:[],index:"040202050001"},{text:" Steroid excess",hierarchyLevel:6,children:[],index:"040202050002"},{text:" Congenital kidney diseases",hierarchyLevel:6,children:[],index:"040202050003"},{text:" Diabetic ketoacidosis",hierarchyLevel:6,children:[],index:"040202050004"}],index:"0402020500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0402020501"},{text:" Mechanism (Disturbance)",hierarchyLevel:5,children:[{text:" Excessive ingestion of alkalis / loss of gastric acid causes HCO to rise. This causes a right and upward movement along the curve, resulting ina significant increase in pH.",hierarchyLevel:6,children:[],index:"040202050200"}],index:"0402020502"},{text:" Mechanism (Reaction)",hierarchyLevel:5,children:[{text:" Lungs decrease in ventilation via mild hypoventilation. Thisincreases PCO . Increase in PCO  causes a leftward shiftin the curve, resulting in the slight increase in pH.",hierarchyLevel:6,children:[],index:"040202050300"},{text:" Increase in PCO  shifts the equilibrium to the right,hence causing HCO  to increase.",hierarchyLevel:6,children:[],index:"040202050301"},{text:" Increase in HCO  results in the rightwardand upward movement long the curve. This causes a slight increase in pH awayfrom the set point.",hierarchyLevel:6,children:[],index:"040202050302"},{text:" Hence, metabolic alkalosis is semi-compensated.",hierarchyLevel:6,children:[],index:"040202050303"}],index:"0402020503"}],index:"04020205"}],index:"040202"}],index:"0402"},{text:" [020] Mechanisms of Pulmonary Ventilation",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Pleura  membranes lining the lung and chest wall",hierarchyLevel:5,children:[],index:"0403000000"},{text:" Intra-pleural pressure  the pressure within the pleura (spacebetween lung and chest wall)",hierarchyLevel:5,children:[],index:"0403000001"}],index:"04030000"},{text:" Purpose of Ventilation",hierarchyLevel:4,children:[{text:" Provides oxygen for cellular respiration to produce energy",hierarchyLevel:5,children:[],index:"0403000100"}],index:"04030001"},{text:" Muscles Involved in Ventilation",hierarchyLevel:4,children:[{text:" Diaphragm",hierarchyLevel:5,children:[],index:"0403000200"},{text:" Intercostals",hierarchyLevel:5,children:[],index:"0403000201"},{text:" Sternocleidomastoid (accessory)",hierarchyLevel:5,children:[],index:"0403000202"},{text:" Scalene (accessory)",hierarchyLevel:5,children:[],index:"0403000203"}],index:"04030002"}],index:"040300"},{text:" Inhalation and Expiration",hierarchyLevel:3,children:[{text:" Process of Inhalation",hierarchyLevel:4,children:[{text:" External intercostal muscles contract and internal intercostalmuscles relax, diaphragm contracts and flattens.",hierarchyLevel:5,children:[],index:"0403010000"},{text:" Volume of thoracic cavity increases, and the pleural pressurebecomes more negative. This causes the intra-pulmonary pressure to become lessthan the atmospheric air.",hierarchyLevel:5,children:[],index:"0403010001"},{text:" As a result, air moves into the lungs.",hierarchyLevel:5,children:[],index:"0403010002"}],index:"04030100"},{text:" Process of Exhalation",hierarchyLevel:4,children:[{text:" Internal intercostal muscles contract and external intercostalmuscles relax, diaphragm relaxes and arches upwards.",hierarchyLevel:5,children:[],index:"0403010100"},{text:" Volume of thoracic cavity decreases, and the pleural pressurebecomes more positive. This causes the intra-pulmonary pressure to become morethan the atmospheric air.",hierarchyLevel:5,children:[],index:"0403010101"},{text:" As a result, air moves out of the lungs.",hierarchyLevel:5,children:[],index:"0403010102"}],index:"04030101"}],index:"040301"},{text:" Respiratory Control",hierarchyLevel:3,children:[{text:" Respiratory Central Pattern Generator",hierarchyLevel:4,children:[{text:" Location",hierarchyLevel:5,children:[{text:" Brainstem (pre-Botzinger complex)",hierarchyLevel:6,children:[],index:"040302000000"}],index:"0403020000"},{text:" Parts of Bilateral Ventral Respiratory Column",hierarchyLevel:5,children:[{text:" Inspiration phase (pre-Botzinger complex)",hierarchyLevel:6,children:[],index:"040302000100"},{text:" Post-inspiration phase",hierarchyLevel:6,children:[],index:"040302000101"},{text:" Expiration phase",hierarchyLevel:6,children:[],index:"040302000102"}],index:"0403020001"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Inhibitory and excitatory neurons generate coordinated motoroutput",hierarchyLevel:6,children:[],index:"040302000200"}],index:"0403020002"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0403020003"},{text:" Abnormal Function",hierarchyLevel:5,children:[{text:" Mismatch between the brain expected respiratory rate and depthand the actual respiratory rate and depth results in the feeling ofbreathlessness (dyspnoea).",hierarchyLevel:6,children:[],index:"040302000400"},{text:" Emotions can affects the respiratory rate and depth resulting ina mismatch to the sensor information detecting the respiratory gas tension andthe cerebrospinal fluid pH.",hierarchyLevel:6,children:[],index:"040302000401"}],index:"0403020004"}],index:"04030200"},{text:" Sensors (inputs to respiratory pacemaker)",hierarchyLevel:4,children:[{text:" Carotid Body Chemoreceptors (O )",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Inhibition of specific O  sensitive K channels results in depolarization of the carotid body receptors",hierarchyLevel:7,children:[],index:"04030201000000"},{text:" Depolarization causes the opening of voltage-gated calciumchannels, resulting in the influx of calcium channels",hierarchyLevel:7,children:[],index:"04030201000001"},{text:" Influx of calcium causes the release of neurotransmitters, whichpasses on the nervous impulse in the post-synaptic neurone.",hierarchyLevel:7,children:[],index:"04030201000002"},{text:" The nerve impulse travels from the post-synaptic neurone throughafferent nerves and into the respiratory pacemaker.",hierarchyLevel:7,children:[],index:"04030201000003"}],index:"040302010000"},{text:" Diagram",hierarchyLevel:6,children:[],index:"040302010001"}],index:"0403020100"},{text:" Chemoreceptors (CO )",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Increase in CO  concentration results in the shiftingof the CO  equilibrium to the right, resulting in increasedgeneration of H  ions",hierarchyLevel:7,children:[],index:"04030201010000"},{text:" This results in the cerebrospinal fluid (CSF) becoming moreacidic.",hierarchyLevel:7,children:[],index:"04030201010001"},{text:" Central chemoreceptors detects the increase in acidity of thecerebrospinal  fluid and generates more afferent action potentials.",hierarchyLevel:7,children:[],index:"04030201010002"},{text:" The respiratory centre responds by generating more efferentaction potentials.",hierarchyLevel:7,children:[],index:"04030201010003"},{text:" This results in the increase in the rate and depth ofrespiration. ",hierarchyLevel:7,children:[],index:"04030201010004"},{text:" Increasing rate and depth of respiration increases the amount ofCO  expelled from the body and hence the acidity of thecerebrospinal fluid decreases.",hierarchyLevel:7,children:[],index:"04030201010005"},{text:" This results in the return of normal respiration rate and depth,hence achieving a negative feedback loop.",hierarchyLevel:7,children:[],index:"04030201010006"}],index:"040302010100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"040302010101"}],index:"0403020101"}],index:"04030201"}],index:"040302"},{text:" Examples of Respiratory Control",hierarchyLevel:3,children:[{text:" Healthy Resting Body",hierarchyLevel:4,children:[{text:" Characteristics",hierarchyLevel:5,children:[{text:" Precise control of blood gas tension (concentration) (O and CO )",hierarchyLevel:6,children:[],index:"040303000000"},{text:" Precise control of blood pH (CO )",hierarchyLevel:6,children:[],index:"040303000001"},{text:" Minimise work of breathing",hierarchyLevel:6,children:[],index:"040303000002"}],index:"0403030000"}],index:"04030300"},{text:" Exercising Body",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" A conscious understanding of the impending exercise results in a  centralfeed-forward control  results in increasedsignals to the respiratory central pattern generator",hierarchyLevel:6,children:[],index:"040303010000"},{text:" Contraction of muscles during exercise results in the firing ofnerve impulses by afferent fibres in the muscles into the respiratory patterngenerators",hierarchyLevel:6,children:[],index:"040303010001"},{text:" This results in the increase in the rate and depth of breathingbefore the chemoreceptors detect a change in cerebrospinal fluid acidity.",hierarchyLevel:6,children:[],index:"040303010002"}],index:"0403030100"},{text:" Experimental Proof",hierarchyLevel:5,children:[{text:" Hypnotic suggestion of exercise results in increased rate anddepth of respiration",hierarchyLevel:6,children:[],index:"040303010100"},{text:" Blocking of signals from muscle afferents with epiduralanaesthetic results in lower respiratory rate and depth",hierarchyLevel:6,children:[{text:" Diagram",hierarchyLevel:7,children:[],index:"04030301010100"},{text:" Analysis",hierarchyLevel:7,children:[{text:" Without signals from muscle afferents the PCO  of theblood increases much more when workload increases. The grey bars are at higherPCO  compared to the black bars.",hierarchyLevel:8,children:[],index:"0403030101010100"},{text:" Higher PCO  is an indication of the lower respiratoryrate and depth when the muscle afferent signals are blocked.",hierarchyLevel:8,children:[],index:"0403030101010101"},{text:" Therefore, muscle afferent feedback provides critical informationwhen deciding cardiorespiratory responses.",hierarchyLevel:8,children:[],index:"0403030101010102"}],index:"04030301010101"}],index:"040303010101"}],index:"0403030101"}],index:"04030301"}],index:"040303"},{text:" Alveolar Ventilation",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Tidal volume  volume of a normal breath",hierarchyLevel:5,children:[],index:"0403040000"},{text:" Respiratory rate  the number of breaths per minute",hierarchyLevel:5,children:[],index:"0403040001"},{text:" Minute ventilation  the amount of air ventilated over a minute",hierarchyLevel:5,children:[],index:"0403040002"},{text:" Deadspace volume  the amount of air that does not reach perfusedalveoli",hierarchyLevel:5,children:[],index:"0403040003"},{text:" Alveolar volume  the amount of air that reaches perfused alveoli",hierarchyLevel:5,children:[],index:"0403040004"},{text:" Deadspace ventilation  the amount of air that passes asdeadspace volume per minute of ventilation",hierarchyLevel:5,children:[],index:"0403040005"},{text:" Alveolar ventilation  the amount of air that passes as alveolarvolume per minute of ventilation",hierarchyLevel:5,children:[],index:"0403040006"}],index:"04030400"},{text:" Diagram",hierarchyLevel:4,children:[],index:"04030401"},{text:" Trends",hierarchyLevel:4,children:[{text:" Increasing the rate will increase the minute ventilation by thesame magnitude",hierarchyLevel:5,children:[],index:"0403040200"},{text:" Increasing the tidal volume will increase the minute ventilationby the same magnitude",hierarchyLevel:5,children:[],index:"0403040201"},{text:" Rapid shallow breathing results in the increase in therespiratory rate but decrease in the tidal volume. This results in the sameminute ventilation.",hierarchyLevel:5,children:[],index:"0403040202"},{text:" Increasing deadspace volume results in a severe decrease inalveolar ventilation.",hierarchyLevel:5,children:[],index:"0403040203"}],index:"04030402"},{text:" Conclusion",hierarchyLevel:4,children:[{text:" Alveolar ventilation depends on respiratory rate, tidal volumeand deadspace volume",hierarchyLevel:5,children:[],index:"0403040300"}],index:"04030403"}],index:"040304"}],index:"0403"},{text:" [025] Viral Respiratory Infections",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Upper Respiratory Tract Infection (URTI)  Rhinitis, Pharyngitis,Croup, Bronchitis",hierarchyLevel:5,children:[],index:"0404000000"},{text:" Lower Respiratory Tract Infection (LRTI)  Bronchiolitis,Pneumonia",hierarchyLevel:5,children:[],index:"0404000001"}],index:"04040000"},{text:" List of Diseases",hierarchyLevel:4,children:[],index:"04040001"}],index:"040400"},{text:" Respiratory Syncytial Virus (RSV)",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Paramyxovirus  negative-sense-strand RNA virus (para  by theside of, myxa  mucus)",hierarchyLevel:5,children:[],index:"0404010000"},{text:" Syncytium  a single cell or cytoplasmic mass containing severalnuclei, formed by fusion of cells",hierarchyLevel:5,children:[],index:"0404010001"},{text:" Respiratory Syncytial Virus (RSV)  enveloped virus has to fusewith plasma membrane, causing infected cells to stick to other infected cells,forming a syncytium",hierarchyLevel:5,children:[],index:"0404010002"},{text:" Fomites  objects or materials that are likely to carry aninfection (clothes, furniture, utensils)",hierarchyLevel:5,children:[],index:"0404010003"}],index:"04040100"},{text:" Transmission Mechanism",hierarchyLevel:4,children:[{text:" Spread through large droplets via direct or indirect contact",hierarchyLevel:5,children:[],index:"0404010100"}],index:"04040101"},{text:" Effects",hierarchyLevel:4,children:[{text:" Children",hierarchyLevel:5,children:[{text:" Infection in children results in severe illness requiring hospitalization",hierarchyLevel:6,children:[],index:"040401020000"},{text:" Young infants have very narrow bronchioles resulting inbronchiolitis",hierarchyLevel:6,children:[],index:"040401020001"},{text:" Most prevalent respiratory pathogen of childhood",hierarchyLevel:6,children:[],index:"040401020002"}],index:"0404010200"},{text:" Adults",hierarchyLevel:5,children:[{text:" The immunity of adults improves and adults have been exposed toRSV multiple times",hierarchyLevel:6,children:[],index:"040401020100"},{text:" Infection of an adult human results in the common cold and cough",hierarchyLevel:6,children:[],index:"040401020101"}],index:"0404010201"},{text:" Elderly",hierarchyLevel:5,children:[{text:" The adaptive immunity of the elderly wanes as it malfunctions. ",hierarchyLevel:6,children:[],index:"040401020200"},{text:" This results in more severe infections, with hospitalizations.",hierarchyLevel:6,children:[],index:"040401020201"}],index:"0404010202"}],index:"04040102"}],index:"040401"},{text:" Influenza",hierarchyLevel:3,children:[{text:" General Characteristics",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[],index:"0404020000"},{text:" Structure",hierarchyLevel:5,children:[{text:" Helical nucleocapsid",hierarchyLevel:6,children:[],index:"040402000100"}],index:"0404020001"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0404020002"}],index:"04040200"},{text:" Specific Structure and Function",hierarchyLevel:4,children:[{text:" Haemagglutinin (H / HA)",hierarchyLevel:5,children:[{text:" Subtypes (only for influenza A)",hierarchyLevel:6,children:[{text:" H1",hierarchyLevel:7,children:[],index:"04040201000000"},{text:" H2",hierarchyLevel:7,children:[],index:"04040201000001"},{text:" H3",hierarchyLevel:7,children:[],index:"04040201000002"}],index:"040402010000"},{text:" Function",hierarchyLevel:6,children:[{text:" Viral attachment protein / receptor binding protein  enablesbinding of the virus to the receptor (sialic acid) on the host cell",hierarchyLevel:7,children:[],index:"04040201000100"},{text:" Fusion protein  enables the fusion between the lipid envelop ofthe virus and the cell membrane of the host cell",hierarchyLevel:7,children:[],index:"04040201000101"}],index:"040402010001"},{text:" Applications",hierarchyLevel:6,children:[{text:" Serves as the main target of neutralizing antibodies (receptorsites / non-receptor sites)",hierarchyLevel:7,children:[],index:"04040201000200"}],index:"040402010002"},{text:" Diagram",hierarchyLevel:6,children:[],index:"040402010003"}],index:"0404020100"},{text:" Neuraminidase",hierarchyLevel:5,children:[{text:" Subtypes",hierarchyLevel:6,children:[{text:" N1",hierarchyLevel:7,children:[],index:"04040201010000"},{text:" N2",hierarchyLevel:7,children:[],index:"04040201010001"}],index:"040402010100"},{text:" Function",hierarchyLevel:6,children:[{text:" Cleaves sialic acid (neuraminic acid) from cell surface forprogeny virus release (prevents virus from being stuck when exiting the hostcell)",hierarchyLevel:7,children:[],index:"04040201010100"}],index:"040402010101"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Neuraminidase breaks the O-glycosidic bond between neuraminidcacid and galactose",hierarchyLevel:7,children:[],index:"04040201010200"}],index:"040402010102"},{text:" Applications",hierarchyLevel:6,children:[{text:" Target for protective antibodies",hierarchyLevel:7,children:[],index:"04040201010300"},{text:" Not a target for neutralizing antibodies (cannot be neutralized)",hierarchyLevel:7,children:[],index:"04040201010301"}],index:"040402010103"},{text:" Diagram",hierarchyLevel:6,children:[{text:" Glycoprotein chain with Sialic acid / Neuraminic acid at the end",hierarchyLevel:7,children:[],index:"04040201010400"},{text:" Molecular Structure of Sialic acid and Glycoprotein",hierarchyLevel:7,children:[],index:"04040201010401"}],index:"040402010104"}],index:"0404020101"}],index:"04040201"},{text:" Clinical Features",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Malaise  general feeling of discomfort",hierarchyLevel:6,children:[],index:"040402020000"},{text:" Prostration  complete physical or mental exhaustion",hierarchyLevel:6,children:[],index:"040402020001"},{text:" Myalgia  muscle aches and pain",hierarchyLevel:6,children:[],index:"040402020002"}],index:"0404020200"},{text:" Transmission",hierarchyLevel:5,children:[{text:" Large droplets through direct or indirect contact via fomites oraerosol",hierarchyLevel:6,children:[],index:"040402020100"}],index:"0404020201"},{text:" Symptoms",hierarchyLevel:5,children:[{text:" Upper respiratory tract infection",hierarchyLevel:6,children:[],index:"040402020200"},{text:" Fever, headache, malaise, myalgia, cough, sore throat",hierarchyLevel:6,children:[],index:"040402020201"}],index:"0404020202"},{text:" Time period",hierarchyLevel:5,children:[{text:" Incubation Period",hierarchyLevel:6,children:[{text:" 1  4 days",hierarchyLevel:7,children:[],index:"04040202030000"}],index:"040402020300"},{text:" Infection Period",hierarchyLevel:6,children:[{text:" 2 weeks  symptoms resolve within a week, cough and malaisepersist for 2 weeks",hierarchyLevel:7,children:[],index:"04040202030100"}],index:"040402020301"}],index:"0404020203"}],index:"04040202"},{text:" Pathogenesis and Complications",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Co-morbidities  characteristics / pre-existing conditions thatmakes the infection worse",hierarchyLevel:6,children:[],index:"040402030000"},{text:" ARDS  acute respiratory distress syndrome",hierarchyLevel:6,children:[],index:"040402030001"}],index:"0404020300"},{text:" Factors",hierarchyLevel:5,children:[{text:" Viral Factors  Airway Damage",hierarchyLevel:6,children:[{text:" Virus infection is limited to the respiratory epithelium andkills the cells it infects and allows for transmission to other cells",hierarchyLevel:7,children:[],index:"04040203010000"},{text:" This results in airway damage",hierarchyLevel:7,children:[],index:"04040203010001"}],index:"040402030100"},{text:" Host Factors  Immunopathologies",hierarchyLevel:6,children:[{text:" Presence of co-morbidities",hierarchyLevel:7,children:[{text:" Chronic respiratory illness",hierarchyLevel:8,children:[],index:"0404020301010000"},{text:" Immunocompromised pregnant women",hierarchyLevel:8,children:[],index:"0404020301010001"},{text:" Morbid obesity",hierarchyLevel:8,children:[],index:"0404020301010002"},{text:" Single nucleotide polymorphisms",hierarchyLevel:8,children:[],index:"0404020301010003"}],index:"04040203010100"},{text:" Immunopathologies",hierarchyLevel:7,children:[{text:" Inflammation causes damage to airways",hierarchyLevel:8,children:[],index:"0404020301010100"},{text:" High cytokines and chemokines cause damage to airways",hierarchyLevel:8,children:[],index:"0404020301010101"}],index:"04040203010101"}],index:"040402030101"},{text:" Bacteria",hierarchyLevel:6,children:[],index:"040402030102"}],index:"0404020301"},{text:" Factor Interactions",hierarchyLevel:5,children:[{text:" Airway Damage + Immunopathology = ARDS",hierarchyLevel:6,children:[],index:"040402030200"},{text:" Viral factors + Host factors = Primary viral pneumonia (rare)",hierarchyLevel:6,children:[],index:"040402030201"},{text:" Viral factors + Host factors + Bacterial factors = Secondarybacterial pneumonia",hierarchyLevel:6,children:[{text:" Upon three days of  contracting primary viral pneumonia , the patient starts torecover. However, after which, the bacteria invade the lung via the damagedepithelium with no protective mucus. ",hierarchyLevel:7,children:[],index:"04040203020200"}],index:"040402030202"}],index:"0404020302"},{text:" Diagram",hierarchyLevel:5,children:[{text:"  ",hierarchyLevel:6,children:[],index:"040402030300"}],index:"0404020303"}],index:"04040203"},{text:" Epidemics and Pandemics",hierarchyLevel:4,children:[{text:" Antigenic Drift  Epidemics",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Viral RNA has no proof-reading ability and hence mutations willbe transcribed and translated.",hierarchyLevel:7,children:[],index:"04040204000000"},{text:" This results in the quick mutation of neuraminidase andhaemagglutinin which results in the immunized population to now only havepartial immunity.",hierarchyLevel:7,children:[],index:"04040204000001"}],index:"040402040000"},{text:" Consequence",hierarchyLevel:6,children:[{text:" Annual recurrence of Flu A and Flu B epidemics",hierarchyLevel:7,children:[],index:"04040204000100"}],index:"040402040001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"040402040002"}],index:"0404020400"},{text:" Antigenic Shift  Pandemics",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" The genome of influenza is segmented (8 segments) and eachsegments coded by a single gene",hierarchyLevel:7,children:[],index:"04040204010000"},{text:" When two influenza viruses infect a cell at the same time, itresults in reassortment, where the viruses exiting the cell have a mix of genesegments from one influenza virus and some gene segments from the otherinfluenza virus",hierarchyLevel:7,children:[],index:"04040204010001"},{text:" The reassortment of gene segments may lead to the expression of anew type of hemagglutinin protein which has not seen by the target (human)population, and hence the population does not have immunity against it",hierarchyLevel:7,children:[],index:"04040204010002"},{text:" Bird influenza can combine with human influenza to produce a verypowerful influenza possible of creating a pandemic",hierarchyLevel:7,children:[],index:"04040204010003"}],index:"040402040100"},{text:" Consequence",hierarchyLevel:6,children:[{text:" Worldwide pandemic outbreak infecting a high percentage of people",hierarchyLevel:7,children:[],index:"04040204010100"},{text:" World population does not have immunity",hierarchyLevel:7,children:[],index:"04040204010101"}],index:"040402040101"},{text:" Diagram",hierarchyLevel:6,children:[{text:" Pigs get infected with both bird influenza virus and humaninfluenza virus",hierarchyLevel:7,children:[],index:"04040204010200"}],index:"040402040102"}],index:"0404020401"}],index:"04040204"},{text:" Diagnosis and Control",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Haemadsorption  sticking / adsorption of blood cells",hierarchyLevel:6,children:[],index:"040402050000"}],index:"0404020500"},{text:" Diagnosis Methods",hierarchyLevel:5,children:[{text:" Detection of virus antigen  nasopharyngeal (nose and throatswab) respiratory epithelial cells",hierarchyLevel:6,children:[],index:"040402050100"},{text:" Detection of virus nucleic acid  nose/throat swab with RT PCR todetect viral RNA in respiratory epithelial cells",hierarchyLevel:6,children:[],index:"040402050101"},{text:" Host antibody response  comparing acute and convalescent sera(10-14 days apart), slow, more useful for seroepidemiology than diagnosis",hierarchyLevel:6,children:[],index:"040402050102"},{text:" Virus isolation for strains   nasopharyngeal swab, grow virusin tissue culture (with animal/human cell monolayer), visualize byhaemadsorption . Produce vaccines in chickembryos based on the strains recognised",hierarchyLevel:6,children:[],index:"040402050103"}],index:"0404020501"},{text:" Control Methods",hierarchyLevel:5,children:[{text:" Antiviral Drugs  Neuraminidase Inhibitors",hierarchyLevel:6,children:[{text:" Mechanism",hierarchyLevel:7,children:[{text:" Neuraminidase inhibitors binds to neuraminidase.",hierarchyLevel:8,children:[],index:"0404020502000000"},{text:" This prevents neuraminidase from cleaving neuraminic acid from theglycoprotein.",hierarchyLevel:8,children:[],index:"0404020502000001"},{text:" Hence, progeny virus is unable to exit the cell and infect othercells.",hierarchyLevel:8,children:[],index:"0404020502000002"}],index:"04040205020000"},{text:" Diagram",hierarchyLevel:7,children:[],index:"04040205020001"}],index:"040402050200"},{text:" Immunization  Vaccines",hierarchyLevel:6,children:[{text:" Type",hierarchyLevel:7,children:[{text:" Inactivated vaccines",hierarchyLevel:8,children:[],index:"0404020502010000"}],index:"04040205020100"},{text:" Composition of Vaccines",hierarchyLevel:7,children:[{text:" One influenza A H3N2 strain",hierarchyLevel:8,children:[],index:"0404020502010100"},{text:" One influenza A H1N1 strain",hierarchyLevel:8,children:[],index:"0404020502010101"},{text:" One or 2 influenza B strains",hierarchyLevel:8,children:[],index:"0404020502010102"}],index:"04040205020101"},{text:" Process",hierarchyLevel:7,children:[{text:" New vaccines need to be produced annually",hierarchyLevel:8,children:[],index:"0404020502010200"},{text:" Strains to be included are reviewed by WHO annually to predictthe next outbreak",hierarchyLevel:8,children:[],index:"0404020502010201"}],index:"04040205020102"}],index:"040402050201"}],index:"0404020502"}],index:"04040205"}],index:"040402"},{text:" Human Coronaviruses  COVID-19",hierarchyLevel:3,children:[{text:" Background",hierarchyLevel:4,children:[{text:" Zoonotic Origins",hierarchyLevel:5,children:[{text:" Animal studies were done on wildlife reservoirs.",hierarchyLevel:6,children:[],index:"040403000000"},{text:" Phylogenic reconstruction allowed for the understanding of whenthe viruses were introduced into the human population.",hierarchyLevel:6,children:[],index:"040403000001"},{text:" Concluded that coronaviruses had zoonotic origins.",hierarchyLevel:6,children:[],index:"040403000002"},{text:" SARS-CoV originated from bats, might have been transmitted frombats to snakes, pangolins first.",hierarchyLevel:6,children:[],index:"040403000003"}],index:"0404030000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0404030001"}],index:"04040300"},{text:" Structure and function",hierarchyLevel:4,children:[{text:" Components",hierarchyLevel:5,children:[{text:" Spike glycoprotein",hierarchyLevel:6,children:[{text:" Binds to receptor on cell Angiotensin Converting Enzyme (ACE2)",hierarchyLevel:7,children:[],index:"04040301000000"}],index:"040403010000"},{text:" Nucleocapsid protein (N)",hierarchyLevel:6,children:[{text:" Low mutation rate due to presence of proofreading mechanism still able to mutate with large replication quantities",hierarchyLevel:7,children:[],index:"04040301000100"},{text:" Contains single stranded positive sense RNA genome",hierarchyLevel:7,children:[],index:"04040301000101"}],index:"040403010001"}],index:"0404030100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0404030101"}],index:"04040301"},{text:" Transmission",hierarchyLevel:4,children:[{text:" Modes",hierarchyLevel:5,children:[{text:" Heavy wet droplets",hierarchyLevel:6,children:[],index:"040403020000"},{text:" Close range aerosol transmission",hierarchyLevel:6,children:[],index:"040403020001"},{text:" Small, floating droplet nuclei (aerosol)  greater distancetransmission (crowded, poorly ventilated, indoor space)",hierarchyLevel:6,children:[],index:"040403020002"},{text:" Fomites  virus on contaminated surface (contagious with highcontact rate from many people)",hierarchyLevel:6,children:[],index:"040403020003"}],index:"0404030200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0404030201"}],index:"04040302"},{text:" Symptoms and Phases",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" Fever",hierarchyLevel:6,children:[],index:"040403030000"},{text:" Headache",hierarchyLevel:6,children:[],index:"040403030001"},{text:" Malaise",hierarchyLevel:6,children:[],index:"040403030002"},{text:" Myalgia",hierarchyLevel:6,children:[],index:"040403030003"},{text:" Dry Cough",hierarchyLevel:6,children:[],index:"040403030004"},{text:" Loss of smell / taste",hierarchyLevel:6,children:[],index:"040403030005"}],index:"0404030300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0404030301"},{text:" Phases",hierarchyLevel:5,children:[{text:" Process",hierarchyLevel:6,children:[{text:" Phase 1: Virus Driven Phase (0  7 days)",hierarchyLevel:7,children:[{text:" Virus replicates rapidly in the body, resulting in viral PCRdetection",hierarchyLevel:8,children:[],index:"0404030302000000"},{text:" Infected person demonstrates maximum infectivity",hierarchyLevel:8,children:[],index:"0404030302000001"}],index:"04040303020000"},{text:" Phase 2: Inflammatory Phase (7  21 days)",hierarchyLevel:7,children:[{text:" Body start developing an immune response and viral antibodyappears",hierarchyLevel:8,children:[],index:"0404030302000100"},{text:" Virus starts getting neutralized and viral PCR declines",hierarchyLevel:8,children:[],index:"0404030302000101"},{text:" This results in lowered or no infectivity of the infected person.While there are virus present, it is neutralized and ineffective.",hierarchyLevel:8,children:[],index:"0404030302000102"},{text:" At day 14, viral antibody reaches plateau",hierarchyLevel:8,children:[],index:"0404030302000103"}],index:"04040303020001"},{text:" Phase 3: Recovery (28 days)",hierarchyLevel:7,children:[{text:" Full recovery occurs 28 days after onset",hierarchyLevel:8,children:[],index:"0404030302000200"},{text:" Death occurs 18 days after disease onset",hierarchyLevel:8,children:[],index:"0404030302000201"}],index:"04040303020002"}],index:"040403030200"},{text:" Diagram",hierarchyLevel:6,children:[],index:"040403030201"}],index:"0404030302"}],index:"04040303"},{text:" Pathogenesis",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Virus enters the cell via ACE2 (angiotensin-converting enzyme).",hierarchyLevel:6,children:[],index:"040403040000"},{text:" ACE2 is required for lowering blood pressure and hence is foundon cell membranes of lungs, arteries, heart, kidney and intestines.",hierarchyLevel:6,children:[],index:"040403040001"},{text:" Virus enters lung cells resulting in pneumonia.",hierarchyLevel:6,children:[],index:"040403040002"},{text:" Virus enters heart cells resulting in heart attack.",hierarchyLevel:6,children:[],index:"040403040003"},{text:" Virus enters kidney resulting in kidney failure.",hierarchyLevel:6,children:[],index:"040403040004"},{text:" Virus enters the intestines resulting in diarrhea.",hierarchyLevel:6,children:[],index:"040403040005"},{text:" As a result, a multi-organ disease is formed.",hierarchyLevel:6,children:[],index:"040403040006"}],index:"0404030400"},{text:" Diagram",hierarchyLevel:5,children:[{text:" Entry of mucus and cells results in the alveoli results inshortness of breath.",hierarchyLevel:6,children:[],index:"040403040100"},{text:" Binding of SARS-CoV-2 on the endothelial cells results ininflammation and formation of blood clots. Which leads to formation ofpulmonary emboli, clots in brain causes stroke, clots in heart results in heartattack, inflammation of the heart (cardiomyocytis) ",hierarchyLevel:6,children:[],index:"040403040101"}],index:"0404030401"}],index:"04040304"},{text:" Risk Factors",hierarchyLevel:4,children:[{text:" Old age",hierarchyLevel:5,children:[],index:"0404030500"},{text:" Male sex",hierarchyLevel:5,children:[],index:"0404030501"},{text:" Co-morbidities  underlying medical conditions",hierarchyLevel:5,children:[{text:" Hypertension",hierarchyLevel:6,children:[],index:"040403050200"},{text:" Cardiovascular disease",hierarchyLevel:6,children:[],index:"040403050201"},{text:" Chronic obstructive pulmonary disease (COPD)",hierarchyLevel:6,children:[],index:"040403050202"},{text:" Diabetes",hierarchyLevel:6,children:[],index:"040403050203"},{text:" Obesity",hierarchyLevel:6,children:[],index:"040403050204"}],index:"0404030502"},{text:" Immunodeficiency",hierarchyLevel:5,children:[],index:"0404030503"}],index:"04040305"},{text:" Diagnosis",hierarchyLevel:4,children:[{text:" Methods",hierarchyLevel:5,children:[{text:" Detection of virus antigen  nasopharyngeal (nose and throatswab) respiratory epithelial cells",hierarchyLevel:6,children:[],index:"040403060000"},{text:" [ ] Detection of virus nucleic acid  nose/throatswab with RT (reverse transcription) PCR to detect viral RNA in respiratoryepithelial cells",hierarchyLevel:6,children:[],index:"040403060001"},{text:" Host antibody response  comparing acute and convalescent sera(10-14 days apart), slow, more useful for seroepidemiology than diagnosis",hierarchyLevel:6,children:[],index:"040403060002"},{text:" Virus isolation for strains   nasopharyngeal swab, grow virusin tissue culture (with animal/human cell monolayer), visualize byhaemadsorption . Produce vaccines in chickembryos based on the strains recognized",hierarchyLevel:6,children:[],index:"040403060003"}],index:"0404030600"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0404030601"}],index:"04040306"},{text:" Treatment",hierarchyLevel:4,children:[{text:" Passive therapy (post-exposure prophylaxis)",hierarchyLevel:5,children:[{text:" Inject monoclonal neutralizing antibodies to prevent severedisease and illness (not practical  requires early identification of diseaseand expensive, only for immunocompromised)",hierarchyLevel:6,children:[],index:"040403070000"}],index:"0404030700"},{text:" Virus replication inhibitors",hierarchyLevel:5,children:[{text:" Antivirals against RNA-dependent RNA polymerase",hierarchyLevel:6,children:[],index:"040403070100"},{text:" Antivirals against viral protease",hierarchyLevel:6,children:[],index:"040403070101"}],index:"0404030701"},{text:" Promote host immune response",hierarchyLevel:5,children:[{text:" Corticosteroids",hierarchyLevel:6,children:[],index:"040403070200"},{text:" Anti-IL6 monoclonal antibody",hierarchyLevel:6,children:[],index:"040403070201"}],index:"0404030702"},{text:" Vaccines",hierarchyLevel:5,children:[{text:" Messenger RNA is enclosed in a lipoprotein nanoparticle",hierarchyLevel:6,children:[],index:"040403070300"},{text:" Once injected into the deltoid, muscle cells starts producing thespike protein, initiating an immune response.",hierarchyLevel:6,children:[],index:"040403070301"}],index:"0404030703"}],index:"04040307"}],index:"040403"}],index:"0404"},{text:" [026] Pneumonia",hierarchyLevel:2,children:[{text:" Respiratory Defences",hierarchyLevel:3,children:[{text:" Sources of Respiratory Infection",hierarchyLevel:4,children:[{text:" Humans (social contact)",hierarchyLevel:5,children:[],index:"0405000000"},{text:" Environment",hierarchyLevel:5,children:[],index:"0405000001"},{text:" Animals",hierarchyLevel:5,children:[],index:"0405000002"}],index:"04050000"},{text:" Requirements to Achieve Pneumonia",hierarchyLevel:4,children:[{text:" Colonize the nasopharynx / Inhaled into the alveolus",hierarchyLevel:5,children:[],index:"0405000100"},{text:" Adhere to respiratory cells",hierarchyLevel:5,children:[],index:"0405000101"},{text:" Evade the immune system",hierarchyLevel:5,children:[],index:"0405000102"},{text:" Divide and multiply",hierarchyLevel:5,children:[],index:"0405000103"},{text:" Express virulence factors that cause disease",hierarchyLevel:5,children:[],index:"0405000104"}],index:"04050001"},{text:" Overview of Respiratory Innate Defences",hierarchyLevel:4,children:[{text:" Nasal Mucus",hierarchyLevel:5,children:[],index:"0405000200"},{text:" Ciliated cells",hierarchyLevel:5,children:[],index:"0405000201"},{text:" Mucociliary clearance elevator",hierarchyLevel:5,children:[],index:"0405000202"},{text:" Alveolar macrophages",hierarchyLevel:5,children:[],index:"0405000203"},{text:" Polymorphonuclear leucocytes",hierarchyLevel:5,children:[],index:"0405000204"},{text:" Complement",hierarchyLevel:5,children:[],index:"0405000205"},{text:" Pathogen pattern recognition receptors",hierarchyLevel:5,children:[],index:"0405000206"}],index:"04050002"},{text:" Mucociliary clearance elevator",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Particles are trapped in mucus covering the respiratory tract",hierarchyLevel:6,children:[],index:"040500030000"},{text:" Ciliary action drags the mucus upwards and is expelled(expectorated)",hierarchyLevel:6,children:[],index:"040500030001"}],index:"0405000300"},{text:" Abnormal Function",hierarchyLevel:5,children:[{text:" Disruption in mucus activity results in chronic infections incystic fibrosis, bronchiectasis, smoking",hierarchyLevel:6,children:[],index:"040500030100"}],index:"0405000301"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"040500030200"}],index:"0405000302"}],index:"04050003"},{text:" Complement",hierarchyLevel:4,children:[{text:" Complement system is activate via the alternative pathway.",hierarchyLevel:5,children:[],index:"0405000400"},{text:" Mast cell degranulation leads to inflammation which attractspolymorphonuclear leucocytes",hierarchyLevel:5,children:[],index:"0405000401"},{text:" Complement proteins opsionize bacteria",hierarchyLevel:5,children:[],index:"0405000402"}],index:"04050004"}],index:"040500"},{text:" Pneumonia",hierarchyLevel:3,children:[{text:" Background Information",hierarchyLevel:4,children:[{text:" 291.8 million cases globally",hierarchyLevel:6,children:[],index:"0405010000"},{text:" 2.38 million deaths globally",hierarchyLevel:6,children:[],index:"0405010001"}],index:"04050100"},{text:" Community acquired pneumonia (CAP)",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Symptoms and signs consistent with an acute lower respiratorytract infections associated with new radiographic shadowing for which there isno other explanation (not pulmonary oedema or infarction)",hierarchyLevel:6,children:[],index:"040501010000"}],index:"0405010100"},{text:" Causes",hierarchyLevel:5,children:[{text:" Extracellular",hierarchyLevel:6,children:[{text:" Streptococcus pneumoniae (> 50%)",hierarchyLevel:7,children:[],index:"04050101010000"},{text:" Hemophilus influenzae (10%)",hierarchyLevel:7,children:[],index:"04050101010001"}],index:"040501010100"},{text:" Intracellular",hierarchyLevel:6,children:[{text:" Mycoplasma pneumoniae (10%)",hierarchyLevel:7,children:[],index:"04050101010100"},{text:" Legionella pneumophila (2%)",hierarchyLevel:7,children:[],index:"04050101010101"},{text:" Chlamydia pneumoniae",hierarchyLevel:7,children:[],index:"04050101010102"},{text:" Chlamydia psitacci",hierarchyLevel:7,children:[],index:"04050101010103"},{text:" Coxiella burnetti",hierarchyLevel:7,children:[],index:"04050101010104"}],index:"040501010101"},{text:" Tuberculosis",hierarchyLevel:6,children:[],index:"040501010102"}],index:"0405010101"},{text:" Prevalence",hierarchyLevel:5,children:[{text:" Most common fatal infectious disease",hierarchyLevel:6,children:[],index:"040501010200"},{text:" 1-3 cases per 1000 population",hierarchyLevel:6,children:[],index:"040501010201"},{text:" Higher incidence in elderly and under 5 years of age",hierarchyLevel:6,children:[],index:"040501010202"}],index:"0405010102"},{text:" Mortality",hierarchyLevel:5,children:[{text:" 5  15%",hierarchyLevel:6,children:[],index:"040501010300"},{text:" High in elderly in developed countries",hierarchyLevel:6,children:[],index:"040501010301"},{text:" High in children in developing countries",hierarchyLevel:6,children:[],index:"040501010302"}],index:"0405010103"},{text:" Complications",hierarchyLevel:5,children:[{text:" Emphysema",hierarchyLevel:6,children:[],index:"040501010400"},{text:" Lung abscess",hierarchyLevel:6,children:[],index:"040501010401"}],index:"0405010104"},{text:" Cost ",hierarchyLevel:5,children:[{text:" 4-5 billion / year in UK",hierarchyLevel:6,children:[],index:"040501010500"}],index:"0405010105"},{text:" Diagram",hierarchyLevel:5,children:[{text:"  ",hierarchyLevel:6,children:[],index:"040501010600"}],index:"0405010106"}],index:"04050101"},{text:" Streptococci pneumoniae ",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Serotypes  classification of organisms based on surface antigen",hierarchyLevel:6,children:[],index:"040501020000"},{text:" Invasin  substances that facilitates the invasion of theorganism",hierarchyLevel:6,children:[],index:"040501020001"}],index:"0405010200"},{text:" Immune evasion mechanisms",hierarchyLevel:5,children:[{text:" Polysaccharide capsule  prevent phagocytosis",hierarchyLevel:6,children:[],index:"040501020100"},{text:" Capsule switching  prevent antibody recognition",hierarchyLevel:6,children:[],index:"040501020101"},{text:" Pneumococcal surface protein A  inhibits deposition ofcomplement on bacterial surface",hierarchyLevel:6,children:[],index:"040501020102"},{text:" IgA protease  cleaves anti-capsular IgA mucosal antibodies",hierarchyLevel:6,children:[],index:"040501020103"}],index:"0405010201"},{text:" Capsule Characteristics",hierarchyLevel:5,children:[{text:" Made up of polysaccharide",hierarchyLevel:6,children:[],index:"040501020200"},{text:" More than 90 serotypes of capsule  only some results in disease(serves as a virulence determinant)",hierarchyLevel:6,children:[],index:"040501020201"},{text:" Able to adhere to respiratory cells",hierarchyLevel:6,children:[],index:"040501020202"},{text:" Has  gene cassette structure  enabling it to switch",hierarchyLevel:6,children:[],index:"040501020203"}],index:"0405010202"},{text:" Virulence Determinants",hierarchyLevel:5,children:[{text:" Capsular polysaccharide",hierarchyLevel:6,children:[{text:" Essential for colonization",hierarchyLevel:7,children:[],index:"04050102030000"},{text:" Resistant to phagocytosis",hierarchyLevel:7,children:[],index:"04050102030001"}],index:"040501020300"},{text:" Pneumococcal pilus",hierarchyLevel:6,children:[{text:" Enable survival in lungs",hierarchyLevel:7,children:[],index:"04050102030100"},{text:" Enables adherence to epithelial cells",hierarchyLevel:7,children:[],index:"04050102030101"},{text:" Induces Tumor Necrosis Factor and hence induces inflammatoryresponse",hierarchyLevel:7,children:[],index:"04050102030102"}],index:"040501020301"},{text:" Hydrogen peroxide",hierarchyLevel:6,children:[{text:" Damages ciliated epithelium and impairs muco-cilliary escalator",hierarchyLevel:7,children:[],index:"04050102030200"}],index:"040501020302"},{text:" Surface proteins",hierarchyLevel:6,children:[{text:" Pneumolysin  toxin",hierarchyLevel:7,children:[],index:"04050102030300"},{text:" Adherence and virulence factors  teichoic acid, lipoteichoicacid",hierarchyLevel:7,children:[],index:"04050102030301"}],index:"040501020303"},{text:" Autolysis",hierarchyLevel:6,children:[{text:" Lyses bacterial cells releasing toxins such as pneumolysin",hierarchyLevel:7,children:[],index:"04050102030400"}],index:"040501020304"}],index:"0405010203"},{text:" Invasins",hierarchyLevel:5,children:[{text:" Pneumolysin",hierarchyLevel:6,children:[],index:"040501020400"},{text:" Hyaluronidase  breaks down connective tissue",hierarchyLevel:6,children:[],index:"040501020401"},{text:" Choline binding protein A  anchors bacteria to cells of nasopharynxand respiratory epithelium",hierarchyLevel:6,children:[],index:"040501020402"}],index:"0405010204"}],index:"04050102"},{text:" Elements of Diagnosis",hierarchyLevel:4,children:[{text:" History ",hierarchyLevel:5,children:[],index:"0405010300"},{text:" Examination",hierarchyLevel:5,children:[],index:"0405010301"},{text:" Imaging ",hierarchyLevel:5,children:[],index:"0405010302"},{text:" Investigations",hierarchyLevel:5,children:[],index:"0405010303"}],index:"04050103"},{text:" Diagnosis",hierarchyLevel:4,children:[{text:" History  risk factors",hierarchyLevel:5,children:[{text:" Age",hierarchyLevel:6,children:[],index:"040501040000"},{text:" Smoking  disrupts cilia and macrophage function",hierarchyLevel:6,children:[],index:"040501040001"},{text:" Underlying respiratory disease  chronic lung disease, cystic fibrosis,bronchiectasis",hierarchyLevel:6,children:[],index:"040501040002"},{text:" Immunodeficiency  congenital diabetes, chemotherapy, HIV",hierarchyLevel:6,children:[],index:"040501040003"},{text:" Impaired cough reflex  alcohol",hierarchyLevel:6,children:[],index:"040501040004"},{text:" Impaired conscious level  stroke, aspiration pneumonia",hierarchyLevel:6,children:[],index:"040501040005"},{text:" Ventilator associated pneumonia",hierarchyLevel:6,children:[],index:"040501040006"}],index:"0405010400"},{text:" Risk factors for contracting pathogens",hierarchyLevel:5,children:[],index:"0405010401"},{text:" Examination  Signs and Symptoms",hierarchyLevel:5,children:[{text:" Metrics to Examine",hierarchyLevel:6,children:[{text:" Respiratory Rate",hierarchyLevel:7,children:[],index:"04050104020000"},{text:" Pulse Rate",hierarchyLevel:7,children:[],index:"04050104020001"},{text:" Blood pressure",hierarchyLevel:7,children:[],index:"04050104020002"},{text:" Oxygen saturations",hierarchyLevel:7,children:[],index:"04050104020003"}],index:"040501040200"},{text:" Focal chest signs to examine",hierarchyLevel:6,children:[{text:" Decreased expansion  damage to alveoli, lowered elasticity andlowered compliance",hierarchyLevel:7,children:[],index:"04050104020100"},{text:" Dullness to percussion  pulmonary oedema from inflammation",hierarchyLevel:7,children:[],index:"04050104020101"},{text:" Reduced air entry  inflammation results in bronchoconstriction",hierarchyLevel:7,children:[],index:"04050104020102"},{text:" Bronchial breath sounds  inflammation results inbronchoconstriction",hierarchyLevel:7,children:[],index:"04050104020103"},{text:" Crepitation  grating or crackling sound or sensation",hierarchyLevel:7,children:[],index:"04050104020104"},{text:" Effusions  escape of fluid from anatomical vessels due torupture",hierarchyLevel:7,children:[],index:"04050104020105"}],index:"040501040201"},{text:" Diagram",hierarchyLevel:6,children:[],index:"040501040202"}],index:"0405010402"},{text:" Imaging",hierarchyLevel:5,children:[{text:" Definitions",hierarchyLevel:6,children:[],index:"040501040300"},{text:" Table",hierarchyLevel:6,children:[],index:"040501040301"}],index:"0405010403"},{text:" Guideline",hierarchyLevel:5,children:[],index:"0405010404"},{text:" Investigations",hierarchyLevel:5,children:[{text:" Definitions",hierarchyLevel:6,children:[{text:" Bronchoalveolar lavage  BAL is used to collect a sample from thelungs for testing. During the procedure, a saline solution is put through thebronchoscope to wash the airways and capture a fluid sample.",hierarchyLevel:7,children:[],index:"04050104050000"}],index:"040501040500"},{text:" Cultures",hierarchyLevel:6,children:[{text:" Sputum culture",hierarchyLevel:7,children:[],index:"04050104050100"},{text:" Bronchoalveolar lavage (BAL)",hierarchyLevel:7,children:[],index:"04050104050101"},{text:" Blood culture",hierarchyLevel:7,children:[],index:"04050104050102"}],index:"040501040501"},{text:" Blood test",hierarchyLevel:6,children:[{text:" Full blood count",hierarchyLevel:7,children:[],index:"04050104050200"},{text:" Urea & electrolytes",hierarchyLevel:7,children:[],index:"04050104050201"},{text:" C-reactive protein",hierarchyLevel:7,children:[],index:"04050104050202"}],index:"040501040502"},{text:" Urine antigens",hierarchyLevel:6,children:[{text:" Legionella antigens",hierarchyLevel:7,children:[],index:"04050104050300"},{text:" Pneumococcal antigens",hierarchyLevel:7,children:[],index:"04050104050301"}],index:"040501040503"},{text:" Polymerase Chain Reaction test",hierarchyLevel:6,children:[{text:" Viruses",hierarchyLevel:7,children:[],index:"04050104050400"},{text:" Bacteria",hierarchyLevel:7,children:[],index:"04050104050401"},{text:" Pneumocystis pneumonia",hierarchyLevel:7,children:[],index:"04050104050402"}],index:"040501040504"},{text:" Serology",hierarchyLevel:6,children:[{text:" Mycoplasma pneumoniae",hierarchyLevel:7,children:[],index:"04050104050500"}],index:"040501040505"},{text:" Histopathology",hierarchyLevel:6,children:[{text:" Aspergillus",hierarchyLevel:7,children:[],index:"04050104050600"}],index:"040501040506"}],index:"0405010405"}],index:"04050104"},{text:" Treatment and Prevention",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Inotrope  an agent that alters the force or energy of muscularcontractions. Negatively inotropic agents weaken the force of muscularcontractions.",hierarchyLevel:6,children:[],index:"040501050000"},{text:" Venous thromboembolism  blood clots in the vein",hierarchyLevel:6,children:[],index:"040501050001"},{text:" Prophylaxis  treatment give to prevent disease",hierarchyLevel:6,children:[],index:"040501050002"},{text:" PPV  23-valent pneumococcal polysaccharide vaccine",hierarchyLevel:6,children:[],index:"040501050003"},{text:" PCV  7-valent / 13-valent pneumococcal conjugate vaccine",hierarchyLevel:6,children:[],index:"040501050004"}],index:"0405010500"},{text:" Principle",hierarchyLevel:5,children:[{text:" provide treatment based on assessment of severity of pneumonia",hierarchyLevel:6,children:[],index:"040501050100"}],index:"0405010501"},{text:" Treatment Options",hierarchyLevel:5,children:[{text:" Antimicrobials based on laboratory results",hierarchyLevel:6,children:[],index:"040501050200"},{text:" Oxygen ventilatory support",hierarchyLevel:6,children:[],index:"040501050201"},{text:" Fluids",hierarchyLevel:6,children:[],index:"040501050202"},{text:" Physiotherapy mobilization",hierarchyLevel:6,children:[],index:"040501050203"},{text:" Venous thromboembolism prophylaxis",hierarchyLevel:6,children:[],index:"040501050204"}],index:"0405010502"},{text:" Prevention Options",hierarchyLevel:5,children:[{text:" Vaccination  streptococcus pneumoniae, influenza, COVID-19, PPV",hierarchyLevel:6,children:[],index:"040501050300"},{text:" Smoking cessation",hierarchyLevel:6,children:[],index:"040501050301"},{text:" Physiotherapy (for cystic fibrosis patients)",hierarchyLevel:6,children:[],index:"040501050302"}],index:"0405010503"}],index:"04050105"},{text:" Penicillin antibiotics",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Act on the cell wall by inhibiting penicillin binding proteins inthe bacterial cell wall",hierarchyLevel:6,children:[],index:"040501060000"}],index:"0405010600"},{text:" Effectiveness",hierarchyLevel:5,children:[{text:" Effective against streptococcus pneumoniae and haemophilusinfluenzae",hierarchyLevel:6,children:[],index:"040501060100"},{text:" Not effective against microbials causing atypical pneumonia",hierarchyLevel:6,children:[],index:"040501060101"}],index:"0405010601"}],index:"04050106"},{text:" Quinolone antibiotics",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Inhibit bacterial DNA synthesis by inhibiting the enzymaticactivities of DNA gyrase and topoisomerase IV",hierarchyLevel:6,children:[],index:"040501070000"}],index:"0405010700"},{text:" Effectiveness",hierarchyLevel:5,children:[{text:" Ciproflaxacin is effective against atypicals",hierarchyLevel:6,children:[],index:"040501070100"},{text:" Levofloxacin is effective against atypicals and streptococcuspneumoniae",hierarchyLevel:6,children:[],index:"040501070101"}],index:"0405010701"}],index:"04050107"},{text:" Epidemiology",hierarchyLevel:4,children:[{text:" Antimicrobial resistance is low in the UK, high in othercountries. Hence, need to check patients travel history",hierarchyLevel:5,children:[],index:"0405010800"},{text:" Hospital acquired pneumonia has more MRSA and hospital specificpathogens",hierarchyLevel:5,children:[],index:"0405010801"},{text:" External acquired pneumonia has more native pathogens",hierarchyLevel:5,children:[],index:"0405010802"}],index:"04050108"}],index:"040501"}],index:"0405"},{text:" [028] Understanding Respiratory Failure",hierarchyLevel:2,children:[{text:" Learning Objectives",hierarchyLevel:3,children:[{text:" Define and understand the differences between type 1 and type 2respiratory failure",hierarchyLevel:4,children:[],index:"04060000"},{text:" Understand the concept of ventilation-perfusion matching",hierarchyLevel:4,children:[],index:"04060001"},{text:" List some causes of V/Q mismatch",hierarchyLevel:4,children:[],index:"04060002"},{text:" Make a basis analysis / interpretation of arterial blood gasresults",hierarchyLevel:4,children:[],index:"04060003"}],index:"040600"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Failure  the state of not functioning",hierarchyLevel:5,children:[],index:"0406010000"},{text:" Failure in medicine",hierarchyLevel:5,children:[{text:" Brain stem death  no activity in the brain stem, permanentlylost consciousness / breathing",hierarchyLevel:6,children:[],index:"040601000100"},{text:" Cardiac / heart failure  heart unable to pump sufficiently tomaintain blood flow",hierarchyLevel:6,children:[],index:"040601000101"},{text:" Liver / hepatic failure  inability of the liver to perform itsnormal synthetic metabolic function",hierarchyLevel:6,children:[],index:"040601000102"},{text:" Kidney / renal failure  kidney stops working well enough to livewithout dialysis (permanent)",hierarchyLevel:6,children:[],index:"040601000103"},{text:" Respiratory (not lung) failure  PaO  < 8 kPa",hierarchyLevel:6,children:[],index:"040601000104"}],index:"0406010001"}],index:"04060100"}],index:"040601"},{text:" Respiratory Failure",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Respiratory Failure  PaO  < 8 kPa (60mmHg)",hierarchyLevel:5,children:[],index:"0406020000"},{text:" Type I Respiratory Failure  PaCO  < 6.0 kPa",hierarchyLevel:5,children:[],index:"0406020001"},{text:" Type II Respiratory Failure  PaCO  > 6.0 kPa",hierarchyLevel:5,children:[],index:"0406020002"}],index:"04060200"},{text:" Clinical Significance of Respiratory Failure",hierarchyLevel:4,children:[{text:" Respiratory failure is the result of an underlying cause ofdisease",hierarchyLevel:5,children:[],index:"0406020100"},{text:" When a disease causes respiratory failure, the disease can befatal.",hierarchyLevel:5,children:[],index:"0406020101"},{text:" To remedy respiratory failure, the true underlying cause must beresolved.",hierarchyLevel:5,children:[],index:"0406020102"}],index:"04060201"},{text:" Differentiating between anxiety and pulmonary embolism",hierarchyLevel:4,children:[{text:" Measure PO  using blood oxygen sensor",hierarchyLevel:5,children:[],index:"0406020200"},{text:" Measure PO  using arterial blood gas",hierarchyLevel:5,children:[],index:"0406020201"}],index:"04060202"},{text:" Type 1 Respiratory Failure",hierarchyLevel:4,children:[{text:" Characteristics",hierarchyLevel:5,children:[{text:" Low partial pressure of oxygen in systemic arterial blood (PaO < 8 kPa)",hierarchyLevel:6,children:[],index:"040602030000"},{text:" PaCO  < 6.0 kPa (hypoxemia without hypercapnia)",hierarchyLevel:6,children:[],index:"040602030001"}],index:"0406020300"},{text:" Cause - problem which affects either ventilation or perfusion orboth",hierarchyLevel:5,children:[{text:" COVID-19",hierarchyLevel:6,children:[],index:"040602030100"},{text:" Pulmonary embolism",hierarchyLevel:6,children:[],index:"040602030101"},{text:" Pneumonia",hierarchyLevel:6,children:[],index:"040602030102"},{text:" ARDS",hierarchyLevel:6,children:[],index:"040602030103"},{text:" Interstitial lung disease",hierarchyLevel:6,children:[],index:"040602030104"},{text:" Pulmonary oedema",hierarchyLevel:6,children:[],index:"040602030105"},{text:" Asthma",hierarchyLevel:6,children:[],index:"040602030106"},{text:" COPD (associated with type 2)",hierarchyLevel:6,children:[],index:"040602030107"},{text:" Pneumothorax",hierarchyLevel:6,children:[],index:"040602030108"},{text:" Pulmonary arterial hypertension",hierarchyLevel:6,children:[],index:"040602030109"},{text:" Cyanotic congenital heart disease",hierarchyLevel:6,children:[],index:"040602030110"},{text:" Bronchiectasis",hierarchyLevel:6,children:[],index:"040602030111"},{text:" Fat embolism syndrome",hierarchyLevel:6,children:[],index:"040602030112"},{text:" Obesity (associated with type 2)",hierarchyLevel:6,children:[],index:"040602030113"},{text:" Kyphoscoliosis (associated with type 2)",hierarchyLevel:6,children:[],index:"040602030114"}],index:"0406020301"},{text:" Treatment",hierarchyLevel:5,children:[{text:" Oxygen supplementation",hierarchyLevel:6,children:[],index:"040602030200"},{text:" Treating underlying cause",hierarchyLevel:6,children:[],index:"040602030201"}],index:"0406020302"}],index:"04060203"},{text:" Type 2 Respiratory Failure",hierarchyLevel:4,children:[{text:" Characteristics",hierarchyLevel:5,children:[{text:" Low partial pressure of oxygen in systemic arterial blood (PaO < 8 kPa)",hierarchyLevel:6,children:[],index:"040602040000"},{text:" PaCO  > 6.0 kPa (hypoxemia with hypercapnia)",hierarchyLevel:6,children:[],index:"040602040001"}],index:"0406020400"},{text:" Cause  problem which affects ability to ventilate",hierarchyLevel:5,children:[{text:" COPD",hierarchyLevel:6,children:[],index:"040602040100"},{text:" Obesity-hypoventilation syndrome (OHS)",hierarchyLevel:6,children:[],index:"040602040101"},{text:" Severe asthma",hierarchyLevel:6,children:[],index:"040602040102"},{text:" Drug overdose  opiates",hierarchyLevel:6,children:[],index:"040602040103"},{text:" Chest wall deformity",hierarchyLevel:6,children:[],index:"040602040104"},{text:" MND",hierarchyLevel:6,children:[],index:"040602040105"},{text:" Myasthenia gravis",hierarchyLevel:6,children:[],index:"040602040106"},{text:" Head & cervical cord injury",hierarchyLevel:6,children:[],index:"040602040107"},{text:" Pulmonary oedema",hierarchyLevel:6,children:[],index:"040602040108"},{text:" ARDS",hierarchyLevel:6,children:[],index:"040602040109"},{text:" Muscle disorders",hierarchyLevel:6,children:[],index:"040602040110"}],index:"0406020401"}],index:"04060204"},{text:" Diagnosing Types of Respiratory Failure (exam)",hierarchyLevel:4,children:[],index:"04060205"}],index:"040602"},{text:" Arterial Blood Gas",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Fraction of Inspired Oxygen (FiO )  the concentrationof oxygen in the gas mixture",hierarchyLevel:5,children:[],index:"0406030000"}],index:"04060300"},{text:" Example Arterial Blood Gas Result",hierarchyLevel:4,children:[],index:"04060301"},{text:" Procedures in Analysing Arterial Blood Gas Results",hierarchyLevel:4,children:[{text:" Understand the presentation of the patient",hierarchyLevel:5,children:[{text:" Check for breathlessness",hierarchyLevel:6,children:[],index:"040603020000"},{text:" Check for hypoxaemia or acidosis",hierarchyLevel:6,children:[],index:"040603020001"}],index:"0406030200"},{text:" Assess oxygenation of the patient",hierarchyLevel:5,children:[{text:" Efficacy of oxygenation needs to be compared to the FiO .If the FiO  is high, we have higher expectations for the PaO .If the PaO  does not correspond to those higher standards, patientmay have oxygenation problems.",hierarchyLevel:6,children:[],index:"040603020100"}],index:"0406030201"},{text:" Assess pH of Blood",hierarchyLevel:5,children:[{text:" Low pH acidotic",hierarchyLevel:6,children:[],index:"040603020200"},{text:" High pH alkalosis",hierarchyLevel:6,children:[],index:"040603020201"}],index:"0406030202"},{text:" Respiratory component",hierarchyLevel:5,children:[{text:" CO  low  respiratory alkalosis (breathing fast)",hierarchyLevel:6,children:[],index:"040603020300"},{text:" CO  high  respiratory acidosis (breathing slow)",hierarchyLevel:6,children:[],index:"040603020301"}],index:"0406030203"},{text:" Metabolic component",hierarchyLevel:5,children:[{text:" HCO  high  metabolic alkalosis",hierarchyLevel:6,children:[],index:"040603020400"},{text:" HCO  low  metabolic acidosis",hierarchyLevel:6,children:[],index:"040603020401"},{text:" Diabetic ketoacidosis  HCO  is aconjugate base of carbonic acid, and will neutralize the excess H ions from diabetic ketoacidosis, resulting in lower remaining amounts of HCO",hierarchyLevel:6,children:[],index:"040603020402"}],index:"0406030204"}],index:"04060302"},{text:" Diagnosis Pathway Diagram (exam)",hierarchyLevel:4,children:[],index:"04060303"},{text:" Possible Conditions from Blood Gas Analysis",hierarchyLevel:4,children:[{text:" Type 1 Respiratory Failure",hierarchyLevel:5,children:[],index:"0406030400"},{text:" Type 2 Respiratory Failure",hierarchyLevel:5,children:[],index:"0406030401"},{text:" Respiratory acidosis",hierarchyLevel:5,children:[],index:"0406030402"},{text:" Respiratory alkalosis",hierarchyLevel:5,children:[],index:"0406030403"},{text:" Hyperventilation",hierarchyLevel:5,children:[],index:"0406030404"},{text:" Hypoventilation",hierarchyLevel:5,children:[],index:"0406030405"},{text:" Metabolic acidosis",hierarchyLevel:5,children:[],index:"0406030406"},{text:" Metabolic alkalosis",hierarchyLevel:5,children:[],index:"0406030407"},{text:" Compensatory",hierarchyLevel:5,children:[],index:"0406030408"}],index:"04060304"},{text:" Interpreting Alveolar - arterial gradient graph (exam)",hierarchyLevel:4,children:[{text:" Graph",hierarchyLevel:5,children:[],index:"0406030500"},{text:" Purpose of the Graph",hierarchyLevel:5,children:[{text:" To determine if PaO  is low enough to be considered asType 2 Respiratory Failure considering the FiO",hierarchyLevel:6,children:[],index:"040603050100"}],index:"0406030501"},{text:" Graph Interpretation",hierarchyLevel:5,children:[{text:" Determine the FiO  and use the line which representsyour FiO",hierarchyLevel:6,children:[],index:"040603050200"},{text:" Given the PaCO  trace the y-value of the PaCO to get the respective x-value of PaO  based on where it intersectsthe line",hierarchyLevel:6,children:[],index:"040603050201"},{text:" A healthy PaO  would be equals to or higher than thePaO  value determined.",hierarchyLevel:6,children:[],index:"040603050202"},{text:" If the value you have is lower, it means that it is Type 2Respiratory Failure.",hierarchyLevel:6,children:[],index:"040603050203"}],index:"0406030502"}],index:"04060305"},{text:" Interpreting Alveolar-arterial gradient (value)",hierarchyLevel:4,children:[{text:" Equation",hierarchyLevel:5,children:[],index:"0406030600"},{text:" Purpose",hierarchyLevel:5,children:[{text:" A-a gradient shows the difference between the partial pressure ofoxygen in the alveoli vs the partial pressure of oxygen in the arteries",hierarchyLevel:6,children:[],index:"040603060100"},{text:" P O  is difficult to determine andtherefore is derived using the alveolar gas equation",hierarchyLevel:6,children:[],index:"040603060101"}],index:"0406030601"},{text:" Interpretation",hierarchyLevel:5,children:[{text:" < 2 kPa  healthy, indicating that oxygen is effectivelymoving form alveoli to arteries",hierarchyLevel:6,children:[],index:"040603060200"},{text:" < 4 kPa  acceptable for hospital patients",hierarchyLevel:6,children:[],index:"040603060201"},{text:" > 6 kPa  not acceptable, indicating that something is wrong",hierarchyLevel:6,children:[],index:"040603060202"}],index:"0406030602"}],index:"04060306"},{text:" Interpreting PaO  / FiO  Ratio",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0406030700"},{text:" Effect of Shunting on PaO  / FiO  Ratio",hierarchyLevel:5,children:[{text:" When there is a shunt, blood is not flowing to the alveoliproperly. As a result, increasing the FiO  results in a very littleincrease in the PaO  as the oxygen is unable to reach the blood.",hierarchyLevel:6,children:[],index:"040603070100"}],index:"0406030701"}],index:"04060307"}],index:"040603"},{text:" Ventilation Perfusion Ratio",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Ventilation  the air the reaches the alveoli",hierarchyLevel:5,children:[],index:"0406040000"},{text:" Perfusion  the blood that reaches the alveoli",hierarchyLevel:5,children:[],index:"0406040001"}],index:"04060400"},{text:" Purpose",hierarchyLevel:4,children:[{text:" Both are required to determine blood oxygen concentration",hierarchyLevel:5,children:[],index:"0406040100"}],index:"04060401"},{text:" Ventilation Perfusion Scan",hierarchyLevel:4,children:[{text:" Procedure",hierarchyLevel:5,children:[{text:" Ventilation  radioisotope is breathed in through the lungs",hierarchyLevel:6,children:[],index:"040604020000"},{text:" Perfusion  radioisotope is injected into the bloodstream",hierarchyLevel:6,children:[],index:"040604020001"}],index:"0406040200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0406040201"}],index:"04060402"},{text:" V/Q Mismatch Diagram (explain with previous knowledge)",hierarchyLevel:4,children:[],index:"04060403"},{text:" Effect of Compression on V/Q Ratio and PA, Pa, Pv",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0406040400"},{text:" Explanation",hierarchyLevel:5,children:[{text:" At the apical side of the lungs, due to lower pressure on thealveoli, the alveoli is able to expand more, resulting in more resistance tothe capillaries. As a result, there will be plenty of oxygen (high PA) in thealveoli, but not a lot of blood for the oxygen to diffuse into (low Pv, low Pa)",hierarchyLevel:6,children:[],index:"040604040100"},{text:" At the base of the lungs, due to higher pressure on the alveoli,the alveoli is not able to expand properly, resulting in less resistance to thecapillaries. As a result of reduced airflow, there is less oxygen (low PA) inthe alveoli, but a lot of blood flowing to the alveoli (high Pv, high Pa)",hierarchyLevel:6,children:[],index:"040604040101"}],index:"0406040401"}],index:"04060404"},{text:" Diagnosis with V / Q Ratios (exam)",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0406040500"}],index:"04060405"},{text:" Causes of V/Q Mismatch",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0406040600"}],index:"04060406"}],index:"040604"}],index:"0406"},{text:" [033] Asthma",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Discuss the epidemiology of asthma",hierarchyLevel:4,children:[],index:"04070000"},{text:" Identify the risk factors for asthma",hierarchyLevel:4,children:[],index:"04070001"},{text:" Identify the symptoms of asthma",hierarchyLevel:4,children:[],index:"04070002"},{text:" Discuss the physiological basis of symptoms",hierarchyLevel:4,children:[],index:"04070003"},{text:" Discuss the inflammatory pathways involved with asthma",hierarchyLevel:4,children:[],index:"04070004"},{text:" Discuss treatments used in asthma therapy",hierarchyLevel:4,children:[],index:"04070005"}],index:"040700"},{text:" Epidemiology",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Epidemiology  who gets asthma and why?",hierarchyLevel:5,children:[],index:"0407010000"},{text:" Asthma  recurrent attacks of breathlessness, inflammation of airpassage reducing the flow of air",hierarchyLevel:5,children:[],index:"0407010001"}],index:"04070100"},{text:" Global Prevalence",hierarchyLevel:4,children:[],index:"04070101"},{text:" Global Burden of Deaths",hierarchyLevel:4,children:[],index:"04070102"},{text:" UK Statistics",hierarchyLevel:4,children:[{text:" 5.4 million receiving treatment",hierarchyLevel:5,children:[],index:"0407010300"},{text:" 1 billion pounds for treatment costs / year",hierarchyLevel:5,children:[],index:"0407010301"},{text:" 1474 deaths in 2017",hierarchyLevel:5,children:[],index:"0407010302"}],index:"04070103"},{text:" Risk Factors",hierarchyLevel:4,children:[{text:" Age  peak prevalence 6  12 years, older people",hierarchyLevel:5,children:[],index:"0407010400"},{text:" Gender  little impact",hierarchyLevel:5,children:[],index:"0407010401"},{text:" Family history  3 to 6x more likely with family history",hierarchyLevel:5,children:[],index:"0407010402"},{text:" Presence of other allergic / atopic conditions  eczema /allergic rhinitis",hierarchyLevel:5,children:[],index:"0407010403"},{text:" Social deprivation  36% for most deprived communities",hierarchyLevel:5,children:[],index:"0407010404"},{text:" Smoking and parental smoking",hierarchyLevel:5,children:[],index:"0407010405"},{text:" Air pollution",hierarchyLevel:5,children:[],index:"0407010406"}],index:"04070104"}],index:"040701"},{text:" Clinical Features of Asthma",hierarchyLevel:3,children:[{text:" Importance of Diagnosis",hierarchyLevel:4,children:[{text:" Underdiagnosis  majority of people with asthma are not diagnosed",hierarchyLevel:5,children:[],index:"0407020000"},{text:" Overdiagnosis  30% of people with a diagnosis of asthma no longerhave asthma",hierarchyLevel:5,children:[],index:"0407020001"}],index:"04070200"},{text:" Diagnosis Techniques",hierarchyLevel:4,children:[{text:" Clinical features",hierarchyLevel:5,children:[],index:"0407020100"},{text:" Physiological tests  peak flow diary, lung function tests",hierarchyLevel:5,children:[],index:"0407020101"},{text:" Biomarkers  FeNO, blood eosinophil count, sensitization toaeroallergens",hierarchyLevel:5,children:[],index:"0407020102"},{text:" Exclusion of other differentials",hierarchyLevel:5,children:[],index:"0407020103"}],index:"04070201"},{text:" Symptoms",hierarchyLevel:4,children:[{text:" Breathlessness, chest tightness",hierarchyLevel:5,children:[],index:"0407020200"},{text:" Cough",hierarchyLevel:5,children:[],index:"0407020201"},{text:" Wheeze",hierarchyLevel:5,children:[],index:"0407020202"},{text:" Recurrent chest infections",hierarchyLevel:5,children:[],index:"0407020203"},{text:" Episodic in nature",hierarchyLevel:5,children:[],index:"0407020204"},{text:" Seasonal and diurnal variation (throughout the day)",hierarchyLevel:5,children:[],index:"0407020205"},{text:" History of exacerbations or attacks",hierarchyLevel:5,children:[],index:"0407020206"},{text:" Atopy / allergy and triggers",hierarchyLevel:5,children:[],index:"0407020207"},{text:" Will respond to therapy",hierarchyLevel:5,children:[],index:"0407020208"}],index:"04070202"},{text:" Signs",hierarchyLevel:4,children:[{text:" Expiratory wheeze may be heard",hierarchyLevel:5,children:[],index:"0407020300"},{text:" Eczema or rhinitis may coexist",hierarchyLevel:5,children:[],index:"0407020301"}],index:"04070203"},{text:" Tests for Asthma",hierarchyLevel:4,children:[{text:" Peak flow diary",hierarchyLevel:5,children:[{text:" Procedure",hierarchyLevel:6,children:[{text:" Peak flows are monitored for 2  4 weeks",hierarchyLevel:7,children:[],index:"04070204000000"}],index:"040702040000"},{text:" Effectiveness",hierarchyLevel:6,children:[{text:" Advantage  cheap and repeatable",hierarchyLevel:7,children:[],index:"04070204000100"},{text:" Disadvantage  requires patient effort and reliability, notspecific to asthma",hierarchyLevel:7,children:[],index:"04070204000101"}],index:"040702040001"},{text:" Interpretation",hierarchyLevel:6,children:[{text:" > 20 % variability in peak flow is suggestive of asthma(diurnal)",hierarchyLevel:7,children:[],index:"04070204000200"}],index:"040702040002"},{text:" Diagram",hierarchyLevel:6,children:[],index:"040702040003"}],index:"0407020400"},{text:" Spirometry / bronchodilator reversibility",hierarchyLevel:5,children:[{text:" Procedure",hierarchyLevel:6,children:[{text:" Measure the flow of air out of the lungs while the patient isbreathing out",hierarchyLevel:7,children:[],index:"04070204010000"},{text:" Look out for lowered airflow, indicating airflow obstruction",hierarchyLevel:7,children:[],index:"04070204010001"}],index:"040702040100"},{text:" Effectiveness",hierarchyLevel:6,children:[{text:" Advantage  definitive test for airflow obstruction, andreversibility; easier to quality control",hierarchyLevel:7,children:[],index:"04070204010100"},{text:" Disadvantage  Often normal airflow detected in asthma patients,specificity is low (normal test does not exclude asthma)",hierarchyLevel:7,children:[],index:"04070204010101"}],index:"040702040101"},{text:" Diagram",hierarchyLevel:6,children:[{text:" Only 35.6% with asthma have significant change in lung function",hierarchyLevel:7,children:[],index:"04070204010200"}],index:"040702040102"}],index:"0407020401"},{text:" FeNO  Fractional Exhaled Nitric Oxide",hierarchyLevel:5,children:[{text:" Procedure",hierarchyLevel:6,children:[{text:" Measure the amount of Nitric oxide in exhaled breath",hierarchyLevel:7,children:[],index:"04070204020000"},{text:" Elevated levels of nitric oxide is an indication of eosinophilicairway inflammation",hierarchyLevel:7,children:[],index:"04070204020001"}],index:"040702040200"},{text:" Effectiveness",hierarchyLevel:6,children:[{text:" Advantages  direct measurement of a biomarker than can altertreatment",hierarchyLevel:7,children:[],index:"04070204020100"},{text:" Disadvantages  elevated in other conditions eg. rhinitis.Measures specific type of inflammation, rather than presence of asthma",hierarchyLevel:7,children:[],index:"04070204020101"}],index:"040702040201"},{text:" Diagram",hierarchyLevel:6,children:[],index:"040702040202"}],index:"0407020402"},{text:" Bronchial challenge",hierarchyLevel:5,children:[{text:" Definitions",hierarchyLevel:6,children:[{text:" Forced Expiratory Volume 1s (FEV1)  the amount of air you canforce from your lungs in one second",hierarchyLevel:7,children:[],index:"04070204030000"}],index:"040702040300"},{text:" Procedure",hierarchyLevel:6,children:[{text:" Metacholine is inhaled at very small concentrations andspirometry is repeated over and over again to detect the concentration requiredto cause a 20% fall in FEV1 ",hierarchyLevel:7,children:[],index:"04070204030100"},{text:" Lower the concentration, the more responsive the airways are themetacholine.",hierarchyLevel:7,children:[],index:"04070204030101"},{text:" This measures the hyper-responsiveness of the airways which is ahallmark of asthma",hierarchyLevel:7,children:[],index:"04070204030102"}],index:"040702040301"},{text:" Effectiveness",hierarchyLevel:6,children:[{text:" Advantages  measures airway hyper-responsiveness",hierarchyLevel:7,children:[],index:"04070204030200"},{text:" Disadvantages  may not be tolerated, time consuming, limitedaccess",hierarchyLevel:7,children:[],index:"04070204030201"}],index:"040702040302"},{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"04070204030300"}],index:"040702040303"}],index:"0407020403"},{text:" Chest X-ray (CXR)",hierarchyLevel:5,children:[{text:" Observe hyperinflation of the lungs",hierarchyLevel:6,children:[],index:"040702040400"}],index:"0407020404"},{text:" Blood Test",hierarchyLevel:5,children:[{text:" Observe eosinophilia, IgE, Aspergillus precipitans",hierarchyLevel:6,children:[],index:"040702040500"},{text:" Definitions",hierarchyLevel:6,children:[{text:" Eosinophilia  higher than normal levels of eosinophils",hierarchyLevel:7,children:[],index:"04070204050100"},{text:" Aspergillus Precipitin testing  test which detects the presenceof IgG antibodies to Aspergillus fumigatus",hierarchyLevel:7,children:[],index:"04070204050101"}],index:"040702040501"}],index:"0407020405"}],index:"04070204"},{text:" NICE Guidance for Asthma Diagnosis",hierarchyLevel:4,children:[{text:" Principle",hierarchyLevel:5,children:[{text:" Use more diagnostic tests before treating",hierarchyLevel:6,children:[],index:"040702050000"},{text:" Move away from treat first approach, as it leads toinappropriate diagnosis and a lack of follow up of whether the patient actuallyhad asthma",hierarchyLevel:6,children:[],index:"040702050001"}],index:"0407020500"},{text:" Procedure",hierarchyLevel:5,children:[{text:" FeNO   Spirometry   Peak flow diary  Bronchial challenge  suspect asthma and review diagnosis after treatment ",hierarchyLevel:6,children:[],index:"040702050100"}],index:"0407020501"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0407020502"}],index:"04070205"}],index:"040702"},{text:" Pathological Basis of Asthma",hierarchyLevel:3,children:[{text:" Histological Characteristics",hierarchyLevel:4,children:[{text:" Observations",hierarchyLevel:5,children:[{text:" Airway inflammation and secretions",hierarchyLevel:6,children:[],index:"040703000000"},{text:" Smooth muscle hypertrophy",hierarchyLevel:6,children:[],index:"040703000001"},{text:" Airway remodeling",hierarchyLevel:6,children:[],index:"040703000002"}],index:"0407030000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0407030001"}],index:"04070300"},{text:" Definitions",hierarchyLevel:4,children:[{text:" Atopy  the tendency to produce an exaggerated amounts of Ig E",hierarchyLevel:5,children:[],index:"0407030100"},{text:" Allergic  breathing in a allergen initiates hypersensitivity inimmune response",hierarchyLevel:5,children:[],index:"0407030101"}],index:"04070301"},{text:" Types of Asthma Pathology",hierarchyLevel:4,children:[{text:" Cellular endotype",hierarchyLevel:5,children:[{text:" TH2  Eosinophilic High Type 2 Airway Inflammation (>50%)",hierarchyLevel:6,children:[],index:"040703020000"},{text:" TH1  Non-eosinophilic High Type 1 Airway Inflammation ",hierarchyLevel:6,children:[],index:"040703020001"},{text:" Atopic (50-60%)",hierarchyLevel:6,children:[],index:"040703020002"}],index:"0407030200"},{text:" Clinical Phenotype",hierarchyLevel:5,children:[{text:" Allergic / Atopic",hierarchyLevel:6,children:[],index:"040703020100"},{text:" Aspirin sensitive",hierarchyLevel:6,children:[],index:"040703020101"},{text:" Late onset",hierarchyLevel:6,children:[],index:"040703020102"},{text:" Exercise-induced",hierarchyLevel:6,children:[],index:"040703020103"},{text:" Catamenial asthma (triggered by menstrual cycle)",hierarchyLevel:6,children:[],index:"040703020104"}],index:"0407030201"}],index:"04070302"},{text:" Inflammatory pathways of asthma",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Dendritic cells receive the allergen",hierarchyLevel:6,children:[],index:"040703030000"},{text:" Dendritic cells signal to lymphocytes including eosinophils.",hierarchyLevel:6,children:[],index:"040703030001"},{text:" This causes eosinophils to produce inflammatory mediators such asIL-4, IL-5",hierarchyLevel:6,children:[],index:"040703030002"},{text:" IL-4, IL-5 signals to other cells in the immune system, causinginflammation.",hierarchyLevel:6,children:[],index:"040703030003"},{text:" B cells produce IgE (allergic type inflammation  mast cells)",hierarchyLevel:6,children:[],index:"040703030004"},{text:" This leads to smooth muscle bronchoconstriction, vasculardilation and remodeling to cause clinical symptoms of asthma",hierarchyLevel:6,children:[],index:"040703030005"}],index:"0407030300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0407030301"}],index:"04070303"},{text:" Triggers of asthma",hierarchyLevel:4,children:[{text:" Indoor sensitizations",hierarchyLevel:5,children:[{text:" House dust mite",hierarchyLevel:6,children:[],index:"040703040000"},{text:" Molds",hierarchyLevel:6,children:[],index:"040703040001"},{text:" Animal danders",hierarchyLevel:6,children:[],index:"040703040002"}],index:"0407030400"},{text:" Outdoor sensitisations",hierarchyLevel:5,children:[{text:" Tree pollen",hierarchyLevel:6,children:[],index:"040703040100"},{text:" Grass pollen",hierarchyLevel:6,children:[],index:"040703040101"}],index:"0407030401"},{text:" Viral infections",hierarchyLevel:5,children:[],index:"0407030402"},{text:" Air pollution",hierarchyLevel:5,children:[],index:"0407030403"},{text:" Sulfites in foodstuffs",hierarchyLevel:5,children:[],index:"0407030404"},{text:" Medications  aspirin",hierarchyLevel:5,children:[],index:"0407030405"}],index:"04070304"}],index:"040703"},{text:" Management and Treatment",hierarchyLevel:3,children:[{text:" Considerations for Planning Treatment",hierarchyLevel:4,children:[{text:" Current medication used",hierarchyLevel:5,children:[],index:"0407040000"},{text:" Frequency of current medication",hierarchyLevel:5,children:[],index:"0407040001"},{text:" Mode of administration of current medication",hierarchyLevel:5,children:[],index:"0407040002"},{text:" Requirement for SABA (salbutamol terbutaline) relievermedications",hierarchyLevel:5,children:[],index:"0407040003"},{text:" Current symptoms, impact on work, sleep",hierarchyLevel:5,children:[],index:"0407040004"},{text:" Exacerbation frequency",hierarchyLevel:5,children:[],index:"0407040005"}],index:"04070400"},{text:" Considerations for Planning Management",hierarchyLevel:4,children:[{text:" Is the diagnosis right?",hierarchyLevel:5,children:[],index:"0407040100"},{text:" Can they use their inhaler properly?",hierarchyLevel:5,children:[],index:"0407040101"},{text:" Are they taking their medications?",hierarchyLevel:5,children:[],index:"0407040102"},{text:" Do we need to change / escalate / reduce their treatment?",hierarchyLevel:5,children:[],index:"0407040103"}],index:"04070401"},{text:" Definition of Uncontrolled Asthma (NICE)",hierarchyLevel:4,children:[{text:" 3 or more days a week with symptoms",hierarchyLevel:5,children:[],index:"0407040200"},{text:" 3 or more days a week with required use of SABA for symptomaticrelief",hierarchyLevel:5,children:[],index:"0407040201"},{text:" 1 or more nights a week with awakening due to asthma",hierarchyLevel:5,children:[],index:"0407040202"}],index:"04070402"},{text:" Asthma Therapies",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0407040300"}],index:"04070403"},{text:" Types of Inhalers",hierarchyLevel:4,children:[{text:" pMDI  pressurized metered-dose inhaler",hierarchyLevel:5,children:[],index:"0407040400"},{text:" pMDI with spacer",hierarchyLevel:5,children:[],index:"0407040401"},{text:" pMDI breath-actuated",hierarchyLevel:5,children:[],index:"0407040402"},{text:" Dry-powder inhaler",hierarchyLevel:5,children:[],index:"0407040403"},{text:" Soft mist inhaler",hierarchyLevel:5,children:[],index:"0407040404"}],index:"04070404"},{text:" Importance of Inhaler Techniques",hierarchyLevel:4,children:[{text:" Importance",hierarchyLevel:5,children:[{text:" Many patients are unable to properly administer inhaler,resulting in them not receiving clinical benefit",hierarchyLevel:6,children:[],index:"040704050000"},{text:" Half of prescribed doses are taken",hierarchyLevel:6,children:[],index:"040704050001"}],index:"0407040500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0407040501"},{text:" Technique",hierarchyLevel:5,children:[{text:" pMDI  slow and steady inhalation over 4-5 seconds",hierarchyLevel:6,children:[],index:"040704050200"},{text:" Dry powder inhalers  quick and deep inhalation within 2-3seconds",hierarchyLevel:6,children:[],index:"040704050201"}],index:"0407040502"}],index:"04070405"},{text:" Carbon Footprint of Inhalers",hierarchyLevel:4,children:[],index:"04070406"},{text:" Escalation of Treatment",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" If patient is not responding well, increase dosage",hierarchyLevel:6,children:[],index:"040704070000"},{text:" If patient still not responding well, change to stronger therapy",hierarchyLevel:6,children:[],index:"040704070001"}],index:"0407040700"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0407040701"},{text:" Assumptions",hierarchyLevel:5,children:[{text:" Assumes that all patients have the same response to treatment ",hierarchyLevel:6,children:[],index:"040704070200"},{text:" Assumes that all patients have the same pathology for asthma",hierarchyLevel:6,children:[],index:"040704070201"}],index:"0407040702"}],index:"04070407"},{text:" Treatment for Mild Asthma",hierarchyLevel:4,children:[{text:" General Principle",hierarchyLevel:5,children:[{text:" Dosage given as per required use rather than constantadministration",hierarchyLevel:6,children:[],index:"040704080000"}],index:"0407040800"},{text:" Maintenance and Reliever Therapy (MART)",hierarchyLevel:5,children:[{text:" One device that has combination of beta agonist to relievesymptoms and a corticosteroid to treat the underlying cause",hierarchyLevel:6,children:[],index:"040704080100"}],index:"0407040801"}],index:"04070408"},{text:" Treatment of Difficult Asthma",hierarchyLevel:4,children:[{text:" Reassessment",hierarchyLevel:5,children:[],index:"0407040900"},{text:" Biologic Therapy",hierarchyLevel:5,children:[{text:" Blocking of interleukin signaling pathways to preventinflammation",hierarchyLevel:6,children:[],index:"040704090100"}],index:"0407040901"}],index:"04070409"},{text:" Self-Management of Asthma",hierarchyLevel:4,children:[{text:" Personal Asthma Action Plan",hierarchyLevel:5,children:[],index:"0407041000"},{text:" Avoidance of Allergens",hierarchyLevel:5,children:[{text:" Asthma avoidance does not significantly improve asthma based ontrials and are not recommended",hierarchyLevel:6,children:[],index:"040704100100"}],index:"0407041001"}],index:"04070410"},{text:" Managing Asthma Exacerbations",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Assess severity  PEF, respiration, SpO , Pulse",hierarchyLevel:6,children:[],index:"040704110000"},{text:" Treatment",hierarchyLevel:6,children:[],index:"040704110001"},{text:" Discharge",hierarchyLevel:6,children:[],index:"040704110002"}],index:"0407041100"}],index:"04070411"}],index:"040704"}],index:"0407"},{text:" [034] Tutorial: Lung Pressures and Compliance",hierarchyLevel:2,children:[{text:" Compliance",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Compliance formula: Change in volume / change in pressure",hierarchyLevel:5,children:[],index:"0408000000"},{text:" Resistance formula: Change in pressure / change in volume",hierarchyLevel:5,children:[],index:"0408000001"},{text:" Elastic recoil: The amount of force exerted by the lung tissue toresist expansion of the lungs",hierarchyLevel:5,children:[],index:"0408000002"},{text:" Elasticity: The ability of the lungs to expand",hierarchyLevel:5,children:[],index:"0408000003"}],index:"04080000"},{text:" Measurements",hierarchyLevel:4,children:[{text:" Volume  the volume of the lungs is measured",hierarchyLevel:5,children:[],index:"0408000100"},{text:" Pressure  the difference in pressure between the intra-pleuralspace and the pulmonary pressure",hierarchyLevel:5,children:[],index:"0408000101"}],index:"04080001"},{text:" Relationship",hierarchyLevel:4,children:[{text:" Compliance is inversely proportionate to elastic recoil  thegreater the amount of force exerted by the lung tissue to resist expansion ofthe lungs, the less change in volume of the lungs per change in pressure of thelungs",hierarchyLevel:5,children:[],index:"0408000200"}],index:"04080002"},{text:" Diagram",hierarchyLevel:4,children:[],index:"04080003"},{text:" Explanation",hierarchyLevel:4,children:[{text:" General Trend",hierarchyLevel:5,children:[{text:" As the pressure increases, more air moves into the lungs, causingvolume to increase",hierarchyLevel:6,children:[],index:"040800040000"},{text:" However, up until a certain point, the lung reaches its elasticlimit and becomes rigid.",hierarchyLevel:6,children:[],index:"040800040001"},{text:" From there, further increases in the pressure of the lungs doesnot further increase the volume of the lungs (resulting in a plateau)",hierarchyLevel:6,children:[],index:"040800040002"}],index:"0408000400"},{text:" Increasing fibrous tissue",hierarchyLevel:5,children:[{text:" Increasing the fibrous tissue results in strengthening theelastic recoil",hierarchyLevel:6,children:[],index:"040800040100"},{text:" As a result, there is a smaller change in volume for everyincrease in pressure",hierarchyLevel:6,children:[],index:"040800040101"},{text:" Due to greater number of fibrous tissues, the lungs reaches itselastic limit earlier, resulting in the plateauing of the volume at a lowerpressure.",hierarchyLevel:6,children:[],index:"040800040102"}],index:"0408000401"},{text:" Decreasing fibrous tissue",hierarchyLevel:5,children:[{text:" Decreasing the fibrous tissue results in weakening of the elasticrecoil",hierarchyLevel:6,children:[],index:"040800040200"},{text:" As a result, there is a greater change in volume for everyincrease in pressure",hierarchyLevel:6,children:[],index:"040800040201"},{text:" Due to lesser number of fibrous tissues, the lungs reaches itselastic limit later, resulting in the plateauing of the volume at a higherpressure.",hierarchyLevel:6,children:[],index:"040800040202"}],index:"0408000402"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0408000403"}],index:"04080004"}],index:"040800"},{text:" Pressures in the Lungs",hierarchyLevel:3,children:[{text:" Generation of Negative Pressures in the Lungs",hierarchyLevel:4,children:[{text:" Due to the muscular structure of the thorax, the ribs has atendency to flatten upwards, become larger and push outwards",hierarchyLevel:5,children:[],index:"0408010000"},{text:" Due to the elastic fibres of the lungs, the lungs has thetendency to compress / contract inwards.",hierarchyLevel:5,children:[],index:"0408010001"},{text:" The thoracic cavity push outwards combined with the lungs pullinginwards results in a constant negative pressure in the interpleural fluid.",hierarchyLevel:5,children:[],index:"0408010002"},{text:" As a result, the pressure of the interpleural fluid is always at-4.",hierarchyLevel:5,children:[],index:"0408010003"}],index:"04080100"},{text:" Pressures in the lungs during inhalation",hierarchyLevel:4,children:[{text:" During inhalation, the thoracic cavity moves outwards, increasingthe volume. As the interpleural fluid is made of liquid with a fixed volume,this creates a negative pressure in the interpleural fluid, which pulls ontothe lungs.",hierarchyLevel:5,children:[],index:"0408010100"},{text:" The force pulling onto the lungs generates a negative pressure inthe lungs, resulting in air to move into the lungs.",hierarchyLevel:5,children:[],index:"0408010101"},{text:" As air moves into the lungs, the pressure in the lungs rises backto 0 (atmospheric pressure).",hierarchyLevel:5,children:[],index:"0408010102"},{text:" Pressure in the  interpleural fluid remains negative .",hierarchyLevel:5,children:[],index:"0408010103"}],index:"04080101"},{text:" Pressures in the lungs during expiration",hierarchyLevel:4,children:[{text:" During expiration, the thoracic cavity moves inwards, decreasingthe volume. This causes the pressure of the interpleural fluid to rise back to-4.",hierarchyLevel:5,children:[],index:"0408010200"},{text:" Increase in the pressure of the interpleural fluid pushes againstthe lungs, causing the pressure of the lungs to rise to above the atmosphericpressure.",hierarchyLevel:5,children:[],index:"0408010201"},{text:" This causes the air to move out of the lungs. ",hierarchyLevel:5,children:[],index:"0408010202"},{text:" As air moves out of the lungs, the pressure in the lungsdecreases back to 0.",hierarchyLevel:5,children:[],index:"0408010203"}],index:"04080102"},{text:" Diagram",hierarchyLevel:4,children:[],index:"04080103"}],index:"040801"},{text:" Pressures in an asthma patient",hierarchyLevel:3,children:[{text:" Phenomenon",hierarchyLevel:4,children:[{text:" An asthma patient would not find it too hard to inspire air",hierarchyLevel:5,children:[],index:"0408020000"},{text:" An asthma patient would find it very difficult to expire air",hierarchyLevel:5,children:[],index:"0408020001"}],index:"04080200"},{text:" Inhalation",hierarchyLevel:4,children:[{text:" During forced inhalation, there is a greater decrease in theinterpleural pressure. The interpleural fluid has a pressure much lower thanthe lungs, and this causes the bronchi to expand and open up. Therefore,inhalation becomes easier.",hierarchyLevel:5,children:[],index:"0408020100"},{text:" During forced exhalation, due to the muscular forces pushing thethoracic cavity inwards, this results in a great increase in the interpleuralpressure to a point where it is greater than the atmospheric pressure.",hierarchyLevel:5,children:[],index:"0408020101"},{text:" The lung pressure does not increase as much as the interpleuralpressure. This results in the interpleural pressure becoming higher pressurethan the lung pressure.",hierarchyLevel:5,children:[],index:"0408020102"},{text:" This  results in the interpleural fluid exerting a force on thebronchi , causing the bronchi to beeven more constricted or even closed.",hierarchyLevel:5,children:[],index:"0408020103"},{text:" This causes difficulty in exhalation.",hierarchyLevel:5,children:[],index:"0408020104"}],index:"04080201"}],index:"040802"}],index:"0408"},{text:" [035] Influence of disease on respiration",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" State the relationship between airway resistance and airwayradium",hierarchyLevel:4,children:[],index:"04090000"},{text:" Explain how dynamic compression limits flow rate in forcedexpiration in healthy patients and normal expiration in COPD",hierarchyLevel:4,children:[],index:"04090001"},{text:" Outline the physiological factors that determine airwayresistance",hierarchyLevel:4,children:[],index:"04090002"},{text:" Describe why compliance changes in lung diseases",hierarchyLevel:4,children:[],index:"04090003"},{text:" Describe the relationship between lung compliance, airway resistanceand work of breathing",hierarchyLevel:4,children:[],index:"04090004"},{text:" Explain how lung volumes change in restrictive and obstructivedisease",hierarchyLevel:4,children:[],index:"04090005"},{text:" Explain V/Q matching",hierarchyLevel:4,children:[],index:"04090006"}],index:"040900"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Obstructive Lung Diseases  blockage on the airway",hierarchyLevel:5,children:[],index:"0409010000"},{text:" Restrictive Lung Diseases  difficulty in fully expanding thelungs by muscular action",hierarchyLevel:5,children:[],index:"0409010001"},{text:" Intrinsic restrictive lung diseases  difficulty in expansion dueto structure of the lungs",hierarchyLevel:5,children:[],index:"0409010002"},{text:" Extrinsic restrictive lung diseases  difficulty in expansion dueto failure of muscles",hierarchyLevel:5,children:[],index:"0409010003"},{text:" Bronchiectasis  airways of the lungs become widened, leading toa build-up of excess mucus",hierarchyLevel:5,children:[],index:"0409010004"}],index:"04090100"},{text:" Types of Lung Diseases",hierarchyLevel:4,children:[{text:" Obstructive",hierarchyLevel:5,children:[{text:" Asthma",hierarchyLevel:6,children:[],index:"040901010000"},{text:" Chronic Obstructive Pulmonary Disease (COPD)",hierarchyLevel:6,children:[],index:"040901010001"},{text:" Bronchiectasis",hierarchyLevel:6,children:[],index:"040901010002"}],index:"0409010100"},{text:" Restrictive",hierarchyLevel:5,children:[{text:" Lung fibrosis (intrinsic)",hierarchyLevel:6,children:[],index:"040901010100"},{text:" Chest wall deformity",hierarchyLevel:6,children:[],index:"040901010101"},{text:" Respiratory muscle weakness",hierarchyLevel:6,children:[],index:"040901010102"},{text:" Pleural disease",hierarchyLevel:6,children:[],index:"040901010103"},{text:" Obesity",hierarchyLevel:6,children:[],index:"040901010104"}],index:"0409010101"}],index:"04090101"},{text:" Airway Resistance and Radius",hierarchyLevel:4,children:[{text:" Understanding",hierarchyLevel:5,children:[{text:" Resistance \u221d1 / radius",hierarchyLevel:6,children:[],index:"040901020000"},{text:" Hence increasing the radius drastically reduces the airwayresistance",hierarchyLevel:6,children:[],index:"040901020001"}],index:"0409010200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0409010201"}],index:"04090102"}],index:"040901"},{text:" Lung Function Tests",hierarchyLevel:3,children:[{text:" Spirogram of Lung Disease",hierarchyLevel:4,children:[{text:" Explanation",hierarchyLevel:5,children:[{text:" In obstructive lung disease, the airway is obstructed but thelungs are still able to compress fully. Therefore, the total expiratory volumewill be the same as without the disease.",hierarchyLevel:6,children:[],index:"040902000000"},{text:" In restrictive lung disease, the lung is restricted in how muchit can expand and contract. However, the airway is fully open and hence it isable to force air out quickly. Hence, the FEV1 will be relatively close tohealthy lung, but the total expiratory volume will be much less due to lessercontraction ability.",hierarchyLevel:6,children:[],index:"040902000001"}],index:"0409020000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0409020001"}],index:"04090200"},{text:" Expiratory flow limitation",hierarchyLevel:4,children:[{text:" Basic Understanding",hierarchyLevel:5,children:[{text:" The alveoli has a tendency to contract due to presence of elastin",hierarchyLevel:6,children:[],index:"040902010000"},{text:" The thoracic cavity has a tendency to expand due to theintercostal muscles",hierarchyLevel:6,children:[],index:"040902010001"},{text:" The opposing movements (inwards for alveoli; outwards forthoracic cavity) results in a negative pressure generated in the pleuralcavity.",hierarchyLevel:6,children:[],index:"040902010002"}],index:"0409020100"},{text:" Effect of Pleural Cavity Pressure on Airway Radius",hierarchyLevel:5,children:[{text:" During pre-inspiration, the thoracic cavity moves outwards,resulting in the further drop in the negative pressure of the pleural cavity.Due to the tendency of the alveoli to contract, the pressure in the alveoli ismuch higher than the pressure in the pleural cavity. As the air in the alveolimoves into the bronchi, due to the resistance in the bronchi, the pressuredrops by half. However, even after dropping the pressure by half, the pressurein the bronchi is still higher than in the pleural cavity. This leads to theincreasing of the bronchi radius, allowing for ease of airflow inwards.",hierarchyLevel:6,children:[],index:"040902010100"},{text:" During forced expiration, the thoracic cavity moves inwardsforcefully, resulting in the generation of a positive pressure in the pleuralcavity. Due to the tendency of the alveoli to contract, the pressure in thealveoli is slightly higher than the pressure in the pleural cavity. It is onlyslightly higher this time because the pleural cavity pressure has increased dueto its inward contraction. Due to the intense contraction of the thoraciccavity, there is less of a pressure difference between the pleural cavity andthe alveoli (slightly more positive). As the air in the alveoli moves into thebronchi, due to the resistance of the bronchi, the pressure drops by half. Thisresults in the pressure in the bronchi to drop to a level lower than thepressure in the pleural cavity. As a result, the pleural cavity exerts a forceon the bronchi, causing it to constrict.",hierarchyLevel:6,children:[],index:"040902010101"}],index:"0409020101"},{text:" Truism",hierarchyLevel:5,children:[{text:" To ensure bronchodilation, you need the bronchi to have a higherpressure than the pleural cavity.",hierarchyLevel:6,children:[],index:"040902010200"},{text:" This can be achieved via: increasing pressure of alveoli withhigher elastic recoil or lowering the pressure of the pleural cavity byincreasing the volume (in inspiration)",hierarchyLevel:6,children:[],index:"040902010201"},{text:" Causes for Increase in Pleural Cavity Pressure(bronchoconstriction)",hierarchyLevel:6,children:[{text:" Exhalation",hierarchyLevel:7,children:[],index:"04090201020200"},{text:" Pleural effusion",hierarchyLevel:7,children:[],index:"04090201020201"},{text:" Pneumothorax",hierarchyLevel:7,children:[],index:"04090201020202"}],index:"040902010202"},{text:" Causes for Decrease in Pleural Cavity Pressure (bronchodilation)",hierarchyLevel:6,children:[{text:" Inhalation",hierarchyLevel:7,children:[],index:"04090201020300"}],index:"040902010203"},{text:" Causes for Decrease in Alveolar Pressure (bronchoconstriction)",hierarchyLevel:6,children:[{text:" Fibrosis  less elastic tissue, less elastic recoil",hierarchyLevel:7,children:[],index:"04090201020400"},{text:" Emphysema",hierarchyLevel:7,children:[],index:"04090201020401"}],index:"040902010204"},{text:" Causes for Increase in Alveolar Pressure (bronchodilation)",hierarchyLevel:6,children:[{text:" More elastic tissue",hierarchyLevel:7,children:[],index:"04090201020500"}],index:"040902010205"}],index:"0409020102"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0409020103"}],index:"04090201"},{text:" Expiratory flow volume",hierarchyLevel:4,children:[{text:" Explanation",hierarchyLevel:5,children:[{text:" Note that the x-axis is the lung volume, indicating how much airis remaining in the lungs. The x-axis is not time.",hierarchyLevel:6,children:[],index:"040902020000"},{text:" At the start of expiration, there is a lot of air the alveoli andtherefore the pressure in the alveoli is reasonably higher than the pressure inthe pleural cavity. This results in the dilation of the bronchi, allowing forfast airflow. This explains the rapidly increasing flow rate and the peak flowrate at the start of expiration. ",hierarchyLevel:6,children:[],index:"040902020001"},{text:" However, as more air moves out of the lungs, the pressure withinthe alveoli starts to decrease. As a result, the differential between thepressure of the alveoli and the lungs becomes less. As a result, the pressurein the bronchi will start to become lower than the pressure in the pleuralcavity.",hierarchyLevel:6,children:[],index:"040902020002"},{text:" Therefore, as the pressure in the alveoli continues to drop, thepressure in the bronchi will likewise drop, leading to greater and greaterconstriction of the bronchi. This leads to a smaller and smaller flow raterecorded.",hierarchyLevel:6,children:[],index:"040902020003"}],index:"0409020200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0409020201"}],index:"04090202"}],index:"040902"},{text:" Abnormal Function",hierarchyLevel:3,children:[{text:" Asthma",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Variable airflow obstruction",hierarchyLevel:6,children:[],index:"040903000000"}],index:"0409030000"},{text:" Reversibility",hierarchyLevel:5,children:[{text:" Totally or partially reversible with therapy or spontaneously",hierarchyLevel:6,children:[],index:"040903000100"}],index:"0409030001"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0409030002"}],index:"04090300"},{text:" COPD",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Chronic airflow obstruction",hierarchyLevel:6,children:[],index:"040903010000"},{text:" Airflow obstruction is progress and associated with abnormalinflammatory response of the lungs to noxious particles or gases",hierarchyLevel:6,children:[],index:"040903010001"}],index:"0409030100"},{text:" Reversibility",hierarchyLevel:5,children:[{text:" Not fully reversible",hierarchyLevel:6,children:[],index:"040903010100"}],index:"0409030101"},{text:" Cause",hierarchyLevel:5,children:[{text:" Cigarette smoking",hierarchyLevel:6,children:[],index:"040903010200"}],index:"0409030102"},{text:" Spectrum of Disease",hierarchyLevel:5,children:[{text:" COPD and emphysema are both intertwined as a disease that existson a spectrum with different severity",hierarchyLevel:6,children:[],index:"040903010300"}],index:"0409030103"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0409030104"}],index:"04090301"},{text:" Pulmonary Fibrosis",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" The formation of excessive fibrous connective tissue in the lungs",hierarchyLevel:6,children:[],index:"040903020000"}],index:"0409030200"},{text:" Effects",hierarchyLevel:5,children:[{text:" Smaller lungs",hierarchyLevel:6,children:[],index:"040903020100"},{text:" Thickened alveolar-capillary membrane",hierarchyLevel:6,children:[],index:"040903020101"},{text:" Obliteration of capillaries",hierarchyLevel:6,children:[],index:"040903020102"},{text:" Stiffer lungs, which increases the work of breathing",hierarchyLevel:6,children:[],index:"040903020103"}],index:"0409030201"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0409030202"}],index:"04090302"},{text:" Effect of Asthma on Expiratory flow limitation",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"040903030000"}],index:"0409030300"},{text:" Explanation",hierarchyLevel:5,children:[{text:" When there is an existing airway obstruction, it takes a lesserdifferential in air pressure to close the bronchi.",hierarchyLevel:6,children:[],index:"040903030100"},{text:" Therefore, an asthmatic patient would experience airway closureat a higher lung volume compared to a healthy patient.",hierarchyLevel:6,children:[],index:"040903030101"}],index:"0409030301"}],index:"04090303"},{text:" Effect of Obstructive vs Restrictive defects in expiratory flowlimitation",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0409030400"},{text:" Explanation  Obstructive ",hierarchyLevel:5,children:[{text:" Obstructive defects results in lower pressure required to closethe bronchi, and hence resulting in pre-mature closure of airways.",hierarchyLevel:6,children:[],index:"040903040100"},{text:" This results in low flow rate in relation to lung volume.",hierarchyLevel:6,children:[],index:"040903040101"}],index:"0409030401"},{text:" Explanation  Restrictive",hierarchyLevel:5,children:[{text:" Restrictive defects result in increased difficulty in compressingthe lungs to force air out.",hierarchyLevel:6,children:[],index:"040903040200"},{text:" As the total lung capacity is lower, the graph starts at a lowerpoint.",hierarchyLevel:6,children:[],index:"040903040201"}],index:"0409030402"}],index:"04090304"},{text:" Effect of Smoking Cessation on FEV1",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0409030500"}],index:"04090305"},{text:" Dynamic Hyperinflation",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Inspiratory Reserve Volume (IRV) - Maximum lung capacity  peakof tidal volume",hierarchyLevel:6,children:[{text:" Shows how much more air you can take in during a deep breath",hierarchyLevel:7,children:[],index:"04090306000000"}],index:"040903060000"},{text:" Expiratory Reserve Volume (ERV) - Minimum lung volume  throughof tidal volume",hierarchyLevel:6,children:[{text:" Shows how much more air you can exhale during forced expiration",hierarchyLevel:7,children:[],index:"04090306000100"}],index:"040903060001"},{text:" Residual Volume (RV)  remaining volume in the lungs after fullexhalation",hierarchyLevel:6,children:[{text:" The amount of air that always remains in the lungs",hierarchyLevel:7,children:[],index:"04090306000200"}],index:"040903060002"},{text:" Tidal volume  amount of air taken in during a normal breath",hierarchyLevel:6,children:[],index:"040903060003"},{text:" Inspiratory Capacity  Tidal Volume + Inspiratory Reserve Volume",hierarchyLevel:6,children:[{text:" The total amount of air that can be inhaled",hierarchyLevel:7,children:[],index:"04090306000400"}],index:"040903060004"},{text:" Functional Residual Capacity (FRC)  Expiratory Reserve Volume +Residual Volume",hierarchyLevel:6,children:[],index:"040903060005"},{text:" Vital Capacity (VC)  Inspiratory Reserve Volume + Tidal Volume +Expiratory Reserve Volume",hierarchyLevel:6,children:[{text:" The maximum amount of volume variation possible in the lungs inan alive human",hierarchyLevel:7,children:[],index:"04090306000600"}],index:"040903060006"},{text:" Total Lung Capacity  the total amount of air in the lungs",hierarchyLevel:6,children:[],index:"040903060007"}],index:"0409030600"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0409030601"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Airway obstruction results in premature closure of the airwaysduring exhalation. This leads to air getting progressively trapped in thelungs. ",hierarchyLevel:6,children:[],index:"040903060200"},{text:" As a result, Total Lung Capacity, Functional Residual Capacityand Residual Volume will increase.",hierarchyLevel:6,children:[],index:"040903060201"}],index:"0409030602"}],index:"04090306"},{text:" Effect of COPD on work of breathing",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Dyspnoea  difficult of laboured breathing",hierarchyLevel:6,children:[],index:"040903070000"}],index:"0409030700"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0409030701"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Increased work of breathing leads to dyspnoea",hierarchyLevel:6,children:[],index:"040903070200"}],index:"0409030702"}],index:"04090307"}],index:"040903"},{text:" Compliance",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Parenchyma  the functional tissue of an organ distinguished fromthe connective and supporting tissue",hierarchyLevel:5,children:[],index:"0409040000"},{text:" Radial traction  the force exerted by the lung parenchyma tokeep the airways open (elastic recoil)",hierarchyLevel:5,children:[],index:"0409040001"}],index:"04090400"},{text:" Definition of Compliance",hierarchyLevel:4,children:[{text:" The ease of the lungs to stretch",hierarchyLevel:5,children:[],index:"0409040100"},{text:" The inverse of the strength of elastic recoil of the lungs",hierarchyLevel:5,children:[],index:"0409040101"}],index:"04090401"},{text:" Mechanism of Compliance Change in Emphysema",hierarchyLevel:4,children:[{text:" Emphysema destroys the lung parenchyma, resulting in the loss ofradial traction of the lungs.",hierarchyLevel:5,children:[],index:"0409040200"},{text:" This leads to less elastic recoil of the lungs and hence increasecompliance",hierarchyLevel:5,children:[],index:"0409040201"}],index:"04090402"},{text:" Mechanism of Compliance Change in Pulmonary fibrosis",hierarchyLevel:4,children:[{text:" Increased in collagen production leads to stiffer lungs",hierarchyLevel:5,children:[],index:"0409040300"},{text:" Stiffer lungs results in lower compliance",hierarchyLevel:5,children:[],index:"0409040301"}],index:"04090403"}],index:"040904"},{text:" Respiratory Failure",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Lung failure  the failure of the alveolar structures resultingin ineffective diffusion / gas exchange",hierarchyLevel:5,children:[],index:"0409050000"},{text:" Pump failure  the failure of the ventilation mechanismsresulting in lack of air entering",hierarchyLevel:5,children:[],index:"0409050001"}],index:"04090500"},{text:" Summary of Types of Respiratory Failure",hierarchyLevel:4,children:[],index:"04090501"},{text:" VQ Matching",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0409050200"},{text:" Explanation",hierarchyLevel:5,children:[{text:" Ventilation is not wasted on under/non-perfused areas, andperfusion is not wasted on unventilated regions",hierarchyLevel:6,children:[],index:"040905020100"},{text:" Healthy VQ matching results in a V/Q ratio of 1",hierarchyLevel:6,children:[],index:"040905020101"}],index:"0409050201"}],index:"04090502"},{text:" Abnormal Function: VQ mismatch",hierarchyLevel:4,children:[{text:" Dead space  Type 1 Respiratory Failure",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"040905030000"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Restrictive defects such as pulmonary fibrosis leads the increasein generation of collagen in the alveoli which results in the obliteration ofcapillaries and the thickening of the alveolar-capillary membrane.",hierarchyLevel:7,children:[],index:"04090503000100"},{text:" As a result, some of the ventilated areas of the lungs now do nothave capillaries to perfused them. This leads to the formation of dead space.The V/Q ratio is > 1",hierarchyLevel:7,children:[],index:"04090503000101"},{text:" This will lead to hypoxemia but not hypercapnia (as it can becompensated), and hence it results in Type 1 Respiratory Failure",hierarchyLevel:7,children:[],index:"04090503000102"}],index:"040905030001"}],index:"0409050300"},{text:" Shunting  Type 2 Respiratory Failure",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"040905030100"},{text:" Explanation",hierarchyLevel:6,children:[{text:" Obstructive defects such as COPD and asthma results in the earlyclosure of the airways. This a pump problem where there is not sufficientventilation.",hierarchyLevel:7,children:[],index:"04090503010100"},{text:" As a result, some perfused areas of the lungs do not receiveventilation, resulting in them passing through the lungs without gas exchange.Hence, a right to left cardiac shunt is formed. The V/Q ratio is < 1.",hierarchyLevel:7,children:[],index:"04090503010101"},{text:" This will lead to hypoxemia but not hypercapnia (as it can becompensated), and hence Type 1 respiratory failure.",hierarchyLevel:7,children:[],index:"04090503010102"}],index:"040905030101"}],index:"0409050301"},{text:" Explanation of lack of hypercapnia due to V/Q mismatch",hierarchyLevel:5,children:[{text:" CO  is much more soluble than O  andtherefore diffuses much more rapidly. This means that even with the shunting orthe dead space, other healthy parts of the lung is able to more than compensateby rapidly removing CO",hierarchyLevel:6,children:[],index:"040905030200"},{text:" Hypercapnia is only caused when the entire lung is beingunderventilated and there is no chance for compensation.",hierarchyLevel:6,children:[],index:"040905030201"}],index:"0409050302"}],index:"04090503"}],index:"040905"}],index:"0409"},{text:" [036] Immune mediated pathology of the lung",hierarchyLevel:2,children:[{text:" Learning Objectives",hierarchyLevel:3,children:[{text:" The normal immune response to infection",hierarchyLevel:4,children:[],index:"04100000"},{text:" Ways in which immune response can damage the lungs",hierarchyLevel:4,children:[],index:"04100001"},{text:" The 4 types of hypersensitivity (or excessive immune response)and examples of each",hierarchyLevel:4,children:[],index:"04100002"}],index:"041000"},{text:" Viral Immune Response in the Lung",hierarchyLevel:3,children:[{text:" Early non-specific innate immunity",hierarchyLevel:4,children:[{text:" Epithelial barrier",hierarchyLevel:5,children:[{text:" Provides a physical barrier with tight junctions and defensinsand cathelicidins",hierarchyLevel:6,children:[],index:"041001000000"}],index:"0410010000"},{text:" Interferons (IFN)  interferes with viral replication",hierarchyLevel:5,children:[{text:" Type I IFN",hierarchyLevel:6,children:[{text:" IFN \u03b1  mononuclear phagocytes and plasmacytoid dendriticcells",hierarchyLevel:7,children:[],index:"04100100010000"},{text:" IFN \u03b2  many cell types",hierarchyLevel:7,children:[],index:"04100100010001"}],index:"041001000100"},{text:" Type II IFN",hierarchyLevel:6,children:[{text:" IFN \u03b3",hierarchyLevel:7,children:[],index:"04100100010100"}],index:"041001000101"}],index:"0410010001"},{text:" Natural killer cells",hierarchyLevel:5,children:[{text:" Kill injured and virally infected cells",hierarchyLevel:6,children:[],index:"041001000200"}],index:"0410010002"},{text:" Macrophages",hierarchyLevel:5,children:[{text:" Kill virally infected cells",hierarchyLevel:6,children:[],index:"041001000300"},{text:" Produce antiviral molecules  TNF\u03b1, nitric oxide and IFN \u03b1",hierarchyLevel:6,children:[],index:"041001000301"}],index:"0410010003"}],index:"04100100"},{text:" Adaptive Immunity",hierarchyLevel:4,children:[{text:" Antivral antibodies",hierarchyLevel:5,children:[{text:" Block binding and viral entry into the cell",hierarchyLevel:6,children:[],index:"041001010000"},{text:" Opsonize viruses and activate complement proteins",hierarchyLevel:6,children:[],index:"041001010001"},{text:" IgA is present in respiratory tract",hierarchyLevel:6,children:[],index:"041001010002"},{text:" IgG allows for antibody dependent cell mediated cytotoxicity(ADCC) Fc\u03b3RIII on natural killer cells",hierarchyLevel:6,children:[],index:"041001010003"}],index:"0410010100"},{text:" Cytotoxic (CD8) T lymphocytes",hierarchyLevel:5,children:[],index:"0410010101"},{text:" Helper T lymphocytes",hierarchyLevel:5,children:[{text:" Produce IL-2 to stimulate CD8 T cell growth",hierarchyLevel:6,children:[],index:"041001010200"},{text:" Chemokines to recruit CD8 T cells",hierarchyLevel:6,children:[],index:"041001010201"},{text:" TNF \u03b1 and IFN \u03b1 to recruit and activate macrophages",hierarchyLevel:6,children:[],index:"041001010202"}],index:"0410010102"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0410010103"}],index:"04100101"}],index:"041001"},{text:" Bacterial Immune Response of the Lung",hierarchyLevel:3,children:[{text:" Pneumonia",hierarchyLevel:4,children:[{text:" Cause",hierarchyLevel:5,children:[{text:" Streptococcus pneumoniae",hierarchyLevel:6,children:[],index:"041002000000"},{text:" Atypicals  mycoplasma, legionella, chlamydia",hierarchyLevel:6,children:[],index:"041002000001"},{text:" Staphylococcus aureus",hierarchyLevel:6,children:[],index:"041002000002"},{text:" Chronic infections  Mycobacterium tuberculosis, actinomycosis",hierarchyLevel:6,children:[],index:"041002000003"}],index:"0410020000"}],index:"04100200"},{text:" Vicious Cycle of Infections",hierarchyLevel:4,children:[{text:" Damage",hierarchyLevel:5,children:[],index:"0410020100"},{text:" Infection",hierarchyLevel:5,children:[],index:"0410020101"},{text:" Immune response (repeat)",hierarchyLevel:5,children:[],index:"0410020102"}],index:"04100201"}],index:"041002"},{text:" Immune Deficiencies",hierarchyLevel:3,children:[{text:" Diagram",hierarchyLevel:4,children:[],index:"04100300"}],index:"041003"},{text:" Chronic Infections",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Chronic bronchitis  chronic inflammation of the bronchi",hierarchyLevel:5,children:[],index:"0410040000"},{text:" Bronchiectasis  dilated and destroyed bronchi",hierarchyLevel:5,children:[],index:"0410040001"}],index:"04100400"},{text:" Cause",hierarchyLevel:4,children:[{text:" Smoking",hierarchyLevel:5,children:[],index:"0410040100"},{text:" Immune system activation which exacerbates damage",hierarchyLevel:5,children:[],index:"0410040101"}],index:"04100401"}],index:"041004"},{text:" Immune cells",hierarchyLevel:3,children:[{text:" Neutrophils",hierarchyLevel:4,children:[{text:" Function",hierarchyLevel:5,children:[{text:" Protease production",hierarchyLevel:6,children:[],index:"041005000000"},{text:" Reactive oxygen species generation",hierarchyLevel:6,children:[],index:"041005000001"},{text:" Reactive nitrogen species generation",hierarchyLevel:6,children:[],index:"041005000002"},{text:" Release of neutrophil extracellular traps (NETs)  immobilizesfor macrophage to phagocytize",hierarchyLevel:6,children:[],index:"041005000003"}],index:"0410050000"},{text:" Neutrophil Extracellular Traps (NETs)",hierarchyLevel:5,children:[{text:" Components",hierarchyLevel:6,children:[{text:" Intricate network of DNA embellished with antimicrobial peptidesand proteases",hierarchyLevel:7,children:[],index:"04100500010000"}],index:"041005000100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"041005000101"},{text:" Abnormal Function",hierarchyLevel:6,children:[{text:" Dysregulated NETosis leads to autoimmune rheumatic disease (ARDs)",hierarchyLevel:7,children:[],index:"04100500010200"},{text:" Dsyregulated NETosis leads to connective tissue disease (CTDs)",hierarchyLevel:7,children:[],index:"04100500010201"}],index:"041005000102"}],index:"0410050001"}],index:"04100500"}],index:"041005"},{text:" Hypersensitivity Immune Injury",hierarchyLevel:3,children:[{text:" Type I Hypersensitivity Immune Injury",hierarchyLevel:4,children:[{text:" Causes",hierarchyLevel:5,children:[{text:" Excess Th2 activity leading to production of IL-4, IL-5 andeosinophil recruitment",hierarchyLevel:6,children:[],index:"041006000000"}],index:"0410060000"}],index:"04100600"},{text:" Type II Hypersensitivity Immune Injury",hierarchyLevel:4,children:[{text:" Causes",hierarchyLevel:5,children:[{text:" Goodpastures disease",hierarchyLevel:6,children:[{text:" Auto-antibodies against type IV collagen",hierarchyLevel:7,children:[],index:"04100601000000"}],index:"041006010000"},{text:" Association with Rheumatoid arthritis",hierarchyLevel:6,children:[],index:"041006010001"},{text:" Association with Systemic Lupus Erythematosus",hierarchyLevel:6,children:[],index:"041006010002"}],index:"0410060100"}],index:"04100601"},{text:" Type III Hypersensitivity Immune Injury",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Bronchoalveolar lavage  collect a sample from the lungs fortesting; a saline solution is put through the bronchoscope to wash the airwaysand capture a fluid sample",hierarchyLevel:6,children:[],index:"041006020000"}],index:"0410060200"},{text:" Symptoms",hierarchyLevel:5,children:[{text:" Abnormal Bronchoalveolar lavage  high CD8, lymphocytosis,macrophage changes",hierarchyLevel:6,children:[],index:"041006020100"},{text:" Circulating precipitin antibodies",hierarchyLevel:6,children:[],index:"041006020101"},{text:" B cell activation with T cell infiltrate and granuloma-likeclusters in interstitium",hierarchyLevel:6,children:[],index:"041006020102"}],index:"0410060201"}],index:"04100602"},{text:" Type IV Hypersensitivity Immune Injury",hierarchyLevel:4,children:[{text:" Symptoms",hierarchyLevel:5,children:[{text:" Granulomatous and fibrotic components in the lung",hierarchyLevel:6,children:[],index:"041006030000"}],index:"0410060300"}],index:"04100603"}],index:"041006"},{text:" Other Conditions",hierarchyLevel:3,children:[{text:" Pulmonary Fibrosis",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Pulmonary Fibrosis  formation and development of excess fibrousconnective tissue in the lung interstitium",hierarchyLevel:6,children:[],index:"041007000000"},{text:" Dyspnoea  difficult or laboured breathing",hierarchyLevel:6,children:[],index:"041007000001"}],index:"0410070000"},{text:" Symptoms",hierarchyLevel:5,children:[{text:" Finger clubbing",hierarchyLevel:6,children:[],index:"041007000100"},{text:" Cyanosis",hierarchyLevel:6,children:[],index:"041007000101"},{text:" Progressive dyspnoea",hierarchyLevel:6,children:[],index:"041007000102"},{text:" Pulmonary hypertension",hierarchyLevel:6,children:[],index:"041007000103"},{text:" End inspiratory crackles",hierarchyLevel:6,children:[],index:"041007000104"}],index:"0410070001"}],index:"04100700"}],index:"041007"}],index:"0410"}]},{text:"Embryology",hierarchyLevel:1,children:[{text:" [024] Lung development",hierarchyLevel:2,children:[{text:" Refresher",hierarchyLevel:3,children:[{text:" Process",hierarchyLevel:4,children:[],index:"05000000"}],index:"050000"},{text:" Overall Development",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Diverticula  a tube leading from a cavity of passage",hierarchyLevel:5,children:[],index:"0500010000"}],index:"05000100"},{text:" Timeframe",hierarchyLevel:4,children:[{text:" Begins on day 22 of embryonic development",hierarchyLevel:5,children:[],index:"0500010100"}],index:"05000101"},{text:" Components",hierarchyLevel:4,children:[{text:" Endoderm -> Respiratory epithelium",hierarchyLevel:5,children:[],index:"0500010200"},{text:" Mesoderm -> Connective tissue, muscle, vasculature andbronchial cartilage",hierarchyLevel:5,children:[],index:"0500010201"},{text:" Neural crest cells -> Laryngeal cartilage",hierarchyLevel:5,children:[],index:"0500010202"}],index:"05000102"},{text:" Diagram",hierarchyLevel:4,children:[],index:"05000103"}],index:"050001"},{text:" Formation of Trachea",hierarchyLevel:3,children:[{text:" Process",hierarchyLevel:4,children:[{text:" oAnterior endoderm folds and forms the foregut, and brings the cardiacmesoderm into the chest",hierarchyLevel:5,children:[],index:"0500020000"},{text:" The cardiac mesoderm secretes Fibroblast Growth Factor (FGF)which stimulates the adjacent ventral foregut endoderm.",hierarchyLevel:5,children:[],index:"0500020001"},{text:" This causes the lung primordia from the ventral foregut endodermto pinch off from the foregut to form the respiratory diverticulum. Therespiratory diverticulum eventually develops into the trachea.",hierarchyLevel:5,children:[],index:"0500020002"},{text:" Fibroblast growth factor further stimulates the formation ofbronchial buds from the trachea.",hierarchyLevel:5,children:[],index:"0500020003"}],index:"05000200"},{text:" Diagram",hierarchyLevel:4,children:[],index:"05000201"},{text:" Abnormal Function",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" Oesophageal atresia  blind oesophagus (oesophagus not connected)",hierarchyLevel:6,children:[],index:"050002020000"},{text:" Tracheo-oesophageal fistula  abnornal connection between tracheaand oesophagus",hierarchyLevel:6,children:[],index:"050002020001"}],index:"0500020200"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"050002020100"}],index:"0500020201"},{text:" Prevalence",hierarchyLevel:5,children:[{text:" 1 in 5000",hierarchyLevel:6,children:[],index:"050002020200"}],index:"0500020202"},{text:" Cause",hierarchyLevel:5,children:[{text:" Unknown  linked to Shh mutations in mouse modals",hierarchyLevel:6,children:[],index:"050002020300"}],index:"0500020203"},{text:" Diagnosis",hierarchyLevel:5,children:[{text:" Visible on ultrasound scans after 26 weeks of pregnancy",hierarchyLevel:6,children:[],index:"050002020400"},{text:" After birth, infant experiences coughing, gagging and chokingwhen attempting to eat",hierarchyLevel:6,children:[],index:"050002020401"},{text:" Infant has bluish skin",hierarchyLevel:6,children:[],index:"050002020402"}],index:"0500020204"},{text:" Treatment",hierarchyLevel:5,children:[{text:" Surgical correction",hierarchyLevel:6,children:[],index:"050002020500"}],index:"0500020205"}],index:"05000202"}],index:"050002"},{text:" Formation of Bronchi",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" SHH  sonic hedgehog",hierarchyLevel:5,children:[],index:"0500030000"},{text:" FGF  fibroblast growth factor",hierarchyLevel:5,children:[],index:"0500030001"},{text:" BMP  bone morphogenetic protein",hierarchyLevel:5,children:[],index:"0500030002"},{text:" WNT  Wingless-related iNTegration site gene",hierarchyLevel:5,children:[],index:"0500030003"},{text:" RA  retinoic acid",hierarchyLevel:5,children:[],index:"0500030004"},{text:" Agenesis  failure of all or part of an organ to develop duringembryonic growth",hierarchyLevel:5,children:[],index:"0500030005"}],index:"05000300"},{text:" Process",hierarchyLevel:4,children:[{text:" Pleural mesenchyme (mesoderm) releases FGF10, BMP4, WNT2, RA tothe epithelium (endoderm), stimulating the elongation and branches of theendoderm (trachea)",hierarchyLevel:5,children:[],index:"0500030100"},{text:" This causes the trachea to branch into two primary bronchialbuds. ",hierarchyLevel:5,children:[],index:"0500030101"},{text:" Primary bronchial buds branches into 3 secondary bronchial budson the right and 2 secondary bronchial buds on the left.",hierarchyLevel:5,children:[],index:"0500030102"},{text:" Secondary bronchial buds further split into tertiary bronchialbuds which become bronchopulmonary segments of the mature lung",hierarchyLevel:5,children:[],index:"0500030103"},{text:" The epithelium expresses FGF9, BMP4, WNT7a/5b and SHH at thedistal tips which affect the pleural mesenchyme.",hierarchyLevel:5,children:[],index:"0500030104"}],index:"05000301"},{text:" Diagram",hierarchyLevel:4,children:[],index:"05000302"},{text:" Abnormal Function: Pulmonary Hypoplasia / Lung Agenesis",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Lack of growth of the lung tissue",hierarchyLevel:6,children:[],index:"050003030000"}],index:"0500030300"},{text:" Prevalence",hierarchyLevel:5,children:[{text:" 1 / 10 000",hierarchyLevel:6,children:[],index:"050003030100"}],index:"0500030301"},{text:" Diagnosis",hierarchyLevel:5,children:[{text:" Abnormally low number of bronchopulmonary segments or alveoli",hierarchyLevel:6,children:[],index:"050003030200"},{text:" Complete absence of lung (agenesis)",hierarchyLevel:6,children:[],index:"050003030201"}],index:"0500030302"},{text:" Cause",hierarchyLevel:5,children:[{text:" Wide variety, associated with congenital malformations",hierarchyLevel:6,children:[],index:"050003030300"}],index:"0500030303"},{text:" Diagram",hierarchyLevel:5,children:[{text:" A  lung agenesis",hierarchyLevel:6,children:[],index:"050003030400"},{text:" B  complete opacity of right hemithorax and displacement ofheart and mediastinum to the right",hierarchyLevel:6,children:[],index:"050003030401"},{text:" C  bronchograph showing absence of right pulmonary bronchus",hierarchyLevel:6,children:[],index:"050003030402"},{text:" D  angiography showing absence of right pulmonary artery",hierarchyLevel:6,children:[],index:"050003030403"}],index:"0500030304"}],index:"05000303"}],index:"050003"},{text:" Formation of Terminal Sacs of Lung",hierarchyLevel:3,children:[{text:" Process",hierarchyLevel:4,children:[{text:" In 26-28 weeks of fetal development, terminal sacs starts todevelop, forming cuboidal cells.",hierarchyLevel:5,children:[],index:"0500040000"},{text:" In 36 weeks of development, cuboidal cells of the terminal sacsflatten to become squamous and the mature alveoli is formed.",hierarchyLevel:5,children:[],index:"0500040001"},{text:" Before birth, 20-70 million terminal sacs are formed in eachlung.",hierarchyLevel:5,children:[],index:"0500040002"},{text:" After birth, there are 300-400 million alveoli in the mature lung",hierarchyLevel:5,children:[],index:"0500040003"}],index:"05000400"},{text:" Diagram",hierarchyLevel:4,children:[],index:"05000401"},{text:" Structure and Function of Mature Alveolus",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0500040200"}],index:"05000402"},{text:" Pulmonary Surfactant",hierarchyLevel:4,children:[{text:" Composition",hierarchyLevel:5,children:[{text:" Lipoprotein complex (69% Phosphatidylcholine, 11% protein (serumproteins and surfactant proteins (A-D), 10% phosphatidylglycerol, 10% otherlipids)",hierarchyLevel:6,children:[],index:"050004030000"}],index:"0500040300"},{text:" Function",hierarchyLevel:5,children:[{text:" Spread as a thin film at air-liquid interface",hierarchyLevel:6,children:[],index:"050004030100"},{text:" Lowers surface tension",hierarchyLevel:6,children:[],index:"050004030101"},{text:" Prevents alveolar collapse (at end of expiration)",hierarchyLevel:6,children:[],index:"050004030102"},{text:" Reduces pressure required for alveolar inflation",hierarchyLevel:6,children:[],index:"050004030103"},{text:" Provides innate immunity in preventing infection",hierarchyLevel:6,children:[],index:"050004030104"}],index:"0500040301"},{text:" Abnormal Function: Neonatal respiratory distress",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Development of terminal sacs and alveoli occurs very late in fetaldevelopment",hierarchyLevel:7,children:[],index:"05000403020000"},{text:" Premature babies do not have fully developed alveoli.",hierarchyLevel:7,children:[],index:"05000403020001"},{text:" Immature alveoli are unable to produce surfactant, leading tosurfactant deficiency.",hierarchyLevel:7,children:[],index:"05000403020002"},{text:" Surfactant deficiency leads to the collapse of the alveoli,leading to difficulty in breathing",hierarchyLevel:7,children:[],index:"05000403020003"}],index:"050004030200"},{text:" Diagnosis",hierarchyLevel:6,children:[{text:" Displayed breathing difficulties in the first few hours of life",hierarchyLevel:7,children:[],index:"05000403020100"},{text:" Hypoxia (low O )",hierarchyLevel:7,children:[],index:"05000403020101"},{text:" Hypercapnia (high CO )",hierarchyLevel:7,children:[],index:"05000403020102"}],index:"050004030201"},{text:" Prevalence",hierarchyLevel:6,children:[{text:" 1 / 100",hierarchyLevel:7,children:[],index:"05000403020200"},{text:" Leading cause of death in infants",hierarchyLevel:7,children:[],index:"05000403020201"},{text:" Risk is correlated inversely with gestational age at birth",hierarchyLevel:7,children:[{text:" > 60% at < 30 weeks",hierarchyLevel:8,children:[],index:"0500040302020200"},{text:" 20% at 34 weeks",hierarchyLevel:8,children:[],index:"0500040302020201"},{text:" < 5% at >36 weeks",hierarchyLevel:8,children:[],index:"0500040302020202"}],index:"05000403020202"}],index:"050004030202"},{text:" Treatment",hierarchyLevel:6,children:[{text:" Stimulate the production of surfactant by injecting the motherwith glucocorticoids routinely",hierarchyLevel:7,children:[],index:"05000403020300"},{text:" Provide oxygen and exogenous preparation of surfactant",hierarchyLevel:7,children:[],index:"05000403020301"}],index:"050004030203"},{text:" Prognosis",hierarchyLevel:6,children:[{text:" Good chance of survival for infants born after 26 weeks",hierarchyLevel:7,children:[],index:"05000403020400"}],index:"050004030204"},{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"05000403020500"}],index:"050004030205"}],index:"0500040302"}],index:"05000403"}],index:"050004"},{text:" Formation of Thoracic Diaphragm",hierarchyLevel:3,children:[{text:" Process",hierarchyLevel:4,children:[{text:" Septum transversum develops into the central tendon of thediaphragm",hierarchyLevel:5,children:[],index:"0500050000"},{text:" Cervical somites develop into the musculature of the diaphgram",hierarchyLevel:5,children:[],index:"0500050001"},{text:" Oesophageal mesoderm develops into the connective tissue of thediaphragm",hierarchyLevel:5,children:[],index:"0500050002"},{text:" Pleuroperitoneal membranes develops into the connective tissue ofthe diaphragm",hierarchyLevel:5,children:[],index:"0500050003"},{text:" In the 3  trimester, upon the development of thediaphragm, fetal respiratory movements occur, preparing the respiratory systemor neonatal function.",hierarchyLevel:5,children:[],index:"0500050004"}],index:"05000500"},{text:" Diagram",hierarchyLevel:4,children:[],index:"05000501"},{text:" Development of Diaphragm Innervation",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Dermatomes of C3, C4, C5 innervates the myotomes of somites",hierarchyLevel:6,children:[],index:"050005020000"},{text:" The myotomes migrate to the septum transversum, forming thediaphragm.",hierarchyLevel:6,children:[],index:"050005020001"},{text:" Nerve fibres that innervated the myotomes follow the migration ofthe myotome from the cervical region to the abdominal region, forming thephrenic nerve",hierarchyLevel:6,children:[],index:"050005020002"}],index:"0500050200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0500050201"}],index:"05000502"},{text:" Abnormal Function: Congenital Diaphragmatic Hernia",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Hernia  internal part of the body pushes through a weakness inthe muscle",hierarchyLevel:6,children:[],index:"050005030000"}],index:"0500050300"},{text:" Cause",hierarchyLevel:5,children:[{text:" Incorrect development of the diaphragm results in the gut pushingthrough the diaphragm into the thoracic cavity",hierarchyLevel:6,children:[],index:"050005030100"},{text:" As a result, the lung on the left side of the fetus is compressedand fail to develop properly, resulting in pulmonary hypoplasia",hierarchyLevel:6,children:[],index:"050005030101"}],index:"0500050301"}],index:"05000503"}],index:"050005"},{text:" Transitions at Birth",hierarchyLevel:3,children:[{text:" Lungs",hierarchyLevel:4,children:[{text:" Transition Process after Birth",hierarchyLevel:5,children:[{text:" Fetal lungs are filled with amniotic fluid in the womb.",hierarchyLevel:6,children:[],index:"050006000000"},{text:" At birth, the fluid is removed by expelling through the mouth,nose and absorbed into the pulmonary vasculature and lymphatics.",hierarchyLevel:6,children:[],index:"050006000001"},{text:" After the fluid is removed, the lungs are filled with air.",hierarchyLevel:6,children:[],index:"050006000002"}],index:"0500060000"}],index:"05000600"},{text:" Circulatory System",hierarchyLevel:4,children:[{text:" Process before Birth",hierarchyLevel:5,children:[{text:" Main Pathway",hierarchyLevel:6,children:[{text:" Oxygenated Blood => Placenta => Ductous Venosus => Body=> Right Atrium =>Foreamen Ovale => Left Atrium => Left Ventricle=> Placenta",hierarchyLevel:7,children:[],index:"05000601000000"}],index:"050006010000"},{text:" Alternate Pathway",hierarchyLevel:6,children:[{text:" Oxygenated Blood => Placenta => Ductous Venosus => Body=> Right Atrium =>   =>  => Placenta",hierarchyLevel:7,children:[],index:"05000601000100"},{text:" Oxygenated Blood => Placenta => Ductous Venosus => Body=> Right Atrium =>   =>   => LeftAtrium => Left Ventricle=> Placenta",hierarchyLevel:7,children:[],index:"05000601000101"}],index:"050006010001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"050006010002"}],index:"0500060100"},{text:" Transition Process after Birth",hierarchyLevel:5,children:[{text:" Baby takes the first breath, resulting in the inflation of thelungs.",hierarchyLevel:6,children:[],index:"050006010100"},{text:" This opens the pulmonary circuit and more blood flows from theright ventricle to the lungs, and more blood flows from the lungs to the leftatrium.",hierarchyLevel:6,children:[],index:"050006010101"},{text:" This results in the rise in the blood pressure of the leftatrium, resulting in the closure of the foramen ovale. ",hierarchyLevel:6,children:[],index:"050006010102"},{text:" Activation of the pulmonary circuit change blood oxygen levelsand changes the blood flow, causing the closure of ductus arteriosus and ductusvenosus. ",hierarchyLevel:6,children:[],index:"050006010103"},{text:" Umbilical cord is cut and the placenta is ejected.",hierarchyLevel:6,children:[],index:"050006010104"}],index:"0500060101"}],index:"05000601"}],index:"050006"}],index:"0500"},{text:" [040] Development of the Cardiovascular System",hierarchyLevel:2,children:[{text:" Embryology Revision",hierarchyLevel:3,children:[{text:" Tracking Cells in Embryology",hierarchyLevel:4,children:[],index:"05010000"},{text:" The Story of Embryology",hierarchyLevel:4,children:[{text:" Cleavage and compaction",hierarchyLevel:5,children:[],index:"0501000100"},{text:" Formation of the Blastocyst",hierarchyLevel:5,children:[],index:"0501000101"},{text:" Hatching",hierarchyLevel:5,children:[],index:"0501000102"},{text:" Implantation",hierarchyLevel:5,children:[],index:"0501000103"},{text:" Formation of the syncytiotrophoblast and cytotrophoblast",hierarchyLevel:5,children:[],index:"0501000104"},{text:" Formation of lacunae and the lacunae network",hierarchyLevel:5,children:[],index:"0501000105"},{text:" Formation of the extra-embryonic mesoderm to form the chorioniccavity",hierarchyLevel:5,children:[],index:"0501000106"},{text:" Differentiation of inner cell mass into hypoblast and epiblast",hierarchyLevel:5,children:[],index:"0501000107"},{text:" Formation of the Heuer membrane and the amniotic cavity",hierarchyLevel:5,children:[],index:"0501000108"},{text:" Gastrulation and formation of the ectoderm, mesoderm and endoderm",hierarchyLevel:5,children:[],index:"0501000109"},{text:" Ectoderm at the top, mesoderm in the middle and the endoderm atthe bottom with the yolk sac",hierarchyLevel:5,children:[],index:"0501000110"}],index:"05010001"}],index:"050100"},{text:" Formation of Blood",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Vasculogenesis  the differentiation of precursor cells intoprimary erythrocytes and endothelial cells to form the primitive vascularnetwork",hierarchyLevel:5,children:[],index:"0501010000"},{text:" Angiogenesis  the growth of new capillaries from pre-existingblood vessels",hierarchyLevel:5,children:[],index:"0501010001"},{text:" Intussusception  the splitting of an existing blood vessel into2",hierarchyLevel:5,children:[],index:"0501010002"},{text:" Aorta-gonad-mesonephros  a region of embryonic mesoderm whichdevelops from the para-aortic splanchnopleura, and contains the dorsa aorta",hierarchyLevel:5,children:[],index:"0501010003"}],index:"05010100"},{text:" Process of Vasculogensis",hierarchyLevel:4,children:[{text:" Outside the endoderm (contains the yolk sac), extra-embryonicmesoderm contains haemangioblasts",hierarchyLevel:5,children:[],index:"0501010100"},{text:" Haemangioblasts expresses Cpeb4 gene, resulting in itsdifferentiation into angioblasts and haematopoietic stem cells.",hierarchyLevel:5,children:[],index:"0501010101"},{text:" Angioblast aggregates at the center, while haematopoietic stemcells aggregate surrounding the angioblasts",hierarchyLevel:5,children:[],index:"0501010102"},{text:" Angioblast differentiates to form primary erythrocytes.",hierarchyLevel:5,children:[],index:"0501010103"},{text:" Haematopoietic stem cells differentiates to form endothelialcells of the blood vessels.",hierarchyLevel:5,children:[],index:"0501010104"},{text:" This results in the formation of blood islands.",hierarchyLevel:5,children:[],index:"0501010105"},{text:" Eventually, the blood islands will organize into capillarieswhich will enlarge and connect to form the primary vascular network.",hierarchyLevel:5,children:[],index:"0501010106"},{text:" The same process occurs for the splanchnic layer of the lateralplate mesoderm.",hierarchyLevel:5,children:[],index:"0501010107"}],index:"05010101"},{text:" Process of Angiogenesis",hierarchyLevel:4,children:[{text:" Extracellular signals such as fibroblast growth factor (FGF),vascular endothelial growth factor (VEGF) and angioproteins stimulates thesprouting of the endothelium of the parent blood vessel.",hierarchyLevel:5,children:[],index:"0501010200"},{text:" This leads to the parent blood vessel proliferating andextending, resulting in vascular sprouting and hence the formation of new bloodvessels.",hierarchyLevel:5,children:[],index:"0501010201"},{text:" Moreover, intussusception occurs, resulting in the parent bloodvessel to split into two blood vessels.",hierarchyLevel:5,children:[],index:"0501010202"}],index:"05010102"},{text:" Process of Haematopoietic Cell Migration",hierarchyLevel:4,children:[{text:" Haematopoietic cells right outside of the yolk sack will migrateto the placenta and the fetal liver.",hierarchyLevel:5,children:[],index:"0501010300"},{text:" Eventually, when the haematopoietic stem cells of the AGM aredeveloped, they will migrate to the fetal liver, yolk sac, umbilical cord andplacenta.",hierarchyLevel:5,children:[],index:"0501010301"}],index:"05010103"},{text:" Types of Haemoglobin during Fetal Development",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" Embryonic Haemoglobin  2\u03b5 + 2 globin subunits",hierarchyLevel:6,children:[],index:"050101040000"},{text:" Fetal Haemoglobin  2\u03b1 + 2\u03b3 globin subunits",hierarchyLevel:6,children:[],index:"050101040001"},{text:" Adult Haemoglobin  2\u03b1 + 2\u03b2 globin subunits",hierarchyLevel:6,children:[],index:"050101040002"}],index:"0501010400"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0501010401"}],index:"05010104"}],index:"050101"},{text:" Development of the Heart",hierarchyLevel:3,children:[{text:" Process of Development of Cardiogenic Mesoderm",hierarchyLevel:4,children:[{text:" The lateral plate mesoderm (splanchnic) differentiates to formthe cardiogenic mesoderm at the rostral end of the embryo.",hierarchyLevel:5,children:[],index:"0501020000"},{text:" The cardiogenic mesoderm differentiates into the primary heartfield and the secondary heart field.",hierarchyLevel:5,children:[],index:"0501020001"},{text:" The primary heart field will differentiate into ventricularmyocytes.",hierarchyLevel:5,children:[],index:"0501020002"},{text:" The secondary heart field will differentiate into atrial myocytesand endocardial cells.",hierarchyLevel:5,children:[],index:"0501020003"},{text:" Transcription factor Nkx2-5 plays a critical role in heartdevelopment, and will lead to severe heart defects if not present.",hierarchyLevel:5,children:[],index:"0501020004"}],index:"05010200"},{text:" Process of Ventral Closure",hierarchyLevel:4,children:[{text:" Ectoderm folds inwards, and joining at the two ends.",hierarchyLevel:5,children:[],index:"0501020100"},{text:" The mesoderm envelops the endoderm and the yolk sac (foregut).",hierarchyLevel:5,children:[],index:"0501020101"},{text:" This folding allows to bring the endocardial tube together andsurrounds with by myogenic mesoderm.",hierarchyLevel:5,children:[],index:"0501020102"}],index:"05010201"},{text:" General stuff about the Embryonic heart",hierarchyLevel:4,children:[{text:" Embryonic heart begins to beat 22-23 days after fertilisation.",hierarchyLevel:5,children:[],index:"0501020200"},{text:" Embryonic heart is fully formed in 9  to 10 weeksafter fertilisation.",hierarchyLevel:5,children:[],index:"0501020201"},{text:" Embryonic veins enters the heart via the inlet sinus",hierarchyLevel:5,children:[],index:"0501020202"},{text:" Embryonic arteries exits the heart via the outlet end",hierarchyLevel:5,children:[],index:"0501020203"},{text:" From the outlet end, oxygenated blood is directed to the aorticarches towards the developing brain and body.",hierarchyLevel:5,children:[],index:"0501020204"}],index:"05010202"},{text:" Overview of Heart Development",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" The medial portion of the  primary heart field forms theventricle and the lateral portion  of the primary heart fieldforms the atrium. ",hierarchyLevel:6,children:[],index:"050102030000"},{text:" The left and right atria twists towards the left, and behind theventricle / aortic sac.",hierarchyLevel:6,children:[],index:"050102030001"},{text:" Cardiac neural crest cells invade the aortic arch and driveremodelling of the pharyngeal arteries that is superior of the aortic sac. Thisresults in the formation of the mature aortic arch.",hierarchyLevel:6,children:[],index:"050102030002"},{text:" The septa divides the right and left atria and ventricles.",hierarchyLevel:6,children:[],index:"050102030003"},{text:" The conotruncal (CT) and atrioventricular valves divides theatria from ventricles by forming cardiac valves.",hierarchyLevel:6,children:[],index:"050102030004"}],index:"0501020300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0501020301"},{text:" Legend",hierarchyLevel:5,children:[{text:" RA  right atrium",hierarchyLevel:6,children:[],index:"050102030200"},{text:" LA  left atrium",hierarchyLevel:6,children:[],index:"050102030201"},{text:" V  ventricle",hierarchyLevel:6,children:[],index:"050102030202"},{text:" III, IV, VI  pharyngeal arteries",hierarchyLevel:6,children:[],index:"050102030203"},{text:" AS  aortic sac",hierarchyLevel:6,children:[],index:"050102030204"},{text:" CT  conotruncal",hierarchyLevel:6,children:[],index:"050102030205"},{text:" AVV  atrioventricular valve",hierarchyLevel:6,children:[],index:"050102030206"},{text:" AO  aorta",hierarchyLevel:6,children:[],index:"050102030207"},{text:" PA  pulmonary artery",hierarchyLevel:6,children:[],index:"050102030208"},{text:" DA  ductus arterosus",hierarchyLevel:6,children:[],index:"050102030209"}],index:"0501020302"}],index:"05010203"},{text:" Formation of atrioventricular canals",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Mesenchyme  a type of animal tissue comprised of loose cellsembedded in a mesh of proteins and fluid",hierarchyLevel:6,children:[],index:"050102040000"},{text:" Endocardial cushions  made up of extracellular matrix ",hierarchyLevel:6,children:[],index:"050102040001"},{text:" Proepicardium  a transitory extracardiac embryonic structurewhich forms the third layer of the heart epicardium and coronary arteries",hierarchyLevel:6,children:[],index:"050102040002"}],index:"0501020400"},{text:" Process",hierarchyLevel:5,children:[{text:" The opposing ventral endocardial cushion grows outwards and fusestogether, forming the atrioventricular septum. This also forms the twoatrioventricular canals in the heart.",hierarchyLevel:6,children:[],index:"050102040100"},{text:" The opposing conotruncal endocardial cushion grows outwards andfuses together to form the outflow vessels.",hierarchyLevel:6,children:[],index:"050102040101"},{text:" Cells from the proepicardial organ migrate to the myocardium toform the epicardium and the coronary arteries.",hierarchyLevel:6,children:[],index:"050102040102"}],index:"0501020401"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0501020402"}],index:"05010204"},{text:" Septation of the Atria",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Septum primum  the thinner atrial septum",hierarchyLevel:6,children:[],index:"050102050000"},{text:" Spina vestibuli  the bony underside of the septum primum",hierarchyLevel:6,children:[],index:"050102050001"},{text:" Septum secundum  a thick and muscular atrial septum",hierarchyLevel:6,children:[],index:"050102050002"},{text:" Foramen primum  the open space between the septum primum and theatrioventricular septum",hierarchyLevel:6,children:[],index:"050102050003"},{text:" Foramen  an opening, hole, or passage",hierarchyLevel:6,children:[],index:"050102050004"},{text:" Foramen secundum  an opening on the septum primum",hierarchyLevel:6,children:[],index:"050102050005"},{text:" Foramne ovale  an opening on the septum secundum",hierarchyLevel:6,children:[],index:"050102050006"}],index:"0501020500"},{text:" Process",hierarchyLevel:5,children:[{text:" The roof of the atrial chamber develops the spina vestibuli andthe septum primum which looks like a crescent-shaped wedge.",hierarchyLevel:6,children:[],index:"050102050100"},{text:" The spina vestibuli and septum primum grows outwards towards theatrioventricular septum.",hierarchyLevel:6,children:[],index:"050102050101"},{text:" As the spina vestibuli and septum primum grows, the size of theremaining open space, foramen primum, becomes smaller.",hierarchyLevel:6,children:[],index:"050102050102"},{text:" Eventually, the septum primum and the atrioventricular septumfuses, hence closing off the foramen primum. ",hierarchyLevel:6,children:[],index:"050102050103"},{text:" However, cell apoptosis on the septum primum results in thecreation of foramen secundum, forming a new opening.",hierarchyLevel:6,children:[],index:"050102050104"},{text:" The roof of the atrial chamber develops the septum secundum. Theseptum secundum grows towards the atrioventricular septum. However, the septumsecundum does not complete close, resulting in the formation of the foramenovale.",hierarchyLevel:6,children:[],index:"050102050105"}],index:"0501020501"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0501020502"}],index:"05010205"},{text:" Valves of the Fetal Heart",hierarchyLevel:4,children:[{text:" Atrial Valve of Fetal Heart",hierarchyLevel:5,children:[{text:" Understandings",hierarchyLevel:6,children:[{text:" The septum secundum is much thicker and more muscular, and willnot be moved by the pressure in the right atrium",hierarchyLevel:7,children:[],index:"05010206000000"},{text:" The septum primum is much thinner, and will be moved by thepressure in the left atrium",hierarchyLevel:7,children:[],index:"05010206000001"}],index:"050102060000"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" High pressure from atrial systole of the right atrium moves theseptum primum towards the left, hence opening the valve. This pressure isunable to move the muscular septum secundum to the left.",hierarchyLevel:7,children:[],index:"05010206000100"},{text:" High pressure from atrial systole of the left atrium moves theseptum primum towards the right, closing the valve. This pressure is unable tomove the muscular septum secundum to the right.",hierarchyLevel:7,children:[],index:"05010206000101"}],index:"050102060001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"050102060002"}],index:"0501020600"},{text:" Atrioventricular Valve of Fetal Heart",hierarchyLevel:5,children:[{text:" Process",hierarchyLevel:6,children:[{text:" The muscular walls of the ventricles develops theatrioventricular valves, the papillary muscles, the chordae tendineae, andcusps of the valves.",hierarchyLevel:7,children:[],index:"05010206010000"}],index:"050102060100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"050102060101"}],index:"0501020601"}],index:"05010206"},{text:" Blood Circulation in the Fetal Heart",hierarchyLevel:4,children:[{text:" Oxygenated Blood Circulation",hierarchyLevel:5,children:[{text:" Process",hierarchyLevel:6,children:[{text:" Oxygenated blood enters from the inferior vena cava into theright atrium.",hierarchyLevel:7,children:[],index:"05010207000000"},{text:" Contraction of the right atrium forces the oxygenated bloodthrough the atrial valves and into the left atrium.",hierarchyLevel:7,children:[],index:"05010207000001"},{text:" Contraction of the left atrium forces the oxygenated blood intothe left ventricles.",hierarchyLevel:7,children:[],index:"05010207000002"},{text:" Contraction of the left ventricle forces the blood into theaorta.",hierarchyLevel:7,children:[],index:"05010207000003"},{text:" The oxygenated blood is then carried from the aorta to the headand the developing brain.",hierarchyLevel:7,children:[],index:"05010207000004"}],index:"050102070000"},{text:" Diagram",hierarchyLevel:6,children:[],index:"050102070001"}],index:"0501020700"},{text:" Deoxygenated Blood Circulation",hierarchyLevel:5,children:[{text:" Process",hierarchyLevel:6,children:[{text:" Deoxygenated blood enters the heart from the superior vena cava intothe right atrium",hierarchyLevel:7,children:[],index:"05010207010000"},{text:" Contraction of the right atrium pumps blood into the rightventricle.",hierarchyLevel:7,children:[],index:"05010207010001"},{text:" Contraction of the right ventricle pumps blood into the pulmonarytrunk.",hierarchyLevel:7,children:[],index:"05010207010002"},{text:" Majority of the blood flows into the ductus arteriosus anddirectly in the aorta.",hierarchyLevel:7,children:[],index:"05010207010003"},{text:" Minority of the blood flows into the pulmonary arteries and intothe lungs.",hierarchyLevel:7,children:[],index:"05010207010004"}],index:"050102070100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"050102070101"}],index:"0501020701"},{text:" Changes at birth",hierarchyLevel:5,children:[{text:" Process",hierarchyLevel:6,children:[{text:" Umbilical vessels are cut and the baby takes it first breath",hierarchyLevel:7,children:[],index:"05010207020000"},{text:" The lung inflate and the pulmonary circuit opens, returningoxygenated blood into the left atrium",hierarchyLevel:7,children:[],index:"05010207020001"},{text:" The rise in the left atrial pressure pushes the septum primumagainst the septum secundum, hence closing the foramen ovale.",hierarchyLevel:7,children:[],index:"05010207020002"},{text:" Changes in the blood oxygen levels and blood flow closes theductus arteriosus.",hierarchyLevel:7,children:[],index:"05010207020003"}],index:"050102070200"},{text:" Diagram",hierarchyLevel:6,children:[],index:"050102070201"}],index:"0501020702"}],index:"05010207"}],index:"050102"},{text:" Congenital Defects of the Heart",hierarchyLevel:3,children:[{text:" Random Statistics",hierarchyLevel:4,children:[{text:" 20% of congenital defects are heart defects",hierarchyLevel:5,children:[],index:"0501030000"},{text:" 1% of live births has detected congenital heart defects",hierarchyLevel:5,children:[],index:"0501030001"},{text:" 2-3% of the population have congenital heart defects",hierarchyLevel:5,children:[],index:"0501030002"}],index:"05010300"},{text:" Distribution of Congenital Heart Defects",hierarchyLevel:4,children:[{text:" Bicuspid aortic valve (1-3% of adults)",hierarchyLevel:5,children:[],index:"0501030100"},{text:" Ventricular septal defects (0.36% live births)",hierarchyLevel:5,children:[],index:"0501030101"},{text:" Atrial septal defects (0.09% live births)",hierarchyLevel:5,children:[],index:"0501030102"},{text:" Patent ductus arteriosus (0.08% live births)",hierarchyLevel:5,children:[],index:"0501030103"},{text:" Pulmonic stenosis (0.07% live births)",hierarchyLevel:5,children:[],index:"0501030104"},{text:" Teratology of Fallot (0.04% live births)",hierarchyLevel:5,children:[],index:"0501030105"},{text:" Coarctation of the aorta (0.04% live births)",hierarchyLevel:5,children:[],index:"0501030106"},{text:" Aortic stenosis (0.04% live births)",hierarchyLevel:5,children:[],index:"0501030107"},{text:" Atrioventricular septal defects (0.3% live births)",hierarchyLevel:5,children:[],index:"0501030108"}],index:"05010301"},{text:" Causes of Congenital Heart Defects",hierarchyLevel:4,children:[{text:" Environmental Causes",hierarchyLevel:5,children:[{text:" Alcohol",hierarchyLevel:6,children:[],index:"050103020000"},{text:" Medication",hierarchyLevel:6,children:[],index:"050103020001"},{text:" Maternal viral infection (rubella virus)",hierarchyLevel:6,children:[],index:"050103020002"}],index:"0501030200"},{text:" Genetic Causes",hierarchyLevel:5,children:[],index:"0501030201"}],index:"05010302"},{text:" Types of Congenital Heart Defects",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Syndromic  occurring as a syndrome or part of a syndrome",hierarchyLevel:6,children:[],index:"050103030000"}],index:"0501030300"},{text:" Atrial septal defect",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" NKX2-5 gene",hierarchyLevel:7,children:[],index:"05010303010000"},{text:" GATA4 gene",hierarchyLevel:7,children:[],index:"05010303010001"},{text:" TBX5 gene",hierarchyLevel:7,children:[],index:"05010303010002"}],index:"050103030100"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Foramen ovale fails to close and remains open after birth.",hierarchyLevel:7,children:[],index:"05010303010100"},{text:" This causes blood to flow freely between the right and the leftatria.",hierarchyLevel:7,children:[],index:"05010303010101"}],index:"050103030101"},{text:" Diagram",hierarchyLevel:6,children:[],index:"050103030102"}],index:"0501030301"},{text:" Patent ductus arteriosus",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Ductus arteriosus fails to close upon birth",hierarchyLevel:7,children:[],index:"05010303020000"},{text:" This allows blood to flow directly from the pulmonary artery intothe aorta, skipping the heart. Hence, this results in a right to left shunt.",hierarchyLevel:7,children:[],index:"05010303020001"}],index:"050103030200"},{text:" Diagram",hierarchyLevel:6,children:[],index:"050103030201"}],index:"0501030302"},{text:" Ventricular septal defect",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" NOTCH2 gene (syndromic)",hierarchyLevel:7,children:[],index:"05010303030000"},{text:" TBX1 gene by 22Q11.2 deletion (syndromic)",hierarchyLevel:7,children:[],index:"05010303030001"},{text:" TBX5 gene",hierarchyLevel:7,children:[],index:"05010303030002"}],index:"050103030300"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Failure of formation of ventricular septum",hierarchyLevel:7,children:[],index:"05010303030100"}],index:"050103030301"},{text:" Diagram",hierarchyLevel:6,children:[],index:"050103030302"}],index:"0501030303"},{text:" Coarctation of aorta",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" The aorta narrows at the site of the ductus arteriosus.",hierarchyLevel:7,children:[],index:"05010303040000"},{text:" This causes the restriction of blood flow outwards, resulting inthe need for strong pumping action by the left ventricle to pump blood athigher pressures to maintain blood flow.",hierarchyLevel:7,children:[],index:"05010303040001"}],index:"050103030400"},{text:" Diagram",hierarchyLevel:6,children:[],index:"050103030401"}],index:"0501030304"}],index:"05010303"},{text:" Pluripotent Stem cells as Treatment for Congenital Heart Defects",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Embryonic stems cells from the blastocyst or induced pluripotentstem cells from adult fibroblasts are stimulated to differentiate intocardiomyocytes.",hierarchyLevel:6,children:[],index:"050103040000"},{text:" Cardiomyocytes are then used for drug testing, fortransplantation into diseased heart and as models to study human heart disease.",hierarchyLevel:6,children:[],index:"050103040001"},{text:" However, currently implanted cardiomyocytes do not functionproperly probably because there are many different types of cardiomyocytes andnot the right type was induced and implanted.",hierarchyLevel:6,children:[],index:"050103040002"}],index:"0501030400"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0501030401"}],index:"05010304"}],index:"050103"}],index:"0501"}]},{text:"Anatomy",hierarchyLevel:1,children:[{text:" [021] Chest Wall and the Anatomy of Ventilation",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Costo  ribs",hierarchyLevel:5,children:[],index:"0600000000"},{text:" Intercostal  between the ribs",hierarchyLevel:5,children:[],index:"0600000001"}],index:"06000000"},{text:" Questions",hierarchyLevel:4,children:[{text:" How the heck do the intercostal muscles depress the ribs if it isbetween the ribs? The external and internal will do the same thing",hierarchyLevel:5,children:[],index:"0600000100"}],index:"06000001"}],index:"060000"},{text:" Thorax",hierarchyLevel:3,children:[{text:" Boundaries",hierarchyLevel:4,children:[{text:" Components",hierarchyLevel:5,children:[{text:" Posterior  Vertebral column",hierarchyLevel:6,children:[],index:"060001000000"},{text:" Anterior  manubrium, sternum, costal cartilages, xiphoid process",hierarchyLevel:6,children:[],index:"060001000001"},{text:" Lateral  ribs",hierarchyLevel:6,children:[],index:"060001000002"},{text:" Ventral / Inferior  diaphragm",hierarchyLevel:6,children:[],index:"060001000003"}],index:"0600010000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0600010001"}],index:"06000100"},{text:" Ribs and thoracic vertebrae connection points",hierarchyLevel:4,children:[{text:" Joint of head of rib  ribs connects with the main vertebral body",hierarchyLevel:5,children:[],index:"0600010100"},{text:" Costotransverse joint  rib contacts the transverse process ofvertebrae",hierarchyLevel:5,children:[],index:"0600010101"}],index:"06000101"},{text:" Surface Anatomy",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Infrasternal angle  angle generated by the ribs and the sternum",hierarchyLevel:6,children:[],index:"060001020000"},{text:" Sternal angle  angle where the 2  rib articulateswith the sternum",hierarchyLevel:6,children:[],index:"060001020001"},{text:" Midclavicular lines  lines perpendicular to the middle of eachclavicle",hierarchyLevel:6,children:[],index:"060001020002"},{text:" Anterior median (midsternal) line  line right down the frontcenter of the body",hierarchyLevel:6,children:[],index:"060001020003"},{text:" Posterior median (midvertebral) line  line right down the vertebrae",hierarchyLevel:6,children:[],index:"060001020004"},{text:" Scapular lines  lines perpendicular to the scapular at the backof the body",hierarchyLevel:6,children:[],index:"060001020005"},{text:" Anterior axillary line  line down the anterior of the side ofthe body",hierarchyLevel:6,children:[],index:"060001020006"},{text:" Posterior axillary line  line down the posterior of the side ofthe body",hierarchyLevel:6,children:[],index:"060001020007"},{text:" Midauxillary line  line down the middle of the side of the body",hierarchyLevel:6,children:[],index:"060001020008"}],index:"0600010200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0600010201"}],index:"06000102"},{text:" Thorax Examination",hierarchyLevel:4,children:[{text:" Auscultation",hierarchyLevel:5,children:[{text:" Process",hierarchyLevel:6,children:[{text:" Listening to sounds with a stethoscope",hierarchyLevel:7,children:[],index:"06000103000000"}],index:"060001030000"},{text:" Purpose",hierarchyLevel:6,children:[{text:" Access airflow",hierarchyLevel:7,children:[],index:"06000103000100"}],index:"060001030001"}],index:"0600010300"},{text:" Percussion",hierarchyLevel:5,children:[{text:" Process",hierarchyLevel:6,children:[{text:" Tapping the thorax over the lungs with fingers to detect soundsin the lungs",hierarchyLevel:7,children:[],index:"06000103010000"}],index:"060001030100"},{text:" Purpose",hierarchyLevel:6,children:[{text:" Check if the lungs are filled with air (resonant sound), fluid(dull sound), solid (flat sound)",hierarchyLevel:7,children:[],index:"06000103010100"}],index:"060001030101"}],index:"0600010301"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0600010302"}],index:"06000103"},{text:" Thoracic Cavity Divisions",hierarchyLevel:4,children:[{text:" Left and Right plural cavity",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" contains the lungs",hierarchyLevel:7,children:[],index:"06000104000000"}],index:"060001040000"}],index:"0600010400"},{text:" Mediastinum",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" A medially positioned continuous, connective tissue space",hierarchyLevel:7,children:[],index:"06000104010000"}],index:"060001040100"},{text:" Components",hierarchyLevel:6,children:[{text:" Circulatory system",hierarchyLevel:7,children:[{text:" Heart",hierarchyLevel:8,children:[],index:"0600010401010000"},{text:" Blood vessels",hierarchyLevel:8,children:[],index:"0600010401010001"}],index:"06000104010100"},{text:" Respiratory system",hierarchyLevel:7,children:[{text:" Trachea",hierarchyLevel:8,children:[],index:"0600010401010100"}],index:"06000104010101"},{text:" Nervous system",hierarchyLevel:7,children:[{text:" Thorax innervation",hierarchyLevel:8,children:[],index:"0600010401010200"},{text:" Vagus nerve",hierarchyLevel:8,children:[],index:"0600010401010201"},{text:" oParasympathetic trunk nerves",hierarchyLevel:8,children:[],index:"0600010401010202"},{text:" Sympathetic trunk nerves",hierarchyLevel:8,children:[],index:"0600010401010203"},{text:" Phrenic nerves",hierarchyLevel:8,children:[],index:"0600010401010204"}],index:"06000104010102"},{text:" Lymphatic system",hierarchyLevel:7,children:[],index:"06000104010103"}],index:"060001040101"}],index:"0600010401"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0600010402"}],index:"06000104"},{text:" Pulmonary Cavities",hierarchyLevel:4,children:[{text:" Components",hierarchyLevel:5,children:[{text:" Parietal (wall) pleura",hierarchyLevel:6,children:[{text:" Location",hierarchyLevel:7,children:[{text:" Adhered to the wall of the thoracic cavity, the diaphragm",hierarchyLevel:8,children:[],index:"0600010500000000"}],index:"06000105000000"},{text:" Property",hierarchyLevel:7,children:[{text:" Contains intercostal nerves and phrenic nerves  causessensitivity to pain , temperature, touch and pressure",hierarchyLevel:8,children:[],index:"0600010500000100"}],index:"06000105000001"}],index:"060001050000"},{text:" Visceral (main cavity) pleura",hierarchyLevel:6,children:[{text:" Location",hierarchyLevel:7,children:[{text:" Adhere tightly to the lungs and interlobar fissures",hierarchyLevel:8,children:[],index:"0600010500010000"}],index:"06000105000100"},{text:" Property",hierarchyLevel:7,children:[{text:" Contains the autonomic nervous system  causes sensitivity tostretching only",hierarchyLevel:8,children:[],index:"0600010500010100"}],index:"06000105000101"},{text:" Diagram",hierarchyLevel:7,children:[],index:"06000105000102"}],index:"060001050001"},{text:" Pleural space",hierarchyLevel:6,children:[{text:" Location",hierarchyLevel:7,children:[{text:" Between the parietal pleura and the visceral pleura",hierarchyLevel:8,children:[],index:"0600010500020000"}],index:"06000105000200"},{text:" Property",hierarchyLevel:7,children:[{text:" Contains fluid which reduces friction from lung movements",hierarchyLevel:8,children:[],index:"0600010500020100"}],index:"06000105000201"}],index:"060001050002"}],index:"0600010500"},{text:" Overall Interaction",hierarchyLevel:5,children:[{text:" The visceral pleura expands and contracts with the lungs",hierarchyLevel:6,children:[],index:"060001050100"},{text:" The parietal pleura remains stuck to the wall",hierarchyLevel:6,children:[],index:"060001050101"},{text:" The pleural fluid reduces friction between the rubbing of thevisceral pleura and the parietal pleura during inhalation and exhalation.",hierarchyLevel:6,children:[],index:"060001050102"}],index:"0600010501"},{text:" Presence of space",hierarchyLevel:5,children:[{text:" At full lung capacity, there is some space between the bottom ofthe visceral pleura and the parietal pleura.",hierarchyLevel:6,children:[],index:"060001050200"},{text:" This empty space should show up as place on the X-ray. A white colorationsuggest that the pleural space is filled with liquid or solid.",hierarchyLevel:6,children:[],index:"060001050201"}],index:"0600010502"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0600010503"},{text:" Embryonic development",hierarchyLevel:5,children:[],index:"0600010504"}],index:"06000105"}],index:"060001"},{text:" Diaphragm",hierarchyLevel:3,children:[{text:" Purpose",hierarchyLevel:4,children:[{text:" Contract and relaxes to modify thoracic cavity volume forrespiration",hierarchyLevel:5,children:[],index:"0600020000"},{text:" Forms a barrier between the thorax and abdomen",hierarchyLevel:5,children:[],index:"0600020001"}],index:"06000200"},{text:" Structure",hierarchyLevel:4,children:[{text:" Made up of skeletal (striated) muscle, allowing for consciouscontrol",hierarchyLevel:5,children:[],index:"0600020100"},{text:" Innervated by dermatomes from C3, C4, C5",hierarchyLevel:5,children:[],index:"0600020101"}],index:"06000201"},{text:" Function",hierarchyLevel:4,children:[{text:" Contraction of the diaphragm increases the thoracic volume,resulting in negative pressure within the thorax, causing air to enter thelungs",hierarchyLevel:5,children:[],index:"0600020200"},{text:" Relaxation of the diaphragm decreases the thoracic volume,resulting in positive pressure within the thorax, causing air to exit the lungs",hierarchyLevel:5,children:[],index:"0600020201"}],index:"06000202"},{text:" Diagram Openings",hierarchyLevel:4,children:[{text:" Aortic opening",hierarchyLevel:5,children:[],index:"0600020300"},{text:" Vena cava (caval) opening",hierarchyLevel:5,children:[],index:"0600020301"},{text:" Esophageal opening ",hierarchyLevel:5,children:[],index:"0600020302"}],index:"06000203"}],index:"060002"},{text:" Intercostal muscles",hierarchyLevel:3,children:[{text:" Location",hierarchyLevel:4,children:[{text:" Between ribs (intercostal spaces)",hierarchyLevel:5,children:[],index:"0600030000"}],index:"06000300"},{text:" Layers",hierarchyLevel:4,children:[{text:" External intercostal  elevate ribs",hierarchyLevel:5,children:[],index:"0600030100"},{text:" Internal intercostal  depresses ribs",hierarchyLevel:5,children:[],index:"0600030101"}],index:"06000301"},{text:" Diagram",hierarchyLevel:4,children:[],index:"06000302"},{text:" Innervation",hierarchyLevel:4,children:[{text:" Description",hierarchyLevel:5,children:[{text:" Ventral rami of spinal nerves give rise to intercostal nerves",hierarchyLevel:6,children:[],index:"060003030000"}],index:"0600030300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0600030301"},{text:" Abnormal Function: Shingles",hierarchyLevel:5,children:[{text:" Process",hierarchyLevel:6,children:[{text:" Reactivation of the chicken pox virus results in a herpes zosterinfection of the spinal ganglia results in Shingles.",hierarchyLevel:7,children:[],index:"06000303020000"},{text:" Shingles affects a single dermatome and is unilateral.",hierarchyLevel:7,children:[],index:"06000303020001"},{text:" This causes red vesicular eruptions on one side of the body.",hierarchyLevel:7,children:[],index:"06000303020002"}],index:"060003030200"}],index:"0600030302"}],index:"06000303"},{text:" Blood supply",hierarchyLevel:4,children:[{text:" Arterial",hierarchyLevel:5,children:[{text:" Source",hierarchyLevel:6,children:[{text:" From the thoracic aorta via the posterior intercostal arteries and lateral cutaneous branches",hierarchyLevel:7,children:[],index:"06000304000000"},{text:" From the subclavian arteries via the internal thoracic arteries andanterior intercostal arteries",hierarchyLevel:7,children:[],index:"06000304000001"}],index:"060003040000"},{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"06000304000100"}],index:"060003040001"}],index:"0600030400"},{text:" Venous",hierarchyLevel:5,children:[{text:" Source",hierarchyLevel:6,children:[{text:" Posterior intercostal veins and cutaneous branches drain into theazygos, hemizygos and accessory hemizygos veins. Azygos veins drains into thesuperior vena cava",hierarchyLevel:7,children:[],index:"06000304010000"},{text:" Anterior intercostal veins drain into the internal thoracic veinand subclavian veins",hierarchyLevel:7,children:[],index:"06000304010001"}],index:"060003040100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"060003040101"}],index:"0600030401"}],index:"06000304"},{text:" Lymphatic drainage",hierarchyLevel:4,children:[{text:" Pathway",hierarchyLevel:5,children:[{text:" The chest wall and parts of the mediastinum drains towards theparavertebral (beside vertebrae) lymph node, parasternal (beside sternum) lymphnodes, paramammary (beside mammary gland) nodes",hierarchyLevel:6,children:[],index:"060003050000"},{text:" From the paravertebral, parasternal and parammary nodes, thelymph drains into the thoracic duct and the right lymphatic duct",hierarchyLevel:6,children:[],index:"060003050001"}],index:"0600030500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0600030501"}],index:"06000305"},{text:" Thoracic Vessel Triad",hierarchyLevel:4,children:[{text:" Location",hierarchyLevel:5,children:[{text:" Intercostal vein, artery and nerve travel through the costalgroove",hierarchyLevel:6,children:[],index:"060003060000"}],index:"0600030600"},{text:" Application",hierarchyLevel:5,children:[{text:" To extract fluid from the pleura space (thoracentesis), theneedle is inserter superior to the rib in the upwards direction to avoid thecollateral branches of intercostal nerve and blood vessels",hierarchyLevel:6,children:[],index:"060003060100"}],index:"0600030601"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"060003060200"}],index:"0600030602"}],index:"06000306"}],index:"060003"},{text:" Respiratory Accessory Muscles",hierarchyLevel:3,children:[{text:" Types of Accessory Muscles",hierarchyLevel:4,children:[{text:" Anterior, middle and posterior scalenus",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Laterally bend the neck",hierarchyLevel:7,children:[],index:"06000400000000"},{text:" Lift or stabilize ribs 1 and 2",hierarchyLevel:7,children:[],index:"06000400000001"}],index:"060004000000"},{text:" Innervation",hierarchyLevel:6,children:[{text:" Innervated by cervical (neck) and brachial (arm) plexi (nerves)(C4-C8)",hierarchyLevel:7,children:[],index:"06000400000100"}],index:"060004000001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"060004000002"}],index:"0600040000"},{text:" Sternocleidomastoid",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Connects the sternum, clavicle and mastoid process (ears)",hierarchyLevel:7,children:[],index:"06000400010000"},{text:" Inserts on the rib cage",hierarchyLevel:7,children:[],index:"06000400010001"}],index:"060004000100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"060004000101"}],index:"0600040001"},{text:" Pectoralis major and Pectoralis Minor",hierarchyLevel:5,children:[{text:" Diagram",hierarchyLevel:6,children:[],index:"060004000200"}],index:"0600040002"}],index:"06000400"},{text:" Action of Accessory Muscles",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0600040100"},{text:" Inhalation",hierarchyLevel:5,children:[{text:" Quiet Inhalation",hierarchyLevel:6,children:[{text:" Diaphragm",hierarchyLevel:7,children:[],index:"06000401010000"},{text:" External intercostals",hierarchyLevel:7,children:[],index:"06000401010001"},{text:" Scaleni (neck)",hierarchyLevel:7,children:[],index:"06000401010002"}],index:"060004010100"},{text:" Active inhalation",hierarchyLevel:6,children:[{text:" Sternocleidomastoid",hierarchyLevel:7,children:[],index:"06000401010100"},{text:" Pectoralis minor",hierarchyLevel:7,children:[],index:"06000401010101"},{text:" Pectoralis major",hierarchyLevel:7,children:[],index:"06000401010102"}],index:"060004010101"}],index:"0600040101"},{text:" Exhalation",hierarchyLevel:5,children:[{text:" Quiet exhalation",hierarchyLevel:6,children:[{text:" Relaxation of diaphragm",hierarchyLevel:7,children:[],index:"06000401020000"},{text:" Internal intercostal muscles",hierarchyLevel:7,children:[],index:"06000401020001"}],index:"060004010200"},{text:" Active exhalation",hierarchyLevel:6,children:[{text:" Abdominal wall muscles (abs)",hierarchyLevel:7,children:[],index:"06000401020100"},{text:" Internal intercostal muscles",hierarchyLevel:7,children:[],index:"06000401020101"}],index:"060004010201"}],index:"0600040102"}],index:"06000401"}],index:"060004"},{text:" Breast",hierarchyLevel:3,children:[{text:" Location",hierarchyLevel:4,children:[{text:" Between 3  and 7  rib, in the middlebetween sternum and axilla",hierarchyLevel:5,children:[],index:"0600050000"},{text:" Lies on pectoral fascia  able to be moved out of position",hierarchyLevel:5,children:[],index:"0600050001"}],index:"06000500"},{text:" Structure",hierarchyLevel:4,children:[{text:" Anchored by suspensory ligaments between mammary gland lobules",hierarchyLevel:5,children:[],index:"0600050100"},{text:" Contains fatty tissue",hierarchyLevel:5,children:[],index:"0600050101"},{text:" Contains apocrine glandular tissue which produces milk",hierarchyLevel:5,children:[],index:"0600050102"},{text:" Contains lymphatic drainage of which 75% goes to axillary lymphnodes, which drains into subclavian veins",hierarchyLevel:5,children:[],index:"0600050103"}],index:"06000501"},{text:" Parts",hierarchyLevel:4,children:[{text:" Upper outer quadrant  with auxiliary tail",hierarchyLevel:5,children:[],index:"0600050200"},{text:" Upper inner quadrant",hierarchyLevel:5,children:[],index:"0600050201"},{text:" Lower outer quadrant",hierarchyLevel:5,children:[],index:"0600050202"},{text:" Lower inner quadrant",hierarchyLevel:5,children:[],index:"0600050203"}],index:"06000502"},{text:" Diagram",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0600050300"}],index:"06000503"},{text:" Abnormal Function: Breast Cancer",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Cancer typically spreads along the lymph passages into superiorand laterally lymph nodes",hierarchyLevel:6,children:[],index:"060005040000"},{text:" From the superior and lateral lymph nodes, cancer spreads to theaxillary lymph nodes",hierarchyLevel:6,children:[],index:"060005040001"},{text:" Cancer in the axillary lymph nodes drains into the subclavianvein, and be rapidly distributed throughout the body",hierarchyLevel:6,children:[],index:"060005040002"}],index:"0600050400"},{text:" Diagnosis",hierarchyLevel:5,children:[{text:" Size of tumor and amount of infested lymph nodes is used todiagnose the stage of cancer and devise a treatment",hierarchyLevel:6,children:[],index:"060005040100"}],index:"0600050401"},{text:" Blockage of Lymph Nodes",hierarchyLevel:5,children:[{text:" Unilateral blockage of lymph nodes  causes lymph with cancercells to drain from other lymphatic vessels which causes metastasis to bones,lungs, liver and the central nervous system",hierarchyLevel:6,children:[],index:"060005040200"}],index:"0600050402"}],index:"06000504"}],index:"060005"}],index:"0600"},{text:" [031] The Lungs, Pleural Cavity, Mediastinum andHeart in Situ",hierarchyLevel:2,children:[{text:" Mediastinum",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Mediastinum  the medial compartment of the thoracic cavity",hierarchyLevel:5,children:[],index:"0601000000"},{text:" Division Line  horizontal line between the sternal angle todivide the superior and inferior mediastinum",hierarchyLevel:5,children:[],index:"0601000001"}],index:"06010000"},{text:" Properties",hierarchyLevel:4,children:[{text:" Mobile in the chest",hierarchyLevel:5,children:[],index:"0601000100"},{text:" Contains all the thoracic viscera other than the lungs",hierarchyLevel:5,children:[],index:"0601000101"}],index:"06010001"},{text:" Diagram",hierarchyLevel:4,children:[],index:"06010002"},{text:" Compartments",hierarchyLevel:4,children:[{text:" Superior Mediastinum",hierarchyLevel:5,children:[],index:"0601000300"},{text:" Inferior Mediastinum",hierarchyLevel:5,children:[{text:" Posterior Mediastinum",hierarchyLevel:6,children:[],index:"060100030100"},{text:" Middle Mediastinum",hierarchyLevel:6,children:[],index:"060100030101"},{text:" Anterior Mediastinum",hierarchyLevel:6,children:[],index:"060100030102"}],index:"0601000301"}],index:"06010003"},{text:" Superior Mediastinum",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0601000400"},{text:" The Great Vessels",hierarchyLevel:5,children:[{text:" Superior vena cava",hierarchyLevel:6,children:[],index:"060100040100"},{text:" Inferior vena cava",hierarchyLevel:6,children:[],index:"060100040101"},{text:" Pulmonary arteries",hierarchyLevel:6,children:[],index:"060100040102"},{text:" Pulmonary veins",hierarchyLevel:6,children:[],index:"060100040103"},{text:" Aorta",hierarchyLevel:6,children:[],index:"060100040104"}],index:"0601000401"},{text:" Nerves",hierarchyLevel:5,children:[{text:" Phrenic Nerve",hierarchyLevel:6,children:[],index:"060100040200"},{text:" Vagus Nerve",hierarchyLevel:6,children:[],index:"060100040201"},{text:" Laryngeal nerve",hierarchyLevel:6,children:[],index:"060100040202"}],index:"0601000402"},{text:" Cervical viscera",hierarchyLevel:5,children:[{text:" Trachea",hierarchyLevel:6,children:[],index:"060100040300"},{text:" Oesophagus",hierarchyLevel:6,children:[],index:"060100040301"}],index:"0601000403"},{text:" Thoracic duct and lymphatic thrunks",hierarchyLevel:5,children:[],index:"0601000404"},{text:" Part of Thymus",hierarchyLevel:5,children:[],index:"0601000405"}],index:"06010004"},{text:" Inferior Mediastinum",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0601000500"},{text:" Posterior Mediastinum",hierarchyLevel:5,children:[{text:" Thoracic aorta",hierarchyLevel:6,children:[],index:"060100050100"},{text:" Thoracic duct",hierarchyLevel:6,children:[],index:"060100050101"},{text:" Lymphatic trunks",hierarchyLevel:6,children:[],index:"060100050102"},{text:" Posterior mediastinal lymph nodes",hierarchyLevel:6,children:[],index:"060100050103"},{text:" Azygos and hemiazygos veins",hierarchyLevel:6,children:[],index:"060100050104"},{text:" Esophagus and esophageal nerve plexus",hierarchyLevel:6,children:[],index:"060100050105"}],index:"0601000501"},{text:" Middle Mediastinum",hierarchyLevel:5,children:[{text:" Parts",hierarchyLevel:6,children:[{text:" Heart",hierarchyLevel:7,children:[],index:"06010005020000"},{text:" Pericardium",hierarchyLevel:7,children:[{text:" Fibrous pericardium  though external layer which protects theheart against sudden overfilling",hierarchyLevel:8,children:[],index:"0601000502000100"},{text:" Serous pericardium",hierarchyLevel:8,children:[{text:" Parietal pericardium",hierarchyLevel:9,children:[],index:"060100050200010100"},{text:" Visceral pericardium",hierarchyLevel:9,children:[],index:"060100050200010101"}],index:"0601000502000101"},{text:" Pericardial cavity  contains serous fluid to provide africtionless environment for the heart to beat",hierarchyLevel:8,children:[],index:"0601000502000102"}],index:"06010005020001"}],index:"060100050200"},{text:" Diagram",hierarchyLevel:6,children:[],index:"060100050201"},{text:" Abnormal Function",hierarchyLevel:6,children:[{text:" Pericardial effusion",hierarchyLevel:7,children:[{text:" Due to inflammatory diseases, fluid from pericardial capillariesor pus gets into the pericardial cavity",hierarchyLevel:8,children:[],index:"0601000502020000"}],index:"06010005020200"},{text:" Cardiac tamponade",hierarchyLevel:7,children:[{text:" Due to extremely tough and inelastic fibrous pericardium,extensive pericardial effusion will compress the heart rather than expand thepericardium",hierarchyLevel:8,children:[],index:"0601000502020100"},{text:" Treated by pericardiocentesis",hierarchyLevel:8,children:[],index:"0601000502020101"}],index:"06010005020201"}],index:"060100050202"}],index:"0601000502"},{text:" Anterior Mediastinum",hierarchyLevel:5,children:[{text:" Connective tissue",hierarchyLevel:6,children:[],index:"060100050300"},{text:" Fats",hierarchyLevel:6,children:[],index:"060100050301"},{text:" Lymphatic vessels and lymph nodes",hierarchyLevel:6,children:[],index:"060100050302"},{text:" Internal thoracic vessels",hierarchyLevel:6,children:[],index:"060100050303"},{text:" Inferior part of thymus (children)",hierarchyLevel:6,children:[],index:"060100050304"}],index:"0601000503"}],index:"06010005"},{text:" Mediastinal Lymphatics",hierarchyLevel:4,children:[{text:" Location of Lymph Nodes",hierarchyLevel:5,children:[{text:" Aorta  mediastinal lymph nodes are in front of the aorta andalongside it",hierarchyLevel:6,children:[],index:"060100060000"},{text:" Bronchi  tracheobronchial lymph nodes are located at thebifurcation of the trachea (carina) which collects lymph from the lungs and theheart",hierarchyLevel:6,children:[],index:"060100060001"}],index:"0601000600"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0601000601"}],index:"06010006"}],index:"060100"},{text:" Heart",hierarchyLevel:3,children:[{text:" The Great Vessels",hierarchyLevel:4,children:[{text:" Superior vena cava",hierarchyLevel:5,children:[],index:"0601010000"},{text:" Inferior vena cava",hierarchyLevel:5,children:[],index:"0601010001"},{text:" Pulmonary arteries",hierarchyLevel:5,children:[],index:"0601010002"},{text:" Pulmonary veins",hierarchyLevel:5,children:[],index:"0601010003"},{text:" Aorta",hierarchyLevel:5,children:[],index:"0601010004"}],index:"06010100"},{text:" Parts of the Heart in Situ",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Right and left phrenic nerves  located in front of the lungroots and visible on the pericardium before reaching the diaphragm",hierarchyLevel:6,children:[],index:"060101010000"},{text:" Right and left vagus nerves  left upper vagus nerve is in frontof the aorta. Lower part of left and right vagus nerve is behind the lung roots,bronchus and pulmonary arteries",hierarchyLevel:6,children:[],index:"060101010001"}],index:"0601010100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0601010101"}],index:"06010101"}],index:"060101"},{text:" Lungs and Lower Airways",hierarchyLevel:3,children:[{text:" Function of Lungs",hierarchyLevel:4,children:[{text:" Gas exchange (oxygen and carbon dioxide exchange)",hierarchyLevel:5,children:[],index:"0601020000"},{text:" Control of blood pH",hierarchyLevel:5,children:[],index:"0601020001"}],index:"06010200"},{text:" Position of Lungs",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Posterior  lung reaches below the 9  pair of ribs;pleura reaches below the 11  pair of ribs into thecostodiaphragmatic recess",hierarchyLevel:6,children:[],index:"060102010000"},{text:" Anterior  lung reaches to the 6  pair of ribs;pleura reaches to the 7  pair of ribs",hierarchyLevel:6,children:[],index:"060102010001"},{text:" Difference between posterior and anterior is due to the fact thatthe ribs are angled downwards, hence each ribs are at a lower position in theanterior view.",hierarchyLevel:6,children:[],index:"060102010002"}],index:"0601020100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0601020101"}],index:"06010201"},{text:" Lung Surface Anatomy",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Right lung  superior lobe, inferior lobe, middle lobe, obliquefissure, horizontal fissure",hierarchyLevel:6,children:[],index:"060102020000"},{text:" Left lungs  superior lobe, inferior lobe, oblique fissure",hierarchyLevel:6,children:[],index:"060102020001"},{text:" Root of lung  contains blood vessels and bronchi entering andleaving the lungs on the mediastinal surface, lymph nodes and neural structures",hierarchyLevel:6,children:[],index:"060102020002"}],index:"0601020200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0601020201"}],index:"06010202"},{text:" Root of the Lung",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Bronchi  part of the airway, central and posteriorly placed inthe root of the lung",hierarchyLevel:6,children:[],index:"060102030000"},{text:" Pulmonary artery  conveys deoxygenated blood from the heart tothe lungs",hierarchyLevel:6,children:[],index:"060102030001"},{text:" Pulmonary veins  conveys oxygenated blood from the lungs back tothe heart",hierarchyLevel:6,children:[],index:"060102030002"}],index:"0601020300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0601020301"}],index:"06010203"},{text:" Trachea and Lower Airways",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Pathway: Trachea   MainBronchi (primary bronchi)   Lobarbronchi (secondary bronchi)  Segmental Bronchi (tertiary bronchi)  Bronchioles",hierarchyLevel:6,children:[],index:"060102040000"},{text:" Tracheal cartilages  prevents the trachea from collapsing",hierarchyLevel:6,children:[],index:"060102040001"},{text:" Left main bronchus  narrower, longer, and more horizontal",hierarchyLevel:6,children:[],index:"060102040002"},{text:" Right main bronchus  wider, shorter, and more vertical (morelikely for foreign objects to be trapped  straighter and wider hole)",hierarchyLevel:6,children:[],index:"060102040003"}],index:"0601020400"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0601020401"}],index:"06010204"},{text:" Lung Organization and Bronchopulmonary Segments",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Right superior lobe  3 lung segments",hierarchyLevel:6,children:[],index:"060102050000"},{text:" Right middle lobe  2 lung segments",hierarchyLevel:6,children:[],index:"060102050001"},{text:" Right inferior lobe  5 lung segments",hierarchyLevel:6,children:[],index:"060102050002"},{text:" Left superior lobe  5 lung segments",hierarchyLevel:6,children:[],index:"060102050003"},{text:" Left inferior lobe  5 lung segments",hierarchyLevel:6,children:[],index:"060102050004"},{text:" Lung Segments  serve as a functional and anatomical unit whichis supplied with air by its respective segmental bronchi",hierarchyLevel:6,children:[],index:"060102050005"}],index:"0601020500"},{text:" Characteristics",hierarchyLevel:5,children:[{text:" Lung diseases can be compartmentalized into the lung segments",hierarchyLevel:6,children:[],index:"060102050100"},{text:" Bronchopulmonary segments can be resected without compromisingthe function of the rest of the lungs",hierarchyLevel:6,children:[],index:"060102050101"},{text:" Different bronchopulmonary segments have different susceptibilityto be flooded by fluids in horizontal or vertical posture",hierarchyLevel:6,children:[{text:" Lower lobe segments are at risk of flooding when upright",hierarchyLevel:7,children:[],index:"06010205010200"},{text:" Apical (top) lobe segments are at risk of flooding when lyingdown",hierarchyLevel:7,children:[],index:"06010205010201"}],index:"060102050102"}],index:"0601020501"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0601020502"}],index:"06010205"},{text:" Alveoli",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Alveoli  the site of gas exchange in the lungs",hierarchyLevel:6,children:[],index:"060102060000"},{text:" Alveolar sacs  large clusters of alveoli",hierarchyLevel:6,children:[],index:"060102060001"},{text:" Alveolar numbers  300 million",hierarchyLevel:6,children:[],index:"060102060002"},{text:" Alveolar diameter  0.05mm (during exhalation) to 0.1mm (duringinhalation)",hierarchyLevel:6,children:[],index:"060102060003"}],index:"0601020600"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0601020601"}],index:"06010206"},{text:" Abnormal Function: Emphysema and Chronic Obstructive PulmonaryDisease",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Chronic obstructive pulmonary disease  inflammatory lung diseasecausing obstructed airflow to the lungs",hierarchyLevel:6,children:[],index:"060102070000"},{text:" Emphysema  damage to the walls of the alveoli",hierarchyLevel:6,children:[],index:"060102070001"},{text:" Bronchitis  increased mucus production and inflammation",hierarchyLevel:6,children:[],index:"060102070002"}],index:"0601020700"},{text:" Symptoms",hierarchyLevel:5,children:[{text:" Breathing difficulty",hierarchyLevel:6,children:[],index:"060102070100"},{text:" Cough",hierarchyLevel:6,children:[],index:"060102070101"},{text:" Mucus (sputum) production",hierarchyLevel:6,children:[],index:"060102070102"},{text:" Wheezing",hierarchyLevel:6,children:[],index:"060102070103"}],index:"0601020701"},{text:" Causes",hierarchyLevel:5,children:[{text:" Long-term exposure to irritating gases, particulate matter,cigarette smoke",hierarchyLevel:6,children:[],index:"060102070200"}],index:"0601020702"},{text:" Contributing conditions",hierarchyLevel:5,children:[{text:" Emphysema and chronic bronchitis",hierarchyLevel:6,children:[],index:"060102070300"}],index:"0601020703"}],index:"06010207"},{text:" Chest Radiology",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Costophrenic angle (CPA)  recess at the bottom where there is fluidand no lungs",hierarchyLevel:6,children:[],index:"060102080000"},{text:" Breast shadow (BS)",hierarchyLevel:6,children:[],index:"060102080001"},{text:" Right Atrium (RA)",hierarchyLevel:6,children:[],index:"060102080002"},{text:" Left Ventricle (LV)",hierarchyLevel:6,children:[],index:"060102080003"},{text:" Aortic Knuckle (AK)",hierarchyLevel:6,children:[],index:"060102080004"},{text:" Hilum (H)  site of entry of pulmonary veins, pulmonary artery,main bronchus into the lung",hierarchyLevel:6,children:[],index:"060102080005"}],index:"0601020800"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0601020801"},{text:" Abnormal Function  Pulmonary Fibrosis",hierarchyLevel:5,children:[],index:"0601020802"}],index:"06010208"}],index:"060102"}],index:"0601"},{text:" [037] The Heart, Its Chambers And The Great Vessels",hierarchyLevel:2,children:[{text:" Overview",hierarchyLevel:3,children:[{text:" HeartDrawings",hierarchyLevel:4,children:[],index:"06020000"},{text:" Heart Tissue",hierarchyLevel:4,children:[],index:"06020001"},{text:" Heart Sounds",hierarchyLevel:4,children:[{text:" lub",hierarchyLevel:5,children:[{text:" Caused by closure of bicuspid and tricuspid valve closure(ventricular systole)",hierarchyLevel:6,children:[],index:"060200020000"}],index:"0602000200"},{text:" dub",hierarchyLevel:5,children:[{text:" Caused by closure of semilunar valves (ventricular diastole)",hierarchyLevel:6,children:[],index:"060200020100"}],index:"0602000201"}],index:"06020002"},{text:" Valves",hierarchyLevel:4,children:[{text:" Atrioventricular valves",hierarchyLevel:5,children:[{text:" Tricuspid valve",hierarchyLevel:6,children:[],index:"060200030000"},{text:" Bicuspid valve (mitral valve)",hierarchyLevel:6,children:[],index:"060200030001"}],index:"0602000300"},{text:" Semilunar valves",hierarchyLevel:5,children:[{text:" Pulmonary valve",hierarchyLevel:6,children:[],index:"060200030100"},{text:" Aortic valve",hierarchyLevel:6,children:[],index:"060200030101"}],index:"0602000301"}],index:"06020003"}],index:"060200"},{text:" Septal Defects",hierarchyLevel:3,children:[{text:" Heart Development",hierarchyLevel:4,children:[{text:" Explanation",hierarchyLevel:5,children:[{text:" At the start, the four chambers of the heart are interconnected",hierarchyLevel:6,children:[],index:"060201000000"},{text:" A dorsal endocardial cushion starts to form and spreads upwardsand downwards, forming in the foramen ovale (develops into atrial septum) andthe interventricular septum.",hierarchyLevel:6,children:[],index:"060201000001"},{text:" Atrioventricular canals starts to form and spreads inwards toform the tricuspid valve and mitral valve.",hierarchyLevel:6,children:[],index:"060201000002"}],index:"0602010000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0602010001"}],index:"06020100"},{text:" Abnormal Function: Septal Defects",hierarchyLevel:4,children:[{text:" Atrial Septal Defect",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Endocardial cushion fails to form the atrial septum duringembryonic development",hierarchyLevel:7,children:[],index:"06020101000000"}],index:"060201010000"},{text:" Prevalence",hierarchyLevel:6,children:[{text:" 15  20% of adults",hierarchyLevel:7,children:[],index:"06020101000100"}],index:"060201010001"},{text:" Consequence",hierarchyLevel:6,children:[{text:" Causes enlargement of the right atrium and ventricle and dilationof the pulmonary trunk",hierarchyLevel:7,children:[],index:"06020101000200"},{text:" This is due to too much blood flowing into the right atrium.",hierarchyLevel:7,children:[],index:"06020101000201"},{text:" Large atrial septal defects will lead to blood shunting from theright atrium to the left atrium, leading to lowered partial pressure of oxygenin the blood.",hierarchyLevel:7,children:[],index:"06020101000202"}],index:"060201010002"},{text:" Diagram",hierarchyLevel:6,children:[],index:"060201010003"}],index:"0602010100"},{text:" Ventricular Septal Defect",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Endocardial cushion fails to form the ventricular septum duringembryonic development",hierarchyLevel:7,children:[],index:"06020101010000"}],index:"060201010100"},{text:" Prevalence",hierarchyLevel:6,children:[{text:" 0.4% of adults",hierarchyLevel:7,children:[],index:"06020101010100"}],index:"060201010101"},{text:" Consequence",hierarchyLevel:6,children:[{text:" Leads to increase in pulmonary blood flow",hierarchyLevel:7,children:[],index:"06020101010200"},{text:" Higher pulmonary blood flow causes severe pulmonary disease,hypertension and increase blood pressure",hierarchyLevel:7,children:[],index:"06020101010201"}],index:"060201010102"}],index:"0602010101"}],index:"06020101"}],index:"060201"}],index:"0602"},{text:" [038] The coronary circulation and conducting systemof the heart",hierarchyLevel:2,children:[{text:" Coronary Arteries",hierarchyLevel:3,children:[{text:" Coronary Arteries of the Heart",hierarchyLevel:4,children:[],index:"06030000"}],index:"060300"},{text:" Heart Disease",hierarchyLevel:3,children:[{text:" Angina",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Angina  sudden crushing substernal pain",hierarchyLevel:6,children:[],index:"060301000000"},{text:" Myocardium  heart muscle / cardiac muscle",hierarchyLevel:6,children:[],index:"060301000001"},{text:" Ischemia  blood flow is restricted or reduced to a part of thebody",hierarchyLevel:6,children:[],index:"060301000002"},{text:" Myocardial ischemia  reduced blood flow to the heart",hierarchyLevel:6,children:[],index:"060301000003"}],index:"0603010000"},{text:" Cause",hierarchyLevel:5,children:[{text:" Narrowing of the coronary arteries / atherosclerosis",hierarchyLevel:6,children:[],index:"060301000100"}],index:"0603010001"},{text:" Triggers",hierarchyLevel:5,children:[{text:" Exercise after a heavy meal",hierarchyLevel:6,children:[],index:"060301000200"},{text:" Stress",hierarchyLevel:6,children:[],index:"060301000201"},{text:" Cold",hierarchyLevel:6,children:[],index:"060301000202"}],index:"0603010002"},{text:" Treatment",hierarchyLevel:5,children:[{text:" Rest",hierarchyLevel:6,children:[],index:"060301000300"}],index:"0603010003"}],index:"06030100"},{text:" Coronary artery disease",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Atherosclerosis  lipid buildup narrowing the lumen of an artery",hierarchyLevel:6,children:[],index:"060301010000"},{text:" Acute disease  plaque breaks away and obstructs vessel",hierarchyLevel:6,children:[],index:"060301010001"},{text:" Infarction  death of tissue from the lack of blood supply",hierarchyLevel:6,children:[],index:"060301010002"},{text:" Myocardial infarction  death of heart tissue due to lack of bloodsupply",hierarchyLevel:6,children:[],index:"060301010003"},{text:" Stenotic  abnormally constricted body canal or passage",hierarchyLevel:6,children:[],index:"060301010004"},{text:" Collateral circulation  a network of tiny blood vesselstypically closed, ischemia in main vessels causes these collateral circulatoryvessels to open",hierarchyLevel:6,children:[],index:"060301010005"}],index:"0603010100"},{text:" Cause",hierarchyLevel:5,children:[{text:" Narrowing of the coronary arteries / atherosclerosis",hierarchyLevel:6,children:[],index:"060301010100"}],index:"0603010101"},{text:" Types",hierarchyLevel:5,children:[{text:" Acute Disease",hierarchyLevel:6,children:[{text:" Plaque breaks away and obstructs vessel, potentially causingmyocardial infarction",hierarchyLevel:7,children:[],index:"06030101020000"}],index:"060301010200"},{text:" Chronic Disease",hierarchyLevel:6,children:[{text:" Gradual narrowing of vessels",hierarchyLevel:7,children:[],index:"06030101020100"}],index:"060301010201"},{text:" Heart attack",hierarchyLevel:6,children:[{text:" Straining heart muscle demands more oxygen than the stenoticarteries provide",hierarchyLevel:7,children:[],index:"06030101020200"},{text:" This results in the ischemic area of the myocardium to undergoinfarction",hierarchyLevel:7,children:[],index:"06030101020201"}],index:"060301010202"}],index:"0603010102"},{text:" Treatment",hierarchyLevel:5,children:[{text:" Collateral Circulation  a network of tiny blood vesselstypically closed, ischemia in main vessels causes these collateral circulatoryvessels to open",hierarchyLevel:6,children:[],index:"060301010300"},{text:" Coronary artery bypass  surgical graft of a vessel to bypass theblockage; using a doner vessel from the internal thoracic artery or greatsaphenous vein to bypass the blockage",hierarchyLevel:6,children:[],index:"060301010301"}],index:"0603010103"}],index:"06030101"},{text:" Referred pain",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Afferent fibres  carry sensory neurons",hierarchyLevel:6,children:[],index:"060301020000"},{text:" Somatic Nervous System  skeletal muscles",hierarchyLevel:6,children:[],index:"060301020001"},{text:" Autonomic Nervous System / Visceral  visceral organs",hierarchyLevel:6,children:[],index:"060301020002"}],index:"0603010200"},{text:" Foundational Understandings",hierarchyLevel:5,children:[{text:" Heart is insensitive to touch, cutting, cold and heat",hierarchyLevel:6,children:[],index:"060301020100"},{text:" Ischemia of myocardium can stimulate pain endings in myocardium",hierarchyLevel:6,children:[],index:"060301020101"},{text:" Visceral afferent fibres and sympathetic fibres have cell bodiesin the same spinal ganglion with afferent fibres of somatic  structures",hierarchyLevel:6,children:[],index:"060301020102"},{text:" Dermatomes from T1-T3, supplying the 2  and 3 intercostal nerves, innervating the medial cutaneous nerve of the arm share thesame spinal cord segments as visceral afferent fibres innervating the coronaryarteries",hierarchyLevel:6,children:[],index:"060301020103"}],index:"0603010201"},{text:" Mechanism of Visceral referred pain",hierarchyLevel:5,children:[{text:" Ischemia of the heart results in the activation of nerve impulsesin the visceral afferent fibres and sympathetic fibres",hierarchyLevel:6,children:[],index:"060301020200"},{text:" Adjacent afferent fibres of somatic structures in the spinalganglion are also activated due to its proximity.",hierarchyLevel:6,children:[],index:"060301020201"},{text:" This results in perceived referred pain in somatic structures.",hierarchyLevel:6,children:[],index:"060301020202"}],index:"0603010202"},{text:" Mechanism of Anginal referred pain",hierarchyLevel:5,children:[{text:" Ischemia of the coronary arteries results in the activation ofthe visceral afferent fibres innervating the coronary arteries",hierarchyLevel:6,children:[],index:"060301020300"},{text:" Adjacent dermatomes from T1  T3 are also activated due to theirproximity, resulting in  referred pain in the arm  and substernal and leftpectorial regions",hierarchyLevel:6,children:[],index:"060301020301"}],index:"0603010203"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0603010204"}],index:"06030102"}],index:"060301"},{text:" Conduction System",hierarchyLevel:3,children:[{text:" The Heart with Conduction System",hierarchyLevel:4,children:[],index:"06030200"},{text:" Parts of the Conducting System",hierarchyLevel:4,children:[{text:" Sinoatrial (SA) node",hierarchyLevel:5,children:[{text:" Function",hierarchyLevel:6,children:[{text:" Sets the normal rhythm and rate in a healthy heart",hierarchyLevel:7,children:[],index:"06030201000000"}],index:"060302010000"},{text:" Location",hierarchyLevel:6,children:[{text:" Located anterolaterally, deep into the epicardium",hierarchyLevel:7,children:[],index:"06030201000100"},{text:" Located at the junction of the superior vena cava and the rightatrium",hierarchyLevel:7,children:[],index:"06030201000101"}],index:"060302010001"},{text:" Components",hierarchyLevel:6,children:[{text:" Small collection of nodal tissue",hierarchyLevel:7,children:[],index:"06030201000200"},{text:" Specialized cardiac muscle fibres",hierarchyLevel:7,children:[],index:"06030201000201"},{text:" Connective Tissue",hierarchyLevel:7,children:[],index:"06030201000202"}],index:"060302010002"}],index:"0603020100"},{text:" Atrioventricular (AV) node",hierarchyLevel:5,children:[{text:" Function",hierarchyLevel:6,children:[{text:" Distributes the signals from the sinoatrial node to theventricles through the atrioventricular bundle",hierarchyLevel:7,children:[],index:"06030201010000"}],index:"060302010100"},{text:" Location",hierarchyLevel:6,children:[{text:" Located in the posteroinferior region of the interatrial septum,near the opening of the coronary sinus",hierarchyLevel:7,children:[],index:"06030201010100"}],index:"060302010101"},{text:" Components",hierarchyLevel:6,children:[{text:" Smaller collection of nodal tissue (than sinoatrial node)",hierarchyLevel:7,children:[],index:"06030201010200"}],index:"060302010102"}],index:"0603020101"}],index:"06030201"},{text:" Conduction in the heart",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" The sinoatrial node initiates a nerve impulse",hierarchyLevel:6,children:[],index:"060302020000"},{text:" The nerve impulse spreads throughout the right atrium and passedthrough the wall of the right atrium via myogenic conduction.",hierarchyLevel:6,children:[],index:"060302020001"},{text:" The nerve impulse arrives at the atrioventricular node.",hierarchyLevel:6,children:[],index:"060302020002"},{text:" The atrioventricular node propagates the nerve impulse to theright and left bundle of nerve fibres.",hierarchyLevel:6,children:[],index:"060302020003"},{text:" The right bundle of nerve fibres propagates the nerve impulsedown the interventricular septum. The nerve impulse is then propagated via theseptomarginal trabecula (moderator band) to the anterior papillary muscle.Papillary muscles contract to prevent the inversion of the atrioventricularvalves.",hierarchyLevel:6,children:[],index:"060302020004"},{text:" The left bundle of nerve fibres propagates the nerve impulse downthe interventricular septum. The nerve impulse then propagates to the leftventricular wall, the muscle of the interventricular septum, the anteriorpapillary muscles and the posterior papillary muscles. The papillary musclescontract to prevent the inversion of the atrioventricular valves.",hierarchyLevel:6,children:[],index:"060302020005"}],index:"0603020200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0603020201"}],index:"06030202"},{text:" Cardiac Plexus",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Supplies the innervation to the heart",hierarchyLevel:6,children:[],index:"060302030000"},{text:" Sympathetic innervation increases the frequency of conduction tothe heart",hierarchyLevel:6,children:[],index:"060302030001"},{text:" Parasympathetic innervation lowers the frequency of conduction tothe heart",hierarchyLevel:6,children:[],index:"060302030002"}],index:"0603020300"},{text:" Location",hierarchyLevel:5,children:[{text:" Located between the aorta and pulmonary trunk and the trachea",hierarchyLevel:6,children:[],index:"060302030100"}],index:"0603020301"},{text:" Components",hierarchyLevel:5,children:[{text:" Sympathetics  contains postsynaptic fibres from superiorthoracic paravertebral ganglia of sympathetic trunks",hierarchyLevel:6,children:[],index:"060302030200"},{text:" Parasympathetics  contains vagus nerves",hierarchyLevel:6,children:[],index:"060302030201"}],index:"0603020302"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0603020303"}],index:"06030203"},{text:" Angiogram",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Diagnose and identify coronary artery ischemia",hierarchyLevel:6,children:[],index:"060302040000"}],index:"0603020400"},{text:" Observation",hierarchyLevel:5,children:[{text:" Look out for parts of the coronary arteries that has a very lightcolouring",hierarchyLevel:6,children:[],index:"060302040100"},{text:" Light colouring indicates a lack of blood flow to the area andhence less radioactive isotopes are present in the area",hierarchyLevel:6,children:[],index:"060302040101"},{text:" Recall from memory the common points of coronary artery ischemia.",hierarchyLevel:6,children:[],index:"060302040102"},{text:" Based on the light zones and the common points of ischemia,choose on of the points as the point of blockage",hierarchyLevel:6,children:[],index:"060302040103"}],index:"0603020401"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0603020402"},{text:" Common Points of Ischemia in the Heart",hierarchyLevel:5,children:[],index:"0603020403"}],index:"06030204"},{text:" Abnormal Function: Artificial Pacemaker",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Initial ventricular contractions at a predetermined rate",hierarchyLevel:6,children:[],index:"060302050000"},{text:" Used to treat slow or irregular heart rate",hierarchyLevel:6,children:[],index:"060302050001"}],index:"0603020500"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Electrode is passed through the superior vena cava to the rightatrium and through the tricuspid valve into the right ventricle",hierarchyLevel:6,children:[],index:"060302050100"},{text:" Electrodes are placed in contact with the endocardium",hierarchyLevel:6,children:[],index:"060302050101"}],index:"0603020501"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0603020502"}],index:"06030205"},{text:" Identifying the position (front/back) of the heart given a randomimage (MAKE THESE NOTES SOON)",hierarchyLevel:4,children:[],index:"06030206"}],index:"060302"}],index:"0603"},{text:" [041] Surgical anatomy and clinical imaging",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Axial  an axial image is one obtained by rotating around theaxis of the body, producing a transverse planar image, that is, a sectiontransverse to the axis.",hierarchyLevel:5,children:[],index:"0604000000"},{text:" Windowing  the process in which the CT image greyscale componentof an image is manipulated via the CT numbers; doing this will change theappearance of the picture to highlight particular structures. The brightness ofthe image is adjusted via the window level. The contrast is adjusted via thewindow width.",hierarchyLevel:5,children:[],index:"0604000001"},{text:" Coeliac trunk / artery  major splanchnic artery in theabdominal cavity which gives rise to left gastric artery, splenic artery, andcommon hepatic artery",hierarchyLevel:5,children:[],index:"0604000002"},{text:" Mesenteric artery  take blood from the aorta and distribute itto a large portion of the gastrointestinal tract",hierarchyLevel:5,children:[],index:"0604000003"},{text:" Consolidation  consolidation is the result of replacement of airin the alveoli by transudate, pus, blood, cells or other substances",hierarchyLevel:5,children:[],index:"0604000004"},{text:" Air bronchogram  the phenomenon of air-filled bronchi (dark)being made visible by the opacification of surrounding alveoli (grey/white)",hierarchyLevel:5,children:[],index:"0604000005"}],index:"06040000"}],index:"060400"},{text:" Normal Images",hierarchyLevel:3,children:[{text:" Frontal chest x-ray",hierarchyLevel:4,children:[],index:"06040100"},{text:" Lateral chest x-ray",hierarchyLevel:4,children:[],index:"06040101"},{text:" Chest CT Axial",hierarchyLevel:4,children:[],index:"06040102"},{text:" Chest CT Coronal",hierarchyLevel:4,children:[],index:"06040103"},{text:" Chest CT Sagittal",hierarchyLevel:4,children:[],index:"06040104"}],index:"060401"},{text:" Abnormal Images",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Hemidiaphragm  the hemidiaphragms are domed structures thatshould be well defined and visible to the midline on a frontal view. Thecontours of the hemidiaphragms do not demarcate the bottom of the lungs; lungmarkings can be seen below the hemidiaphragms.",hierarchyLevel:5,children:[],index:"0604020000"},{text:" Hemithorax  half of the thorax or, more simply, one side of thechest",hierarchyLevel:5,children:[],index:"0604020001"},{text:" Filling defect  a filling defect is a general term used to referto any abnormality on an imaging study which disrupts the normal opacification(filling) of a cavity or lumen",hierarchyLevel:5,children:[],index:"0604020002"},{text:" Thrombectomy  surgical thrombectomy is a type of surgery toremove a blood clot from inside an artery or vein.",hierarchyLevel:5,children:[],index:"0604020003"}],index:"06040200"},{text:" Left Collapsed Lung",hierarchyLevel:4,children:[],index:"06040201"},{text:" Right Collapsed Lung",hierarchyLevel:4,children:[],index:"06040202"},{text:" Consolidated Lung x-ray",hierarchyLevel:4,children:[],index:"06040203"},{text:" Consolidated Lung CT",hierarchyLevel:4,children:[],index:"06040204"},{text:" COVID-19 Lung bilateral predominantly peripheral pulmonaryopacities",hierarchyLevel:4,children:[],index:"06040205"},{text:" Pleural Effusion Lung (x-ray)",hierarchyLevel:4,children:[],index:"06040206"},{text:" Pleural Effusion Lung (CT)",hierarchyLevel:4,children:[],index:"06040207"},{text:" Pleural Effusion Lung (ultrasound)",hierarchyLevel:4,children:[],index:"06040208"},{text:" Trauma (stab injury)",hierarchyLevel:4,children:[],index:"06040209"},{text:" Trauma (car accident)",hierarchyLevel:4,children:[],index:"06040210"},{text:" Trauma",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0604021100"}],index:"06040211"}],index:"060402"},{text:" Bronchoscopy",hierarchyLevel:3,children:[{text:" Trachea (healthy)",hierarchyLevel:4,children:[],index:"06040300"},{text:" Trachea (with stone)",hierarchyLevel:4,children:[],index:"06040301"},{text:" Trachea (with broncho lesion)",hierarchyLevel:4,children:[],index:"06040302"},{text:" Trachea (dry cough  diffused nodules)",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0604030300"}],index:"06040303"},{text:" Bronchoobstruciton (x-ray)",hierarchyLevel:4,children:[],index:"06040304"},{text:" Biopsy for cavitation lesions in the lung",hierarchyLevel:4,children:[],index:"06040305"},{text:" Diagnostic Aortagram",hierarchyLevel:4,children:[],index:"06040306"},{text:" Treating aortic aneurism by seclusion with stent",hierarchyLevel:4,children:[],index:"06040307"},{text:" Coronary angiogram  identify occluded vessels",hierarchyLevel:4,children:[],index:"06040308"},{text:" CT Reconstruction of Coronary Vessels",hierarchyLevel:4,children:[],index:"06040309"},{text:" Dual chambered (dual lead) pacemaker",hierarchyLevel:4,children:[],index:"06040310"},{text:" CT Pulmonary Angiogram",hierarchyLevel:4,children:[],index:"06040311"},{text:" Diagnostic Pulmonary Angiogram",hierarchyLevel:4,children:[],index:"06040312"},{text:" Mechanical Thrombectomy of Pulmonary Embolus",hierarchyLevel:4,children:[],index:"06040313"}],index:"060403"}],index:"0604"}]},{text:"Pharmacology",hierarchyLevel:1,children:[{text:" Poster",hierarchyLevel:2,children:[{text:" Feedback",hierarchyLevel:3,children:[],index:"070000"}],index:"0700"}]}]},ind:{text:"Infection and Defence",hierarchyLevel:0,children:[{text:"Immunology",hierarchyLevel:1,children:[{text:" [004] Cells and Tissues of the Immune System",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" To know the major cell types and organs of the immune system",hierarchyLevel:4,children:[],index:"00000000"},{text:" To understand what distinguishes the anatomy of the immune systemfrom that of other physiological systems ",hierarchyLevel:4,children:[],index:"00000001"},{text:" To understand the broad developmental pathways of the cells ofthe immune system",hierarchyLevel:4,children:[],index:"00000002"},{text:" To know the major types of immune cells and what they do ",hierarchyLevel:4,children:[],index:"00000003"},{text:" To understand how different stages of T-cell & B-celldevelopment and differentiation relate to different anatomical/histologicalcompartments",hierarchyLevel:4,children:[],index:"00000004"},{text:" To know the migratory pathways of the major cell types whichcomprise the immune system.",hierarchyLevel:4,children:[],index:"00000005"}],index:"000000"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Classification of the Immune System",hierarchyLevel:4,children:[{text:" Understanding",hierarchyLevel:5,children:[{text:" Immune system is ubiquitous (spread throughout the entire body)and cannot be identified by a geographic location on the body",hierarchyLevel:6,children:[],index:"000001000000"},{text:" Hence, classification of the cells of the immune system is basedon the progenitor (less differentiated cells)",hierarchyLevel:6,children:[],index:"000001000001"},{text:" All cells in the immune system are derived from a singlehaematopoietic stem cell (stem cells that create the haematopoetic system)",hierarchyLevel:6,children:[],index:"000001000002"}],index:"0000010000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0000010001"}],index:"00000100"},{text:" Challenges arising from haemopoetic system (widely distributedand decentralized)",hierarchyLevel:4,children:[],index:"00000101"},{text:" Geography of the Immune System",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0000010200"}],index:"00000102"}],index:"000001"},{text:" Key Cellular Players",hierarchyLevel:3,children:[{text:" Structure of Notes",hierarchyLevel:4,children:[{text:" Structure",hierarchyLevel:5,children:[],index:"0000020000"},{text:" Function",hierarchyLevel:5,children:[],index:"0000020001"},{text:" Location (geography)",hierarchyLevel:5,children:[],index:"0000020002"}],index:"00000200"},{text:" Overview of Key Cellular Players",hierarchyLevel:4,children:[{text:" Innate",hierarchyLevel:5,children:[{text:" Granulocyte",hierarchyLevel:6,children:[],index:"000002010000"},{text:" Macrophage",hierarchyLevel:6,children:[],index:"000002010001"},{text:" Dendritic (hybrid)",hierarchyLevel:6,children:[],index:"000002010002"}],index:"0000020100"},{text:" Adaptive",hierarchyLevel:5,children:[{text:" T cell",hierarchyLevel:6,children:[],index:"000002010100"},{text:" B cells",hierarchyLevel:6,children:[],index:"000002010101"}],index:"0000020101"},{text:" Borderlands",hierarchyLevel:5,children:[{text:" Innate lymphoid cells",hierarchyLevel:6,children:[],index:"000002010200"},{text:" Natural Killer cells",hierarchyLevel:6,children:[],index:"000002010201"},{text:" Natural Killer T cells",hierarchyLevel:6,children:[],index:"000002010202"},{text:" \u03b3\u03b4 T cells",hierarchyLevel:6,children:[],index:"000002010203"}],index:"0000020102"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0000020103"}],index:"00000201"},{text:" Granulocytes (Innate)",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" Neutrophils",hierarchyLevel:6,children:[],index:"000002020000"},{text:" Eosinophils",hierarchyLevel:6,children:[],index:"000002020001"},{text:" Basophils",hierarchyLevel:6,children:[],index:"000002020002"}],index:"0000020200"},{text:" Location",hierarchyLevel:5,children:[{text:" Found in the blood",hierarchyLevel:6,children:[],index:"000002020100"}],index:"0000020201"},{text:" Properties",hierarchyLevel:5,children:[{text:" Short lived  lifecycle",hierarchyLevel:6,children:[],index:"000002020200"}],index:"0000020202"},{text:" Function (General)",hierarchyLevel:5,children:[{text:" Rapid defense against infection by phagocytosis and killing",hierarchyLevel:6,children:[],index:"000002020300"}],index:"0000020203"},{text:" Structure and Function",hierarchyLevel:5,children:[],index:"0000020204"},{text:" General Mechanism",hierarchyLevel:5,children:[{text:" Recruited from blood to tissue during inflammation",hierarchyLevel:6,children:[],index:"000002020500"},{text:" Produces many cytotoxic mediators (reactive oxygen species / bleach)",hierarchyLevel:6,children:[],index:"000002020501"}],index:"0000020205"},{text:" Detailed Mechanism (no infection)",hierarchyLevel:5,children:[{text:" Created in the bone marrow, circulates the entire circulatorysystem",hierarchyLevel:6,children:[],index:"000002020600"},{text:" If no pathogens are detected, it dies within 24 hours",hierarchyLevel:6,children:[],index:"000002020601"}],index:"0000020206"},{text:" Detailed Mechanism (infection)",hierarchyLevel:5,children:[{text:" Created in the bone marrow, circulates the entire circulatorysystem",hierarchyLevel:6,children:[],index:"000002020700"},{text:" Human experiences a cut",hierarchyLevel:6,children:[],index:"000002020701"},{text:" Endothelial cells of the blood vessels release chemicals",hierarchyLevel:6,children:[],index:"000002020702"},{text:" Chemicals attracts neutrophils, causing them to migrate to thesite",hierarchyLevel:6,children:[],index:"000002020703"},{text:" At the site, the neutrophils detect the stickiness of theendothelial cell by detect the change in its own cell wall",hierarchyLevel:6,children:[],index:"000002020704"},{text:" If there is stickiness, neutrophils will undergo extravasationand flatten itself to squeeze through the endothelial wall to exit the bloodvessel and move into the site of infection",hierarchyLevel:6,children:[],index:"000002020705"}],index:"0000020207"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0000020208"}],index:"00000202"},{text:" Macrophages (Innate)",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" Monocytes  blood (precursor)",hierarchyLevel:6,children:[],index:"000002030000"},{text:" Macrophages  tissues",hierarchyLevel:6,children:[],index:"000002030001"}],index:"0000020300"},{text:" Location",hierarchyLevel:5,children:[{text:" Found in the tissues",hierarchyLevel:6,children:[],index:"000002030100"}],index:"0000020301"},{text:" Function",hierarchyLevel:5,children:[{text:" Phagocytose cell debris in tissue",hierarchyLevel:6,children:[],index:"000002030200"}],index:"0000020302"},{text:" Properties",hierarchyLevel:5,children:[{text:" Long lived",hierarchyLevel:6,children:[],index:"000002030300"},{text:" Every tissue has its own population of macrophages (Kuppfer cells liver)",hierarchyLevel:6,children:[],index:"000002030301"}],index:"0000020303"},{text:" Function (General)",hierarchyLevel:5,children:[{text:" Provides second wave of defense (when granulocytes calls forbackup)",hierarchyLevel:6,children:[],index:"000002030400"}],index:"0000020304"},{text:" Structure and Function",hierarchyLevel:5,children:[],index:"0000020305"}],index:"00000203"},{text:" Mast Cells",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Contains many granules ",hierarchyLevel:6,children:[],index:"000002040000"},{text:" Contains Fc Receptors",hierarchyLevel:6,children:[],index:"000002040001"},{text:" Contains Fc receptor for IgE",hierarchyLevel:6,children:[],index:"000002040002"}],index:"0000020400"},{text:" Location",hierarchyLevel:5,children:[{text:" Found in tissues (predominantly in skin and mucosal tissues),line the surface of the body",hierarchyLevel:6,children:[],index:"000002040100"},{text:" Rarely found in blood",hierarchyLevel:6,children:[],index:"000002040101"},{text:" Precursors found in blood",hierarchyLevel:6,children:[],index:"000002040102"}],index:"0000020401"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0000020402"}],index:"00000204"},{text:" Lymphocytes (adaptive)",hierarchyLevel:4,children:[{text:" Types",hierarchyLevel:5,children:[{text:" T cell (thymus)",hierarchyLevel:6,children:[],index:"000002050000"},{text:" B cell (bone marrow / bursa)",hierarchyLevel:6,children:[],index:"000002050001"},{text:" T and B cells are histologically indistinguishable",hierarchyLevel:6,children:[],index:"000002050002"}],index:"0000020500"},{text:" Properties",hierarchyLevel:5,children:[{text:" Small",hierarchyLevel:6,children:[],index:"000002050100"},{text:" Very long lived (10-20 years if never activated)",hierarchyLevel:6,children:[],index:"000002050101"}],index:"0000020501"},{text:" Location",hierarchyLevel:5,children:[{text:" Found in blood",hierarchyLevel:6,children:[],index:"000002050200"}],index:"0000020502"},{text:" Movement",hierarchyLevel:5,children:[{text:" Fighting infection",hierarchyLevel:6,children:[{text:" Lymphocytes leaves the bloodstream at the site of the infectedtissue",hierarchyLevel:7,children:[],index:"00000205030000"}],index:"000002050300"},{text:" Not fighting infection",hierarchyLevel:6,children:[{text:" Lymphocytes leaves the bloodstream via the lymph node and checkfor compatible antigens",hierarchyLevel:7,children:[],index:"00000205030100"},{text:" Searches the lymph node because it is the site where all immuneresponses begin (with the lymphocyte recognizes its antigen target at the lymphnode)",hierarchyLevel:7,children:[],index:"00000205030101"}],index:"000002050301"},{text:" Diagram",hierarchyLevel:6,children:[],index:"000002050302"}],index:"0000020503"},{text:" Prevalence",hierarchyLevel:5,children:[{text:" Consist of 25% of circulating white blood cells",hierarchyLevel:6,children:[{text:" Lymphocytes: 25%",hierarchyLevel:7,children:[],index:"00000205040000"},{text:" Monocytes: 5%",hierarchyLevel:7,children:[],index:"00000205040001"},{text:" Granulocytes: 70%",hierarchyLevel:7,children:[],index:"00000205040002"}],index:"000002050400"},{text:" Make up 2% of total blood",hierarchyLevel:6,children:[],index:"000002050401"}],index:"0000020504"},{text:" Mechanism of Activation",hierarchyLevel:5,children:[{text:" B cells upon contact with antigens, will differentiatesignificantly to form plasma cells",hierarchyLevel:6,children:[],index:"000002050500"}],index:"0000020505"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0000020506"}],index:"00000205"},{text:" Dendritic cell (hybrid  innate / adaptive)",hierarchyLevel:4,children:[{text:" Location",hierarchyLevel:5,children:[{text:" Located in tissues",hierarchyLevel:6,children:[],index:"000002060000"},{text:" More prevalent in locations where infection is most likely tooccur",hierarchyLevel:6,children:[{text:" Lung",hierarchyLevel:7,children:[],index:"00000206000100"},{text:" Skin",hierarchyLevel:7,children:[],index:"00000206000101"},{text:" Gut",hierarchyLevel:7,children:[],index:"00000206000102"}],index:"000002060001"}],index:"0000020600"},{text:" Function",hierarchyLevel:5,children:[{text:" Sampling antigen from the environment and carry it to the lymphnodes (for the lymphocytes to detect)",hierarchyLevel:6,children:[],index:"000002060100"}],index:"0000020601"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Dendritic cells extend their arms out searching for pathogens",hierarchyLevel:6,children:[],index:"000002060200"},{text:" The arms are constantly retracting and extending, going in andout looking for antigens",hierarchyLevel:6,children:[],index:"000002060201"},{text:" As soon as the dendritic cells finds an antigen, the dendriticcell retracts its arms, swims down the lymphatic vessels, and finds the nearestlymph nodes",hierarchyLevel:6,children:[],index:"000002060202"},{text:" The dendritic cells then extends its arms again and wait for alymphocyte to arrive at the lymph node",hierarchyLevel:6,children:[],index:"000002060203"},{text:" Once the lymphocyte and the dendritic cell meets, the immuneresponse starts",hierarchyLevel:6,children:[],index:"000002060204"}],index:"0000020602"}],index:"00000206"}],index:"000002"}],index:"0000"},{text:" [007] Innate Immunity",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Commensal bacteria",hierarchyLevel:4,children:[{text:" 1. Bacteriaexist on the skin and do not cause infection unless they enter the tissues",hierarchyLevel:5,children:[],index:"0001000000"},{text:" 2. Co-existenceplays a positive role in maintaining health",hierarchyLevel:5,children:[],index:"0001000001"}],index:"00010000"},{text:" First Line of Defence",hierarchyLevel:4,children:[{text:" 1. Components",hierarchyLevel:5,children:[{text:" Skin",hierarchyLevel:6,children:[{text:" Keeps microbes out",hierarchyLevel:7,children:[],index:"00010001000000"}],index:"000100010000"},{text:" Mucus",hierarchyLevel:6,children:[{text:" Skin in lungs, digestive and respiratory tract are thinner andhence easier for microbes to get in",hierarchyLevel:7,children:[],index:"00010001000100"},{text:" Mucus provides a further physical barrier in these locations",hierarchyLevel:7,children:[],index:"00010001000101"}],index:"000100010001"}],index:"0001000100"},{text:" 2. Process",hierarchyLevel:5,children:[{text:" Once the first line of defence is breached, the innate immunesystem activates",hierarchyLevel:6,children:[],index:"000100010100"}],index:"0001000101"}],index:"00010001"},{text:" Types of Immunity",hierarchyLevel:4,children:[{text:" 1. Innate",hierarchyLevel:5,children:[{text:" : Neutralizes microbes once they get past firstbarriers (skin)",hierarchyLevel:6,children:[],index:"000100020000"},{text:" : All components of the immune system that arenot lymphocytes",hierarchyLevel:6,children:[],index:"000100020001"}],index:"0001000200"},{text:" 2. Adaptive",hierarchyLevel:5,children:[],index:"0001000201"}],index:"00010002"},{text:" Overview of Innate Immunity",hierarchyLevel:4,children:[{text:" 1. Recognition",hierarchyLevel:5,children:[],index:"0001000300"},{text:" 2. EffectorMechanisms",hierarchyLevel:5,children:[],index:"0001000301"},{text:" 3. Amplificationand Regulation",hierarchyLevel:5,children:[],index:"0001000302"},{text:" 4.",hierarchyLevel:5,children:[],index:"0001000303"}],index:"00010003"}],index:"000100"},{text:" Recognition",hierarchyLevel:3,children:[{text:" Components",hierarchyLevel:4,children:[{text:" Receptor (lock)  Pattern Recognition Receptors (PRR)",hierarchyLevel:5,children:[],index:"0001010000"},{text:" Ligand (key)  Pathogen Associated Molecular Patterns (PAMPs)",hierarchyLevel:5,children:[],index:"0001010001"}],index:"00010100"},{text:" Properties",hierarchyLevel:4,children:[{text:" Highly specific  small molecular changes can cause recognitionchange",hierarchyLevel:5,children:[],index:"0001010100"},{text:" Small scale  size of the key is only a few amino acids",hierarchyLevel:5,children:[],index:"0001010101"}],index:"00010101"},{text:" Example: Toll-like Receptor (TLR) ligand recognition",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Horse-shoe shape which can bind to PAMPs which are associatedwith a particular microorganism",hierarchyLevel:6,children:[],index:"000101020000"}],index:"0001010200"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"000101020100"}],index:"0001010201"},{text:" Cells",hierarchyLevel:5,children:[{text:" Mainly expressed by antigen presenting cells such as dendriticcells and macrophages, but they are also found in other immune and non-immunecells",hierarchyLevel:6,children:[],index:"000101020200"}],index:"0001010202"},{text:" Locations",hierarchyLevel:5,children:[{text:" Extracellular (on plasma membrane)",hierarchyLevel:6,children:[],index:"000101020300"},{text:" Endosomal (in vesicles)",hierarchyLevel:6,children:[],index:"000101020301"},{text:" Cytosolic (in cytoplasm)",hierarchyLevel:6,children:[],index:"000101020302"}],index:"0001010203"}],index:"00010102"},{text:" Function",hierarchyLevel:4,children:[{text:" Problem",hierarchyLevel:5,children:[{text:" Need to recognize and respond to any microbe, virus, bacteria ormulticellular parasite",hierarchyLevel:6,children:[],index:"000101030000"}],index:"0001010300"},{text:" Solution",hierarchyLevel:5,children:[{text:" Continuously evolve PRR that currently recognizes PAMPs",hierarchyLevel:6,children:[],index:"000101030100"}],index:"0001010301"}],index:"00010103"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" Upon binding of PAMPs to PRR, the innate immune system isactivated",hierarchyLevel:5,children:[],index:"0001010400"}],index:"00010104"}],index:"000101"},{text:" Effector Mechanisms",hierarchyLevel:3,children:[{text:" Main Effector Mechanisms",hierarchyLevel:4,children:[{text:" Phagocytosis and intracellular killing",hierarchyLevel:5,children:[],index:"0001020000"},{text:" Complement  Extracellular killing ",hierarchyLevel:5,children:[],index:"0001020001"},{text:" Interferon and restriction factors (prevent viral replication)",hierarchyLevel:5,children:[],index:"0001020002"}],index:"00010200"},{text:" Complement",hierarchyLevel:4,children:[{text:" Components",hierarchyLevel:5,children:[{text:" 20-30 different proteins in blood",hierarchyLevel:6,children:[],index:"000102010000"}],index:"0001020100"},{text:" Properties",hierarchyLevel:5,children:[{text:" Act in a proteolytic amplification cascade system",hierarchyLevel:6,children:[],index:"000102010100"},{text:" Fast (startup to fully active: seconds)",hierarchyLevel:6,children:[],index:"000102010101"},{text:" Highly regulated (50% of the complementary system)",hierarchyLevel:6,children:[],index:"000102010102"}],index:"0001020101"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" C3 is cleaved into C3a and C3b, enabling the function of thecomplement system",hierarchyLevel:6,children:[],index:"000102010200"}],index:"0001020102"},{text:" Activation Pathways",hierarchyLevel:5,children:[{text:" Alternative",hierarchyLevel:6,children:[],index:"000102010300"},{text:" Classical",hierarchyLevel:6,children:[],index:"000102010301"},{text:" Lectin",hierarchyLevel:6,children:[],index:"000102010302"}],index:"0001020103"},{text:" Function",hierarchyLevel:5,children:[{text:" Opsonization - Phagocytosis and intracellular killing",hierarchyLevel:6,children:[],index:"000102010400"},{text:" Lysis - Extracellular killing ",hierarchyLevel:6,children:[],index:"000102010401"},{text:" Inflammation",hierarchyLevel:6,children:[],index:"000102010402"}],index:"0001020104"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0001020105"},{text:" Goal",hierarchyLevel:5,children:[{text:" Make the bacteria more attractive to phagocytes",hierarchyLevel:6,children:[],index:"000102010600"},{text:" Cover the bacteria with a (protein) which makes it easier tophagocytosis",hierarchyLevel:6,children:[],index:"000102010601"}],index:"0001020106"},{text:" Mechanism: Activation",hierarchyLevel:5,children:[{text:" Bacteria enters the bloodstream, activating the complement system",hierarchyLevel:6,children:[],index:"000102010700"},{text:" C3b is released and binds to the surface of the bacteria",hierarchyLevel:6,children:[],index:"000102010701"},{text:" All phagocytes (neutrophils, macrophages) have cell surfacereceptors that recognize C3b",hierarchyLevel:6,children:[],index:"000102010702"},{text:" Neutrophil comes and recognizes the C3b and phagocytose thebacteria",hierarchyLevel:6,children:[],index:"000102010703"},{text:" C3b activates other proteins. C9",hierarchyLevel:6,children:[],index:"000102010704"}],index:"0001020107"},{text:" Mechanism: Non-activation",hierarchyLevel:5,children:[{text:" C3b is released and does not bind to the surface of any bacteria (nobacteria present)",hierarchyLevel:6,children:[],index:"000102010800"},{text:" C3b will be deactivated and stop binding to anything",hierarchyLevel:6,children:[],index:"000102010801"},{text:" In a few seconds, C3b will be further degraded and removed fromcirculation",hierarchyLevel:6,children:[],index:"000102010802"},{text:" This provides basic regulation of the complement system",hierarchyLevel:6,children:[],index:"000102010803"}],index:"0001020108"},{text:" Goal",hierarchyLevel:5,children:[{text:" Direct killing of bacteria",hierarchyLevel:6,children:[],index:"000102010900"}],index:"0001020109"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" C3b activates other complements, C5, C9",hierarchyLevel:6,children:[],index:"000102011000"},{text:" C9 combines to form a terminal attack complex / membrane attackcomplex",hierarchyLevel:6,children:[],index:"000102011001"},{text:" C9 causes the formation of pores in the plasma membrane of thebacteria, resulting in cell lysis and bacterial cell death",hierarchyLevel:6,children:[],index:"000102011002"}],index:"0001020110"},{text:" Goal",hierarchyLevel:5,children:[{text:" Attract other immune cells to the site of the infection(neutrophils)",hierarchyLevel:6,children:[],index:"000102011100"}],index:"0001020111"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" During the activation of the complement system, C3 is cleaved into C3a and C3b",hierarchyLevel:6,children:[],index:"000102011200"},{text:" C3b cleaves C5 into C5a and C5b",hierarchyLevel:6,children:[],index:"000102011201"},{text:" C5a and C3a leads to the movement of neutrophils to the site ofinfection",hierarchyLevel:6,children:[],index:"000102011202"},{text:" Movement of millions of granulocytes (neutrophils) results in aninflammatory reaction",hierarchyLevel:6,children:[],index:"000102011203"}],index:"0001020112"},{text:" Microbial cell walls results in the formation of C3bBb",hierarchyLevel:5,children:[],index:"0001020113"},{text:" Antibody bound to microbe results in the activation of C1q =>C1r => C1s",hierarchyLevel:5,children:[],index:"0001020114"},{text:" This eventually lead to the activation of C4b2a",hierarchyLevel:5,children:[],index:"0001020115"},{text:" PRR (manitose binding protein) binds to PAMPs (manitose - fungi)",hierarchyLevel:5,children:[],index:"0001020116"},{text:" PRR activates other proteins which results in the activation ofC4b2a",hierarchyLevel:5,children:[],index:"0001020117"},{text:" C3bBb and C4b2a cleaves C3 into C3a and C3b, activating thecomplement system",hierarchyLevel:5,children:[],index:"0001020118"}],index:"00010201"},{text:" Interferon",hierarchyLevel:4,children:[{text:" Background",hierarchyLevel:5,children:[{text:" Problem",hierarchyLevel:6,children:[{text:" Viruses enter the cells and hence are protected from thecomplement system",hierarchyLevel:7,children:[],index:"00010202000000"},{text:" Interferon aims to bridge the gap",hierarchyLevel:7,children:[],index:"00010202000001"}],index:"000102020000"},{text:" Solution",hierarchyLevel:6,children:[{text:" Antiviral proteins in the cell (restriction factors) restrict theability of viruses to divide",hierarchyLevel:7,children:[],index:"00010202000100"}],index:"000102020001"}],index:"0001020200"},{text:" Definition",hierarchyLevel:5,children:[{text:" Interferon  proteins that interferes with the replication ofviruses.",hierarchyLevel:6,children:[],index:"000102020100"}],index:"0001020201"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Virus enters the cell cytoplasm and triggers the cell innaterecognition receptors",hierarchyLevel:6,children:[],index:"000102020200"},{text:" This causes the cell to produce interferons.",hierarchyLevel:6,children:[],index:"000102020201"},{text:" Interferons spreads to the neighboring cells",hierarchyLevel:6,children:[],index:"000102020202"},{text:" With the presence of interferons, 1000 times more viruses arerequired to replicate within the cells. However, the viral resistant stateprevents the cell from performing many of the normal cellular activities",hierarchyLevel:6,children:[],index:"000102020203"},{text:" This enables neighboring cells to become resistant to viralinfection",hierarchyLevel:6,children:[],index:"000102020204"}],index:"0001020202"}],index:"00010202"},{text:" Inflammation",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" The immune system overreacts to a particular challenge",hierarchyLevel:6,children:[],index:"000102030000"},{text:" This overreaction results to the symptoms of the disease",hierarchyLevel:6,children:[],index:"000102030001"}],index:"0001020300"},{text:" Classical signs of inflammation",hierarchyLevel:5,children:[{text:" Cator (heat)",hierarchyLevel:6,children:[],index:"000102030100"},{text:" Rubor (redness)",hierarchyLevel:6,children:[],index:"000102030101"},{text:" Tumor (swelling)",hierarchyLevel:6,children:[],index:"000102030102"},{text:" Dolor (pain)",hierarchyLevel:6,children:[],index:"000102030103"},{text:" Function Laesa (loss of function)",hierarchyLevel:6,children:[],index:"000102030104"}],index:"0001020301"},{text:" Mechanism of Inflammation",hierarchyLevel:5,children:[{text:" Infection results in the recruitment of cells (neutrophils) andserum which contains proteins required for the complement system",hierarchyLevel:6,children:[],index:"000102030200"},{text:" To aid in recruitment, vasodilation occurs, enabling bloodvessels to become bigger and hence increase the number of cells that can travelto infection site. Vasodilation results in redness in the skin.",hierarchyLevel:6,children:[],index:"000102030201"},{text:" To aid in recruitment, vasopermeability is increased, enablingthe blood vessels to become leaky to that the components like neutrophils",hierarchyLevel:6,children:[],index:"000102030202"},{text:" Neutrophils that arrive will release toxic mediators to kill thepathogen. Mediators results in the damage of surrounding cells and damages theneighboring nerve endings. This causing tissue necrosis pain.",hierarchyLevel:6,children:[],index:"000102030203"},{text:" Due to the number of neutrophils that flood the infection site,the middle of the infection site runs out of oxygen and turns into a hypoxicstate. This leads to the inability of tissue to function and hence tissuedeath.",hierarchyLevel:6,children:[],index:"000102030204"}],index:"0001020302"},{text:" Inflammatory Mediators - Cytokines (hormones of the immunesystem)",hierarchyLevel:5,children:[{text:" Definition",hierarchyLevel:6,children:[{text:" Act on the cells of the immune system to stimulate them toproduce an immune response",hierarchyLevel:7,children:[],index:"00010203030000"}],index:"000102030300"},{text:" Types",hierarchyLevel:6,children:[{text:" Cytokines",hierarchyLevel:7,children:[],index:"00010203030100"},{text:" Chemokines",hierarchyLevel:7,children:[],index:"00010203030101"}],index:"000102030301"},{text:" Examples and Function",hierarchyLevel:6,children:[],index:"000102030302"}],index:"0001020303"}],index:"00010203"},{text:" Acute Phase Response",hierarchyLevel:4,children:[{text:" Interleukin 6 stimulates the up regulation of proteins in theblood during the acute phase response",hierarchyLevel:5,children:[],index:"0001020400"},{text:" Clinicians measures the presence of these proteins as a marker ofinflammation",hierarchyLevel:5,children:[],index:"0001020401"}],index:"00010204"},{text:" Chronic Inflammation",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Chronic activation of macrophages results in the further damageof tissues",hierarchyLevel:6,children:[],index:"000102050000"},{text:" This may lead to aging",hierarchyLevel:6,children:[],index:"000102050001"}],index:"0001020500"},{text:" Diseases",hierarchyLevel:5,children:[{text:" Arthritis (joints)",hierarchyLevel:6,children:[],index:"000102050100"},{text:" Atherosclerosis",hierarchyLevel:6,children:[],index:"000102050101"},{text:" Diabetes",hierarchyLevel:6,children:[],index:"000102050102"},{text:" Dementia",hierarchyLevel:6,children:[],index:"000102050103"},{text:" Cancer",hierarchyLevel:6,children:[],index:"000102050104"}],index:"0001020501"}],index:"00010205"},{text:" Random thoughts: key to good education is continuinty andbuilding based on previous knowledge learnt. Struggles come when there are gapsin knowledge which the new lessons depends on. Having a knowledge graph andflashcard testing identifies what are the dependencies in which a learnershould have first",hierarchyLevel:4,children:[],index:"00010206"},{text:" Decentralized bundling of education",hierarchyLevel:4,children:[],index:"00010207"}],index:"000102"}],index:"0001"},{text:" [009] Antigen recognition by B-cells and antibody",hierarchyLevel:2,children:[{text:" Background Story",hierarchyLevel:3,children:[{text:" Side Chain Theory",hierarchyLevel:4,children:[{text:" Paul Ehrlich realized that blood serum post-tetanus injectionneutralized tetanus but not anthrax. Blood serum post-anthrax injectionneutralized anthrax but not tetanus.",hierarchyLevel:5,children:[],index:"0002000000"},{text:" Reasoned that the cells produced numerous different side chains(antibody  anti-of-whatever-injected) to combat the pathogen injection",hierarchyLevel:5,children:[],index:"0002000001"},{text:" Reasoned that the toxin will first bind to the side chain that iscompatible. This causes the cell to produce and release many of the specificfreely-floating side chains into the bloodstream. Freely floating side chainsthen bind to the toxin, hence neutralizing it.",hierarchyLevel:5,children:[],index:"0002000002"},{text:" Correct Postulations",hierarchyLevel:5,children:[{text:" B-lymphocytes can convert its receptor on the cell surface to beproduced and secreted in large amounts into the blood",hierarchyLevel:6,children:[],index:"000200000300"}],index:"0002000003"}],index:"00020000"},{text:" Clonal Selection Theory",hierarchyLevel:4,children:[{text:" Macfarlane Burnet reasoned that rather than every cell havingcountless different types of side chains, each cell only contained a singletype of side chain",hierarchyLevel:5,children:[],index:"0002000100"},{text:" Upon binding of the toxin to the right cell with the compatibleside chain, the cell undergoes rapid clonal selection, making multiple bodiesof itself",hierarchyLevel:5,children:[],index:"0002000101"},{text:" Each of these cells then produce the freely floating antibody andrelease it into the bloodstream",hierarchyLevel:5,children:[],index:"0002000102"},{text:" Correct Postulations",hierarchyLevel:5,children:[{text:" Each lymphocyte only contains 1 receptor, but contain massivenumbers of lymphocytes that have unique receptors",hierarchyLevel:6,children:[],index:"000200010300"},{text:" Lymphocytes can be activated and divide rapidly upon infection,providing memory function of immune system",hierarchyLevel:6,children:[],index:"000200010301"}],index:"0002000103"}],index:"00020001"}],index:"000200"},{text:" Principals of Adaptive Immunity",hierarchyLevel:3,children:[{text:" Able to recognize molecules at a nanometer scale  other sensesare unable to detect molecular change at this tiny scale",hierarchyLevel:4,children:[],index:"00020100"},{text:" To aid in the nanometer scale recognition, diversity of receptorsis enormous, 10 - 10 , with 10  cells,meaning that only 10 cells for each type",hierarchyLevel:4,children:[],index:"00020101"}],index:"000201"},{text:" Structure of Antibody",hierarchyLevel:3,children:[{text:" Assembling Overall Structure",hierarchyLevel:4,children:[{text:" 1 heavy chain and 1 light chain joined together by a disulphidebridge forming a dimer",hierarchyLevel:5,children:[],index:"0002020000"},{text:" 2 dimers (containing 1 heavy and 1 light chain) join together bya disulphide bridge forming a dimer of dimers",hierarchyLevel:5,children:[],index:"0002020001"}],index:"00020200"},{text:" Generating Antigen Receptor Specificity",hierarchyLevel:4,children:[{text:" Variable Loops",hierarchyLevel:5,children:[{text:" Distal end of the heavy and light chains contains amino acidwhich forms variable loops.",hierarchyLevel:6,children:[],index:"000202010000"},{text:" The variable loops are highly variable in the amino acid sequence(from one antibody to the next)",hierarchyLevel:6,children:[],index:"000202010001"},{text:" The variable loops can bind to the corresponding antigen whichhas its complementary shape. Binding involves non-covalent bonds",hierarchyLevel:6,children:[],index:"000202010002"}],index:"0002020100"},{text:" Binding Forces",hierarchyLevel:5,children:[{text:" Van der Waals forces ",hierarchyLevel:6,children:[{text:" London Dispersion Forces (Cl2  Cl2) (Instantaneous-induced)",hierarchyLevel:7,children:[],index:"00020201010000"},{text:" Permanent Dipole-Permanent Dipole Interactions (HCl  HCl)",hierarchyLevel:7,children:[],index:"00020201010001"},{text:" Dipole-Induced Dipole Interactions (HCl  Cl2)",hierarchyLevel:7,children:[],index:"00020201010002"}],index:"000202010100"},{text:" Hydrogen bonding",hierarchyLevel:6,children:[],index:"000202010101"}],index:"0002020101"},{text:" Complementarity Determining Regions",hierarchyLevel:5,children:[{text:" Due to the specificity of the binding, the variable loops formthe Complementarity Determining Regions (CDRs)",hierarchyLevel:6,children:[],index:"000202010200"},{text:" 3 CDRs on 1 heavy chain and 3CDRs on 1 light chain",hierarchyLevel:6,children:[],index:"000202010201"}],index:"0002020102"}],index:"00020201"},{text:" Generating diverse variable regions",hierarchyLevel:4,children:[{text:" Strategy",hierarchyLevel:5,children:[{text:" There is a need for a massive amount of diversity in the antibodystructure to cater to every single type of antigen that can enter the body",hierarchyLevel:6,children:[],index:"000202020000"},{text:" However, there is only limited space in the DNA and hence it isnot possible to have a different segment of DNA for each type of antibody",hierarchyLevel:6,children:[],index:"000202020001"},{text:" The solution is to have a smaller piece of DNA, but generatevariability through gene recombination of gene segments, coupled with randommutations",hierarchyLevel:6,children:[],index:"000202020002"}],index:"0002020200"},{text:" Components of Recombination",hierarchyLevel:5,children:[{text:" Components (Genes)",hierarchyLevel:6,children:[{text:" Variable (V) genes  40 segments",hierarchyLevel:7,children:[],index:"00020202010000"},{text:" Diversity (D) genes  27 segments",hierarchyLevel:7,children:[],index:"00020202010001"},{text:" Joining (J) genes  6 segments",hierarchyLevel:7,children:[],index:"00020202010002"}],index:"000202020100"},{text:" Components (Chain Locations)",hierarchyLevel:6,children:[{text:" Heavy Chain",hierarchyLevel:7,children:[{text:" 1 set of gene segments on Chromosome 14",hierarchyLevel:8,children:[],index:"0002020201010000"}],index:"00020202010100"},{text:" Light Chains",hierarchyLevel:7,children:[{text:" 1 set kappa (\u03ba) on Chromosome 22",hierarchyLevel:8,children:[],index:"0002020201010100"},{text:" 1 set lambda (\u03bb) on Chromosome 22",hierarchyLevel:8,children:[],index:"0002020201010101"}],index:"00020202010101"}],index:"000202020101"}],index:"0002020201"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0002020202"},{text:" Process of Recombination",hierarchyLevel:5,children:[{text:" Choosing",hierarchyLevel:6,children:[{text:" In the germ-line cells (oocyte and sperm), recombinationactivating genes RAG-1 and RAG-2 are transcribed and translated to formrecombinase enzymes",hierarchyLevel:7,children:[],index:"00020202030000"},{text:" V, D and J genes segments are flanked by recombination signalsequence (RSS)",hierarchyLevel:7,children:[],index:"00020202030001"},{text:" Recombinase enzymes recognizes the recombination signal sequence(RSS) and chooses 1 gene segment from each of the immunoglobulin V, D and Jgenes",hierarchyLevel:7,children:[],index:"00020202030002"},{text:" Recombinase enzymes recombine the 3 chosen segments by pullingthem together and joining them by ligases. The resulting DNA is incorporatedinto the B-cell DNA",hierarchyLevel:7,children:[],index:"00020202030003"}],index:"000202020300"},{text:" Recombinatorial Inaccuracies (I) ",hierarchyLevel:6,children:[{text:" During the recombination process, the recombinase enzyme mayrandomly delete base pairs from the end of the V gene and the start of the Jgene. ",hierarchyLevel:7,children:[],index:"00020202030100"},{text:" This deletion (if not done in the multiples of 3) will lead to aframeshift mutation. This then causes all the amino acids in the J gene to bein the wrong reading frame, resulting in a completely different sequence ofamino acid translated and eventually the failure of the formation of theantibody",hierarchyLevel:7,children:[],index:"00020202030101"},{text:" However, if the deletion is in multiples of 3, it would result ina point mutation, which can lead to the formation of a new and potentiallyfunctional amino acid sequence and hence antibody",hierarchyLevel:7,children:[],index:"00020202030102"},{text:" Due to the probability of introducing a frameshift mutation(2/3), antibody recombination is highly inefficient, resulting in the generationof a nonsense proteins and causing the process to restart until a viableantibody is formed",hierarchyLevel:7,children:[],index:"00020202030103"}],index:"000202020301"},{text:" Recombinatorial Inaccuracies (II) ",hierarchyLevel:6,children:[{text:" After the random deletion of base pairs by recombinase enzyme,the Terminal Deoxynucleotidyl Transferase enzyme will randomly add back basepairs.",hierarchyLevel:7,children:[],index:"00020202030200"},{text:" This further increases the probability of introducing aframeshift mutation, resulting in the recombination process in becoming moreinefficient, with a high probability of producing a nonsense protein. Thisnonsense protein will not be transcribed. 90% of B cells die during development",hierarchyLevel:7,children:[],index:"00020202030201"}],index:"000202020302"},{text:" Mitigating Recombinatory Inefficiencies ",hierarchyLevel:6,children:[{text:" The cell will attempt to exhaust all possible alternativepathways if the present recombination fails",hierarchyLevel:7,children:[{text:" Paternal Chromosomes",hierarchyLevel:8,children:[{text:" Lambda / Kappa light chain",hierarchyLevel:9,children:[],index:"000202020303000000"}],index:"0002020203030000"},{text:" Maternal Chromosomes",hierarchyLevel:8,children:[{text:" Lambda / Kappa light chain",hierarchyLevel:9,children:[],index:"000202020303000100"}],index:"0002020203030001"}],index:"00020202030300"}],index:"000202020303"},{text:" Process (T-cell modification)",hierarchyLevel:6,children:[{text:" TCR gene is recombined in T-cells",hierarchyLevel:7,children:[],index:"00020202030400"}],index:"000202020304"}],index:"0002020203"}],index:"00020202"},{text:" Generating irreversible binding strength",hierarchyLevel:4,children:[{text:" Equilibrium constant (K) of binding of antigen to antibody isextremely high",hierarchyLevel:5,children:[],index:"0002020300"},{text:" The equilibrium point is heavily skewed towards theantigen-antibody complex",hierarchyLevel:5,children:[],index:"0002020301"}],index:"00020203"},{text:" Generating greater antigen affinity during infection",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" After a B cell has bound to a specific antigen, the antibody VDJheavy chain and VJ light chain genes can undergo further somatic mutation toimprove the binding of the antibody variable region to antigen (i.e. toincrease antibody affinity). Somatic hypermutation occurs in germinal centresfollowing exposure to antigen and involves the enzyme activation induceddeaminase (AID). It leads to affinity maturation.",hierarchyLevel:6,children:[],index:"000202040000"}],index:"0002020400"}],index:"00020204"}],index:"000202"},{text:" Action of Antigen Receptor",hierarchyLevel:3,children:[{text:" Components",hierarchyLevel:4,children:[{text:" oImmunoglobulin  \u03b1",hierarchyLevel:5,children:[],index:"0002030000"},{text:" Immunoglobulin \u03b2",hierarchyLevel:5,children:[],index:"0002030001"}],index:"00020300"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" The antigen binds to the antibody receptor, causing receptors onthe  cell surface to be brought together",hierarchyLevel:5,children:[],index:"0002030100"},{text:" This then causes Immunoglobulin \u03b1 and Immunoglobulin \u03b2(\u03b1 and \u03b2 chains) to be phosphorylated and hence become activated",hierarchyLevel:5,children:[],index:"0002030101"},{text:" The activated Immunoglobulin \u03b1 and Immunoglobulin \u03b2then transmit a signal to the B cell ",hierarchyLevel:5,children:[],index:"0002030102"},{text:" The signal transmitted within the B cells causes",hierarchyLevel:5,children:[{text:" B cell differentiation which results in the production of solubleantibody (not membrane bound) to be secreted out of the cell",hierarchyLevel:6,children:[],index:"000203010300"},{text:" B cell proliferation which results in clonal selection, creatingmany more B cells that produces the same soluble antibody ",hierarchyLevel:6,children:[],index:"000203010301"}],index:"0002030103"}],index:"00020301"}],index:"000203"}],index:"0002"},{text:" [015] Antigen Recognition: T cells and MHC",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Explain the structure , function and genetics of the MHC and itsrole in T cell recognition",hierarchyLevel:4,children:[],index:"00030000"},{text:" Understand the difference between B cell and T cell recognition ",hierarchyLevel:4,children:[],index:"00030001"},{text:" Know the two major pathways, endogenous and exogenous, by whichpeptide antigens are loaded onto MHC molecules.",hierarchyLevel:4,children:[],index:"00030002"},{text:" Explain the structure of the T-cell receptor CD3 complex",hierarchyLevel:4,children:[],index:"00030003"},{text:" Know the main molecules which form part of the immunologicalsynapse ",hierarchyLevel:4,children:[],index:"00030004"},{text:" Understand the role of primary and secondary signals in T cellactivation",hierarchyLevel:4,children:[],index:"00030005"}],index:"000300"},{text:" T-cell Receptor Characteristics",hierarchyLevel:3,children:[{text:" Prevalence",hierarchyLevel:4,children:[{text:" 60% of blood lymphocytes",hierarchyLevel:5,children:[],index:"0003010000"},{text:" Mainly found in lymphoid tissue",hierarchyLevel:5,children:[],index:"0003010001"}],index:"00030100"},{text:" Types of T-cell Receptors (TCR)",hierarchyLevel:4,children:[{text:" TCR\u03b1\u03b2  1 alpha and 1 beta chain",hierarchyLevel:5,children:[{text:" Identifies and recognizes protein antigen",hierarchyLevel:6,children:[],index:"000301010000"}],index:"0003010100"},{text:" TCR\u03b3\u03b4  1 gamma and 1 delta  CD3",hierarchyLevel:5,children:[{text:" Identifies and recognizes non-protein antigens (eg. Lipids)",hierarchyLevel:6,children:[],index:"000301010100"}],index:"0003010101"}],index:"00030101"},{text:" Structure of T-cell Receptor (TCR)",hierarchyLevel:4,children:[{text:" \u03b1, \u03b2 chain  contains a constant region and  avariable region  which form loops joined bydisulphide bridges",hierarchyLevel:5,children:[],index:"0003010200"},{text:" T-cell Receptor (TCR)  contains an \u03b1 chain and \u03b2 chainjoined together by a disulphide bridge and anchored directly into the plasmamembrane (no stalk  always remains on the plasma membrane, never secreted)",hierarchyLevel:5,children:[],index:"0003010201"}],index:"00030102"},{text:" Mechanism of TCR Diversity  same principle as B-cellrecombination",hierarchyLevel:4,children:[{text:" Multiple germ line genes",hierarchyLevel:5,children:[],index:"0003010300"},{text:" V-J and V-D-J recombination",hierarchyLevel:5,children:[],index:"0003010301"},{text:" Combinatorial inaccuracies",hierarchyLevel:5,children:[],index:"0003010302"},{text:" N-nucleotide addition",hierarchyLevel:5,children:[],index:"0003010303"},{text:" Chain combinations",hierarchyLevel:5,children:[],index:"0003010304"}],index:"00030103"},{text:" Properties of TCR",hierarchyLevel:4,children:[{text:" Does not change in the lifetime of the T-cell",hierarchyLevel:5,children:[],index:"0003010400"}],index:"00030104"},{text:" B-cell vs T-cell recognition",hierarchyLevel:4,children:[{text:" Antibody receptors on the B-cells bind to the antigen",hierarchyLevel:5,children:[],index:"0003010500"},{text:" TCR bind to the peptide but is also flanked by the MajorHistocompatibility Complex (MHC) / Human Leucocyte Antigen (HLA  MHC inhumans) on both sides",hierarchyLevel:5,children:[],index:"0003010501"}],index:"00030105"}],index:"000301"},{text:" T cell receptor transduction",hierarchyLevel:3,children:[{text:" Requirements for Signal Transduction",hierarchyLevel:4,children:[{text:" Sufficient tightness in the binding between peptide and TCR",hierarchyLevel:5,children:[],index:"0003020000"},{text:" Recognition of non-antigen specific signals from costimulatorymolecules",hierarchyLevel:5,children:[],index:"0003020001"}],index:"00030200"},{text:" Process",hierarchyLevel:4,children:[{text:" T-cells undergo recombination in the thymus",hierarchyLevel:5,children:[],index:"0003020100"},{text:" If recombination is successful (with alpha and beta chainsrecombined), the TCR is expressed at the plasma membrane, together with theassociated \u03b4\u03bb\u03f5 chain, which makes up the CD3 complex",hierarchyLevel:5,children:[],index:"0003020101"},{text:" When the requirements of signal transduction are met, the CD3complex facilitates with the signal transduction within the cell, which resultsin the decision to either kill the target or divide and proliferate itself",hierarchyLevel:5,children:[],index:"0003020102"}],index:"00030201"},{text:" Non-antigen specific signals for Signal Transduction ",hierarchyLevel:4,children:[{text:" Production Mechanism",hierarchyLevel:5,children:[{text:" Innate immune system recognizes a pathogen via patternrecognition receptors",hierarchyLevel:6,children:[],index:"000302020000"},{text:" This induces co-stimulator molecules on antigen presenting cells",hierarchyLevel:6,children:[],index:"000302020001"},{text:" This then helps activate adaptive immunity via T-cell activation",hierarchyLevel:6,children:[],index:"000302020002"}],index:"0003020200"},{text:" Examples",hierarchyLevel:5,children:[{text:" Co-stimulation of CD28 and CD80/86",hierarchyLevel:6,children:[],index:"000302020100"},{text:" Negative signals  CD28/CTLA4; PD1/PDL1  serve as brakes (treatautoimmune diseases)",hierarchyLevel:6,children:[],index:"000302020101"}],index:"0003020201"}],index:"00030202"},{text:" Diagram",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0003020300"}],index:"00030203"}],index:"000302"},{text:" Major Histocompatibility Complex (MHC) / Human Leucocyte Antigen (HLA)",hierarchyLevel:3,children:[{text:" Overall Strategy of Major Histocompatibility Complex and AntigenPresenting Cells",hierarchyLevel:4,children:[{text:" B-cells analyze the surface antigens of the pathogens to detectthem. However, it is easy for the pathogens to change its antigen to avoidgetting detected by the immune system",hierarchyLevel:5,children:[],index:"0003030000"},{text:" T-cells instead analyze the internal proteins / peptide of thepathogens to detect them. It is much more difficult for pathogens to changetheir internal proteins to avoid detection.",hierarchyLevel:5,children:[],index:"0003030001"},{text:" However, it is much more difficult to obtain and analyze theinternal proteins of the pathogens. It is obtained from two sources",hierarchyLevel:5,children:[{text:" When pathogens are dead destroyed, the remains are picked up by phagocytosisand analyzed",hierarchyLevel:6,children:[],index:"000303000200"},{text:" When the virus is in a host cell and producing proteins (or moreof itself  viruses), the internal proteins are analyzed",hierarchyLevel:6,children:[],index:"000303000201"}],index:"0003030002"}],index:"00030300"},{text:" Purpose of MHC",hierarchyLevel:4,children:[{text:" Provides stability to the peptides  enabling it to be presentedto the TCR",hierarchyLevel:5,children:[],index:"0003030100"}],index:"00030301"},{text:" Structure of MHC",hierarchyLevel:4,children:[],index:"00030302"},{text:" Properties of MHC",hierarchyLevel:4,children:[{text:" Able to bind to thousands of slightly different structuredpeptide",hierarchyLevel:5,children:[{text:" This is because the peptide binds to the backbone of MHC (\u03b1helix) and not to the side chains",hierarchyLevel:6,children:[],index:"000303030000"},{text:" There are holes at the bottom and in the walls of the alphahelixes that enable the side chains of the peptides to fit in",hierarchyLevel:6,children:[],index:"000303030001"}],index:"0003030300"}],index:"00030303"},{text:" Limitations of MHC",hierarchyLevel:4,children:[{text:" Parts of the pathogen (eg. larger proteins) that cannot fit intothe groove of the MHC will not illicit an immune response through T-cells. Thislimits the strength of the immune response to the pathogen.",hierarchyLevel:5,children:[],index:"0003030400"},{text:" MHC Class I and MHC Class II provides a greater chance that atleast one of the peptides will be able to bind to MHC",hierarchyLevel:5,children:[],index:"0003030401"}],index:"00030304"},{text:" Types of MHCs in Humans",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Recognize different sets of peptides",hierarchyLevel:6,children:[],index:"000303050000"},{text:" Interact with different sub-populations of T-cells",hierarchyLevel:6,children:[],index:"000303050001"}],index:"0003030500"},{text:" Properties",hierarchyLevel:5,children:[{text:" Highly polymorphic, due to the thousands of different MHC allelesin the populations, resulting in each individual having slightly different MHCmolecules. As a result, as a population, humans can bind to a massive number ofpeptides",hierarchyLevel:6,children:[],index:"000303050100"}],index:"0003030501"},{text:" Types",hierarchyLevel:5,children:[{text:" MHC Class 1 (CD8 T-cells) - Endogenous",hierarchyLevel:6,children:[{text:" MHC Class 1a",hierarchyLevel:7,children:[],index:"00030305020000"},{text:" MHC Class 1b",hierarchyLevel:7,children:[],index:"00030305020001"},{text:" MHC Class 1c",hierarchyLevel:7,children:[],index:"00030305020002"}],index:"000303050200"},{text:" MHC Class 2 (D) (CD4 T-cells) - Exogenous",hierarchyLevel:6,children:[{text:" MHC Class DP",hierarchyLevel:7,children:[{text:" MHC Class DPA1",hierarchyLevel:8,children:[],index:"0003030502010000"},{text:" MHC Class DPA2",hierarchyLevel:8,children:[],index:"0003030502010001"},{text:" MHC Class DPB1",hierarchyLevel:8,children:[],index:"0003030502010002"},{text:" MHC Class DPB2",hierarchyLevel:8,children:[],index:"0003030502010003"}],index:"00030305020100"},{text:" MHC Class DQ",hierarchyLevel:7,children:[{text:" MHC Class DQA1",hierarchyLevel:8,children:[],index:"0003030502010100"},{text:" MHC Class DQA2",hierarchyLevel:8,children:[],index:"0003030502010101"},{text:" MHC Class DQB1",hierarchyLevel:8,children:[],index:"0003030502010102"},{text:" MHC Class DQB2",hierarchyLevel:8,children:[],index:"0003030502010103"},{text:" MHC Class DQB3",hierarchyLevel:8,children:[],index:"0003030502010104"}],index:"00030305020101"},{text:" MHC Class DR",hierarchyLevel:7,children:[{text:" MHC Class DRA",hierarchyLevel:8,children:[],index:"0003030502010200"},{text:" MHC Class DRB1 - 8",hierarchyLevel:8,children:[],index:"0003030502010201"}],index:"00030305020102"}],index:"000303050201"}],index:"0003030502"}],index:"00030305"}],index:"000303"},{text:" Antigen Processing",hierarchyLevel:3,children:[{text:" Exogenous pathway (CD4)  MHC Class II",hierarchyLevel:4,children:[{text:" Antigen Presenting Cells",hierarchyLevel:5,children:[{text:" Dendritic cell",hierarchyLevel:6,children:[],index:"000304000000"}],index:"0003040000"},{text:" Process",hierarchyLevel:5,children:[{text:" Viral / pathogenic proteins are taken up from outside the cell",hierarchyLevel:6,children:[{text:" Small piece of protein that has fallen off from the virus",hierarchyLevel:7,children:[],index:"00030400010000"},{text:" Intact pathogen (virus)",hierarchyLevel:7,children:[],index:"00030400010001"},{text:" Dead virus / chopped up virus",hierarchyLevel:7,children:[],index:"00030400010002"},{text:" Non-productive virus",hierarchyLevel:7,children:[],index:"00030400010003"}],index:"000304000100"},{text:" Lysosomes fuses with the endosome, releasing lysozymes into theendosome",hierarchyLevel:6,children:[],index:"000304000101"},{text:" The lysozymes (proteases) breaks down the pathogenic proteinsinto small peptides",hierarchyLevel:6,children:[],index:"000304000102"},{text:" MHC II is synthesized in the endoplasmic reticulum and pinchesoff into a vesicle. The invariant chain ensures that the MHC II does not bindto any peptides until it fuses with the endosome",hierarchyLevel:6,children:[],index:"000304000103"},{text:" The vesicle containing MHC II fuses with the endosome (containingsmall pathogenic peptides), forming the MHC II loading compartment",hierarchyLevel:6,children:[],index:"000304000104"},{text:" Peptides are loaded onto MHC II, and MHC II with peptide isexported to the cell plasma membrane, and fuses with the plasma membrane,causing the peptides to be presented onto the surface",hierarchyLevel:6,children:[],index:"000304000105"},{text:" A t-cell will eventually recognize the antigen presented on theantigen presenting cell",hierarchyLevel:6,children:[],index:"000304000106"}],index:"0003040001"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0003040002"}],index:"00030400"},{text:" Endogenous Pathway (CD8)  MHC Class I",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Viruses that are hiding in host cells are normally hidden fromantibodies enabling them to evade the immune system",hierarchyLevel:6,children:[],index:"000304010000"},{text:" However, the antigen processing mechanism enables the body tocheck if any foreign peptides are present in the internal cells, henceeffectively detecting hiding viruses",hierarchyLevel:6,children:[],index:"000304010001"},{text:" Antigen presenting cell presents a snapshot of what is happeningin the cell",hierarchyLevel:6,children:[],index:"000304010002"},{text:" This snapshot can then be analyzed by t-cells",hierarchyLevel:6,children:[],index:"000304010003"}],index:"0003040100"},{text:" Process",hierarchyLevel:5,children:[{text:" Pathogenic proteins come from within the cell\ufffd\ufffd ",hierarchyLevel:6,children:[{text:" Bacteria the lives within the cell",hierarchyLevel:7,children:[],index:"00030401010000"},{text:" Viruses that are present in cell cytoplasm",hierarchyLevel:7,children:[],index:"00030401010001"},{text:" Cancer cells that produce antigens",hierarchyLevel:7,children:[],index:"00030401010002"}],index:"000304010100"},{text:" Pathogenic proteins are captured by the proteosome and brokendown into small peptides.",hierarchyLevel:6,children:[],index:"000304010101"},{text:" Peptides are transported to the endoplasmic reticulum byTransporter of Antigen Peptides (TAP)",hierarchyLevel:6,children:[],index:"000304010102"},{text:" Peptides enter the endoplasmic reticulum, where MHC I is present",hierarchyLevel:6,children:[],index:"000304010103"},{text:" Peptides bind to MHC I",hierarchyLevel:6,children:[],index:"000304010104"},{text:" MHC I containing the peptides pinches off from the endoplasmicreticulum as a trans-Golgi vesicle and fuses with the plasma membrane, hencepresenting the peptide on the plasma membrane.",hierarchyLevel:6,children:[],index:"000304010105"}],index:"0003040101"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0003040102"}],index:"00030401"},{text:" Exceptions",hierarchyLevel:4,children:[{text:" Presentation of exogenous proteins on MHC I",hierarchyLevel:5,children:[],index:"0003040200"},{text:" Presentation of endogenous proteins on MHC II",hierarchyLevel:5,children:[],index:"0003040201"}],index:"00030402"},{text:" Abnormal Function: Viruses interfering with antigen presentation",hierarchyLevel:4,children:[{text:" Viruses interfere with the antigen processing pathways",hierarchyLevel:5,children:[],index:"0003040300"},{text:" Arms race where viruses find new ways to evade immune responseand immune system comes up with new responses",hierarchyLevel:5,children:[],index:"0003040301"}],index:"00030403"}],index:"000304"}],index:"0003"},{text:" [018] Humoral Immunity and antibody mediated responses",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" To understand the relationship between soluble antibody and theantigen-specific receptor on the surface of B cells",hierarchyLevel:4,children:[],index:"00040000"},{text:" To understand the difference between primary and secondary immuneresponses ",hierarchyLevel:4,children:[],index:"00040001"},{text:" To know the main antibody isotypes, their structure and theirfunction",hierarchyLevel:4,children:[],index:"00040002"},{text:" To understand the concept of antibody affinity and avidity",hierarchyLevel:4,children:[],index:"00040003"},{text:" To understand the three major effector functions of antibody:neutralisation, opsonisation and complement activation",hierarchyLevel:4,children:[],index:"00040004"},{text:" To understand the basic concepts behind monoclonal antibodytechnology",hierarchyLevel:4,children:[],index:"00040005"}],index:"000400"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Humoral immunity  immunity mediated by the antibody",hierarchyLevel:5,children:[],index:"0004010000"}],index:"00040100"}],index:"000401"},{text:" Soluble Antibodies",hierarchyLevel:3,children:[{text:" Manufacture of soluble antibodies",hierarchyLevel:4,children:[{text:" Precursor",hierarchyLevel:5,children:[{text:" Upon the binding of the B-cell antibody receptor to the antigen,the B-cell undergoes a series of differentiation events to differentiate into aplasma cell. The plasma cell is able to start producing soluble antibodies tobe secreted into the blood",hierarchyLevel:6,children:[],index:"000402000000"}],index:"0004020000"},{text:" Process",hierarchyLevel:5,children:[{text:" B-cell starts transcription from the first constant gene segmentrather than from the transmembrane gene segments (green)",hierarchyLevel:6,children:[],index:"000402000100"},{text:" mRNA is then translated into antibodies in the endoplasmicreticulum and secretes the antibodies out of the cell",hierarchyLevel:6,children:[],index:"000402000101"},{text:" Plasma cells move out of the bloodstream and into the bone marrowand continue producing antibodies. Continuous production of antibodies in thebone marrow by the B-cells (for years) enables the memory function of theimmune system",hierarchyLevel:6,children:[],index:"000402000102"}],index:"0004020001"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"000402000200"}],index:"0004020002"}],index:"00040200"}],index:"000402"},{text:" Secondary Immune Responses",hierarchyLevel:3,children:[{text:" Primary and Secondary Immune Response",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Primary Response  the first exposure to the antigen",hierarchyLevel:6,children:[],index:"000403000000"},{text:" Secondary Response  any exposure to the antigen after the first",hierarchyLevel:6,children:[],index:"000403000001"}],index:"0004030000"},{text:" Distinguishing Factor of the Secondary Immune Response",hierarchyLevel:5,children:[{text:" Quantity - more antibodies are produced",hierarchyLevel:6,children:[],index:"000403000100"},{text:" Quality - affinity maturation  each antibody has a strongerbinding affinity",hierarchyLevel:6,children:[],index:"000403000101"},{text:" Speed - faster production of antibodies / faster response",hierarchyLevel:6,children:[],index:"000403000102"}],index:"0004030001"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0004030002"}],index:"00040300"},{text:" Process of Affinity Maturation",hierarchyLevel:4,children:[{text:" During the initial response to the antigen, any B-cell that hasan antibody that as some binding ability (weak or strong) to the antigen isreplicated via clonal selection, and starts producing antibodies",hierarchyLevel:5,children:[],index:"0004030100"},{text:" As a result, a mixture of antibodies will be present in theblood, some with higher antigen binding affinity than others",hierarchyLevel:5,children:[],index:"0004030101"},{text:" Eventually, as the immune response proceeds, the body selects forthe B-cells that produce antibodies with the highest antigen binding affinity.The B-cells that produce weaker binding antibodies will eventually die off.",hierarchyLevel:5,children:[],index:"0004030102"},{text:" As a result, the overall average antigen binding affinity willincrease as the immune response proceeds. Hence, affinity Maturation isachieved",hierarchyLevel:5,children:[],index:"0004030103"}],index:"00040301"}],index:"000403"},{text:" Antibody Isotypes",hierarchyLevel:3,children:[{text:" Premise",hierarchyLevel:4,children:[{text:" Variable Regions",hierarchyLevel:5,children:[{text:" Variable regions change between different B-cells",hierarchyLevel:6,children:[],index:"000404000000"},{text:" Variable regions are the ",hierarchyLevel:6,children:[],index:"000404000001"}],index:"0004040000"},{text:" Constant regions ",hierarchyLevel:5,children:[{text:" Constant regions ",hierarchyLevel:6,children:[],index:"000404000100"}],index:"0004040001"}],index:"00040400"},{text:" Purpose",hierarchyLevel:4,children:[{text:" Each type of the constant region give the antibodies a differentfunctional property",hierarchyLevel:5,children:[],index:"0004040100"}],index:"00040401"},{text:" Isotypes",hierarchyLevel:4,children:[{text:" Concept",hierarchyLevel:5,children:[{text:" The type of constant region (heavy chain) determines the class ofthe antibody / immunoglobulin",hierarchyLevel:6,children:[],index:"000404020000"}],index:"0004040200"},{text:" Types",hierarchyLevel:5,children:[],index:"0004040201"}],index:"00040402"},{text:" Generation of the constant regions",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" The cell goes through the constant gene segments sequentially andpicks 2 to be added to the recombined DNA",hierarchyLevel:6,children:[],index:"000404030000"}],index:"0004040300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0004040301"}],index:"00040403"}],index:"000404"},{text:" Immunoglobulin Polymers",hierarchyLevel:3,children:[{text:" Process",hierarchyLevel:4,children:[{text:" IgA forms a dimer upon synthesis",hierarchyLevel:5,children:[],index:"0004050000"},{text:" IgM forms a pentamer upon synthesis  molecular weight > 1mill",hierarchyLevel:5,children:[],index:"0004050001"},{text:" Polymers are held together by a J chain",hierarchyLevel:5,children:[],index:"0004050002"}],index:"00040500"},{text:" Purpose",hierarchyLevel:4,children:[{text:" Forming polymers with antibodies increases the number of bindingsites",hierarchyLevel:5,children:[],index:"0004050100"},{text:" It is expected that pathogens have repeating sequences of itsantigen on the plasma membrane",hierarchyLevel:5,children:[],index:"0004050101"},{text:" More binding sites means that the polymers will be able to bindto pathogen at multiple points (via pathogen antigens). ",hierarchyLevel:5,children:[],index:"0004050102"},{text:" Therefore, even if one antigen binding site dissociates (due tolow binding affinity), the overall polymer is still attached to the pathogen",hierarchyLevel:5,children:[],index:"0004050103"},{text:" Formation of polymers compensates for the lack of bindingaffinity in the early stages of immune response as affinity maturation has notoccurred",hierarchyLevel:5,children:[],index:"0004050104"}],index:"00040501"},{text:" Definitions",hierarchyLevel:4,children:[{text:" Antibody/antigen binding affinity",hierarchyLevel:5,children:[],index:"0004050200"},{text:" Avidity",hierarchyLevel:5,children:[{text:" The overall binding strength of the polymer",hierarchyLevel:6,children:[],index:"000405020100"}],index:"0004050201"}],index:"00040502"},{text:" Application  stop gap measure in initial immune response",hierarchyLevel:4,children:[{text:" During the initial immune response, it is expected averagebinding affinity is low, due to the lack of time to select and proliferate thehighest binding affinity B-cells",hierarchyLevel:5,children:[],index:"0004050300"},{text:" Therefore, to combat this B-cells will produce IgM beforeproducing IgG",hierarchyLevel:5,children:[],index:"0004050301"},{text:" IgM forms a polymer which significantly increases the bindingaffinity, hence compensating for the lack of natural talent in binding",hierarchyLevel:5,children:[],index:"0004050302"},{text:" As the immune system starts to select for the talented B-cells,and immune system is able to start producing higher antigen affinity IgG, thequantity of IgM starts to decrease",hierarchyLevel:5,children:[],index:"0004050303"}],index:"00040503"},{text:" Cons of Polymers",hierarchyLevel:4,children:[{text:" Antibodies in the form of polymers form can bind to multiple antigens.This results in the formation of large  immune complexes",hierarchyLevel:5,children:[],index:"0004050400"},{text:" Due to the size of the immune complexes, they start to obstructthe functioning of blood vessels. This may result in inflammation",hierarchyLevel:5,children:[],index:"0004050401"}],index:"00040504"},{text:" Diagram",hierarchyLevel:4,children:[],index:"00040505"}],index:"000405"},{text:" Antibody Effector Function",hierarchyLevel:3,children:[{text:" Neutralization of Toxins",hierarchyLevel:4,children:[{text:" Mechanisms",hierarchyLevel:5,children:[{text:" Toxins binds to cell surface receptors to cause a pathogeniceffect (neuron hyperstimulation)",hierarchyLevel:6,children:[],index:"000406000000"},{text:" Antibodies bind to the toxins, preventing the toxin from bindingto the receptor and hence preventing the pathogenic effect",hierarchyLevel:6,children:[],index:"000406000001"},{text:" Due to the high binding affinity, the toxin will never be able toexert its pathological effect again. Eventually, the toxin and the antibody areremoved from circulation by macrophages and destroyed",hierarchyLevel:6,children:[],index:"000406000002"}],index:"0004060000"},{text:" Temporal Considerations",hierarchyLevel:5,children:[{text:" Toxin acts quickly on the body. Therefore, it will exert itspathogenic effect before the body has time to produce antibodies to combat it",hierarchyLevel:6,children:[],index:"000406000100"},{text:" Hence, the individual must have antibodies already circulating inthe blood (via vaccination) to bind to the toxin to avoid a pathogenic effect",hierarchyLevel:6,children:[],index:"000406000101"}],index:"0004060001"},{text:" Examples",hierarchyLevel:5,children:[{text:" Tetanus  Clostridium, environment, spores",hierarchyLevel:6,children:[],index:"000406000200"},{text:" Diptheria  Elongation factor translation",hierarchyLevel:6,children:[],index:"000406000201"}],index:"0004060002"}],index:"00040600"},{text:" Neutralization of Viruses",hierarchyLevel:4,children:[{text:" Mechanisms",hierarchyLevel:5,children:[{text:" Viruses contains receptors on the surface which attaches to thehost cell plasma membrane receptors, enabling it to enter the cell",hierarchyLevel:6,children:[],index:"000406010000"},{text:" Antibodies bind to the receptors on the viruses, hence preventingit from binding to the host cell receptors. This prevents the host cell frombeing invaded by the virus",hierarchyLevel:6,children:[],index:"000406010001"}],index:"0004060100"},{text:" Concept",hierarchyLevel:5,children:[{text:" Presence of antibodies \u2260 neutralization of toxin",hierarchyLevel:6,children:[],index:"000406010100"},{text:" Presence of the right antibodies = neutralization of toxin",hierarchyLevel:6,children:[],index:"000406010101"}],index:"0004060101"},{text:" Examples",hierarchyLevel:5,children:[{text:" HIV",hierarchyLevel:6,children:[{text:" HIV causes the body to produce antibodies. However, theantibodies are not targeting the part the virus uses to bind to the host cell",hierarchyLevel:7,children:[],index:"00040601020000"},{text:" As a result, HIV can evade the immune system",hierarchyLevel:7,children:[],index:"00040601020001"}],index:"000406010200"}],index:"0004060102"}],index:"00040601"},{text:" Opsonisation and phagocytosis",hierarchyLevel:4,children:[{text:" Background",hierarchyLevel:5,children:[{text:" Bacteria and viruses are able to evolve to avoid phagocytosis",hierarchyLevel:6,children:[],index:"000406020000"},{text:" Bacteria produces proteins that prevent phagocytosis",hierarchyLevel:6,children:[],index:"000406020001"},{text:" Bacteria produces an anti-phagocytic capsule, giving phagocytesdifficulty in grasping the capsule and hence difficulty in carrying outphagocytosis",hierarchyLevel:6,children:[],index:"000406020002"}],index:"0004060200"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Antibody attaches to the antigen on the pathogen. Binding of theantibody to the antigen causes a 3D conformation change in the heavy (constant)chain of the antibody. This 3D change then allows for binding by phagocytes.",hierarchyLevel:6,children:[],index:"000406020100"},{text:" Phagocytic neutrophils utilize a  Fc \u03b3  (fragment C gamma) receptorwhich binds to the corresponding (IgG) immunoglobulin which is attached to thepathogen.",hierarchyLevel:6,children:[],index:"000406020101"},{text:" Phagocytotic Intake",hierarchyLevel:6,children:[{text:" This enables the phagocyte to only need to recognize the antibodyand bypasses the anti-phagocytic mechanisms put in place by the pathogen.Hence, this increase the phagocytic uptake of pathogens",hierarchyLevel:7,children:[],index:"00040602010200"}],index:"000406020102"},{text:" Cytotoxic Mediators of Phagocytes",hierarchyLevel:6,children:[{text:" Binding of the Fc\u03b3 to the bound IgG antibody activates thephagocytic killing mechanisms of phagocytes",hierarchyLevel:7,children:[],index:"00040602010300"},{text:" Synthesis and release of reactive oxygen species (oxygen burst)",hierarchyLevel:7,children:[],index:"00040602010301"},{text:" Synthesis and release of hypochlorous acid (bleach)",hierarchyLevel:7,children:[],index:"00040602010302"},{text:" Synthesis and release of enzymes from the granules ofgranulocytes",hierarchyLevel:7,children:[],index:"00040602010303"}],index:"000406020103"}],index:"0004060201"},{text:" Examples of Fragments",hierarchyLevel:5,children:[{text:" FcR\u03f5",hierarchyLevel:6,children:[],index:"000406020200"},{text:" FcR\u03b1",hierarchyLevel:6,children:[],index:"000406020201"}],index:"0004060202"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0004060203"}],index:"00040602"},{text:" Activate Complement System  Classical pathway",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Antibody bound to the pathogen binds to the Fc receptor on C1qprotein of the complement system",hierarchyLevel:6,children:[],index:"000406030000"},{text:" This binding causes the enzymes inside C1q to be activated. Thisstimulates a whole cascade eventually leading to the cleavage of C3 into C3aand C3b",hierarchyLevel:6,children:[],index:"000406030001"}],index:"0004060300"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0004060301"}],index:"00040603"}],index:"000406"},{text:" Monoclonal Antibodies",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Monoclonal antibodies  containing only one type of antibody",hierarchyLevel:5,children:[],index:"0004070000"},{text:" Monoclonal antibodies as medicine  a biological molecule used asa drug",hierarchyLevel:5,children:[],index:"0004070001"},{text:" Polyclonal antibodies  containing many types of antibodies",hierarchyLevel:5,children:[],index:"0004070002"}],index:"00040700"},{text:" Examples",hierarchyLevel:4,children:[{text:" Injection of antigen into human  immune system producespolyclonal antibodies (produced by different B-cells)",hierarchyLevel:5,children:[],index:"0004070100"}],index:"00040701"},{text:" Application  Problem of Polyclonal Antibodies",hierarchyLevel:4,children:[{text:" Antibodies can be used to treat diseases or conduct research /drug development",hierarchyLevel:5,children:[],index:"0004070200"},{text:" However, only polyclonal antibody mixture is generated fromhumans upon exposure to antigens. This is due to the multiple B-cells that areproducing the antibody",hierarchyLevel:5,children:[],index:"0004070201"},{text:" Polyclonal antibodies are not very good for experimentation asthe mixture and composition of the polyclonal antibody solution will beslightly different and it becomes harder to produce replicable results",hierarchyLevel:5,children:[],index:"0004070202"}],index:"00040702"},{text:" Application  Solution with Monoclonal Antibodies",hierarchyLevel:4,children:[{text:" B-cells are taken from animals / humans",hierarchyLevel:5,children:[],index:"0004070300"},{text:" B-cells are fused with cancer cells to cause it to becomeimmortal and cause it to divide indefinitely in vitro (test tube)",hierarchyLevel:5,children:[],index:"0004070301"},{text:" B-cells are screened to find a specific B-cell producing theantibody of the researchers interest",hierarchyLevel:5,children:[],index:"0004070302"},{text:" Pick one B-cell after the screening process, and grow itindefinitely",hierarchyLevel:5,children:[],index:"0004070303"},{text:" The resulting culture will only contain one B-cell, and theseB-cells being genetically identical will only produce on type of antibody,resulting in a solution of monoclonal antibodies",hierarchyLevel:5,children:[],index:"0004070304"},{text:" The monoclonal antibodies can be standardized and purified as adrug",hierarchyLevel:5,children:[],index:"0004070305"}],index:"00040703"},{text:" Diagram",hierarchyLevel:4,children:[],index:"00040704"}],index:"000407"},{text:" Flow Cytometry",hierarchyLevel:3,children:[{text:" Purpose",hierarchyLevel:4,children:[{text:" Enables researchers to count the number of different cell types",hierarchyLevel:5,children:[],index:"0004080000"}],index:"00040800"},{text:" Process",hierarchyLevel:4,children:[{text:" Make various antibodies that are only specific to each cell type",hierarchyLevel:5,children:[],index:"0004080100"},{text:" Antibodies are labelled that a unique fluorescence will beemitted when light is shone on it",hierarchyLevel:5,children:[],index:"0004080101"},{text:" Cells are passed one by one via a fine nozzle through the flowcytometer",hierarchyLevel:5,children:[],index:"0004080102"},{text:" A laser light is shown through the passing cells",hierarchyLevel:5,children:[],index:"0004080103"},{text:" The emitting fluorescence produced by each cell is recorded",hierarchyLevel:5,children:[],index:"0004080104"}],index:"00040801"},{text:" Data Interpretation",hierarchyLevel:4,children:[{text:" Dot plot  every dot is a cell signature",hierarchyLevel:5,children:[],index:"0004080200"},{text:" X-axis  the intensity of fluorescence A",hierarchyLevel:5,children:[],index:"0004080201"},{text:" Y-axis  the intensity of fluorescence B ",hierarchyLevel:5,children:[],index:"0004080202"},{text:" Histogram can be generated",hierarchyLevel:5,children:[{text:" X-axis  fluorescence intensity",hierarchyLevel:6,children:[],index:"000408020300"},{text:" Y-axis  number of cells",hierarchyLevel:6,children:[],index:"000408020301"}],index:"0004080203"}],index:"00040802"},{text:" Diagram",hierarchyLevel:4,children:[],index:"00040803"}],index:"000408"}],index:"0004"},{text:" [027] Cellular Immunity: T cells",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Background of Cellular Immunity",hierarchyLevel:4,children:[{text:" Cellular immunity was called cellular as it could not betransferred by serum, but only through live cells",hierarchyLevel:5,children:[],index:"0005000000"},{text:" Cellular adaptive immunity resides in T lymphocytes",hierarchyLevel:5,children:[],index:"0005000001"}],index:"00050000"},{text:" Types of T cells",hierarchyLevel:4,children:[{text:" CD4 Helper cells (Th)  stimulate other components of adaptiveand innate immunity",hierarchyLevel:5,children:[],index:"0005000100"},{text:" CD8 Cytotoxic Killer cells (Tc)",hierarchyLevel:5,children:[],index:"0005000101"},{text:" CD4 Regulatory (Treg)  limit the activity of cells",hierarchyLevel:5,children:[],index:"0005000102"}],index:"00050001"}],index:"000500"},{text:" Cytotoxic Cells",hierarchyLevel:3,children:[{text:" CD8 Cytotoxic Cells (Tc / CTL)",hierarchyLevel:4,children:[{text:" Pre-activation",hierarchyLevel:5,children:[{text:" CD8 Cytotoxic T Cells must recognize the antigen before it can beactivated",hierarchyLevel:6,children:[],index:"000501000000"},{text:" CD8 Cytotoxic T Cell recognizes MHC Class I which utilizesprocesses antigen via endogenous presentation (hence makes sense to kill theAPC)",hierarchyLevel:6,children:[],index:"000501000001"}],index:"0005010000"},{text:" Concept",hierarchyLevel:5,children:[{text:" The antigen presenting cells are infected and are host to theviruses (endogenous presentation pathway).",hierarchyLevel:6,children:[],index:"000501000100"},{text:" Hence, it makes sense for the immune system to kill those antigenpresenting cells before the virus can replicate and spread",hierarchyLevel:6,children:[],index:"000501000101"},{text:" This works for all diseases that uses humans cells as the host(mycobacterium tuberculosis)",hierarchyLevel:6,children:[],index:"000501000102"}],index:"0005010001"},{text:" General Mechanism",hierarchyLevel:5,children:[{text:" Recognition of target via T cell receptor / MHC",hierarchyLevel:6,children:[],index:"000501000200"},{text:" CD8 Cytotoxic cells kills the target",hierarchyLevel:6,children:[],index:"000501000201"}],index:"0005010002"},{text:" Killing Mechanism (1)  Granzymes / Perforin Pathway",hierarchyLevel:5,children:[{text:" T cells releases enzymes (granzymes) ",hierarchyLevel:6,children:[],index:"000501000300"},{text:" T cells also releases perforin (related to C9 complement protein)which makes small holes in the cell surface of the target. The small holes arenot sufficient to kill the target as the target is able to mend the holes",hierarchyLevel:6,children:[],index:"000501000301"},{text:" The small hole enables the movement of granzymes into the plasmamembrane of the target cells and into the cytoplasm",hierarchyLevel:6,children:[],index:"000501000302"},{text:" The granzymes activate the caspase pathways, which is a series ofcascade proteases, which activate the apoptotic pathway of the target, leadingto nuclear fragmentation which leads to the cell shriveling up and dies",hierarchyLevel:6,children:[],index:"000501000303"}],index:"0005010003"},{text:" Killing Mechanism (2)  Fas/FasL Pathway",hierarchyLevel:5,children:[{text:" T cell expresses FasL (Fas ligand) on the cell surface, whichbinds to Fas on the plasma membrane of the target (expressed in many cells inresponse to viral infection)",hierarchyLevel:6,children:[],index:"000501000400"},{text:" This causes the death of the target cell",hierarchyLevel:6,children:[],index:"000501000401"}],index:"0005010004"}],index:"00050100"},{text:" Innate Lymphoid Cells (Natural Killer Cells)",hierarchyLevel:4,children:[{text:" Activation",hierarchyLevel:5,children:[{text:" Antigen recognition pathway is different from cytotoxic T cells",hierarchyLevel:6,children:[],index:"000501010000"}],index:"0005010100"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Kill cells in the similar mechanism as cytotoxic T cells",hierarchyLevel:6,children:[],index:"000501010100"}],index:"0005010101"}],index:"00050101"},{text:" Cytokines",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Soluble intercellular messengers of the immune system",hierarchyLevel:6,children:[],index:"000501020000"}],index:"0005010200"},{text:" General Properties",hierarchyLevel:5,children:[{text:" Acts like a hormones  synthesized in one location, and generatesan effect in another location",hierarchyLevel:6,children:[],index:"000501020100"},{text:" Act as immunotransmitters (neurotransmitters)  some act in avery short distance, two cells must come together to communicate, release ofcytokine in small amount which can only have an effect on the immediateadjacent cell",hierarchyLevel:6,children:[],index:"000501020101"}],index:"0005010201"},{text:" Specific Properties",hierarchyLevel:5,children:[{text:" Pleiotropism  one cytokine acts on several different cell types,resulting in different outcomes",hierarchyLevel:6,children:[],index:"000501020200"},{text:" Redundancy  several cytokines create a similar effect on targetcells",hierarchyLevel:6,children:[],index:"000501020201"},{text:" Synergism  cytokines work together to produce an effect",hierarchyLevel:6,children:[],index:"000501020202"},{text:" Antagonism  cytokines that inhibits the effect of anothercytokine",hierarchyLevel:6,children:[],index:"000501020203"}],index:"0005010202"},{text:" Function",hierarchyLevel:5,children:[{text:" Enables the different types of cells in the immune system tocommunicate with each other",hierarchyLevel:6,children:[],index:"000501020300"},{text:" Enables the immune cells to communicate with non-immune cells(endothelial cells)",hierarchyLevel:6,children:[],index:"000501020301"}],index:"0005010203"},{text:" Examples",hierarchyLevel:5,children:[{text:" Interleukins  molecules that communicates between leucocytes(wbc)",hierarchyLevel:6,children:[],index:"000501020400"},{text:" Chemokines  molecules that communicate location of movement ofwbc",hierarchyLevel:6,children:[],index:"000501020401"},{text:" Interferons  prevent replication of viruses",hierarchyLevel:6,children:[],index:"000501020402"},{text:" Tumor Necrosis Factors  inflammation, recruiting cells to siteof infection",hierarchyLevel:6,children:[],index:"000501020403"},{text:" Colony Stimulating factors  act on the bone marrow to stimulateproduction of cells",hierarchyLevel:6,children:[],index:"000501020404"},{text:" Growth Factors ",hierarchyLevel:6,children:[],index:"000501020405"}],index:"0005010204"}],index:"00050102"},{text:" Random Extra Info",hierarchyLevel:4,children:[{text:" Colony Stimulating Factors",hierarchyLevel:5,children:[{text:" Colony stimulating factors can be used for people who justdonated cells of their bone marrow",hierarchyLevel:6,children:[],index:"000501030000"},{text:" Using colony stimulating factors for granulocytes, stimulates thebone marrow cells to grow back and quickly start producing granulocytes toboost the immune system",hierarchyLevel:6,children:[],index:"000501030001"}],index:"0005010300"},{text:" Pleiotropism",hierarchyLevel:5,children:[{text:" Interleukin 1 acts on the hypothalamus to raise temperature.Interleukin 1 acts on the bone marrow to induce bone degradation (boneresorption), also induces bone metabolism to generate new bone",hierarchyLevel:6,children:[],index:"000501030100"}],index:"0005010301"},{text:" Redundancy",hierarchyLevel:5,children:[{text:" Useful to combat pathogens subverting one kind of chemokineproduction. Another chemokine can take its place and the immune system willstill be functional",hierarchyLevel:6,children:[],index:"000501030200"},{text:" Inteferons  11 different type 1 interferons have similarfunctions and bind to the same receptor. This enables a more robust system tocombat viral arms race.",hierarchyLevel:6,children:[],index:"000501030201"}],index:"0005010302"},{text:" Antagonism",hierarchyLevel:5,children:[{text:" Anti-Tumor necrosis factor alpha switches off cytokines to treatautoimmune diseases",hierarchyLevel:6,children:[],index:"000501030300"}],index:"0005010303"}],index:"00050103"}],index:"000501"},{text:" Helper Cells",hierarchyLevel:3,children:[{text:" CD4 Helper T cells",hierarchyLevel:4,children:[{text:" Function",hierarchyLevel:5,children:[{text:" Regulators / brain of the immune system to decide the branch ofimmunity to activate in the context of an infection",hierarchyLevel:6,children:[],index:"000502000000"}],index:"0005020000"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" The resting nave T cell recognizes an antigen, goes through aseries of differentiation steps to become one of the subpopulations of thehelper t cell",hierarchyLevel:6,children:[],index:"000502000100"},{text:" The helper t cell becomes bigger and produce granules, produces cytokines,and expresses other molecules",hierarchyLevel:6,children:[],index:"000502000101"},{text:" This causes it to upregulate and amplify different branches ofimmunity",hierarchyLevel:6,children:[],index:"000502000102"}],index:"0005020001"},{text:" Types  T helper cell subpopulations",hierarchyLevel:5,children:[{text:" Tfh (follicular)  help B cells make specific antibody",hierarchyLevel:6,children:[],index:"000502000200"},{text:" Th1  activate macrophages and cytotoxic T cells",hierarchyLevel:6,children:[],index:"000502000201"},{text:" Th2  activate mast cells, eosinophils, IgE",hierarchyLevel:6,children:[],index:"000502000202"},{text:" Th17  activate neutrophils (secrete interleukin-17)",hierarchyLevel:6,children:[],index:"000502000203"}],index:"0005020002"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0005020003"}],index:"00050200"},{text:" Full Activation of B cell with Tfh cell",hierarchyLevel:4,children:[{text:" Background  B cell independent responses",hierarchyLevel:5,children:[{text:" Antibody receptor on the B cell recognizes a polysaccharide fromthe surface of a bacterial cell (t-independent antigen)",hierarchyLevel:6,children:[],index:"000502010000"},{text:" B cell differentiates and produces soluble antibodies",hierarchyLevel:6,children:[],index:"000502010001"},{text:" However, without T cell help, isotype switching does not happen,and only IgM is synthesized, affinity maturation does not occur",hierarchyLevel:6,children:[],index:"000502010002"}],index:"0005020100"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" B cell recognizes antigen and binds it via the receptor",hierarchyLevel:6,children:[],index:"000502010100"},{text:" B cell takes up the antigen via the endosome",hierarchyLevel:6,children:[],index:"000502010101"},{text:" B cell constitutively expresses MHC Class II",hierarchyLevel:6,children:[],index:"000502010102"},{text:" In the endosome, the antigen enters the class II MHC pathway andis processed and presented on the plasma membrane",hierarchyLevel:6,children:[],index:"000502010103"},{text:" The T cell receptor on the T cell recognizes the peptidepresented on MHC Class II on the B cell. The co-stimulatory molecules are alsoactivated. This causes the activation of the complementary T cell",hierarchyLevel:6,children:[],index:"000502010104"},{text:" Upon T cell activation, the T cell will release cytokines whichdrives differentiation and isotype switching",hierarchyLevel:6,children:[],index:"000502010105"}],index:"0005020101"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0005020102"},{text:" Abnormal Function",hierarchyLevel:5,children:[{text:" Missing of CD40 ligand, this results in poor T cell help andhence little B cell differentiation",hierarchyLevel:6,children:[],index:"000502010300"}],index:"0005020103"}],index:"00050201"},{text:" T Helper cell 1 (Th1)",hierarchyLevel:4,children:[{text:" Mechanism of Activation of Macrophages",hierarchyLevel:5,children:[{text:" Macrophages carries out phagocytosis on mycobacteriumtuberculosis. However, due to the thick cell wall and resistance carried bymycobacterium tuberculosis, it does not die upon being phagocytosed.",hierarchyLevel:6,children:[],index:"000502020000"},{text:" The macrophage processes the antigen on the mycobacteriumtuberculosis and present the peptides on MHC Class II",hierarchyLevel:6,children:[],index:"000502020001"},{text:" A compatible T cell arrives and binds to the peptide frommycobacterium tuberculosis presented on MHC Class II by the macrophage ",hierarchyLevel:6,children:[],index:"000502020002"},{text:" Activated T cells produces several cytokines which activates themacrophage (interferon \u03b3  activate t-cell)",hierarchyLevel:6,children:[],index:"000502020003"},{text:" These cytokines activate advanced killing mechanisms of themacrophage, causing it produce nitrogen radicals (nitric oxide) which caneffectively kill the intracellular mycobacterium tuberculosis",hierarchyLevel:6,children:[],index:"000502020004"},{text:" Th1 cell releases a small amount of tumor necrosis factor \u03b1and interleukin-1. Activated macrophages releases large amounts of tumornecrosis factor \u03b1 and interleukin 1, aiding in the inflammatory response.",hierarchyLevel:6,children:[],index:"000502020005"}],index:"0005020200"}],index:"00050202"},{text:" T Helper Cell 2 (Th2)",hierarchyLevel:4,children:[{text:" Mechanism of Activating Mast cells and eosinophils (MetazoanParasite Infections)",hierarchyLevel:5,children:[{text:" IL3 and IL9 drive mast cell recruitment, causing the release ofgranules which recruit inflammatory cells",hierarchyLevel:6,children:[],index:"000502030000"},{text:" IL5 recruits and activates eosinophils, which causes the releaseof granules which causes parasite killing",hierarchyLevel:6,children:[],index:"000502030001"},{text:" IL3 incudes epithelial cell proliferation and stimulates mucusproductions, this hinders parasite colonization",hierarchyLevel:6,children:[],index:"000502030002"},{text:" IL4 favours IgE production. IgE arms mast cells and eosinophils.",hierarchyLevel:6,children:[],index:"000502030003"}],index:"0005020300"}],index:"00050203"},{text:" T Helper Cell 17 (Th17)  releases interleukin 17",hierarchyLevel:4,children:[{text:" General",hierarchyLevel:5,children:[{text:" IL17 serves to amplify the immune response.",hierarchyLevel:6,children:[],index:"000502040000"}],index:"0005020400"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" IL17 activates immune (myeloid) and non-immune (stromal) cells toproduce G-CSF (granulocytes colony stimulating factor) and IL8",hierarchyLevel:6,children:[],index:"000502040100"},{text:" This results in the recruitment and activation of neutrophils",hierarchyLevel:6,children:[],index:"000502040101"},{text:" Recruited neutrophils releases granules and kills the bacteria",hierarchyLevel:6,children:[],index:"000502040102"}],index:"0005020401"},{text:" Abnormal Function",hierarchyLevel:5,children:[{text:" There are individuals who possess rare genetic immunedeficiencies where the mechanism for producing IL17 is deficient.",hierarchyLevel:6,children:[],index:"000502040200"},{text:" This causes the individual to experience recurrent fungalinfections, showing the importance in the role of IL17 in amplifying the immuneresponse",hierarchyLevel:6,children:[],index:"000502040201"}],index:"0005020402"}],index:"00050204"},{text:" Classification of T Helper Cell Subpopulations",hierarchyLevel:4,children:[{text:" Principle",hierarchyLevel:5,children:[{text:" Cytokines in the environment can be produced by the innate immunecells. Therefore, innate immune cells can determine the Th type. Cytokines alsoinhibit the differentiation of Th cells into other subtypes. Hence, immuneresponses are dominated by 1 particular subtype of Th cells.",hierarchyLevel:6,children:[],index:"000502050000"},{text:" Decision of which T Helper Cell Subpopulation to become isdependent on the cytokine environment. ",hierarchyLevel:6,children:[],index:"000502050001"},{text:" Classification of a T helper cell into subpopulations depends onthe cytokines produced in response to antigen",hierarchyLevel:6,children:[],index:"000502050002"},{text:" Benny Chain:",hierarchyLevel:6,children:[{text:" The Th type is determined by the microenvironment around theantigen presenting cells at the time the T cell is activated",hierarchyLevel:7,children:[],index:"00050205000300"},{text:" The different Th cells tend to suppress the differentiation ofother cell types (eg. IL4 inhibits Th1) leading to polarized immune responses",hierarchyLevel:7,children:[],index:"00050205000301"},{text:" Excessive Th function associated with pathology",hierarchyLevel:7,children:[],index:"00050205000302"}],index:"000502050003"}],index:"0005020500"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Individual is exposed to a parasite.",hierarchyLevel:6,children:[],index:"000502050100"},{text:" The parasite causes the activation of mast cells in the mucosa. ",hierarchyLevel:6,children:[],index:"000502050101"},{text:" Activated mast cells produces IL-4.",hierarchyLevel:6,children:[],index:"000502050102"},{text:" The presence of IL-4 in the microenvironment suppresses thedifferentiation of Th cell into all other subtypes except for Th2.",hierarchyLevel:6,children:[],index:"000502050103"},{text:" This results in Th2 to be produced. Th2 releases more IL-4causing further differentiation of other cells into Th2.",hierarchyLevel:6,children:[],index:"000502050104"},{text:" Eventually, the positive feedback cycle will lead to the immuneresponse mounted against the bacteria to be pre-dominated by one particular Thcell type. Moreover, the positive feedback cycle also enables the amplificationof the immune system.",hierarchyLevel:6,children:[],index:"000502050105"},{text:" Moreover, the produced Th2 cells will remain in the body. Whenthere is a re-infection, the  Th2 cells will immediately start  producing IL-4 which thenkickstarts the amplification process of the immune response (by causingdifferentiation into Th2).",hierarchyLevel:6,children:[],index:"000502050106"}],index:"0005020501"},{text:" Classification",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"000502050200"}],index:"0005020502"},{text:" Innate Immune Cells  cytokine production",hierarchyLevel:5,children:[{text:" There are equivalent groups of innate helpers cells which aresimilar to their respective T helper cells, similar to Natural Killer Cells andTc",hierarchyLevel:6,children:[],index:"000502050300"},{text:" Mechanism of activity of innate cells are not clear",hierarchyLevel:6,children:[],index:"000502050301"}],index:"0005020503"}],index:"00050205"}],index:"000502"},{text:" Overview",hierarchyLevel:3,children:[{text:" Big Picture Role of T Cells",hierarchyLevel:4,children:[{text:" Responsible for how much and what type of response to activate",hierarchyLevel:5,children:[],index:"0005030000"}],index:"00050300"}],index:"000503"}],index:"0005"},{text:" [032] Tissue Immune Responses",hierarchyLevel:2,children:[{text:" Antigen Capture",hierarchyLevel:3,children:[{text:" Function of Lymphoid Tissues",hierarchyLevel:4,children:[{text:" Reticular meshwork to trap antigens",hierarchyLevel:5,children:[],index:"0006000000"}],index:"00060000"},{text:" Antigen Capture",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Microbes release antigens after infection. The antigens need tobe trapped to be recognized by the immune system.",hierarchyLevel:6,children:[],index:"000600010000"}],index:"0006000100"},{text:" Mechanism  blood ",hierarchyLevel:5,children:[{text:" To trap the antigens, the antigens in the blood will be trappedin the spleen. ",hierarchyLevel:6,children:[],index:"000600010100"},{text:" This is because the blood vessels open out into the spleen, andblood flows slowly in the spleen. Therefore, anything insoluble in blood (smallmolecules) will be trapped into the spleen.",hierarchyLevel:6,children:[],index:"000600010101"}],index:"0006000101"},{text:" Mechanism  tissue",hierarchyLevel:5,children:[{text:" Antigens will drain through lymphatic system and then will travelto the lymph node and will be trapped at the margins of the lymph node.",hierarchyLevel:6,children:[],index:"000600010200"},{text:" The lymph node acts as a sieve to trap the antigens for longenough for immune response to be mounted. ",hierarchyLevel:6,children:[],index:"000600010201"}],index:"0006000102"}],index:"00060001"},{text:" Structure of Lymph Node  antigen capture",hierarchyLevel:4,children:[{text:" Structure",hierarchyLevel:5,children:[{text:" Taking a lymph node and get rid of all the cells, the lymph noderesembles a meshwork, like a net which traps the antigens",hierarchyLevel:6,children:[],index:"000600020000"}],index:"0006000200"},{text:" Purpose",hierarchyLevel:5,children:[{text:" Meshwork acts as a scaffold for the lymphocytes to move around totry to search for antigens in the lymph node",hierarchyLevel:6,children:[],index:"000600020100"}],index:"0006000201"},{text:" Function",hierarchyLevel:5,children:[{text:" Antigens can remain in the lymph node for days and months",hierarchyLevel:6,children:[],index:"000600020200"}],index:"0006000202"}],index:"00060002"}],index:"000600"},{text:" Lymphocyte Migration",hierarchyLevel:3,children:[{text:" Lymphocyte Migration into Lymph Node",hierarchyLevel:4,children:[{text:" Structure",hierarchyLevel:5,children:[{text:" Blood vessels beside the lymph node has a specialized endothelium",hierarchyLevel:6,children:[],index:"000601000000"},{text:" The endothelium is higher and thicker, like a columnarendothelium, called high endothelial venules (HEV) ",hierarchyLevel:6,children:[],index:"000601000001"},{text:" These carry molecules on the surface which allows the lymphocytesto leave and search for antigens",hierarchyLevel:6,children:[],index:"000601000002"}],index:"0006010000"},{text:" Molecules on surface of High Endothelial Venules (HEV)",hierarchyLevel:5,children:[{text:" Selectins  molecules which engage with the surface of thelymphocyte. Interaction is not strong enough to stop the lymphocyte, but causesthem to roll around the area",hierarchyLevel:6,children:[],index:"000601000100"},{text:" Interactions with Beta-2-integrins / intra-cellular adhesionmolecule",hierarchyLevel:6,children:[],index:"000601000101"}],index:"0006010001"},{text:" Process of Migration",hierarchyLevel:5,children:[{text:" Lymphocytes rush through the blood, interact with the selectinand integrins.",hierarchyLevel:6,children:[],index:"000601000200"},{text:" This causes the lymphocytes to slow down, stop and migrate outand into the lymph node. ",hierarchyLevel:6,children:[],index:"000601000201"},{text:" The lymphocytes then look for antigens for a few hours, then moveout and into the blood and try again",hierarchyLevel:6,children:[],index:"000601000202"}],index:"0006010002"},{text:" Properties of Migratory Process",hierarchyLevel:5,children:[{text:" Stochastic process  each lymphocyte will have a chance of movingout at each lymph node, probabilistic",hierarchyLevel:6,children:[],index:"000601000300"},{text:" Each lymphocyte within 24 hours will visit a lymph node. Only 1%are in the blood, 99% in tissues",hierarchyLevel:6,children:[],index:"000601000301"}],index:"0006010003"},{text:" Process of Migration Avoidance",hierarchyLevel:5,children:[{text:" Once the lymphocyte has recognized the tissue, they switch itssurface so that it will not be sensitive to other lymph nodes and will notenter other lymph nodes.",hierarchyLevel:6,children:[],index:"000601000400"},{text:" This enables it to focus on going to the site of infection",hierarchyLevel:6,children:[],index:"000601000401"}],index:"0006010004"}],index:"00060100"},{text:" Structure and Function of Lymph Node  migration",hierarchyLevel:4,children:[{text:" Overall Function",hierarchyLevel:5,children:[{text:" Slow cells down, cells can touch each other and explore themicroenvironment in more detail",hierarchyLevel:6,children:[],index:"000601010000"}],index:"0006010100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0006010101"},{text:" Specific Structure and Function",hierarchyLevel:5,children:[],index:"0006010102"}],index:"00060101"},{text:" Movement of Various Cells into and out of Lymph Node",hierarchyLevel:4,children:[{text:" Dendritic cells come from the tissue",hierarchyLevel:5,children:[],index:"0006010200"},{text:" T and B cells enter through the endothelium HEV",hierarchyLevel:5,children:[],index:"0006010201"},{text:" Once the B and T cells are done, they migrate out of the medulla,via the lymphatics and back into the blood",hierarchyLevel:5,children:[],index:"0006010202"}],index:"00060102"}],index:"000601"},{text:" B-cell Activities",hierarchyLevel:3,children:[{text:" Germinal centre",hierarchyLevel:4,children:[{text:" Function",hierarchyLevel:5,children:[{text:" Enable the process of b cell differentiation and maturation",hierarchyLevel:6,children:[],index:"000602000000"}],index:"0006020000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0006020001"},{text:" Mechanism of B-cell activation",hierarchyLevel:5,children:[{text:" Antigen specific B cell and antigen specific T cell independentlybinds to antigens on the dendritic cell in the lymph node (outside the germinalcentre)",hierarchyLevel:6,children:[],index:"000602000200"},{text:" B cells and T cells migrate into the germinal centre (driven bythe chemokines)",hierarchyLevel:6,children:[],index:"000602000201"},{text:" The B cell undergoes clonal amplification and division, with asingle b-cell generating thousands of other identical B-cells",hierarchyLevel:6,children:[],index:"000602000202"},{text:" [ ] After some proliferative rounds, B cellsleave the germinal centres and become the memory cells. This enables them to beready for the next exposure to the antigen",hierarchyLevel:6,children:[],index:"000602000203"},{text:" [ ] After some proliferative rounds, B cellsleaves the germinal centres and becomes plasma cells which produces antibodies.Plasma cells move out of the lymph node and travel to the bone marrow or thespleen and produce antibodies ",hierarchyLevel:6,children:[],index:"000602000204"},{text:" The remaining B cells undergoes the cycle of affinity maturation",hierarchyLevel:6,children:[],index:"000602000205"}],index:"0006020002"},{text:" Mechanism of Affinity Maturation via Somatic Cell Mutation",hierarchyLevel:5,children:[{text:" During the B cell division, a special set of enzymes thatintroduces single point mutations on the gene of the B cells",hierarchyLevel:6,children:[],index:"000602000300"},{text:" The introduction of mutations is a highly regulated process toavoid cancerous growth",hierarchyLevel:6,children:[],index:"000602000301"},{text:" As a result, some B cells produces a slightly different antibodymolecule. ",hierarchyLevel:6,children:[],index:"000602000302"},{text:" B cells leave the dark zone of the germinal centre and move tothe light zone of the germinal centre",hierarchyLevel:6,children:[],index:"000602000303"},{text:" The follicular dendritic cell in the light zone carries antigenson its native conformational surface, with only a small number of antigens ofeach type",hierarchyLevel:6,children:[],index:"000602000304"},{text:" B cells in the light zone compete to bind to the small number ofantigens on the follicular dendritic cell. B cells will successfully bind tothe antigens if its antibody has a higher antigen affinity than thepre-existing antibodies. Failure to bind to the antigen causes B cell death,leaving behind only the B cells with superior antibodies",hierarchyLevel:6,children:[],index:"000602000305"},{text:" The surviving B cells move back into the dark zone of thegerminal centre and continue proliferating and experiencing somatic cell mutation",hierarchyLevel:6,children:[],index:"000602000306"},{text:" T follicular cells ensure the repeating nature of the process ",hierarchyLevel:6,children:[],index:"000602000307"}],index:"0006020003"},{text:" Accumulator characteristic of somatic cell mutation",hierarchyLevel:5,children:[{text:" Case Study",hierarchyLevel:6,children:[{text:" It is rare for an antibody to be able to neutralize HIV",hierarchyLevel:7,children:[],index:"00060200040000"},{text:" For those that can, 30% of the antibody have been mutated.",hierarchyLevel:7,children:[],index:"00060200040001"}],index:"000602000400"},{text:" Characteristic",hierarchyLevel:6,children:[{text:" Somatic hypermutation only generates very small changes in theamino acids",hierarchyLevel:7,children:[],index:"00060200040100"},{text:" However, through accumulation of these mutations, significantvariation in the traits and shapes of the antibodies can be derived",hierarchyLevel:7,children:[],index:"00060200040101"}],index:"000602000401"}],index:"0006020004"}],index:"00060200"}],index:"000602"},{text:" Tissue Immune Cell Population and Activation",hierarchyLevel:3,children:[{text:" Differential immune cell populations",hierarchyLevel:4,children:[{text:" Trend",hierarchyLevel:5,children:[{text:" The greater the chance of a tissue being exposed to pathogens,the greater the numbers of resident immune cells",hierarchyLevel:6,children:[],index:"000603000000"},{text:" All tissues have resident immune cells",hierarchyLevel:6,children:[],index:"000603000001"}],index:"0006030000"},{text:" Resident Immune Cells",hierarchyLevel:5,children:[{text:" Lymphocytes",hierarchyLevel:6,children:[],index:"000603000100"},{text:" Dendritic cells",hierarchyLevel:6,children:[],index:"000603000101"},{text:" Macrophage",hierarchyLevel:6,children:[],index:"000603000102"}],index:"0006030001"},{text:" Process",hierarchyLevel:5,children:[{text:" During an immune response, the process of inflammation causes amassive amplification in the number of immune cells to the tissues",hierarchyLevel:6,children:[],index:"000603000200"}],index:"0006030002"}],index:"00060300"},{text:" Reactivation Mechanism of Lymphocytes",hierarchyLevel:4,children:[{text:" Antigens in the tissues travel through the lymphatics and to thelymph node and activates the lymphocytes. The lymphocytes then leave the lymphnode to move to the infected tissue initiate the immune response",hierarchyLevel:5,children:[],index:"0006030100"},{text:" When the activated lymphocytes return to the site of infection,it binds to the antigen on the antigen presenting cell to  be re-activated . This enables it toprovide a strong immune response.",hierarchyLevel:5,children:[],index:"0006030101"},{text:" If the activated lymphocytes are not re-activated (due to a lackof dendritic cells at the tissue cell), the immune response will be subdued.",hierarchyLevel:5,children:[],index:"0006030102"}],index:"00060301"}],index:"000603"},{text:" Mucosal Immune System",hierarchyLevel:3,children:[{text:" General Stuff",hierarchyLevel:4,children:[{text:" Definition of Mucosal surfaces",hierarchyLevel:5,children:[{text:" Surfaces of the body that releases mucous",hierarchyLevel:6,children:[],index:"000604000000"}],index:"0006040000"},{text:" Types",hierarchyLevel:5,children:[{text:" Gut associated",hierarchyLevel:6,children:[],index:"000604000100"},{text:" Bronchus associated",hierarchyLevel:6,children:[],index:"000604000101"}],index:"0006040001"}],index:"00060400"},{text:" Preferential return of Memory B cells",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" A lymphocyte moves into a lymph node at one of the mucosal sites ",hierarchyLevel:6,children:[],index:"000604010000"},{text:" The lymphocyte detects a suitable antigen and is activated",hierarchyLevel:6,children:[],index:"000604010001"},{text:" Clonal amplification occurs, generating memory B cells",hierarchyLevel:6,children:[],index:"000604010002"},{text:" Memory B cells re-enters the lymphatic system and drains backinto the bloodstream",hierarchyLevel:6,children:[],index:"000604010003"},{text:" Memory B cells re-circulates in the bloodstream andpreferentially moves out of the bloodstream into the lymph nodes and tissues atwhich at the same mucosal sites it was first activated",hierarchyLevel:6,children:[],index:"000604010004"}],index:"0006040100"},{text:" Implication",hierarchyLevel:5,children:[{text:" Lymphocytes at mucosal surfaces do not randomly move into lymphnodes in a stochastic manner",hierarchyLevel:6,children:[],index:"000604010100"},{text:" Lymphocytes at mucosal surfaces preferentially moves out of thebloodstream and into the lymph node where it was first activated",hierarchyLevel:6,children:[],index:"000604010101"}],index:"0006040101"},{text:" Reasoning",hierarchyLevel:5,children:[{text:" Bacteria would likely attack again from the same location, hencestoring memory B cells at the site of previous infection enables it to detectthe antigen quickly and respond quickly in the next infection",hierarchyLevel:6,children:[],index:"000604010200"}],index:"0006040102"},{text:" Mechanism of Preferential Migration",hierarchyLevel:5,children:[{text:" Migration is mediated by a different mechanism",hierarchyLevel:6,children:[],index:"000604010300"},{text:" MAdCAM-1, alpha 4 beta 7 integrin",hierarchyLevel:6,children:[],index:"000604010301"},{text:" Different molecules can direct the cell into differentcompartments",hierarchyLevel:6,children:[],index:"000604010302"}],index:"0006040103"}],index:"00060401"},{text:" Production of IgA (dimer) at mucosal surfaces",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0006040200"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Unlike any other antibody, the isotype is secreted out of thetissue into the body cavity, into the mucosal surface lumen (gut, bronchi,tears)",hierarchyLevel:6,children:[],index:"000604020100"},{text:" Poly Ig A receptors, picks up the IgA and secretes it across the epitheliuminto the body cavity",hierarchyLevel:6,children:[],index:"000604020101"}],index:"0006040201"},{text:" Function",hierarchyLevel:5,children:[{text:" IgA prevents the adhesion of microbes to the surface of themucosa, preventing them from invading the tissue",hierarchyLevel:6,children:[],index:"000604020200"},{text:" IgA acts as an opsonin for the granulocytes. Granulocytes rapidlyeat bacteria at the epithelium",hierarchyLevel:6,children:[],index:"000604020201"}],index:"0006040202"},{text:" Uncertainty on IgA",hierarchyLevel:5,children:[{text:" IgA immunodeficiency is very common",hierarchyLevel:6,children:[],index:"000604020300"},{text:" However, there are very few symptoms that arise from it",hierarchyLevel:6,children:[],index:"000604020301"},{text:" There are some slight increases in severity for fungal diseasebut overall not sure how much importance function of IgA",hierarchyLevel:6,children:[],index:"000604020302"}],index:"0006040203"}],index:"00060402"},{text:" Immune Responses at Mucosal Layers",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0006040300"},{text:" Structure",hierarchyLevel:5,children:[{text:" Lymphocytes line the area below of the mucosa layer, ready todestroy any bacteria that manages to breach the initial layer",hierarchyLevel:6,children:[],index:"000604030100"},{text:" Below the epithelial lining is a huge population of \u03b3\u03b4-Tcells which repairs the epithelial integrity",hierarchyLevel:6,children:[],index:"000604030101"},{text:" Hundreds of miniature lymph nodes (payers patches) which sitright next to the gut, serving as a tiny localized immune system to deal withanything that crosses the layer. ",hierarchyLevel:6,children:[],index:"000604030102"}],index:"0006040301"},{text:" Development of Chronic Gastrointestinal Diseases",hierarchyLevel:5,children:[{text:" Small damages to the epithelium happen often in the day,resulting in the entry of pathogens into the epithelial lining",hierarchyLevel:6,children:[],index:"000604030200"},{text:" Phagocytes near the mucosal surface conducts intracellularkilling on the pathogens that has breached the epithelial lining",hierarchyLevel:6,children:[],index:"000604030201"},{text:" However, when the phagocytes are unable to successfullyneutralize the pathogen, the body reacts by initiating inflammation and therecruitment of more phagocytes",hierarchyLevel:6,children:[],index:"000604030202"},{text:" The influx of phagocytes together with the release of cytotoxicmediators results in damage of the surrounding cells",hierarchyLevel:6,children:[],index:"000604030203"},{text:" If the phagocytes continue to fail to neutralise the pathogen,this leads to chronic inflammation and damage. Over time this causes chronicgastrointestinal diseases.",hierarchyLevel:6,children:[],index:"000604030204"}],index:"0006040302"}],index:"00060403"}],index:"000604"},{text:" Other Immune Tissues",hierarchyLevel:3,children:[{text:" Skin",hierarchyLevel:4,children:[{text:" Epidermis",hierarchyLevel:5,children:[{text:" The epidermis contains Langerhans cells (macrophage / dendriticcell hybrid) which would phagocytise any pathogens that breaches the skinbarrier",hierarchyLevel:6,children:[],index:"000605000000"},{text:" Langerhans cells utilises its dendrites to bind to antigens onthe pathogen. Upon binding, Langerhans cells retracts its dendrites, and carrythe antigen to the lymph nodes",hierarchyLevel:6,children:[],index:"000605000001"},{text:" In the lymph nodes, the antigen presented on the Langerhans cellswill activate a t-cell",hierarchyLevel:6,children:[],index:"000605000002"},{text:" The activated t-cell would have preferential migratorycharacteristics and hence will return to the site of infection and attach tothe pathogen",hierarchyLevel:6,children:[],index:"000605000003"}],index:"0006050000"},{text:" Dermis",hierarchyLevel:5,children:[{text:" The dermis a small population of macrophage and dendritic cellswhich are patrolling",hierarchyLevel:6,children:[],index:"000605000100"},{text:" Upon the detection of a pathogen, the cells send signals to allother cells to deal with the infection, resulting in an inflammatory response",hierarchyLevel:6,children:[],index:"000605000101"},{text:" The inflammatory response causes a massive recruitment oflymphocytes and mononuclear cells to come to the site of infection",hierarchyLevel:6,children:[],index:"000605000102"}],index:"0006050001"}],index:"00060500"},{text:" Liver",hierarchyLevel:4,children:[{text:" Structure and Function",hierarchyLevel:5,children:[],index:"0006050100"},{text:" Infection Response",hierarchyLevel:5,children:[{text:" If an infection of the liver, numerous lymphocytes enter liver toneutralise pathogens",hierarchyLevel:6,children:[],index:"000605010100"},{text:" The entry of immune cells results in a significant change in thestructure of the liver",hierarchyLevel:6,children:[],index:"000605010101"}],index:"0006050101"},{text:" Abnormal",hierarchyLevel:5,children:[{text:" Overactivation of the immune system to the liver (hepatitis)causes the destruction of the liver",hierarchyLevel:6,children:[],index:"000605010200"}],index:"0006050102"}],index:"00060501"}],index:"000605"}],index:"0006"},{text:" [029] Immunodeficiency",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Describe and list the way in which immunodeficiencies areclassified",hierarchyLevel:4,children:[],index:"00070000"},{text:" List the primary immunodeficiencies and explain the mechanismsresponsible for them",hierarchyLevel:4,children:[],index:"00070001"},{text:" Describe and list the main factors leading to the development ofsecondary immunodeficiencies",hierarchyLevel:4,children:[],index:"00070002"},{text:" Discuss the types of organisms that are associated withparticular types of immunodeficiency",hierarchyLevel:4,children:[],index:"00070003"},{text:" List the main kinds of treatments for immunodeficiency",hierarchyLevel:4,children:[],index:"00070004"}],index:"000700"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" General Properties",hierarchyLevel:4,children:[{text:" Immune system matures and declines over life",hierarchyLevel:5,children:[],index:"0007010000"}],index:"00070100"}],index:"000701"},{text:" Primary Immunodeficiencies (PID)",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Rare inborn errors of immunity  a group of conditions whichresults in primary immunodeficiencies",hierarchyLevel:5,children:[],index:"0007020000"},{text:" Immune system does not work correctly due to genetic reasons",hierarchyLevel:5,children:[],index:"0007020001"}],index:"00070200"},{text:" Cause",hierarchyLevel:4,children:[{text:" Rare inborn errors of immunity  300 genes identified",hierarchyLevel:5,children:[],index:"0007020100"}],index:"00070201"},{text:" Mechanism Pathways",hierarchyLevel:4,children:[{text:" Disabling neutrophil function  bacterial infections",hierarchyLevel:5,children:[],index:"0007020200"},{text:" Disabling T cell function  viral infections",hierarchyLevel:5,children:[],index:"0007020201"},{text:" Disabling B cell function  respiratory tract infections(antibody production)",hierarchyLevel:5,children:[],index:"0007020202"}],index:"00070202"},{text:" Consequences",hierarchyLevel:4,children:[{text:" Increased susceptibility to infection",hierarchyLevel:5,children:[],index:"0007020300"},{text:" Increase risk of autoimmunity",hierarchyLevel:5,children:[],index:"0007020301"},{text:" Increased risk of malignancy",hierarchyLevel:5,children:[],index:"0007020302"},{text:" Increased risk of auto-inflammation",hierarchyLevel:5,children:[],index:"0007020303"},{text:" Functional Classification",hierarchyLevel:5,children:[],index:"0007020304"}],index:"00070203"},{text:" Causal Classification",hierarchyLevel:4,children:[],index:"00070204"},{text:" Classification according to Infection Susceptibility",hierarchyLevel:4,children:[{text:" Virus  NK-cell, T-cell",hierarchyLevel:5,children:[],index:"0007020500"},{text:" Mycobacteria  macrophages, T-cell",hierarchyLevel:5,children:[],index:"0007020501"},{text:" Bacteria  Neutrophil, B-cell",hierarchyLevel:5,children:[],index:"0007020502"},{text:" Fungi  Neutrophil, T-cell",hierarchyLevel:5,children:[],index:"0007020503"}],index:"00070205"},{text:" Diagnosis",hierarchyLevel:4,children:[{text:" Main Principles",hierarchyLevel:5,children:[{text:" Look for frequent and unusual types of infection",hierarchyLevel:6,children:[],index:"000702060000"}],index:"0007020600"},{text:" Factors",hierarchyLevel:5,children:[{text:" Clinical Presentation",hierarchyLevel:6,children:[],index:"000702060100"},{text:" Genetic Analysis",hierarchyLevel:6,children:[],index:"000702060101"},{text:" Immune Cell Function",hierarchyLevel:6,children:[],index:"000702060102"}],index:"0007020601"},{text:" Decision Logic",hierarchyLevel:5,children:[{text:" Are the infections unusual",hierarchyLevel:6,children:[],index:"000702060200"},{text:" Is there an obvious cause",hierarchyLevel:6,children:[{text:" HIV",hierarchyLevel:7,children:[],index:"00070206020100"}],index:"000702060201"},{text:" Are there other symptom / complications",hierarchyLevel:6,children:[{text:" Structural lung disease from recurrent infections",hierarchyLevel:7,children:[],index:"00070206020200"}],index:"000702060202"},{text:" Family history",hierarchyLevel:6,children:[],index:"000702060203"}],index:"0007020602"}],index:"00070206"},{text:" Tests",hierarchyLevel:4,children:[{text:" Basic",hierarchyLevel:5,children:[{text:" Full blood count",hierarchyLevel:6,children:[],index:"000702070000"},{text:" Immunodeficiency panel - 336 gene panel that includes assessmentof non-coding variants",hierarchyLevel:6,children:[],index:"000702070001"}],index:"0007020700"},{text:" Complex",hierarchyLevel:5,children:[{text:" Nave and memory T-cells",hierarchyLevel:6,children:[],index:"000702070100"},{text:" T-cell repertoire",hierarchyLevel:6,children:[],index:"000702070101"},{text:" TRECS",hierarchyLevel:6,children:[],index:"000702070102"}],index:"0007020701"}],index:"00070207"},{text:" Treatments",hierarchyLevel:4,children:[{text:" Antibiotics",hierarchyLevel:5,children:[],index:"0007020800"},{text:" Immunoglobulins for antibody deficiencies",hierarchyLevel:5,children:[],index:"0007020801"},{text:" Cell Replacement  bone-marrow and thymus transplants",hierarchyLevel:5,children:[],index:"0007020802"},{text:" Gene Therapy  SCID (ADA, gC)",hierarchyLevel:5,children:[],index:"0007020803"}],index:"00070208"}],index:"000702"},{text:" Tests for Primary Immunodeficiencies",hierarchyLevel:3,children:[{text:" T Cell Function Test",hierarchyLevel:4,children:[{text:" Add chemicals and antibodies (co-stimulatory receptors) to causeT cells to multiply",hierarchyLevel:5,children:[],index:"0007030000"},{text:" Measure to see whether T cells did indeed multiply",hierarchyLevel:5,children:[],index:"0007030001"}],index:"00070300"},{text:" B Cell Function Test",hierarchyLevel:4,children:[{text:" Test antibodies for the antigens in vaccines to identify theantibodies we expect to be produced by the body",hierarchyLevel:5,children:[],index:"0007030100"},{text:" Vaccinate patients and look to see if their antibodies for thespecific vaccines are activated",hierarchyLevel:5,children:[],index:"0007030101"}],index:"00070301"},{text:" Neutrophil Function Test",hierarchyLevel:4,children:[{text:" Test for oxidative burst  enables neutrophils to kill bacteria",hierarchyLevel:5,children:[{text:" Neutraphils are given a dye until they are stimulated/",hierarchyLevel:6,children:[],index:"000703020000"},{text:" The oxidative burst turns the dye to fluorescent",hierarchyLevel:6,children:[],index:"000703020001"},{text:" Fluorescence is detected",hierarchyLevel:6,children:[],index:"000703020002"}],index:"0007030200"},{text:" Analysis",hierarchyLevel:5,children:[{text:" If neutrophils take a long time to respond with an oxidativeburst, then the fluorescence will be recorded quite late",hierarchyLevel:6,children:[],index:"000703020100"}],index:"0007030201"}],index:"00070302"},{text:" Protein Test",hierarchyLevel:4,children:[],index:"00070303"}],index:"000703"},{text:" Diagnosis of Primary Immunodeficiencies",hierarchyLevel:3,children:[{text:" Genetic Diagnosis of PID",hierarchyLevel:4,children:[{text:" Candidate gene analysis",hierarchyLevel:5,children:[{text:" Shortlist certain diseases and test with the patient gene hasmutations for those diseases",hierarchyLevel:6,children:[],index:"000704000000"}],index:"0007040000"},{text:" Gene chip panel",hierarchyLevel:5,children:[{text:" Able to test hundreds of genes at the same time",hierarchyLevel:6,children:[],index:"000704000100"}],index:"0007040001"},{text:" Whole exome sequencing",hierarchyLevel:5,children:[{text:" Sequence all the exons",hierarchyLevel:6,children:[],index:"000704000200"}],index:"0007040002"},{text:" Whole genome sequencing",hierarchyLevel:5,children:[{text:" Sequence the entire genome (exons and introns)",hierarchyLevel:6,children:[],index:"000704000300"}],index:"0007040003"}],index:"00070400"},{text:" Complexity of mutations causing PID",hierarchyLevel:4,children:[{text:" Homozygous Loss of Function (LOF)",hierarchyLevel:5,children:[{text:" Mutation causes a loss of gene function on both the alleles ofthe gene",hierarchyLevel:6,children:[],index:"000704010000"},{text:" As a result, the disease is more severe",hierarchyLevel:6,children:[],index:"000704010001"}],index:"0007040100"},{text:" Compound Heterozygous Loss of Function (LOF)",hierarchyLevel:5,children:[{text:" Both alleles contain a mistake, but the mistakes on each alleleare different",hierarchyLevel:6,children:[],index:"000704010100"}],index:"0007040101"},{text:" X-linked disorders",hierarchyLevel:5,children:[{text:" Mutation is on the X chromosome",hierarchyLevel:6,children:[],index:"000704010200"}],index:"0007040102"},{text:" Heterozygous Gain of Function",hierarchyLevel:5,children:[{text:" Loss of Function  A single mistake on one of the alleles resultsin the loss of function",hierarchyLevel:6,children:[],index:"000704010300"},{text:" Gain of Function  A single mistake results in the gain offunction, resulting in the gene overactivity, resulting in the disruption ofthe immune system and cause immunodeficiency",hierarchyLevel:6,children:[],index:"000704010301"},{text:" No change  One allele does not work, but the other allele isable to produce enough proteins to preserve cell function",hierarchyLevel:6,children:[],index:"000704010302"},{text:" Half of Function  One allele does not work, but the other alleleonly produces half the number of proteins produced, resulting inhaploinsufficiency",hierarchyLevel:6,children:[],index:"000704010303"}],index:"0007040103"},{text:" Frontiers",hierarchyLevel:5,children:[{text:" Digenic  two genes can cause disease",hierarchyLevel:6,children:[],index:"000704010400"},{text:" Oligogenic  more than two genes can cause disease",hierarchyLevel:6,children:[],index:"000704010401"},{text:" Epigenetic  regulation of genes can cause disease",hierarchyLevel:6,children:[],index:"000704010402"}],index:"0007040104"}],index:"00070401"},{text:" CASE",hierarchyLevel:4,children:[{text:" 38 year old woman",hierarchyLevel:5,children:[],index:"0007040200"},{text:" CVID diagnosed",hierarchyLevel:5,children:[],index:"0007040201"},{text:" Hypogammaglobulinaemia with absent B-cells",hierarchyLevel:5,children:[],index:"0007040202"}],index:"00070402"}],index:"000704"},{text:" [Case] Primary Immunodeficiencies",hierarchyLevel:3,children:[{text:" Profile",hierarchyLevel:4,children:[{text:" 40-year-old",hierarchyLevel:5,children:[],index:"0007050000"}],index:"00070500"},{text:" Symptoms",hierarchyLevel:4,children:[{text:" 10-year history of recurrent chest infections",hierarchyLevel:5,children:[],index:"0007050100"},{text:" 6-8 courses of antibiotics per year",hierarchyLevel:5,children:[],index:"0007050101"},{text:" Hospitalised recently for pneumonia",hierarchyLevel:5,children:[],index:"0007050102"},{text:" No prior history of immunosuppression",hierarchyLevel:5,children:[],index:"0007050103"},{text:" CT scan shows bronchiectasis",hierarchyLevel:5,children:[],index:"0007050104"}],index:"00070501"},{text:" Scans",hierarchyLevel:4,children:[{text:" Fluffy appearance  inflammatory",hierarchyLevel:5,children:[],index:"0007050200"},{text:" Airways are dilated",hierarchyLevel:5,children:[],index:"0007050201"}],index:"00070502"},{text:" Analysis",hierarchyLevel:4,children:[{text:" Respiratory tract infections are typically indicative of B-cellfunction problems",hierarchyLevel:5,children:[],index:"0007050300"},{text:" Hence, order a B-cell function test, and some other T cell and NKcell just in case.",hierarchyLevel:5,children:[],index:"0007050301"}],index:"00070503"},{text:" Test",hierarchyLevel:4,children:[{text:" Normal numbers and percentages of T/B and NK cells",hierarchyLevel:5,children:[],index:"0007050400"},{text:" Low levels of IgG and IgA",hierarchyLevel:5,children:[],index:"0007050401"},{text:" Normal Albumin",hierarchyLevel:5,children:[],index:"0007050402"}],index:"00070504"},{text:" Analysis",hierarchyLevel:4,children:[{text:" Low levels of IgG with low albumin indicates protein leak whichis a secondary problem",hierarchyLevel:5,children:[],index:"0007050500"},{text:" Since the patient has normal levels of albumin and low IgG, thisshows a primary problem",hierarchyLevel:5,children:[],index:"0007050501"}],index:"00070505"},{text:" Diagnosis",hierarchyLevel:4,children:[{text:" Common Variable Immunodeficiency (CVID)",hierarchyLevel:5,children:[{text:" Primary Cause of Adult-Onset Antibody Deficiency",hierarchyLevel:6,children:[],index:"000705060000"},{text:" Characterized by infections in respiratory tract",hierarchyLevel:6,children:[],index:"000705060001"},{text:" 30% of patients have auto immune complications andautoinflammatory features such as lymphadenopathy and splenomegaly",hierarchyLevel:6,children:[],index:"000705060002"}],index:"0007050600"}],index:"00070506"}],index:"000705"},{text:" Neutrophil Disorders",hierarchyLevel:3,children:[{text:" Neutrophil Lifecycle",hierarchyLevel:4,children:[{text:" Neutrophils are produced in the bone marrow and released into theblood",hierarchyLevel:5,children:[],index:"0007060000"},{text:" Movement out of the blood vessel",hierarchyLevel:5,children:[{text:" Neutrophils at the ends of the blood vessels move more slowly",hierarchyLevel:6,children:[],index:"000706000100"},{text:" During inflammation, selectins and integrin ligands are releasedon the plasma membrane of the endothelial cells",hierarchyLevel:6,children:[],index:"000706000101"},{text:" Interactions between neutrophils and selectins and integrinligands results in slowing down of neutrophils",hierarchyLevel:6,children:[],index:"000706000102"},{text:" Rolling  neutrophils slow to a roll",hierarchyLevel:6,children:[],index:"000706000103"},{text:" Tethering  neutrophils stops",hierarchyLevel:6,children:[],index:"000706000104"},{text:" Diapedesis  become flat and exit the blood vessel",hierarchyLevel:6,children:[],index:"000706000105"}],index:"0007060001"},{text:" Action",hierarchyLevel:5,children:[{text:" Phagocytose pathogen",hierarchyLevel:6,children:[],index:"000706000200"},{text:" Kill pathogen with oxidative burst and enzymatic killing",hierarchyLevel:6,children:[],index:"000706000201"}],index:"0007060002"},{text:" Death",hierarchyLevel:5,children:[{text:" Neutrophils dies by apoptosis",hierarchyLevel:6,children:[],index:"000706000300"}],index:"0007060003"}],index:"00070600"},{text:" Types of Disorders",hierarchyLevel:4,children:[{text:" Disorders of production",hierarchyLevel:5,children:[],index:"0007060100"},{text:" Disorders of function",hierarchyLevel:5,children:[],index:"0007060101"}],index:"00070601"},{text:" Disorders of Production  neutropenia (low levels)",hierarchyLevel:4,children:[{text:" Cause",hierarchyLevel:5,children:[{text:" Results in the production of abnormal proteins or intracellulartoxin which results in apoptosis of developing neutrophils",hierarchyLevel:6,children:[],index:"000706020000"}],index:"0007060200"},{text:" Process",hierarchyLevel:5,children:[{text:" Block of neutrophil maturation from promyelocyte to myelocytestage",hierarchyLevel:6,children:[],index:"000706020100"},{text:" This causes immature neutrophils (promyelocyte and myeloblast) tobe formed, but no mature neutrophils",hierarchyLevel:6,children:[],index:"000706020101"},{text:" This results in extremely low absent neutrophil count in blood",hierarchyLevel:6,children:[],index:"000706020102"}],index:"0007060201"}],index:"00070602"},{text:" Disorders of Function",hierarchyLevel:4,children:[{text:" Defects of Oxidative Metabolism",hierarchyLevel:5,children:[{text:" Chronic Granuloma Disease",hierarchyLevel:6,children:[],index:"000706030000"}],index:"0007060300"},{text:" Leucocyte Adhesion Deficiencies",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Molecules that are required for adhesion (selectins, iCAM intracellular adhesion molecule) are not present or are not functional",hierarchyLevel:7,children:[],index:"00070603010000"},{text:" This causes the neutrophils to be unable to exit the bloodstream",hierarchyLevel:7,children:[],index:"00070603010001"},{text:" This causes high levels of neutrophils in the bloodstream, but nofunctional neutrophils in the peripheral tissue.",hierarchyLevel:7,children:[],index:"00070603010002"},{text:" Hence, these individuals get severe infections but do not developany pus",hierarchyLevel:7,children:[],index:"00070603010003"}],index:"000706030100"}],index:"0007060301"},{text:" Very rare defects",hierarchyLevel:5,children:[{text:" Associated with cytoskeletal defects",hierarchyLevel:6,children:[],index:"000706030200"},{text:" Associated with defects of granule production or function",hierarchyLevel:6,children:[],index:"000706030201"}],index:"0007060302"}],index:"00070603"},{text:" Chronic Granuloma Disease",hierarchyLevel:4,children:[{text:" Cause",hierarchyLevel:5,children:[{text:" Defects in the NADPH oxidase complex which is responsible ofproducing oxidative burst",hierarchyLevel:6,children:[],index:"000706040000"},{text:" Errors in the DNA of any of the molecules in the oxidative burstcomplex results in the failure of oxidative burst",hierarchyLevel:6,children:[],index:"000706040001"},{text:" Protein expression shows which proteins is not being producedproperly",hierarchyLevel:6,children:[],index:"000706040002"}],index:"0007060400"},{text:" Properties",hierarchyLevel:5,children:[{text:" Diseases are typical X linked and Autosomal recessive",hierarchyLevel:6,children:[],index:"000706040100"}],index:"0007060401"},{text:" Diseases",hierarchyLevel:5,children:[{text:" Results in severe bacterial and fungal infections",hierarchyLevel:6,children:[{text:" Bacteria are catalase positive   able to survive inneutrophils with no respiratory burst",hierarchyLevel:7,children:[],index:"00070604020000"},{text:" Bacteria that are catalase negative are killed by other enzymes",hierarchyLevel:7,children:[],index:"00070604020001"}],index:"000706040200"},{text:" Non-infective granulomas",hierarchyLevel:6,children:[{text:" Inability of neutrophils to clear up inflammation",hierarchyLevel:7,children:[],index:"00070604020100"}],index:"000706040201"}],index:"0007060402"},{text:" Onset",hierarchyLevel:5,children:[{text:" Early childhood (<2 years of age)",hierarchyLevel:6,children:[],index:"000706040300"}],index:"0007060403"}],index:"00070604"},{text:" Oxidative / Respiratory Burst",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" When the neutrophil is activated, gp91  and p22 are activated and come together to form a dimer",hierarchyLevel:6,children:[],index:"000706050000"},{text:" The dimer then recruits other molecules which are required forthe respiratory burst to occur ",hierarchyLevel:6,children:[],index:"000706050001"},{text:" The complex act as a shuttle of electrons from the cytoplasm intothe phagosome",hierarchyLevel:6,children:[],index:"000706050002"},{text:" The phagosome becomes dense with electrons, causing it to becomenegatively charged",hierarchyLevel:6,children:[],index:"000706050003"},{text:" This causes oxygen to be converted into superoxide radicals",hierarchyLevel:6,children:[],index:"000706050004"},{text:" Superoxide radicals are further altered in the phagosome intohydrogen peroxide",hierarchyLevel:6,children:[],index:"000706050005"},{text:" Myeloperoxidase converts hydrogen peroxide into hypochlorous acid",hierarchyLevel:6,children:[],index:"000706050006"}],index:"0007060500"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0007060501"}],index:"00070605"}],index:"000706"},{text:" [Case] Neutrophil Disorders",hierarchyLevel:3,children:[{text:" Profile",hierarchyLevel:4,children:[{text:" 30 years old",hierarchyLevel:5,children:[],index:"0007070000"}],index:"00070700"},{text:" Symptoms",hierarchyLevel:4,children:[{text:" At baby",hierarchyLevel:5,children:[{text:" Diagnosed with Crohns disease at age 19 months",hierarchyLevel:6,children:[],index:"000707010000"},{text:" Developed salmonella sepsis",hierarchyLevel:6,children:[],index:"000707010001"}],index:"0007070100"},{text:" At age 12,",hierarchyLevel:5,children:[{text:" Recurrent granulomatous cystitis and gastric outlet obstruction treated with steroids",hierarchyLevel:6,children:[],index:"000707010100"},{text:" Acne",hierarchyLevel:6,children:[],index:"000707010101"},{text:" Cervical adenitis with abscesses",hierarchyLevel:6,children:[],index:"000707010102"}],index:"0007070101"},{text:" Now,",hierarchyLevel:5,children:[{text:" Presented with fever",hierarchyLevel:6,children:[],index:"000707010200"},{text:" Started empiric meropenem S.aureus",hierarchyLevel:6,children:[],index:"000707010201"}],index:"0007070102"}],index:"00070701"},{text:" History",hierarchyLevel:4,children:[{text:" Given steroids for abdominal obstruction at age 3",hierarchyLevel:5,children:[],index:"0007070200"}],index:"00070702"},{text:" Diagnosis",hierarchyLevel:4,children:[{text:" X-linked CGD",hierarchyLevel:5,children:[],index:"0007070300"}],index:"00070703"},{text:" Scan",hierarchyLevel:4,children:[{text:" Abscess grew Staphylococcus aureus",hierarchyLevel:5,children:[],index:"0007070400"},{text:" Flucloxacillin is given",hierarchyLevel:5,children:[],index:"0007070401"},{text:" Oral steroid is given to damp down the inflammation for antibioticsto penetrate the abscesses",hierarchyLevel:5,children:[],index:"0007070402"}],index:"00070704"},{text:" Treatment",hierarchyLevel:4,children:[{text:" Conservative treatment with antibiotics vs bone marrow transplant",hierarchyLevel:5,children:[],index:"0007070500"}],index:"00070705"}],index:"000707"},{text:" Secondary Immunodeficiency",hierarchyLevel:3,children:[{text:" Causes",hierarchyLevel:4,children:[{text:" Malnutrition",hierarchyLevel:5,children:[{text:" Protein-calorie malnutrition",hierarchyLevel:6,children:[],index:"000708000000"},{text:" Lack of dietary elements",hierarchyLevel:6,children:[],index:"000708000001"}],index:"0007080000"},{text:" Loss of cellular/humoral components",hierarchyLevel:5,children:[{text:" Lymphocytes passively lost into the intestine in intestinallymphangiectasia",hierarchyLevel:6,children:[],index:"000708000100"},{text:" Proteins lost into urine in nephrotic syndrome",hierarchyLevel:6,children:[],index:"000708000101"},{text:" Tumours  direct effect of tumours of the immune system",hierarchyLevel:6,children:[],index:"000708000102"}],index:"0007080001"},{text:" Cytotoxic drugs / irradiation",hierarchyLevel:5,children:[{text:" Used to inhibit tumour cell growth but simultaneously damageimmune cells",hierarchyLevel:6,children:[],index:"000708000200"}],index:"0007080002"},{text:" Diabetes",hierarchyLevel:5,children:[],index:"0007080003"},{text:" Malaria",hierarchyLevel:5,children:[{text:" Inhibit the development of immune responses",hierarchyLevel:6,children:[],index:"000708000400"}],index:"0007080004"},{text:" HIV",hierarchyLevel:5,children:[{text:" HIV binds to CD4 receptors on T cells and co-receptors",hierarchyLevel:6,children:[],index:"000708000500"},{text:" HIV enters the cell and causes cell lysis",hierarchyLevel:6,children:[],index:"000708000501"}],index:"0007080005"}],index:"00070800"},{text:" Treatments",hierarchyLevel:4,children:[{text:" Chemotherapy",hierarchyLevel:5,children:[{text:" Act by inhibiting cell proliferation and causing cel death",hierarchyLevel:6,children:[],index:"000708010000"},{text:" Causes neutropenia",hierarchyLevel:6,children:[],index:"000708010001"}],index:"0007080100"},{text:" Steroids",hierarchyLevel:5,children:[{text:" Suppress the immune system",hierarchyLevel:6,children:[],index:"000708010100"},{text:" Prolonged use permanently damages the immune system",hierarchyLevel:6,children:[],index:"000708010101"}],index:"0007080101"},{text:" Haematopoietic stem cell transplant",hierarchyLevel:5,children:[{text:" Cause immunosuppression",hierarchyLevel:6,children:[],index:"000708010200"}],index:"0007080102"},{text:" Other immunosuppressive drugs",hierarchyLevel:5,children:[{text:" Biologics  monoclonal antibodies against specific cytokines",hierarchyLevel:6,children:[],index:"000708010300"},{text:" Small molecule inhibitiors of cell signalling (against BTK)",hierarchyLevel:6,children:[],index:"000708010301"}],index:"0007080103"}],index:"00070801"}],index:"000708"}],index:"0007"},{text:" [031] Allergies and Hypersensitivities",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" To understand the concept of hypersensitivities  the immunesystem can over-react to foreign and self-antigens in a number of ways",hierarchyLevel:4,children:[],index:"00080000"},{text:" To know the accepted classification of hypersensitivities",hierarchyLevel:4,children:[],index:"00080001"},{text:" To describe the main mechanisms for each class ofhypersensitivity",hierarchyLevel:4,children:[],index:"00080002"},{text:" To be able to give examples of each type of hypersensitivity",hierarchyLevel:4,children:[],index:"00080003"}],index:"000800"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Hypersensitivity  damage to the host arising from immuneresponse",hierarchyLevel:5,children:[],index:"0008010000"},{text:" Allergy  hypersensitivity arising from responses to innocuousstimuli",hierarchyLevel:5,children:[],index:"0008010001"},{text:" Autoimmunity  immune responses to self-tissues",hierarchyLevel:5,children:[],index:"0008010002"},{text:" Immunopathology  side effect of responses to pathogens",hierarchyLevel:5,children:[],index:"0008010003"},{text:" Mast cells  a form of granulocyte",hierarchyLevel:5,children:[],index:"0008010004"}],index:"00080100"},{text:" 4 Classical Types of Hypersensitivity",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0008010100"},{text:" NOTE: Hypersensitivity is the mechanism in which disease iscaused",hierarchyLevel:5,children:[],index:"0008010101"}],index:"00080101"}],index:"000801"},{text:" Type I Hypersensitivity (Immediate)",hierarchyLevel:3,children:[{text:" Cause",hierarchyLevel:4,children:[{text:" Upper respiratory tract allergies  larger allergens",hierarchyLevel:5,children:[{text:" Rhinitis",hierarchyLevel:6,children:[],index:"000802000000"},{text:" Hay fever",hierarchyLevel:6,children:[],index:"000802000001"}],index:"0008020000"},{text:" Lower respiratory tract / lung allergies  smaller allergens ",hierarchyLevel:5,children:[{text:" Asthma (allergy is one of the causes of asthma)",hierarchyLevel:6,children:[],index:"000802000100"}],index:"0008020001"},{text:" Skin ",hierarchyLevel:5,children:[{text:" Allergic eczema",hierarchyLevel:6,children:[],index:"000802000200"}],index:"0008020002"},{text:" Mouth, throat, gut",hierarchyLevel:5,children:[{text:" Food (eg. fish)",hierarchyLevel:6,children:[],index:"000802000300"}],index:"0008020003"},{text:" Infections",hierarchyLevel:5,children:[{text:" Worms (shistosomiasis)",hierarchyLevel:6,children:[],index:"000802000400"}],index:"0008020004"}],index:"00080200"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" Skin and mucosal tissues contain mast cells",hierarchyLevel:5,children:[],index:"0008020100"},{text:" The body makes IgE antibodies against the allergen",hierarchyLevel:5,children:[],index:"0008020101"},{text:" oTh2 produces cytokines (interleukin-4, interleukin-13) whichtriggers the B cell isotype  switching, resulting in theproduction of IgE by the B cell.",hierarchyLevel:5,children:[],index:"0008020102"},{text:" During the first exposure, IgE is made and binds to the Fc\u03f5receptors on the mast cells in the tissue. Nothing happens.",hierarchyLevel:5,children:[],index:"0008020103"},{text:" Fc\u03b3 receptors only binds to IgG only after it has been boundto its target",hierarchyLevel:5,children:[],index:"0008020104"},{text:" Fc\u03f5 receptors binds to IgE before it has been bound to itstarget",hierarchyLevel:5,children:[],index:"0008020105"},{text:" Once the individual is re-exposed to the same allergen, theallergen enters the body and then binds very rapidly to the antibodies on themast cells that were generated during the previous exposure.",hierarchyLevel:5,children:[],index:"0008020106"},{text:" These binding triggers signaling via the Fc\u03f5 receptors,triggering the release of mast cell granules into the environment. The mastcell granules include inflammatory mediators (histamine, serotonin)",hierarchyLevel:5,children:[],index:"0008020107"},{text:" The inflammatory mediators causes the blood vessels to become leaky,resulting in more blood arriving at the site of infection.",hierarchyLevel:5,children:[],index:"0008020108"},{text:" Mast cell releases cytokines and chemokines (tumor necrosisfactor). This causes the activation of other chemo attractants, which attractsmore cells to the site.",hierarchyLevel:5,children:[],index:"0008020109"},{text:" Mast cell releases prostaglandins and leukotriene, which induceslocal inflammation by modulating blood flow.",hierarchyLevel:5,children:[],index:"0008020110"}],index:"00080201"},{text:" Mechanism of Peanut Allergies",hierarchyLevel:4,children:[{text:" Allergen from the peanut is released, and moves out of the gut",hierarchyLevel:5,children:[],index:"0008020200"},{text:" The allergen travels rapidly throughout the body, activating theIgE on mast cells on many parts of the body, and hence triggering mast celldegranulation throughout the body",hierarchyLevel:5,children:[],index:"0008020201"},{text:" This results in an allergic reaction throughout the body.",hierarchyLevel:5,children:[],index:"0008020202"},{text:" This may result in a catastrophic fall in blood pressure.",hierarchyLevel:5,children:[],index:"0008020203"}],index:"00080202"},{text:" Properties",hierarchyLevel:4,children:[{text:" Make take long - takes months of years for the full process tocomplete",hierarchyLevel:5,children:[],index:"0008020300"}],index:"00080203"},{text:" Differential Allergic responses in people",hierarchyLevel:4,children:[{text:" Main Principle",hierarchyLevel:5,children:[{text:" Some individuals have atopy (raised) levels of IgE",hierarchyLevel:6,children:[],index:"000802040000"}],index:"0008020400"},{text:" Reasons",hierarchyLevel:5,children:[{text:" Genes",hierarchyLevel:6,children:[{text:" Children of people who are allergic have a higher risk ofdeveloping an allergy",hierarchyLevel:7,children:[],index:"00080204010000"},{text:" Genetic differences in HLA (MHC) genes may lead to allergies (asusceptibility locus)",hierarchyLevel:7,children:[],index:"00080204010001"},{text:" Polymorphisms in other immunological mediators may lead toallergies",hierarchyLevel:7,children:[],index:"00080204010002"}],index:"000802040100"},{text:" Environment",hierarchyLevel:6,children:[{text:" Due to individual from wealthier countries living in environmentswhich are very clean. This disturbs of the balance between the Th1 and Th2 response.Hence, the body is more likely to develop a Th2 response and hence producesmore IgE, resulting in allergies.",hierarchyLevel:7,children:[],index:"00080204010100"},{text:" In countries where peanuts are commonly given to young children,they are less likely to develop subsequent allergies, than in other countrieswhere peanuts are not generally eat in the young babies. This increases therisk of latent development.",hierarchyLevel:7,children:[],index:"00080204010101"}],index:"000802040101"}],index:"0008020401"}],index:"00080204"},{text:" Treatment",hierarchyLevel:4,children:[{text:" Allergen avoidance",hierarchyLevel:5,children:[],index:"0008020500"},{text:" Pharmacotherapy",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Prevent the immediate effect of histamines",hierarchyLevel:7,children:[{text:" Antihistamines",hierarchyLevel:8,children:[],index:"0008020501000000"}],index:"00080205010000"},{text:" Prevent mast cell degranulation",hierarchyLevel:7,children:[{text:" Steroids  corticosteroids [long term steroid consequences]",hierarchyLevel:8,children:[],index:"0008020501000100"},{text:" Sodium chromoglycate",hierarchyLevel:8,children:[],index:"0008020501000101"}],index:"00080205010001"}],index:"000802050100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"000802050101"}],index:"0008020501"},{text:" Immunotherapy",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Expose the body to very low doses of allergens, resulting indesensitization ",hierarchyLevel:7,children:[],index:"00080205020000"}],index:"000802050200"},{text:" Disadvantages",hierarchyLevel:6,children:[{text:" Carries the risk of initiating immune response of type Ihypersensitivity",hierarchyLevel:7,children:[],index:"00080205020100"}],index:"000802050201"}],index:"0008020502"}],index:"00080205"}],index:"000802"},{text:" Type II Hypersensitivity",hierarchyLevel:3,children:[{text:" General Mechanism",hierarchyLevel:4,children:[{text:" Mediated by IgG responses against inappropriate targets",hierarchyLevel:5,children:[],index:"0008030000"}],index:"00080300"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" IgG for the host cell is synthesized for some reason",hierarchyLevel:5,children:[],index:"0008030100"},{text:" IgG binds to the host cell antigens",hierarchyLevel:5,children:[{text:" IgGon the host cell antigen binds to complement proteins, activating thecomplement system via the classical pathway",hierarchyLevel:6,children:[],index:"000803010100"},{text:" FcReceptors on the macrophage cell binds to IgG on the host cell, stimulating themacrophage to ingest and destroy the host cell",hierarchyLevel:6,children:[],index:"000803010101"},{text:" FcReceptors  on Natural Killer Cells  binds to IgG on the hostcell, stimulating it to destroy and damage the host cell",hierarchyLevel:6,children:[],index:"000803010102"}],index:"0008030101"}],index:"00080301"},{text:" Examples",hierarchyLevel:4,children:[{text:" Transplantation",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" During blood transfusion, if the blood groups do not match, theantibodies will bind to the antigens on the red blood cells. ",hierarchyLevel:7,children:[],index:"00080302000000"},{text:" This causes the activation of the complement system via theclassical pathway, resulting in red blood cell lysis by the complement system.",hierarchyLevel:7,children:[],index:"00080302000001"},{text:" This leads to hemolytic anaemia.",hierarchyLevel:7,children:[],index:"00080302000002"}],index:"000803020000"}],index:"0008030200"},{text:" Haemolytic disease of the newborn",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Blood cells of the fetus containing D antigens, while themothers blood does not contain D antigens ",hierarchyLevel:7,children:[],index:"00080302010000"},{text:" During birth, due to the traumatic movements, the placentalbarrier might break slightly, this causes the fetus blood cells to bleed intothe mothers bloodstream",hierarchyLevel:7,children:[],index:"00080302010001"},{text:" This causes the mother to produce a IgG and IgM response againstthe D antigen",hierarchyLevel:7,children:[],index:"00080302010002"},{text:" This does not affect the baby as the baby is moving out of thevagina",hierarchyLevel:7,children:[],index:"00080302010003"},{text:" However, during the second pregnancy, the antibodies that arepresent since the last pregnancy will cross the placenta, and into the embryoand bind to the red blood cells",hierarchyLevel:7,children:[],index:"00080302010004"},{text:" This leads to the blue baby syndrome, as the fetal red bloodcells are killed by complement lysis and there is a lack of fetal haemoglobin",hierarchyLevel:7,children:[],index:"00080302010005"}],index:"000803020100"},{text:" Treatment",hierarchyLevel:6,children:[{text:" At the time the baby is born (or before), inject a small amountof pre-formed antibody against the rhesus antigen (monoclonal)",hierarchyLevel:7,children:[],index:"00080302010100"},{text:" There are not enough antibodies to cause damage to the embryo,however, there is enough to coat the fetal red blood cells with the antibodies",hierarchyLevel:7,children:[],index:"00080302010101"},{text:" This enables the macrophages to recognize the fetal red bloodcells, capture it via phagocytosis and destroy it",hierarchyLevel:7,children:[],index:"00080302010102"}],index:"000803020101"},{text:" Diagram",hierarchyLevel:6,children:[],index:"000803020102"}],index:"0008030201"},{text:" Infection  Streptococcal endocarditis",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Antibodies against Streptococcal endocarditis also binds with theantigens on the surface of the heart muscle",hierarchyLevel:7,children:[],index:"00080302020000"},{text:" This then triggers the complement, macrophage activation andinflammation, leading to the damage to the heart",hierarchyLevel:7,children:[],index:"00080302020001"}],index:"000803020200"},{text:" Examples",hierarchyLevel:6,children:[{text:" Streptococcal endocarditis",hierarchyLevel:7,children:[],index:"00080302020100"},{text:" Chagas disease, Trypanosoma cruzi (parasite)",hierarchyLevel:7,children:[],index:"00080302020101"}],index:"000803020201"}],index:"0008030202"},{text:" Autoimmune diseases",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" Antibodies are made against self-cells",hierarchyLevel:7,children:[],index:"00080302030000"}],index:"000803020300"},{text:" Examples",hierarchyLevel:6,children:[{text:" Goodpastures Syndrome",hierarchyLevel:7,children:[],index:"00080302030100"}],index:"000803020301"},{text:" Diagram",hierarchyLevel:6,children:[],index:"000803020302"}],index:"0008030203"}],index:"00080302"}],index:"000803"},{text:" Type V Hypersensitivity",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" A special case of Type II Hypersensitivity",hierarchyLevel:5,children:[],index:"0008040000"}],index:"00080400"},{text:" Example",hierarchyLevel:4,children:[{text:" Graves Disease  autoimmune disease of thyroid",hierarchyLevel:5,children:[],index:"0008040100"}],index:"00080401"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" The regulation of antibody synthesis breaks down, causing theproduction of auto antibodies against the receptor of thyroid stimulatinghormones on the thyroid cells",hierarchyLevel:5,children:[],index:"0008040200"},{text:" The antibodies bind to the receptor and stimulate the cell,acting as if the cell is responding to thyroid stimulating hormone. Binding forantibody to host cell does not activate the complement system, mast cell orinflammation.",hierarchyLevel:5,children:[],index:"0008040201"},{text:" Antibody causes the overstimulation of the thyroid cell,resulting in hyperthyroidism",hierarchyLevel:5,children:[],index:"0008040202"}],index:"00080402"},{text:" Diagram",hierarchyLevel:4,children:[],index:"00080403"}],index:"000804"},{text:" Type III Hypersensitivity ",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Mediated by the immune complex",hierarchyLevel:5,children:[],index:"0008050000"}],index:"00080500"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" Antibody binds to the antigens that are present in the blood orextracellular fluid",hierarchyLevel:5,children:[],index:"0008050100"},{text:" Due to the amounts of antibodies and antigens, rather thangetting small complexes that can be cleared from the blood, large complexes areformed with many antibodies and antigens being bound together. ",hierarchyLevel:5,children:[],index:"0008050101"},{text:" The immune complexes obstructs the blood vessels, especially inthe capillaries (under the skin and in kidneys, in the lungs). This situationoccurs worse where blood moves slowly and the vessels are very fine.",hierarchyLevel:5,children:[],index:"0008050102"},{text:" The immune complexes get stuck to the endothelial lining, causingthe activation of complement system, macrophages and neutrophils.",hierarchyLevel:5,children:[],index:"0008050103"}],index:"00080501"},{text:" Diagram",hierarchyLevel:4,children:[],index:"00080502"},{text:" Examples",hierarchyLevel:4,children:[{text:" Allergies",hierarchyLevel:5,children:[{text:" Farmers lung",hierarchyLevel:6,children:[{text:" Fungus is found in hay and fungus releases spores",hierarchyLevel:7,children:[],index:"00080503000000"},{text:" The farmer breathes in the fungus and causes a massive productionof antibodies against the spores of the fungus",hierarchyLevel:7,children:[],index:"00080503000001"},{text:" The antibodies bind to the spores, resulting in the formation ofan immune complex in the lungs",hierarchyLevel:7,children:[],index:"00080503000002"},{text:" This causes shortness of breath",hierarchyLevel:7,children:[],index:"00080503000003"}],index:"000805030000"},{text:" Pigeon Fanciers Disease",hierarchyLevel:6,children:[],index:"000805030001"}],index:"0008050300"},{text:" Infections",hierarchyLevel:5,children:[{text:" Post-streptococcal glomerular nephritis",hierarchyLevel:6,children:[{text:" Antigens released by the dying bacteria bind to antibodies andform complexes",hierarchyLevel:7,children:[],index:"00080503010000"},{text:" Immune complexes that forms in the kidney causes damage to thekidney, resulting in nephritis",hierarchyLevel:7,children:[],index:"00080503010001"}],index:"000805030100"}],index:"0008050301"},{text:" Autoimmune diseases",hierarchyLevel:5,children:[{text:" Systemic lupus erythematosus",hierarchyLevel:6,children:[{text:" Antigen are self-DNA protein complexes (chromatin complexes)",hierarchyLevel:7,children:[],index:"00080503020000"},{text:" Antigens are found in the blood as they escape from the blood",hierarchyLevel:7,children:[],index:"00080503020001"},{text:" Antibodies against the antigens recognize them in the blood andform complexes with them",hierarchyLevel:7,children:[],index:"00080503020002"},{text:" Symptoms manifest in the skin (inflammatory lesions in the skin),lung, kidneys",hierarchyLevel:7,children:[],index:"00080503020003"}],index:"000805030200"}],index:"0008050302"}],index:"00080503"}],index:"000805"},{text:" Type IV Hypersensitivity (Delayed Type)",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" T cell mediated hypersensitivity (delayed type)",hierarchyLevel:5,children:[],index:"0008060000"},{text:" Attraction and activation of T cell occurs over hours and days",hierarchyLevel:5,children:[],index:"0008060001"}],index:"00080600"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" When T cell  has an immune resp onse against a particularantigen, T cell recognizes the peptide on MHC and is activated",hierarchyLevel:5,children:[],index:"0008060100"},{text:" The T cell releases Th1 type cytokines, interferon \u03b3 andtumour necrosis factors",hierarchyLevel:5,children:[],index:"0008060101"},{text:" This causes the T cells to activate macrophages, which thenreleases inflammatory mediators, interferon \u03b3 and tumour necrosis factors,which results in inflammation and damage to the host over time",hierarchyLevel:5,children:[],index:"0008060102"},{text:" This also results in the more recruitment of macrophages and Tcells, resulting in a vicious cycle",hierarchyLevel:5,children:[],index:"0008060103"}],index:"00080601"},{text:" Diagram",hierarchyLevel:4,children:[],index:"00080602"},{text:" Example",hierarchyLevel:4,children:[{text:" Infections",hierarchyLevel:5,children:[{text:" Tuberculosis",hierarchyLevel:6,children:[{text:" Typically, when an individual recognizes the tuberculosisantigen, they activate the T cells, which then activates the macrophages, whichare infected with tuberculosis, and the macrophages kill the tuberculosis",hierarchyLevel:7,children:[],index:"00080603000000"},{text:" However, when the macrophages fails to completely kill the mycobacteriatuberculosis, this results in the continued growth of the mycobacteriatuberculosis.",hierarchyLevel:7,children:[],index:"00080603000001"},{text:" This then results in the activation of more T cells andmacrophages, resulting in a vicious cycle.",hierarchyLevel:7,children:[],index:"00080603000002"},{text:" Eventually, this results in the formation of a granuloma, whichis a large structure made up of macrophages and T cells and necrotic tissue(destroyed by inflammatory mediators made by macrophages)",hierarchyLevel:7,children:[],index:"00080603000003"},{text:" Test inject small amount of tuberculin in the skin and test for aresponse (hours or a day to develop)",hierarchyLevel:7,children:[],index:"00080603000004"}],index:"000806030000"},{text:" Viral Hepatitis",hierarchyLevel:6,children:[],index:"000806030001"},{text:" COVID-19",hierarchyLevel:6,children:[],index:"000806030002"}],index:"0008060300"},{text:" Allergies",hierarchyLevel:5,children:[{text:" Allergic contact dermatitis",hierarchyLevel:6,children:[{text:" Nickel, poison ivy, hair dye activates a T cell response, whichactivates macrophages",hierarchyLevel:7,children:[],index:"00080603010000"}],index:"000806030100"},{text:" Coeliac Disease (food allergy)",hierarchyLevel:6,children:[{text:" Intolerant to gluten products, resulting from aT cell responseagainst gluten, resulting in inflammation in the gut.",hierarchyLevel:7,children:[],index:"00080603010100"}],index:"000806030101"}],index:"0008060301"},{text:" Acute Graft Rejection",hierarchyLevel:5,children:[],index:"0008060302"},{text:" Autoimmunity",hierarchyLevel:5,children:[{text:" Hashimotos thyroiditis",hierarchyLevel:6,children:[],index:"000806030300"}],index:"0008060303"}],index:"00080603"}],index:"000806"},{text:" Innate Hypersensitivity",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Mediated by the innate immune response",hierarchyLevel:5,children:[],index:"0008070000"}],index:"00080700"},{text:" Acute Inflammation",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" When a patient has an infection during surgery (or a cut), thisresults in the entry of large number of bacteria in which the body is unable toclear",hierarchyLevel:6,children:[],index:"000807010000"},{text:" The bacteria will then start growing rapidly, stimulating theinnate immune response. The endotoxins on the surface of the bacteria (LPS)binds to the toll-like receptor on the macrophages, and hence initiating aninnate immune response",hierarchyLevel:6,children:[],index:"000807010001"},{text:" Small number of bacteria initiates a local innate immuneresponse.",hierarchyLevel:6,children:[],index:"000807010002"},{text:" However, when the bacteria grow rapidly, this results in asystemic innate immune response on the whole body. The release of theinflammatory mediators, causes vasodilation, dropping of the blood pressure andhence organ failure.",hierarchyLevel:6,children:[],index:"000807010003"},{text:" This results in sepsis. ",hierarchyLevel:6,children:[],index:"000807010004"}],index:"0008070100"},{text:" Examples",hierarchyLevel:5,children:[{text:" Sepsis",hierarchyLevel:6,children:[],index:"000807010100"},{text:" Toxic Shock Syndrome",hierarchyLevel:6,children:[],index:"000807010101"}],index:"0008070101"}],index:"00080701"},{text:" Chronic Diseases",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Macrophages collect cellular debris, destroy it and recycle it",hierarchyLevel:6,children:[],index:"000807020000"},{text:" However, as macrophages get older, the macrophages start to enteran inflammatory stage. By constantly clearing out damage tissue or detritus,they become chronically activated.",hierarchyLevel:6,children:[],index:"000807020001"},{text:" This results in the causing of local chronic hypersensitivitywhich leads to damage and failure of function at that organ",hierarchyLevel:6,children:[],index:"000807020002"}],index:"0008070200"},{text:" Examples",hierarchyLevel:5,children:[{text:" Atherosclerosis (blood vessels)",hierarchyLevel:6,children:[],index:"000807020100"},{text:" Alzheimers (brain)",hierarchyLevel:6,children:[],index:"000807020101"},{text:" Type II Diabetes (fatty tissue)",hierarchyLevel:6,children:[],index:"000807020102"}],index:"0008070201"}],index:"00080702"}],index:"000807"}],index:"0008"},{text:" [035] Immunological Tolerance",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Principle",hierarchyLevel:4,children:[{text:" Immune system has to strike a fine balance between defendingagainst pathogens and not killing own cells",hierarchyLevel:5,children:[],index:"0009000000"}],index:"00090000"},{text:" Normal Function Mechanism",hierarchyLevel:4,children:[{text:" Protective immunity relies on T cells that have diverserecognition receptors (TCR)",hierarchyLevel:5,children:[],index:"0009000100"},{text:" The receptors are very diverse and are able to recognise a hugerange of different things, hence being able to detect all types of pathogens",hierarchyLevel:5,children:[],index:"0009000101"},{text:" This diversity is achieved through gene recombination.",hierarchyLevel:5,children:[],index:"0009000102"},{text:" Each T cell has it own specific receptors that recognises itsrespective antigens",hierarchyLevel:5,children:[],index:"0009000103"},{text:" Upon recognition, T cells undergoes clonal expansion",hierarchyLevel:5,children:[],index:"0009000104"}],index:"00090001"},{text:" Abnormal Function Mechanism",hierarchyLevel:4,children:[{text:" The danger is that our bodies will generate T cells with T cellreceptors that will recognise peptides from our own tissues",hierarchyLevel:5,children:[],index:"0009000200"}],index:"00090002"},{text:" Definition of Immunological Tolerance",hierarchyLevel:4,children:[{text:" Mechanisms that prevent the recognition of self-antigens by T andB cells",hierarchyLevel:5,children:[],index:"0009000300"}],index:"00090003"}],index:"000900"},{text:" Specific Immunological Tolerance",hierarchyLevel:3,children:[{text:" Purpose",hierarchyLevel:4,children:[{text:" Prevent undesirable immune responses being launch againstself-antigens / self-tissues",hierarchyLevel:5,children:[],index:"0009010000"}],index:"00090100"},{text:" Types of Immunological Tolerance",hierarchyLevel:4,children:[{text:" Central Tolerance",hierarchyLevel:5,children:[],index:"0009010100"},{text:" Peripheral Tolerance",hierarchyLevel:5,children:[],index:"0009010101"}],index:"00090101"}],index:"000901"},{text:" Central Tolerance",hierarchyLevel:3,children:[{text:" Location",hierarchyLevel:4,children:[{text:" Occurs in central (primary) lymphoid organs, where the T and Bcells are developing",hierarchyLevel:5,children:[],index:"0009020000"}],index:"00090200"},{text:" Principle",hierarchyLevel:4,children:[{text:" Control how cells are shaped during their development before theyreach maturity",hierarchyLevel:5,children:[],index:"0009020100"}],index:"00090201"},{text:" Mechanism",hierarchyLevel:4,children:[{text:" All B cells come from the same precursor (bone marrow), and stayin the bone marrow for development",hierarchyLevel:5,children:[],index:"0009020200"},{text:" All T cells come from the same precursor (bone marrow), but movesinto the thymus eventually",hierarchyLevel:5,children:[],index:"0009020201"}],index:"00090202"},{text:" Mechanism of B cell Central Tolerance",hierarchyLevel:4,children:[{text:" B cell develops in the bone marrow",hierarchyLevel:5,children:[],index:"0009020300"},{text:" In order for the B cell to survive, it must generate a functionalantigen receptor (BCR). If the B cell is unable to do so, it will die.",hierarchyLevel:5,children:[],index:"0009020301"},{text:" If a B cell generates a receptor that recognizes self-antigens,it will become engage with self-antigens during its development in bone marrow.This may lead to receptor editing which changes its receptors. This may lead todeletion where the B cell will die and be removed from the repertoire (negativeselection).",hierarchyLevel:5,children:[],index:"0009020302"}],index:"00090203"},{text:" Mechanism of T cell Central Tolerance",hierarchyLevel:4,children:[{text:" Precursor",hierarchyLevel:5,children:[{text:" T cells complete its maturation in the thymus",hierarchyLevel:6,children:[],index:"000902040000"},{text:" As the T cell differentiate and mature, they move in an orderedway through the cortex and medulla of the thymus",hierarchyLevel:6,children:[],index:"000902040001"},{text:" The T cells are educated in the thymus where they learn what theyshould respond to and what they should not respond to.",hierarchyLevel:6,children:[],index:"000902040002"}],index:"0009020400"},{text:" Process of MHC Recognition  Positive Selection / Death byNeglect",hierarchyLevel:5,children:[{text:" Goal",hierarchyLevel:6,children:[{text:" T cells must recognize self-MHC molecules because they can onlysee peptides (antigens) that are on MHC molecules",hierarchyLevel:7,children:[],index:"00090204010000"}],index:"000902040100"},{text:" During the start of development of T cells, they have neither CD4or CD8 co-receptor.",hierarchyLevel:6,children:[],index:"000902040101"},{text:" Afterwards, they develop both CD4 and CD8 co-receptors.",hierarchyLevel:6,children:[],index:"000902040102"},{text:" Thymocytes that contains the CD4 co-receptors are able tointeract with MHC Class II. This causes the down regulation of CD8 co-receptor,leading to the formation of a mature CD4 T cell. ",hierarchyLevel:6,children:[],index:"000902040103"},{text:" Thymocytes that contains the CD8 co-receptors are able tointeract with MHC Class I. This causese the down regulation of CD4 co-receptor,leading to the formation of a mature CD8 T cell",hierarchyLevel:6,children:[],index:"000902040104"},{text:" Thymocytes that do not possess either CD4 or CD8 co-receptors areunable to recognize any MHC molecules and hence dies by apoptosis (death byneglect)",hierarchyLevel:6,children:[],index:"000902040105"}],index:"0009020401"},{text:" Process of Preventing self-antigen recognition",hierarchyLevel:5,children:[{text:" However, there is a need to ensure that T cells do not recognizetoo strongly to self-MHC and self-peptides",hierarchyLevel:6,children:[],index:"000902040200"},{text:" T cells that recognize peptides in MHC Class I or II too stronglyduring development in the thymus are deleted (negative selection). Hence, cellsthat might give autoimmunity are purged.",hierarchyLevel:6,children:[],index:"000902040201"},{text:" However, negative selection is not perfect, resulting in someself-reactive T cells to escape and become mature T cells",hierarchyLevel:6,children:[],index:"000902040202"}],index:"0009020402"},{text:" Process  of Self-antigen  representation",hierarchyLevel:5,children:[{text:" However, in the thymus, not all self-peptides are represented assome self-antigens are only express in some organs. ",hierarchyLevel:6,children:[],index:"000902040300"},{text:" To overcome this, there is a particular transcription factor AIRE(Autoimmune regulator transcription factor) which switches on expression oftissue-restricted antigens in the thymus",hierarchyLevel:6,children:[],index:"000902040301"}],index:"0009020403"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0009020404"}],index:"00090204"}],index:"000902"},{text:" Peripheral Tolerance",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Tolerance that is not occurring in the primary lymphoid organsbut in the periphery where the cells are matured",hierarchyLevel:5,children:[],index:"0009030000"}],index:"00090300"},{text:" Purpose",hierarchyLevel:4,children:[{text:" Deals with any self-reactive lymphocytes that escape centraltolerance",hierarchyLevel:5,children:[],index:"0009030100"}],index:"00090301"},{text:" Locations",hierarchyLevel:4,children:[{text:" Lymph nodes",hierarchyLevel:5,children:[],index:"0009030200"},{text:" Spleen",hierarchyLevel:5,children:[],index:"0009030201"},{text:" Mucosal and cutaneous lymphoid tissues",hierarchyLevel:5,children:[],index:"0009030202"}],index:"00090302"},{text:" Types",hierarchyLevel:4,children:[{text:" Cell intrinsic mechanisms  cell controls its own behavior",hierarchyLevel:5,children:[],index:"0009030300"},{text:" Cell extrinsic mechanisms  another cell is controlling theself-reactivity",hierarchyLevel:5,children:[],index:"0009030301"}],index:"00090303"},{text:" Cell Intrinsic Mechanism",hierarchyLevel:4,children:[{text:" Components",hierarchyLevel:5,children:[{text:" Ignorance ",hierarchyLevel:6,children:[],index:"000903040000"},{text:" Anergy",hierarchyLevel:6,children:[],index:"000903040001"},{text:" Apoptosis",hierarchyLevel:6,children:[],index:"000903040002"}],index:"0009030400"},{text:" Ignorance",hierarchyLevel:5,children:[{text:" Self-reactive T cells that are allowed to exist in the immunesystem ",hierarchyLevel:6,children:[],index:"000903040100"},{text:" If they dont meet the self-antigen they recognize, auto immunedisease is not activated.",hierarchyLevel:6,children:[],index:"000903040101"},{text:" There are immune privilege sites where the immune system cannotaccess. Hence these antigens are protected by the immune system and will beprotected from attack by self-reactive T cells",hierarchyLevel:6,children:[],index:"000903040102"}],index:"0009030401"},{text:" Anergy - antigen specific unresponsiveness",hierarchyLevel:5,children:[{text:" For the T cell to be fully activated, it requires the TCR to beengaged and other co-stimulatory receptors (CD28).",hierarchyLevel:6,children:[],index:"000903040200"},{text:" If there is a self-antigen presented by a resting antigenpresenting cell, the antigen presenting cell will not express co-stimulatoryligands. Therefore, without the co-stimulatory ligands, the T cells will not beactivated.",hierarchyLevel:6,children:[],index:"000903040201"},{text:" This results in anergy.",hierarchyLevel:6,children:[],index:"000903040202"},{text:" However, when there is a microbe in the system, the microbe willactivate the antigen presenting cell (by ligating toll-like receptors), theantigen presenting cell gets excited and expresses the B7 co-stimulatory ligandwhich binds to CD28. This results in successful activation of T cells.",hierarchyLevel:6,children:[],index:"000903040203"},{text:" This results in T cell proliferation and differentiation andproduction of cytokines.",hierarchyLevel:6,children:[],index:"000903040204"}],index:"0009030402"},{text:" Apoptosis",hierarchyLevel:5,children:[{text:" When the T cell sees a self-antigen on an antigen presentingcell, the cell will undergo apoptosis (can also become anergic)",hierarchyLevel:6,children:[],index:"000903040300"}],index:"0009030403"}],index:"00090304"},{text:" Cell Extrinsic Tolerance - Regulatory T cells",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Specialize in suppressing unwanted immune responses",hierarchyLevel:6,children:[],index:"000903050000"}],index:"0009030500"},{text:" oMechanism of Development",hierarchyLevel:5,children:[{text:" Develop in the thymus (mainly) and in the periphery (some)",hierarchyLevel:6,children:[],index:"000903050100"},{text:" Express CD25 which is a receptor for cytokine IL-2, henceenabling the growth of Tregs",hierarchyLevel:6,children:[],index:"000903050101"},{text:" Express the transcription factor Foxp3, which is the mastertranscription factor for regulatory T cells",hierarchyLevel:6,children:[],index:"000903050102"}],index:"0009030501"},{text:" Mechanism of Action",hierarchyLevel:5,children:[{text:" Secrete inhibitory cytokines (IL-10, TGF\u03b2  transforminggrowth factor)",hierarchyLevel:6,children:[],index:"000903050200"},{text:" Express regulatory protein CTLA-4 to modify the phenotype ofantigen presenting cells  CTLA-4 binds to the co-stimulatory ligands toactivate T cells)",hierarchyLevel:6,children:[{text:" CTLA-4 can bind to the ligands (B7 ligands), block the ligands orcompletely remove the ligands. This prevents B7 ligands from binding to CD28and activating the T cell",hierarchyLevel:7,children:[],index:"00090305020100"}],index:"000903050201"},{text:" Express CD25 which has a high affinity for IL-2 which is a growthfactor for T cells",hierarchyLevel:6,children:[{text:" This enables the mopping up of IL-2 from the environment,preventing T cells from using IL-2 as a growth factor",hierarchyLevel:7,children:[],index:"00090305020200"}],index:"000903050202"}],index:"0009030502"},{text:" Importance",hierarchyLevel:5,children:[{text:" Evidence in Mice",hierarchyLevel:6,children:[{text:" Mice that fail to express Tregs (due to failure of expressingtranscription factor FoxP3) have a hyperactivated immune system, with massivelymph nodes",hierarchyLevel:7,children:[],index:"00090305030000"},{text:" This causes the T cells to be all activated and not regulated,resulting in the T cells infiltrating tissues, causing lethal autoimmunity(death 4 weeks post birth)",hierarchyLevel:7,children:[],index:"00090305030001"}],index:"000903050300"},{text:" Evidence in Humans",hierarchyLevel:6,children:[{text:" Humans that have mutations in the FoxP3 gene, have IPEX (immunedysregulation polyendocrinopathy enteropathy X-linked syndrome)",hierarchyLevel:7,children:[],index:"00090305030100"},{text:" They have very aggressive autoimmunity and early death within afew month of birth",hierarchyLevel:7,children:[],index:"00090305030101"},{text:" 80% of individuals with IPEX have Type I Diabetes with otherconditions (IBD, allergy)",hierarchyLevel:7,children:[],index:"00090305030102"}],index:"000903050301"}],index:"0009030503"}],index:"00090305"},{text:" Importance",hierarchyLevel:4,children:[{text:" Helper T cells controls the behaviour of many other cell types inthe immune system",hierarchyLevel:5,children:[{text:" Cytotoxic T cells",hierarchyLevel:6,children:[],index:"000903060000"},{text:" Activate macrophages",hierarchyLevel:6,children:[],index:"000903060001"},{text:" Provide specific help to B cells",hierarchyLevel:6,children:[],index:"000903060002"}],index:"0009030600"},{text:" Hence, it is critical to control the activation of the helper Tcells, due to the numerous downstream effects",hierarchyLevel:5,children:[],index:"0009030601"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0009030602"}],index:"00090306"}],index:"000903"}],index:"0009"},{text:" [037] Autoimmunity",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Challenge of the Immune System",hierarchyLevel:4,children:[{text:" Respond to infectious agents but to respond to self-tissue",hierarchyLevel:5,children:[],index:"0010000000"}],index:"00100000"},{text:" Types of Autoimmune diseases",hierarchyLevel:4,children:[],index:"00100001"},{text:" Immunological Tolerance",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Avoid the development of autoimmunity by tolerating self-antigens",hierarchyLevel:6,children:[],index:"001000020000"}],index:"0010000200"},{text:" Properties",hierarchyLevel:5,children:[{text:" Loss of immunological tolerance causes autoimmunity",hierarchyLevel:6,children:[],index:"001000020100"}],index:"0010000201"},{text:" Types",hierarchyLevel:5,children:[{text:" Central tolerance",hierarchyLevel:6,children:[{text:" Thymus attempts to remove self-reactive T cells duringdevelopment. However, central tolerance is incomplete and fails to remove allself-reactive T cells during development. Some self-reactive T cells reachmaturity and exit the thymus and enter the peripheral repertoire. Peripheraltolerance takes care of escaping T cells.",hierarchyLevel:7,children:[],index:"00100002020000"}],index:"001000020200"},{text:" Peripheral tolerance",hierarchyLevel:6,children:[{text:" Prevents potentially dangerous T cells from the Thymus from doingharm (essential)",hierarchyLevel:7,children:[],index:"00100002020100"}],index:"001000020201"}],index:"0010000202"},{text:" Components",hierarchyLevel:5,children:[{text:" Tregs (Regulatory T cells)",hierarchyLevel:6,children:[],index:"001000020300"}],index:"0010000203"}],index:"00100002"},{text:" Tregs (Regulatory T cells)",hierarchyLevel:4,children:[{text:" Purpose\ufffd\ufffd\ufffd\ufffd\ufffd ",hierarchyLevel:5,children:[{text:" Express the transcription factor FoxP3 and have immunoregulatoryproperties",hierarchyLevel:6,children:[],index:"001000030000"},{text:" Essential to prevent autoimmune disease",hierarchyLevel:6,children:[],index:"001000030001"}],index:"0010000300"},{text:" Evidence Mice",hierarchyLevel:5,children:[{text:" Mice that fail to express Tregs (due to failure of expressingtranscription factor FoxP3) have a hyperactivated immune system, with massivelymph nodes",hierarchyLevel:6,children:[],index:"001000030100"},{text:" This causes the T cells to be all activated and not regulated,resulting in the T cells infiltrating tissues, causing lethal autoimmunity(death 4 weeks post birth)",hierarchyLevel:6,children:[],index:"001000030101"}],index:"0010000301"},{text:" Evidence Humans",hierarchyLevel:5,children:[{text:" Humans that have mutations in the FoxP3 gene, have IPEX (immunedysregulation polyendocrinopathy enteropathy X-linked syndrome)",hierarchyLevel:6,children:[],index:"001000030200"},{text:" They have very aggressive autoimmunity and early death within afew month of birth",hierarchyLevel:6,children:[],index:"001000030201"},{text:" 80% of individuals with IPEX have Type I Diabetes with otherconditions (IBD, allergy)",hierarchyLevel:6,children:[],index:"001000030202"}],index:"0010000302"}],index:"00100003"}],index:"001000"},{text:" Factors leading to Autoimmune disease",hierarchyLevel:3,children:[{text:" Genetic susceptibility",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Autoimmune disease frequently runs in family",hierarchyLevel:6,children:[],index:"001001000000"},{text:" Low concordance rates between twins   showing other factors atplay",hierarchyLevel:6,children:[],index:"001001000001"}],index:"0010010000"},{text:" MHC",hierarchyLevel:5,children:[{text:" Mechanism",hierarchyLevel:6,children:[{text:" MHC genes control what T cells can recognize",hierarchyLevel:7,children:[],index:"00100100010000"},{text:" Depending on the MHC molecules the individual have, it controlswhat self-proteins can be presented and hence recognized by the T cell andinitiating an immune response",hierarchyLevel:7,children:[],index:"00100100010001"}],index:"001001000100"},{text:" Examples",hierarchyLevel:6,children:[],index:"001001000101"}],index:"0010010001"},{text:" Variants in Genes",hierarchyLevel:5,children:[{text:" Mechanism ",hierarchyLevel:6,children:[{text:" Variant and polymorphism control the function of the gene and cancontribute to the susceptibility to autoimmunity",hierarchyLevel:7,children:[],index:"00100100020000"},{text:" Protein CTLA4 / CD25 are expressed on regulatory T cells. PTPN22expressed on T cells and controls T cell activation. Different people can havedifferent version of the genes, and some people may have stronger T cellactivation than another person, causing that person to be more likely todevelop autoimmunity if the right MHC is in-place to present the self-antigen",hierarchyLevel:7,children:[],index:"00100100020001"},{text:" People with heterozygous CTLA-4 deficiency have Tregs thatexpresses low levels of CTLA-4. Hence the Tregs are not able to use theregulatory protein to illicit suppression and control the immune system. Thiscauses disease such as arthritis, type I diabetes, gastric issues, autoimmuneantibodies",hierarchyLevel:7,children:[],index:"00100100020002"}],index:"001001000200"},{text:" Examples ",hierarchyLevel:6,children:[],index:"001001000201"}],index:"0010010002"}],index:"00100100"},{text:" Environmental influences",hierarchyLevel:4,children:[{text:" Examples",hierarchyLevel:5,children:[{text:" Infection",hierarchyLevel:6,children:[],index:"001001010000"},{text:" Sunlight  exacerbate Systemic lupus erythematosus (SLE)",hierarchyLevel:6,children:[],index:"001001010001"},{text:" Diet",hierarchyLevel:6,children:[],index:"001001010002"},{text:" Microbiome",hierarchyLevel:6,children:[],index:"001001010003"},{text:" Obesity",hierarchyLevel:6,children:[],index:"001001010004"},{text:" Stress",hierarchyLevel:6,children:[],index:"001001010005"},{text:" Drugs",hierarchyLevel:6,children:[],index:"001001010006"}],index:"0010010100"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Self-tolerance",hierarchyLevel:6,children:[{text:" T cells are exposed to antigens presented by antigen presentingcells. When self-antigen is presented by a resting antigen presenting cell, Tcells will become tolerized to that antigen, causing allergy or deletes itself.",hierarchyLevel:7,children:[],index:"00100101010000"}],index:"001001010100"},{text:" Autoimmunity",hierarchyLevel:6,children:[{text:" If there are microbes present, the microbes activate the antigen presentingcell. The antigen presenting cell upregulate the co-stimulatory ligand B7 whichprovides the co-stimulatory signals through CD28 which then causes theactivation of T cell. This activated self-reactive T cells cause autoimmunity",hierarchyLevel:7,children:[],index:"00100101010100"}],index:"001001010101"},{text:" Molecular Mimicry",hierarchyLevel:6,children:[{text:" Microbes may possess a ligand which is quite similar to aself-antigen. This results in activation of a T cell with a TCR that cancross-react with a self-antigen in the peripheral tissue. ",hierarchyLevel:7,children:[],index:"00100101010200"}],index:"001001010102"}],index:"0010010101"}],index:"00100101"},{text:" Gender",hierarchyLevel:4,children:[{text:" Autoimmune diseases are more common in women than in men",hierarchyLevel:5,children:[],index:"0010010200"}],index:"00100102"},{text:" Failed regulation",hierarchyLevel:4,children:[],index:"00100103"}],index:"001001"},{text:" Autoantibodies Mechanisms of Autoimmunity",hierarchyLevel:3,children:[{text:" Acting as Antagonists: Blocking of a receptor",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Antibodies against acetylcholine receptor binds to theacetylcholine recptor and prevents the acetylcholine receptor from binding it. ",hierarchyLevel:6,children:[],index:"001002000000"},{text:" This results in the nerve being unable to communicate with themuscle, leading to skeletal muscle weakness. ",hierarchyLevel:6,children:[],index:"001002000001"},{text:" When this happens in the face, it leads to drooping eyelids andproblems with chewing and swallowing. ",hierarchyLevel:6,children:[],index:"001002000002"}],index:"0010020000"},{text:" Example",hierarchyLevel:5,children:[{text:" Myasthenia gravis",hierarchyLevel:6,children:[],index:"001002000100"}],index:"0010020001"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0010020002"}],index:"00100200"},{text:" Acting as Agonists: Stimulating the receptor (Type VHypersensitivity)",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Autoantibodies against the thyroid stimulating hormone (TSH)receptor binds to the TSH receptor, triggering signals through it.",hierarchyLevel:6,children:[],index:"001002010000"},{text:" This causes the release of thyroid hormones in a dysregulatedway, leading to symptoms such as bulging eyes",hierarchyLevel:6,children:[],index:"001002010001"}],index:"0010020100"},{text:" Example",hierarchyLevel:5,children:[{text:" Thyroid stimulating hormone receptor",hierarchyLevel:6,children:[],index:"001002010100"}],index:"0010020101"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0010020102"}],index:"00100201"},{text:" Depleting cells  Opsonization of Host Cells and removing them(Type II Hypersensitivity)",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" The autoantibody binds to its target host cell, causingphagocytes with the Fc Receptors to bind to the Fc region of the antibodies. ",hierarchyLevel:6,children:[],index:"001002020000"},{text:" This stimulates the phagocytes to engulf, ingest and destroy thehost cell by phagocytosis",hierarchyLevel:6,children:[],index:"001002020001"}],index:"0010020200"},{text:" Examples",hierarchyLevel:5,children:[{text:" Platelets removed / targeted  autoimmune thrombocytopenia",hierarchyLevel:6,children:[],index:"001002020100"},{text:" Erythrocytes removed / targeted  autoimmune haemolytic anaemia",hierarchyLevel:6,children:[],index:"001002020101"},{text:" Neutrophils removed / targeted  autoimmune neutropenia",hierarchyLevel:6,children:[],index:"001002020102"}],index:"0010020201"}],index:"00100202"}],index:"001002"},{text:" T-cell mediated Mechanisms of Autoimmunity",hierarchyLevel:3,children:[{text:" Example",hierarchyLevel:4,children:[{text:" Multiple Scelerosis",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" T cell driven attack of the central nervous system",hierarchyLevel:7,children:[],index:"00100300000000"}],index:"001003000000"},{text:" Mechanism\ufffd ",hierarchyLevel:6,children:[{text:" CD4 T cells infiltrate CNS, activate macrophages and B cells",hierarchyLevel:7,children:[],index:"00100300000100"},{text:" This give rise to the destruction of the myelin sheathe, leadingto slower nerve conduction",hierarchyLevel:7,children:[],index:"00100300000101"}],index:"001003000001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"001003000002"}],index:"0010030000"},{text:" Type I Diabetes",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" T cell driven attack of insulin-producing pancreatic beta cellsin the islet of Langerhans",hierarchyLevel:7,children:[],index:"00100300010000"}],index:"001003000100"},{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"00100300010100"}],index:"001003000101"}],index:"0010030001"},{text:" Systemic Lupus Erythematosus",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Autoantibodies against nuclear components",hierarchyLevel:7,children:[],index:"00100300020000"}],index:"001003000200"},{text:" Mechanism (Type III Hypersensitivity)",hierarchyLevel:6,children:[{text:" Antibody binding to the antigen forming an immune complex",hierarchyLevel:7,children:[],index:"00100300020100"},{text:" This immune complex can lodge in vessels and skin and causedamage",hierarchyLevel:7,children:[],index:"00100300020101"},{text:" There are defects in complement system leading to the failure ofthe clearance of dead cells. These dead cells and its components can be exposedto the immune system. This results in the development of an immune responseagaisnt intracellular compounds (which are normally protected from beingdetected by the immune system)",hierarchyLevel:7,children:[],index:"00100300020102"}],index:"001003000201"},{text:" Diagram (Symptoms)",hierarchyLevel:6,children:[],index:"001003000202"}],index:"0010030002"}],index:"00100300"}],index:"001003"},{text:" Treatment",hierarchyLevel:3,children:[{text:" Anti-cytokine antibodies",hierarchyLevel:4,children:[{text:" Anti-TNF in rheumatoid arthritis",hierarchyLevel:5,children:[],index:"0010040000"},{text:" Anti-IL-17 in psoriasis",hierarchyLevel:5,children:[],index:"0010040001"}],index:"00100400"},{text:" Therapies that target T cell activation",hierarchyLevel:4,children:[{text:" CTLA-4-Ig  inhibits T cell activation by blocking co-stimulation",hierarchyLevel:5,children:[],index:"0010040100"}],index:"00100401"},{text:" Cellular depletion therapies",hierarchyLevel:4,children:[{text:" B cell depletion in multiple sclerosis",hierarchyLevel:5,children:[],index:"0010040200"}],index:"00100402"}],index:"001004"}],index:"0010"},{text:" [041] How microbes avoid the immune system",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Factors affecting Immune System Strength",hierarchyLevel:4,children:[{text:" Weaken: Immunosuppression",hierarchyLevel:5,children:[],index:"0011000000"},{text:" Strengthen: Vaccines",hierarchyLevel:5,children:[],index:"0011000001"}],index:"00110000"},{text:" Overview ",hierarchyLevel:4,children:[{text:" Infectious agents can evade every step of the immune system",hierarchyLevel:5,children:[],index:"0011000100"}],index:"00110001"},{text:" Strategies of the Immune System",hierarchyLevel:4,children:[{text:" Evasion of Immune System",hierarchyLevel:5,children:[{text:" Passive  Hide from the immune system",hierarchyLevel:6,children:[],index:"001100020000"},{text:" Active  Change the exterior appearance of pathogen",hierarchyLevel:6,children:[],index:"001100020001"}],index:"0011000200"},{text:" Suppression of Immune System",hierarchyLevel:5,children:[],index:"0011000201"}],index:"00110002"}],index:"001100"},{text:" Innate Immunity Evasion",hierarchyLevel:3,children:[{text:" 3 main functions of Complement",hierarchyLevel:4,children:[{text:" Opsonization",hierarchyLevel:5,children:[],index:"0011010000"},{text:" Lysis",hierarchyLevel:5,children:[],index:"0011010001"},{text:" Inflammation  immune effector recruitment / activation",hierarchyLevel:5,children:[],index:"0011010002"}],index:"00110100"},{text:" Strategies to Disable Complement System",hierarchyLevel:4,children:[{text:" Cause failure in activation of complement system (Entire)",hierarchyLevel:5,children:[],index:"0011010100"},{text:" Accelerate the breakdown of complement proteins (Entire)",hierarchyLevel:5,children:[],index:"0011010101"},{text:" Block Membrane Attack Complex (C9) (Lysis)",hierarchyLevel:5,children:[],index:"0011010102"},{text:" Neutralizes cytokines / interferons (Inflammation)",hierarchyLevel:5,children:[],index:"0011010103"}],index:"00110101"},{text:" Neutralization cytokines / interferons",hierarchyLevel:4,children:[{text:" Mechanism of Disease",hierarchyLevel:5,children:[{text:" Virus produces a viral interferon binding protein",hierarchyLevel:6,children:[],index:"001101020000"},{text:" Viral interferon (IFN) binding protein binds to the interferon",hierarchyLevel:6,children:[],index:"001101020001"},{text:" This causes the interferon to be unable to bind to the interferonreceptor on the immune cells",hierarchyLevel:6,children:[],index:"001101020002"},{text:" Hence, the signal to induce the antiviral state in cells is notactivated and virus are able to replicate easily to neighbouring cells",hierarchyLevel:6,children:[],index:"001101020003"}],index:"0011010200"},{text:" Mechanism of Treatment",hierarchyLevel:5,children:[{text:" Antibody binds to the viral IFN binding protein",hierarchyLevel:6,children:[],index:"001101020100"},{text:" This prevents the interferon from being blocked by the viralinterferon binding protein. ",hierarchyLevel:6,children:[],index:"001101020101"},{text:" Interferon is able to bind to the interferon receptor and henceable to trigger an antiviral state in the cell",hierarchyLevel:6,children:[],index:"001101020102"}],index:"0011010201"}],index:"00110102"},{text:" Avoiding Phagocytosis",hierarchyLevel:4,children:[{text:" Mechanism - Capsule",hierarchyLevel:5,children:[{text:" Use a capsule",hierarchyLevel:6,children:[],index:"001101030000"}],index:"0011010300"},{text:" Mechanism  Active ",hierarchyLevel:5,children:[{text:" Yersinia pestis contains a plasmid which encodes for aninjectisome",hierarchyLevel:6,children:[],index:"001101030100"},{text:" The plasmids also encode for Yop proteins",hierarchyLevel:6,children:[],index:"001101030101"},{text:" The injectisome injects Yop proteins through the plasma membraneof the phagocyte",hierarchyLevel:6,children:[],index:"001101030102"},{text:" Yop proteins enter the phagocyte and paralyzes the actinfilaments in the intracellular exoskeleton",hierarchyLevel:6,children:[],index:"001101030103"},{text:" This prevents the phagocyte from carrying out phagocytosis.",hierarchyLevel:6,children:[],index:"001101030104"},{text:" The phagocyte now becomes a safe haven for the bacteria",hierarchyLevel:6,children:[],index:"001101030105"},{text:" This results in Bubonic plague",hierarchyLevel:6,children:[],index:"001101030106"}],index:"0011010301"},{text:" Mechanism  dot/icm system",hierarchyLevel:5,children:[{text:" Dot/icm  defect in organelle trafficking / intracellularmultiplication",hierarchyLevel:6,children:[],index:"001101030200"},{text:" Legionella pneumophila allows itself to be phagocytosed",hierarchyLevel:6,children:[],index:"001101030201"},{text:" The pathogen then inject proteins into the cytoplasm through thephagosome to prevent the fusing of the lysosome with the phagosome",hierarchyLevel:6,children:[],index:"001101030202"},{text:" The pathogen can then replicate within the phagosome which iswithin the macrophage",hierarchyLevel:6,children:[],index:"001101030203"}],index:"0011010302"}],index:"00110103"},{text:" Blocking antibody induction of phagocytosis via Fc receptors(Opsionisation)",hierarchyLevel:4,children:[{text:" Mechanism - Bacteria",hierarchyLevel:5,children:[{text:" Staphylococcus aureus produces Protein A which binds to the Fcregion on phagocytes",hierarchyLevel:6,children:[],index:"001101040000"},{text:" This prevents the antibody from binding to the Fc region andhence prevents the induction of phagocytosis",hierarchyLevel:6,children:[],index:"001101040001"}],index:"0011010400"},{text:" Mechanism  Virus ",hierarchyLevel:5,children:[{text:" Herpes simplex virus produces Fc receptors on glycoprotein complex",hierarchyLevel:6,children:[],index:"001101040100"},{text:" The variable region of the antibody binds to the antigen on thesurface of the virus",hierarchyLevel:6,children:[],index:"001101040101"},{text:" The constant region (Fc) binds to the Fc receptor on the virus",hierarchyLevel:6,children:[],index:"001101040102"},{text:" This forms a bipolar bridge which results in the sequestering ofthe antibody, hence preventing macrophages from binding to the Fc region",hierarchyLevel:6,children:[],index:"001101040103"}],index:"0011010401"}],index:"00110104"}],index:"001101"},{text:" Adaptive Immunity Evasion",hierarchyLevel:3,children:[{text:" Overall Strategy",hierarchyLevel:4,children:[{text:" Viruses become latent in the body, with maintenance of genomebefore the disease reoccurs",hierarchyLevel:5,children:[],index:"0011020000"}],index:"00110200"},{text:" Immune Evasion by Antigenic Change",hierarchyLevel:4,children:[{text:" Background",hierarchyLevel:5,children:[{text:" Trypanosoma brucei contains 1600 distant variant surfaceglycoprotein (vsg) genes",hierarchyLevel:6,children:[],index:"001102010000"},{text:" The variant surface glycoproteins allows itself to be bound byantibodies",hierarchyLevel:6,children:[],index:"001102010001"},{text:" Only one glycoprotein is expressed by a single cell",hierarchyLevel:6,children:[],index:"001102010002"}],index:"0011020100"},{text:" Mechanism  VSG",hierarchyLevel:5,children:[{text:" Initially, all invading trypanosome brucei contains the samevariant surface glycoprotein",hierarchyLevel:6,children:[],index:"001102010100"},{text:" As the host immune system starts to produce antibodies againstthat particular variant surface glycoprotein, one pathogen switches to anothervariant surface glycoprotein and escapes the immune system",hierarchyLevel:6,children:[],index:"001102010101"},{text:" The evading pathogen then multiplies to form a new population ",hierarchyLevel:6,children:[],index:"001102010102"},{text:" Cycle repeats",hierarchyLevel:6,children:[],index:"001102010103"}],index:"0011020101"},{text:" Mechanism  Influenza (Antigenic Drift)",hierarchyLevel:5,children:[{text:" Haemagglutinin is the receptors which binds to the sialic acidand enables the cell to enter the host",hierarchyLevel:6,children:[],index:"001102010200"},{text:" Haemagglutinin is also the major target of neutralizingantibodies.",hierarchyLevel:6,children:[],index:"001102010201"},{text:" Small changes in the amino acid sequence of haemagglutinin cancause the inability of neutralizing antibodies to bind to hemagglutinin,causing them to be ineffective",hierarchyLevel:6,children:[],index:"001102010202"}],index:"0011020102"},{text:" Mechanism  Influenza (Antigenic Shift)",hierarchyLevel:5,children:[{text:" The genome of influenza is segmented (8 segments) and eachsegments coded by a single gene",hierarchyLevel:6,children:[],index:"001102010300"},{text:" When two influenza viruses infect a cell at the same time, itresults in reassortment, where the viruses exiting the cell have a mix of genesegments from one influenza virus and some gene segments from the otherinfluenza virus",hierarchyLevel:6,children:[],index:"001102010301"},{text:" The reassortment of gene segments may lead to the expression of anew type of hemagglutinin protein which has not seen by the target (human)population, and hence the population does not have immunity against it",hierarchyLevel:6,children:[],index:"001102010302"},{text:" Bird influenza can combine with human influenza to produce a verypowerful influenza possible of creating a pandemic",hierarchyLevel:6,children:[],index:"001102010303"}],index:"0011020103"},{text:" Immune Memory in Antigenic Shift and Drift",hierarchyLevel:5,children:[{text:" Combination of hemagglutinin that is similar to the ones from along time ago will be less effective against old people who have developedimmunity against them",hierarchyLevel:6,children:[],index:"001102010400"}],index:"0011020104"}],index:"00110201"},{text:" Immune Evasion by Persistent Infection",hierarchyLevel:4,children:[{text:" Goal",hierarchyLevel:5,children:[{text:" Must stay within the human body for a long time and evade theimmune system by itself, rather than relying on a population",hierarchyLevel:6,children:[],index:"001102020000"}],index:"0011020200"},{text:" Overview",hierarchyLevel:5,children:[{text:" HIV is targeted by antibodies (which binds to gp120 envelopeprotein on the surface )",hierarchyLevel:6,children:[],index:"001102020100"},{text:" HIV is targeted by T cells (CTL) which targets Gag capsid proteininside the virus",hierarchyLevel:6,children:[],index:"001102020101"}],index:"0011020201"},{text:" Strategy",hierarchyLevel:5,children:[{text:" Virus evades the immune system by rapid accumulation of geneticchange",hierarchyLevel:6,children:[],index:"001102020200"}],index:"0011020202"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Patient becomes infected with HIV",hierarchyLevel:6,children:[],index:"001102020300"},{text:" Over time, mutation on the protein accumulates and the proteinchanges",hierarchyLevel:6,children:[],index:"001102020301"},{text:" Every time HIV changes its proteins, the effectiveness of theneutralization by the immune system using antibodies becomes less effective",hierarchyLevel:6,children:[],index:"001102020302"},{text:" This shows that the virus is mutating faster than the body canproduce new antibodies. The immune system will produce new antibodies withrespect to the virus. However, by the time the new antibodies are produced, thevirus has changed its protein structure",hierarchyLevel:6,children:[],index:"001102020303"}],index:"0011020203"},{text:" Mechanism  Glycan shield",hierarchyLevel:5,children:[{text:" HIV envelope is protected by a glycan shield (heavilyglycosylated with glycosyl sugars) which shield the HIV from antibody recognition",hierarchyLevel:6,children:[],index:"001102020400"},{text:" The glycan shield can change in response to the changes to the peptidesequence",hierarchyLevel:6,children:[],index:"001102020401"},{text:" Hence, this makes it difficult to produce a vaccine for HIV",hierarchyLevel:6,children:[],index:"001102020402"}],index:"0011020204"}],index:"00110202"},{text:" Active suppression of adaptive immunity  T cell responses",hierarchyLevel:4,children:[{text:" Mechanism  suppression of antigen presentation",hierarchyLevel:5,children:[{text:" HSV ICP47 binds to TAP and blocks the flow of peptides into theendoplasmic reticulum, resulting in no peptide being presented on MHC",hierarchyLevel:6,children:[],index:"001102030000"},{text:" E3/19Kprotein binds to MHC class I, preventing peptides frombeing loaded onto the MHC, resulting in no peptide being presented on MHC, andprevents the MHC from exiting the endoplasmic reticulum",hierarchyLevel:6,children:[],index:"001102030001"},{text:" E3/19K binds to region of the MHC which is conserved among allthe different alleles of MHC, enabling it to bind to any MHC/HLA type. E3/19Kbinding site is far away from the peptide binding site, and hence thevariability of the peptide binding site would not affect the binding ability ofE3/19K",hierarchyLevel:6,children:[],index:"001102030002"}],index:"0011020300"},{text:" Overview of Mechanisms",hierarchyLevel:5,children:[],index:"0011020301"}],index:"00110203"}],index:"001102"}],index:"0011"},{text:" [042] Emerging Infectious Diseases",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definition of Emerging Infectious Diseases",hierarchyLevel:4,children:[{text:" A disease that has recently appeared within a population",hierarchyLevel:5,children:[],index:"0012000000"},{text:" A disease with increasing incidence or range",hierarchyLevel:5,children:[],index:"0012000001"},{text:" A disease with incidence or range that is likely to increase soon",hierarchyLevel:5,children:[],index:"0012000002"}],index:"00120000"},{text:" Primers of an Emerging Infectious Disease",hierarchyLevel:4,children:[{text:" A recognized infection spreading to new areas or populations",hierarchyLevel:5,children:[],index:"0012000100"},{text:" A known disease because associated with an infectious agent",hierarchyLevel:5,children:[],index:"0012000101"},{text:" A new infectious agent is introduced",hierarchyLevel:5,children:[],index:"0012000102"},{text:" A change in an existing infectious agent makes it more infectious",hierarchyLevel:5,children:[],index:"0012000103"},{text:" Re-emergence of an old infection through drug resistance orpublic health failure",hierarchyLevel:5,children:[],index:"0012000104"},{text:" Infectious agents get transferred from other animals to humans",hierarchyLevel:5,children:[],index:"0012000105"}],index:"00120001"},{text:" Environmental Primers of Emerging Infectious Diseases",hierarchyLevel:4,children:[{text:" Global",hierarchyLevel:5,children:[{text:" Population mobility",hierarchyLevel:6,children:[],index:"001200020000"},{text:" Climate",hierarchyLevel:6,children:[],index:"001200020001"},{text:" Urbanization",hierarchyLevel:6,children:[],index:"001200020002"},{text:" Human habits",hierarchyLevel:6,children:[],index:"001200020003"},{text:" War ",hierarchyLevel:6,children:[],index:"001200020004"},{text:" Poverty",hierarchyLevel:6,children:[],index:"001200020005"}],index:"0012000200"},{text:" Local",hierarchyLevel:5,children:[{text:" Immune suppression",hierarchyLevel:6,children:[],index:"001200020100"},{text:" Vaccines",hierarchyLevel:6,children:[],index:"001200020101"},{text:" Bioterror",hierarchyLevel:6,children:[],index:"001200020102"},{text:" Drugs",hierarchyLevel:6,children:[],index:"001200020103"}],index:"0012000201"}],index:"00120002"}],index:"001200"},{text:" Requirements for Successful Spread",hierarchyLevel:3,children:[{text:" Requirements for a successful infectious disease",hierarchyLevel:4,children:[{text:" Establish productive infection  evading host immune system",hierarchyLevel:5,children:[],index:"0012010000"},{text:" Secure onwards transmission",hierarchyLevel:5,children:[],index:"0012010001"}],index:"00120100"},{text:" Establish Productive Infection",hierarchyLevel:4,children:[{text:" Able to evade the new host immune system (when moving from animalto human)",hierarchyLevel:5,children:[],index:"0012010100"},{text:" Able to acquire mechanisms to infect cells of the new host",hierarchyLevel:5,children:[],index:"0012010101"}],index:"00120101"},{text:" Secure onwards transmission",hierarchyLevel:4,children:[{text:" HIV",hierarchyLevel:5,children:[{text:" Hemagglutinin binds to sialic acid for virus to enter",hierarchyLevel:6,children:[],index:"001201020000"},{text:" Neuraminidase is the enzyme breaking down sialic acid (neuraminicacid) to enable progeny virus release",hierarchyLevel:6,children:[],index:"001201020001"},{text:" Without neuraminidase the viral progeny will stick to sialic acidon the way out, and will not be able to infect other host cells",hierarchyLevel:6,children:[],index:"001201020002"}],index:"0012010200"},{text:" Virus-Host Adaptations",hierarchyLevel:5,children:[{text:" Viral Adaptation  Virulence Balance of Successful VirusTransmission",hierarchyLevel:6,children:[{text:" High virulence virus kills the host before transmission",hierarchyLevel:7,children:[],index:"00120102010000"},{text:" Low virulence strains dont produce enough viral load to betransmitted",hierarchyLevel:7,children:[],index:"00120102010001"},{text:" A middle group is the most successful",hierarchyLevel:7,children:[],index:"00120102010002"}],index:"001201020100"},{text:" Host Adaptation  Evolution in Rabbits ",hierarchyLevel:6,children:[{text:" The more cycles of infection the rabbits have gone through, thehigher the survival rate when infected with the original virus",hierarchyLevel:7,children:[],index:"00120102010100"}],index:"001201020101"},{text:" Scientific Methodology",hierarchyLevel:6,children:[{text:" Principle",hierarchyLevel:7,children:[{text:" Cannot simply measure death rate, must keep variables constant tohave an accurate picture of host and viral adaptation",hierarchyLevel:8,children:[],index:"0012010201020000"}],index:"00120102010200"},{text:" Virulence Measuring",hierarchyLevel:7,children:[{text:" Same rabbit population (nave)",hierarchyLevel:8,children:[],index:"0012010201020100"},{text:" Different strains of virus",hierarchyLevel:8,children:[],index:"0012010201020101"},{text:" Measure death rate",hierarchyLevel:8,children:[],index:"0012010201020102"}],index:"00120102010201"},{text:" Host Adaptation Measuring",hierarchyLevel:7,children:[{text:" Same strain of virus",hierarchyLevel:8,children:[],index:"0012010201020200"},{text:" Different rabbit populations (exposed / unexposed)",hierarchyLevel:8,children:[],index:"0012010201020201"},{text:" Measure death rate",hierarchyLevel:8,children:[],index:"0012010201020202"}],index:"00120102010202"}],index:"001201020102"}],index:"0012010201"}],index:"00120102"}],index:"001201"},{text:" Climate Change and Infectious Diseases",hierarchyLevel:3,children:[{text:" Deforestation increases contact with human and host species,hence increasing chance of zoonotic infections",hierarchyLevel:4,children:[],index:"00120200"},{text:" Global warming results in longer transmission season for vectors,and hence vectors will broaden their range of operation, increase its spread",hierarchyLevel:4,children:[],index:"00120201"}],index:"001202"}],index:"0012"}]},{text:"Pathology",hierarchyLevel:1,children:[{text:" [016] Inflammation",hierarchyLevel:2,children:[{text:" Learning Objectives",hierarchyLevel:3,children:[{text:" Define inflammation",hierarchyLevel:4,children:[],index:"01000000"},{text:" Name at least two causes of infectious and non-infectiousinflammation",hierarchyLevel:4,children:[],index:"01000001"},{text:" Classify acute inflammation according to morphology",hierarchyLevel:4,children:[],index:"01000002"},{text:" Explain the pathogenesis of acute inflammation (the five stagesof acute inflammation)",hierarchyLevel:4,children:[],index:"01000003"},{text:" Enumerate the main morphological components of chronicinflammation",hierarchyLevel:4,children:[],index:"01000004"},{text:" Define granulomatous inflammation and give two causes ofgranuloma formation",hierarchyLevel:4,children:[],index:"01000005"}],index:"010000"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definition of Inflammation",hierarchyLevel:4,children:[{text:" The biological response of immune system of living organism todifferent types of injury",hierarchyLevel:5,children:[],index:"0100010000"}],index:"01000100"},{text:" Sources of Injury",hierarchyLevel:4,children:[{text:" Infections",hierarchyLevel:5,children:[{text:" Bacteria",hierarchyLevel:6,children:[],index:"010001010000"},{text:" Viruses",hierarchyLevel:6,children:[],index:"010001010001"},{text:" Parasites",hierarchyLevel:6,children:[],index:"010001010002"},{text:" Fungi",hierarchyLevel:6,children:[],index:"010001010003"}],index:"0100010100"},{text:" Non-infectious",hierarchyLevel:5,children:[{text:" Physical injury",hierarchyLevel:6,children:[],index:"010001010100"},{text:" Chemical injury",hierarchyLevel:6,children:[],index:"010001010101"},{text:" Abnormal / injured cells",hierarchyLevel:6,children:[],index:"010001010102"}],index:"0100010101"}],index:"01000101"},{text:" Benefits of Inflammation",hierarchyLevel:4,children:[{text:" Good Inflammation",hierarchyLevel:5,children:[{text:" Temporary alternation of normal cell and tissue function enablesthe restoration of homeostasis",hierarchyLevel:6,children:[],index:"010001020000"}],index:"0100010200"},{text:" Harmful Inflammation",hierarchyLevel:5,children:[{text:" Too high levels of inflammatory response or in the wrong placeleads to tissue damage",hierarchyLevel:6,children:[],index:"010001020100"}],index:"0100010201"}],index:"01000102"},{text:" Types of Inflammation",hierarchyLevel:4,children:[{text:" Acute Inflammation",hierarchyLevel:5,children:[],index:"0100010300"},{text:" Chronic Inflammation",hierarchyLevel:5,children:[],index:"0100010301"}],index:"01000103"}],index:"010001"},{text:" Acute Inflammation",hierarchyLevel:3,children:[{text:" General Stuff",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Fast response  develops within minutes / hours of infection ortissue damage",hierarchyLevel:6,children:[],index:"010002000000"},{text:" Long lasting  lasts for hours / days",hierarchyLevel:6,children:[],index:"010002000001"}],index:"0100020000"},{text:" Key Components",hierarchyLevel:5,children:[{text:" Blood vessels",hierarchyLevel:6,children:[{text:" During inflammation, blood vessels dilate, increasing the permeabilityat the site of injury",hierarchyLevel:7,children:[],index:"01000200010000"},{text:" This results in extravasation of fluid, inflammatory proteins andleucocytes, leading to oedema (fluid build up)",hierarchyLevel:7,children:[],index:"01000200010001"}],index:"010002000100"},{text:" Predominant leucocytes",hierarchyLevel:6,children:[{text:" Neutrophils (polymorphonuclear leukocytes)",hierarchyLevel:7,children:[],index:"01000200010100"}],index:"010002000101"}],index:"0100020001"},{text:" Mediators",hierarchyLevel:5,children:[{text:" Produced by injured cells or derived from plasma proteins",hierarchyLevel:6,children:[],index:"010002000200"}],index:"0100020002"},{text:" Goal / Purpose",hierarchyLevel:5,children:[{text:" Tissue Repair",hierarchyLevel:6,children:[],index:"010002000300"}],index:"0100020003"},{text:" Alternative (Goal Failure)",hierarchyLevel:5,children:[{text:" Chronic Inflammation",hierarchyLevel:6,children:[],index:"010002000400"}],index:"0100020004"}],index:"01000200"},{text:" Stages of Acute Inflammation",hierarchyLevel:4,children:[{text:" Step 1: Recognition",hierarchyLevel:5,children:[{text:" Host cells contains Pattern Recognition Receptors that detectforeign pathogens",hierarchyLevel:6,children:[],index:"010002010000"},{text:" Cell damage sensors detect damage that occurs on the cell",hierarchyLevel:6,children:[],index:"010002010001"}],index:"0100020100"},{text:" Step 2: Recruitment",hierarchyLevel:5,children:[{text:" Blood vessels dilate, causing blood flow to slow. ",hierarchyLevel:6,children:[],index:"010002010100"},{text:" The space between the endothelial cells is increased and thepermeability of the vessel increases. ",hierarchyLevel:6,children:[],index:"010002010101"},{text:" This enables fluids, plasma proteins and neutrophils to move outof the blood vessels and into the site of injury in the extravascular space(edema) ",hierarchyLevel:6,children:[],index:"010002010102"}],index:"0100020101"},{text:" Step 3: Destruction of the damaging Element",hierarchyLevel:5,children:[{text:" Neutrophils phagocytize pathogens and secrete toxic substances tokill the pathogen. However, the toxic substances can also damage the host cellssurrounding the pathogen. This leads to liquefactive necrosis.",hierarchyLevel:6,children:[],index:"010002010200"},{text:" Once, the damaging element is destroyed, the inflammation willsubside",hierarchyLevel:6,children:[],index:"010002010201"}],index:"0100020102"},{text:" Step 4: Inflammation subsides",hierarchyLevel:5,children:[{text:" The blood vessels decrease in vascular permeability, hencestopping neutrophilic infiltration into the extravascular space",hierarchyLevel:6,children:[],index:"010002010300"},{text:" The remaining neutrophils undergo apoptosis (physiologicalapoptosis) or are eliminated by the macrophages",hierarchyLevel:6,children:[],index:"010002010301"}],index:"0100020103"}],index:"01000201"},{text:" Morphological types of Acute Inflammation",hierarchyLevel:4,children:[{text:" General Properties",hierarchyLevel:5,children:[{text:" Morphological types of acute inflammation can co-exist",hierarchyLevel:6,children:[],index:"010002020000"},{text:" Tissues can transform from one type of inflammation to another",hierarchyLevel:6,children:[],index:"010002020001"}],index:"0100020200"},{text:" Serous Inflammation (eg. blister) - serum",hierarchyLevel:5,children:[{text:" Serous fluid is produced the mesothelial cells",hierarchyLevel:6,children:[],index:"010002020100"},{text:" Serous fluid is derived from the blood plasma",hierarchyLevel:6,children:[],index:"010002020101"},{text:" Serous fluid accumulates in cavities created by the injury",hierarchyLevel:6,children:[],index:"010002020102"},{text:" Serous fluid accumulates in cell-lined body cavities (effusions)",hierarchyLevel:6,children:[],index:"010002020103"}],index:"0100020201"},{text:" Fibrinous Inflammation (common in mesothelial lined cavities)",hierarchyLevel:5,children:[{text:" Severe increase in vascular permeability allow fibrin to exit theblood vessel",hierarchyLevel:6,children:[],index:"010002020200"},{text:" Fibrin will be converted into fibrous tissue and lead to scarring",hierarchyLevel:6,children:[],index:"010002020201"},{text:" If too much fibrin is released, fibrin will be broken downthrough the process of fibrinolysis",hierarchyLevel:6,children:[],index:"010002020202"}],index:"0100020202"},{text:" Purulent / Suppurative Inflammation",hierarchyLevel:5,children:[{text:" Pus formation is initiated from an infection from a pyogenic (pusproducing) bacteria like staphylococci",hierarchyLevel:6,children:[],index:"010002020300"},{text:" Pus is formed from liquefactive tissue necrosis",hierarchyLevel:6,children:[],index:"010002020301"},{text:" Pus is formed from neutrophils",hierarchyLevel:6,children:[],index:"010002020302"},{text:" Pus is formed from oedema",hierarchyLevel:6,children:[],index:"010002020303"}],index:"0100020203"},{text:" Ulcerative Inflammation (eg. gastric ulcers)",hierarchyLevel:5,children:[{text:" Inflammation occurs at the surface of the organ, resulting intissue necrosis",hierarchyLevel:6,children:[],index:"010002020400"},{text:" Necrotic tissue is shed from the surface of the organ, resultingin the formation of a local defect",hierarchyLevel:6,children:[],index:"010002020401"}],index:"0100020204"}],index:"01000202"}],index:"010002"},{text:" Chronic Inflammation",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Chronic inflammation is a response of the living tissue tochronic injury (injury of increased duration)",hierarchyLevel:5,children:[],index:"0100030000"}],index:"01000300"},{text:" Chronic Inflammation vs Acute Inflammation",hierarchyLevel:4,children:[],index:"01000301"},{text:" Causes",hierarchyLevel:4,children:[{text:" Persistent / untreated infections",hierarchyLevel:5,children:[],index:"0100030200"},{text:" Pathogens (mycobacteria)  difficult to eradicate and invokesdelayed-type IV hyper-sensitivity",hierarchyLevel:5,children:[],index:"0100030201"},{text:" Prolonged exposure to injurious agents (internal / external)",hierarchyLevel:5,children:[],index:"0100030202"},{text:" Hypersensitivity  inappropriate activation of the immune system,leading to excessive reaction against external or self-antigens) [allergicreactions, inflammatory bowel disease, rheumatoid arthritis (autoimmune)]",hierarchyLevel:5,children:[],index:"0100030203"}],index:"01000302"},{text:" Morphological Changes in Chronic Inflammation",hierarchyLevel:4,children:[{text:" Presence of Mononuclear cells",hierarchyLevel:5,children:[{text:" Macrophages (histiocytes) and plasma cells (BASIC)",hierarchyLevel:6,children:[],index:"010003030000"},{text:" Eosinophils, mast cells (Allergies / Parasitic Infections)",hierarchyLevel:6,children:[],index:"010003030001"},{text:" Neutrophils",hierarchyLevel:6,children:[{text:" Occur when infective agent persists within the body",hierarchyLevel:7,children:[],index:"01000303000200"},{text:" Occur when mediators produced by macrophages / t-cells persists",hierarchyLevel:7,children:[],index:"01000303000201"},{text:" These fuel neutrophilic infiltrate",hierarchyLevel:7,children:[],index:"01000303000202"}],index:"010003030002"}],index:"0100030300"},{text:" Tissue Injury",hierarchyLevel:5,children:[{text:" Caused by injurious agent or inflammatory cells",hierarchyLevel:6,children:[],index:"010003030100"}],index:"0100030301"},{text:" Healing attempts",hierarchyLevel:5,children:[{text:" Replacement of injury tissue with connective tissue (angiogenesisand fibrosis plays a role)",hierarchyLevel:6,children:[],index:"010003030200"}],index:"0100030302"}],index:"01000303"},{text:" Granulomatous inflammation",hierarchyLevel:4,children:[{text:" Cause - Immune Granuloma",hierarchyLevel:5,children:[{text:" The sustained and prolonged activation of T lymphocytes leads tothe formation of a granuloma",hierarchyLevel:6,children:[],index:"010003040000"}],index:"0100030400"},{text:" Cause  Foreign body Granuloma",hierarchyLevel:5,children:[{text:" When the infective agent cannot be removed or eliminated, theimmune system reacts by surrounding the infective agent will be surrounded by agranuloma",hierarchyLevel:6,children:[],index:"010003040100"},{text:" Macrophage takes in the bacteria by phagocytosis (bacteria doesnot have an anti-phagocytosis coat). The bacteria are resistant to themacrophage pathogen killing mechanisms in the cytoplasm. ",hierarchyLevel:6,children:[],index:"010003040101"},{text:" The immune system reacts by forming a region of low oxygenconcentration at the location of the macrophage, hoping to kill the bacteria.This reaction leads to the formation of the granuloma.",hierarchyLevel:6,children:[],index:"010003040102"}],index:"0100030401"},{text:" Example",hierarchyLevel:5,children:[{text:" Mycobacterium tuberculosis (immune granuloma)",hierarchyLevel:6,children:[],index:"010003040200"},{text:" Treponema pallidum  syphilis",hierarchyLevel:6,children:[],index:"010003040201"},{text:" Mycobacterium leprae  leprosy",hierarchyLevel:6,children:[],index:"010003040202"},{text:" Bartonella henselae  cat-scratch disease",hierarchyLevel:6,children:[],index:"010003040203"},{text:" Fungi",hierarchyLevel:6,children:[],index:"010003040204"}],index:"0100030402"},{text:" Structure",hierarchyLevel:5,children:[{text:" Epithelioid cells",hierarchyLevel:6,children:[{text:" Macrophages (histiocytes) found in a granuloma have granularcytoplasm and indistinct cell borders",hierarchyLevel:7,children:[],index:"01000304030000"}],index:"010003040300"},{text:" Langerhans giant cells",hierarchyLevel:6,children:[{text:" Macrophages fuse together forming large (40-50\u03bcm) giantcells that contain multiple nuclei",hierarchyLevel:7,children:[],index:"01000304030100"}],index:"010003040301"},{text:" Rim of Lymphocytes",hierarchyLevel:6,children:[],index:"010003040302"},{text:" Rim of Fibrous Tissue (older granulomas)",hierarchyLevel:6,children:[],index:"010003040303"},{text:" Central Necrosis",hierarchyLevel:6,children:[{text:" Occurs in granulomas associated with Mycobacterium tuberculosis(caseous granulomas / caseous necrosis)",hierarchyLevel:7,children:[],index:"01000304030400"}],index:"010003040304"}],index:"0100030403"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0100030404"}],index:"01000304"},{text:" Outcomes of chronic inflammation",hierarchyLevel:4,children:[{text:" Path 1: Infectious agent is eliminated",hierarchyLevel:5,children:[{text:" Inflammation subsides and tissue repair occurs. Tissue repair canbe complete, leaving nothing behind. However, if tissue destruction is toolarge for adequate healing, the body repairs by scarring, producing fibrin tothe area. This results in dystrophic calcification to be seen",hierarchyLevel:6,children:[],index:"010003050000"}],index:"0100030500"},{text:" Path 2: Infectious agent persists",hierarchyLevel:5,children:[{text:" This leads to the escalation of chronic inflammation (progressivechronic inflammation). The organism will try to limit damage, but may lead toeventual organ disfunction",hierarchyLevel:6,children:[],index:"010003050100"}],index:"0100030501"}],index:"01000305"},{text:" Abrupt Definitions",hierarchyLevel:4,children:[{text:" Mesothelial cell-lined body cavities",hierarchyLevel:5,children:[{text:" Two thin layers of cells with a fluid separating the layers",hierarchyLevel:6,children:[],index:"010003060000"},{text:" Peritoneum, pleura, pericardium",hierarchyLevel:6,children:[],index:"010003060001"}],index:"0100030600"},{text:" Effusions",hierarchyLevel:5,children:[{text:" Accumulation of fluids in the cavities",hierarchyLevel:6,children:[],index:"010003060100"}],index:"0100030601"},{text:" Edema",hierarchyLevel:5,children:[{text:" Accumulation of fluids in the tissue, between the cells",hierarchyLevel:6,children:[],index:"010003060200"}],index:"0100030602"},{text:" -itis",hierarchyLevel:5,children:[{text:" Inflammation",hierarchyLevel:6,children:[],index:"010003060300"}],index:"0100030603"},{text:" Peri-",hierarchyLevel:5,children:[{text:" Around",hierarchyLevel:6,children:[],index:"010003060400"}],index:"0100030604"},{text:" -card-",hierarchyLevel:5,children:[{text:" Heart",hierarchyLevel:6,children:[],index:"010003060500"}],index:"0100030605"},{text:" Angiogenesis",hierarchyLevel:5,children:[{text:" Formation of new blood vessels",hierarchyLevel:6,children:[],index:"010003060600"}],index:"0100030606"}],index:"01000306"}],index:"010003"}],index:"0100"},{text:" [017] Cancer",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Telomeres  short, repeated units of DNA which prevent celldivision when it becomes too short",hierarchyLevel:5,children:[],index:"0101000000"},{text:" Telomerase  keeps telomeres long in cells that need tocontinuously divide (stem cells)",hierarchyLevel:5,children:[],index:"0101000001"}],index:"01010000"}],index:"010100"},{text:" Regulatory Genes",hierarchyLevel:3,children:[{text:" Classes of Normal Regulatory Genes",hierarchyLevel:4,children:[{text:" Proto-oncogenes",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Promote cellular growth",hierarchyLevel:7,children:[],index:"01010100000000"}],index:"010101000000"},{text:" Application",hierarchyLevel:6,children:[{text:" Switched on in angiogenesis",hierarchyLevel:7,children:[],index:"01010100000100"}],index:"010101000001"}],index:"0101010000"},{text:" Tumor suppressor genes (RB, P53)",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Inhibit cellular growth",hierarchyLevel:7,children:[],index:"01010100010000"}],index:"010101000100"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Form a network of checkpoints which prevent uncontrolled growth",hierarchyLevel:7,children:[],index:"01010100010100"},{text:" Toxic stress from any source, which may lead to the abnormal expressionof proliferating signals in normal cells",hierarchyLevel:7,children:[],index:"01010100010101"},{text:" The tumour suppressor gene recognises the abnormal expression andresponds by temporarily arresting the G1 phase, or permanent arrest of the cellcycle.",hierarchyLevel:7,children:[],index:"01010100010102"},{text:" This prevents the cell from experiencing uncontrolled celldivision",hierarchyLevel:7,children:[],index:"01010100010103"}],index:"010101000101"},{text:" Example",hierarchyLevel:6,children:[{text:" RB",hierarchyLevel:7,children:[],index:"01010100010200"},{text:" P53",hierarchyLevel:7,children:[],index:"01010100010201"}],index:"010101000102"}],index:"0101010001"},{text:" Apoptosis genes",hierarchyLevel:5,children:[{text:" Application",hierarchyLevel:6,children:[{text:" Induced when the tumour suppressor genes fails to prevent thepassing of cell cycle checkpoints after the cell has encountered DNA damage",hierarchyLevel:7,children:[],index:"01010100020000"}],index:"010101000200"}],index:"0101010002"},{text:" Genes involved in DNA repair",hierarchyLevel:5,children:[],index:"0101010003"}],index:"01010100"},{text:" Types of Regulatory Genes",hierarchyLevel:4,children:[{text:" Gatekeepers",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Regulate cell proliferation",hierarchyLevel:7,children:[],index:"01010101000000"},{text:" Act as guards to prevent cells from passing through cell cyclecheckpoints",hierarchyLevel:7,children:[],index:"01010101000001"},{text:" Trigger apoptosis",hierarchyLevel:7,children:[],index:"01010101000002"}],index:"010101010000"}],index:"0101010100"},{text:" Caretakers",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Maintain and protect the integrity of the genome",hierarchyLevel:7,children:[],index:"01010101010000"},{text:" Involved in DNA repair and prevent accumulation of mutations",hierarchyLevel:7,children:[],index:"01010101010001"},{text:" Carries out DNA base excision repair, prevents pathologicchromosomal rearrangement, mismatch repair, telomere maintenance",hierarchyLevel:7,children:[],index:"01010101010002"}],index:"010101010100"}],index:"0101010101"}],index:"01010101"},{text:" Other Limiting Factors of Cell Division - Sensitivity of Signalof Neighbouring Cells",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" A cell within in a compact tissue will only divide when the spacepermits",hierarchyLevel:6,children:[],index:"010101020000"},{text:" Epithelial cells are anchored to the basal membrane and tosurrounding cells. Therefore, they are able to detect whether there areadjacent cells beside them.",hierarchyLevel:6,children:[],index:"010101020001"},{text:" If they are adjacent cells beside them, they will not be able togrow.",hierarchyLevel:6,children:[],index:"010101020002"},{text:" This ensures that the tissue architecture is preserved andensures that tissue function is preserved",hierarchyLevel:6,children:[],index:"010101020003"}],index:"0101010200"}],index:"01010102"}],index:"010101"},{text:" Neoplasia",hierarchyLevel:3,children:[{text:" Cellular Injury Agents",hierarchyLevel:4,children:[{text:" Mechanisms",hierarchyLevel:5,children:[{text:" Mutations on DNA, causes change of protein, which causes failureof generator of transcription factors, which affects expression of other genes",hierarchyLevel:6,children:[],index:"010102000000"},{text:" This causes failure of production of promoters and silencers,which affects the expression of other genes",hierarchyLevel:6,children:[],index:"010102000001"}],index:"0101020000"},{text:" Physical Agents",hierarchyLevel:5,children:[{text:" Extreme temperatures",hierarchyLevel:6,children:[],index:"010102000100"},{text:" Electromagnetic radiations (x-rays and gamma rays_",hierarchyLevel:6,children:[],index:"010102000101"},{text:" Corpuscular radiations (alpha and beta particles)",hierarchyLevel:6,children:[],index:"010102000102"},{text:" Mechanical traumas",hierarchyLevel:6,children:[],index:"010102000103"}],index:"0101020001"},{text:" Chemical Agents",hierarchyLevel:5,children:[{text:" Alkylating agents",hierarchyLevel:6,children:[],index:"010102000200"},{text:" Aromatic amines",hierarchyLevel:6,children:[],index:"010102000201"},{text:" Polycyclic hydrocarbons",hierarchyLevel:6,children:[],index:"010102000202"}],index:"0101020002"},{text:" Microbial agents",hierarchyLevel:5,children:[{text:" Helicobacter pylori",hierarchyLevel:6,children:[],index:"010102000300"},{text:" Human Papillomavirus",hierarchyLevel:6,children:[],index:"010102000301"},{text:" Human T-cell Leukemia Virus Type 1 (HTLV-1)",hierarchyLevel:6,children:[],index:"010102000302"},{text:" Hepatitis B Virus (HBV)",hierarchyLevel:6,children:[],index:"010102000303"},{text:" Hepatitis C Virus (HCV)",hierarchyLevel:6,children:[],index:"010102000304"},{text:" Epstein-Barr Virus (EBV)",hierarchyLevel:6,children:[],index:"010102000305"}],index:"0101020003"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0101020004"}],index:"01010200"},{text:" Generation of Neoplastic Cells (Neoplasm)",hierarchyLevel:4,children:[{text:" Nomenclature of Benign Tumours",hierarchyLevel:5,children:[{text:" {{ tissue of origin }} + -oma",hierarchyLevel:6,children:[],index:"010102010000"}],index:"0101020100"},{text:" Definitions of Neoplasm / Neoplasia",hierarchyLevel:5,children:[{text:" A disorder of cell growth that is triggered by a series ofacquired mutations that affect a single cell and its clonal progeny",hierarchyLevel:6,children:[],index:"010102010100"},{text:" An abnormal mass of tissue, which has a growth that exceeds thenormal tissues and is uncoordinated. This uncoordinated growth persists in evenwith the cessation of stimuli",hierarchyLevel:6,children:[],index:"010102010101"}],index:"0101020101"},{text:" Mechanism of Neoplasm",hierarchyLevel:5,children:[{text:" Injurious agents hurt the protection mechanisms at cell cyclecheckpoints",hierarchyLevel:6,children:[],index:"010102010200"},{text:" This causes apoptosis to not be triggered even with cellularinjury, resulting in the formation of transformed neoplastic cells.",hierarchyLevel:6,children:[],index:"010102010201"}],index:"0101020102"},{text:" Properties of Transformed Neoplastic Cells",hierarchyLevel:5,children:[{text:" Proliferate independent of adjacent cell anchorage",hierarchyLevel:6,children:[],index:"010102010300"},{text:" Proliferate independent of adjacent cell contact",hierarchyLevel:6,children:[],index:"010102010301"},{text:" Grows in an unlimited and chaotic fashion, on top of each other",hierarchyLevel:6,children:[],index:"010102010302"},{text:" Proliferate in the absence of growth and survival factors",hierarchyLevel:6,children:[],index:"010102010303"},{text:" Develops into benign tumours",hierarchyLevel:6,children:[],index:"010102010304"}],index:"0101020103"},{text:" Components of Neoplasm",hierarchyLevel:5,children:[{text:" Parenchyma  neoplastic cells",hierarchyLevel:6,children:[],index:"010102010400"},{text:" Stroma  connective tissue with blood vessels and inflammatorycells, mostly macrophages and lymphocytes",hierarchyLevel:6,children:[],index:"010102010401"}],index:"0101020104"},{text:" Compounds Involved in Transformation",hierarchyLevel:5,children:[{text:" Initiators",hierarchyLevel:6,children:[{text:" Substances that create a heritable change in DNA, leading toneoplastic growth",hierarchyLevel:7,children:[],index:"01010201050000"}],index:"010102010500"},{text:" Promoters",hierarchyLevel:6,children:[{text:" Substances that can induce cell division, typically derived fromcellular products",hierarchyLevel:7,children:[],index:"01010201050100"}],index:"010102010501"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010102010502"}],index:"0101020105"}],index:"01010201"},{text:" Definitions",hierarchyLevel:4,children:[{text:" Tumours / Neoplasm",hierarchyLevel:5,children:[{text:" Tumour is any swelling or mass caused by abnormal growth",hierarchyLevel:6,children:[],index:"010102020000"}],index:"0101020200"},{text:" Benign Tumour",hierarchyLevel:5,children:[{text:" A mass that has a slower growth rate, does not invadeneighbouring tissues and hence does not spread to distant parts of the body",hierarchyLevel:6,children:[],index:"010102020100"}],index:"0101020201"},{text:" Malignant Tumour / Cancer",hierarchyLevel:5,children:[{text:" A mass that has the ability to invade and destroy adjacentstructure and spread to other sites",hierarchyLevel:6,children:[],index:"010102020200"}],index:"0101020202"},{text:" Carcinogenesis (Oncogenesis)",hierarchyLevel:5,children:[{text:" The transformation of normal cells into cancer cells, through acomplex multistep process influenced by external (environmental) and internal(genetic) factors",hierarchyLevel:6,children:[],index:"010102020300"}],index:"0101020203"},{text:" Epidemiology",hierarchyLevel:5,children:[{text:" The study of the distribution determinants and causes and riskfactors of health-related state of events in a specified population",hierarchyLevel:6,children:[],index:"010102020400"}],index:"0101020204"},{text:" Dysplasia",hierarchyLevel:5,children:[{text:" The presence of atypical cells within a tissue, with loss of celluniformity and disorganised architecture",hierarchyLevel:6,children:[],index:"010102020500"}],index:"0101020205"}],index:"01010202"}],index:"010102"},{text:" Malignant Neoplasm (Cancer)",hierarchyLevel:3,children:[{text:" Prevalence",hierarchyLevel:4,children:[{text:" Leading cause of death worldwide",hierarchyLevel:5,children:[],index:"0101030000"}],index:"01010300"},{text:" Risk Factors",hierarchyLevel:4,children:[{text:" Environmental Factors (modifiable)",hierarchyLevel:5,children:[{text:" Tobacco use",hierarchyLevel:6,children:[],index:"010103010000"},{text:" Obesity",hierarchyLevel:6,children:[],index:"010103010001"},{text:" Diet",hierarchyLevel:6,children:[],index:"010103010002"},{text:" Lack of Physical activity",hierarchyLevel:6,children:[],index:"010103010003"},{text:" Alcohol",hierarchyLevel:6,children:[],index:"010103010004"},{text:" Infections  HPV, Hepatitis",hierarchyLevel:6,children:[],index:"010103010005"},{text:" Radiation",hierarchyLevel:6,children:[],index:"010103010006"},{text:" Pollution ",hierarchyLevel:6,children:[],index:"010103010007"},{text:" Indoor smoke from solid fuels",hierarchyLevel:6,children:[],index:"010103010008"}],index:"0101030100"},{text:" Acquired Predisposing Conditions",hierarchyLevel:5,children:[{text:" Chronic Inflammation  increase the pool of tissue stem cells,ROS generation",hierarchyLevel:6,children:[],index:"010103010100"},{text:" Precursor lesions  do not progress to cancer, but are correlated",hierarchyLevel:6,children:[],index:"010103010101"},{text:" Immunodeficiency",hierarchyLevel:6,children:[],index:"010103010102"}],index:"0101030101"},{text:" Age",hierarchyLevel:5,children:[{text:" Accumulation of somatic mutations",hierarchyLevel:6,children:[],index:"010103010200"},{text:" Decline in immunocompetence",hierarchyLevel:6,children:[],index:"010103010201"}],index:"0101030102"},{text:" Genetic Predisposition",hierarchyLevel:5,children:[{text:" Inherit traits from parents",hierarchyLevel:6,children:[],index:"010103010300"},{text:" Interaction between genetic and nongentic factors",hierarchyLevel:6,children:[],index:"010103010301"}],index:"0101030103"}],index:"01010301"},{text:" Process of Carcinogenesis",hierarchyLevel:4,children:[{text:" Initiation  Initiators create a heritable change in DNA",hierarchyLevel:5,children:[],index:"0101030200"},{text:" Promotion  Promotors induce cell division",hierarchyLevel:5,children:[],index:"0101030201"},{text:" Progression  further genetic and phenotypic changes leads tosubsequent tumour growth and further spread",hierarchyLevel:5,children:[],index:"0101030202"}],index:"01010302"},{text:" Process of Carcinogenesis (Detailed)",hierarchyLevel:4,children:[{text:" A mutation on the tumour suppressor gene of the normal mucosacells is acquired or from germline",hierarchyLevel:5,children:[],index:"0101030300"},{text:" This single mutation is not enough to cause transformation butcauses the tissue to be at higher risk of other mutations and transformation",hierarchyLevel:5,children:[],index:"0101030301"},{text:" A second round of mutation occurs on the second copy (homologous)of the tumour suppressor gene, resulting in the inactivation of normal alleleby methylation abnormalities.",hierarchyLevel:5,children:[],index:"0101030302"},{text:" The disabling of both tumour suppressor genes (bi-allelic loss) resultsin the manifestation of the phenotype with the tumour suppressor gene notexpressing itself. This results in these cells having a survival advantage.This results in the formation of an adenoma. Hence, the process of initiationis complete.",hierarchyLevel:5,children:[],index:"0101030303"},{text:" If the mutations occur at the stem cells with an activetelomerase, this results in the growth advantage (promotion).",hierarchyLevel:5,children:[],index:"0101030304"},{text:" Following which, further genetic alteration occur, with themutation of a proto-oncogene into oncogenes, providing the cell with extragrowth advantage.",hierarchyLevel:5,children:[],index:"0101030305"},{text:" Following which, further genetic alterations occur, with the lossof additional tumour suppressor genes. This results in the cell having sufficientgenetic abnormalities and enough growth and survival advantage (Darwinianselection) to growth without inhibition.",hierarchyLevel:5,children:[],index:"0101030306"},{text:" The cell will then cross through the basal membrane through theprocess of invasion, forming the adenocarcinoma",hierarchyLevel:5,children:[],index:"0101030307"}],index:"01010303"},{text:" Overall Characteristics of Malignant Neoplasm",hierarchyLevel:4,children:[{text:" Transition from well differentiated into poorly differentiatedcells",hierarchyLevel:5,children:[],index:"0101030400"},{text:" Unpredictable growth rate  much faster than benign neoplasm",hierarchyLevel:5,children:[],index:"0101030401"},{text:" Poorly demarcated  invades the surrounding tissue",hierarchyLevel:5,children:[],index:"0101030402"},{text:" Able to metastasize  spread to distant sides",hierarchyLevel:5,children:[],index:"0101030403"}],index:"01010304"},{text:" Morphological Characteristics of Malignant Neoplasm",hierarchyLevel:4,children:[{text:" Cytological atypia  nuclei are large and irregular,multi-nucleated",hierarchyLevel:5,children:[],index:"0101030500"},{text:" Loss of nuclear polarity  nuclei are no longer only found onlower part of the cell, stratified and chaotic",hierarchyLevel:5,children:[],index:"0101030501"},{text:" Back-to-back glands  normal distribution is lost",hierarchyLevel:5,children:[],index:"0101030502"},{text:" Desmoplastic stroma  a dense connective tissue surrounds themalignant glands, an attempt of the organ to limit the invasion of theneoplastic cells",hierarchyLevel:5,children:[],index:"0101030503"},{text:" Necrosis",hierarchyLevel:5,children:[],index:"0101030504"}],index:"01010305"},{text:" Barriers to Spread",hierarchyLevel:4,children:[{text:" Immune responses against it",hierarchyLevel:5,children:[],index:"0101030600"},{text:" Requires nutrients and blood to grow, competition withsurrounding cells",hierarchyLevel:5,children:[],index:"0101030601"}],index:"01010306"},{text:" Properties to enable distance spread of Malignant Neoplasm",hierarchyLevel:4,children:[{text:" Limitless replicative potential",hierarchyLevel:5,children:[],index:"0101030700"},{text:" Ability to invade the basement membrane",hierarchyLevel:5,children:[],index:"0101030701"}],index:"01010307"},{text:" Nomenclature",hierarchyLevel:4,children:[{text:" {{ tissue of origin }} + carcinoma (epithelial)",hierarchyLevel:5,children:[],index:"0101030800"},{text:" {{ tissue of origin }} + sarcoma (mesenchymal)",hierarchyLevel:5,children:[],index:"0101030801"}],index:"01010308"},{text:" Hallmarks of Cancer",hierarchyLevel:4,children:[{text:" Self-sufficiency in growth signals",hierarchyLevel:5,children:[{text:" Oncogenes  gain of function (growth promotion)",hierarchyLevel:6,children:[],index:"010103090000"},{text:" Tumour suppressor genes  loss of function, increase survivaladvantage, insensitivity to growth inhibition",hierarchyLevel:6,children:[],index:"010103090001"}],index:"0101030900"},{text:" Insensitivity to growth-inhibitory signals",hierarchyLevel:5,children:[],index:"0101030901"},{text:" Altered cellular metabolism  high levels of glucose uptake",hierarchyLevel:5,children:[],index:"0101030902"},{text:" Evasion of apoptosis  loss of pro and antiapoptotic proteinsbalance",hierarchyLevel:5,children:[],index:"0101030903"},{text:" Limitless replicative potential  activation of telomerase,tumour suppressor genes",hierarchyLevel:5,children:[],index:"0101030904"},{text:" Sustained angiogenesis  to sustain the new nutritional need",hierarchyLevel:5,children:[],index:"0101030905"},{text:" Ability to invade and metastasize",hierarchyLevel:5,children:[],index:"0101030906"},{text:" Ability to evade the host immune response",hierarchyLevel:5,children:[],index:"0101030907"}],index:"01010309"}],index:"010103"},{text:" Clinical Cases",hierarchyLevel:3,children:[{text:" Slide 0",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0101040000"},{text:" Analysis",hierarchyLevel:5,children:[{text:" Small mass composed of fibrovascular cores lined by squamousepithelium with focal acute inflammation",hierarchyLevel:6,children:[],index:"010104000100"},{text:" No epithelial atypia was identified",hierarchyLevel:6,children:[],index:"010104000101"},{text:" Hence, squamous cell papilloma was identified, showing that it isa benign lesion",hierarchyLevel:6,children:[],index:"010104000102"},{text:" However, a squamous cell lesion could be worsened by HPV, furthergenetic alteration would lead to malignancy. Hence, some doctors may ask forPCR to look for the virus.",hierarchyLevel:6,children:[],index:"010104000103"},{text:" However, the doctor can check for checkpoint proteins too",hierarchyLevel:6,children:[],index:"010104000104"}],index:"0101040001"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0101040002"},{text:" Analysis",hierarchyLevel:5,children:[{text:" HPV upregulates p16 and its products",hierarchyLevel:6,children:[],index:"010104000300"},{text:" P16 acts as a tumour suppressor gene as it slows the progressionof the cell cycle from the G1 phase to the S phase",hierarchyLevel:6,children:[],index:"010104000301"},{text:" Since the protein is not present, the antibody does not bind tothe protein, and hence there Is no enzyme to convert the substrate from whiteto brown",hierarchyLevel:6,children:[],index:"010104000302"},{text:" Since brown  coloration is seen, this shows the presence of theprotein, which ",hierarchyLevel:6,children:[],index:"010104000303"}],index:"0101040003"}],index:"01010400"},{text:" Slide 1",hierarchyLevel:4,children:[{text:" Diagram",hierarchyLevel:5,children:[],index:"0101040100"},{text:" Analysis",hierarchyLevel:5,children:[{text:" Tubular adenoma with low grade dysplasia. No high grade dysplasiaor malignancy identified.",hierarchyLevel:6,children:[],index:"010104010100"},{text:" Hence, lesion is benign.",hierarchyLevel:6,children:[],index:"010104010101"},{text:" Doctor will arrange for lesion to be excised.",hierarchyLevel:6,children:[],index:"010104010102"}],index:"0101040101"}],index:"01010401"},{text:" Slide 2",hierarchyLevel:4,children:[{text:" Diagram 1",hierarchyLevel:5,children:[],index:"0101040200"},{text:" Analysis 1",hierarchyLevel:5,children:[{text:" Shows irregular glandular structures with nuclear atypia",hierarchyLevel:6,children:[],index:"010104020100"},{text:" There is presence of desmoplastic stroma and necrosis",hierarchyLevel:6,children:[],index:"010104020101"},{text:" Focal invasion of lymphatic vessels is noted",hierarchyLevel:6,children:[],index:"010104020102"},{text:" Hence, this is adenocarcinoma",hierarchyLevel:6,children:[],index:"010104020103"}],index:"0101040201"},{text:" Diagram 2",hierarchyLevel:5,children:[],index:"0101040202"},{text:" Analysis 2",hierarchyLevel:5,children:[{text:" When there is no colour, it means that the proteins is notpresent.",hierarchyLevel:6,children:[],index:"010104020300"},{text:" The diagram shows that both the proteins are no present. ",hierarchyLevel:6,children:[],index:"010104020301"},{text:" Need to check if this is epigenetic inactivation ",hierarchyLevel:6,children:[],index:"010104020302"}],index:"0101040203"},{text:" MLH1",hierarchyLevel:5,children:[{text:" Reasons for Loss",hierarchyLevel:6,children:[{text:" Somatic Inactivation of the gene (sporadic promoter methylation)",hierarchyLevel:7,children:[],index:"01010402040000"},{text:" Germline mutation (Lynch syndrome)",hierarchyLevel:7,children:[{text:" Inherited cancer syndrome",hierarchyLevel:8,children:[],index:"0101040204000100"},{text:" Autosomal dominant inheritance",hierarchyLevel:8,children:[],index:"0101040204000101"},{text:" Genetic predisposition to difference cancer types (higher risk),especially colorectal cancer",hierarchyLevel:8,children:[],index:"0101040204000102"}],index:"01010402040001"}],index:"010104020400"}],index:"0101040204"},{text:" Analysis 3",hierarchyLevel:5,children:[{text:" Immunohistochemistry for mismatch repair proteins shows loss ofMLH1",hierarchyLevel:6,children:[],index:"010104020500"},{text:" Methylation analysis does not show MLH1 promotor methylation",hierarchyLevel:6,children:[],index:"010104020501"},{text:" Therefore, genetic testing for Lynch syndrome is recommended",hierarchyLevel:6,children:[],index:"010104020502"}],index:"0101040205"}],index:"01010402"}],index:"010104"}],index:"0101"},{text:" [020] Healing, Repair and Degeneration ",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Define healing, repair and regeneration",hierarchyLevel:4,children:[],index:"01020000"},{text:" Regeneration and repair in skin wounds",hierarchyLevel:4,children:[],index:"01020001"},{text:" Primary intention",hierarchyLevel:4,children:[],index:"01020002"},{text:" Secondary intention",hierarchyLevel:4,children:[],index:"01020003"},{text:" Tertiary intention",hierarchyLevel:4,children:[],index:"01020004"},{text:" Healing of bone fracture",hierarchyLevel:4,children:[],index:"01020005"},{text:" Factors that influence healing",hierarchyLevel:4,children:[],index:"01020006"},{text:" Complications of healing",hierarchyLevel:4,children:[],index:"01020007"}],index:"010200"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Requirements of Homeostasis",hierarchyLevel:4,children:[{text:" Homeostasis",hierarchyLevel:5,children:[{text:" Homeostasis enables the maintenance of organ and tissue size",hierarchyLevel:6,children:[],index:"010201000000"},{text:" This is done through balancing mitogenic signals and growthinhibiting signals",hierarchyLevel:6,children:[],index:"010201000001"},{text:" This ensures that the organ size will be unchanged through thehealing and repair process",hierarchyLevel:6,children:[],index:"010201000002"}],index:"0102010000"}],index:"01020100"},{text:" Cell Types",hierarchyLevel:4,children:[{text:" Labile  skin epithelial cells, bone marrow cells",hierarchyLevel:5,children:[{text:" Constantly in a state of division ",hierarchyLevel:6,children:[],index:"010201010000"}],index:"0102010100"},{text:" Stable  kidney epithelial cells, liver, fibroblasts, smoothmuscle",hierarchyLevel:5,children:[{text:" Low level of replication under normal circumstance",hierarchyLevel:6,children:[],index:"010201010100"},{text:" Undergoes rapid replication under the right stimulus ",hierarchyLevel:6,children:[],index:"010201010101"}],index:"0102010101"},{text:" Permanent cells  neurons, skeletal and cardiac cells",hierarchyLevel:5,children:[{text:" Incapable of mitosis or organized replication",hierarchyLevel:6,children:[],index:"010201010200"}],index:"0102010102"}],index:"01020101"},{text:" Healing",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Replacement of injured cells by parenchymal cells of same type",hierarchyLevel:6,children:[],index:"010201020000"},{text:" Replacement of damage tissue by healthy tissue",hierarchyLevel:6,children:[],index:"010201020001"}],index:"0102010200"},{text:" Example",hierarchyLevel:5,children:[{text:" Skin repairs itself",hierarchyLevel:6,children:[],index:"010201020100"}],index:"0102010201"},{text:" Processes",hierarchyLevel:5,children:[{text:" Regeneration",hierarchyLevel:6,children:[],index:"010201020200"},{text:" Repair",hierarchyLevel:6,children:[],index:"010201020201"}],index:"0102010202"}],index:"01020102"},{text:" Regeneration",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Generate new cells to replace the damaged cells",hierarchyLevel:6,children:[],index:"010201030000"}],index:"0102010300"},{text:" Requirements",hierarchyLevel:5,children:[{text:" Labile and stable cells",hierarchyLevel:6,children:[],index:"010201030100"},{text:" Supporting framework  residual framework, granulation tissue /fibroblasts",hierarchyLevel:6,children:[],index:"010201030101"}],index:"0102010301"},{text:" Types",hierarchyLevel:5,children:[{text:" Pure regeneration (rare)  no wounds or scars left behind",hierarchyLevel:6,children:[],index:"010201030200"},{text:" Regeneration with repair  scars left behind",hierarchyLevel:6,children:[],index:"010201030201"}],index:"0102010302"},{text:" Process",hierarchyLevel:5,children:[{text:" When the supporting framework (containing the basement membrane containing Malpighian layer) is not damaged, the labile and stable cells of theMalpighian layer will regenerate and replace damaged cells on the surface",hierarchyLevel:6,children:[],index:"010201030300"},{text:" Regeneration starts when the stems cells at the edge of the woundstart proliferating. New cells are generated towards to the centre of thelesion.",hierarchyLevel:6,children:[],index:"010201030301"}],index:"0102010303"}],index:"01020103"},{text:" Repair",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Replacement of injured cell by fibrous connective tissue",hierarchyLevel:6,children:[],index:"010201040000"}],index:"0102010400"},{text:" Requirements",hierarchyLevel:5,children:[{text:" Supporting framework of labile / stable / permanent tissue cellsare destroyed",hierarchyLevel:6,children:[],index:"010201040100"}],index:"0102010401"},{text:" Types",hierarchyLevel:5,children:[{text:" Regeneration with repair  scars left behind",hierarchyLevel:6,children:[],index:"010201040200"},{text:" Pure repair  more scars left behind",hierarchyLevel:6,children:[],index:"010201040201"}],index:"0102010402"},{text:" Process",hierarchyLevel:5,children:[{text:" Due to the deeper levels of damage, blood clots and granulationtissue will fill up the defect",hierarchyLevel:6,children:[],index:"010201040300"},{text:" Regeneration of new cells occurs at the edge of the damage, andproliferates towards the centre of the granulation tissue",hierarchyLevel:6,children:[],index:"010201040301"}],index:"0102010403"}],index:"01020104"},{text:" Examples of Tissue Healing",hierarchyLevel:4,children:[{text:" Permanent Cell Population  tissues unable to regenerate andhence only granulation",hierarchyLevel:5,children:[],index:"0102010500"},{text:" Heart",hierarchyLevel:5,children:[{text:" scar formation",hierarchyLevel:6,children:[],index:"010201050100"}],index:"0102010501"},{text:" Brain",hierarchyLevel:5,children:[{text:" Tissue undergoes liquefactive necrosis",hierarchyLevel:6,children:[],index:"010201050200"},{text:" No collagen or fibroblasts in the brain and hence scar tissuecannot form",hierarchyLevel:6,children:[],index:"010201050201"},{text:" As a result, the empty space is filled with cerebral spinal fluid(CSF)",hierarchyLevel:6,children:[],index:"010201050202"}],index:"0102010502"}],index:"01020105"}],index:"010201"},{text:" Wound Healing (Skin)",hierarchyLevel:3,children:[{text:" Diagram",hierarchyLevel:4,children:[],index:"01020200"},{text:" Phases of Would Healing",hierarchyLevel:4,children:[{text:" Haemostasis Phase",hierarchyLevel:5,children:[{text:" Immediately after wound formation, it is important for formstability in blood to support wound healing",hierarchyLevel:6,children:[],index:"010202010000"},{text:" Damaged vessels constrict to slow blood flow",hierarchyLevel:6,children:[],index:"010202010001"},{text:" Platelets stick together and seal the leak",hierarchyLevel:6,children:[],index:"010202010002"},{text:" Coagulation (prothrombin and procoagulants) reinforce theplatelet plug with thrombus",hierarchyLevel:6,children:[],index:"010202010003"}],index:"0102020100"},{text:" Inflammatory Phase",hierarchyLevel:5,children:[{text:" Injured blood vessels leak transudate",hierarchyLevel:6,children:[],index:"010202010100"},{text:" This controls bleed and prevents infections",hierarchyLevel:6,children:[],index:"010202010101"},{text:" Damaged cells, pathogens and bacteria are removed",hierarchyLevel:6,children:[],index:"010202010102"}],index:"0102020101"},{text:" Proliferative Phase",hierarchyLevel:5,children:[{text:" Brief",hierarchyLevel:6,children:[{text:" Rebuilding of wound occurs",hierarchyLevel:7,children:[],index:"01020201020000"},{text:" Angiogensis  blood vessels reforms",hierarchyLevel:7,children:[],index:"01020201020001"},{text:" Connective tissue reforms  migration of fibroblasts and thegeneration of new extracellular matrix",hierarchyLevel:7,children:[],index:"01020201020002"}],index:"010202010200"},{text:" Fibroblasts",hierarchyLevel:6,children:[{text:" Fibroblasts enters and lays down collagen and extracellularmatrix. Fibroblasts secrete growth factors, which helps the formation ofgranulation.",hierarchyLevel:7,children:[],index:"01020201020100"},{text:" The influx of white blood cells and formation of blood vessels,the jelly like clot develops into a granulation tissue.",hierarchyLevel:7,children:[],index:"01020201020101"},{text:" The granulation tissue is more structured and serves as ascaffolding for the healing process",hierarchyLevel:7,children:[],index:"01020201020102"},{text:" The granulation tissue enables cells to move through the wound,into the centre of the wound to start the healing process",hierarchyLevel:7,children:[],index:"01020201020103"},{text:" After laying down collagen, fibroblasts differentiate intomyofibroblasts, which have muscular capacity. ",hierarchyLevel:7,children:[],index:"01020201020104"},{text:" Myofibroblasts then contract, making the wound smaller.",hierarchyLevel:7,children:[],index:"01020201020105"}],index:"010202010201"},{text:" Keratinocytes",hierarchyLevel:6,children:[{text:" Keratinocytes are located over the top and underneath the scab",hierarchyLevel:7,children:[],index:"01020201020200"},{text:" Stimulated keratinocytes start slowly proliferating and migratesfrom the periphery into the centre of the wound under the scab",hierarchyLevel:7,children:[],index:"01020201020201"}],index:"010202010202"}],index:"0102020102"},{text:" Remodelling",hierarchyLevel:5,children:[{text:" Collagen fibres are realigned along the tension lines",hierarchyLevel:6,children:[],index:"010202010300"},{text:" Type III collagen fibres are replaced with Type I collagne fibres",hierarchyLevel:6,children:[],index:"010202010301"},{text:" Cross-linking of collagen fibres occurs",hierarchyLevel:6,children:[],index:"010202010302"},{text:" This enables the strengthening of the granulation tissue",hierarchyLevel:6,children:[],index:"010202010303"}],index:"0102020103"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"010202010400"}],index:"0102020104"}],index:"01020201"},{text:" Control of Healing",hierarchyLevel:4,children:[{text:" Growth factors",hierarchyLevel:5,children:[],index:"0102020200"},{text:" Hormones",hierarchyLevel:5,children:[],index:"0102020201"},{text:" Cell-cell and cell-matrix interactions  contact stimulates asignal to stop proliferation",hierarchyLevel:5,children:[],index:"0102020202"}],index:"01020202"},{text:" Types of Healing",hierarchyLevel:4,children:[{text:" Primary Intention",hierarchyLevel:5,children:[{text:" Appearance",hierarchyLevel:6,children:[{text:" Edges of wound is parallel",hierarchyLevel:7,children:[],index:"01020203000000"}],index:"010202030000"},{text:" Example",hierarchyLevel:6,children:[{text:" Surgical wound",hierarchyLevel:7,children:[],index:"01020203000100"}],index:"010202030001"},{text:" Outcome",hierarchyLevel:6,children:[{text:" Very little scarring",hierarchyLevel:7,children:[],index:"01020203000200"}],index:"010202030002"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010202030003"}],index:"0102020300"},{text:" Secondary intention",hierarchyLevel:5,children:[{text:" Appearance",hierarchyLevel:6,children:[{text:" Edges of the wound is not parallel",hierarchyLevel:7,children:[],index:"01020203010000"}],index:"010202030100"},{text:" Example",hierarchyLevel:6,children:[{text:" Burn",hierarchyLevel:7,children:[],index:"01020203010100"}],index:"010202030101"},{text:" Outcomes",hierarchyLevel:6,children:[{text:" Edges of the wound cannot be put together, resulting in a largecrater filled with blood clot and granulation tissue",hierarchyLevel:7,children:[],index:"01020203010200"}],index:"010202030102"},{text:" Diagram",hierarchyLevel:6,children:[{text:" ",hierarchyLevel:7,children:[],index:"01020203010300"}],index:"010202030103"}],index:"0102020301"},{text:" Tertiary intention",hierarchyLevel:5,children:[{text:" Appearance",hierarchyLevel:6,children:[{text:" Delayed primary closure of the wound results in poor healing",hierarchyLevel:7,children:[],index:"01020203020000"}],index:"010202030200"},{text:" Example",hierarchyLevel:6,children:[{text:" Surgical procedures that require the wound to be opened fromprolonger periods to constantly remove necrotic tissue throughout disease",hierarchyLevel:7,children:[],index:"01020203020100"}],index:"010202030201"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010202030202"}],index:"0102020302"},{text:" Healing of Bone Fracture",hierarchyLevel:5,children:[],index:"0102020303"}],index:"01020203"},{text:" Cells of Wound Healing",hierarchyLevel:4,children:[{text:" Neutrophils",hierarchyLevel:5,children:[{text:" Clear invading microbes",hierarchyLevel:6,children:[],index:"010202040000"},{text:" Produce proteases and reactive oxygen species",hierarchyLevel:6,children:[],index:"010202040001"}],index:"0102020400"},{text:" Lymphocytes",hierarchyLevel:5,children:[{text:" Involved in fibroblast activity",hierarchyLevel:6,children:[],index:"010202040100"},{text:" CD8 T cells are involved in down regulating the healing responseas the wound closes",hierarchyLevel:6,children:[],index:"010202040101"},{text:" T cell depletion results in a weaker wound",hierarchyLevel:6,children:[],index:"010202040102"}],index:"0102020401"},{text:" Macrophages",hierarchyLevel:5,children:[{text:" Early  release cytokines for recruitment",hierarchyLevel:6,children:[],index:"010202040200"},{text:" Resolution  clear cell debris",hierarchyLevel:6,children:[],index:"010202040201"},{text:" Regeneration  stimulates keratinocytes, fibroblasts andangiogenesis, transition into proliferative phase of healing",hierarchyLevel:6,children:[],index:"010202040202"}],index:"0102020402"},{text:" Fibroblasts",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Lay down collagen",hierarchyLevel:7,children:[],index:"01020204030000"},{text:" Produce growth factors which encourage angiogenesis",hierarchyLevel:7,children:[],index:"01020204030001"}],index:"010202040300"},{text:" Production Output",hierarchyLevel:6,children:[{text:" Growth Factors: PDGF, EGF",hierarchyLevel:7,children:[],index:"01020204030100"},{text:" Collagen Type III",hierarchyLevel:7,children:[],index:"01020204030101"},{text:" Collagen Type I",hierarchyLevel:7,children:[],index:"01020204030102"},{text:" Glycoaminoglycan (GAG)",hierarchyLevel:7,children:[],index:"01020204030103"},{text:" Fibronectin",hierarchyLevel:7,children:[],index:"01020204030104"},{text:" Elastin fibres",hierarchyLevel:7,children:[],index:"01020204030105"}],index:"010202040301"},{text:" Properties",hierarchyLevel:6,children:[{text:" Can become myofibroblast",hierarchyLevel:7,children:[],index:"01020204030200"},{text:" Can transition from producing Type III to Type I Collagen",hierarchyLevel:7,children:[],index:"01020204030201"}],index:"010202040302"}],index:"0102020403"}],index:"01020204"}],index:"010202"},{text:" Fractures",hierarchyLevel:3,children:[{text:" Types of Fracture",hierarchyLevel:4,children:[{text:" Complete fracture  bone is completely broken with no linkingparts",hierarchyLevel:5,children:[],index:"0102030000"},{text:" Incomplete fracture  bone is not completely broken with linkingparts",hierarchyLevel:5,children:[],index:"0102030001"},{text:" Closed fracture  skin is intact",hierarchyLevel:5,children:[],index:"0102030002"},{text:" Open fracture  skin is not intact",hierarchyLevel:5,children:[],index:"0102030003"},{text:" Compound fracture  fracture site communicates with skin surface",hierarchyLevel:5,children:[],index:"0102030004"},{text:" Comminuted fracture  bone is splintered",hierarchyLevel:5,children:[],index:"0102030005"},{text:" Displaced fracture  ends of bone at fracture site is not aligned",hierarchyLevel:5,children:[],index:"0102030006"},{text:" Pathological fracture  tumors cause the fracture",hierarchyLevel:5,children:[],index:"0102030007"},{text:" Stress fracture  excessive loads cause the fracture",hierarchyLevel:5,children:[],index:"0102030008"}],index:"01020300"},{text:" Cells involved in Bone Regeneration",hierarchyLevel:4,children:[{text:" Osteoblast",hierarchyLevel:5,children:[{text:" Properties",hierarchyLevel:6,children:[{text:" Single nucleus",hierarchyLevel:7,children:[],index:"01020301000000"}],index:"010203010000"},{text:" Purpose",hierarchyLevel:6,children:[{text:" Synthesis and mineralization of bone",hierarchyLevel:7,children:[],index:"01020301000100"}],index:"010203010001"},{text:" Other cell  osteocyte (a osteoblast trapped inside bone)",hierarchyLevel:6,children:[],index:"010203010002"}],index:"0102030100"},{text:" Osteoclast",hierarchyLevel:5,children:[{text:" Properties",hierarchyLevel:6,children:[{text:" Multinucleated",hierarchyLevel:7,children:[],index:"01020301010000"}],index:"010203010100"},{text:" Purpose\ufffd\ufffd\ufffd\ufffd\ufffd ",hierarchyLevel:6,children:[{text:" Breaks down bone after the bone fracture (macrophage of the bone)",hierarchyLevel:7,children:[],index:"01020301010100"},{text:" Involved in maintenance repair and remodeling",hierarchyLevel:7,children:[],index:"01020301010101"}],index:"010203010101"}],index:"0102030101"}],index:"01020301"},{text:" Process of Bone Healing",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Blood vessels at the bone is ruptured, leading to bleeding",hierarchyLevel:6,children:[],index:"010203020000"},{text:" A blood clot forms and fills the wound gap and surrounds the area",hierarchyLevel:6,children:[],index:"010203020001"},{text:" Neutrophils and macrophages migrate into the site of the woundand phagocytose debris",hierarchyLevel:6,children:[],index:"010203020002"},{text:" Granulation tissue forms",hierarchyLevel:6,children:[],index:"010203020003"},{text:" Cartilage cells from the edge of the wound start proliferating",hierarchyLevel:6,children:[],index:"010203020004"},{text:" Cartilage and granulation tissue fill the wound, forming theprovisional callus (procallus)",hierarchyLevel:6,children:[],index:"010203020005"},{text:" Cartilage begins to calcify",hierarchyLevel:6,children:[],index:"010203020006"},{text:" Osteoblasts begin laying down osteoid, formingfibrocartilaginous callus and then becoming a bony callus. The bony callusis weak as it is composed of woven disorganized bone",hierarchyLevel:6,children:[],index:"010203020007"},{text:" Bony callus remodels through the activity of osteoclasts andosteoblasts, with lamella (organized) bone replacing the woven bone",hierarchyLevel:6,children:[],index:"010203020008"},{text:" As a result, the marrow cavity is restored and the bone strengthreturns to normal. This enables no macroscopic or microscopic evidence ofinjury",hierarchyLevel:6,children:[],index:"010203020009"}],index:"0102030200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0102030201"}],index:"01020302"}],index:"010203"},{text:" Factors and Complications of Wound Healing",hierarchyLevel:3,children:[{text:" Factors affect wound healing",hierarchyLevel:4,children:[{text:" Local Factors",hierarchyLevel:5,children:[{text:" Infection  delays wound healing",hierarchyLevel:6,children:[],index:"010204000000"},{text:" Mechanical factors  early wound movement or constant disruptionin wound healing process",hierarchyLevel:6,children:[],index:"010204000001"},{text:" Foreign material  foreign matter cannot be phagocytized and cancause infection",hierarchyLevel:6,children:[],index:"010204000002"}],index:"0102040000"},{text:" Systemic Factors",hierarchyLevel:5,children:[{text:" Nutrition  Protein / Vitamin C deficiencies",hierarchyLevel:6,children:[],index:"010204000100"},{text:" Diabetes Mellitus  increased risk of infection, poorer overallcell function",hierarchyLevel:6,children:[],index:"010204000101"},{text:" Circulation  atherosclerosis reduces blood flow in blood vessels",hierarchyLevel:6,children:[],index:"010204000102"},{text:" Immunosuppression  reduced or poorly functioning leucocytesaffect wound healing",hierarchyLevel:6,children:[],index:"010204000103"},{text:" Smoking",hierarchyLevel:6,children:[],index:"010204000104"},{text:" Drugs  glucocorticoids",hierarchyLevel:6,children:[],index:"010204000105"},{text:" NSAIDs",hierarchyLevel:6,children:[],index:"010204000106"},{text:" Aspirin",hierarchyLevel:6,children:[],index:"010204000107"},{text:" Chemotherapeutics",hierarchyLevel:6,children:[],index:"010204000108"}],index:"0102040001"}],index:"01020400"},{text:" Complication of Wound Healing",hierarchyLevel:4,children:[{text:" Wound ulceration",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Poor vascularity",hierarchyLevel:7,children:[],index:"01020401000000"}],index:"010204010000"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010204010001"}],index:"0102040100"},{text:" Wound Dehiscence",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Increased pressure on scar (wound being pulled apart)",hierarchyLevel:7,children:[],index:"01020401010000"}],index:"010204010100"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010204010101"}],index:"0102040101"},{text:" Stretching of scar",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Increased pressure on scar",hierarchyLevel:7,children:[],index:"01020401020000"}],index:"010204010200"},{text:" Diagram (heart)",hierarchyLevel:6,children:[],index:"010204010201"}],index:"0102040102"}],index:"01020401"},{text:" Excessive growth of scar elements",hierarchyLevel:4,children:[{text:" Keloid",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Excessive collgen leading to tumour-like outgrowth",hierarchyLevel:7,children:[],index:"01020402000000"},{text:" Genetic predisposition, with black people having a great riskthan white people",hierarchyLevel:7,children:[],index:"01020402000001"}],index:"010204020000"},{text:" Properties",hierarchyLevel:6,children:[{text:" Different from hypertrophic scar, where the scarred tissue doesnot grow out and stays within the scarred area",hierarchyLevel:7,children:[],index:"01020402000100"}],index:"010204020001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010204020002"}],index:"0102040200"},{text:" Exuberant granulation tissue (proud flsh)",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Formation of excess granulation tissue",hierarchyLevel:7,children:[],index:"01020402010000"}],index:"010204020100"},{text:" Consequence",hierarchyLevel:6,children:[{text:" Blocks regeneration of epithelium",hierarchyLevel:7,children:[],index:"01020402010100"}],index:"010204020101"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010204020102"}],index:"0102040201"},{text:" Contracture",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Exaggeration of normal wound contraction",hierarchyLevel:7,children:[],index:"01020402020000"}],index:"010204020200"},{text:" Consequence",hierarchyLevel:6,children:[{text:" Impair movement or function",hierarchyLevel:7,children:[],index:"01020402020100"},{text:" Lungs  prevent breathing",hierarchyLevel:7,children:[],index:"01020402020101"},{text:" Joints  prevent movement of joint",hierarchyLevel:7,children:[],index:"01020402020102"}],index:"010204020201"},{text:" Diagram",hierarchyLevel:6,children:[],index:"010204020202"}],index:"0102040202"},{text:" Persistent cavity  Non-union",hierarchyLevel:5,children:[{text:" Cause",hierarchyLevel:6,children:[{text:" Failure of bone healing process",hierarchyLevel:7,children:[],index:"01020402030000"},{text:" A joint is formed from the location of the fracture",hierarchyLevel:7,children:[],index:"01020402030001"}],index:"010204020300"}],index:"0102040203"}],index:"01020402"}],index:"010204"}],index:"0102"},{text:" [043] Cancer Immunology",hierarchyLevel:2,children:[{text:" Immune Surveillance",hierarchyLevel:3,children:[{text:" Stages of Immune Surveillance",hierarchyLevel:4,children:[{text:" Normal cells are transformed into malignant cells through geneticmutation which cause abnormal growth",hierarchyLevel:5,children:[],index:"0103000000"},{text:" Elimination Phase",hierarchyLevel:5,children:[{text:" Immune system eliminated mutation carry cells an preventmalignant transformation",hierarchyLevel:6,children:[],index:"010300000100"}],index:"0103000001"},{text:" Equilibrium Phase",hierarchyLevel:5,children:[{text:" However, if the elimination does not occur, there is a co-existenceof transformed and immune cells and the immune cells continue to attack thetransformed cells, reaching an equilibrium",hierarchyLevel:6,children:[],index:"010300000200"}],index:"0103000002"},{text:" Escape Phase",hierarchyLevel:5,children:[{text:" Once, a transformed cell evades immune surveillance, cancer willmanifest",hierarchyLevel:6,children:[],index:"010300000300"}],index:"0103000003"}],index:"01030000"},{text:" Properties of Immune Surveillance",hierarchyLevel:4,children:[{text:" The time for each stage can take a long time",hierarchyLevel:5,children:[],index:"0103000100"},{text:" The position of equilibrium can remain for a long time",hierarchyLevel:5,children:[],index:"0103000101"}],index:"01030001"},{text:" Process of Immune editing in cancer cells",hierarchyLevel:4,children:[{text:" Immune system recognises proteins antigens in cancer cells",hierarchyLevel:5,children:[],index:"0103000200"},{text:" Killer cells eliminate cancer cells",hierarchyLevel:5,children:[],index:"0103000201"},{text:" Cancer cells lose proteins recognise by killer cells",hierarchyLevel:5,children:[],index:"0103000202"},{text:" Cancer can grow despite the presence of killer cells",hierarchyLevel:5,children:[],index:"0103000203"},{text:" Cancer developing in the absence of an immune system can berejected by killer cells",hierarchyLevel:5,children:[],index:"0103000204"}],index:"01030002"},{text:" Experiment for Immune Editing",hierarchyLevel:4,children:[{text:" Form cancer in immunocompe",hierarchyLevel:5,children:[],index:"0103000300"}],index:"01030003"}],index:"010300"},{text:" Immune Therapy",hierarchyLevel:3,children:[{text:" Types",hierarchyLevel:4,children:[{text:" Active Immunetherapy  the patients immune system needs toproduce the immune response",hierarchyLevel:5,children:[],index:"0103010000"},{text:" Passive Immunetherapy  the patients receive antibodies or immunecells, works for patients who are immune-incompetent",hierarchyLevel:5,children:[],index:"0103010001"}],index:"01030100"},{text:" Versions",hierarchyLevel:4,children:[{text:" Vaccination  good for virus causing cancer cells",hierarchyLevel:5,children:[{text:" Prophylatic (preventing)",hierarchyLevel:6,children:[],index:"010301010000"},{text:" Therapeutic ",hierarchyLevel:6,children:[],index:"010301010001"}],index:"0103010100"},{text:" Passive Immunotherapy",hierarchyLevel:5,children:[{text:" Antibody therapy",hierarchyLevel:6,children:[],index:"010301010100"},{text:" Cell therapy",hierarchyLevel:6,children:[],index:"010301010101"},{text:" Gene therapy",hierarchyLevel:6,children:[],index:"010301010102"}],index:"0103010101"}],index:"01030101"}],index:"010301"}],index:"0103"},{text:" [044] Transplantation",hierarchyLevel:2,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Autograph  cells transplanted from the same part of the body",hierarchyLevel:5,children:[],index:"01040000"},{text:" Isograph  cells transplanted from identical twins",hierarchyLevel:5,children:[],index:"01040001"},{text:" Allograph  cells transplanted from an individual which differ atmany gene loci",hierarchyLevel:5,children:[],index:"01040002"},{text:" Xenograph  cells transplanted from animals",hierarchyLevel:5,children:[],index:"01040003"},{text:" Problems in Transplantation",hierarchyLevel:4,children:[{text:" Differences in genetic makeup between donor and recipient",hierarchyLevel:5,children:[],index:"0104000400"}],index:"01040004"},{text:" Popular Transplanting Organs",hierarchyLevel:4,children:[{text:" Bone",hierarchyLevel:5,children:[],index:"0104000500"},{text:" Haemopoeitic",hierarchyLevel:5,children:[],index:"0104000501"},{text:" Cornea",hierarchyLevel:5,children:[],index:"0104000502"},{text:" Heart Valves",hierarchyLevel:5,children:[],index:"0104000503"}],index:"01040005"},{text:" Mechanisms of Tissue Rejection",hierarchyLevel:4,children:[{text:" Hyperacute",hierarchyLevel:5,children:[{text:" Time Course",hierarchyLevel:6,children:[{text:" Minutes",hierarchyLevel:7,children:[],index:"01040006000000"}],index:"010400060000"},{text:" Prevalence",hierarchyLevel:6,children:[{text:" Experimentally",hierarchyLevel:7,children:[],index:"01040006000100"},{text:" Rare in clinical (due to pre-transplant testing)",hierarchyLevel:7,children:[],index:"01040006000101"}],index:"010400060001"},{text:" Cause",hierarchyLevel:6,children:[{text:" Tissues taken from someone who is not from the same blood group",hierarchyLevel:7,children:[],index:"01040006000200"},{text:" Tissues taken from another animal",hierarchyLevel:7,children:[],index:"01040006000201"}],index:"010400060002"},{text:" Mechanisms",hierarchyLevel:6,children:[],index:"010400060003"}],index:"0104000600"},{text:" Acute",hierarchyLevel:5,children:[{text:" Time Course",hierarchyLevel:6,children:[{text:" Several days",hierarchyLevel:7,children:[],index:"01040006010000"}],index:"010400060100"},{text:" Cause",hierarchyLevel:6,children:[{text:" Lymphocyte activation",hierarchyLevel:7,children:[],index:"01040006010100"}],index:"010400060101"}],index:"0104000601"},{text:" Chronic",hierarchyLevel:5,children:[{text:" Time Course",hierarchyLevel:6,children:[{text:" Month to years",hierarchyLevel:7,children:[],index:"01040006020000"}],index:"010400060200"}],index:"0104000602"}],index:"01040006"},{text:" Major Histocompatibility Complex",hierarchyLevel:4,children:[],index:"01040007"}],index:"010400"}],index:"0104"},{text:" [045] Vaccines",hierarchyLevel:2,children:[],index:"0105"}]},{text:"Virology",hierarchyLevel:1,children:[{text:" [003] Viruses: Structure and Properties",hierarchyLevel:2,children:[{text:" Learning Objectives",hierarchyLevel:3,children:[{text:" Describe the differences between viruses and other infectiousagents",hierarchyLevel:4,children:[],index:"02000000"},{text:" Describe the small size and general patterns of structure thatviruses exhibit",hierarchyLevel:4,children:[],index:"02000001"},{text:" Explain that a virus genome is either RNA or DNA depending on thevirus species",hierarchyLevel:4,children:[],index:"02000002"},{text:" Describe how new viruses might be identified",hierarchyLevel:4,children:[],index:"02000003"}],index:"020000"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Criteria to prove agent causes disease (Kochs postulates)",hierarchyLevel:4,children:[{text:" Presence of agent in lesions (damage to tissue)",hierarchyLevel:5,children:[],index:"0200010000"},{text:" Agent can be isolated in pure culture",hierarchyLevel:5,children:[],index:"0200010001"},{text:" Inoculation of agent in pure culture to living organism mustcause disease",hierarchyLevel:5,children:[],index:"0200010002"},{text:" Agent must be able to be recovered from the lesion of inoculatedorganism",hierarchyLevel:5,children:[],index:"0200010003"}],index:"02000100"},{text:" Indirect demonstration of presence of virus",hierarchyLevel:4,children:[{text:" Grind animal or plant infected tissue into fluid suspension",hierarchyLevel:5,children:[],index:"0200010100"},{text:" Filter to retain bacteria",hierarchyLevel:5,children:[],index:"0200010101"},{text:" Inoculate filtrate to animals/plants",hierarchyLevel:5,children:[],index:"0200010102"},{text:" Watch for disease",hierarchyLevel:5,children:[],index:"0200010103"},{text:" Repeat whole process to confirm",hierarchyLevel:5,children:[],index:"0200010104"}],index:"02000101"},{text:" Discovery (1): Viruses are smaller than bacteria",hierarchyLevel:4,children:[{text:" 1917: dHerelle discovered the bacteriophage",hierarchyLevel:5,children:[],index:"0200010200"},{text:" This showed that viruses can infect bacteria, indicating thatviruses are smaller than bacteria",hierarchyLevel:5,children:[],index:"0200010201"}],index:"02000102"},{text:" Discovery (2): Viruses are particles",hierarchyLevel:4,children:[{text:" Previously suspected that viruses were a fluid toxin/poison",hierarchyLevel:5,children:[],index:"0200010300"},{text:" Chicken chorioallantois is inoculated with virus spread from cellto cell forming a pock",hierarchyLevel:5,children:[],index:"0200010301"},{text:" Presence of pock shows that viruses are particles which can spreadcell by cell",hierarchyLevel:5,children:[],index:"0200010302"},{text:" 1931: Discovered that viruses are particles",hierarchyLevel:5,children:[],index:"0200010303"}],index:"02000103"},{text:" Discovery (3): Virus genomes are either DNA or RNA molecules",hierarchyLevel:4,children:[{text:" 1935: Discovered that tobacco mosaic virus contained RNA",hierarchyLevel:5,children:[],index:"0200010400"},{text:" 1940: Discovered that vaccinia virus contained DNA",hierarchyLevel:5,children:[],index:"0200010401"}],index:"02000104"},{text:" Discovery (4): Use of Tissue Culture",hierarchyLevel:4,children:[{text:" Applications",hierarchyLevel:5,children:[{text:" Develop Vaccines",hierarchyLevel:6,children:[],index:"020001050000"},{text:" Identify new viruses",hierarchyLevel:6,children:[],index:"020001050001"},{text:" Virus diagnosis (isolate virus from clinical samples, make viraltest kits)",hierarchyLevel:6,children:[],index:"020001050002"}],index:"0200010500"},{text:" Process",hierarchyLevel:5,children:[{text:" Kidney is taken, chopped up and put into a suspension to keep thecells alive",hierarchyLevel:6,children:[],index:"020001050100"},{text:" Grind the cells up with a magnetic stirrer to attain single cells(not clumps)",hierarchyLevel:6,children:[],index:"020001050101"},{text:" Suspension of kidney cells are put into a plastic flask",hierarchyLevel:6,children:[],index:"020001050102"},{text:" Plastic flask contains nutrients, antibiotics, pH indicator",hierarchyLevel:6,children:[],index:"020001050103"},{text:" Introduce viruses, allow the cells to grow and incubate in theflask at 37C to form a tissue culture",hierarchyLevel:6,children:[],index:"020001050104"},{text:" Observe the tissue culture under a light microscope, and look forcytopathic effect (cell-disease effect)",hierarchyLevel:6,children:[],index:"020001050105"}],index:"0200010501"}],index:"02000105"},{text:" Discovery (5): Use of Electron Microscopy (1950s)",hierarchyLevel:4,children:[{text:" Properties of Electron Microscope",hierarchyLevel:5,children:[{text:" Resolution Limit: 1nm (vs 200nm in light microscope)",hierarchyLevel:6,children:[],index:"020001060000"}],index:"0200010600"},{text:" Fully understood the size and structure of viruses (small)",hierarchyLevel:5,children:[],index:"0200010601"}],index:"02000106"},{text:" Discovery (6): Use of Molecular Techniques (1960s)",hierarchyLevel:4,children:[],index:"02000107"}],index:"020001"},{text:" Viral Structure (Electron Microscopy)",hierarchyLevel:3,children:[{text:" Overall Structure",hierarchyLevel:4,children:[{text:" Genetic Material (DNA / RNA)",hierarchyLevel:5,children:[],index:"0200020000"},{text:" Protein Coat (capsid)",hierarchyLevel:5,children:[],index:"0200020001"},{text:" Nucleocapsid (capsid + nucleic acid)",hierarchyLevel:5,children:[],index:"0200020002"},{text:" Enzymes (non structural proteins)",hierarchyLevel:5,children:[],index:"0200020003"},{text:" Envelope (lipid bilayer + glycoproteins)",hierarchyLevel:5,children:[],index:"0200020004"}],index:"02000200"},{text:" Helical Nucleocapsid - rod-shaped capsids (protein coat)",hierarchyLevel:4,children:[{text:" Principles",hierarchyLevel:5,children:[{text:" Achieve symmetry for ease of replication",hierarchyLevel:6,children:[],index:"020002010000"}],index:"0200020100"},{text:" Property",hierarchyLevel:5,children:[{text:" Helical Symmetry",hierarchyLevel:6,children:[],index:"020002010100"}],index:"0200020101"},{text:" Formation",hierarchyLevel:5,children:[{text:" Capsomere are individual protein subunits",hierarchyLevel:6,children:[],index:"020002010200"},{text:" Capsomeres roll to form helical symmetry",hierarchyLevel:6,children:[],index:"020002010201"},{text:" Viral DNA is in the lumen of the capsid",hierarchyLevel:6,children:[],index:"020002010202"}],index:"0200020102"},{text:" Diagram",hierarchyLevel:5,children:[{text:" ",hierarchyLevel:6,children:[],index:"020002010300"}],index:"0200020103"},{text:" Example - SARS-CoV-2",hierarchyLevel:5,children:[{text:" Properties",hierarchyLevel:6,children:[{text:" RNA is organized in one long continuous strand",hierarchyLevel:7,children:[],index:"02000201040000"},{text:" mRNA of the entire genome is produced",hierarchyLevel:7,children:[],index:"02000201040001"},{text:" NOTE: this structure does not work in eukaryotes as it givesreplication problems",hierarchyLevel:7,children:[],index:"02000201040002"}],index:"020002010400"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020002010401"}],index:"0200020104"},{text:" Example  Influenza A virus",hierarchyLevel:5,children:[{text:" Properties",hierarchyLevel:6,children:[{text:" RNA is organized in segments",hierarchyLevel:7,children:[],index:"02000201050000"}],index:"020002010500"},{text:" Effects",hierarchyLevel:6,children:[{text:" RNA separated into multiple segments allows for the ease ofreplication",hierarchyLevel:7,children:[],index:"02000201050100"}],index:"020002010501"},{text:" Diagram",hierarchyLevel:6,children:[],index:"020002010502"}],index:"0200020105"}],index:"02000201"},{text:" Spherical nucleocapsid",hierarchyLevel:4,children:[{text:" Property",hierarchyLevel:5,children:[{text:" Icosahedral symmetry (twenty-sided 3D shape)",hierarchyLevel:6,children:[],index:"020002020000"}],index:"0200020200"},{text:" Formation",hierarchyLevel:5,children:[{text:" Capsomere are individual protein subunits",hierarchyLevel:6,children:[],index:"020002020100"},{text:" Capsomeres fold to form icosahedral symmetry",hierarchyLevel:6,children:[],index:"020002020101"}],index:"0200020201"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0200020202"}],index:"02000202"}],index:"020002"},{text:" Molecular Techniques with Viruses",hierarchyLevel:3,children:[{text:" Background Story (FOR FUN ONLY)",hierarchyLevel:4,children:[{text:" Problem (I)",hierarchyLevel:5,children:[{text:" Hepatitis is caused by the inflammation of the liver, affectingthe bilirubin metabolism",hierarchyLevel:6,children:[],index:"020003000000"},{text:" This causes the eyes to look yellow",hierarchyLevel:6,children:[],index:"020003000001"},{text:" In the past, post-transfusion hepatitis B became prevalent",hierarchyLevel:6,children:[],index:"020003000002"}],index:"0200030000"},{text:" Solution (I)",hierarchyLevel:5,children:[{text:" Scientist identified that it was caused by Hepatitis B virus",hierarchyLevel:6,children:[],index:"020003000100"},{text:" Hence, blood transfusion was checked for Hepatitis B virus. ",hierarchyLevel:6,children:[],index:"020003000101"}],index:"0200030001"},{text:" Problem (II)",hierarchyLevel:5,children:[{text:" However, the problem still occurred.",hierarchyLevel:6,children:[],index:"020003000200"},{text:" Scientist realized that an unknown agent still caused the disease",hierarchyLevel:6,children:[],index:"020003000201"},{text:" Kochs postulates was used and the agent was successfullytransferred to chimps, showing that it is indeed a virus",hierarchyLevel:6,children:[],index:"020003000202"},{text:" Plasma filtration was used to identify the size as 40-50nm",hierarchyLevel:6,children:[],index:"020003000203"},{text:" Scientist discovered that it was sensitive to chloroform, showinga lipid envelope",hierarchyLevel:6,children:[],index:"020003000204"},{text:" However, the virus cannot be seen under the electron microscopeand cannot be grown in vitro",hierarchyLevel:6,children:[],index:"020003000205"}],index:"0200030002"},{text:" Solution (II)  Use of genetic sequencing",hierarchyLevel:5,children:[{text:" Blood from human carrier of non-A non-B hepatitis was used toinfect the chimp",hierarchyLevel:6,children:[],index:"020003000300"},{text:" Ultracentrifuge plasma from infected chimp",hierarchyLevel:6,children:[],index:"020003000301"},{text:" Extract nucleic acid from pellet",hierarchyLevel:6,children:[],index:"020003000302"},{text:" Use reverse transcriptase to convert RNA to cDNA ( RNA?  DNA?)",hierarchyLevel:6,children:[],index:"020003000303"},{text:" Package cDNA into bacteriophages",hierarchyLevel:6,children:[],index:"020003000304"},{text:" Use bacteriophages to infect bacteria",hierarchyLevel:6,children:[],index:"020003000305"},{text:" Spread and inoculate the bacteria on the agar plate",hierarchyLevel:6,children:[],index:"020003000306"},{text:" Bacteria that have been infected by the bacteriophage will dieand form plaques",hierarchyLevel:6,children:[],index:"020003000307"},{text:" Dead bacteria from each plaque was extracted and the proteinsthe dead bacteria produced was tested by antibodies produced by the infectedhuman",hierarchyLevel:6,children:[],index:"020003000308"},{text:" One out of a million plaques, produced a proteins that react withthe infected human antibodies",hierarchyLevel:6,children:[],index:"020003000309"},{text:" DNA of the bacteria from that particular plaque was analyzed andfound to be homologous to one of the RNA virus found in infected carriers",hierarchyLevel:6,children:[],index:"020003000310"},{text:" Hence, the entire RNA genome of the Hepatitis C virus wasdiscovered",hierarchyLevel:6,children:[],index:"020003000311"},{text:" Diagnosis tests were developed for hepatitis C",hierarchyLevel:6,children:[],index:"020003000312"}],index:"0200030003"}],index:"02000300"},{text:" Use of Next-Generation Sequencing to discover viruses",hierarchyLevel:4,children:[{text:" Requirements",hierarchyLevel:5,children:[{text:" Computational Tools",hierarchyLevel:6,children:[],index:"020003010000"},{text:" Thousands of genomes of viruses",hierarchyLevel:6,children:[],index:"020003010001"}],index:"0200030100"},{text:" Process",hierarchyLevel:5,children:[{text:" Get a particular DNA sequence from a patient with a particulardisease",hierarchyLevel:6,children:[],index:"020003010100"},{text:" Run the sequence through the gene bank and see if it has anassociation with any of the thousands of viruses that are in the bank",hierarchyLevel:6,children:[],index:"020003010101"},{text:" If sufficient association is found, it may imply that thepresence of the virus is associated with the disease",hierarchyLevel:6,children:[],index:"020003010102"},{text:" However, association is not causation, and we cannot be sure thatit is the presence of the virus that caused a disease",hierarchyLevel:6,children:[],index:"020003010103"}],index:"0200030101"}],index:"02000301"}],index:"020003"},{text:" Sub-viral Agents",hierarchyLevel:3,children:[{text:" Satellites",hierarchyLevel:4,children:[{text:" Structure",hierarchyLevel:5,children:[{text:" Contains nucleic acid",hierarchyLevel:6,children:[],index:"020004000000"},{text:" Lack genes for replication",hierarchyLevel:6,children:[],index:"020004000001"}],index:"0200040000"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Spreads through depending on coinfection with helper virus",hierarchyLevel:6,children:[],index:"020004000100"}],index:"0200040001"},{text:" Example",hierarchyLevel:5,children:[{text:" Hepatitis delta virus requires hepatitis B virus for replication",hierarchyLevel:6,children:[],index:"020004000200"}],index:"0200040002"}],index:"02000400"},{text:" Prions",hierarchyLevel:4,children:[{text:" Structure",hierarchyLevel:5,children:[{text:" No nucleic acid",hierarchyLevel:6,children:[],index:"020004010000"},{text:" Has infectious proteins",hierarchyLevel:6,children:[],index:"020004010001"}],index:"0200040100"},{text:" Example",hierarchyLevel:5,children:[{text:" Bovine spongiform encephalopathy (BSE)",hierarchyLevel:6,children:[],index:"020004010100"}],index:"0200040101"}],index:"02000401"}],index:"020004"}],index:"0200"},{text:" [013] How Viruses Multiply",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Properties of Viruses",hierarchyLevel:4,children:[{text:" Infect animals, plants, bacteria",hierarchyLevel:5,children:[],index:"0201000000"},{text:" Size  too small for light microscope",hierarchyLevel:5,children:[],index:"0201000001"},{text:" Classified by morphology and behavior",hierarchyLevel:5,children:[],index:"0201000002"},{text:" DNA or RNA + protein coat + envelope",hierarchyLevel:5,children:[],index:"0201000003"},{text:" Extracellular infectious phase",hierarchyLevel:5,children:[],index:"0201000004"},{text:" Obligatory intracellular replication",hierarchyLevel:5,children:[],index:"0201000005"},{text:" Viral genes subvert cell biosynthesis to replicate",hierarchyLevel:5,children:[],index:"0201000006"}],index:"02010000"},{text:" Measuring Viruses (Pocks viruses)",hierarchyLevel:4,children:[{text:" Count the number of pocks formed (each pock first started with 1virus)",hierarchyLevel:5,children:[],index:"0201000100"}],index:"02010001"},{text:" Measuring Viruses (Tissue Culture)",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Take a sample",hierarchyLevel:6,children:[],index:"020100020000"},{text:" Perform serial dilutions (10 fold)",hierarchyLevel:6,children:[],index:"020100020001"},{text:" Take a tissue culture with a single layer of cell, and overlaywith agar (prevent spread of virus after landing)",hierarchyLevel:6,children:[],index:"020100020002"},{text:" Add the diluted solutions into the single layer of cells",hierarchyLevel:6,children:[],index:"020100020003"},{text:" Incubate the petri dish for several days. The cells on the singlelayer than has been infected will die and hence form an empty region (plaque)",hierarchyLevel:6,children:[],index:"020100020004"},{text:" Each plaque is a single virus",hierarchyLevel:6,children:[],index:"020100020005"},{text:" Compare the number of plaques found from the different dilutionsto find and verify the concentration of the virus",hierarchyLevel:6,children:[],index:"020100020006"}],index:"0201000200"},{text:" Analyzing virus count via Growth Curve",hierarchyLevel:5,children:[{text:" Initially when the virus is first introduce to the single layerof cells on the tissue culture, the viruses penetrates the cells and ejects itown DNA into the cell. Therefore, the infection units of viruses / cell is verylow",hierarchyLevel:6,children:[],index:"020100020100"},{text:" However after some time, the DNA causes the host cell to startreplicating the virus, and this results in the infectious units within the cellto start increasing drastically",hierarchyLevel:6,children:[],index:"020100020101"}],index:"0201000201"}],index:"02010002"}],index:"020100"},{text:" Infectious Cycle",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" An infectious cycle includes attachment and entry of virion,decoding of genome information, translation of viral mRNA by host ribosomes,genome replication, and assembly and release of particles containing the genome",hierarchyLevel:5,children:[],index:"0201010000"}],index:"02010100"},{text:" Structure and Function",hierarchyLevel:4,children:[],index:"02010101"},{text:" Enveloped",hierarchyLevel:4,children:[{text:" Fusion",hierarchyLevel:5,children:[{text:" Virus binds to the receptor on the surface of the plasma membrane",hierarchyLevel:6,children:[],index:"020101020000"},{text:" The viral membrane fuses with the plasma membrane of the cell,releasing the inner capsid containing the genetic material",hierarchyLevel:6,children:[],index:"020101020001"}],index:"0201010200"},{text:" Endocytosis + Fusion",hierarchyLevel:5,children:[{text:" The virus binds to the receptor on the surface of the plasmamembrane",hierarchyLevel:6,children:[],index:"020101020100"},{text:" The virus is unable to fuse with the plasma membrane of the hostdue to incorrect pH conditions outside the cell",hierarchyLevel:6,children:[],index:"020101020101"},{text:" The virus is taken in by endocytosis, forming a vesicle",hierarchyLevel:6,children:[],index:"020101020102"},{text:" A digestive endosome with low pH fuses with the vesicle,decreasing the pH within the vesicle, enabling the two membranes to fusetogether and hence releasing the capsid within",hierarchyLevel:6,children:[],index:"020101020103"}],index:"0201010201"},{text:" Reason for pH sensitivity of Enveloped Viruses",hierarchyLevel:5,children:[{text:" Enveloped viruses have a lipid envelope",hierarchyLevel:6,children:[],index:"020101020200"},{text:" The lipid enveloped can be destroyed by the presence of alcoholand hence rendering the virus unable to transmit",hierarchyLevel:6,children:[],index:"020101020201"}],index:"0201010202"}],index:"02010102"},{text:" Non-enveloped",hierarchyLevel:4,children:[{text:" The virus receptor on the host cell binds to the canyon of thevirus",hierarchyLevel:5,children:[],index:"0201010300"},{text:" The virus is taken in by endocytosis, forming a vesicle",hierarchyLevel:5,children:[],index:"0201010301"},{text:" A digestive endosome fuses with the vesicle, causing the innercapsid to be released into the cytoplasm of the host cell",hierarchyLevel:5,children:[],index:"0201010302"}],index:"02010103"},{text:" Diagram",hierarchyLevel:4,children:[],index:"02010104"},{text:" Viral genome is released from the capsid / lipid envelope",hierarchyLevel:4,children:[],index:"02010105"},{text:" Requirements",hierarchyLevel:4,children:[{text:" Viral genome contains the information for instituting andcompleting an infectious cycle within a cell",hierarchyLevel:5,children:[],index:"0201010600"},{text:" Cells need to be both susceptible and permissive for replication",hierarchyLevel:5,children:[],index:"0201010601"}],index:"02010106"},{text:" Key Players",hierarchyLevel:4,children:[{text:" Viral mRNA  virus DNA / RNA will be converted into viral mRNA",hierarchyLevel:5,children:[],index:"0201010700"}],index:"02010107"},{text:" Process  Early Viral Genes",hierarchyLevel:4,children:[{text:" Early viral genes are transcribed before the replication ofviruses takes place",hierarchyLevel:5,children:[],index:"0201010800"},{text:" The early viral genes regulate cell protein and nucleic acidsynthesis. This can prevent the action of interferons, stopping apoptosisresponse, maintain the basic functions of the cell.",hierarchyLevel:5,children:[],index:"0201010801"},{text:" After the defenses have been disabled and the normal cellactivity is stabilized, the viral genes regulate its own expression",hierarchyLevel:5,children:[],index:"0201010802"},{text:" With the expression of viral genes, viral enzymes are synthesizedthe enable to replication of viral nucleic acid",hierarchyLevel:5,children:[],index:"0201010803"}],index:"02010108"},{text:" Process  Late Viral Gene",hierarchyLevel:4,children:[{text:" With the early viral genes, viral nucleic acid is formed, and thevirus now needs to package it ",hierarchyLevel:5,children:[],index:"0201010900"},{text:" Late viral genes synthesize the viral capsid",hierarchyLevel:5,children:[],index:"0201010901"},{text:" The viral capsid and the viral nucleic acid is self-assembled,and the final virus product is released when the host cell dies (lysis) / or /it is secreted out of the cell",hierarchyLevel:5,children:[],index:"0201010902"}],index:"02010109"}],index:"020101"},{text:" HIV Replication",hierarchyLevel:3,children:[{text:" Types of Viral RNA",hierarchyLevel:4,children:[{text:" Positive Sense  Viral RNA acts as Viral mRNA",hierarchyLevel:5,children:[],index:"0201020000"},{text:" Negative Sense  Viral RNA is complementary to mRNA. Converted topositive sense strand when copied by RNA-dependent RNA, and hence can act asViral mRNA",hierarchyLevel:5,children:[],index:"0201020001"}],index:"02010200"},{text:" Baltimore Classification",hierarchyLevel:4,children:[{text:" Truism",hierarchyLevel:5,children:[{text:" All viral genomes lead to mRNA",hierarchyLevel:6,children:[],index:"020102010000"}],index:"0201020100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0201020101"},{text:" Spastic Narration",hierarchyLevel:5,children:[{text:" Double Stranded DNA (dsDNA) must contain a sense strand, hence ().dsDNA can be converted into mRNA through normal transcription by RNA polymerase(dsDNA dependent)",hierarchyLevel:6,children:[],index:"020102010200"},{text:" Single Stranded DNA (ssDNA) can either be the sense strand or theantisense strand, hence (+ or -). Through DNA replication, a ssDNA can be convertedinto a dsDNA",hierarchyLevel:6,children:[],index:"020102010201"},{text:" Double Stranded RNA (viral) (dsRNA ) must contain a sensestrand, hence (). dsRNA can be converted into mRNA by RNA polymerase (dsRNAdependent)",hierarchyLevel:6,children:[],index:"020102010202"},{text:" Single Stranded RNA (ssRNA +) (viral) can contain the sensestrand, hence +. It will directly be used as the mRNA",hierarchyLevel:6,children:[],index:"020102010203"},{text:" Single Stranded RNA (ssRNA -) (viral) may contain the anti-sensestrand, hence -. ssRNA (-) can be converted into mRNA (+) by RNA polymerase(ssRNA dependent)",hierarchyLevel:6,children:[],index:"020102010204"},{text:" Single Stranded Retrovirus RNA (ss Retrovirus RNA) must containthe sense strand, hence +. ss Retrovirus RNA can be converted in dsDNA throughvirla reverse transcriptase",hierarchyLevel:6,children:[],index:"020102010205"},{text:" Partially Double Stranded Hepadnavirus DNA  contains two strandand hence must contain the sense strand. It can be converted into dsDNA viaviral DNA polymerase (replication)",hierarchyLevel:6,children:[],index:"020102010206"}],index:"0201020102"}],index:"02010201"},{text:" HIV Virus (Retrovirus)",hierarchyLevel:4,children:[{text:" Structure",hierarchyLevel:5,children:[{text:" Contains glycoprotein complex on the cell surface made up of gp120 (outside) and gp 41 (inside)",hierarchyLevel:6,children:[],index:"020102020000"},{text:" Contains Capsid protein containing the genetic material and ",hierarchyLevel:6,children:[],index:"020102020001"}],index:"0201020200"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0201020201"},{text:" Entry of HIV",hierarchyLevel:5,children:[{text:" Gp120 binds to CD4 on the plasma membrane of helper T-cells(antigen presenting cells)",hierarchyLevel:6,children:[],index:"020102020200"},{text:" This induces a conformational change in the shape of CD4 causingit to bend sideways",hierarchyLevel:6,children:[],index:"020102020201"},{text:" This then enables gp120 to further bind to a chemokine receptorwhich happens to act as a coreceptor for the virus.",hierarchyLevel:6,children:[],index:"020102020202"},{text:" Upon binding with the co-receptor, gp120 dissociates from gp41(not covalently bound together).",hierarchyLevel:6,children:[],index:"020102020203"},{text:" Gp41 contains alpha helix chains, C-helix and H-helix and afusion peptide. The fusion peptide is lipophilic / hydrophobic and hence isable to penetrate into the phospholipid bilayer",hierarchyLevel:6,children:[],index:"020102020204"},{text:" The dissociation of gp41 causes a conformational change inH-helix and C-helix resulting in the formation of a 6-helix bundle.",hierarchyLevel:6,children:[],index:"020102020205"}],index:"0201020202"},{text:" Replication of HIV",hierarchyLevel:5,children:[{text:" Upon entry of the nucleocapsid into the host cell, reversetranscriptase (non-structural protein) in the capsid converts ss Retrovirus RNA(+) into dsDNA",hierarchyLevel:6,children:[],index:"020102020300"},{text:" dsDNA then moves into the nucleus of the host cell",hierarchyLevel:6,children:[],index:"020102020301"},{text:" Integrase from the nucleocapsid catalyzes the insertion of viralDNA into the host cell genome, forming the proviral DNA",hierarchyLevel:6,children:[],index:"020102020302"},{text:" The proviral DNA can stay in the host cell and not betranscribed, becoming latent for a long time. However, the proviral DNA canalso be transcribed to form viral RNA. The viral RNA is then used to produceviral proteins to further aid in replication for packaging. The proviral DNAcan also be transcribed to form small pieces of ss Retrovirus RNA (+)",hierarchyLevel:6,children:[],index:"020102020303"},{text:" The proteins made from viral mRNA and the ss Retrovirus RNA (+)is then assembled and packaged at the host cell plasma membrane",hierarchyLevel:6,children:[],index:"020102020304"},{text:" The assembled virus is then secreted out of the cell byexocytosis",hierarchyLevel:6,children:[],index:"020102020305"},{text:" In the newly released virus, protease hydrolyses proteins to formthe capsid around the viral RNA",hierarchyLevel:6,children:[],index:"020102020306"}],index:"0201020203"}],index:"02010202"},{text:" Abrupt Definitions",hierarchyLevel:4,children:[{text:" Cytokine  small proteins that acts for intercellular signaling",hierarchyLevel:5,children:[],index:"0201020300"},{text:" Chemokine  small proteins that attract cells by chemotaxis",hierarchyLevel:5,children:[],index:"0201020301"},{text:" Provirus  retroviral DNA integrated into host cell genome",hierarchyLevel:5,children:[],index:"0201020302"}],index:"02010203"}],index:"020102"},{text:" Diversity of Viruses",hierarchyLevel:3,children:[{text:" Sources of Variation in Viruses",hierarchyLevel:4,children:[{text:" Point Mutation",hierarchyLevel:5,children:[{text:" RNA polymerases generated from viral genome does not haveproof-reading ability. This results in a much higher error rate",hierarchyLevel:6,children:[],index:"020103000000"},{text:" Reverse transcriptase (RNA dependent DNA polymerase) does nothave proof reading ability. This results in a much higher error rate",hierarchyLevel:6,children:[],index:"020103000001"}],index:"0201030000"},{text:" Reassortment",hierarchyLevel:5,children:[{text:" Viral DNA can have a segmented genome. Each segment of the genomecan be rearranged and reassorted with another genetically related virus,forming greater diversity",hierarchyLevel:6,children:[],index:"020103000100"}],index:"0201030001"}],index:"02010300"}],index:"020103"}],index:"0201"},{text:" [022] Transmission and Epidemiology of Viruses",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Background",hierarchyLevel:4,children:[{text:" Viruses are inert outside the body and hence need to find a wayto transmit",hierarchyLevel:5,children:[],index:"0202000000"}],index:"02020000"},{text:" Importance",hierarchyLevel:4,children:[{text:" Understand the mechanism of transmission enables the understandof how to prevent the transmission",hierarchyLevel:5,children:[],index:"0202000100"}],index:"02020001"},{text:" Definitions",hierarchyLevel:4,children:[{text:" Vertical transmission  parent to embryo / fetus / newborn",hierarchyLevel:5,children:[],index:"0202000200"},{text:" Horizontal transmission  between individuals",hierarchyLevel:5,children:[],index:"0202000201"},{text:" Iatrogenic infection  doctor to patient during treatment",hierarchyLevel:5,children:[],index:"0202000202"},{text:" Nosocomial infection  hospital to patient / carer",hierarchyLevel:5,children:[],index:"0202000203"},{text:" Zoonosis  animals to humans",hierarchyLevel:5,children:[],index:"0202000204"}],index:"02020002"},{text:" Types",hierarchyLevel:4,children:[{text:" Horizontal transmission  from one individual to anotherindividual",hierarchyLevel:5,children:[],index:"0202000300"},{text:" Vertical transmission  spread from parent to offspring (motherto child)",hierarchyLevel:5,children:[{text:" Catergories",hierarchyLevel:6,children:[{text:" Transplacental / congenital",hierarchyLevel:7,children:[],index:"02020003010000"},{text:" Perinatal infection  acquired at birth mother to child",hierarchyLevel:7,children:[],index:"02020003010001"}],index:"020200030100"},{text:" Medium",hierarchyLevel:6,children:[{text:" Milk, contact",hierarchyLevel:7,children:[],index:"02020003010100"},{text:" Ovum, sperm placenta (not significant in humans)",hierarchyLevel:7,children:[],index:"02020003010101"},{text:" Leukemia viruses, congenital rubella",hierarchyLevel:7,children:[],index:"02020003010102"}],index:"020200030101"}],index:"0202000301"}],index:"02020003"}],index:"020200"},{text:" Modes of Direct Transmission",hierarchyLevel:3,children:[{text:" Skin",hierarchyLevel:4,children:[{text:" Rabies virus (zoonosis)",hierarchyLevel:5,children:[{text:" Dog bites a person, the dog saliva penetrates the skin and getsinto the nerves in the skin",hierarchyLevel:6,children:[],index:"020201000000"},{text:" The virus enters the nerve and slowly travels up to the brain",hierarchyLevel:6,children:[],index:"020201000001"},{text:" The causes encephalitis  infection of the brain",hierarchyLevel:6,children:[],index:"020201000002"},{text:" This causes the host to die",hierarchyLevel:6,children:[],index:"020201000003"}],index:"0202010000"}],index:"02020100"},{text:" Touching / kissing",hierarchyLevel:4,children:[{text:" Herpes simplex virus (HSV)",hierarchyLevel:5,children:[{text:" Close contact with other children causes acquisition",hierarchyLevel:6,children:[],index:"020201010000"},{text:" Virus is shared in saliva (kiss, sucking toys)",hierarchyLevel:6,children:[],index:"020201010001"}],index:"0202010100"},{text:" Epstein-Barr virus",hierarchyLevel:5,children:[],index:"0202010101"}],index:"02020101"},{text:" Sexual",hierarchyLevel:4,children:[{text:" Male Genital Herpes",hierarchyLevel:5,children:[],index:"0202010200"},{text:" Female Genital Herpes",hierarchyLevel:5,children:[],index:"0202010201"},{text:" Penile Warts (papillomavirus)",hierarchyLevel:5,children:[],index:"0202010202"},{text:" HSV, Hepatitis B virus (HBV)",hierarchyLevel:5,children:[],index:"0202010203"}],index:"02020102"},{text:" Congenital / Transplacental",hierarchyLevel:4,children:[{text:" Congenital Rubella",hierarchyLevel:5,children:[{text:" Results in cataracts",hierarchyLevel:6,children:[],index:"020201030000"}],index:"0202010300"},{text:" Congenital cytomegalovirus",hierarchyLevel:5,children:[{text:" Mother gets infected with a primary infection (might be silent)",hierarchyLevel:6,children:[],index:"020201030100"},{text:" The virus then crosses the placenta then causes severeneurological damage on the fetus",hierarchyLevel:6,children:[],index:"020201030101"},{text:" The virus infects the cells in the kidney and will be shred inthe urine",hierarchyLevel:6,children:[],index:"020201030102"}],index:"0202010301"}],index:"02020103"},{text:" Perinatal  birth canal / breast milk",hierarchyLevel:4,children:[{text:" Birth canal  HIV, HBV, HSV",hierarchyLevel:5,children:[],index:"0202010400"},{text:" Breast milk  HIV",hierarchyLevel:5,children:[],index:"0202010401"}],index:"02020104"},{text:" Airborne droplets",hierarchyLevel:4,children:[{text:" Respiratory secretions can be transmitted into conjunctiva,mucous membranes of eye, nose and mouth",hierarchyLevel:5,children:[],index:"0202010500"},{text:" Influenza, SARS-Cov-2",hierarchyLevel:5,children:[],index:"0202010501"}],index:"02020105"},{text:" Repeating ",hierarchyLevel:4,children:[{text:" HSV  touching, kissing, sexual, perinatal",hierarchyLevel:5,children:[],index:"0202010600"},{text:" HIV, HBV  sexual, perinatal",hierarchyLevel:5,children:[],index:"0202010601"}],index:"02020106"}],index:"020201"},{text:" Modes of Indirect Transmission",hierarchyLevel:3,children:[{text:" Inhalation of aerosols or droplet nuclei",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" Droplets are formed from sneezing",hierarchyLevel:6,children:[],index:"020202000000"},{text:" Droplets are carried by air currents and remain in the air forminutes or hours",hierarchyLevel:6,children:[],index:"020202000001"}],index:"0202020000"}],index:"02020200"},{text:" Vehicle-borne",hierarchyLevel:4,children:[{text:" Fomite  object or material able to harbour infectious agent andtransmit ",hierarchyLevel:5,children:[{text:" Examples",hierarchyLevel:6,children:[{text:" Door handles",hierarchyLevel:7,children:[],index:"02020201000000"},{text:" Toilet handles",hierarchyLevel:7,children:[],index:"02020201000001"}],index:"020202010000"}],index:"0202020100"},{text:" Examples",hierarchyLevel:5,children:[{text:" Hepatitis B  blood (fomite) => needlestick",hierarchyLevel:6,children:[],index:"020202010100"},{text:" Needlestick: HIV, HBV, HCV",hierarchyLevel:6,children:[],index:"020202010101"},{text:" Transfusion: HIV, HBV, HCV",hierarchyLevel:6,children:[],index:"020202010102"},{text:" Organ transplant: CMV",hierarchyLevel:6,children:[],index:"020202010103"}],index:"0202020101"},{text:" Application",hierarchyLevel:5,children:[{text:" Not the major mode of transmission for SARS-COV2",hierarchyLevel:6,children:[],index:"020202010200"},{text:" Difficult for SARS-COV2 to transmit via fomites in normalsituations",hierarchyLevel:6,children:[],index:"020202010201"}],index:"0202020102"}],index:"02020201"},{text:" Ingestions  fecal / oral route",hierarchyLevel:4,children:[{text:" Flies interact commonly with food and faeces, resulting in faeceson food",hierarchyLevel:5,children:[],index:"0202020200"},{text:" Examples",hierarchyLevel:5,children:[{text:" Hepatitis A",hierarchyLevel:6,children:[],index:"020202020100"},{text:" Rotavirus",hierarchyLevel:6,children:[],index:"020202020101"},{text:" Norovirus",hierarchyLevel:6,children:[],index:"020202020102"}],index:"0202020201"}],index:"02020202"},{text:" Vector-borne",hierarchyLevel:4,children:[{text:" Arthopod Borne Virus (Arbovirus)",hierarchyLevel:5,children:[{text:" Arthropod bitten another previously infected person",hierarchyLevel:6,children:[],index:"020202030000"},{text:" Virus replicates and amplifies itself within the first",hierarchyLevel:6,children:[],index:"020202030001"},{text:" Arthropod bites another person (insect, arachnid)",hierarchyLevel:6,children:[],index:"020202030002"}],index:"0202020300"},{text:" Tick-borne Encephalitis",hierarchyLevel:5,children:[{text:" Tick transmits to rodent",hierarchyLevel:6,children:[],index:"020202030100"},{text:" Rodent transmits to tick (cycle)",hierarchyLevel:6,children:[],index:"020202030101"},{text:" Tick bites humans",hierarchyLevel:6,children:[],index:"020202030102"}],index:"0202020301"},{text:" Mosquito-borne Yellow Fever  hepatitis (liver inflammation)",hierarchyLevel:5,children:[{text:" Mosquito transmits to monkeys",hierarchyLevel:6,children:[],index:"020202030200"},{text:" Monkey transmits to mosquitos (cycle)",hierarchyLevel:6,children:[],index:"020202030201"},{text:" Mosquito transmits to humans",hierarchyLevel:6,children:[],index:"020202030202"},{text:" Humans transmit to mosquito (cycle)",hierarchyLevel:6,children:[],index:"020202030203"}],index:"0202020302"}],index:"02020203"}],index:"020202"},{text:" Factors determining transmission",hierarchyLevel:3,children:[{text:" Virus titre  amount of virus shed",hierarchyLevel:4,children:[],index:"02020300"},{text:" Incubation period",hierarchyLevel:4,children:[],index:"02020301"},{text:" Period of Infectivity  duration of shedding",hierarchyLevel:4,children:[{text:" Short  influenza, measles",hierarchyLevel:5,children:[],index:"0202030200"},{text:" Long  HIV, herpes (varicella zoster virus)",hierarchyLevel:5,children:[],index:"0202030201"}],index:"02020302"},{text:" Critical community size  require a large enough community to persistin a community",hierarchyLevel:4,children:[{text:" Measles  needs to large enough community to persist, if not willbe gone",hierarchyLevel:5,children:[],index:"0202030300"},{text:" Varicella (chicken pox)  are always present, always have anopportunity to transmit",hierarchyLevel:5,children:[],index:"0202030301"}],index:"02020303"},{text:" External survival (ability to survive the environment)",hierarchyLevel:4,children:[{text:" Resistant to drying, temperature, pH, lipid solvents  HepatitisA virus",hierarchyLevel:5,children:[],index:"0202030400"}],index:"02020304"},{text:" Evasion of host immunity",hierarchyLevel:4,children:[{text:" Able to replicate on skin, mucous membrane  Papilloma,respiratory virus",hierarchyLevel:5,children:[],index:"0202030500"},{text:" Antigenic variation  influenza virus, HIV",hierarchyLevel:5,children:[],index:"0202030501"}],index:"02020305"}],index:"020203"},{text:" Prevention of Transmission",hierarchyLevel:3,children:[{text:" General Hygiene  hand washing, barrier nursing, disinfection,autoclaves",hierarchyLevel:4,children:[],index:"02020400"},{text:" Protected sex",hierarchyLevel:4,children:[],index:"02020401"},{text:" Food and water hygiene",hierarchyLevel:4,children:[],index:"02020402"},{text:" Arthropod vector control",hierarchyLevel:4,children:[],index:"02020403"},{text:" Vaccines",hierarchyLevel:4,children:[],index:"02020404"},{text:" Protection of Susceptible hosts  Post Exposure Prophylaxis (PEP)",hierarchyLevel:4,children:[{text:" Process",hierarchyLevel:5,children:[{text:" If the incubation of the virus is long, intervention can be donebefore the pathogenic effect is felt",hierarchyLevel:6,children:[],index:"020204050000"},{text:" After the exposure, antiviral drugs can be given ",hierarchyLevel:6,children:[],index:"020204050001"}],index:"0202040500"},{text:" Examples",hierarchyLevel:5,children:[{text:" Antiviral drugs given for HIV post exposure",hierarchyLevel:6,children:[],index:"020204050100"},{text:" HBV",hierarchyLevel:6,children:[{text:" Immunoglobulin is given immediately after infection to bridge thetime taken for the body to generate antibodies (immunoglobulin prophylaxis)",hierarchyLevel:7,children:[],index:"02020405010100"},{text:" Vaccination",hierarchyLevel:7,children:[],index:"02020405010101"}],index:"020204050101"}],index:"0202040501"}],index:"02020405"}],index:"020204"}],index:"0202"},{text:" [026] How Viruses Cause Disease (Pathogenesis)",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Multicellular host vs single cell",hierarchyLevel:4,children:[],index:"02030000"},{text:" Disease pattern depends on organ/tissue infected",hierarchyLevel:4,children:[],index:"02030001"},{text:" Virus tropism = ability to infect specific cell type  HIV gp120/CD4 T lymphocyte",hierarchyLevel:4,children:[{text:" Susceptible  have the receptor for the virus to get in",hierarchyLevel:5,children:[],index:"0203000200"},{text:" Permissive  allow for the virus to replicate within the cell",hierarchyLevel:5,children:[],index:"0203000201"}],index:"02030002"}],index:"020300"},{text:" Portals of Entry",hierarchyLevel:3,children:[{text:" Requirement for Infection",hierarchyLevel:4,children:[{text:" After entry requires a sufficient viral load to cause disease",hierarchyLevel:5,children:[],index:"0203010000"}],index:"02030100"},{text:" Examples of Portals",hierarchyLevel:4,children:[{text:" Mucosal surfaces",hierarchyLevel:5,children:[{text:" Eye  conjuctivita",hierarchyLevel:6,children:[],index:"020301010000"},{text:" Gut epithelium",hierarchyLevel:6,children:[],index:"020301010001"},{text:" Urinogential tract",hierarchyLevel:6,children:[],index:"020301010002"}],index:"0203010100"},{text:" Skin (less penetrable)",hierarchyLevel:5,children:[{text:" Arthropod",hierarchyLevel:6,children:[],index:"020301010100"}],index:"0203010101"}],index:"02030101"},{text:" Reasoning for Epithelial Portals of Entry",hierarchyLevel:4,children:[{text:" Limited virus tropism  virus only has ability to bind toreceptors on epithelial surface",hierarchyLevel:5,children:[],index:"0203010200"},{text:" Optimal local temperature  requires an optimal temperature thatis lower than body temperature to grow (rhinovirus = virus of the nose)",hierarchyLevel:5,children:[],index:"0203010201"},{text:" Polarized virus assembly  virus only release on one side (eg.influenza)",hierarchyLevel:5,children:[{text:" Apical transport pathway  virus only release on apical side",hierarchyLevel:6,children:[],index:"020301020200"},{text:" Basolateral transport pathway",hierarchyLevel:6,children:[],index:"020301020201"}],index:"0203010202"},{text:" Polarized virus production (4-6 weeks infectious cycle)",hierarchyLevel:5,children:[{text:" Virus infects the primitive basal keratinocyte",hierarchyLevel:6,children:[],index:"020301020300"},{text:" In the primitive basal keratinocyte, only early genes areexpressed and very low levels of protein is made",hierarchyLevel:6,children:[],index:"020301020301"},{text:" As the primitive basal keratinocyte replicates, the virus alsoreplicates together",hierarchyLevel:6,children:[],index:"020301020302"},{text:" As the epithelial cells become non-dividing, the viral DNA willstart amplifying",hierarchyLevel:6,children:[],index:"020301020303"},{text:" As the cells continue to differentiate, the early and late virlagenes are to be expressed, resulting in high levels of viral proteins made indifferentiating keratinocytes",hierarchyLevel:6,children:[],index:"020301020304"},{text:" At the apical side of the epithelium, the epithelial cells havedifferentiated into squamous epithelium",hierarchyLevel:6,children:[],index:"020301020305"},{text:" The virus is ready to be released at the apical side to infect anave individual",hierarchyLevel:6,children:[],index:"020301020306"}],index:"0203010203"},{text:" Immune response",hierarchyLevel:5,children:[{text:" Innate immune response repels invasion of pathogens, hence thevirus does not have the opportunity to enter deep into the body",hierarchyLevel:6,children:[],index:"020301020400"}],index:"0203010204"}],index:"02030102"}],index:"020301"},{text:" Target Tissues",hierarchyLevel:3,children:[{text:" Target tissue for replication and disease [Localised Infection]",hierarchyLevel:4,children:[{text:" Respiratory  influenza, respiratory syncytial virus (youngchildren)",hierarchyLevel:5,children:[],index:"0203020000"},{text:" Gastrointestinal  rotavirus, norovirus",hierarchyLevel:5,children:[],index:"0203020001"},{text:" Genitourinary  papillomavirus",hierarchyLevel:5,children:[],index:"0203020002"},{text:" Skin  papillomavirus",hierarchyLevel:5,children:[],index:"0203020003"}],index:"02030200"},{text:" Target tissue for replication and disease [Systemic Infection]",hierarchyLevel:4,children:[{text:" General",hierarchyLevel:5,children:[{text:" Longer incubation period due to systemic nature, access to thetarget organ is more complicated",hierarchyLevel:6,children:[],index:"020302010000"}],index:"0203020100"},{text:" Treatment",hierarchyLevel:5,children:[{text:" Post-exposure prophylaxis",hierarchyLevel:6,children:[{text:" Immunization  immunization or inject of antibodies",hierarchyLevel:7,children:[],index:"02030201010000"},{text:" Anti-viral drugs",hierarchyLevel:7,children:[],index:"02030201010001"}],index:"020302010100"}],index:"0203020101"},{text:" Types",hierarchyLevel:5,children:[],index:"0203020102"}],index:"02030201"}],index:"020302"},{text:" Viral Subepithelial Invasion",hierarchyLevel:3,children:[{text:" Types",hierarchyLevel:4,children:[],index:"02030300"},{text:" General Mechanism  Lymphatics to Blood to Systemic Infection",hierarchyLevel:4,children:[{text:" Inoculation",hierarchyLevel:5,children:[{text:" Virus lands on the mucosal surface and replicates among tosusceptible cell",hierarchyLevel:6,children:[],index:"020303010000"},{text:" The basement membrane holds up infection",hierarchyLevel:6,children:[],index:"020303010001"},{text:" However, inflammation results in the breaking down of theintegrity of the basement membrane enabling the virus to move into thesubepithelial tissue",hierarchyLevel:6,children:[],index:"020303010002"},{text:" Upon entry into the subepithelial tissue the macrophages respondsby phagocytosis. Dendritic cells pick up antigens from the virus and transportit into the lymph node",hierarchyLevel:6,children:[],index:"020303010003"},{text:" Some viruses enter the lymphatic capillary, and if there aresufficient numbers of viruses, the viruses will be able to pass the macrophagesand make it into the lymph node and eventually into the efferent lymphaticvessel and be drained into the blood",hierarchyLevel:6,children:[],index:"020303010004"}],index:"0203030100"},{text:" Primary Viraemia / Incubation Phase",hierarchyLevel:5,children:[{text:" From the blood, the virus moves into the liver, spleen and bloodvessel endothelium.",hierarchyLevel:6,children:[],index:"020303010100"},{text:" In the organs, the virus demonstrates low levels of viralreplication. This results in a silent infection where there is no sign of disease",hierarchyLevel:6,children:[],index:"020303010101"},{text:" When there is sufficient virus replicating in the liver, spleenand blood vessels, virus gets released into the blood again, forming secondaryviraemia",hierarchyLevel:6,children:[],index:"020303010102"}],index:"0203030101"},{text:" Secondary Viraemia",hierarchyLevel:5,children:[{text:" From the blood the virus in the blood then spreads to otherorgans such as, skin (smallpox), brain (poliovirus), lung (measles)",hierarchyLevel:6,children:[],index:"020303010200"},{text:" Virus then exits via one of the viral exit portals.",hierarchyLevel:6,children:[],index:"020303010201"}],index:"0203030102"}],index:"02030301"},{text:" Virus Exit Portals",hierarchyLevel:4,children:[],index:"02030302"}],index:"020303"},{text:" Acute and Persistent Viral Infections",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Short-lived (acute)",hierarchyLevel:5,children:[{text:" permanent clearance of virus infection (influenza, poliovirus)",hierarchyLevel:6,children:[],index:"020304000000"}],index:"0203040000"},{text:" Persistent",hierarchyLevel:5,children:[{text:" virus persists for a prolonged period (Herpesviruses, VZV, HIV,HCV)",hierarchyLevel:6,children:[],index:"020304000100"}],index:"0203040001"},{text:" Productive",hierarchyLevel:5,children:[{text:" Virus replication with production of virions",hierarchyLevel:6,children:[],index:"020304000200"}],index:"0203040002"},{text:" Latent",hierarchyLevel:5,children:[{text:" Non-productive",hierarchyLevel:6,children:[],index:"020304000300"},{text:" Infection in active state but no obvious effect on cell function",hierarchyLevel:6,children:[],index:"020304000301"},{text:" Infection may be persistent which last for the whole life of thehost",hierarchyLevel:6,children:[],index:"020304000302"},{text:" Few or no viral particles are produced despite the presence ofthe viral genome, and hence the immune system is unable to get rid of the virus",hierarchyLevel:6,children:[],index:"020304000303"},{text:" Latent infection can be activated again to cause disease",hierarchyLevel:6,children:[],index:"020304000304"}],index:"0203040003"}],index:"02030400"}],index:"020304"},{text:" Persistent Viral Infections",hierarchyLevel:3,children:[{text:" Diagram",hierarchyLevel:4,children:[{text:" Legend",hierarchyLevel:5,children:[{text:" Time scale is in years",hierarchyLevel:6,children:[],index:"020305000000"}],index:"0203050000"},{text:" Inference",hierarchyLevel:5,children:[{text:" Latent infection can be activated many years down the road",hierarchyLevel:6,children:[],index:"020305000100"}],index:"0203050001"}],index:"02030500"},{text:" Latency with intermittent virus production  VSV",hierarchyLevel:4,children:[{text:" Characteristics",hierarchyLevel:5,children:[{text:" Virus intermittently switches from the latent state to theproductive state",hierarchyLevel:6,children:[],index:"020305010000"},{text:" The latent state of the virus is protected from immune response",hierarchyLevel:6,children:[],index:"020305010001"}],index:"0203050100"},{text:" Properties of Primary Infection",hierarchyLevel:5,children:[{text:" Silent, asymptomatic",hierarchyLevel:6,children:[],index:"020305010100"}],index:"0203050101"},{text:" Mechanism of First/Primary Infection",hierarchyLevel:5,children:[{text:" Inoculation",hierarchyLevel:6,children:[{text:" The respiratory mucosa gets infected with the inoculation of thevirus",hierarchyLevel:7,children:[],index:"02030501020000"},{text:" Virus replicates in the regional nodes",hierarchyLevel:7,children:[],index:"02030501020001"},{text:" Virus spread to the blood resulting in primary viraemia",hierarchyLevel:7,children:[],index:"02030501020002"},{text:" From the blood virus moves into the liver and spleen andreplicates",hierarchyLevel:7,children:[],index:"02030501020003"}],index:"020305010200"},{text:" Acute Illness  chicken pox",hierarchyLevel:6,children:[{text:" Virus from the liver and spleen is released, resulting insecondary viraemia",hierarchyLevel:7,children:[],index:"02030501020100"},{text:" Virus is transported into skin and mucous membranes throughmononuclear cell transport",hierarchyLevel:7,children:[],index:"02030501020101"},{text:" From the mucous membranes, the virus is released into respiratorysecretions from sneezing",hierarchyLevel:7,children:[],index:"02030501020102"},{text:" Virus also spread to the epidermal cells in the skin, and virusreplicates in the epidermal cells and sheds itself from the skin cells",hierarchyLevel:7,children:[],index:"02030501020103"},{text:" This results in blisters and itchiness in the skin, resulting insymptoms of chicken pox",hierarchyLevel:7,children:[],index:"02030501020104"},{text:" Virus from the skin travels via the sensory nerve, up the axon ofthe sensory neuron and into the dorsal root ganglion",hierarchyLevel:7,children:[],index:"02030501020105"}],index:"020305010201"},{text:" Immunity",hierarchyLevel:6,children:[{text:" The body develops VZV specific immunity, hence preventing furtherreplication of the virus and recovery of the host",hierarchyLevel:7,children:[],index:"02030501020200"}],index:"020305010202"},{text:" Re-infection",hierarchyLevel:6,children:[{text:" The virus remains latent in the cell body of the sensory neuronsin the dorsal root ganglion. Virus does not express viral proteins and hence isundetected by the immune system",hierarchyLevel:7,children:[],index:"02030501020300"},{text:" Intermittently, the virus will move back down the sensory nerveand to the skin, causing the re-emergence of the virus. However, typically,before being able to arrive at the skin, the immune system reacts and neutralizesthe virus.",hierarchyLevel:7,children:[],index:"02030501020301"},{text:" However, when the immune system is weaker (older age), the viruswould be able re-infect the skin and affect a particular region of the sensoryinnervation of the skin",hierarchyLevel:7,children:[],index:"02030501020302"}],index:"020305010203"}],index:"0203050102"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0203050103"}],index:"02030501"},{text:" Latency with continual productive virus infection",hierarchyLevel:4,children:[],index:"02030502"},{text:" Persistent infection without latency",hierarchyLevel:4,children:[{text:" Implications",hierarchyLevel:5,children:[{text:" Anti-viral drugs can fully cure HCV since it does not havelatency",hierarchyLevel:6,children:[],index:"020305030000"}],index:"0203050300"}],index:"02030503"}],index:"020305"},{text:" Consequences of Viral Infections",hierarchyLevel:3,children:[{text:" General Consequences",hierarchyLevel:4,children:[{text:" Cell death leading to tissue injury",hierarchyLevel:5,children:[{text:" Examples",hierarchyLevel:6,children:[{text:" Poliovirus damages central nervous system",hierarchyLevel:7,children:[],index:"02030600000000"},{text:" Influenza virus damages respiratory tract",hierarchyLevel:7,children:[],index:"02030600000001"}],index:"020306000000"}],index:"0203060000"},{text:" Excessive immune response",hierarchyLevel:5,children:[{text:" Examples",hierarchyLevel:6,children:[{text:" Acute hepatitis B virus infection in adults",hierarchyLevel:7,children:[],index:"02030600010000"},{text:" Primary Epstein-Barr virus (EBV) infection in glandularfever/infectious mononucleosis",hierarchyLevel:7,children:[],index:"02030600010001"}],index:"020306000100"}],index:"0203060001"},{text:" Immunosuppression (HIV and opportunistic infectious disease)",hierarchyLevel:5,children:[],index:"0203060002"},{text:" Neoplasm (cancer)",hierarchyLevel:5,children:[{text:" 20% of cancers are virus induced",hierarchyLevel:6,children:[],index:"020306000300"}],index:"0203060003"}],index:"02030600"},{text:" EBV  Infectious mononucleosis",hierarchyLevel:4,children:[{text:" Transmission ",hierarchyLevel:5,children:[{text:" Saliva  via kissing",hierarchyLevel:6,children:[],index:"020306010000"}],index:"0203060100"},{text:" Targets",hierarchyLevel:5,children:[{text:" Oral epithelial cells",hierarchyLevel:6,children:[],index:"020306010100"},{text:" B cells",hierarchyLevel:6,children:[],index:"020306010101"}],index:"0203060101"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Immortalizes B cells with production of heterophile antibodies",hierarchyLevel:6,children:[],index:"020306010200"},{text:" Epstein-Barr virus causes the random stimulation of B cells,resulting in the constant division of B cell and the differentiation intoplasma cells. Plasma cells will then produce polyclonal antibodies.",hierarchyLevel:6,children:[],index:"020306010201"},{text:" T cells help to control B cell infection but also worsenssymptoms",hierarchyLevel:6,children:[],index:"020306010202"}],index:"0203060102"}],index:"02030601"}],index:"020306"},{text:" Host Status Effect on Viral Disease",hierarchyLevel:3,children:[{text:" Examples",hierarchyLevel:4,children:[{text:" Epstein-Barr Virus",hierarchyLevel:5,children:[{text:" Child  silent primary infection",hierarchyLevel:6,children:[],index:"020307000000"},{text:" Adolescent/adult  not silent",hierarchyLevel:6,children:[],index:"020307000001"}],index:"0203070000"},{text:" Rubella (German measles)",hierarchyLevel:5,children:[{text:" Mother  rash",hierarchyLevel:6,children:[],index:"020307000100"},{text:" Fetus -congenital infection",hierarchyLevel:6,children:[],index:"020307000101"}],index:"0203070001"},{text:" Herpes simplex virus",hierarchyLevel:5,children:[{text:" Immunocompetent  cold sores",hierarchyLevel:6,children:[],index:"020307000200"},{text:" Immunocompromised  pneumonia (virus able to travel down thetrachea) (opportunistic infection)",hierarchyLevel:6,children:[],index:"020307000201"},{text:" Genetically-determined specific immunodeficiency  herpes simplexencephalitis",hierarchyLevel:6,children:[],index:"020307000202"}],index:"0203070002"}],index:"02030700"}],index:"020307"},{text:" Virus Effect on Viral Disease",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Virulence  the relative capacity of viral infection to causedisease",hierarchyLevel:5,children:[],index:"0203080000"}],index:"02030800"},{text:" Understanding",hierarchyLevel:4,children:[{text:" Virus is pathogenic for a particular host if it can infect thehost and produce a disease",hierarchyLevel:5,children:[],index:"0203080100"},{text:" Infection of the host does not automatically mean the generationof disease",hierarchyLevel:5,children:[],index:"0203080101"}],index:"02030801"},{text:" Iceberg Concept of Infection",hierarchyLevel:4,children:[{text:" Most viruses do not cause disease",hierarchyLevel:5,children:[],index:"0203080200"}],index:"02030802"}],index:"020308"}],index:"0203"},{text:" [028] Laboratory Investigation of Viral Infections",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Purpose of Viral Infection Diagnosis",hierarchyLevel:4,children:[{text:" Management of Infection  with anti-viral drugs",hierarchyLevel:5,children:[],index:"0204000000"},{text:" Prophylaxis  prevent the spread of infection (HBV  prevent pregnantwomen spread to child)",hierarchyLevel:5,children:[],index:"0204000001"},{text:" Surveillance  detect outbreaks in the population, immunizeaffect populations",hierarchyLevel:5,children:[],index:"0204000002"}],index:"02040000"},{text:" Diagnosis Methods",hierarchyLevel:4,children:[{text:" Detect Host Antibody Response",hierarchyLevel:5,children:[],index:"0204000100"},{text:" Detection of virus, antigen or nucleic acid ",hierarchyLevel:5,children:[],index:"0204000101"}],index:"02040001"},{text:" Definitions",hierarchyLevel:4,children:[{text:" Serology",hierarchyLevel:5,children:[{text:" Study of antigen-antibody reactions in vitro",hierarchyLevel:6,children:[],index:"020400020000"},{text:" Measurement of   in serum (or plasma)",hierarchyLevel:6,children:[],index:"020400020001"}],index:"0204000200"},{text:" Plasma",hierarchyLevel:5,children:[{text:" Separate the cells from blood, leaving behind a clear plasmafluid",hierarchyLevel:6,children:[],index:"020400020100"}],index:"0204000201"},{text:" Serum",hierarchyLevel:5,children:[{text:" Clear fluid from clotted blood",hierarchyLevel:6,children:[],index:"020400020200"}],index:"0204000202"}],index:"02040002"}],index:"020400"},{text:" Host Antibody Response for Diagnosis",hierarchyLevel:3,children:[{text:" Measurement Molecule",hierarchyLevel:4,children:[{text:" IgG",hierarchyLevel:5,children:[{text:" Requires acute and convalescent sera at least 10 days apart todemonstrate seroconversion",hierarchyLevel:6,children:[],index:"020401000000"}],index:"0204010000"},{text:" IgM",hierarchyLevel:5,children:[{text:" Gives rapid diagnosis and suitable for congenital infection",hierarchyLevel:6,children:[],index:"020401000100"}],index:"0204010001"},{text:" Others",hierarchyLevel:5,children:[{text:" IgA  cannot use to measure as it is secreted in mucosal surfaces",hierarchyLevel:6,children:[],index:"020401000200"},{text:" IgE  found in very small amounts",hierarchyLevel:6,children:[],index:"020401000201"}],index:"0204010002"}],index:"02040100"},{text:" Diagram",hierarchyLevel:4,children:[{text:" IgG  will not tell you when the person got infected",hierarchyLevel:6,children:[],index:"0204010100"},{text:" IgM is more reliable",hierarchyLevel:6,children:[],index:"0204010101"},{text:" IgG is able to cross the placenta",hierarchyLevel:6,children:[],index:"0204010102"},{text:" Analyzing IgG in the fetus is just the IgG from the mother, andhence IgG declines after birth",hierarchyLevel:6,children:[],index:"0204010103"},{text:" To recognize an infection on the fetus, it is more useful toanalyze IgM because IgM cannot cross the placenta (immune complex), so any IgMfound must be generated by the fetus",hierarchyLevel:6,children:[],index:"0204010104"}],index:"02040101"},{text:" Detecting Persistent Infections",hierarchyLevel:4,children:[{text:" IgG to herpesvirus  cytomegalovirus, varicella-zoster virus",hierarchyLevel:5,children:[],index:"0204010200"},{text:" IgG to HIV",hierarchyLevel:5,children:[],index:"0204010201"}],index:"02040102"},{text:" Detecting Susceptibility to Infection",hierarchyLevel:4,children:[{text:" IgG to rubella in pregnant women",hierarchyLevel:5,children:[],index:"0204010300"},{text:" IgG to hepatitis B surface antigen after immunization",hierarchyLevel:5,children:[],index:"0204010301"}],index:"02040103"},{text:" Method of Detecting Antibodies (ELISA)",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0204010400"}],index:"02040104"},{text:" Disadvantages of Antibody Detection for Viral Infection Diagnosis",hierarchyLevel:4,children:[{text:" Immunosuprressed patietn may not make antibodies",hierarchyLevel:5,children:[],index:"0204010500"},{text:" Newborn may acquire antibodies from their mother, and hence it isnot a good indicator of infection",hierarchyLevel:5,children:[],index:"0204010501"},{text:" Antibody production is slow and hence there is a time lag beforeantibodies are detected",hierarchyLevel:5,children:[{text:" 14 days before antibodies are detected",hierarchyLevel:6,children:[],index:"020401050200"}],index:"0204010502"}],index:"02040105"},{text:" Samples for Antibody Detection ",hierarchyLevel:4,children:[{text:" Blood  HIV",hierarchyLevel:5,children:[],index:"0204010600"},{text:" Urine  cytomegalovirus (CMV kidney)",hierarchyLevel:5,children:[],index:"0204010601"},{text:" Faeces  rotavirus, norovirus",hierarchyLevel:5,children:[],index:"0204010602"},{text:" Nose and throat epithelial cells  respiratory syncytial virus (RSV),influenza",hierarchyLevel:5,children:[],index:"0204010603"},{text:" Vesicle fluid",hierarchyLevel:5,children:[],index:"0204010604"}],index:"02040106"},{text:" Viral Isolation",hierarchyLevel:4,children:[{text:" Tissue culture",hierarchyLevel:5,children:[{text:" Inoculate a human or animal cell monolayer with the sample",hierarchyLevel:6,children:[],index:"020401070000"},{text:" Observe for cytopathic effect (CPE)",hierarchyLevel:6,children:[],index:"020401070001"}],index:"0204010700"},{text:" Disadvantages",hierarchyLevel:5,children:[{text:" Takes weeks for cytopathic effect to appear",hierarchyLevel:6,children:[],index:"020401070100"},{text:" Some viruses cannot be cultured",hierarchyLevel:6,children:[],index:"020401070101"},{text:" Better alternative methods are available",hierarchyLevel:6,children:[],index:"020401070102"}],index:"0204010701"},{text:" Viral Culture test for neutralizing antibody",hierarchyLevel:5,children:[{text:" If antibody is present, antibody will bind to virus, then viruswill not infect the cell",hierarchyLevel:6,children:[],index:"020401070200"},{text:" If antibody is not present, then virus will infect the cell",hierarchyLevel:6,children:[],index:"020401070201"},{text:" Infected cell shows the lack of neutralizing antibodies",hierarchyLevel:6,children:[],index:"020401070202"}],index:"0204010702"}],index:"02040107"}],index:"020401"},{text:" Antigen Detection for Viral Infection Diagnosis",hierarchyLevel:3,children:[{text:" Application - Used as a point of care test (POCT) (hospital bythe bedside)",hierarchyLevel:4,children:[{text:" Example Viruses",hierarchyLevel:5,children:[{text:" Rotavirus",hierarchyLevel:6,children:[],index:"020402000000"},{text:" Respiratory Viruses (RSV, SARS-CoV2)",hierarchyLevel:6,children:[],index:"020402000001"}],index:"0204020000"}],index:"02040200"},{text:" Application  Used as Diagnostic Laboratory Test",hierarchyLevel:4,children:[{text:" ELIZA Sandwich Antigen Test",hierarchyLevel:5,children:[{text:" Immobilize antibodies on the plastic surface rather than antigens",hierarchyLevel:6,children:[],index:"020402010000"}],index:"0204020100"},{text:" Application",hierarchyLevel:5,children:[{text:" Used for pregnant women for HB, as it may affect the fetus",hierarchyLevel:6,children:[],index:"020402010100"}],index:"0204020101"},{text:" Example Viruses",hierarchyLevel:5,children:[{text:" Hepatitis B surface antigen (HBsAg) in serum",hierarchyLevel:6,children:[],index:"020402010200"}],index:"0204020102"}],index:"02040201"}],index:"020402"},{text:" Viral Nucleic Acid Detection",hierarchyLevel:3,children:[{text:" Tools",hierarchyLevel:4,children:[{text:" Polymerase chain reaction",hierarchyLevel:5,children:[],index:"0204030000"}],index:"02040300"},{text:" Results",hierarchyLevel:4,children:[{text:" Qualitative  yes or no",hierarchyLevel:5,children:[],index:"0204030100"},{text:" Quantitative  quantify the amount of virus in the sample (usefulfor treatable viruses)",hierarchyLevel:5,children:[],index:"0204030101"}],index:"02040301"},{text:" PCR Process",hierarchyLevel:4,children:[{text:" Taq Polymerase  Thermoaquaticus Polymerase (thermoresistant)",hierarchyLevel:5,children:[],index:"0204030200"},{text:" Preparation",hierarchyLevel:5,children:[{text:" Use reverse transcriptase to prepare cDNA from viral RNA",hierarchyLevel:6,children:[],index:"020403020100"}],index:"0204030201"}],index:"02040302"},{text:" Real-time PCR Process",hierarchyLevel:4,children:[{text:" Purpose of Taqman probe",hierarchyLevel:5,children:[{text:" Prevents the replication of sequences of DNA  which fits the primer butare not of interest",hierarchyLevel:6,children:[],index:"020403030000"},{text:" Enable the measurement of the amount of nucleic acid was presentat the start",hierarchyLevel:6,children:[],index:"020403030001"}],index:"0204030300"},{text:" Structure of the Taqman probe - oligonucleotide",hierarchyLevel:5,children:[{text:" Reporter  fluorescent if exposed to light",hierarchyLevel:6,children:[],index:"020403030100"},{text:" Quencher  quenches fluorescent if near enough",hierarchyLevel:6,children:[],index:"020403030101"}],index:"0204030301"},{text:" Process",hierarchyLevel:5,children:[{text:" A forward primer, reverse primer and TaqMan probe is added",hierarchyLevel:6,children:[],index:"020403030200"},{text:" Taq polymerase proceeds and reaches the report segment of TaqManprobe",hierarchyLevel:6,children:[],index:"020403030201"},{text:" Taq polymerase recognizes the TaqMan probe as foreign. Hence, Taqpolymerase utilises its 5-3 exonuclease to cleave of the TaqMan probe as itproceeds.",hierarchyLevel:6,children:[],index:"020403030202"},{text:" This causes the reporter molecule to be cleaved from the DNA.Removal of the reporter enables it to be no longer quenched by the Quencher onthe TaqMan probe.",hierarchyLevel:6,children:[],index:"020403030203"},{text:" This causes the Reporter to release fluorescent light whenexcited by light. The amount of fluorescence produced is measured and isproportional to the amount of PCR product made.",hierarchyLevel:6,children:[],index:"020403030204"},{text:" Taq polymerase proceeds and removes the rest of the TaqMan probeincluding the quencher",hierarchyLevel:6,children:[],index:"020403030205"}],index:"0204030302"},{text:" Advantages of Real-time (quantitative) PCR",hierarchyLevel:5,children:[{text:" Able to amplify and detect the product together with a TaqManprobe",hierarchyLevel:6,children:[],index:"020403030300"},{text:" Product can be detect through the fluorescence emission",hierarchyLevel:6,children:[],index:"020403030301"},{text:" A computer software can be used to monitor the product quantityfrom each PCR cycle",hierarchyLevel:6,children:[],index:"020403030302"},{text:" Able to conduct quantitation by analysis in log phase of reaction",hierarchyLevel:6,children:[],index:"020403030303"}],index:"0204030303"},{text:" Results",hierarchyLevel:5,children:[{text:" Legend",hierarchyLevel:6,children:[{text:" Y-axis: intensity of fluorescence",hierarchyLevel:7,children:[],index:"02040303040000"},{text:" X-axis: number of cycle",hierarchyLevel:7,children:[],index:"02040303040001"},{text:" Threshold  threshold line shows the point of logarithmic phaseof the reaction",hierarchyLevel:7,children:[],index:"02040303040002"}],index:"020403030400"},{text:" Analysis",hierarchyLevel:6,children:[{text:" The number of cycles a particular sample takes to reach thethreshold fluorescence is noted",hierarchyLevel:7,children:[],index:"02040303040100"},{text:" The greater the number of cycles the less the amount of startingnucleic acid present in the sample",hierarchyLevel:7,children:[],index:"02040303040101"},{text:" A standard curve is used to quantify the amount of nucleic acidpresent from the number of cycles taken",hierarchyLevel:7,children:[],index:"02040303040102"}],index:"020403030401"}],index:"0204030304"}],index:"02040303"}],index:"020403"}],index:"0204"},{text:" [040] Antivirals",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Methods of Discovering Antivirals",hierarchyLevel:4,children:[{text:" Serendipitous discovery",hierarchyLevel:5,children:[],index:"0205000000"},{text:" Specific development based on known structure of viruses",hierarchyLevel:5,children:[],index:"0205000001"}],index:"02050000"},{text:" Development of Antivirals",hierarchyLevel:4,children:[{text:" Requirements",hierarchyLevel:5,children:[{text:" Antiviral drugs must inhibit virus replication",hierarchyLevel:6,children:[],index:"020500010000"},{text:" Antiviral drugs depend on host metabolic pathways",hierarchyLevel:6,children:[],index:"020500010001"}],index:"0205000100"},{text:" Solution",hierarchyLevel:5,children:[{text:" Inhibit virus encoded proteins with essential functions in ahighly specific manner",hierarchyLevel:6,children:[],index:"020500010100"}],index:"0205000101"}],index:"02050001"},{text:" Analysing Antiviral Drug Efficacy",hierarchyLevel:4,children:[{text:" At least 10, preferably 100  1000",hierarchyLevel:5,children:[],index:"0205000200"}],index:"02050002"},{text:" Overall Strategy",hierarchyLevel:4,children:[{text:" Look at the overall viral replication system and look at whichlocation can be inhibited and is more susceptible",hierarchyLevel:5,children:[],index:"0205000300"}],index:"02050003"},{text:" Inhibition Strategy",hierarchyLevel:4,children:[{text:" Inhibit viral attachment to plasma membrane",hierarchyLevel:5,children:[],index:"0205000400"},{text:" Inhibit entry / uncoating of viruses",hierarchyLevel:5,children:[],index:"0205000401"},{text:" Inhibit nucleic acid synthesis of viruses",hierarchyLevel:5,children:[],index:"0205000402"},{text:" Inhibit assembly of virons",hierarchyLevel:5,children:[],index:"0205000403"},{text:" Inhibit release of viruses",hierarchyLevel:5,children:[],index:"0205000404"}],index:"02050004"},{text:" Proteins involved in Viral Nucleic Acid Synthesis",hierarchyLevel:4,children:[{text:" Viral DNA polymerase",hierarchyLevel:5,children:[],index:"0205000500"},{text:" Viral reverse transcriptase  RNA viruses",hierarchyLevel:5,children:[],index:"0205000501"},{text:" Viral RNA polymerase",hierarchyLevel:5,children:[],index:"0205000502"},{text:" Viral RNA polymerase  required to copy RNA from RNA, henceenables replication",hierarchyLevel:5,children:[],index:"0205000503"}],index:"02050005"},{text:" Strategy to Target Proteins",hierarchyLevel:4,children:[{text:" Utilize nucleoside analouges to inhibit viral nucleic acidproteins",hierarchyLevel:5,children:[],index:"0205000600"}],index:"02050006"}],index:"020500"},{text:" HSV and VZV: Inhibit nuclei acid synthesis of viruses",hierarchyLevel:3,children:[{text:" Properties Aciclovir",hierarchyLevel:4,children:[{text:" Prodrug  biologically inactive which can be activated to producethe antiviral drug (precursor of the drug)",hierarchyLevel:5,children:[],index:"0205010000"}],index:"02050100"},{text:" Structure of Aciclovir (Acycloguanosine)",hierarchyLevel:4,children:[{text:" Has a guanine base",hierarchyLevel:5,children:[],index:"0205010100"},{text:" Does not have the 3 hydroxyl of the ribose ring, does not havethe cyclic structure on the ribose, (a  cylco = lack of cyclic structure)",hierarchyLevel:5,children:[],index:"0205010101"}],index:"02050101"},{text:" Mode of Action of Aciclovir (ACV)",hierarchyLevel:4,children:[{text:" Definitions",hierarchyLevel:5,children:[{text:" Pyrophosphate  phosphate groups on nucleoside triphosphate thatis released",hierarchyLevel:6,children:[],index:"020501020000"}],index:"0205010200"},{text:" Background Info\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd ",hierarchyLevel:5,children:[{text:" The virus has thymidine kinase because the virus needs to subvertthe cell into a virus factory. ",hierarchyLevel:6,children:[],index:"020501020100"},{text:" To become a virus factory, the cell needs to produce morenucleotide for the virus DNA to be replicated.",hierarchyLevel:6,children:[],index:"020501020101"},{text:" To assist taking over the cell, the virus makes its down kinaseto phosphorylate guanosine.",hierarchyLevel:6,children:[],index:"020501020102"}],index:"0205010201"},{text:" Goal",hierarchyLevel:5,children:[{text:" Create a viral nucleoside triphosphate analogue to disrupt viralDNA polymerase",hierarchyLevel:6,children:[],index:"020501020200"}],index:"0205010202"},{text:" Mechanism of Drug Generation",hierarchyLevel:5,children:[{text:" Viral thymidine kinase is able to recognize the guanosine analogand modified ACV into ACV-P with a phosphate group attached to the 5 hydroxyl.",hierarchyLevel:6,children:[],index:"020501020300"},{text:" Cellular kinases converts ACV-P into ACV-PPP (normal cellmachinery)",hierarchyLevel:6,children:[],index:"020501020301"},{text:" ACV-PPP is a dGTP analogue and hence serves as the antiviral drug",hierarchyLevel:6,children:[],index:"020501020302"},{text:" ACV-PPP inhibits HSV and VZV DNA polymerase",hierarchyLevel:6,children:[],index:"020501020303"}],index:"0205010203"},{text:" Mechanism of Drug Action",hierarchyLevel:5,children:[],index:"0205010204"},{text:" Reasons for Low Toxicity",hierarchyLevel:5,children:[{text:" ACV is only phosphorylated by viral thymidine kinase, cannot bephosphorylated by cellular thymidine kinase. This is because viral thymidinekinase has broad specificity. This is because broad specificity of viral kinaseis advantageous to increase the pool of nucleotides and assist replication.",hierarchyLevel:6,children:[],index:"020501020500"},{text:" Cellular thymidine kinase does not phosphorylate ACV",hierarchyLevel:6,children:[],index:"020501020501"},{text:" ACVTP 10x more effective at inhibiting viral DNA polymerase thancellular DNA polymerase",hierarchyLevel:6,children:[],index:"020501020502"}],index:"0205010205"},{text:" Disadvantages of Aciclovir",hierarchyLevel:5,children:[{text:" Only works when the adaptive immune system in intact",hierarchyLevel:6,children:[],index:"020501020600"},{text:" In patient with HIV and HSV, acyclovir would not work as theadaptive immune system is compromised.",hierarchyLevel:6,children:[],index:"020501020601"},{text:" HSV is a latent virus, hence it is able to continue replicatingat low levels when the adaptive immune system is down. ",hierarchyLevel:6,children:[],index:"020501020602"},{text:" Over time, through natural selection, continuous replication ofHSV in HIV patient results in the development of resistance to Aciclovir",hierarchyLevel:6,children:[],index:"020501020603"}],index:"0205010206"},{text:" Resistance to Acyclovir",hierarchyLevel:5,children:[{text:" Viral thymidine kinase is absent or has an altered substratespecificity (common)",hierarchyLevel:6,children:[],index:"020501020700"},{text:" Virus DNA polymerase has altered substrate specificity (rare)",hierarchyLevel:6,children:[],index:"020501020701"}],index:"0205010207"}],index:"02050102"}],index:"020501"},{text:" HIV",hierarchyLevel:3,children:[{text:" Strategy for Antivirals",hierarchyLevel:4,children:[{text:" Inhibition of Entry",hierarchyLevel:5,children:[],index:"0205020000"},{text:" Inhibit reverse transcriptase",hierarchyLevel:5,children:[],index:"0205020001"},{text:" Block CD4 binding ",hierarchyLevel:5,children:[],index:"0205020002"},{text:" Block coreceptor binding",hierarchyLevel:5,children:[],index:"0205020003"}],index:"02050200"},{text:" Nucleoside Reverse Transcriptase Inhibitors (NRTI)",hierarchyLevel:4,children:[{text:" Strategies for Reverse Transcriptase Inhibition",hierarchyLevel:5,children:[{text:" Nucleoside analog",hierarchyLevel:6,children:[],index:"020502010000"},{text:" Nucleotide analog",hierarchyLevel:6,children:[],index:"020502010001"}],index:"0205020100"},{text:" Examples",hierarchyLevel:5,children:[{text:" Azidothymidine (zidovudine)",hierarchyLevel:6,children:[],index:"020502010100"}],index:"0205020101"},{text:" Mechanism of Drug Generation",hierarchyLevel:5,children:[{text:" Cellular kinases is able to recognize the thymidine analog andmodifies AZT into AZT-P with a phosphate group attached to the 5 hydroxyl. ",hierarchyLevel:6,children:[],index:"020502010200"},{text:" Cellular kinases convert AZT-P into ACV-PPP (normal cellmachinery)",hierarchyLevel:6,children:[],index:"020502010201"},{text:" AZT-PPP is a dTTP analogue and hence serves as the antiviral drug",hierarchyLevel:6,children:[],index:"020502010202"},{text:" AZT-PPP inhibits HIV reverse transcriptase by early chaintermiantion",hierarchyLevel:6,children:[],index:"020502010203"}],index:"0205020102"},{text:" Mechanism of Drug Action",hierarchyLevel:5,children:[{text:" Azidothymidine is a thymine analog, with no 3 OH group andinstead has an azide group",hierarchyLevel:6,children:[],index:"020502010300"}],index:"0205020103"},{text:" Reason for higher toxicity",hierarchyLevel:5,children:[{text:" AZT can be activated in any cell in the body because it does notrequire a viral kinase and only relies of cellular kinases for drug generation.",hierarchyLevel:6,children:[],index:"020502010400"},{text:" Therefore, AZT not only inhibits viral reverse transcriptase, butit also inhibit host DNA replication",hierarchyLevel:6,children:[],index:"020502010401"}],index:"0205020104"}],index:"02050201"},{text:" Mechanism Comparison between Acyclovir and Azidothymidine",hierarchyLevel:4,children:[],index:"02050202"},{text:" Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)",hierarchyLevel:4,children:[{text:" Examples",hierarchyLevel:5,children:[{text:" Nevirapine",hierarchyLevel:6,children:[],index:"020502030000"}],index:"0205020300"},{text:" Strategy for Inibition",hierarchyLevel:5,children:[{text:" Allosteric inhibition of HIV Reverse Transcriptase, results inconformational change in of the active site and hence disabling the enzyme",hierarchyLevel:6,children:[],index:"020502030100"},{text:" AZT binding site is different from the Polymerase active site",hierarchyLevel:6,children:[],index:"020502030101"}],index:"0205020301"}],index:"02050203"},{text:" Inhibition of Viral Integrase",hierarchyLevel:4,children:[{text:" Strategy",hierarchyLevel:5,children:[],index:"0205020400"},{text:" Examples",hierarchyLevel:5,children:[{text:" Raltegravir",hierarchyLevel:6,children:[],index:"020502040100"}],index:"0205020401"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0205020402"},{text:" Mechanism of Drug Action",hierarchyLevel:5,children:[{text:" Normal Function",hierarchyLevel:6,children:[{text:" Integrase catalyzes the incorporation of the viral DNA into thehost chromosome. This requires the action of the DNA repair enzyme.",hierarchyLevel:7,children:[],index:"02050204030000"},{text:" Integrase attaches to the host chromosome in a region wheretranscription is active and there are transcription factors for it to attach to",hierarchyLevel:7,children:[],index:"02050204030001"}],index:"020502040300"},{text:" Raltegravir Action",hierarchyLevel:6,children:[{text:" Raltegravir binds to the integrase, preventing it from binding tothe host DNA and inserting the viral DNA",hierarchyLevel:7,children:[],index:"02050204030100"},{text:" In theory by preventing integration of viral DNA, we can preventthe latency problem of viruses, however, the technology is not there yet",hierarchyLevel:7,children:[],index:"02050204030101"}],index:"020502040301"}],index:"0205020403"}],index:"02050204"},{text:" Inhibition of Viral Proteases",hierarchyLevel:4,children:[{text:" Examples",hierarchyLevel:5,children:[{text:" Saquinavir",hierarchyLevel:6,children:[],index:"020502050000"}],index:"0205020500"},{text:" Drug Development and Research",hierarchyLevel:5,children:[{text:" Studying the HIV protease using X ray analysis, working out itsstructure and deciding what would be a good peptide analogue to lock the HIVprotease by binding to the active site",hierarchyLevel:6,children:[],index:"020502050100"}],index:"0205020501"},{text:" Mechanism of Drug Action",hierarchyLevel:5,children:[{text:" Normal Function",hierarchyLevel:6,children:[{text:" HIV protease splits of up viral polyproteins into essential components",hierarchyLevel:7,children:[{text:" Capsid",hierarchyLevel:8,children:[],index:"0205020502000000"},{text:" Matrix Protein",hierarchyLevel:8,children:[],index:"0205020502000001"},{text:" Envelope",hierarchyLevel:8,children:[],index:"0205020502000002"}],index:"02050205020000"},{text:" HIV protease utilizes viral polyprotein to produce HIV reversetranscriptase and HIV integrase, which are associated with the viral RNA at thecore",hierarchyLevel:7,children:[],index:"02050205020001"}],index:"020502050200"},{text:" Drug Action",hierarchyLevel:6,children:[],index:"020502050201"}],index:"0205020502"}],index:"02050205"}],index:"020502"},{text:" Applications in Clinical Practice",hierarchyLevel:3,children:[{text:" Trend",hierarchyLevel:4,children:[{text:" Initially, the drug suppresses the virus. However, over time, theselection pressure applied by the drug selects for viruses that are able toevade the drug and hence the RNA change starts going up over time",hierarchyLevel:5,children:[],index:"0205030000"}],index:"02050300"},{text:" Highly Active Anti-retroviral Therapy (HAART)",hierarchyLevel:4,children:[{text:" Use 2 NRTI with slightly different properties and molecularstructure together with a protease inhibitor",hierarchyLevel:5,children:[],index:"0205030100"},{text:" Chance of Developing Resistance to 1 drug: 1 / 1000",hierarchyLevel:5,children:[],index:"0205030101"},{text:" Chance of Developing Resistance to 3 drugs together: 1 / 1 000000 000",hierarchyLevel:5,children:[],index:"0205030102"}],index:"02050301"},{text:" Disadvantages of HAART",hierarchyLevel:4,children:[{text:" Toxicity",hierarchyLevel:5,children:[],index:"0205030200"},{text:" Viral load rebounds if treatment is stopped",hierarchyLevel:5,children:[],index:"0205030201"},{text:" Resistance may develop if doses are missed",hierarchyLevel:5,children:[],index:"0205030202"},{text:" Unable to eradicate latent virus",hierarchyLevel:5,children:[],index:"0205030203"}],index:"02050302"},{text:" Lipodystrophy (fat illness) from HAART",hierarchyLevel:4,children:[{text:" Caused by Protease inhibitors",hierarchyLevel:5,children:[],index:"0205030300"}],index:"02050303"},{text:" Diagram",hierarchyLevel:4,children:[],index:"02050304"},{text:" Challenges of Antiviral Therapy",hierarchyLevel:4,children:[{text:" Difficult because viruses are intracellular",hierarchyLevel:5,children:[],index:"0205030500"},{text:" Latent viruses cannot be eradicated",hierarchyLevel:5,children:[],index:"0205030501"}],index:"02050305"},{text:" Overview",hierarchyLevel:4,children:[],index:"02050306"}],index:"020503"}],index:"0205"}]},{text:"Bacteriology",hierarchyLevel:1,children:[{text:" [005] Bacteria: Structure and Properties",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Describe the structure of bacteria",hierarchyLevel:4,children:[],index:"03000000"},{text:" Describe the major groupings of bacteria",hierarchyLevel:4,children:[],index:"03000001"},{text:" Recognize the staining reactions of bacteria",hierarchyLevel:4,children:[],index:"03000002"},{text:" Recognize the names of the common bacteria",hierarchyLevel:4,children:[],index:"03000003"},{text:" Describe the growth characteristics of bacteria",hierarchyLevel:4,children:[],index:"03000004"}],index:"030000"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Structure",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Naked DNA in the form of DNA coiled into nucleoid (no nucleus)",hierarchyLevel:6,children:[],index:"030001000000"},{text:" Pili  adhere to surfaces",hierarchyLevel:6,children:[],index:"030001000001"},{text:" Flagellum  movement",hierarchyLevel:6,children:[],index:"030001000002"},{text:" 70S ribosomes  target of antibiotics",hierarchyLevel:6,children:[],index:"030001000003"}],index:"0300010000"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0300010001"}],index:"03000100"},{text:" Broad Classification",hierarchyLevel:4,children:[{text:" Prokaryotes",hierarchyLevel:5,children:[],index:"0300010100"}],index:"03000101"},{text:" Detailed Classification of Bacteria",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Identify the kind of infection that occurred",hierarchyLevel:6,children:[],index:"030001020000"},{text:" Identify the bacteria and where the bacteria is from",hierarchyLevel:6,children:[],index:"030001020001"},{text:" Identify the right antibiotics that would be effective",hierarchyLevel:6,children:[],index:"030001020002"}],index:"0300010200"},{text:" Methods",hierarchyLevel:5,children:[{text:" Gram Stain",hierarchyLevel:6,children:[],index:"030001020100"},{text:" Shape",hierarchyLevel:6,children:[],index:"030001020101"},{text:" Taxonomy",hierarchyLevel:6,children:[],index:"030001020102"},{text:" Aerobe vs Anaerobe",hierarchyLevel:6,children:[],index:"030001020103"}],index:"0300010201"},{text:" Gram Stain (Process)",hierarchyLevel:5,children:[{text:" Take blood samples",hierarchyLevel:6,children:[],index:"030001020200"},{text:" Culture the blood samples in an incubator machine in the lab",hierarchyLevel:6,children:[],index:"030001020201"},{text:" After 5 days, look to see if the bottle pings positive",hierarchyLevel:6,children:[],index:"030001020202"},{text:" Ping indicates bacterial growth at the logarithmic phase.Carbon dioxide content increases due to rapid bacterial growth, resulting inping",hierarchyLevel:6,children:[],index:"030001020203"},{text:" Take a sample of bacteria from the blood sample and culture it onan agar plate, and incubate it",hierarchyLevel:6,children:[],index:"030001020204"},{text:" Perform a gram stain on the bacteria on the agar plate",hierarchyLevel:6,children:[{text:" Iodine causes everything to be purple",hierarchyLevel:7,children:[],index:"03000102020500"},{text:" Alcohol turns gram negative bacteria colourless (due to thinnercell wall)",hierarchyLevel:7,children:[],index:"03000102020501"},{text:" Safranin turns gram negative bacteria red",hierarchyLevel:7,children:[],index:"03000102020502"}],index:"030001020205"}],index:"0300010202"},{text:" Shape",hierarchyLevel:5,children:[{text:" Coccus (singular: cocci) - spherical",hierarchyLevel:6,children:[],index:"030001020300"},{text:" Bacillus (singular: bacilli) / rods",hierarchyLevel:6,children:[],index:"030001020301"},{text:" Spirochetes",hierarchyLevel:6,children:[],index:"030001020302"}],index:"0300010203"},{text:" Aerobe vs Anaerobe",hierarchyLevel:5,children:[{text:" Examples",hierarchyLevel:6,children:[{text:" Require oxygen  obligate aerobe",hierarchyLevel:7,children:[],index:"03000102040000"},{text:" Reduced oxygen  microaerophile",hierarchyLevel:7,children:[],index:"03000102040001"},{text:" Total absence of oxygen  obligate anaerobe",hierarchyLevel:7,children:[],index:"03000102040002"},{text:" Tolerant of oxygen level  facultative anaerobe",hierarchyLevel:7,children:[],index:"03000102040003"},{text:" Require increased CO  - capnophile",hierarchyLevel:7,children:[],index:"03000102040004"}],index:"030001020400"},{text:" Process",hierarchyLevel:6,children:[{text:" Take two blood cultures and analyze them by pings and gramstaining separately",hierarchyLevel:7,children:[],index:"03000102040100"}],index:"030001020401"},{text:" Reasoning",hierarchyLevel:6,children:[{text:" Some bacteria only proliferate in aerobic environment and someonly in anerobic environment",hierarchyLevel:7,children:[],index:"03000102040200"},{text:" Need to provide both environments such that all types of bacteriacan be detected",hierarchyLevel:7,children:[],index:"03000102040201"}],index:"030001020402"}],index:"0300010204"}],index:"03000102"},{text:" Common Bacteria",hierarchyLevel:4,children:[{text:" Table",hierarchyLevel:5,children:[],index:"0300010300"}],index:"03000103"}],index:"030001"},{text:" Gram Positive Bacteria",hierarchyLevel:3,children:[{text:" Diagram",hierarchyLevel:4,children:[],index:"03000200"},{text:" General Properties",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Thick murein layer protects against desiccation",hierarchyLevel:6,children:[],index:"030002010000"}],index:"0300020100"},{text:" Location",hierarchyLevel:5,children:[{text:" Lives on the skin  thick murein layer enables it to surviveharsh external environment while living on the skin",hierarchyLevel:6,children:[],index:"030002010100"}],index:"0300020101"},{text:" Drugs Targeting  Penicillin",hierarchyLevel:5,children:[{text:" Penicillin destroys the thick murein cell wall, hence killing thebacteria",hierarchyLevel:6,children:[],index:"030002010200"}],index:"0300020102"}],index:"03000201"},{text:" Gram positive Cocci",hierarchyLevel:4,children:[{text:" Clumps  Staphylococcus sp.",hierarchyLevel:5,children:[{text:" Examples",hierarchyLevel:6,children:[],index:"030002020000"},{text:" Identification (Coagulase)",hierarchyLevel:6,children:[],index:"030002020001"},{text:" Diagram",hierarchyLevel:6,children:[],index:"030002020002"}],index:"0300020200"},{text:" Chains  Streptococcus sp.",hierarchyLevel:5,children:[{text:" Examples",hierarchyLevel:6,children:[{text:" Alpha Hemolysis  Streptococcus viridans (green)",hierarchyLevel:7,children:[],index:"03000202010000"},{text:" Beta Hemolysis - group A Streptococcus (strep throat)",hierarchyLevel:7,children:[],index:"03000202010001"},{text:" Gamma Hemolysis",hierarchyLevel:7,children:[],index:"03000202010002"}],index:"030002020100"},{text:" Identification",hierarchyLevel:6,children:[],index:"030002020101"},{text:" Diagram",hierarchyLevel:6,children:[],index:"030002020102"}],index:"0300020201"}],index:"03000202"},{text:" Gram positive bacilli",hierarchyLevel:4,children:[{text:" Sporing",hierarchyLevel:5,children:[{text:" Significance",hierarchyLevel:6,children:[{text:" Spores are extremely resistant and respond to unfavorableconditions",hierarchyLevel:7,children:[],index:"03000203000000"},{text:" Spores can stay on surfaces for a long time and spread to otherorganisms in the hospital",hierarchyLevel:7,children:[],index:"03000203000001"}],index:"030002030000"},{text:" Examples",hierarchyLevel:6,children:[{text:" Bacillus",hierarchyLevel:7,children:[],index:"03000203000100"},{text:" Clostridium",hierarchyLevel:7,children:[],index:"03000203000101"}],index:"030002030001"}],index:"0300020300"},{text:" Non-sporing",hierarchyLevel:5,children:[{text:" Examples",hierarchyLevel:6,children:[{text:" Listeria  causes meningitis, may cause miscarriage",hierarchyLevel:7,children:[],index:"03000203010000"}],index:"030002030100"}],index:"0300020301"}],index:"03000203"},{text:" Diagram",hierarchyLevel:4,children:[],index:"03000204"}],index:"030002"},{text:" Gram Negative Bacteria",hierarchyLevel:3,children:[{text:" Properties",hierarchyLevel:4,children:[{text:" Contains porins which are able to pump out antibiotics, hence ",hierarchyLevel:5,children:[],index:"0300030000"},{text:" Cell wall is more complex with an inner and outer membraneseparated by periplasm and a thin layer of murein",hierarchyLevel:5,children:[],index:"0300030001"}],index:"03000300"},{text:" Gram -ve bacillus",hierarchyLevel:4,children:[{text:" Examples - enterobacteriaciae (bacteria in the gut)",hierarchyLevel:5,children:[{text:" Escherichia coli",hierarchyLevel:6,children:[],index:"030003010000"},{text:" Klebsiella",hierarchyLevel:6,children:[],index:"030003010001"},{text:" Salmonella",hierarchyLevel:6,children:[],index:"030003010002"}],index:"0300030100"}],index:"03000301"},{text:" Gram -ve curved bacillus (curved rods)",hierarchyLevel:4,children:[{text:" Examples",hierarchyLevel:5,children:[{text:" Campylobacter",hierarchyLevel:6,children:[],index:"030003020000"},{text:" Helicobacter (helicobacter pylori)  gastric ulcers",hierarchyLevel:6,children:[],index:"030003020001"},{text:" Vibrio (Vibrio cholerae)",hierarchyLevel:6,children:[],index:"030003020002"}],index:"0300030200"},{text:" Properties - Campylobacter",hierarchyLevel:5,children:[{text:" Causes diarrhea ",hierarchyLevel:6,children:[],index:"030003020100"},{text:" Microaerophillic  require low oxygen tension",hierarchyLevel:6,children:[],index:"030003020101"},{text:" Thermophillic  able to grow at 42C",hierarchyLevel:6,children:[],index:"030003020102"}],index:"0300030201"}],index:"03000302"},{text:" Gram -ve diplo cocci",hierarchyLevel:4,children:[{text:" Examples",hierarchyLevel:5,children:[{text:" Neisseria meningitidis",hierarchyLevel:6,children:[],index:"030003030000"},{text:" Neisseria gonorrhea",hierarchyLevel:6,children:[],index:"030003030001"}],index:"0300030300"}],index:"03000303"}],index:"030003"},{text:" Spirochaetes",hierarchyLevel:3,children:[{text:" Examples",hierarchyLevel:4,children:[{text:" Syphilis (treponema)",hierarchyLevel:5,children:[],index:"0300040000"}],index:"03000400"},{text:" Diagram",hierarchyLevel:4,children:[{text:" ",hierarchyLevel:5,children:[],index:"0300040100"}],index:"03000401"}],index:"030004"},{text:" Other Exceptions",hierarchyLevel:3,children:[{text:" Mycobacteria",hierarchyLevel:4,children:[{text:" Properties of Mycobacteria",hierarchyLevel:5,children:[{text:" Has a thick and lipid rich cell wall  does not stain as positiveor negative",hierarchyLevel:6,children:[],index:"030005000000"}],index:"0300050000"},{text:" Detecting Tuberculosis (Mycobacteria)",hierarchyLevel:5,children:[{text:" Use Ziehl Neelsen stain, causes Acid Fast Bacilli (AFB) to becomevisible",hierarchyLevel:6,children:[],index:"030005000100"}],index:"0300050001"}],index:"03000500"},{text:" Mycoplasma",hierarchyLevel:4,children:[{text:" Properties of Mycoplasmas",hierarchyLevel:5,children:[{text:" Lack a rigid cell wall  antibiotics that work on the cell wallwill not work",hierarchyLevel:6,children:[],index:"030005010000"},{text:" Causes atypical pneumonia  requires a different type of bacteria",hierarchyLevel:6,children:[],index:"030005010001"}],index:"0300050100"}],index:"03000501"}],index:"030005"}],index:"0300"},{text:"",hierarchyLevel:2,children:[{text:"",hierarchyLevel:3,children:[{text:" Understand that commensal flora can become pathogenic",hierarchyLevel:4,children:[],index:"03010000"},{text:" Understand major reservoirs of pathogens",hierarchyLevel:4,children:[],index:"03010001"},{text:" Understand main routes of transmission of pathogens",hierarchyLevel:4,children:[],index:"03010002"}],index:"030100"},{text:"",hierarchyLevel:3,children:[{text:" Definition",hierarchyLevel:4,children:[{text:" Commensals  bacteria that live on the surface and providebenefit to humans ",hierarchyLevel:5,children:[],index:"0301010000"}],index:"03010100"},{text:" Location",hierarchyLevel:4,children:[{text:" Skin and Mucosa",hierarchyLevel:5,children:[],index:"0301010100"}],index:"03010101"},{text:" Examples",hierarchyLevel:4,children:[{text:" Staph epidermidis",hierarchyLevel:5,children:[],index:"0301010200"},{text:" Viridans type streptococci",hierarchyLevel:5,children:[],index:"0301010201"},{text:" Enterobacteriaceae",hierarchyLevel:5,children:[],index:"0301010202"},{text:" Anaerobes",hierarchyLevel:5,children:[],index:"0301010203"}],index:"03010102"},{text:" Pathogenic Effect",hierarchyLevel:4,children:[{text:" General Mechanism",hierarchyLevel:5,children:[{text:" Commensal bacteria move from the surface of the body, into thebody",hierarchyLevel:6,children:[],index:"030101030000"},{text:" This causes commensals to become pathogens",hierarchyLevel:6,children:[],index:"030101030001"}],index:"0301010300"},{text:" Examples",hierarchyLevel:5,children:[{text:" Viridanstype streptococci in the mouth enter the bloodstream, causing infectiveendocarditis",hierarchyLevel:6,children:[],index:"030101030100"},{text:" Enterobacteriaceae and anaerobes in the gut enter peritonuealcavity (sterile), causing peritonitis",hierarchyLevel:6,children:[],index:"030101030101"},{text:" Staphylococcus epidermidis gets onto a prosthetic surface causinga prosthetic infection (pacemaker / central line infection)",hierarchyLevel:6,children:[],index:"030101030102"}],index:"0301010301"}],index:"03010103"}],index:"030101"},{text:" Reservoir of Bacteria",hierarchyLevel:3,children:[],index:"030102"}],index:"0301"},{text:" [014] How bacteria cause disease",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Types of Pathogens",hierarchyLevel:4,children:[{text:" Commensals",hierarchyLevel:5,children:[],index:"0302000000"},{text:" Never commensals",hierarchyLevel:5,children:[{text:" Streptococcus pyogenes",hierarchyLevel:6,children:[],index:"030200000100"},{text:" Neisseria gonorrhea",hierarchyLevel:6,children:[],index:"030200000101"},{text:" Bordetella pertussis",hierarchyLevel:6,children:[],index:"030200000102"},{text:" Mycobacterium tuberculosis",hierarchyLevel:6,children:[],index:"030200000103"}],index:"0302000001"},{text:" Environmental  low virulence, causes diseases in compromisedpeople (opportunist)",hierarchyLevel:5,children:[{text:" Pseudomonas aeruginosa",hierarchyLevel:6,children:[],index:"030200000200"}],index:"0302000002"}],index:"03020000"},{text:" Definitions",hierarchyLevel:4,children:[{text:" Primary pathogen  possess the inherent ability to breach hostdefences",hierarchyLevel:5,children:[],index:"0302000100"},{text:" Opportunistic pathogen  only able to infect host when host hascompromised defenses (defect or alteration in defenses)",hierarchyLevel:5,children:[],index:"0302000101"},{text:" Polymicrobial infection  an infection resulting from more thanone micro-organism, working synergistically with one another to producepathogenic effect",hierarchyLevel:5,children:[],index:"0302000102"}],index:"03020001"},{text:" Factors affecting pathogenicity (how toxic) of bacteria",hierarchyLevel:4,children:[{text:" Presence of bacteriophage that produces bacteriophage encodedtoxins",hierarchyLevel:5,children:[],index:"0302000200"},{text:" Expression levels of toxins",hierarchyLevel:5,children:[],index:"0302000201"},{text:" Possession of a polysaccharide vacuole that is anti-phagocytic tothe right serotype",hierarchyLevel:5,children:[],index:"0302000202"}],index:"03020002"}],index:"030200"},{text:" Pathogenic Powers",hierarchyLevel:3,children:[{text:" Access",hierarchyLevel:4,children:[{text:" Basic Principle",hierarchyLevel:5,children:[{text:" Pathogen must be able to move to access the right location /niche in the host to exert its pathogenic effect",hierarchyLevel:6,children:[],index:"030201000000"}],index:"0302010000"},{text:" Enablers",hierarchyLevel:5,children:[{text:" Motility  flagellum",hierarchyLevel:6,children:[],index:"030201000100"},{text:" Chemotaxis  ability to figure how where in the body to move tobased on chemicals released by the body. Electrostatic forces and van der waalsforces draws bacteria to the surface",hierarchyLevel:6,children:[],index:"030201000101"},{text:" Adhesins  production of adhesins enable to adhere to the targetpart of the body and produce a pathogenic effect. Fimbriae enables the bacteriato adhere to host cell surface. Coaggregation enables the bacteria to adhere toother bacteria instead of the cell surface, making it easier to adhere",hierarchyLevel:6,children:[],index:"030201000102"}],index:"0302010001"}],index:"03020100"},{text:" Defence Counterstrategy  Virulence Factors",hierarchyLevel:4,children:[{text:" Antiphagocytic capsule  prevents ease of phagocytosis byphagocytes. antiphagocytic capsule is specific to the host serotype (whiteblood cells), and hence can have different effects on different individuals",hierarchyLevel:5,children:[],index:"0302010100"},{text:" Protein A  binds to the Fc (constant chain) of the antibodies,causing opsonization process to fail",hierarchyLevel:5,children:[],index:"0302010101"},{text:" Enables skin and soft tissue invasion",hierarchyLevel:5,children:[{text:" Hyaluronidase  breaks down hyaluronan which forms the backboneof proteoglycans, which is used in connective tissue increase the ease ofinvasion",hierarchyLevel:6,children:[],index:"030201010200"},{text:" Collagenase  breaks down collagen which is an essential part ofconnective tissue, increasing the ease of invasion",hierarchyLevel:6,children:[],index:"030201010201"},{text:" DNase  breaks down DNA",hierarchyLevel:6,children:[],index:"030201010202"}],index:"0302010102"},{text:" Leukocidin, Leukotoxin  kills white blood cells",hierarchyLevel:5,children:[],index:"0302010103"},{text:" Coagulase  causes blood clotting",hierarchyLevel:5,children:[],index:"0302010104"},{text:" Staphylokinase  prevents blood clotting",hierarchyLevel:5,children:[],index:"0302010105"},{text:" Steptolysin S, Steptolysin O  breaks down blood clots",hierarchyLevel:5,children:[],index:"0302010106"},{text:" Pyogenic exotoxins (A, B, C),Toxic Shock Syndrome Toxin (TSST)  causesnon-specific activation of the immune system, causing the immune system toproduce random things that are not useful",hierarchyLevel:5,children:[],index:"0302010107"},{text:" Biofilm formation  biofilms are many layers of bacteriaaggregated together. The bottom layers of the biofilm are metabolicallyineffective and therefore highly resistant to immune system and antibiotics.Hence, it is very hard to eradicate a bacteria once the biofilm forms",hierarchyLevel:5,children:[],index:"0302010108"},{text:" C5a and Ig-binding proteins  facilitates immune evasion",hierarchyLevel:5,children:[],index:"0302010109"},{text:" M-proteins  cross reacts with human host proteins, resulting in immune-pathologyoccurring several weeks after the organism is gone",hierarchyLevel:5,children:[],index:"0302010110"},{text:"   The Staph Cell",hierarchyLevel:5,children:[{text:" TSST",hierarchyLevel:6,children:[],index:"030201011100"},{text:" Haemolysin",hierarchyLevel:6,children:[],index:"030201011101"},{text:" Enterotoxin",hierarchyLevel:6,children:[],index:"030201011102"},{text:" Staphylokinase  convert plasminidins and plasmins",hierarchyLevel:6,children:[],index:"030201011103"},{text:" Teichoic Acid  component of cell wall, trigger cytokine release",hierarchyLevel:6,children:[],index:"030201011104"},{text:" A Protein A",hierarchyLevel:6,children:[],index:"030201011105"},{text:" Penicillinase ",hierarchyLevel:6,children:[],index:"030201011106"},{text:" C/C Catalase/Coagulase",hierarchyLevel:6,children:[],index:"030201011107"},{text:" Exfolatin",hierarchyLevel:6,children:[],index:"030201011108"},{text:" Leukocidin",hierarchyLevel:6,children:[],index:"030201011109"},{text:" Lipase",hierarchyLevel:6,children:[],index:"030201011110"}],index:"0302010111"}],index:"03020101"}],index:"030201"},{text:" Toxins",hierarchyLevel:3,children:[{text:" Broad Classification",hierarchyLevel:4,children:[{text:" Endotoxin",hierarchyLevel:5,children:[],index:"0302020000"},{text:" Exotoxin",hierarchyLevel:5,children:[],index:"0302020001"}],index:"03020200"},{text:" Endotoxin",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Toxins that are located within the bacterial cell or on theplasma membrane",hierarchyLevel:6,children:[],index:"030202010000"},{text:" The toxins are not secreted",hierarchyLevel:6,children:[],index:"030202010001"}],index:"0302020100"},{text:" General Action",hierarchyLevel:5,children:[{text:" Acts on endothelial cell  epithelial surface lining the bloodvessels",hierarchyLevel:6,children:[],index:"030202010100"}],index:"0302020101"},{text:" Examples",hierarchyLevel:5,children:[{text:" Liqid A molecule [Gram Negative] [real endotoxin]",hierarchyLevel:6,children:[{text:" Location",hierarchyLevel:7,children:[{text:" Found in lipopolysaccharide of Gram-negative organisms",hierarchyLevel:8,children:[],index:"0302020102000000"}],index:"03020201020000"},{text:" Effects",hierarchyLevel:7,children:[{text:" Stimulates cytokine production (intercellular signalingmolecules) of interleukin-1 and tumor necrosis factor",hierarchyLevel:8,children:[],index:"0302020102000100"},{text:" Causes inappropriate activation of the coagulation system,resulting in the clotting factor being used up unnecessarily. This causesbleeding when an injury occurs as blood can no longer clot.",hierarchyLevel:8,children:[],index:"0302020102000101"},{text:" Effect on the kinin, bradykinin system disrupts the ability ofvasoconstriction and vasodilation",hierarchyLevel:8,children:[],index:"0302020102000102"},{text:" Myocardial depressant factor has a direct impact on the heart",hierarchyLevel:8,children:[],index:"0302020102000103"}],index:"03020201020001"},{text:" Extended Effects",hierarchyLevel:7,children:[{text:" Overall, endotoxins causes increased permeability of endothelialcells of the capillaries, resulting in the capillary leak syndrome. Due toleaking, the cardiovascular compartments become depleted, and this results incardiovascular shock. Leaked fluids move into a third space such as lungs,resulting in Acute Respiratory Distress Syndrome (ARDS)  cannot breathe",hierarchyLevel:8,children:[],index:"0302020102000200"},{text:" Myocardial depressant factor has a direct impact on the heart,causing the heart to not pump as efficiently, possibly leading to the heart tostart to fail",hierarchyLevel:8,children:[],index:"0302020102000201"},{text:" Due to the movement of fluids out of the cardiovascular system,the blood pressure drops. The excretory system and kidneys require a good bloodpressure to function, and this results in renal failure.",hierarchyLevel:8,children:[],index:"0302020102000202"},{text:" Due to 3 organs starting to fail, heart, lungs, kidney, multipleorgan failure is a result.",hierarchyLevel:8,children:[],index:"0302020102000203"}],index:"03020201020002"},{text:" Diagram",hierarchyLevel:7,children:[],index:"03020201020003"}],index:"030202010200"},{text:" Teichoic aicd in S. pneumoniae [Gram Positive]  cell wallcomponent",hierarchyLevel:6,children:[],index:"030202010201"},{text:" Peptidoglycan [Gram Positive]  cell wall component",hierarchyLevel:6,children:[],index:"030202010202"}],index:"0302020102"}],index:"03020201"},{text:" Exotoxins (cytotoxins)",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Toxins that are secreted and acts outside the bacterial cell",hierarchyLevel:6,children:[],index:"030202020000"}],index:"0302020200"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Acts as cytotoxins and directly poisons cells",hierarchyLevel:6,children:[],index:"030202020100"}],index:"0302020201"},{text:" Examples",hierarchyLevel:5,children:[{text:" Shiga toxin",hierarchyLevel:6,children:[{text:" Mechanism",hierarchyLevel:7,children:[{text:" Destroys ribosomes",hierarchyLevel:8,children:[],index:"0302020202000000"}],index:"03020202020000"},{text:" Effects",hierarchyLevel:7,children:[{text:" Kills cells in the gut epithelium, resulting in bloody diarrhoea",hierarchyLevel:8,children:[],index:"0302020202000100"},{text:" Kills cells in the endothelium, resulting in the endothelialcells becoming more thrombogenic. As a result, there is a tendency for bloodclots to form in the blood vessels. This results in thrombocytopenia, due tousing up platelets for clotting. This clotting severely affects the bloodvessels leading to the kidneys, resulting in renal failure. Due to renalfailure, the urea levels increases in the blood. Moreover, due to the blockageof the blood vessels, the red blood cells that are passing through thosevessels get damaged, resulting in the haemolysis of red blood cells. The combinedeffect resutls in haemolytic uraemic syndrome",hierarchyLevel:8,children:[],index:"0302020202000101"}],index:"03020202020001"}],index:"030202020200"},{text:" Diphtheria toxin",hierarchyLevel:6,children:[{text:" Properties",hierarchyLevel:7,children:[{text:" Bacteriophage encoded toxin",hierarchyLevel:8,children:[],index:"0302020202010000"}],index:"03020202020100"},{text:" Mechanism",hierarchyLevel:7,children:[{text:" Disrupts eukaryotic elongation factor and hence disruptstranslation of mRNA into polypeptides",hierarchyLevel:8,children:[],index:"0302020202010100"}],index:"03020202020101"},{text:" Effects",hierarchyLevel:7,children:[{text:" Causes damage to pharynx, myocardium, axons",hierarchyLevel:8,children:[],index:"0302020202010200"}],index:"03020202020102"}],index:"030202020201"}],index:"0302020202"}],index:"03020202"},{text:" Exotoxins (enterotoxins)",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Causes overactivity of secretory mechanisms",hierarchyLevel:6,children:[],index:"030202030000"}],index:"0302020300"},{text:" Examples",hierarchyLevel:5,children:[{text:" Entereotoxigenic E. coli",hierarchyLevel:6,children:[{text:" Properties",hierarchyLevel:7,children:[{text:" Heat labile / heat stable",hierarchyLevel:8,children:[],index:"0302020301000000"},{text:" Plasmid-encoded",hierarchyLevel:8,children:[],index:"0302020301000001"}],index:"03020203010000"}],index:"030202030100"},{text:" Cholera toxin ",hierarchyLevel:6,children:[{text:" Properties",hierarchyLevel:7,children:[{text:" Bacteriophage encoded toxin",hierarchyLevel:8,children:[],index:"0302020301010000"}],index:"03020203010100"},{text:" Mechanism",hierarchyLevel:7,children:[{text:" Binding starts a cascade of reactions within the cell, eventuallyleading to the inhibition of absorption of sodium, glucose and water",hierarchyLevel:8,children:[],index:"0302020301010100"},{text:" As a result, cell is unable to maintain its osmotic pressure,hence it is unable to absorb water from the intestine. Moreover, this causesthe cell to oversecrete water back into the intestinal lumen. This results in avery watery diarrhoea,which contains, sodium, glucose, water, chloride andbicarbonate",hierarchyLevel:8,children:[],index:"0302020301010101"}],index:"03020203010101"},{text:" Treatment",hierarchyLevel:7,children:[{text:" Rehydrate patient with water, give patient sodium and glucose",hierarchyLevel:8,children:[],index:"0302020301010200"}],index:"03020203010102"}],index:"030202030101"}],index:"0302020301"}],index:"03020203"},{text:" Exotoxins (neurotoxins)",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Interfere with neurotransmitter activity",hierarchyLevel:6,children:[],index:"030202040000"}],index:"0302020400"},{text:" Examples",hierarchyLevel:5,children:[{text:" Botulinum toxin  flaccid paralysis",hierarchyLevel:6,children:[],index:"030202040100"},{text:" Tetanus toxin  spastic paralysis",hierarchyLevel:6,children:[],index:"030202040101"}],index:"0302020401"}],index:"03020204"},{text:" Exotoxins (toxic shock syndrome)",hierarchyLevel:4,children:[{text:" Mechanisms",hierarchyLevel:5,children:[{text:" Acts as superantigens resulting in the non-specific activation oft-cells",hierarchyLevel:6,children:[],index:"030202050000"}],index:"0302020500"},{text:" Examples",hierarchyLevel:5,children:[{text:" Staphylococcus aureus  toxic shock syndrome toxin",hierarchyLevel:6,children:[],index:"030202050100"},{text:" Staphylococcus pyogenes  Streptococcal pyrogenic exotoxins",hierarchyLevel:6,children:[{text:" Properties",hierarchyLevel:7,children:[{text:" Produces bacteriophage encoded toxins",hierarchyLevel:8,children:[{text:" Bacterial chromosome does not produce the toxin",hierarchyLevel:9,children:[],index:"030202050101000000"},{text:" The virus particle within the bacteria encodes the toxin. ",hierarchyLevel:9,children:[],index:"030202050101000001"},{text:" Hence, toxin only produced when bacteria is infected with thebacteriophage. Infection by Streptococcal pyrogenic is very common but most donot contain the bacteriophage and hence no pathogenic toxin is produced",hierarchyLevel:9,children:[],index:"030202050101000002"}],index:"0302020501010000"},{text:" Cardiotoxic",hierarchyLevel:8,children:[{text:" Inhibits cardiac activity",hierarchyLevel:9,children:[],index:"030202050101000100"}],index:"0302020501010001"},{text:" Mitogenic",hierarchyLevel:8,children:[{text:" Causes cell division",hierarchyLevel:9,children:[],index:"030202050101000200"}],index:"0302020501010002"}],index:"03020205010100"},{text:" Diseases",hierarchyLevel:7,children:[{text:" Toxic shock syndrome",hierarchyLevel:8,children:[],index:"0302020501010100"},{text:" Scarlet fever",hierarchyLevel:8,children:[],index:"0302020501010101"}],index:"03020205010101"}],index:"030202050101"}],index:"0302020501"}],index:"03020205"}],index:"030202"},{text:" Post Infectious Syndromes",hierarchyLevel:3,children:[{text:" Rheumatic fever  Staphylococcus pyogenes",hierarchyLevel:4,children:[{text:" Properties",hierarchyLevel:5,children:[{text:" Strains with serotypes of M-protein are more rheumatogenic",hierarchyLevel:6,children:[],index:"030203000000"}],index:"0302030000"},{text:" Process",hierarchyLevel:5,children:[{text:" Acute streptococcal infection (pharyngotonsillitis)",hierarchyLevel:6,children:[],index:"030203000100"},{text:" Rheumatic fever",hierarchyLevel:6,children:[],index:"030203000101"},{text:" Multi-system illness  caused by M-protein cross-reacting withthe immune system. The antibodies that attack M-protein start attacking othertissues",hierarchyLevel:6,children:[],index:"030203000102"}],index:"0302030001"},{text:" Effects",hierarchyLevel:5,children:[{text:" Cardiac damage  mitral valve damage via stenosis (narrowing)",hierarchyLevel:6,children:[],index:"030203000200"}],index:"0302030002"}],index:"03020300"},{text:" Glomerulonephritis  Staphylococcus pyogenes",hierarchyLevel:4,children:[{text:" Mechanism",hierarchyLevel:5,children:[{text:" Immune complex deposition within the renal tubules, resulting ininflammation, glomerular damage and renal failure",hierarchyLevel:6,children:[],index:"030203010000"}],index:"0302030100"},{text:" Process",hierarchyLevel:5,children:[{text:" Staphylococcal pyogenes infection",hierarchyLevel:6,children:[],index:"030203010100"}],index:"0302030101"}],index:"03020301"},{text:" Reactive arthritis  Salmonella, Shigella, Neisseria gonorrhoea, Chlamydia,trachomatis",hierarchyLevel:4,children:[],index:"03020302"},{text:" Overall Consequence",hierarchyLevel:4,children:[{text:" Altered host physiology  resulting in organ failure (water inthe lungs)",hierarchyLevel:5,children:[],index:"0302030300"},{text:" Tissue damage",hierarchyLevel:5,children:[],index:"0302030301"}],index:"03020303"}],index:"030203"}],index:"0302"},{text:" [021] Bacterial Diagnosis",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[{text:" Method of Diagnosis",hierarchyLevel:4,children:[{text:" Microscope",hierarchyLevel:5,children:[],index:"0303000000"},{text:" Culture",hierarchyLevel:5,children:[],index:"0303000001"},{text:" Biochemical Identification",hierarchyLevel:5,children:[{text:" Coagulase Test",hierarchyLevel:6,children:[],index:"030300000200"},{text:" MALDI-ToF  mass spectroscopy",hierarchyLevel:6,children:[],index:"030300000201"}],index:"0303000002"},{text:" Serology - the study of serum, study of many different fluids,detection of antigen or antibody",hierarchyLevel:5,children:[],index:"0303000003"},{text:" Molecular Biology  PCR",hierarchyLevel:5,children:[],index:"0303000004"}],index:"03030000"}],index:"030300"},{text:" Test-Species Summary",hierarchyLevel:3,children:[],index:"030301"},{text:" Stain-Shape Summary",hierarchyLevel:3,children:[],index:"030302"},{text:" Microscopy",hierarchyLevel:3,children:[{text:" Principles",hierarchyLevel:4,children:[{text:" Bacterial cell is made of water",hierarchyLevel:5,children:[],index:"0303030000"},{text:" Shining light through water will not show anything. Hence need tostain bacteria, use gram stain",hierarchyLevel:5,children:[],index:"0303030001"}],index:"03030300"},{text:" Stains",hierarchyLevel:4,children:[{text:" Gram stain",hierarchyLevel:5,children:[{text:" Weaknesses",hierarchyLevel:6,children:[{text:" Spiral organisms",hierarchyLevel:7,children:[],index:"03030301000000"},{text:" Mycobacteria",hierarchyLevel:7,children:[],index:"03030301000001"},{text:" [ ] Mycoplasma, chlamydia, Coxiella ",hierarchyLevel:7,children:[],index:"03030301000002"},{text:" rickettsia",hierarchyLevel:7,children:[],index:"03030301000003"}],index:"030303010000"}],index:"0303030100"},{text:" Ziehl Nielsen stain  mycobacteria, cryptosporidia, nocardia",hierarchyLevel:5,children:[],index:"0303030101"},{text:" India Ink  cryptococcus (negative stain  stain everything butthe organism)",hierarchyLevel:5,children:[],index:"0303030102"},{text:" Silver stain  pneumocystis jiroveci",hierarchyLevel:5,children:[],index:"0303030103"}],index:"03030301"},{text:" Identification",hierarchyLevel:4,children:[{text:" Shape  rods (bacilli) or cocci",hierarchyLevel:5,children:[],index:"0303030200"},{text:" Colour  gram positive (purple) or gram negative (pink)",hierarchyLevel:5,children:[],index:"0303030201"}],index:"03030302"},{text:" Limitation",hierarchyLevel:4,children:[{text:" Difficult to identify the organism  due to similar appearance ofbacteria",hierarchyLevel:5,children:[{text:" S. aureus (bad) vs S. epidermidis (ok)",hierarchyLevel:6,children:[],index:"030303030000"},{text:" Salmonella (bad) vs E. coli (ok)",hierarchyLevel:6,children:[],index:"030303030001"}],index:"0303030300"},{text:" Low field of vision  only a snapshot at a particular moment(insensitive)",hierarchyLevel:5,children:[],index:"0303030301"}],index:"03030303"},{text:" Use",hierarchyLevel:4,children:[{text:" Identification of bacteria with characteristic appearance",hierarchyLevel:5,children:[],index:"0303030400"},{text:" Examination of sterile fluids",hierarchyLevel:5,children:[],index:"0303030401"},{text:" Cell Counts",hierarchyLevel:5,children:[{text:" Celebrospinal fluid  WCC < 6 /mm , Protein <0.4g / L, Glucose > 40% of serum glucose",hierarchyLevel:6,children:[],index:"030303040200"},{text:" Ascites  chronic liver disease [bacterial peritonitis] - Neutrophils< 250 / mm",hierarchyLevel:6,children:[],index:"030303040201"}],index:"0303030402"}],index:"03030304"}],index:"030303"},{text:" Culture",hierarchyLevel:3,children:[{text:" Properties  gold standard",hierarchyLevel:4,children:[{text:" Highly sensitive  due to the exponential growth phase",hierarchyLevel:5,children:[],index:"0303040000"}],index:"03030400"},{text:" Process",hierarchyLevel:4,children:[{text:" Use different culture media and condition to make sure only aspecific type of bacteria (of interest) is exponentially grown",hierarchyLevel:5,children:[],index:"0303040100"},{text:" Identification and antibiotic sensitivity testing",hierarchyLevel:5,children:[],index:"0303040101"}],index:"03030401"},{text:" Limitations",hierarchyLevel:4,children:[{text:" Slow  requires at least 24 hours for the exponential growthphase",hierarchyLevel:5,children:[],index:"0303040200"},{text:" Hampered by antibiotic treatment  dead bacteria",hierarchyLevel:5,children:[],index:"0303040201"},{text:" Difficulty in culturing",hierarchyLevel:5,children:[],index:"0303040202"}],index:"03030402"},{text:" Advantages",hierarchyLevel:4,children:[{text:" Able to determine the type of haemolysis with one look",hierarchyLevel:5,children:[],index:"0303040300"}],index:"03030403"},{text:" Techniques",hierarchyLevel:4,children:[{text:" Selective media",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Only enabling pathogens of interest to grow",hierarchyLevel:7,children:[],index:"03030404000000"}],index:"030304040000"},{text:" Examples",hierarchyLevel:6,children:[{text:" Neisseria gonnorrhoea is diagnosed using a urethra swab. However,the urethera is not sterile and this lead to the overgrowth of all otherbacteria, leading to the inability of the bacteria the flourish and show on theagar plate",hierarchyLevel:7,children:[],index:"03030404000100"},{text:" Campylobacter takes three days to grow, use agar plates tosuppress other organisms and grow at 42 degrees (optimal temperature) topromote campylobacter",hierarchyLevel:7,children:[],index:"03030404000101"}],index:"030304040001"}],index:"0303040400"},{text:" Differential media",hierarchyLevel:5,children:[{text:" Purpose",hierarchyLevel:6,children:[{text:" Quickly picking up pathogens and disposing commensals",hierarchyLevel:7,children:[],index:"03030404010000"}],index:"030304040100"},{text:" Media",hierarchyLevel:6,children:[{text:" MacConkey",hierarchyLevel:7,children:[],index:"03030404010100"},{text:" CLED / DCLS",hierarchyLevel:7,children:[],index:"03030404010101"},{text:" Tellurite",hierarchyLevel:7,children:[],index:"03030404010102"}],index:"030304040101"},{text:" Process",hierarchyLevel:6,children:[{text:" Use MacConkey agar which contains lactose and contains a pHindicator",hierarchyLevel:7,children:[],index:"03030404010200"},{text:" Gut pathogens do not ferment lactose",hierarchyLevel:7,children:[],index:"03030404010201"},{text:" Commensal bacteria ferments lactose",hierarchyLevel:7,children:[],index:"03030404010202"},{text:" Fermentation of lactose results in the production of acid whichdecreases the pH",hierarchyLevel:7,children:[],index:"03030404010203"},{text:" This activates the pH indicator to turn into pink",hierarchyLevel:7,children:[],index:"03030404010204"},{text:" Therefore, the pink region of the agar plates should be ignoredas they are commensals",hierarchyLevel:7,children:[],index:"03030404010205"}],index:"030304040102"},{text:" Colors",hierarchyLevel:6,children:[{text:" Pink (ignore) / Colourless [MacConkey]",hierarchyLevel:7,children:[],index:"03030404010300"},{text:" Yellow (ignore) / Blue [CLED]",hierarchyLevel:7,children:[],index:"03030404010301"},{text:" Red (ignore) / Black [Tellurite]",hierarchyLevel:7,children:[],index:"03030404010302"}],index:"030304040103"},{text:" Diagrams",hierarchyLevel:6,children:[],index:"030304040104"}],index:"0303040401"},{text:" Antibiotic Susceptibility Testing",hierarchyLevel:5,children:[{text:" Inoculation",hierarchyLevel:6,children:[{text:" Inoculate the bacteria on a plate",hierarchyLevel:7,children:[],index:"03030404020000"},{text:" Put antibiotics on the plate, measure the size of the inhibitionzone to understand how resistant the bacteria is to the particular antibiotic",hierarchyLevel:7,children:[],index:"03030404020001"},{text:" The measurement of the inhibition zone is compared to theinternational standard to determine how sensitive the bacteria is to the antibiotics",hierarchyLevel:7,children:[],index:"03030404020002"}],index:"030304040200"},{text:" Doubling Dilutions",hierarchyLevel:6,children:[{text:" Do 10-fold dilutions of the antibiotic agent into different test tubes",hierarchyLevel:7,children:[],index:"03030404020100"},{text:" Add a bit of bacteria sample into each of the test tube",hierarchyLevel:7,children:[],index:"03030404020101"},{text:" Incubate the test tubes and analyze how clear or cloudy thesolution is",hierarchyLevel:7,children:[],index:"03030404020102"},{text:" The first tube that shows clear is the Minimum InhibitoryConcentration of antibiotics",hierarchyLevel:7,children:[],index:"03030404020103"},{text:" This concentration is compared to the international standard",hierarchyLevel:7,children:[],index:"03030404020104"}],index:"030304040201"},{text:" Gradient Method",hierarchyLevel:6,children:[{text:" Gradient of antibiotic concentrations are embed into a singlestrip",hierarchyLevel:7,children:[],index:"03030404020200"},{text:" Place strip on a agar plate with inoculated bacteria",hierarchyLevel:7,children:[{text:" Beta hemolysis  clearing of the blood, clear area around thebacteria",hierarchyLevel:5,children:[],index:"0303040402020100"},{text:" Alpha hemoloysis  partial breakdown of haemoglobin, releasingbile pigments which are green, green area around the bacteria colony",hierarchyLevel:5,children:[],index:"0303040402020101"}],index:"03030404020201"}],index:"030304040202"}],index:"0303040402"}],index:"03030404"}],index:"030304"},{text:" Biochemical Identification",hierarchyLevel:3,children:[{text:" Coagulase Test",hierarchyLevel:4,children:[{text:" Take a test tube with rabbit plasma, add the colonies in ",hierarchyLevel:5,children:[],index:"0303050000"},{text:" If it forms a clot in 4 hours, it is coagulase positive, andhence S. Aureus",hierarchyLevel:5,children:[],index:"0303050001"},{text:" If it does not form a clot in 4 hours, it is coagulase negativeand hence the non-harmful bacteria",hierarchyLevel:5,children:[],index:"0303050002"}],index:"03030500"},{text:" Advanced Biochemical Identification  takes 24 hours",hierarchyLevel:4,children:[{text:" Detecting presence of a variety of enzymes within a bunch ofreagents",hierarchyLevel:5,children:[],index:"0303050100"},{text:" A code is derived from the battery of tests",hierarchyLevel:5,children:[],index:"0303050101"},{text:" Feed the code into a computer and the computer will churn out abacteria species",hierarchyLevel:5,children:[],index:"0303050102"}],index:"03030501"},{text:" Mass Spectroscopy (MALDI-ToF)  5 minutes",hierarchyLevel:4,children:[{text:" Definition",hierarchyLevel:5,children:[{text:" Matrix Assisted Laser Desorption Ionization",hierarchyLevel:6,children:[],index:"030305020000"}],index:"0303050200"},{text:" Process",hierarchyLevel:5,children:[{text:" Slide is taken with a matrix on top",hierarchyLevel:6,children:[],index:"030305020100"},{text:" A loopful of the microorganism is stuck to the matrix",hierarchyLevel:6,children:[],index:"030305020101"},{text:" Hit the slide with a laser, this results in the ionization ofparticles on the slide",hierarchyLevel:6,children:[],index:"030305020102"},{text:" If the matrix is not present, the organism is vaporized",hierarchyLevel:6,children:[],index:"030305020103"},{text:" If the matrix is present, the organism is ionized",hierarchyLevel:6,children:[],index:"030305020104"},{text:" The particles are accelerated, and the particles are separatedbased on the mass charge ratio",hierarchyLevel:6,children:[],index:"030305020105"},{text:" The separation of the mass charge ratio is used to generate aspectral identify which serves as spectral fingerprints which are unique foreach type of bacteria",hierarchyLevel:6,children:[],index:"030305020106"}],index:"0303050201"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0303050202"}],index:"03030502"}],index:"030305"},{text:" Serology",hierarchyLevel:3,children:[{text:" Purpose",hierarchyLevel:4,children:[{text:" Antibody detection  widely available",hierarchyLevel:5,children:[],index:"0303060000"},{text:" Antigen detection",hierarchyLevel:5,children:[],index:"0303060001"}],index:"03030600"},{text:" [ ] Process  ELISA (enzyme linked immune-absorbantassay)",hierarchyLevel:4,children:[{text:" Coat the wells with the antigen of the organism of interest",hierarchyLevel:5,children:[],index:"0303060100"},{text:" Add the patients serum, which contain antibodies",hierarchyLevel:5,children:[],index:"0303060101"},{text:" Antibodies will bind to the antigen",hierarchyLevel:5,children:[],index:"0303060102"},{text:" Wash the wells",hierarchyLevel:5,children:[],index:"0303060103"},{text:" Get a second layer of antibodies which have a immune-fluorescenttag or enzyme tag",hierarchyLevel:5,children:[],index:"0303060104"},{text:" If the first layer of antibodies is present, the second layer ofantibodies will bind to the first layer of antibodies and the tags will bepresent",hierarchyLevel:5,children:[],index:"0303060105"},{text:" If it is an enzyme tag, add a substrate.",hierarchyLevel:5,children:[],index:"0303060106"},{text:" The presence of the tag will cause the substrate to change color.The presence of the fluorescent tag will give out fluorescent",hierarchyLevel:5,children:[],index:"0303060107"},{text:" Many dilutions of antigen of organism of interest are conductedto identify at which concentration of antigen the patients serum is sensitive",hierarchyLevel:5,children:[],index:"0303060108"}],index:"03030601"},{text:" [ ] Limitations",hierarchyLevel:4,children:[{text:" Requires time",hierarchyLevel:5,children:[],index:"0303060200"},{text:" Requries immunocompetence",hierarchyLevel:5,children:[],index:"0303060201"},{text:" Require an acute sample and a convalescent sample",hierarchyLevel:5,children:[{text:" Acute  current",hierarchyLevel:6,children:[],index:"030306020200"},{text:" Convalescent  10 to 14 days alter",hierarchyLevel:6,children:[],index:"030306020201"}],index:"0303060202"},{text:" Temporal un-specificity",hierarchyLevel:5,children:[{text:" Presence of IgG only indicates that exposure occurred, but doesnot show when",hierarchyLevel:6,children:[],index:"030306020300"},{text:" IgM is needed to indicate timeframe",hierarchyLevel:6,children:[],index:"030306020301"}],index:"0303060203"}],index:"03030602"},{text:" [ ] Process",hierarchyLevel:4,children:[],index:"03030603"},{text:" [ ] Properties",hierarchyLevel:4,children:[{text:" Rapid",hierarchyLevel:5,children:[],index:"0303060400"},{text:" Serotype specific  disadvantage ",hierarchyLevel:5,children:[{text:" Antigen tests may not test all the different types of diseases",hierarchyLevel:6,children:[],index:"030306040100"},{text:" Therefore, antigen test can only prove a patient have a disease.Cannot prove that the patient does not have a disease",hierarchyLevel:6,children:[],index:"030306040101"}],index:"0303060401"}],index:"03030604"}],index:"030306"},{text:" Other Tests",hierarchyLevel:3,children:[{text:" Molecular Biological Tests  PCR ",hierarchyLevel:4,children:[{text:" Use a variety of amplification assays (Clamydia trachomatis,mycobacterium tuberculosis)",hierarchyLevel:5,children:[],index:"0303070000"}],index:"03030700"},{text:" Skin tests",hierarchyLevel:4,children:[{text:" Process  Tuberculosis",hierarchyLevel:5,children:[{text:" Perform an intradermal injection to the mycobacterial antigeninto the surface of the skin",hierarchyLevel:6,children:[],index:"030307010000"},{text:" Look for the hypersensitivity response, shown by the wheel andflat reaction",hierarchyLevel:6,children:[],index:"030307010001"}],index:"0303070100"},{text:" Diagram",hierarchyLevel:5,children:[],index:"0303070101"}],index:"03030701"},{text:" ELISPOT",hierarchyLevel:4,children:[{text:" Based on the cytokine response of T-cell",hierarchyLevel:5,children:[],index:"0303070200"},{text:" If the patient is already exposed, there will be a much largercytokine release",hierarchyLevel:5,children:[],index:"0303070201"}],index:"03030702"},{text:" Fluorescent in situ Hybridization",hierarchyLevel:4,children:[{text:" Take a drop of blood from the positive blood culture",hierarchyLevel:5,children:[],index:"0303070300"},{text:" Put it on a slide and add antibodies that is specific to theorganism of interest with a fluorescent tag",hierarchyLevel:5,children:[],index:"0303070301"},{text:" Antibodies will specifically bind to a section of the DNA of thebacteria of interest",hierarchyLevel:5,children:[],index:"0303070302"},{text:" Detecting of the fluorescent shows the presence of the organism",hierarchyLevel:5,children:[],index:"0303070303"},{text:" ",hierarchyLevel:5,children:[],index:"0303070304"}],index:"03030703"},{text:" Urine Dipstick Screening",hierarchyLevel:4,children:[{text:" Purpose",hierarchyLevel:5,children:[{text:" Enables for rapid and mass screening of bacteria",hierarchyLevel:6,children:[],index:"030307040000"}],index:"0303070400"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Detects nitrites (produced by entereobacteria leucii)",hierarchyLevel:6,children:[],index:"030307040100"},{text:" Detects leucoyte esterase (produced by the white cells in theurine sample)",hierarchyLevel:6,children:[],index:"030307040101"},{text:" If both are not detected, it is very likely to be uninfected",hierarchyLevel:6,children:[],index:"030307040102"},{text:" Cannot test for positive or prove presence of infection",hierarchyLevel:6,children:[],index:"030307040103"},{text:" Only proceed with culture when it tests positive",hierarchyLevel:6,children:[],index:"030307040104"}],index:"0303070401"}],index:"03030704"}],index:"030307"},{text:" Challenges in Sample Collection",hierarchyLevel:3,children:[{text:" Samples from Prosthetic parts",hierarchyLevel:4,children:[{text:" Drains catheters are good for surveillance, but cannot prove thatthere is an infection",hierarchyLevel:5,children:[],index:"0303080000"},{text:" Must take a direct sample from the patient",hierarchyLevel:5,children:[],index:"0303080001"}],index:"03030800"},{text:" Difficulty in Analyzing Commensal bacteria",hierarchyLevel:4,children:[{text:" Streptococcus pneumoniae is a commensal bacteria that becomepathogenic when found in the lungs",hierarchyLevel:5,children:[],index:"0303080100"},{text:" Taking a sample from a cough may cause the sample to becontaminated from the commensal bacteria from other parts of the body (throat)",hierarchyLevel:5,children:[],index:"0303080101"},{text:" Hence, a good quality deep cough is required",hierarchyLevel:5,children:[],index:"0303080102"},{text:" Bronchoalveolar lavage (BAL) ",hierarchyLevel:5,children:[{text:" Stick an endoscope into the lungs and aspirate some fluid back",hierarchyLevel:6,children:[],index:"030308010300"}],index:"0303080103"},{text:" Patient take a midstream urine",hierarchyLevel:5,children:[],index:"0303080104"},{text:" This gets rid of the flora in the early part of the stream, andminmises the contamination from the perinium",hierarchyLevel:5,children:[],index:"0303080105"}],index:"03030801"}],index:"030308"}],index:"0303"},{text:" [023] Antibiotics",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Overview of mechanisms of actions of antibiotics",hierarchyLevel:4,children:[],index:"03040000"},{text:" To gain an overview of the various considerations involved inantibiotic use",hierarchyLevel:4,children:[],index:"03040001"},{text:" To appreciate the significance of the spectra of antibioticresistance",hierarchyLevel:4,children:[],index:"03040002"}],index:"030400"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" Definitions",hierarchyLevel:4,children:[{text:" Antibiotic  substance produced by a microorganism that in smallamounts inhibits the growth of another microbe",hierarchyLevel:5,children:[],index:"0304010000"}],index:"03040100"},{text:" Principle of Selective Toxicity",hierarchyLevel:4,children:[{text:" Antibiotics cause harm to cells.",hierarchyLevel:5,children:[],index:"0304010100"},{text:" Therefore, it is important for antibiotics to harm bacteria butnot the host cell. ",hierarchyLevel:5,children:[],index:"0304010101"},{text:" Hence, antibiotics must only target a mechanism that is unique inthe pathogen and not found in the host",hierarchyLevel:5,children:[],index:"0304010102"}],index:"03040101"}],index:"030401"},{text:" Mechanisms of Antibiotic Action",hierarchyLevel:3,children:[{text:" Inhibition of Cell Wall Synthesis",hierarchyLevel:4,children:[{text:" Insight",hierarchyLevel:5,children:[{text:" Mammalian cells do not have a cell wall. Therefore, eukaryoticcells will not be affected.",hierarchyLevel:6,children:[],index:"030402000000"}],index:"0304020000"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Beta-lactams in penicillin interrupts peptidoglycan synthesis byinhibiting certain enzymes, thus resulting in the failure of synthesis ofbacterial cell wall",hierarchyLevel:6,children:[],index:"030402000100"},{text:" Glycopeptides in vancomycin interrupts peptidoglycan synthesis byphysically blocking the subunits from assembling. This results in the failureof synthesis of bacterial cell wall",hierarchyLevel:6,children:[],index:"030402000101"},{text:" This leads to cell lysis and bacterial cell death",hierarchyLevel:6,children:[],index:"030402000102"}],index:"0304020001"}],index:"03040200"},{text:" Inhibition of Protein Synthesis",hierarchyLevel:4,children:[{text:" Insight",hierarchyLevel:5,children:[{text:" Eukaryotic ribosomes are 80s while prokaryotic ribosomes are 70s",hierarchyLevel:6,children:[],index:"030402010000"}],index:"0304020100"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Antibiotic only selectively bind to the prokaryotic 70s ribosomeand hence inhibiting protein synthesis",hierarchyLevel:6,children:[],index:"030402010100"}],index:"0304020101"},{text:" Examples",hierarchyLevel:5,children:[{text:" Tetracyclines",hierarchyLevel:6,children:[],index:"030402010200"},{text:" Macrolides (erythromycin)",hierarchyLevel:6,children:[],index:"030402010201"},{text:" Aminoglycosides (gentamicin)",hierarchyLevel:6,children:[],index:"030402010202"}],index:"0304020102"}],index:"03040201"},{text:" Injury to the plasma membrane",hierarchyLevel:4,children:[{text:" Mechanism  Bacterial",hierarchyLevel:5,children:[{text:" Damages the bacterial cell membrane",hierarchyLevel:6,children:[],index:"030402020000"},{text:" However, it has little selective toxicity and affects human cells(neurotoxic, nephrotoxic)",hierarchyLevel:6,children:[],index:"030402020001"},{text:" Used more commonly topically with less damage to human cells",hierarchyLevel:6,children:[],index:"030402020002"}],index:"0304020200"},{text:" Mechanism  Fungal",hierarchyLevel:5,children:[{text:" Damages fungal plasma membrane",hierarchyLevel:6,children:[],index:"030402020100"},{text:" Fungal membrane is completely different chemically from theeukaryotic plasma membrane, hence the drug has high selective toxicity",hierarchyLevel:6,children:[],index:"030402020101"},{text:" Fungal membrane contains ergosterol and anti-fungal drugs targetthe synthesis of ergosterol",hierarchyLevel:6,children:[],index:"030402020102"}],index:"0304020201"}],index:"03040202"},{text:" Inhibition of Nuclei Acid (DNA / RNA) Synthesis",hierarchyLevel:4,children:[{text:" Insight",hierarchyLevel:5,children:[{text:" Bacterial DNA is supercoiled",hierarchyLevel:6,children:[],index:"030402030000"}],index:"0304020300"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Quinolones inhibits DNA gyrase and topoisomerase, preventing thesupercoiling process of bacterial DNA",hierarchyLevel:6,children:[],index:"030402030100"}],index:"0304020301"}],index:"03040203"},{text:" Inhibition of Synthesis of Essential Metabolites",hierarchyLevel:4,children:[{text:" Insight",hierarchyLevel:5,children:[{text:" Some metabolic pathways are unique to bacteria or more importantin bacteria cells than human cells",hierarchyLevel:6,children:[],index:"030402040000"}],index:"0304020400"},{text:" Mechanism",hierarchyLevel:5,children:[{text:" Trimethoprim inhibits the synthesis of folic acids by inhibitingdihydrofolate reductase (urinary tract infection)",hierarchyLevel:6,children:[],index:"030402040100"},{text:" Folic acids are crucial for the synthesis of purines and pyrimidines",hierarchyLevel:6,children:[],index:"030402040101"},{text:" Humans are able to take in tetrahydrofolate to avoid gettingaffected by the antibiotic",hierarchyLevel:6,children:[],index:"030402040102"}],index:"0304020401"},{text:" Drugs",hierarchyLevel:5,children:[{text:" Trimethoprim  inhibit dihydrofolate reductase",hierarchyLevel:6,children:[],index:"030402040200"},{text:" Dapsone  leprosy",hierarchyLevel:6,children:[],index:"030402040201"},{text:" Sulfamethoxazole  used topically for burns, used in combinationwith trimethoprim, used systematically for a number of infections",hierarchyLevel:6,children:[],index:"030402040202"}],index:"0304020402"}],index:"03040204"},{text:" Additional Drug Detail",hierarchyLevel:4,children:[{text:" Macrolides ",hierarchyLevel:5,children:[{text:" Macrolides prevents the formation of the peptide bond between twoamino acids during translation",hierarchyLevel:6,children:[],index:"030402050000"}],index:"0304020500"},{text:" Beta-lactams",hierarchyLevel:5,children:[{text:" Groups",hierarchyLevel:6,children:[{text:" Penicillin",hierarchyLevel:7,children:[],index:"03040205010000"},{text:" Cephalosporins",hierarchyLevel:7,children:[],index:"03040205010001"},{text:" Carbapenems",hierarchyLevel:7,children:[],index:"03040205010002"}],index:"030402050100"},{text:" Mechanism",hierarchyLevel:6,children:[{text:" Inhibit enzymes involved in cell wall assembly (transglycosylase, transpeptidase)",hierarchyLevel:7,children:[],index:"03040205010100"}],index:"030402050101"},{text:" Exceptions: No activity against bacteria without a cell wall",hierarchyLevel:6,children:[{text:" Mycoplasma",hierarchyLevel:7,children:[],index:"03040205010200"},{text:" Legionella",hierarchyLevel:7,children:[],index:"03040205010201"},{text:" Chlamydia",hierarchyLevel:7,children:[],index:"03040205010202"}],index:"030402050102"}],index:"0304020501"}],index:"03040205"}],index:"030402"},{text:" Influences on drug efficacy",hierarchyLevel:3,children:[{text:" Distribution  antibiotic must travel to the site of infection tobe effective",hierarchyLevel:4,children:[],index:"03040300"},{text:" Metabolism  dosage regiment enough to maintain bloodconcentration for a certain amount of time",hierarchyLevel:4,children:[],index:"03040301"},{text:" Excretion  consideration of accumulation of drug during renalfailure and hence leading to toxicity",hierarchyLevel:4,children:[],index:"03040302"}],index:"030403"},{text:" Administration of Antibiotics",hierarchyLevel:3,children:[{text:" Topical",hierarchyLevel:4,children:[],index:"03040400"},{text:" Systemic  bloodstream",hierarchyLevel:4,children:[{text:" Intravenous",hierarchyLevel:5,children:[],index:"0304040100"},{text:" Intramuscular",hierarchyLevel:5,children:[],index:"0304040101"},{text:" Orally",hierarchyLevel:5,children:[],index:"0304040102"}],index:"03040401"}],index:"030404"},{text:" Safety Concerns",hierarchyLevel:3,children:[{text:" Toxicity",hierarchyLevel:4,children:[{text:" Types of Damage",hierarchyLevel:5,children:[{text:" Kidney and ear damage (aminoglycosides  gentamycin)",hierarchyLevel:6,children:[],index:"030405000000"},{text:" Liver damage",hierarchyLevel:6,children:[],index:"030405000001"},{text:" Damage to gut flora  resulting in the proliferation of Clostridiumdifficile, resulting in diarrhea, resulting in pseudomembranous colitis ",hierarchyLevel:6,children:[],index:"030405000002"}],index:"0304050000"},{text:" Solution",hierarchyLevel:5,children:[{text:" Adjust the dose based on the patient weight, measure blood vesselof the drugs directly and keep the concentration within the therapeutic range",hierarchyLevel:6,children:[],index:"030405000100"}],index:"0304050001"}],index:"03040500"},{text:" Interactions with other medications  Rifamycin",hierarchyLevel:4,children:[{text:" Rifamycin induces the destruction of steroids by the cytochromep460 system",hierarchyLevel:5,children:[],index:"0304050100"},{text:" Hence, women on the pill need to use alternative forms of contraception",hierarchyLevel:5,children:[],index:"0304050101"},{text:" Patients taking supplements need to increase the dose",hierarchyLevel:5,children:[],index:"0304050102"}],index:"03040501"},{text:" Hypersensitivity reactions",hierarchyLevel:4,children:[{text:" Penicillin causes rash to life-threatening anaphylactic reactions",hierarchyLevel:5,children:[],index:"0304050200"}],index:"03040502"},{text:" Pregnancy / Childhood / Neonatal",hierarchyLevel:4,children:[{text:" Tetracycline ",hierarchyLevel:5,children:[{text:" Safe in adult",hierarchyLevel:6,children:[],index:"030405030000"},{text:" Liver damage, tooth and bone damage in children and pregnantwomen",hierarchyLevel:6,children:[],index:"030405030001"}],index:"0304050300"},{text:" Fluoroquinolones  used in some reluctance in children",hierarchyLevel:5,children:[],index:"0304050301"},{text:" Antifolates  cannot be used in the first trimester",hierarchyLevel:5,children:[],index:"0304050302"}],index:"03040503"},{text:" Antibiotic resistance",hierarchyLevel:4,children:[],index:"03040504"}],index:"030405"},{text:" Antibiotic Resistance",hierarchyLevel:3,children:[{text:" Process",hierarchyLevel:4,children:[{text:" There is random variation in the bacterial genome",hierarchyLevel:5,children:[],index:"0304060000"},{text:" This may give rise to a competitive advantage",hierarchyLevel:5,children:[{text:" Target sites may be altered so that antibiotics cannot bind",hierarchyLevel:6,children:[],index:"030406000100"},{text:" Penetration of antibiotics into the bacterial cell can be impairthrough the loss of protein channels (porins)",hierarchyLevel:6,children:[],index:"030406000101"},{text:" Efflux pump on the plasma membrane pumps out antibiotics",hierarchyLevel:6,children:[],index:"030406000102"},{text:" Enzymes encoded by plasmid which can breakdown antibiotics(beta-lactamase  hydrolyses beta-lactams)",hierarchyLevel:6,children:[],index:"030406000103"},{text:" Bypass pathways  antibiotics impose a metabolic block on theantifolate synthesis pathway",hierarchyLevel:6,children:[],index:"030406000104"}],index:"0304060001"},{text:" However, the development of a resistance mechanism results in abiological cost (loss of function, less efficient)",hierarchyLevel:5,children:[],index:"0304060002"},{text:" Due to the biological cost, the micro-organism is less fit, willbe outgrown by the non-resistance strain.",hierarchyLevel:5,children:[],index:"0304060003"},{text:" However, with the selection pressure of antibiotics, theresistance strain will win out",hierarchyLevel:5,children:[],index:"0304060004"},{text:" Humans should modulate the antibiotic selection pressure appliedto bacterial cells",hierarchyLevel:5,children:[],index:"0304060005"}],index:"03040600"}],index:"030406"}],index:"0304"}]},{text:"Eukaryotic Infections",hierarchyLevel:1,children:[{text:" [008] Fungal Infections",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Describe the characteristics and morphotypes (shapes) of commonfungal pathogens and give examples of each ",hierarchyLevel:4,children:[],index:"04000000"},{text:" Understand the general structure of the fungal cell ",hierarchyLevel:4,children:[],index:"04000001"},{text:" Understand the clinical significance of fungal infections",hierarchyLevel:4,children:[],index:"04000002"},{text:" Name the fungal infections important in the immunocompromised andthe type of disease they cause",hierarchyLevel:4,children:[],index:"04000003"}],index:"040000"},{text:" General Stuff",hierarchyLevel:3,children:[{text:" General Info",hierarchyLevel:4,children:[{text:" Classification: Eukaryotic",hierarchyLevel:5,children:[],index:"0400010000"},{text:" Types",hierarchyLevel:5,children:[{text:" Yeasts  single celled budding organisms (with / without hyphae)",hierarchyLevel:6,children:[],index:"040001000100"},{text:" Moulds  multicellular filamentous organisms with hyphae andfruiting structures",hierarchyLevel:6,children:[],index:"040001000101"},{text:" Dimorphic  Mould phase at 30C / Yeast phase at 37C",hierarchyLevel:6,children:[],index:"040001000102"}],index:"0400010001"}],index:"04000100"},{text:" Fungal Life Cycle",hierarchyLevel:4,children:[{text:" Moulds",hierarchyLevel:5,children:[{text:" Moulds releases spores (conidia)",hierarchyLevel:6,children:[],index:"040001010000"},{text:" In the right environment, conidia germinate, producing hyphae",hierarchyLevel:6,children:[],index:"040001010001"},{text:" Hyphae will further develop into a mycelium network",hierarchyLevel:6,children:[],index:"040001010002"},{text:" Mycelium network will then develop fruiting structures ",hierarchyLevel:6,children:[],index:"040001010003"},{text:" Fruiting structures will produce conidia",hierarchyLevel:6,children:[],index:"040001010004"}],index:"0400010100"},{text:" Yeast",hierarchyLevel:5,children:[{text:" Yeast exists in unicellular form that reproduce by budding",hierarchyLevel:6,children:[],index:"040001010100"},{text:" Some yeast can produce pseudohyphae / hyphae",hierarchyLevel:6,children:[],index:"040001010101"},{text:" Pseudohyphae / hyphae can then form a mycelium network",hierarchyLevel:6,children:[],index:"040001010102"},{text:" [does not result in fruiting structures]",hierarchyLevel:6,children:[],index:"040001010103"}],index:"0400010101"}],index:"04000101"},{text:" Properties of Fungi",hierarchyLevel:4,children:[],index:"04000102"},{text:" Location of Fungi",hierarchyLevel:4,children:[],index:"04000103"}],index:"040001"},{text:" Defences against Fungi",hierarchyLevel:3,children:[{text:" Immune system",hierarchyLevel:4,children:[{text:" Alveolar macrophages, tissue macrophages, neutrophils clearfungal spores when inhaled",hierarchyLevel:5,children:[],index:"0400020000"},{text:" Cilla clears fungal spores from respiratory tract",hierarchyLevel:5,children:[],index:"0400020001"}],index:"04000200"},{text:" Mucosal surfaces",hierarchyLevel:4,children:[{text:" Mucosal surfaces prevents colonizing yeast from entering the mody",hierarchyLevel:5,children:[],index:"0400020100"}],index:"04000201"},{text:" Epithelial surfaces",hierarchyLevel:4,children:[{text:" Prevents surface superficial infection from yeast",hierarchyLevel:5,children:[],index:"0400020200"}],index:"04000202"},{text:" Body Temperature",hierarchyLevel:4,children:[{text:" Most yeast and moulds do not grow above 30C",hierarchyLevel:5,children:[],index:"0400020300"}],index:"04000203"}],index:"040002"}],index:"0400"}]}]},fhmp:{text:"FHMP",hierarchyLevel:0,children:[{text:"Molecular Biology",hierarchyLevel:1,children:[{text:" [002] DNA Structure and Replication",hierarchyLevel:2,children:[{text:" Central Dogma of Molecular Biology",hierarchyLevel:3,children:[],index:"000000"},{text:" Three Domains of Life",hierarchyLevel:3,children:[],index:"000001"},{text:" Building Blocks of DNA",hierarchyLevel:3,children:[{text:" \u2261 C (3 hydrogen bonds)",hierarchyLevel:6,children:[],index:"00000200"},{text:" Purines - Pyrimidines",hierarchyLevel:6,children:[],index:"00000201"},{text:" Sugars",hierarchyLevel:4,children:[{text:" Deoxyribose (5 carbon sugar  O on 2  carbon)",hierarchyLevel:5,children:[],index:"0000020200"},{text:" Ribose (5 carbon sugar  OH on 2  carbon)",hierarchyLevel:5,children:[],index:"0000020201"}],index:"00000202"}],index:"000002"},{text:" Replication",hierarchyLevel:3,children:[],index:"000003"},{text:" E. Coli",hierarchyLevel:3,children:[],index:"000004"},{text:" DNA Sequencing",hierarchyLevel:3,children:[],index:"000005"},{text:" Polymerase Chain Reaction",hierarchyLevel:3,children:[],index:"000006"}],index:"0000"},{text:" [003] Control of Transcription",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[],index:"000100"},{text:" Gene Expression and Control InProkaryotes",hierarchyLevel:3,children:[],index:"000101"},{text:" Lactose Operon",hierarchyLevel:3,children:[],index:"000102"},{text:" Transcription And Its Control InEukaryotes",hierarchyLevel:3,children:[],index:"000103"},{text:" Transcription of A Protein-EncodingEukaryotic Gene To mRNA",hierarchyLevel:3,children:[],index:"000104"}],index:"0001"}]},{text:"Histology",hierarchyLevel:1,children:[{text:" General Differentiation Chart",hierarchyLevel:2,children:[{text:"",hierarchyLevel:3,children:[],index:"010000"}],index:"0100"},{text:" [017] Tissues and Organs: ProfKristjan Jessen",hierarchyLevel:2,children:[{text:" Key Components for Cellular Development",hierarchyLevel:3,children:[],index:"010100"},{text:" 5 Primary Tissues",hierarchyLevel:3,children:[],index:"010101"},{text:" Advantage of MulticellularOrganisms",hierarchyLevel:3,children:[],index:"010102"},{text:" Requirements to build amulticellular Organism",hierarchyLevel:3,children:[],index:"010103"},{text:" Strategies for cells cohesion",hierarchyLevel:3,children:[],index:"010104"},{text:" Tissue Maintenance",hierarchyLevel:3,children:[],index:"010105"}],index:"0101"},{text:" [018] Practical: Tissue and Organs",hierarchyLevel:2,children:[{text:" Trachea",hierarchyLevel:3,children:[],index:"010200"},{text:" Eosophagus",hierarchyLevel:3,children:[],index:"010201"},{text:" Cardiac Muscles",hierarchyLevel:3,children:[],index:"010202"}],index:"0102"},{text:" [019] Connective Tissue",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[],index:"010300"},{text:" Collagen",hierarchyLevel:3,children:[],index:"010301"},{text:" Elastin Fibres",hierarchyLevel:3,children:[],index:"010302"},{text:" Proteoglycans (aminoglycans)",hierarchyLevel:3,children:[],index:"010303"},{text:" Fats",hierarchyLevel:3,children:[],index:"010304"},{text:" Histological Stains",hierarchyLevel:3,children:[],index:"010305"}],index:"0103"},{text:" [020] Practical: Connective Tissue",hierarchyLevel:2,children:[],index:"0104"},{text:" [020] Epithelia",hierarchyLevel:2,children:[{text:" Diffusion barrier function",hierarchyLevel:3,children:[],index:"010500"},{text:" Secretion function",hierarchyLevel:3,children:[],index:"010501"},{text:" Absorption",hierarchyLevel:3,children:[],index:"010502"},{text:" Protective function",hierarchyLevel:3,children:[],index:"010503"},{text:" Random Skin Functions",hierarchyLevel:3,children:[],index:"010504"}],index:"0105"},{text:" [021] Practical: Epithelia",hierarchyLevel:2,children:[],index:"0106"}]},{text:"Embryology",hierarchyLevel:1,children:[{text:" [023] Introduction to Development",hierarchyLevel:2,children:[{text:" Beginnings of Embryology",hierarchyLevel:3,children:[],index:"020000"},{text:" Epigenesis",hierarchyLevel:3,children:[],index:"020001"},{text:" Mechanism of Cell Commitment",hierarchyLevel:3,children:[],index:"020002"},{text:" Cell Communication  EmbryonicInduction",hierarchyLevel:3,children:[],index:"020003"}],index:"0200"},{text:" [024] Fertilization and Cleavage Divisions",hierarchyLevel:2,children:[{text:" Oogenesis",hierarchyLevel:3,children:[],index:"020100"},{text:" Spermatogenesis",hierarchyLevel:3,children:[],index:"020101"},{text:"  Fertilisation",hierarchyLevel:3,children:[{text:" Process",hierarchyLevel:4,children:[{text:" Entry",hierarchyLevel:5,children:[{text:" As the sperm approaches the egg, it will increase its activitysignificantly",hierarchyLevel:6,children:[],index:"020102000000"},{text:" The sperm secretes enzymes to penetrate the follicle cells",hierarchyLevel:6,children:[],index:"020102000001"},{text:" The sperm interacts with the sperm receptor (Zp3), which causesthe acrosome to burst",hierarchyLevel:6,children:[],index:"020102000002"},{text:" Acrosome releases enzymes to digest the zona pellucida, allowingthe sperm to penetrate through",hierarchyLevel:6,children:[],index:"020102000003"},{text:" A receptor on the sperm then interacts with another spermreceptor on the plasma membrane of the egg cell, allowing for the sperm to fusewith the egg, and allows the nucleus to pass inside",hierarchyLevel:6,children:[],index:"020102000004"},{text:" Entry of the nucleus causes and increase in the intracellularcalcium levels which causes,",hierarchyLevel:6,children:[{text:" The egg nucleus to complete Meiosis II",hierarchyLevel:7,children:[],index:"02010200000500"},{text:" The cortical granules to fuse with the plasma membrane",hierarchyLevel:7,children:[],index:"02010200000501"}],index:"020102000005"},{text:" The enzymes released by the cortical granules digests the spermreceptors and forms cross-links on the zona pellucida, causing the egg cell tobecome impenetrable to more sperm cell, preventing polyspermy",hierarchyLevel:6,children:[],index:"020102000006"}],index:"0201020000"},{text:" Fusing",hierarchyLevel:5,children:[{text:" The female pro-nucleii lies near the plasma membrane. Once,Meiosis II completes, it ejects the polar body out of the plasma membrane",hierarchyLevel:6,children:[],index:"020102000100"},{text:" The female pro-nucleii then moves towards the male pro-nucleii",hierarchyLevel:6,children:[],index:"020102000101"},{text:" The nuclear membrane between them breaks down, causing themchromosomes to come together in one nuclear membrane",hierarchyLevel:6,children:[],index:"020102000102"},{text:" This forms the zygotic genome (embryonic genome)",hierarchyLevel:6,children:[],index:"020102000103"}],index:"0201020001"}],index:"02010200"},{text:" Property",hierarchyLevel:4,children:[{text:" Both male and female chromsomes are required for embryonicdevelopment in humans",hierarchyLevel:5,children:[],index:"0201020100"},{text:" Reason  Genomic Inprinting",hierarchyLevel:5,children:[{text:" There are about 80 genes in the human genome, which aremethylated during oogenesis or spermatogenesis. As a result, they cannot beactive during the early phases of embryonic development.",hierarchyLevel:6,children:[],index:"020102010100"},{text:" All 80 of these genes are required for the early phases ofembryonic development.",hierarchyLevel:6,children:[],index:"020102010101"},{text:" Only able to achieve all 80 active copies if both male and femalechromosomes are present.",hierarchyLevel:6,children:[],index:"020102010102"}],index:"0201020101"},{text:" Disease  Hydatidiform Moles",hierarchyLevel:5,children:[{text:" Prevalence  1/ 500",hierarchyLevel:6,children:[],index:"020102010200"},{text:" Symptoms",hierarchyLevel:6,children:[{text:" The trophoblast grows uncontrollably",hierarchyLevel:7,children:[],index:"02010201020100"}],index:"020102010201"},{text:" Types",hierarchyLevel:6,children:[{text:" Complete (2 male) - no embryo",hierarchyLevel:7,children:[],index:"02010201020200"},{text:" Partial (2 male, 1 female)  poorly formed chromosome",hierarchyLevel:7,children:[],index:"02010201020201"}],index:"020102010202"},{text:" Conclusion",hierarchyLevel:6,children:[{text:" For proper embryonic development, even number of male and femalechromosomes are required",hierarchyLevel:7,children:[],index:"02010201020300"}],index:"020102010203"}],index:"0201020102"}],index:"02010201"}],index:"020102"},{text:" Cleavage",hierarchyLevel:3,children:[],index:"020103"},{text:" Implantation",hierarchyLevel:3,children:[],index:"020104"}],index:"0201"},{text:" [025] Gastrulation",hierarchyLevel:2,children:[{text:" Germ Layers",hierarchyLevel:3,children:[],index:"020200"},{text:" Gastrulation",hierarchyLevel:3,children:[],index:"020201"},{text:" Neurulation",hierarchyLevel:3,children:[],index:"020202"}],index:"0202"}]},{text:"Blood",hierarchyLevel:1,children:[{text:" [030] Blood Groups",hierarchyLevel:2,children:[{text:" Blood Components",hierarchyLevel:3,children:[],index:"030000"},{text:" General Stuff",hierarchyLevel:3,children:[],index:"030001"},{text:" Abnormal Function: HaemolyticDisease of the Newborn (HDN)",hierarchyLevel:3,children:[],index:"030002"},{text:" Transfusion Reactions",hierarchyLevel:3,children:[],index:"030003"},{text:" Major Hemorrhage",hierarchyLevel:3,children:[],index:"030004"},{text:" Antiglobulin Tests",hierarchyLevel:3,children:[{text:" [031] Anaemia",hierarchyLevel:4,children:[],index:"03000500"}],index:"030005"},{text:" General Stuff",hierarchyLevel:3,children:[],index:"030006"},{text:" Life and Death of Red Blood Cell",hierarchyLevel:3,children:[],index:"030007"},{text:" Regulation of Red Blood CellNumbers (Erythropoiesis)",hierarchyLevel:3,children:[],index:"030008"},{text:" Anaemia General Stuff",hierarchyLevel:3,children:[],index:"030009"},{text:" Causes of Anaemia",hierarchyLevel:3,children:[],index:"030010"},{text:" Diagnosis of Anaemia",hierarchyLevel:3,children:[],index:"030011"},{text:" Integrated Clinical Diagnosis",hierarchyLevel:3,children:[],index:"030012"},{text:" Physiologic Classification ofAnaemia",hierarchyLevel:3,children:[],index:"030013"}],index:"0300"},{text:" [035] Coagulation",hierarchyLevel:2,children:[{text:" Normal Function",hierarchyLevel:3,children:[{text:" Haemostasis",hierarchyLevel:5,children:[],index:"03010000"}],index:"030100"}],index:"0301"}]},{text:"Anatomy",hierarchyLevel:1,children:[{text:" [036] Introduction to Anatomy",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Understand basic anatomical terminology and the need tocommunicate using a precise descriptive language of human structure.",hierarchyLevel:4,children:[],index:"04000000"},{text:" Understand how bones are classified and the general layout of thehuman skeleton.",hierarchyLevel:4,children:[],index:"04000001"},{text:" Describe the basic kinds of joints found between bones and theirrange of movement.",hierarchyLevel:4,children:[],index:"04000002"}],index:"040000"},{text:" General Stuff",hierarchyLevel:3,children:[],index:"040001"}],index:"0400"},{text:" [036] Introduction to Anatomy 2",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Understand the segmental organisation of the vertebrate body planwith regards to the spine and peripheral nervous system",hierarchyLevel:4,children:[],index:"04010000"},{text:" Describe the basic segmental arrangement of motor (efferent) andsensory (afferent) nerves",hierarchyLevel:4,children:[],index:"04010001"},{text:" Appreciate the ordered pattern of dermatomes and myotomes in thetrunk and limbs",hierarchyLevel:4,children:[],index:"04010002"},{text:" Recognise the basic components of a vertebra and understand howvertebrae differ from each other in number, shape and range of motion dependingon their regional identity",hierarchyLevel:4,children:[],index:"04010003"}],index:"040100"},{text:" Segmentation",hierarchyLevel:3,children:[{text:" Development of Spinal curves",hierarchyLevel:5,children:[{text:" Cervical lordosis",hierarchyLevel:6,children:[{text:" carrying the head upright",hierarchyLevel:7,children:[],index:"040101000000"},{text:" Develops around 6 months (when babies start carrying their headon their own, after muscles develop).",hierarchyLevel:7,children:[],index:"040101000001"},{text:" Thoracic kyphosis",hierarchyLevel:6,children:[{text:" already present at birth but gets more accentuated throughoutpostnatal development.",hierarchyLevel:7,children:[],index:"04010100000200"}],index:"040101000002"},{text:" Lumbar lordosis",hierarchyLevel:6,children:[{text:" upright walking",hierarchyLevel:7,children:[],index:"04010100000300"},{text:" Develop around 1 year old, once the baby starts to walk.",hierarchyLevel:7,children:[],index:"04010100000301"}],index:"040101000003"},{text:" Sacrum and coccyx kyphosis",hierarchyLevel:6,children:[{text:" upright walking.",hierarchyLevel:7,children:[],index:"04010100000400"}],index:"040101000004"}],index:"0401010000"}],index:"04010100"}],index:"040101"},{text:" Vertebra",hierarchyLevel:3,children:[{text:" Diagrams",hierarchyLevel:6,children:[],index:"04010200"},{text:"  ",hierarchyLevel:6,children:[{text:" Thoracic vertebrae (12)",hierarchyLevel:5,children:[{text:" Structure and Function",hierarchyLevel:6,children:[],index:"040102010000"}],index:"0401020100"},{text:" Lumbar vertebrae",hierarchyLevel:5,children:[{text:" Structure and Function ",hierarchyLevel:6,children:[],index:"040102010100"}],index:"0401020101"}],index:"04010201"},{text:" Vertebral Movement Table",hierarchyLevel:4,children:[],index:"04010202"},{text:" Changes in the facet joints (articular processes)",hierarchyLevel:4,children:[],index:"04010203"}],index:"040102"},{text:" Nervous System",hierarchyLevel:3,children:[],index:"040103"}],index:"0401"},{text:" [039] Anatomy Terminologies",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Use simple anatomical terminology with confidence",hierarchyLevel:4,children:[],index:"04020000"},{text:" Identify the bones of the skeleton",hierarchyLevel:4,children:[],index:"04020001"},{text:" Identify the different types of joints and describe their rangeof movement",hierarchyLevel:4,children:[],index:"04020002"},{text:" Identify different kinds of images of the thorax and vertebral column",hierarchyLevel:4,children:[],index:"04020003"},{text:" Identify a cervical, thoracic and lumbar vertebra and the sacrumand coccyx",hierarchyLevel:4,children:[],index:"04020004"},{text:" Relate key dermatomes and myotomes in the limbs and trunk to thebasic segmental pattern of the peripheral nervous system.",hierarchyLevel:4,children:[],index:"04020005"}],index:"040200"},{text:" Definitions",hierarchyLevel:3,children:[],index:"040201"}],index:"0402"},{text:" [041] Anatomy of the LymphaticSystem",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[{text:" Understand the layout and topography of the lymphatic system",hierarchyLevel:4,children:[],index:"04030000"},{text:" Recognise the components of the lymphatic system both withregards to location and anatomy",hierarchyLevel:4,children:[],index:"04030001"},{text:" Have a general understanding of the function of the lymphaticsystem",hierarchyLevel:4,children:[],index:"04030002"},{text:" Have an appreciation for the lymphatic system with regards toclinical issues",hierarchyLevel:4,children:[],index:"04030003"}],index:"040300"},{text:" General stuff",hierarchyLevel:3,children:[],index:"040301"},{text:" Lymphatic Vessels",hierarchyLevel:3,children:[],index:"040302"},{text:" Lymphatic Circulation",hierarchyLevel:3,children:[{text:" brachiocephalicveins",hierarchyLevel:6,children:[],index:"04030300"},{text:" Differential Draining",hierarchyLevel:4,children:[{text:" Right side of neck",hierarchyLevel:5,children:[{text:" Components",hierarchyLevel:6,children:[],index:"040303010000"}],index:"0403030100"}],index:"04030301"}],index:"040303"},{text:" Lymphatic Organs (Primary)",hierarchyLevel:3,children:[],index:"040304"},{text:" Lymph nodes (Secondary Organs)",hierarchyLevel:3,children:[],index:"040305"},{text:" Lymphoid Tissues",hierarchyLevel:3,children:[],index:"040306"}],index:"0403"},{text:" [043] Homeostasis",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[],index:"040400"}],index:"0404"}]},{text:"Medical Imaging",hierarchyLevel:1,children:[{text:" [045] Introduction to Medical Imaging",hierarchyLevel:2,children:[{text:" Learning Objectives",hierarchyLevel:3,children:[{text:" Understand the physics of basic radiography and be able tointerpret radiolucency and radiodensity on simple radiographs and on CT images.",hierarchyLevel:4,children:[],index:"05000000"},{text:" Recognise contrast images (e.g. bronchograms, angiograms andIVUs, for example).",hierarchyLevel:4,children:[],index:"05000001"},{text:" Understand the basis of MRI and be able to distinguish betweenand MRI and CT scan e.g. of the head or chest.",hierarchyLevel:4,children:[],index:"05000002"},{text:" Understand the basis of ultrasound and related imaging techniquesand recognise simple images of e.g. developing embryos IU, or even kidneystones etc etc.",hierarchyLevel:4,children:[],index:"05000003"},{text:" Understand the importance of knowing normal structure well andbeing able to interpret 2D images of 3D structures as a basis for recognizingabnormal structures.",hierarchyLevel:4,children:[],index:"05000004"}],index:"050000"},{text:" General Stuff",hierarchyLevel:3,children:[],index:"050001"},{text:" Imaging Types",hierarchyLevel:3,children:[],index:"050002"},{text:" Imaging Components",hierarchyLevel:3,children:[],index:"050003"}],index:"0500"}]},{text:"Pharmacology",hierarchyLevel:1,children:[{text:" [UMP1001] Introduction to Pharmacology",hierarchyLevel:2,children:[{text:" General Stuff",hierarchyLevel:3,children:[],index:"060000"},{text:" Overview",hierarchyLevel:3,children:[],index:"060001"},{text:" Drug Mechanism",hierarchyLevel:3,children:[{text:" Tyrosine kinase (",hierarchyLevel:6,children:[],index:"06000200"}],index:"060002"}],index:"0600"},{text:" [UMP1002] Drug receptors andmechanisms",hierarchyLevel:2,children:[{text:" Learning Outcomes",hierarchyLevel:3,children:[],index:"060100"},{text:" Properties of Drugs",hierarchyLevel:3,children:[],index:"060101"},{text:" Drug Targets",hierarchyLevel:3,children:[],index:"060102"}],index:"0601"},{text:" [UMP1003] Drug receptorinteractions",hierarchyLevel:2,children:[{text:" Learning Objectives",hierarchyLevel:3,children:[{text:" Nature of chemical bonds between drugs and receptors",hierarchyLevel:4,children:[],index:"06020000"},{text:" Relation between drug dose/concentration and effect: from singlemolecule to organ to organism",hierarchyLevel:4,children:[],index:"06020001"},{text:" Potency and EC50; efficacy: full and partial agonists",hierarchyLevel:4,children:[],index:"06020002"}],index:"060200"},{text:" General Stuff",hierarchyLevel:3,children:[],index:"060201"}],index:"0602"}]},{text:"Pathology",hierarchyLevel:1,children:[{text:" [049] Introduction to PathologicalSciences",hierarchyLevel:2,children:[{text:" Learning Objectives",hierarchyLevel:3,children:[],index:"070000"},{text:" General Stuff",hierarchyLevel:3,children:[],index:"070001"},{text:" Basic Pathological Concepts",hierarchyLevel:3,children:[],index:"070002"},{text:" Cellular Injury",hierarchyLevel:3,children:[],index:"070003"},{text:" Adaptive Responses of CellularInjury",hierarchyLevel:3,children:[],index:"070004"},{text:" Clinical Example",hierarchyLevel:3,children:[],index:"070005"}],index:"0700"}]}]}},F=r(18),B=r.n(F),G=function(){var e=Object(t.useState)(),i=Object(c.a)(e,2),r=i[0],n=i[1],h=Object(t.useState)(),a=Object(c.a)(h,2),l=a[0],d=(a[1],Object(x.h)());return Object(t.useEffect)((function(){var e=localStorage.getItem(d.documentId);!e&&d.documentId?(n(V[d.documentId]),localStorage.setItem(d.documentId,JSON.stringify(V[d.documentId]))):n(JSON.parse(e))}),[]),Object(p.jsx)("div",{className:B.a.wrapper,children:r&&P(r,l)})},z=r(11),j=r.n(z),q=function(){return Object(p.jsxs)("div",{className:j.a.wrapper,children:[Object(p.jsx)("h1",{className:j.a.header,children:"Graph Notes"}),Object(p.jsx)("p",{className:j.a.subheader,children:"by Yi Hein Builds"}),Object(p.jsxs)("div",{className:j.a.notes__wrapper,children:[Object(p.jsx)(M.b,{to:"/graph-notes/document/cnb",children:Object(p.jsx)(O,{children:"Circulation and Breathing"})}),Object(p.jsx)(M.b,{to:"/graph-notes/document/ind",children:Object(p.jsx)(O,{children:"Infection and Defence"})}),Object(p.jsx)(M.b,{to:"/graph-notes/document/fhmp",children:Object(p.jsx)(O,{children:"FHMP"})}),Object.keys(localStorage).filter((function(e){return"fhmp"!==e&&"ind"!==e&&"cnb"!==e})).map((function(e){var i=JSON.parse(localStorage.getItem(e)).text;return Object(p.jsxs)("div",{style:{position:"relative"},children:[Object(p.jsx)(M.b,{to:"/graph-notes/document/".concat(e),children:Object(p.jsx)(O,{children:i})}),Object(p.jsx)("div",{onClick:function(){return localStorage.removeItem(e)},style:{position:"absolute",right:"-3rem",bottom:"1.3rem",cursor:"pointer"},children:Object(p.jsx)(u.c,{style:{color:"#a1a1aa"}})})]})})),Object(p.jsx)(M.b,{to:"/graph-notes/document/new",children:Object(p.jsx)(O,{children:"Add your own notes"})})]})]})},_=function(){var e=Object(t.useState)(!1),i=Object(c.a)(e,2),r=i[0],n=i[1],h=Object(t.useState)(),a=Object(c.a)(h,2),d=a[0],o=a[1],s=Object(t.useState)(),x=Object(c.a)(s,2),y=x[0],v=x[1],u=Object(t.useState)(),m=Object(c.a)(u,2),L=m[0],f=m[1],g=Object(t.useState)(),b=Object(c.a)(g,2),w=b[0],C=b[1],T=Object(t.useState)(),M=Object(c.a)(T,2),R=M[0],E=M[1];Object(t.useEffect)((function(){var e=localStorage.getItem("storedNotes");e&&f(JSON.parse(e))}),[]),Object(t.useEffect)((function(){L&&R&&localStorage.setItem(R,JSON.stringify(L))}),[L]);var O=Object(t.useCallback)((function(e){return f(e)})),N=Object(t.useMemo)((function(){return L}),[L]);return Object(p.jsx)("div",{style:{display:"flex",flexFlow:"row",justifyContent:"center"},children:Object(p.jsxs)("div",{style:{maxWidth:"1000px",minWidth:"1000px"},children:[Object(p.jsx)(D,{submitHandler:o}),Object(p.jsx)("input",{placeholder:"File Name",value:w,onChange:function(e){return C(e.target.value)}}),Object(p.jsx)("input",{placeholder:"File ID",value:R,onChange:function(e){return E(e.target.value)}}),Object(p.jsx)("button",{onClick:function(){var e={h1:1,h2:2,h3:3,p:{"":4,"72pt":5,"108pt":6,"144pt":7,"180pt":8,"216pt":9,"254pt":10,"290pt":11}},i=document.querySelector("#uploadedDocument").querySelectorAll(".WordSection1 > *"),r=Object(l.a)(i).reduce((function(i,r,t,n){if("h1"===r.localName)return H(i[1],{text:r.textContent,hierarchyLevel:1,children:[]}),[1,i[1]];if(t>0&&n[t-1].localName){if("p"!=r.localName&&"h1"!=r.localName&&"h2"!=r.localName&&"h3"!=r.localName)return i;var h;if("p"===r.localName){if(0===A(r).trim().length)return i;h=e[r.localName][r.style.marginLeft]}else h=e[r.localName],console.log(r.localName,A(r));return i[0]===h?I(i[1],{text:A(r).replace(/[\x00-\x1F\x7F-\xFF]/g,"").replace("\ufffd","").replace("\ufffd","").replace("\ufffd","").replace("\ufffd","").replace("\ufffd",""),hierarchyLevel:h,children:[]}):i[0]>h?S(i[1],{text:A(r).replace(/[\x00-\x1F\x7F-\xFF]/g,"").replace("\ufffd","").replace("\ufffd","").replace("\ufffd","").replace("\ufffd","").replace("\ufffd",""),hierarchyLevel:h,children:[]},h):i[0]<h&&k(i[1],{text:A(r).replace(/[\x00-\x1F\x7F-\xFF]/g,"").replace("\ufffd","").replace("\ufffd","").replace("\ufffd","").replace("\ufffd","").replace("\ufffd",""),hierarchyLevel:h,children:[]}),[h,i[1]]}return i}),[-1,{text:w||"User Notes",hierarchyLevel:0,children:[]}]);O(r[1])},children:"Click to process"}),Object(p.jsx)("button",{onClick:function(){var e;e=N,localStorage.setItem("storedNotes",JSON.stringify(e))},children:"Store Data in LocalStorage"}),Object(p.jsx)("button",{onClick:function(){localStorage.clear()},children:"Clear LocalStorage"}),Object(p.jsx)("button",{onClick:function(){return n((function(e){return!e}))},children:"Toggle Mindmap Mode"}),d&&function(){var e=new FileReader;e.onload=function(e){v(e.target.result)},e.readAsText(d)}(),Object(p.jsx)("div",{children:d&&d.name}),L&&P(L,r),Object(p.jsx)("div",{id:"uploadedDocument",style:{display:"none"},dangerouslySetInnerHTML:{__html:y}})]})})},K=function(){return Object(p.jsx)(M.a,{children:Object(p.jsxs)(x.d,{children:[Object(p.jsx)(x.b,{path:"/graph-notes/",element:Object(p.jsx)(q,{})}),Object(p.jsxs)(x.b,{path:"/graph-notes/document/",element:Object(p.jsx)(N,{}),children:[Object(p.jsx)(x.b,{path:":documentId",element:Object(p.jsx)(G,{})}),Object(p.jsx)(x.b,{path:"new",element:Object(p.jsx)(_,{})})]})]})})};a.a.render(Object(p.jsx)(K,{}),document.getElementById("root"))},4:function(e,i,r){e.exports={container:"ListText_container__2oWhs",text__wrapper_mindmap:"ListText_text__wrapper_mindmap__1jwpV",text__wrapper_document:"ListText_text__wrapper_document__1_Sf9",text__card_mindmap:"ListText_text__card_mindmap__1nML6",text__card_document:"ListText_text__card_document__2lf4s",text_mindmap:"ListText_text_mindmap__2x8bl",text_document:"ListText_text_document__3pbA-",text_expandable:"ListText_text_expandable__1nZxg",text__hierarchy_0:"ListText_text__hierarchy_0__1xsE3",text__hierarchy_1:"ListText_text__hierarchy_1__3MBMS",text__hierarchy_2:"ListText_text__hierarchy_2__1zPTN",text__hierarchy_3:"ListText_text__hierarchy_3__46smZ",text__card__hierarchy_1:"ListText_text__card__hierarchy_1__2JHoq",text__card__hierarchy_2:"ListText_text__card__hierarchy_2__2CKBN",text__card__hierarchy_3:"ListText_text__card__hierarchy_3__Kmezw",document__toggle:"ListText_document__toggle__2iM0T",document__toggle_icon:"ListText_document__toggle_icon__88xxq",toggle__open:"ListText_toggle__open__1s8Cy",toggle__closed:"ListText_toggle__closed__2VGPT",icon__wrapper:"ListText_icon__wrapper__nUfWv",text__input:"ListText_text__input__3CmKb"}}},[[29,1,2]]]);
//# sourceMappingURL=main.f47e7c2f.chunk.js.map